defm14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
|
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
þ |
|
Definitive Proxy Statement |
|
o |
|
Definitive Additional Materials |
|
o |
|
Soliciting Material Pursuant to §240.14a-12 |
L-1 IDENTITY SOLUTIONS, INC.
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
o |
|
No fee required. |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange
Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it
was determined): |
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
(5) |
|
Total fee paid: |
þ |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing
by registration statement number, or the Form or Schedule and the
date of its filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
L-1 IDENTITY SOLUTIONS,
INC.
177 Broad Street
Stamford, Connecticut 06901
Dear Stockholder:
We cordially invite you to attend the special meeting of
stockholders of L-1 Identity Solutions, Inc. at the Hyatt
Regency-Greenwich hotel located at 1800 E Putnam Avenue, Old
Greenwich, CT, on February 3, 2011 at 2:00 p.m.
Eastern Time.
At the special meeting, you will be asked to consider and vote
upon a proposal to adopt the Agreement and Plan of Merger, dated
as of September 19, 2010 (as may be amended from time to
time), by and among L-1, Safran SA, a French société
anonyme, and Laser Acquisition Sub Inc., a Delaware corporation
and a wholly owned subsidiary of Safran, and to approve the
merger contemplated by the merger agreement. Pursuant to the
merger agreement, Laser Acquisition Sub will merge with and into
L-1, with L-1 surviving the merger and becoming a wholly owned
subsidiary of Safran. Further information about the merger and
the merger agreement is provided in the proxy statement
accompanying this letter.
If the merger is completed, you will be entitled to receive
$12.00 in cash, without interest and less any applicable
withholding taxes, for each share of L-1 common stock you own as
of the date of the merger (unless you have properly exercised
your appraisal rights with respect to the merger).
After careful consideration, our board of directors, by
unanimous vote, approved and declared advisable the execution,
delivery and performance of the merger agreement and the
transactions contemplated by the merger agreement, including the
merger, and determined that the merger agreement and the
transactions contemplated by the merger agreement, including the
merger, are advisable and in the best interests of L-1s
stockholders. Accordingly, our board of directors recommends
that you vote FOR the adoption of the merger
agreement and approval of the merger.
The proxy statement accompanying this letter provides you with
detailed information about the proposed merger and the special
meeting of stockholders to vote on the adoption of the merger
agreement and approval of the merger. We encourage you to read
the entire proxy statement and the merger agreement carefully. A
copy of the merger agreement is attached as Annex A to the
accompanying proxy statement. You may also obtain more
information about L-1 from documents we have filed with the
Securities and Exchange Commission.
Your vote is very important, regardless of the number of
shares of stock that you own. The merger cannot be completed
unless the merger agreement is adopted and the merger is
approved by the affirmative vote (in person or by proxy) of
holders of at least a majority of the outstanding shares of our
common stock entitled to vote at the special meeting. If you
fail to vote on the proposal to adopt the merger agreement and
approve the merger, the effect will be the same as a vote
AGAINST the adoption of the merger agreement and
approval of the merger.
IT IS IMPORTANT THAT YOUR SHARES BE REPRESENTED, EVEN IF
YOU DO NOT PLAN ON ATTENDING THE SPECIAL MEETING IN PERSON.
ACCORDINGLY, WE URGE YOU TO VOTE BY COMPLETING, SIGNING, DATING
AND PROMPTLY RETURNING THE ENCLOSED PROXY CARD IN THE ENVELOPE
PROVIDED, OR YOU MAY VOTE THROUGH THE INTERNET OR BY TELEPHONE
AS DIRECTED ON THE ENCLOSED PROXY CARD. IF YOU RECEIVE MORE THAN
ONE PROXY CARD BECAUSE YOU OWN SHARES THAT ARE REGISTERED
DIFFERENTLY, PLEASE VOTE ALL OF YOUR SHARES SHOWN ON ALL OF
YOUR PROXY CARDS.
On behalf of your board of directors, thank you for your
continued support.
Sincerely,
Robert V. LaPenta
Chairman of the Board, President and
Chief Executive Officer
L-1 IDENTITY SOLUTIONS,
INC.
177 Broad Street
Stamford, Connecticut 06901
NOTICE OF SPECIAL MEETING OF
STOCKHOLDERS
TO BE HELD ON FEBRUARY 3,
2011
To Stockholders of L-1 Identity
Solutions, Inc.:
Notice is hereby given that a special meeting of stockholders of
L-1 Identity Solutions, Inc., a Delaware corporation, will be
held at the Hyatt Regency-Greenwich hotel located at 1800 E
Putnam Avenue, Old Greenwich, CT, on February 3, 2011 at
2:00 p.m. Eastern Time, for the following purposes:
1. to consider and vote upon a proposal to adopt the
Agreement and Plan of Merger, dated as of September 19,
2010 (as may be amended from time to time), by and among L-1,
Safran SA, a French société anonyme, and Laser
Acquisition Sub Inc., a Delaware corporation and a wholly owned
subsidiary of Safran, and to approve the merger contemplated by
the merger agreement. A copy of the merger agreement is attached
as Annex A to the accompanying proxy statement; and
2. to consider and vote upon a proposal to adjourn or
postpone the special meeting, if necessary or appropriate, to
solicit additional proxies if there are insufficient votes at
the time of the special meeting to adopt the merger agreement
and approve the merger.
Only stockholders of record of our common stock at the close of
business on December 27, 2010, the record date for the
special meeting, are entitled to notice of and to vote at the
special meeting and at any adjournment or postponement of the
special meeting. A list of stockholders entitled to vote at the
special meeting will be available for inspection by stockholders
of record during business hours at L-1s executive offices
at 177 Broad Street, Stamford, CT 06901 for ten days prior to
the date of the special meeting and will also be available at
the special meeting.
Your vote is very important, regardless of the number of shares
of stock that you own. The adoption of the merger agreement and
approval of the merger requires the affirmative vote (in person
or by proxy) of holders of at least a majority of the
outstanding shares of our common stock entitled to vote at the
special meeting. The proposal to adjourn or postpone the
meeting, if necessary or appropriate, to solicit additional
proxies requires the affirmative vote of the holders of a
majority of the voting power present and entitled to vote at the
special meeting, whether or not a quorum is present.
Whether or not you plan to attend the special meeting, we urge
you to vote your shares by completing, signing, dating and
returning the accompanying proxy card as promptly as possible in
the postage-paid envelope or to submit your proxy by telephone
or the Internet prior to the special meeting to ensure that your
shares will be represented at the special meeting. If you sign
and return your proxy card without indicating how you wish to
vote, your proxy will be voted FOR the adoption of
the merger agreement and approval of the merger and
FOR the proposal to adjourn or postpone the special
meeting, if necessary or appropriate, to solicit additional
proxies if there are insufficient votes to adopt the merger
agreement and approve the merger at the time of the special
meeting. If you fail to return your proxy card or fail to submit
your proxy by telephone or the Internet and do not vote in
person at the special meeting, it will have the same effect as a
vote AGAINST the adoption of the merger agreement
and approval of the merger, but will not affect the outcome of
the vote regarding any adjournment or postponement proposal. Any
stockholder attending the special meeting may vote in person
even if he or she has already voted by proxy card, telephone or
Internet; such vote by ballot will revoke any proxy previously
submitted. If you hold your shares through a bank, broker or
other custodian, you must provide a legal proxy issued from such
bank, broker or other custodian in order to vote your shares in
person at the special meeting.
The Companys stockholders who do not vote in favor of the
adoption of the merger agreement and approval of the merger will
have the right to seek appraisal of the fair value of their
shares of the Companys common stock if the merger
contemplated by the merger agreement is completed, but only if
they submit a written demand for appraisal of their shares
before the taking of the vote on the merger agreement at the
special meeting and they comply with all requirements of
Delaware law, which are summarized in greater detail in the
accompanying proxy statement.
After careful consideration, our board of directors, by
unanimous vote, has approved and declared advisable the
execution, delivery and performance of the merger agreement and
the transactions contemplated by the merger agreement, including
the merger, and has determined that the merger agreement and the
transactions contemplated by the merger agreement, including the
merger, are advisable and in the best interests of the
Companys stockholders.
OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE
FOR THE ADOPTION OF THE MERGER AGREEMENT AND
APPROVAL OF THE MERGER AND FOR THE PROPOSAL TO
ADJOURN OR POSTPONE THE SPECIAL MEETING, IF NECESSARY OR
APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE
INSUFFICIENT VOTES AT THE TIME OF THE SPECIAL MEETING TO ADOPT
THE MERGER AGREEMENT AND APPROVE THE MERGER.
The accompanying proxy statement is first being mailed to
stockholders of the Company on or about January 3, 2011.
By Order of the Board of Directors,
Mark S. Molina
Executive Vice President, Chief
Legal Officer and
Secretary
January 3, 2011
PLEASE DO NOT SEND YOUR STOCK CERTIFICATES AT THIS TIME. IF
THE MERGER IS COMPLETED, YOU WILL BE SENT
INSTRUCTIONS REGARDING THE SURRENDER OF YOUR STOCK
CERTIFICATES.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
12
|
|
|
|
|
18
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
22
|
|
|
|
|
23
|
|
|
|
|
23
|
|
|
|
|
24
|
|
|
|
|
24
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
37
|
|
|
|
|
40
|
|
|
|
|
49
|
|
|
|
|
56
|
|
|
|
|
58
|
|
|
|
|
58
|
|
|
|
|
59
|
|
|
|
|
60
|
|
|
|
|
61
|
|
|
|
|
67
|
|
|
|
|
69
|
|
|
|
|
69
|
|
|
|
|
72
|
|
|
|
|
73
|
|
|
|
|
73
|
|
|
|
|
74
|
|
|
|
|
74
|
|
|
|
|
74
|
|
|
|
|
75
|
|
|
|
|
75
|
|
|
|
|
75
|
|
|
|
|
77
|
|
|
|
|
78
|
|
|
|
|
80
|
|
|
|
|
81
|
|
|
|
|
82
|
|
|
|
|
82
|
|
i
|
|
|
|
|
|
|
Page
|
|
|
|
|
84
|
|
|
|
|
85
|
|
|
|
|
85
|
|
|
|
|
86
|
|
|
|
|
87
|
|
|
|
|
87
|
|
|
|
|
89
|
|
|
|
|
90
|
|
|
|
|
91
|
|
|
|
|
92
|
|
|
|
|
92
|
|
|
|
|
92
|
|
|
|
|
93
|
|
|
|
|
95
|
|
|
|
|
98
|
|
|
|
|
99
|
|
|
|
|
99
|
|
|
|
|
99
|
|
|
|
|
99
|
|
|
|
|
100
|
|
ANNEXES
|
|
|
|
|
|
|
|
A-i
|
|
|
|
|
B-i
|
|
|
|
|
C-1
|
|
|
|
|
D-1
|
|
|
|
|
E-1
|
|
ii
PROXY
STATEMENT
SUMMARY
The following summary highlights selected information in this
proxy statement and may not contain all the information that may
be important to you. Accordingly, we encourage you to read
carefully this entire proxy statement, its annexes and the
documents referred to or incorporated by reference in this proxy
statement. Each item in this summary includes a page reference
directing you to a more complete description of that topic. See
the section of this proxy statement entitled Where
You Can Find More Information beginning on page 99.
Unless otherwise indicated or unless the context requires
otherwise, all references in this proxy statement to the
Company, L-1, we,
our and us refer to L-1 Identity
Solutions, Inc. and its subsidiaries; all references to the
Merger Agreement refer to the Agreement and Plan of
Merger, dated as of September 19, 2010, by and among the
Company, Safran and Merger Sub, as may be amended from time to
time, a copy of which is attached as Annex A to this proxy
statement; all references to the Merger refer to the
merger contemplated by the Merger Agreement; and all references
to the SEC refer to the Securities and Exchange
Commission.
Overview
of the Merger and the BAE Transaction (pages 73 and
69)
On September 19, 2010, we entered into the Agreement and
Plan of Merger by and among the Company, Safran SA (which we
refer to in this proxy statement as Safran) and Laser
Acquisition Sub Inc., a wholly owned subsidiary of Safran (which
we refer to in this proxy statement as Merger Sub). Upon the
terms and subject to the conditions of the Merger Agreement,
Merger Sub will merge with and into L-1, and L-1 will continue
as the surviving corporation and a wholly owned subsidiary of
Safran. Upon consummation of the Merger, holders of our common
stock will be entitled to receive the per share merger
consideration of $12.00 in cash, without interest and less
applicable withholding taxes, for each share of common stock
issued and outstanding immediately prior to the effective time
of the Merger. The Merger Agreement, which is the principal
document governing the Merger, is attached as Annex A to
this proxy statement, and we encourage you to read the Merger
Agreement in its entirety.
In connection with the proposed merger with Safran, on
September 19, 2010, we entered into the Purchase Agreement
(which we refer to in this proxy statement as the BAE Agreement)
by and between L-1 and BAE Systems Information Solutions, Inc.
(which we refer to in this proxy statement as BAE), a Virginia
corporation and subsidiary of BAE Systems, Inc. (the
U.S. affiliate of BAE Systems plc). Upon the terms and
subject to the conditions of the BAE Agreement, BAE will acquire
L-1s intelligence services business group (in this proxy
statement we refer to the sale of the Companys
intelligence services business pursuant to the terms and subject
to the conditions of the BAE Agreement as the BAE Transaction).
The closing of the Merger is conditioned on the prior
consummation of the BAE Transaction; however, completion of the
BAE Transaction is not conditioned on the consummation of the
Merger and the BAE Transaction may be completed even if the
Merger is not consummated or the Merger Agreement is terminated.
The BAE Agreement, which is the principal document governing the
BAE Transaction, is attached as Annex B to this proxy
statement and we encourage you to read the BAE Agreement in its
entirety.
The
Parties to the Merger (page 20)
L-1
Identity Solutions, Inc.
L-1 Identity Solutions, Inc. protects and secures personal
identities and assets. Its identity solutions business group is
comprised of the Biometric / Enterprise Access, Secure
Credentialing and Enrollment Services divisions. Its
intelligence services business group is comprised of McClendon,
LLC, SpecTal, LLC and Advanced Concepts, Inc. L-1 has more than
2,200 employees worldwide and is headquartered in Stamford,
Connecticut. Our common stock is listed on the New York Stock
Exchange under the symbol ID.
Safran
SA
Safran SA is a France-based, international high-technology group
with three core businesses: Aerospace (propulsion and
equipment), Defense and Security. Operating worldwide, Safran
has 55,000 employees. Safran is listed on the NYSE Euronext
Paris under the symbol SAF.
1
Laser
Acquisition Sub Inc.
Laser Acquisition Sub Inc. is a Delaware corporation and a
wholly owned subsidiary of Safran. It was formed solely for the
purpose of effecting the Merger and the transactions
contemplated by the Merger Agreement and has not engaged in any
business except in furtherance of this purpose and activities
incident to its formation.
The
Merger and the Closing (page 73)
The Agreement and Plan of Merger, dated as of September 19,
2010, by and among L-1, Safran and Merger Sub, provides that, if
the Merger Agreement is adopted and the Merger is approved by
our stockholders and the other conditions to closing are
satisfied or waived, Merger Sub will merge with and into L-1,
and L-1 will continue as the surviving corporation and a wholly
owned subsidiary of Safran. Upon completion of the Merger, each
share of L-1 common stock issued and outstanding immediately
prior to the effective time of the Merger (other than shares
held by (i) L-1 as treasury stock, (ii) Safran, Merger
Sub, or L-1s subsidiaries and (iii) stockholders, if
any, who properly exercise their appraisal rights under Delaware
law) will be converted into the right to receive $12.00 in cash,
without interest and less any applicable withholding taxes. As a
result of the Merger, the Company will cease to be an
independent, publicly-traded company, and you will not own any
shares of the surviving corporation.
The
Special Meeting (page 21)
Date,
Time and Place (page 21)
The special meeting of our stockholders will be held at the
Hyatt Regency-Greenwich hotel located at 1800 E Putnam Avenue,
Old Greenwich, CT, on February 3, 2011 at 2:00 p.m.
Eastern Time.
Purpose
of the Special Meeting (page 21)
At the special meeting, you will be asked to consider and vote
upon a proposal to (1) adopt the Merger Agreement and
approve the Merger, pursuant to which Merger Sub will merge with
and into L-1, with L-1 continuing as the surviving corporation
and a wholly owned subsidiary of Safran; and (2) approve
the adjournment or postponement of the special meeting, if
necessary or appropriate, to solicit additional proxies if there
are insufficient votes at the time of the special meeting to
adopt the Merger Agreement and approve the Merger.
Record
Date and Quorum (page 21)
You are entitled to vote at the special meeting if you owned
shares of our common stock at the close of business on
December 27, 2010, the record date for the special meeting.
You will have one vote for each share of our common stock that
you owned on the record date. As of December 27, 2010,
there were 93,623,464 shares of our common stock
outstanding and entitled to vote at the special meeting.
The presence at the special meeting in person or by proxy of the
holders of a majority of the issued and outstanding shares of
our capital stock entitled to vote at the special meeting as of
the close of business on the record date will constitute a
quorum for purposes of considering the proposals at the special
meeting.
Vote
Required for Approval (page 21)
The adoption of the Merger Agreement and approval of the Merger
requires the affirmative vote of the holders of a majority of
the outstanding shares of our common stock entitled to vote. A
failure to vote your shares of common stock, an abstention or a
broker non-vote will have the same effect as voting
AGAINST the adoption of the Merger Agreement and
approval of the Merger at the special meeting. A broker non-vote
occurs on an item when a broker is not permitted to vote on that
item without instructions from the beneficial owner of the
shares and no instructions are given.
Approval of the proposal to adjourn or postpone the special
meeting, if necessary or appropriate, to solicit additional
proxies requires the affirmative vote of a majority of the
shares of our common stock present in person or represented by
proxy at the special meeting and entitled to vote on the matter,
whether or not a quorum is present. A failure to attend the
special meeting and vote your shares of common stock or failure
to submit a proxy or a broker
2
non-vote will have no effect on the outcome of any vote to
adjourn or postpone the special meeting. An abstention will have
the same effect as voting AGAINST any proposal to
adjourn or postpone the special meeting.
Contemporaneously with the execution of the Merger Agreement, on
September 19, 2010, Robert V. LaPenta, Chairman, President
and Chief Executive Officer of the Company, and Aston Capital
Partners L.P. (which we refer to in this proxy statement as
Aston), a private investment fund that is indirectly controlled
by Mr. LaPenta and other executive officers of the Company,
entered into a voting and support agreement with Safran and
Merger Sub. Pursuant to the voting and support agreement,
Mr. LaPenta and Aston agreed, among other things, to vote
their shares of our common stock in favor of the adoption of the
Merger Agreement and approval of the Merger, unless our board of
directors changes its recommendation of the Merger to
stockholders (in which case, Mr. LaPenta and Aston may vote
for or against the Merger). As of December 27, 2010, the
record date for the special meeting, Mr. LaPenta and Aston
together beneficially owned approximately 14.59% of our
outstanding common stock. See the section of this proxy
statement entitled The Merger Interests of
Certain Persons in the Merger Relationships with
Aston and Stone Key for a discussion regarding certain
other relationships with Aston.
Voting
and Proxies (page 22)
Any stockholder of record entitled to vote at the special
meeting may submit a proxy by (i) returning the enclosed
proxy card by mail, (ii) using the telephone number printed
on your proxy card, (iii) using the Internet voting
instructions printed on your proxy card or (iv) appearing
at the special meeting and voting in person. If no instructions
are indicated on your signed proxy card, your shares will be
voted FOR the adoption of the Merger
Agreement and the approval of the Merger and FOR
adjournment or postponement of the meeting, if necessary or
appropriate, to solicit additional proxies.
If your shares of common stock are held in street
name by your broker, bank or other nominee, you should
instruct your broker, bank or other nominee on how to vote your
shares of common stock using the instructions provided by your
broker, bank or other nominee. If your shares of common stock
are held in street name and you do not provide your
broker, bank or other nominee with instructions, your shares of
common stock will not be voted and that will have the same
effect as voting AGAINST the adoption of the
Merger Agreement but will have no effect on the outcome of any
vote to adjourn or postpone the special meeting.
Revocability
of Proxy (page 22)
If you hold your shares in your name as a stockholder of record,
you have the right to change or revoke your proxy at any time
before the vote taken at the special meeting by:
|
|
|
|
|
delivering to our Corporate Secretary, at 177 Broad Street,
Stamford, Connecticut 06901, a signed written notice of
revocation, bearing a date later than the date of the proxy,
stating that the proxy is revoked;
|
|
|
|
attending the special meeting and voting in person (your
attendance at the meeting will not, by itself, change or revoke
your proxy you must vote in person at the meeting to
revoke a prior proxy);
|
|
|
|
completing, executing and delivering a later dated proxy
card; or
|
|
|
|
voting again at a later time by telephone or the Internet prior
to the time at which the telephone and Internet voting
facilities close by following the procedures applicable to those
methods of voting.
|
If you hold your shares through a broker, bank or other nominee,
you have the right to change or revoke your proxy at any time
before the vote taken at the special meeting by following the
directions received from your broker, bank or other nominee to
change or revoke those instructions.
Ownership
of Common Stock by Directors and Executive Officers (page
95)
As of December 27, 2010, the record date for the special
meeting, our directors and executive officers beneficially
owned, and had the right to vote, in the aggregate,
16,028,257 shares of our common stock (which excludes
shares that may be acquired by such persons pursuant to stock
option grants but includes shares held by Aston that are deemed
to be held beneficially by certain directors and executive
officers), which represented approximately 17.12% of the
outstanding shares of our common stock as of such date. Our
current directors and
3
executive officers have informed us that they intend to vote all
their shares of common stock FOR the adoption
of the Merger Agreement and approval of the Merger and
FOR the adjournment or postponement of the
special meeting, if necessary or appropriate, to solicit
additional proxies.
Treatment
of Stock Options, Other Equity-Based Awards and Long-Term Cash
Awards (page 75)
Immediately prior to the consummation of the Merger, all
outstanding and unvested stock options, restricted stock awards
and long-term cash awards will become vested, and upon
consummation of the Merger (i) each outstanding stock
option will be cancelled in exchange for the right to receive a
cash payment equal to the excess, if any, of the $12.00 per
share merger consideration over the exercise price of the
option, less any applicable withholding taxes, (ii) each
outstanding restricted stock award shall be treated in the same
manner as all other shares of our common stock in the Merger,
(iii) each outstanding deferred stock unit will be
cancelled and the holder will be entitled to receive a cash
payment equal to the $12.00 per share merger consideration, less
any applicable withholding taxes, and (iv) payment will be
made with respect to each long-term cash award no later than 10
business days following the consummation of the Merger.
Reasons
for the Merger; Recommendation of Our Board of Directors
(page 37)
After careful consideration, our board of directors, by
unanimous vote and upon the recommendation of a special
committee of our board of directors established in connection
with the Companys review of strategic alternatives,
approved and declared advisable the execution, delivery and
performance of the Merger Agreement and the transactions
contemplated by the Merger Agreement, including the Merger, and
determined that the Merger Agreement and the transactions
contemplated by the Merger Agreement, including the Merger, are
advisable and in the best interests of the Companys
stockholders. Our board of directors recommends that you vote
FOR the proposal to adopt the Merger Agreement and
approve the Merger and FOR the proposal to adjourn
or postpone the special meeting, if necessary or appropriate, to
solicit additional proxies. For a discussion of the material
factors considered by our board of directors in reaching its
conclusions, see the section of this proxy statement entitled
The Merger Reasons for the Merger;
Recommendation of Our Board of Directors.
Interests
of Certain Persons in the Merger (page 61)
In considering the recommendation of our board of directors with
respect to the Merger, you should be aware that certain
individuals, including our directors and executive officers, may
have interests in the Merger that may be different from, or in
addition to, the interests of our stockholders generally. These
interests include the accelerated vesting and payment of stock
options and other equity-based awards and the accelerated
vesting and payment of long-term cash awards held by one
executive officer and approximately forty-eight non-executive
employees of the Company. In addition, severance benefits will
become payable to certain of our executive officers and cash
transaction bonuses, which were awarded to one executive officer
and approximately thirty non-executive employees of the Company,
will become payable. Our board of directors was aware of these
differing interests and considered them, among other matters, in
reaching its decision to approve the Merger Agreement and the
Merger and to recommend that you vote in favor of adopting the
Merger Agreement and approving the Merger.
Opinion
of Goldman, Sachs & Co. (page 40)
Goldman, Sachs & Co. (which we refer to in this proxy
statement as Goldman Sachs) delivered its opinion to the
Companys board of directors that, as of September 19,
2010 and based upon and subject to the limitations and
assumptions set forth therein, the $12.00 per share in cash to
be paid to the holders (other than Safran and its affiliates) of
the outstanding shares of common stock of the Company pursuant
to the Merger Agreement was fair from a financial point of view
to such holders.
The full text of the written opinion of Goldman Sachs, dated
as of September 19, 2010, which sets forth assumptions
made, procedures followed, matters considered and limitations on
the review undertaken in connection with the opinion, is
attached as Annex C to this proxy statement. Goldman Sachs
provided its opinion for the information and assistance of the
Companys board of directors in connection with its
consideration of the Merger. The Goldman Sachs opinion is not a
recommendation as to how any holder of
4
the Companys common stock should vote with respect to
the Merger or any other matter. Pursuant to the engagement
letter between Goldman Sachs and the Company, the Company has
agreed to pay Goldman Sachs a fee totaling approximately
$11 million, of which approximately $9.4 million will
be paid upon the consummation of the Merger. In addition, the
Company has agreed to reimburse Goldman Sachs for certain
expenses and to indemnify Goldman Sachs against certain
liabilities arising out of Goldman Sachs engagement.
For a more complete description, see the section of this proxy
statement entitled The Merger Opinion of
Goldman, Sachs & Co. beginning on
page 40. See also Annex C to this proxy statement.
Opinion
of Stone Key Partners LLC (page 49)
At the September 18, 2010 meeting of the Companys
board of directors, Stone Key Partners LLC and the Stone Key
securities division of Hudson Partners Securities LLC (which,
together, we refer to in this proxy statement as Stone Key)
delivered its oral opinion, which was subsequently confirmed in
writing, that, as of September 18, 2010, and based upon and
subject to the assumptions, qualifications and limitations set
forth in the written opinion, the $12.00 per share merger
consideration was fair, from a financial point of view, to the
stockholders of the Company.
The full text of Stone Keys written opinion is attached
as Annex D to this proxy statement and you should read the
opinion carefully and in its entirety. The opinion sets forth
the assumptions made, some of the matters considered and
qualifications to and limitations of the review undertaken by
Stone Key. The Stone Key opinion, which was authorized for
issuance by the Fairness Opinion and Valuation Committee of
Stone Key, is subject to the assumptions and conditions
contained in the opinion and is necessarily based on economic,
market and other conditions and the information made available
to Stone Key as of the date of the Stone Key opinion.
Pursuant to an engagement letter between Stone Key and the
Company, the Company has agreed to pay Stone Key a fee totaling
approximately $8 million, of which approximately
$1.2 million was payable in connection with delivery of its
opinion and the remaining portion of which will be paid upon the
consummation of the transactions. In addition, the Company has
agreed to reimburse Stone Key for certain expenses and to
indemnify Stone Key against certain liabilities arising out of
Stone Keys engagement.
Financing
of the Merger (page 58)
The obligations of Safran and Merger Sub under the Merger
Agreement are not subject to a condition regarding Safrans
or Merger Subs obtaining of funds to consummate the Merger
and the other transactions contemplated by the Merger Agreement.
Safran and Merger Sub have represented in the Merger Agreement
that Safran has, and as of the closing of the Merger, Safran
will have, sufficient funds available (through existing credit
arrangements or otherwise) to fully fund all of its and Merger
Subs obligations under the Merger Agreement, including
payment of the aggregate merger consideration and other cash
consideration in respect of equity awards pursuant to the Merger
Agreement, and payment of all fees and expenses related to the
transactions contemplated by the Merger Agreement and any
refinancing of indebtedness of Safran or the Company or their
respective subsidiaries in connection with the transactions
contemplated by the Merger Agreement.
Governmental
and Regulatory Approvals (page 67)
Antitrust Clearance. Under the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (which we refer
to in this proxy statement as the HSR Act) and the rules
promulgated thereunder by the Federal Trade Commission (which we
refer to in this proxy statement as the FTC), the Merger may not
be completed until notification and report forms have been filed
with the FTC and the Antitrust Division of the Department of
Justice (which we refer to in this proxy statement as the DOJ)
and the applicable waiting period has expired or been
terminated. L-1 and Safran filed the notification and report
forms under the HSR Act with the FTC and the DOJ on
December 13, 2010.
CFIUS. The Merger is also subject to review
and clearance by the Committee on Foreign Investment in the
United States (which we refer to in this proxy statement as
CFIUS) under the Defense Production Act of 1950, as amended by
Section 5021 of the Omnibus Trade and Competitiveness Act
of 1988 and subsequent amendments (which we refer to in this
proxy statement as Exon-Florio), which provides for national
security reviews of foreign
5
acquisitions of U.S. companies that may have an impact on
national security. CFIUS notification is voluntary, but provides
a means to assure that the President of the United States will
not exercise his authority to block the transaction or require
divestiture after closing. On November 24, 2010, the
Company and Safran submitted a joint voluntary notice to CFIUS.
The initial
30-day CFIUS
review period was completed on December 28, 2010. On
December 28, 2010, the parties received a letter advising
that CFIUS would proceed with a
45-day
investigation of the Merger, which was expected given the nature
of the Companys business and the French governments
ownership stake in Safran. Following the
45-day
investigation, a report may be sent to the President of the
United States, who then has 15 days to decide whether to
block the transaction or to take other action. Also, the CFIUS
review period may be extended by mutual consent of the parties
and CFIUS. During the course of the CFIUS review, Safran and the
Company will also work with the Defense Security Service to
develop an appropriate structure to mitigate any foreign
ownership, control or influence over the operations of the
Company in order to comply with the National Industrial Security
Program Operating Manual. The U.S. government recognizes
that foreign investment can play an important role in
maintaining the viability of the U.S. industrial base.
Therefore, it is the stated policy of the U.S. government
to allow foreign investment consistent with national security
interests.
We cannot assure you that an antitrust, CFIUS or other
regulatory challenge to the Merger will not be made.
Voting
and Support Agreement (page 60)
Contemporaneously with the execution of the Merger Agreement, on
September 19, 2010, Mr. LaPenta and Aston entered into
a voting and support agreement with Safran and Merger Sub.
Pursuant to the voting and support agreement, Mr. LaPenta
and Aston agreed, among other things, to vote their shares of
our common stock in favor of the adoption of the Merger
Agreement and approval of the Merger, unless our board of
directors changes its recommendation of the Merger to
stockholders (in which case, Mr. LaPenta and Aston may vote
for or against the Merger). As of December 27, 2010, the
record date for the special meeting, Mr. LaPenta and Aston
together beneficially owned approximately 14.59% of our
outstanding common stock. See the section of this proxy
statement entitled The Merger Interests of
Certain Persons in the Merger Relationships with
Aston and Stone Key for a discussion regarding certain
other relationships with Aston.
Material
U.S. Federal Income Tax Consequences (page 59)
The receipt of cash in exchange for shares of our common stock
pursuant to the Merger will be a taxable transaction for
U.S. federal income tax purposes. In general,
U.S. holders who exchange their shares of our common stock
in the Merger will recognize gain or loss in an amount equal to
the difference, if any, between the cash received in the Merger
and their adjusted tax basis in such shares. Such gain or loss
will be capital gain or loss if such shares are held as a
capital asset in the hands of the U.S. holders and will be
long-term capital gain or loss if such shares have a holding
period of more than one year at the time the Merger is
consummated. See the section of this proxy statement entitled
The Merger Material U.S. Federal
Income Tax Consequences. You should consult your
independent tax advisor as to the particular tax consequences of
the Merger to you, including the tax consequences under state,
local, foreign or estate and gift tax laws.
Restrictions
on Solicitations of Other Offers and Change of Recommendation
(pages 80 and 81)
The Merger Agreement provides that, prior to the consummation of
the Merger, neither the Company nor any of its subsidiaries
will, and each will use best efforts to cause its and their
respective officers, directors, employees and representatives
not to:
|
|
|
|
|
initiate, solicit, knowingly encourage, knowingly induce or
knowingly take any other action designed to, or which would
reasonably be expected to lead to, the making of any Acquisition
Proposal (as defined in the Merger Agreement and described in
the section of this proxy statement entitled The Merger
Agreement Restrictions on Solicitations of Other
Offers); or
|
6
|
|
|
|
|
participate or engage in any negotiations or discussions with,
or furnish any material nonpublic information to, any person or
take action to knowingly facilitate any inquiries relating to,
or making of any proposal that constitutes, or would reasonably
be expected to lead to, any Acquisition Proposal.
|
Notwithstanding these restrictions, the Merger Agreement
provides that if, at any time prior to adoption of the Merger
Agreement and approval of the Merger by our stockholders, the
Company receives an unsolicited, bona fide written Acquisition
Proposal made after the date of the Merger Agreement in
circumstances not involving a breach of the Merger Agreement by
the Company, the Company and our board of directors may engage
in negotiations or substantive discussions with, and furnish any
information and other access to, any person making such
Acquisition Proposal and such persons representatives or
potential sources of financing if our board of directors
determines in good faith, after consultation with the
Companys outside legal and financial advisors, that:
|
|
|
|
|
such Acquisition Proposal constitutes or could reasonably be
expected to result in a Superior Proposal (as defined in the
Merger Agreement and described in the section of this proxy
statement entitled The Merger Agreement
Restrictions on Solicitations of Other
Offers); and
|
|
|
|
the failure to take such action would be reasonably likely to be
inconsistent with the directors fiduciary duties to the
stockholders of the Company under applicable law.
|
The Merger Agreement also contains restrictions on the ability
of our board of directors to withhold, withdraw, modify or amend
its recommendation that our stockholders adopt the Merger
Agreement and approve the Merger, and on the ability of our
board of directors to recommend, adopt or approve, or publicly
propose to recommend, adopt or approve, any Acquisition
Proposal, in each case, subject to certain exceptions. See the
section of this proxy statement entitled The Merger
Agreement Change of Recommendation for a
description of these restrictions and exceptions. Under the
terms of the Merger Agreement, we are obligated to hold the
stockholders meeting and submit the Merger Agreement and Merger
for adoption and approval by our stockholders at that meeting,
even if our board of directors has changed its recommendation or
an Acquisition Proposal has been received, disclosed or
commenced.
Conditions
to the Completion of the Merger (page 87)
Conditions to Each Partys
Obligations. The obligations of the Company,
Safran and Merger Sub to consummate the Merger are subject to
the satisfaction (or waiver, if permissible under applicable
law) of the following conditions at or prior to the closing of
the Merger:
|
|
|
|
|
approval of the Merger Agreement by the holders of a majority of
the outstanding shares of our common stock;
|
|
|
|
absence of any injunction, law, judgment, order, decree or
ruling in effect which seeks to or has the effect of enjoining
or otherwise prohibiting the consummation of the Merger (unless
vacated, terminated or withdrawn) or making the consummation of
the Merger illegal;
|
|
|
|
expiration or termination of any waiting period (including any
extension) applicable to the consummation of the Merger under
the HSR Act;
|
|
|
|
receipt by Safran and the Company of written confirmation by
CFIUS of the completion of the review, and if applicable,
investigation process, under Exon-Florio and CFIUSs
determination that there are no unresolved national security
concerns with respect to the transactions contemplated by the
Merger Agreement and the BAE Agreement; and
|
|
|
|
|
|
the expiration of a 35 trading day notice period under the terms
governing the Companys convertible notes (which notice was
distributed on December 20, 2010).
|
7
Conditions to Safrans and Merger Subs
Obligations. Safrans and Merger Subs
obligations to consummate the Merger are subject to the
satisfaction (or waiver by Safran and Merger Sub, if permissible
under applicable law) of additional conditions at or prior to
the closing of the Merger, including, among other things:
|
|
|
|
|
the representations and warranties made by the Company contained
in the Merger Agreement being true and correct as of the date of
the Merger Agreement and the closing of the Merger, subject to
certain materiality thresholds;
|
|
|
|
the Companys performance in all material respects of all
of its material obligations under the Merger Agreement to be
performed by it at or prior to the closing of the Merger;
|
|
|
|
the absence of a Company Material Adverse Effect (as defined in
the Merger Agreement and described in the section of this proxy
statement entitled The Merger Agreement
Company Material Adverse Effect Definition) since the
date of the Merger Agreement;
|
|
|
|
the receipt by the Company of the purchase price to be paid by
BAE to the Company in connection with the closing of the BAE
Transaction (for a discussion of the BAE Agreement and the BAE
Transaction, see the section of this proxy statement entitled
The Merger BAE Agreement);
|
|
|
|
completion of the novation, assignment, termination or
expiration of certain of the Companys contracts involving
classified information; and
|
|
|
|
subject to certain exceptions, no contracts, assets or
liabilities from the Intel Companies (as defined below) having
been assigned or novated to the Company or its subsidiaries
(other than the Intel Companies).
|
Conditions to the Companys
Obligations. The Companys obligations to
consummate the Merger are subject to the satisfaction (or waiver
by the Company, if permissible under applicable law), of
additional conditions at or prior to the closing of the Merger,
including, among other things:
|
|
|
|
|
the representations and warranties made by Safran and Merger Sub
contained in the Merger Agreement being true and correct as of
the date of the Merger Agreement and the closing of the Merger,
subject to certain materiality thresholds; and
|
|
|
|
Safrans and Merger Subs performance in all material
respects of all material obligations required to be performed by
each of them under the Merger Agreement at or prior to the
closing of the Merger.
|
Termination
of the Merger Agreement (page 89)
The Company and Safran may agree to terminate the Merger
Agreement without completing the Merger at any time, even after
our stockholders have adopted the Merger Agreement. The Merger
Agreement may also be terminated in certain other circumstances,
including:
|
|
|
|
|
by either the Company or Safran if:
|
|
|
|
|
|
the Merger has not been consummated on or prior to June 19,
2011 (or, at the parties election under certain
circumstances, September 19, 2011);
|
|
|
|
any injunction, law, judgment, order, decree or ruling
permanently enjoining or otherwise prohibiting the consummation
of the Merger has become final and non-appealable;
|
|
|
|
the BAE Agreement has been terminated in accordance with its
terms, subject to the Companys ability to exercise certain
substitution rights relating to the sale of the Companys
intelligence services business, which rights are described in
the section of this proxy statement entitled The Merger
Agreement Certain Substitution Rights in Connection
with the Sale of the Transferred Intel Companies;
|
|
|
|
the Companys stockholders do not approve the Merger
Agreement at the special meeting; or
|
|
|
|
the other party has breached any of its representations,
warranties, covenants or agreements contained in the Merger
Agreement, which breach would result in a failure of a closing
condition to the obligations of the terminating party and which
breach has not been waived and is incapable of being cured, or
is not cured, within 45 days following receipt of written
notice of such breach by the party seeking to terminate
|
8
|
|
|
|
|
(so long as the party seeking to terminate the agreement has not
materially breached any of its material obligations under the
Merger Agreement); or
|
|
|
|
|
|
the Companys board of directors has changed its
recommendation of the Merger or the Merger Agreement, or has
recommended, adopted or approved, or publicly proposed to
recommend, adopt or approve, any Acquisition Proposal;
|
|
|
|
the Company has breached its obligations under the Merger
Agreement by failing to (i) call the stockholders meeting,
(ii) mail this proxy statement in accordance with the terms
of the Merger Agreement or (iii) include in this proxy
statement the board of directors recommendation that the
stockholders adopt and approve the Merger Agreement and the
Merger; or
|
|
|
|
the Company has violated or breached in any material respect any
of its material obligations described in the sections of this
proxy statement entitled The Merger
Agreement Restrictions on Solicitations of Other
Offers or The Merger Agreement
Change of Recommendation.
|
Termination
Fees and Reimbursement of Expenses (page 90)
The Company has agreed to pay Safran a termination fee of
$25,000,000 in cash (minus any amounts paid by the Company in
connection with the reimbursement of expenses described below)
if:
|
|
|
|
|
prior to the special meeting, the Merger Agreement is terminated
by Safran pursuant to its termination rights related to the
board of directors change of recommendation or breach of
the Companys obligations regarding the stockholders
special meeting, the proxy statement or the non-solicitation
obligations described above; or
|
|
|
|
each of the following has occurred:
|
|
|
|
|
|
(a) Safran terminates the Merger Agreement pursuant to its
termination rights related to the Companys breach of its
representations, warranties, covenants or agreements contained
in the Merger Agreement, which breach would result in a failure
of a condition to Safrans and Merger Subs
obligations to consummate the Merger; (b) either Safran or
the Company terminates the Merger Agreement as a result of the
Merger failing to be consummated on or prior to June 19,
2011 (or, under certain circumstances, September 19,
2011) or (c) the stockholders do not approve the
Merger at the special meeting;
|
|
|
|
an Acquisition Proposal is publicly announced (prior to the
special meeting, in the case of clause (c) above); and
|
|
|
|
within nine months after termination of the Merger Agreement,
the Company enters into (and subsequently consummates) an
agreement providing for a qualifying Acquisition Proposal.
|
The Company is required to reimburse up to $12,500,000 of
Safrans documented
out-of-pocket
fees and expenses in connection with the Merger Agreement and
the Merger if:
|
|
|
|
|
either Safran or the Company terminates the Merger Agreement as
a result of the Merger failing to be consummated on or prior to
June 19, 2011 (or, under certain circumstances,
September 19, 2011), and at the time of termination all
conditions related to regulatory approvals have been
satisfied; or
|
|
|
|
the BAE Agreement is terminated (subject to the Companys
substitution rights relating to the sale of the Companys
intelligence services business, which are discussed in the
section of this proxy statement entitled The Merger
Agreement Certain Substitution Rights in Connection
with the Sale of the Transferred Intel Companies).
|
Safran has agreed to pay the Company a termination fee of
$75,000,000 in cash if the Merger Agreement is terminated and
all conditions to the consummation of the Merger have been
satisfied, other than those conditions related to regulatory
approvals and those to be satisfied at or immediately prior to
the closing.
9
BAE
Agreement (page 69)
On September 19, 2010, simultaneously with the execution of
the Merger Agreement, the Company entered into the BAE
Agreement, pursuant to which, subject to the terms and
conditions of the BAE Agreement, BAE will acquire the
Companys intelligence services business group through the
acquisition of the outstanding capital stock and membership
interests of McClendon, LLC, SpecTal, LLC and Advanced Concepts,
Inc. (which we collectively refer to in this proxy statement as
the Transferred Intel Companies and which, together with
Patriot, LLC, an entity in which Advanced Concepts, Inc. owns a
49% equity interest, we collectively refer to as the Intel
Companies) for a purchase price of $295,833,000 in cash and
approximately $7,291,000 of certain assumed obligations related
to the payments to officers and employees of the Transferred
Intel Companies under the Intel Companies Special Employee Plan
to be adopted in connection with the BAE Transaction.
The proposed sale to BAE is subject to the terms and conditions
set forth in the BAE Agreement, which is attached as
Annex B to this proxy statement. These conditions include,
among other things, (i) the expiration or termination of
the applicable waiting periods related to the BAE Transaction
under the HSR Act (termination of the applicable waiting period
was granted on November 3, 2010); (ii) termination or
expiration of the CFIUS review period for the BAE Transaction
(which period has terminated); (iii) no Business Material
Adverse Effect (as defined in the BAE Agreement and described in
the section of this proxy statement entitled The
Merger BAE Agreement) having occurred
since September 19, 2010, the date of the BAE Agreement;
(iv) subject to certain materiality exceptions, the
accuracy of the representations and warranties made by the
Company and BAE, respectively, and compliance by the Company and
BAE with their respective obligations under the BAE Agreement;
(v) the completion of certain actions in respect of
organizational conflict of interest provisions under certain
contracts of the intelligence services business; (vi) no
law or judgment prohibiting the BAE Transaction; and
(vii) other customary conditions.
The closing of the Merger is conditioned on the prior completion
of the BAE Transaction; however, the BAE Transaction is not
conditioned on the consummation of the Merger, and the BAE
Transaction may be completed even if the Merger is not
consummated or the Merger Agreement is terminated. Taking into
account the required governmental and regulatory approvals
described above, we expect that the BAE Transaction will close a
period of time in advance of consummation of the Merger.
Procedure
for Receiving the Merger Consideration (page 74)
As soon as practicable after the effective time of the Merger, a
paying agent designated by Safran (and reasonably acceptable to
the Company) will mail a letter of transmittal and instructions
to all Company stockholders, to the extent deemed necessary or
appropriate by the paying agent. The letter of transmittal and
instructions will tell you how to surrender your certificates of
common stock in exchange for the merger consideration, without
interest and less applicable withholding taxes. The paying agent
will provide stockholders with the consideration due pursuant to
the Merger Agreement as soon as practicable following the
receipt of your certificates of common stock in accordance with
the instructions set forth in the letter of transmittal. You
should not return any share certificates you hold with the
enclosed proxy card, and you should not forward your share
certificates to the paying agent without a letter of transmittal.
Appraisal
Rights (page 93)
Under Delaware law, if the Merger is completed, holders of
shares of our common stock who do not vote in favor of adopting
the Merger Agreement and approving the Merger will have the
right to seek appraisal of the fair value of their shares of
common stock as determined by the Delaware Court of Chancery,
but only if they comply with all requirements of Delaware law
(including Section 262 of the General Corporation Law of
the State of Delaware (which we refer to in this proxy statement
as the DGCL), the text of which is attached as Annex E to,
and the terms of which are summarized in, this proxy statement).
This appraisal amount could be more than, the same as or less
than the $12.00 per share merger consideration pursuant to the
terms of the Merger Agreement. Any holder of common stock
intending to exercise appraisal rights must, among other things,
submit a written demand for an appraisal to the Company prior to
the vote of stockholders on the adoption of the Merger Agreement
and approval of the Merger and must not vote or otherwise submit
a proxy in favor of adoption of the Merger Agreement and
approval of the Merger. Your failure to follow exactly the
procedures specified under Delaware law will result in the
10
loss of your appraisal rights. This proxy statement constitutes
our notice to our stockholders of the availability of appraisal
rights in connection with the Merger in compliance with the
requirements of Section 262 of the DGCL.
Market
Price of the Company Common Stock (page 98)
Our common stock is listed on the New York Stock Exchange under
the trading symbol ID. The closing sale price of our
common stock on the New York Stock Exchange on
September 17, 2010, the last trading day prior to
announcement of the execution of the Merger Agreement, was $9.70
per share. The closing sale price of our common stock on the New
York Stock Exchange was $7.23 on January 5, 2010, the
trading day prior to our public announcement of the strategic
alternatives review process. On December 28, 2010, which is
the most recent practicable date prior to the date of this proxy
statement, the closing sale price of our common stock was $11.90
per share.
11
QUESTIONS
AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER
The following questions and answers are intended to briefly
address some commonly asked questions you may have regarding the
special meeting, the Merger Agreement and the proposed Merger.
These questions and answers may not address all questions that
may be important to you as a stockholder of the Company. Please
refer to the more detailed information contained elsewhere in
this proxy statement, the annexes to this proxy statement and
the documents referred to or incorporated by reference in this
proxy statement, which you should read carefully. See the
section of this proxy statement entitled Where You Can
Find More Information beginning on page 99.
|
|
|
Q: |
|
What is the proposed transaction? |
|
A: |
|
The proposed transaction is the acquisition of the Company by
Safran pursuant to the Merger Agreement. If the Merger Agreement
is adopted and the Merger is approved by the Companys
stockholders and the other closing conditions under the Merger
Agreement have been satisfied or waived, Merger Sub, a wholly
owned subsidiary of Safran, will merge with and into the
Company. Prior to the consummation of the Merger (and as a
condition to the consummation of the Merger), the Company will
sell its intelligence services business group to BAE pursuant to
the terms and subject to the conditions set forth in the BAE
Agreement. Upon consummation of the Merger, the Company will be
the surviving corporation in the Merger and will be a wholly
owned subsidiary of Safran. After the Merger, shares of the
Companys common stock will not be publicly traded. |
|
Q: |
|
What will I receive for my shares of the Companys
common stock in the Merger? |
|
A: |
|
Upon consummation of the Merger, you will receive $12.00 in
cash, without interest and less any applicable withholding
taxes, for each share of our common stock that you own at the
effective time of the Merger (unless you have properly demanded
and perfected your appraisal rights under Delaware law, in which
case any consideration that you receive will be determined by
the Delaware Court of Chancery). Upon consummation of the
Merger, you will no longer own shares in L-1, nor will you be
entitled to receive any shares in Safran or the surviving
corporation. |
|
|
|
See the section of this proxy statement entitled The
Merger Material U.S. Federal Income Tax
Consequences for a description of the tax consequences
of the Merger. You should consult your own tax advisor for a
full understanding of how the Merger will affect your federal,
state, local and foreign taxes. |
|
Q: |
|
How does the merger consideration compare to the market price
of the common stock prior to announcement of the Merger? |
|
A: |
|
The per share merger consideration of $12.00 in cash, without
interest and less applicable withholding taxes, contemplated to
be received by the holders of our common stock pursuant to the
Merger Agreement represents a premium to historic trading
prices, including (i) a premium of 66% over the closing
sale price of $7.23 on the New York Stock Exchange on
January 5, 2010, the trading day prior to our public
announcement of the strategic alternatives review process and
(ii) a premium of approximately 24% over the closing sale
price of $9.70 on the New York Stock Exchange on
September 17, 2010, the last trading day prior to
announcement of the Merger Agreement. |
|
Q: |
|
How will the Companys stock options, other equity-based
awards and long-term cash awards be treated in the Merger? |
|
A: |
|
Pursuant to the Merger Agreement, immediately prior to the
consummation of the Merger, all outstanding and unvested stock
options, restricted stock awards and long-term cash awards will
become vested, and upon consummation of the Merger (i) each
outstanding stock option will be cancelled in exchange for the
right to receive a cash payment equal to the excess, if any, of
the $12.00 per share merger consideration over the exercise
price of the option, less any applicable withholding taxes,
(ii) each outstanding restricted stock award shall be
treated in the same manner as all other shares of common stock
in the Merger, (iii) each outstanding deferred stock unit
will be cancelled and the holder will be entitled to receive a
cash payment equal to the $12.00 per share merger consideration,
less any applicable withholding taxes, and (iv) payment
will be made with respect to each long-term cash award no later
than 10 business days following the consummation of the Merger. |
12
|
|
|
Q: |
|
Where and when is the special meeting? |
|
|
|
A: |
|
The special meeting will be held at the Hyatt Regency-Greenwich
hotel located at 1800 E Putnam Avenue, Old Greenwich, CT, on
February 3, 2011 at 2:00 p.m. Eastern Time. |
|
|
|
Q: |
|
Are all stockholders of the Company as of the record date
entitled to vote at the special meeting? |
|
|
|
A: |
|
Yes. All stockholders who own shares of our common stock at the
close of business on December 27, 2010, the record date for
the special meeting, will be entitled to receive notice of the
special meeting and to vote (in person or by proxy) the shares
of our common stock that they hold on that date at the special
meeting, or any adjournments or postponements of the special
meeting. |
|
|
|
Q: |
|
What matters am I being asked to vote on at the special
meeting? |
|
A: |
|
You are being asked to vote: |
|
|
|
FOR or AGAINST the adoption
of the Merger Agreement and the approval of the Merger; and
|
|
|
|
FOR or AGAINST the proposal
to adjourn or postpone the special meeting to a later date, if
necessary or appropriate, to solicit additional proxies if there
are insufficient votes at the time of the special meeting to
adopt the Merger Agreement and approve the Merger. |
|
|
|
The sale of the Companys intelligence services business
group to BAE does not require a vote of the Companys
stockholders. For a discussion of the BAE Transaction, see the
section of this proxy statement entitled The
Merger BAE Agreement. |
|
Q: |
|
What vote of the Companys stockholders is required to
adopt the Merger Agreement? |
|
A: |
|
For us to complete the Merger, a majority of the outstanding
shares of our common stock at the close of business on the
record date must vote FOR the adoption of the
Merger Agreement and approval of the Merger, with each share
having a single vote. |
|
|
|
Because the affirmative vote required to adopt the Merger
Agreement is based upon the total number of shares of
outstanding common stock, a failure to vote, an abstention or a
broker non-vote will have the same effect as a vote
AGAINST adoption of the Merger Agreement. |
|
|
|
|
|
Mr. LaPenta and Aston entered into a voting and support
agreement, which is described in more detail in the section
entitled The Special Meeting Vote Required
for Approval, pursuant to which Mr. LaPenta and
Aston agreed, among other things, to vote their shares of our
common stock in favor of the adoption of the Merger Agreement
and approval of the Merger, unless our board of directors
changes its recommendation of the Merger to stockholders (in
which case, Mr. LaPenta and Aston may vote for or against
the Merger). As of December 27, 2010, the record date for
the special meeting, Mr. LaPenta and Aston together
beneficially owned approximately 14.59% of our outstanding
common stock. |
|
|
|
Q: |
|
What vote of the Companys stockholders is required to
adjourn or postpone the special meeting? |
|
A: |
|
Approval of the proposal to adjourn or postpone the special
meeting, if necessary or appropriate, to solicit additional
proxies requires the affirmative vote of a majority of the
shares of our common stock present in person or represented by
proxy at the special meeting and entitled to vote on the matter,
whether or not a quorum is present. A failure to attend the
special meeting and vote your shares of common stock or failure
to submit a proxy or a broker non-vote, will have no effect on
the outcome of any vote to adjourn or postpone the special
meeting. However, an abstention will have the same effect as
voting AGAINST any proposal to adjourn or postpone
the special meeting. |
13
|
|
|
Q: |
|
Does the board of directors recommend that the Companys
stockholders vote FOR the adoption of the Merger
Agreement and the approval of the Merger? |
|
A: |
|
Yes. After careful consideration and upon the recommendation of
a special committee of the board of directors established in
connection with the Companys review of strategic
alternatives, the board of directors of the Company, by a
unanimous vote of the directors, recommends that you vote: |
|
|
|
FOR the adoption of the Merger Agreement
and approval of the Merger. You should read the section entitled
The Merger Reasons for the Merger;
Recommendation of Our Board of Directors of this proxy
statement for a discussion of the factors that our board of
directors considered in deciding to recommend the adoption of
the Merger Agreement and approval of the Merger; and
|
|
|
|
FOR the adjournment or postponement of
the special meeting, if necessary or appropriate, to solicit
additional proxies if there are insufficient votes at the time
of the special meeting to adopt the Merger Agreement and approve
the Merger.
|
|
Q: |
|
Do any of the Companys directors or executive officers
have interests in the Merger that may differ from or be in
addition to my interests as a stockholder? |
|
A: |
|
In considering the recommendation of our board of directors with
respect to the Merger, you should be aware that our directors
and executive officers, and certain other persons, may have
interests in the Merger that may be different from, or in
addition to, the interests of our stockholders generally. These
interests include the accelerated vesting and payment of stock
options and other equity-based awards and the accelerated
vesting and payment of long-term cash awards held by one
executive officer and approximately forty-eight non-executive
employees of the Company. In addition, severance benefits will
become payable to certain of our executive officers and cash
transaction bonuses, which were awarded to one executive officer
and approximately thirty non-executive employees of the Company,
will become payable. See the section of this proxy statement
entitled The Merger Interests of Certain
Persons in the Merger. Our board of directors was
aware of these differing interests and considered them, among
other matters, in reaching its decision to approve the Merger
Agreement and the Merger and to recommend that you vote in favor
of adopting the Merger Agreement and approving the Merger. |
|
Q: |
|
What effects will the proposed Merger have on the Company? |
|
A: |
|
Upon consummation of the proposed Merger, L-1 will cease to be a
publicly traded company and will become wholly owned by Safran.
You will no longer have any interest in the future earnings or
growth, if any, of the Company. Following consummation of the
Merger, the registration of our common stock and our reporting
obligations with respect to our common stock under the
Securities Exchange Act of 1934, as amended (which we refer to
in this proxy statement as the Exchange Act) will be terminated
upon application to the SEC. In addition, upon completion of the
proposed Merger, shares of L-1 common stock will no longer be
listed on the New York Stock Exchange, or any other stock
exchange or quotation system. |
|
Q: |
|
What happens if the BAE Transaction is not completed? |
|
A: |
|
Since the Merger is conditioned on the closing of the BAE
Transaction, if the BAE Transaction is not completed for any
reason and a substitute transaction is not implemented pursuant
to the terms of the Merger Agreement, the Merger will not be
consummated and you will not receive any payment for your shares
of the Companys common stock in connection with the
Merger. Instead, the Company will remain an independent public
company and its common stock will continue to be listed and
traded on the New York Stock Exchange. For a discussion of the
BAE Transaction, see the section of this proxy statement
entitled The Merger BAE Agreement. |
|
Q: |
|
What happens if the Merger is not consummated? |
|
A: |
|
If the Merger Agreement is not adopted and the Merger is not
approved by stockholders or if the Merger is not completed for
any other reason, stockholders will not receive any payment for
their shares in connection with the Merger. Instead, L-1 will
remain an independent public company and our common stock will
continue to be listed and traded on the New York Stock Exchange.
Completion of the BAE Transaction is not conditioned |
14
|
|
|
|
|
on the Merger, and this sale may be completed even if the Merger
is not completed or the Merger Agreement is terminated. If the
Merger Agreement is terminated, under specified circumstances,
L-1 may be required to pay Safran a termination fee or reimburse
Safran for its
out-of-pocket
expenses. Safran may be required to pay L-1 a termination fee
under certain circumstances. See the section of this proxy
statement entitled The Merger Agreement
Termination Fees and Reimbursement of Expenses. |
|
Q: |
|
How do I vote my shares without attending the special
meeting? |
|
A: |
|
You may vote without attending the special meeting by: |
|
|
|
completing, signing and dating each proxy card you
receive and returning it in the enclosed prepaid envelope;
|
|
|
|
using the telephone number printed on your proxy
card;
|
|
|
|
using the Internet voting instructions printed on
your proxy card; or
|
|
|
|
|
|
if you hold your shares in street name,
following the procedures provided by your broker, bank or other
nominee.
|
|
|
|
Q: |
|
How do I vote my shares in person at the special meeting? |
|
A: |
|
If you hold shares in your name as a stockholder of record, you
may attend the special meeting and vote those shares in person
at the meeting by giving us a signed proxy card or ballot before
voting is closed. If you decide to vote in person, please bring
proof of identification with you to the special meeting. Even if
you plan to attend the meeting, we recommend that you vote your
shares in advance as described above, so your vote will be
counted if you later decide not to attend. |
|
|
|
If you hold shares in street name through a broker,
bank or other nominee, you may vote those shares in person at
the meeting only if you obtain and bring with you a signed proxy
from the necessary nominees giving you the right to vote the
shares. To do this, you should contact your broker, bank or
other nominee. |
|
Q: |
|
If my shares are held in street name by my
broker, bank or other nominee, will my broker, bank or other
nominee vote my shares for me? |
|
A: |
|
Your broker, bank or other nominee will not be able to vote
your shares without instructions from you. You should
instruct your broker, bank or other nominee to vote your shares
following the procedure provided by your broker, bank or other
nominee. Without instructions, your shares will not be voted,
which will have the same effect as if you voted
AGAINST adoption of the Merger Agreement and
approval of the Merger, but will have no effect on the proposal
to adjourn or postpone the special meeting if necessary or
appropriate, to solicit additional proxies. |
|
Q: |
|
Can I revoke or change my vote? |
|
A: |
|
Yes. If you hold your shares in your name as a stockholder of
record, you have the right to change or revoke your proxy at any
time before the vote taken at the special meeting by:
(i) delivering to our Secretary, at 177 Broad Street,
Stamford, Connecticut 06901, a signed written notice of
revocation, bearing a date later than the date of the proxy,
stating that the proxy is revoked; (ii) attending the
special meeting and voting in person (your attendance at the
meeting will not, by itself, change or revoke your
proxy you must vote in person at the meeting to
change or revoke a prior proxy); (iii) completing,
executing and delivering a later dated proxy card; or
(iv) voting again at a later time by telephone or the
Internet prior to the time at which the telephone and Internet
voting facilities close by following the procedures applicable
to those methods of voting. Simply attending the special meeting
will not revoke your proxy. If you hold your shares through a
broker, bank, or other nominee, follow the directions received
from your broker, bank or other nominee to change or revoke your
instructions. |
|
Q: |
|
What does it mean if I get more than one proxy card or vote
instruction form? |
|
A: |
|
If your shares are registered differently and are in more than
one account, you may receive more than one proxy card or vote
instruction form. Please complete, sign, date and return all of
the proxy cards and vote |
15
|
|
|
|
|
instruction forms you receive regarding the special meeting (or
submit your proxy for all shares by telephone or the Internet)
to ensure that all of your shares are voted. |
|
Q: |
|
When should I send my proxy card? |
|
A: |
|
You should send your proxy card as soon as possible so that your
shares will be voted at the special meeting. |
|
Q: |
|
What do I need to do now? |
|
A: |
|
Even if you plan to attend the special meeting, after carefully
reading and considering the information contained in this proxy
statement, if you hold your shares in your own name as the
stockholder of record, please vote your shares by completing,
signing, dating and returning the enclosed proxy card; using the
telephone number printed on your proxy card; or using the
Internet voting instructions printed on your proxy card. You can
also attend the special meeting and vote. Do NOT return your
stock certificate(s) with your proxy card. |
|
|
|
If your shares of common stock are held in street
name by your broker, bank or other nominee, you should
instruct your broker, bank or other nominee on how to vote your
shares of common stock using the instructions provided by your
broker, bank or other nominee. If your shares of common stock
are held in street name and you do not provide your
broker, bank or other nominee with instructions, your shares of
common stock will not be voted and that will have the same
effect as voting AGAINST the adoption of the Merger
Agreement but will have no effect on the outcome of any vote to
adjourn or postpone the special meeting. |
|
Q: |
|
Are appraisal rights available? |
|
A: |
|
Yes. As a holder of common stock of the Company, you are
entitled to appraisal rights under Delaware law if you do not
vote in favor of adoption of the Merger Agreement and approval
of the Merger and you have properly demanded and perfected your
appraisal rights under Delaware law. See the section of this
proxy statement entitled Appraisal Rights. |
|
Q: |
|
When do you expect the Merger to be completed? |
|
A: |
|
We anticipate that the Merger will be completed by the end of
the first quarter of 2011, assuming satisfaction or waiver of
all of the conditions to the Merger. However, the Merger is
subject to various regulatory approvals and other conditions,
and it is possible that factors outside the control of Safran
and the Company could result in the Merger being completed at a
later time, an earlier time or not at all. In addition, there
may be a substantial amount of time between the date of the
special meeting and completion of the Merger. |
|
Q: |
|
If the Merger is completed, when can I expect to receive the
merger consideration for my shares of common stock? |
|
A: |
|
Promptly after the completion of the Merger, you will be sent a
letter of transmittal describing how you may exchange your
shares of common stock for the merger consideration. You should
not send your common stock certificates to us or anyone else
until you receive these instructions. |
|
Q: |
|
Who will bear the cost of this solicitation? |
|
A: |
|
The expenses of preparing, printing and mailing this proxy
statement and the proxies solicited hereby will be borne by the
Company. The Company will, upon request, reimburse brokerage
houses and other custodians, nominees and fiduciaries for their
reasonable expenses for forwarding material to the beneficial
owners of shares held of record by others. Additional
solicitations may be made by telephone, facsimile or other
contact by certain directors, officers or employees of the
Company, none of whom will receive additional compensation
therefor, and by our proxy solicitor, as described below. |
|
Q: |
|
Will a proxy solicitor be used? |
|
A: |
|
Yes. The Company has engaged Morrow & Co., LLC to
assist in the solicitation of proxies for the special meeting
and the Company estimates that it will pay Morrow &
Co., LLC a fee of approximately $25,000. The Company has also
agreed to reimburse Morrow & Co., LLC for
out-of-pocket
expenses and to indemnify them against certain losses arising
out of their proxy solicitation services. |
16
|
|
|
Q: |
|
Should I send in my stock certificates now? |
|
A: |
|
No. PLEASE DO NOT SEND IN YOUR STOCK CERTIFICATES WITH
YOUR PROXY. |
|
|
|
Shortly after the Merger is completed, you will receive a letter
of transmittal with instructions informing you how to send in
your stock certificates to the paying agent in order to receive
the merger consideration in respect of your shares of our common
stock. You should use the letter of transmittal to exchange your
stock certificates for the merger consideration which you are
entitled to receive as a result of the Merger. |
|
Q: |
|
Is the Merger expected to be taxable to me? |
|
A: |
|
Yes. The exchange of shares of common stock for cash pursuant to
the Merger Agreement generally will be a taxable transaction to
U.S. holders (as defined in The Merger
Material U.S. Federal Income Tax Consequences)
for U.S. federal income tax purposes. If you are a
U.S. holder and you exchange your shares of our common
stock in the Merger, you will generally recognize gain or loss
in an amount equal to the difference, if any, between the cash
received in the Merger and your adjusted tax basis in such
shares. |
|
|
|
See the section of this proxy statement entitled The
Merger Material U.S. Federal Income Tax
Consequences for a more detailed discussion of the
U.S. federal income tax consequences of the Merger. You
should also consult your independent tax advisor as to the
particular tax consequences of the Merger to you, including the
tax consequences under state, local, foreign and other tax laws. |
|
Q: |
|
What happens if I sell my shares before the special
meeting? |
|
A: |
|
The record date of the special meeting is earlier than the
special meeting and the date that the Merger is expected to be
completed. If you transfer your shares of common stock after the
record date but before the special meeting, you will retain your
right to vote at the special meeting, but will have transferred
the right to receive $12.00 per share in cash, without interest
and less applicable withholding taxes, to be received by our
stockholders in the Merger. In order to receive the $12.00 per
share, without interest and less applicable withholding taxes,
you must hold your shares through completion of the Merger. |
|
Q: |
|
Who can help answer my other questions? |
|
A: |
|
If you have more questions about the Merger, need assistance in
submitting your proxy or voting your shares, or need additional
copies of the proxy statement or the enclosed proxy card, you
should contact our proxy solicitor: |
Morrow & Co., LLC
470 West Avenue
Stamford, CT 06902
Stockholders Call:
(877) 366-1578
Banks and Brokers Call:
(203) 658-9400
17
CAUTIONARY
STATEMENT CONCERNING FORWARD-LOOKING INFORMATION
This proxy statement, and the documents to which we refer you in
this proxy statement, contain forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Exchange Act.
Forward-looking statements include, among others, information
concerning the possible or assumed future results of operations
of the Company, the expected completion and timing of the Merger
and the BAE Transaction and other information relating to the
Merger and the BAE Transaction. There are forward-looking
statements throughout this proxy statement, including, without
limitation, under the headings Proxy Statement
Summary, Questions and Answers about the
Special Meeting and the Merger, The
Merger, The Merger Certain
Forecasts, The Merger
Governmental and Regulatory Approvals, The
Merger Opinion of Goldman, Sachs &
Co., and The Merger Opinion of
Stone Key Partners LLC. Forward-looking statements can
be identified by words such as believes,
expects, predicts,
estimates, anticipates,
continues, contemplates,
projects, intends, may,
will, could, should or
would or similar expressions, or by discussion of
competitive strengths or strategy that involve risks and
uncertainties. These statements, which are based on information
currently available to us, are not guarantees of future
performance, actual outcomes or developments and may involve
risks and uncertainties that could cause our actual outcomes,
developments, growth, results of operations, performance and
business prospects and opportunities to materially differ from
those expressed in, or implied by, these statements. In addition
to other factors and matters contained or incorporated in this
document, these statements are subject to risks, uncertainties,
and other factors, including, among others:
|
|
|
|
|
the occurrence of any event, change or other circumstances that
could give rise to the termination of the Merger Agreement or
the BAE Agreement;
|
|
|
|
the outcome of any legal proceeding that has been or may be
instituted against L-1 and others relating to the Merger
Agreement or the BAE Agreement;
|
|
|
|
the inability to complete the Merger due to the failure to
obtain stockholder approval, the failure to obtain regulatory
approvals or the failure to satisfy other conditions to
consummation of the Merger, including the failure to consummate
the BAE Transaction;
|
|
|
|
the failure of the Merger to close for any other reason;
|
|
|
|
risks that the proposed transactions disrupt current business
plans and operations and the potential difficulties in
attracting and retaining employees as a result of the Merger or
the BAE Transaction;
|
|
|
|
business uncertainty and contractual restrictions during the
pendency of the Merger and the BAE Transaction;
|
|
|
|
the diversion of managements attention from ongoing
business concerns;
|
|
|
|
the risk of loss of senior management;
|
|
|
|
the effect of the announcement of the Merger and the BAE
Transaction on our customer and supplier relationships,
operating results and business generally;
|
|
|
|
the amount of the costs, fees, expenses and charges related to
the Merger and the BAE Transaction;
|
|
|
|
the timing of the completion of the Merger and the BAE
Transaction and the impact of the Merger and the BAE Transaction
on our indebtedness, capital resources, cash requirements,
profitability, management resources and liquidity;
|
|
|
|
risks and uncertainties relating to our business (including our
ability to achieve strategic goals, objectives and targets over
applicable periods), industry performance and the regulatory
environment;
|
|
|
|
the effects of a recession in the United States or other parts
of the world and general downturn in the economy, including the
illiquidity in the debt / capital markets; and
|
|
|
|
other risks detailed in our current filings with the SEC,
including our most recent filings on
Forms 8-K,
10-Q and
10-K. See
the section of this proxy statement entitled Where You
Can Find More Information.
|
18
The forward-looking statements contained in this proxy statement
speak only as of the date on which such statements were made and
we undertake no obligation, other than as may be required under
the federal securities laws, to publicly update or revise any
forward-looking statements, whether as a result of new
information, future events or otherwise. We do not assume
responsibility for the accuracy and completeness of
forward-looking statements. Any or all of the forward-looking
statements contained in this proxy statement and in any other
public statements that are made may prove to be incorrect. This
may occur as a result of inaccurate assumptions or as a
consequence of known or unknown risks and uncertainties. All of
the forward-looking statements are qualified in their entirety
by reference to the factors discussed above and under the
caption Risk Factors of our most recent filings on
Forms 10-Q
and 10-K and
on our
Form 8-K
filed on November 17, 2010. We caution that these risk
factors may not be exhaustive. We operate in a continually
changing business environment, and new risk factors emerge from
time to time. We cannot predict these new risk factors, nor can
we assess the impact, if any, of the new risk factors on our
business or the extent to which any factor or combination of
factors may cause actual results or outcomes to differ
materially from those expressed or implied by any
forward-looking statement. In light of these risks,
uncertainties and assumptions, the forward-looking events
discussed in this proxy statement might not occur.
19
THE
PARTIES TO THE MERGER
L-1 Identity Solutions, Inc.
177 Broad Street
Stamford, Connecticut 06901
(203) 504-1109
L-1 Identity Solutions, Inc. protects and secures personal
identities and assets. Its identity solutions business group is
comprised of the Biometric / Enterprise Access, Secure
Credentialing and Enrollment Services divisions. Its
intelligence services business group is comprised of McClendon,
LLC, SpecTal, LLC and Advanced Concepts, Inc. L-1 has more than
2,200 employees worldwide and is headquartered in Stamford,
Connecticut.
For more information about us, please visit our website
http://www.L1id.com.
Our website address is provided as an inactive textual reference
only. The information provided on our website is not part of
this proxy statement, and therefore is not incorporated by
reference. See also the section of this proxy statement entitled
Where You Can Find More Information beginning
on page 99. Our common stock is publicly traded on the New
York Stock Exchange under the trading symbol ID.
Safran SA
2, boulevard du Général Martial Valin
75724 Paris Cedex 15
France
+33 14 0 60 84 28
Safran is a France-based international high-technology group
with three core businesses: Aerospace (propulsion and
equipment), Defense and Security. Operating worldwide, Safran
has 55,000 employees. Safran is listed on the NYSE Euronext
Paris under the symbol SAF.
Laser Acquisition Sub Inc.
c/o Safran
USA, Inc.
2850 Safran Drive
Grand Prairie, Texas 75052
(972) 606-7108
Merger Sub is a wholly owned subsidiary of Safran and is a
Delaware corporation. It was formed solely for the purpose of
effecting the Merger and the other transactions contemplated by
the Merger Agreement and has not engaged in any business except
in furtherance of this purpose and activities incident to its
formation.
20
THE
SPECIAL MEETING
Date,
Time, Place and Purpose of the Special Meeting
This proxy statement is being furnished to our stockholders as
part of the solicitation of proxies by our board of directors
for use at the special meeting to be held at the Hyatt
Regency-Greenwich hotel located at 1800 E Putnam Avenue, Old
Greenwich, CT, on February 3, 2011 at 2:00 p.m.
Eastern Time, or at any postponement or adjournment thereof. The
purpose of the special meeting is for our stockholders to
consider and vote upon a proposal to adopt the Merger Agreement
and approve the Merger (and to approve the adjournment or
postponement of the special meeting, if necessary or
appropriate, to solicit additional proxies if there are
insufficient votes at the time of the special meeting to adopt
the Merger Agreement and approve the Merger). Stockholders
holding a majority of our issued and outstanding common stock at
the close of business on the record date must vote to adopt the
Merger Agreement and approve the Merger in order for the Merger
to occur. A copy of the Merger Agreement is attached as
Annex A to this proxy statement.
Board of
Directors Recommendation
After careful consideration, our board of directors, by
unanimous vote, approved and declared advisable the execution,
delivery and performance of the Merger Agreement and the
transactions contemplated by the Merger Agreement, including the
Merger, and has determined that the Merger Agreement and the
transactions contemplated by the Merger Agreement, including the
Merger, are advisable and in the best interests of the
Companys stockholders. Our board of directors
recommends that you vote FOR the proposal to adopt
the Merger Agreement and approve the Merger and FOR
the proposal to adjourn or postpone the special meeting, if
necessary or appropriate, to solicit additional proxies. For
a discussion of the material factors considered by our board of
directors in reaching its conclusions, see the section of this
proxy statement entitled The Merger Reasons
for the Merger; Recommendation of Our Board of
Directors.
Record
Date and Quorum
We have fixed the close of business on December 27, 2010 as
the record date for the special meeting, and only holders of
record of our common stock on the record date are entitled to
vote at the special meeting. On December 27, 2010, there
were 93,623,464 shares of our common stock entitled to be
voted at the special meeting. Each share of common stock
outstanding on the record date entitles its holder to one vote
on all matters properly coming before the special meeting.
The presence at the special meeting in person or by proxy of the
holders of a majority of the issued and outstanding shares of
our capital stock entitled to vote at the special meeting as of
the close of business on the record date will constitute a
quorum for purposes of considering the proposals at the special
meeting. Shares of common stock represented at the special
meeting but not voted, including shares of common stock for
which we have received proxies indicating that the submitting
stockholders have abstained and broker non-votes will be treated
as present at the special meeting for purposes of determining
the presence or absence of a quorum for the transaction of all
business. A broker non-vote occurs on an item when a broker is
not permitted to vote on that item without instructions from the
beneficial owner of the shares and no instructions are given.
Vote
Required for Approval
The adoption of the Merger Agreement and approval of the Merger
requires the affirmative vote (in person or by proxy) of the
holders of a majority of the outstanding shares of our common
stock at the close of business on the record date. For the
proposal to adopt the Merger Agreement and approve the Merger,
you may vote FOR, AGAINST or
ABSTAIN. Abstentions will not be counted as votes
cast or shares voting on the proposal to adopt the Merger
Agreement and approve the Merger, but will count for the purpose
of determining whether a quorum is present. If you abstain,
it will have the same effect as a vote AGAINST the
adoption of the Merger Agreement and approval of the Merger.
Brokers, banks or other nominees who hold shares of our common
stock in street name for customers who are the
beneficial owners of such shares may not give a proxy to vote
those customers shares in the absence of specific
instructions from those customers. These non-voted shares of our
common stock will not be counted as
21
votes cast or shares voting and will have the same effect as
votes AGAINST approval and adoption of the Merger
Agreement.
Contemporaneously with the execution of the Merger Agreement, on
September 19, 2010, Mr. LaPenta and Aston entered into
a voting and support agreement with Safran and Merger Sub, which
is described in more detail below. Pursuant to the voting and
support agreement, Mr. LaPenta and Aston agreed, among
other things, to vote their shares of our common stock in favor
of the adoption of the Merger Agreement and approval of the
Merger, unless our board of directors changes its recommendation
of the Merger to stockholders (in which case, Mr. LaPenta
and Aston may vote for or against the Merger). As of
December 27, 2010, the record date for the special meeting,
Mr. LaPenta and Aston together beneficially owned
approximately 14.59% of our outstanding common stock. See the
section of this proxy statement entitled The
Merger Interests of Certain Persons in the
Merger Relationships with Aston and Stone
Key for a discussion regarding certain other
relationships with Aston.
Approval of any proposal to adjourn or postpone the special
meeting, if necessary or appropriate, for the purpose of
soliciting additional proxies requires the affirmative vote of a
majority of the shares of our common stock present in person or
represented by proxy at the special meeting and entitled to vote
on the matter, whether or not a quorum is present. A failure to
vote your shares of common stock or a broker non-vote will have
no effect on the outcome of any vote to adjourn or postpone the
special meeting. An abstention will have the same effect as
voting AGAINST any proposal to adjourn or postpone
the special meeting.
As of December 27, 2010, the record date for the special
meeting, our current directors and executive officers
beneficially owned, and had the right to vote, in the aggregate,
16,028,257 shares of our common stock (which excludes
shares that may be acquired by such persons pursuant to stock
option grants but includes shares held by Aston that are deemed
to be held beneficially by certain directors and executive
officers), which represented approximately 17.12% of the
outstanding shares of our common stock. Our current directors
and executive officers have informed us that they intend to vote
all of their shares of common stock FOR the
adoption of the Merger Agreement and approval of the Merger and
FOR the adjournment or postponement of the
special meeting, if necessary or appropriate, to solicit
additional proxies.
Proxies
and Revocation
In order for your shares of common stock to be included in the
vote, if you are a stockholder of record, you must either have
your shares voted by returning the enclosed proxy card or by
authorizing your proxy or voting instructions by telephone or
Internet or voting in person at the special meeting.
Record holders may vote or cause their shares of common stock to
be voted by proxy using one of the following methods:
|
|
|
|
|
completing, signing and dating each proxy card you receive and
returning it in the enclosed prepaid envelope;
|
|
|
|
using the telephone number printed on your proxy card;
|
|
|
|
using the Internet voting instructions printed on your proxy
card; or
|
|
|
|
appearing and voting in person by ballot at the special meeting.
|
If you hold your shares in street name, you may vote
or cause shares of common stock to be voted by proxy by
following the instructions and procedures provided by your
broker, bank or other nominee.
WHETHER OR NOT YOU PLAN TO ATTEND THE SPECIAL MEETING, PLEASE
COMPLETE, DATE, SIGN AND RETURN, AS PROMPTLY AS POSSIBLE, THE
ENCLOSED PROXY CARD IN THE ACCOMPANYING REPLY ENVELOPE, OR
SUBMIT YOUR PROXY BY TELEPHONE OR THE INTERNET. STOCKHOLDERS WHO
ATTEND THE MEETING MAY REVOKE THEIR PROXIES AND VOTE IN
PERSON.
If you submit a proxy by telephone or the Internet or by
returning a signed proxy card by mail, your shares will be voted
at the special meeting as you indicate on your proxy card or by
such other method. If you sign your proxy card without
indicating your vote, your shares will be voted
FOR the adoption of the Merger Agreement and
22
approval of the Merger and FOR the
adjournment or postponement of the special meeting, if necessary
or appropriate, to solicit additional proxies.
If you abstain, your shares of common stock will be treated as
present at the special meeting for purposes of determining the
presence or absence of a quorum for the transaction of business;
however, your shares will not be counted as votes cast or shares
voting on the proposals. If you abstain, it will have the same
effect as a vote AGAINST the proposals.
If your shares of common stock are held in street
name, you will receive instructions from your broker, bank
or other nominee that you must follow in order to have your
shares voted. If you do not instruct your broker, bank or other
nominee to vote your shares, it has the same effect as a vote
AGAINST the proposal to adopt the Merger Agreement
and approve the Merger but will have no effect on the proposal
to adjourn or postpone the special meeting, if necessary or
appropriate, to solicit additional proxies.
Proxies received at any time before the special meeting, and not
revoked or superseded before being voted, will be voted at the
special meeting. If you hold your shares in your name as a
stockholder of record, you have the right to change or revoke
your proxy at any time before the vote taken at the special
meeting by:
|
|
|
|
|
delivering to our Corporate Secretary, at 177 Broad Street,
Stamford, Connecticut 06901, a signed written notice of
revocation, bearing a date later than the date of the proxy,
stating that the proxy is revoked;
|
|
|
|
attending the special meeting and voting in person (your
attendance at the meeting will not, by itself, change or revoke
your proxy you must vote in person at the meeting to
change or revoke a prior proxy);
|
|
|
|
completing, executing and delivering a later dated proxy
card; or
|
|
|
|
voting again at a later time by telephone or the Internet prior
to the time at which the telephone and Internet voting
facilities close by following the procedures applicable to those
methods of voting.
|
If you hold your shares through a broker, bank, or other
nominee, you have the right to change or revoke your proxy at
any time before the vote taken at the special meeting by
following the directions received from your broker, bank or
other nominee to change or revoke those instructions.
PLEASE DO NOT SEND IN YOUR STOCK CERTIFICATES WITH YOUR PROXY
CARD. IF THE MERGER IS COMPLETED, A SEPARATE LETTER OF
TRANSMITTAL WILL BE MAILED TO YOU THAT WILL ENABLE YOU TO
RECEIVE THE MERGER CONSIDERATION IN EXCHANGE FOR YOUR L-1 STOCK
CERTIFICATES.
Adjournments
and Postponements
Although it is not currently expected, the special meeting may
be adjourned or postponed for the purpose of soliciting
additional proxies. Any adjournment may be made without notice,
other than by an announcement made at the special meeting of the
time, date and place of the adjourned meeting, provided that if
the adjournment is for 30 days or more, or if after the
adjournment a new record date is fixed for the adjourned
meeting, notice of the adjourned meeting in accordance with the
by-laws of the Company will be given to each stockholder of
record entitled to notice of and to vote at the meeting. Whether
or not a quorum exists, holders of a majority of the common
stock present in person or represented by proxy at the special
meeting and entitled to vote may adjourn or postpone the special
meeting at any time. Any signed proxies received by us in which
no voting instructions are provided on the matter will be voted
FOR an adjournment or postponement of the
special meeting, if necessary or appropriate, to solicit
additional proxies. Any adjournment or postponement of the
special meeting for the purpose of soliciting additional proxies
will allow our stockholders who have already sent in their
proxies to revoke them at any time prior to their use at the
special meeting as adjourned or postponed.
Rights of
Stockholders Who Dissent From the Merger
Stockholders are entitled to statutory appraisal rights under
Delaware law in connection with the Merger. This means that you
are entitled to have the value of your shares of our common
stock determined by the Delaware Court of Chancery and to
receive payment based on that valuation. The ultimate amount you
receive as a dissenting
23
stockholder in an appraisal proceeding may be more than, the
same as or less than the amount you would have received under
the Merger Agreement.
To exercise your appraisal rights, you must submit a written
demand for appraisal to us before the vote is taken on the
Merger Agreement and you must not vote in favor of the adoption
of the Merger Agreement. Your failure to follow exactly the
procedures specified under Delaware law will result in the loss
of your appraisal rights. See the section of this proxy
statement entitled Appraisal Rights and the
text of the Delaware appraisal rights statute, Section 262
of the DGCL, reproduced in its entirety as Annex E to this
proxy statement. This proxy statement constitutes our notice to
our stockholders of the availability of appraisal rights in
connection with the Merger in compliance with the requirements
of Section 262 of the DGCL.
Solicitation
of Proxies
This proxy solicitation is being made and paid for by us on
behalf of our board of directors. In addition, we have engaged
Morrow & Co., LLC to assist in the solicitation of
proxies for the special meeting and we estimate that we will pay
Morrow & Co., LLC a fee of approximately $25,000. We
also have agreed to reimburse Morrow & Co., LLC for
out of pocket expenses and to indemnify them against certain
losses arising out of their proxy soliciting services. Our
directors, officers and employees may also solicit proxies by
personal interview, mail,
e-mail,
telephone, facsimile or other means of communication. These
persons will not be paid additional compensation for their
efforts. We will also request brokers, banks and other nominees
to forward proxy solicitation material to the beneficial owners
of our shares of common stock that the brokers, banks and
nominees hold of record. Upon request, we will reimburse them
for their reasonable
out-of-pocket
expenses related to forwarding the material.
Questions
and Additional Information
If you have more questions about the Merger, need assistance in
submitting your proxy or voting your shares, or need additional
copies of the proxy statement or the enclosed proxy card, you
should contact our proxy solicitor:
Morrow & Co., LLC
470 West Avenue
Stamford, CT 06902
Stockholders Call:
(877) 366-1578
Banks and Brokers Call:
(203) 658-9400
24
THE
MERGER
Background
of the Merger
As part of the ongoing evaluation of business and strategic
planning, the Companys board of directors, from time to
time has discussed and reviewed strategic goals and
alternatives. These reviews have included consideration of
potential transactions and business combinations, as well as the
Companys standalone business plans and prospects. The
Company also has made several acquisitions in recent years,
including the acquisition of the assets of Retica Systems, Inc.
in 2010, the acquisition of Bioscrypt Inc. and the ID Systems
business of Digimarc Corporation in 2008 and the acquisition of
Advanced Concepts, Inc., McClendon Corporation and ComnetiX Inc.
in 2007.
On January 6, 2010, as part of the Companys press
release announcing preliminary results for the fourth quarter
and full year ended December 31, 2009, the Company
announced that one of its strategic goals and objectives for
2010 was to explore strategic alternatives to enhance
stockholder value.
On February 9, 2010, the board of directors met with
representatives of various investment banks, including
representatives of Goldman, Sachs & Co. (which we
refer to in this proxy statement as Goldman Sachs) and Stone Key
Partners LLC and the Stone Key Securities division of Hudson
Partners Securities LLC (which together we refer to in this
proxy statement as Stone Key) to identify financial advisors to
assist in the strategic alternatives process. During these
meetings, representatives of the financial advisors each
separately discussed with the board of directors certain market
trends and certain strategic alternatives potentially available
to the Company to enhance stockholder value. Representatives of
Goldman Sachs and Stone Key also discussed potential processes
to ascertain third party interest in an acquisition of the
Company, including a publicly announced auction process, noting
that certain potential buyers may not be interested in acquiring
the Company in its entirety, and, accordingly, a sale of the
Company in two or more parts might need to be considered. The
financial advisors and the board of directors also discussed
preliminary lists of potential buyers of the whole Company, as
well as potential buyers of selected parts of the Company.
The board of directors discussed the presentations made by the
various investment banks at a telephonic meeting on
February 10, 2010. Also on February 10, 2010, as part
of the Companys 2009 earnings release and conference call,
the Company reported, among other things, that the Company was
in the process of exploring strategic alternatives, including
the potential sale of the Company.
At a telephonic meeting on February 24, 2010, the board of
directors approved the engagement of each of Goldman Sachs and
Stone Key (which together we refer to in this proxy statement as
the financial advisors) as the Companys financial advisors
in connection with the Companys exploration of strategic
alternatives to enhance stockholder value, including the
possible sale of all or a portion of the common stock or assets
of the Company. Prior to approving the engagement of Stone Key,
the board of directors considered and evaluated certain
relationships among officers of Stone Key, the Company and Aston
(see the section of this proxy statement entitled
Interests of Certain Persons in the
Merger Relationships with Aston and Stone
Key).
Following the Companys public announcements regarding its
exploration of strategic alternatives, representatives of Safran
contacted the Company to request that Safran be included in such
process. From time to time in prior years, representatives of
Safran and the Company had discussed in general terms potential
transactions involving the Company and Safran, but had not
discussed any particular terms or transactions. On
February 25, 2010, representatives of the Company
(including Robert V. LaPenta, Chairman of the Board, President
and Chief Executive Officer) met with representatives of Safran
and its representatives to discuss Safrans request to be
included in the Companys strategic alternatives process.
On February 26, 2010, the Company entered into an
engagement letter with Goldman Sachs and, on February 28,
2010, the Company entered into an engagement letter with Stone
Key, to act as financial advisors to the Company in connection
with the strategic alternatives process (including a potential
sale of the Company). On March 1, 2010, the Company
publicly announced that it had retained Goldman Sachs and Stone
Key in such capacity.
During March 2010, representatives of the financial advisors
discussed with members of management the potential process for
an auction of the Company and / or its business
divisions. During this time, representatives of
25
the financial advisors met with members of the Companys
management to discuss and commence the process of gathering due
diligence materials to be made available to potential buyers.
The financial advisors also assisted the Companys
management in preparing confidential marketing materials that
would be provided to potential buyers.
On March 24, 2010, following approval by the board of
directors, the Company engaged Skadden, Arps, Slate,
Meagher & Flom LLP (which we refer to in this proxy
statement as Skadden) as legal counsel to the Company in
connection with its exploration of strategic alternatives.
On April 6, 2010, representatives of the financial advisors
and Skadden discussed with members of Company management the
potential process and timeline for an auction of the Company,
including the potential buyers identified by management and the
financial advisors that might be contacted in connection with
such process. The working group acknowledged that, for a variety
of reasons, certain potential buyers may only be interested in
an acquisition of the Companys intelligence services
business group, while others may only be interested in the
Companys identity solutions business group. Among other
things, the Company and its advisors discussed the fact that a
number of the most interested potential identity solutions group
buyers were foreign companies which may be unable to acquire the
intelligence services business without addressing significant
regulatory hurdles. In this regard, representatives of the
financial advisors also discussed with members of management
various structures and the process for a potential sale of the
Company, including the sale of the whole Company to a single
party and a multi-buyer transaction structure
whereby the Companys intelligence services business group
would be sold to one party simultaneously with or preceding a
sale of the Companys identity solutions business group to
another party. In addition, representatives of the financial
advisors identified approximately 100 potential strategic and
financial buyers that may be interested in an acquisition of all
or a portion of the Company.
Beginning on April 8, 2010, at the direction of the
Companys management, representatives of the financial
advisors contacted the approximately 100 parties, including
approximately 60 potential strategic buyers and 40 potential
financial buyers, and subsequently distributed a form of
confidentiality agreement, together with certain publicly
available information about the Company, to approximately 70
parties that indicated potential interest in acquiring the
Company or one of its business groups. Over the next several
weeks, confidentiality agreements were negotiated with the
various potential buyers and, ultimately, over 50 potential
buyers executed confidentiality agreements with the Company,
including Safran (confidentiality agreement executed on
May 19, 2010) and BAE (confidentiality agreement
executed on May 21, 2010). Upon executing a confidentiality
agreement, each potential buyer was provided with confidential
marketing materials regarding the Company, including certain
financial projections prepared by the management of the Company
with respect to the Company and each of the identity solutions
and intelligence services business groups. The auction process
provided substantially equal access to information throughout
the various stages of the process to the potential buyers that
remained interested in a transaction with the Company,
regardless of the nationality of such buyers. However, CFIUS
regulations impose additional regulatory processes on a
potential transaction involving certain foreign bidders and,
throughout the process, the board of directors, management and
the Companys advisors had extensive discussions regarding
the incremental consummation and timing risks presented by
certain foreign buyers due to the applicable CFIUS regulations.
Pursuant to the Merger Agreement, Safran has agreed that it will
be obligated to pay the Company a $75 million reverse
termination fee if Safran is unable to get CFIUS or other
regulatory approvals in connection with the Merger (see the
section of this proxy statement entitled The Merger
Agreement Termination Fees and Reimbursement of
Expenses for a description of the circumstances under
which such fee is payable).
On April 9, 2010 and April 19, 2010, at telephonic
meetings of the board of directors, Mr. LaPenta provided
updates to the board of directors regarding the Companys
strategic alternatives process.
On May 5, 2010, the board of directors held a regularly
scheduled meeting with representatives of the financial advisors
and Skadden attending. Representatives of the financial advisors
and Skadden reviewed the current status of the Companys
exploration of strategic alternatives, including the various
parties that had expressed interest in a potential transaction
involving all or a portion of the Company and the status of the
confidentiality agreements that were being negotiated with
potential buyers. Representatives of Skadden also addressed
various regulatory considerations in connection with a potential
sale of the Company. At the conclusion of this meeting, the
board of directors determined to establish a special committee
of the board of directors (which we refer to in this proxy
statement as the special committee) to oversee the strategic
alternatives process and to report to the board of directors
with respect thereto. The board determined that the authority
and specific duties of the special committee
26
would be further discussed and agreed to at a future meeting of
the board. The special committee was initially comprised
Messrs. Nessen, Lawler and Gudis and, on May 13, 2010,
Mr. Rose was added as a member of the committee (each of
Messrs. Nessen, Lawler, Gudis and Rose are
independent under the NYSEs listing
standards). Each member of the special committee is entitled to
a fee of $2,000 per meeting of the special committee, which is
in addition to the other board of director fees such members are
entitled to receive. As of the date of this proxy statement, the
special committee has held approximately fifty-two meetings.
Also on May 5, 2010, during the Companys conference
call regarding its first quarter 2010 earnings, the Company
reported, among other things, that it was continuing the process
of exploring strategic alternatives, including the potential
sale of the Company.
Beginning in May 2010, the special committee met regularly in
respect of the strategic alternatives process. On May 24,
2010, the special committee engaged Steptoe & Johnson
LLP (which we refer to in this proxy statement as Steptoe) as
legal counsel to the special committee. The special committee
considered engaging, but determined not to engage, its own
financial advisor.
From May 18, 2010 through June 3, 2010, 15 potential
buyers (each of which had executed a confidentiality agreement
with the Company) attended summary presentations by
Mr. LaPenta and other members of senior management
regarding the Companys businesses.
On May 19, 2010, at a telephonic meeting of the board of
directors, Mr. LaPenta provided an update on the
Companys exploration of strategic alternatives, including
the number and identity of parties that had entered into, or
were in discussions to enter into, a confidentiality agreement
with the Company.
Beginning on May 28, 2010, at the direction of the
Companys management and following review and comment by
management and the Companys advisors, a bid instruction
letter was distributed by the financial advisors to
approximately 44 parties (approximately 20 of which were
potential strategic buyers and the remainder of which were
potential financial buyers). The bid instruction letter
requested preliminary, non-binding indications of interest
regarding the potential acquisition of 100% of the Company in a
single transaction, or the acquisition of either of the
Companys identity solutions business group or intelligence
services business group, by June 8, 2010.
On June 1, 2010, at a telephonic meeting of the board of
directors, Mr. LaPenta provided an update on the strategic
alternatives review process. In addition, throughout the month
of June, the special committee continued to hold regular
meetings with representatives of Steptoe regarding the strategic
alternatives review process. Beginning in June 2010,
representatives of Skadden and Steptoe were also in frequent
contact regarding the process, which matters were reported to
the special committee by Steptoe.
On June 8 and 9, 2010, the Company received initial indications
of interest from thirteen companies pursuant to the May 28,
2010 bid instruction letter. The responses included one
indication of interest which contemplated the acquisition of the
entire Company, seven of which contemplated an acquisition of
the Companys intelligence services business group and four
of which (including an indication of interest from Safran)
contemplated an acquisition of the Companys identity
solutions business group. An additional indication of interest
in respect of the intelligence services business group was also
received the following week. Each of the indications of interest
contemplated transactions in which the purchase price would be
payable in the form of cash. BAE did not submit an initial
indication of interest during this time.
On June 9, 2010, the Company filed a
Form 8-K
disclosing a presentation that was being delivered by the
Company at an investor conference. The presentation disclosed
that, among other things, the financial advisors were continuing
their discussions with a number of interested parties as part of
the previously announced strategic alternative process.
On June 10, 2010, the board of directors held a telephonic
meeting with representatives of the financial advisors and
Skadden at which, among other things, representatives of the
financial advisors reviewed the terms of the initial indications
of interest that had been received. The Companys financial
advisors noted that the whole-company valuation implied by a
combination of the identity solutions and intelligence services
indications of interest was greater than the single
whole-company indication of interest that had been received. At
this meeting, the board of directors also adopted resolutions
specifying the authority and duties of the special committee,
which resolutions had been considered by the special committee
at its meetings with Steptoe that had been held during the weeks
leading up to the June 10, 2010 board meeting. Pursuant to
the resolutions adopted by the board of directors,
27
the authority and duties of the special committee included
evaluating and recommending or rejecting potential transactions
resulting from the Companys exploration of strategic
alternatives (including a potential sale of the Company) and
updating the board of directors with respect to the
committees deliberations and evaluations regarding the
strategic alternatives process.
During mid to late June 2010, representatives of the financial
advisors engaged with the parties that had submitted initial
indications of interest to clarify the terms of the submissions.
At the direction of the Companys board of directors, the
representatives of the financial advisors also contacted a
number of other potential buyers that had not submitted initial
indications of interest to assess interest in a potential
transaction involving the Company. During this time, Company
management and the financial advisors discussed which of the
potential buyers might be invited to conduct a due diligence
review of the Company and attend presentations by management
based on the terms of the initial indications of interest and
the subsequent discussions between the Companys financial
advisors and the applicable potential buyers. Also during this
time, representatives of Skadden engaged in a number of
discussions with the financial advisors regarding key
considerations implicated by a multi-buyer
transaction structure providing for a sale of the entire Company
in two separate transactions, including, among other things,
conditionality, the process and documentation for concurrent
auctions of the two business groups and the key transaction
terms expected to require negotiation between a buyer of the
identity solutions business group and a buyer of the
intelligence services business group in such a multi-buyer
transaction structure. Representatives of Skadden also worked
with management and the financial advisors to prepare auction
drafts of the alternative versions of the transaction agreements
that would be delivered to the potential buyers, consisting of:
(i) a draft merger agreement providing for a sale of the
entire company, (ii) a draft purchase agreement providing
for a sale of the stock and membership interests of McClendon,
LLC, SpecTal, LLC and Advanced Concepts, Inc. (the
Companys subsidiaries comprising the intelligence services
business group) and (iii) a draft merger agreement
providing for a sale of the Company following the consummation
of the sale of the intelligence services business group (with
the closing of the sale of remainco conditioned on
the prior or concurrent closing of the sale of the intelligence
services business group). The Skadden team also prepared a term
sheet for distribution to potential buyers of the identity
solutions or intelligence services business groups outlining the
key terms of the relationship between such buyers in a
multi-buyer transaction structure.
On June 21, 2010, at a telephonic meeting of the board of
directors, members of the board of directors, management and
representatives of the Companys advisors discussed the
status of the strategic alternatives process, the management
presentations being prepared and the scope of the due diligence
review to be undertaken as part of the potential buyers
evaluation of a possible transaction involving the Company. The
group also discussed each of the potential buyers and potential
multi-buyer transaction structures for a sale of the
intelligence services business group to one party simultaneously
with, or preceding, the sale of the Companys identity
solutions business group to another party.
From June 28, 2010 through July 9, 2010, management
presentations were conducted for nine of the parties that had
submitted initial indications of interest for all or a portion
of the Company (including Safran). During the management
presentations, members of the Companys management provided
the respective parties information concerning the sectors in
which the Company operates, the Companys business,
operations, technology and intellectual property as well as
other matters concerning the Company. During this period, these
nine potential buyers (each of which had previously executed a
confidentiality agreement) were also granted access to an online
data room containing non-public information about the Company,
including, among other things, information regarding financial
and accounting matters, legal entities, third party contracts,
employment matters, intellectual property, regulatory matters
and litigation. Buyers interested in an acquisition of the
intelligence services business group were provided with access
to the portion of the online data room containing due diligence
information concerning the intelligence services business group
and the legal entities comprising that business group. Buyers
interested in the acquisition of the identity solutions business
were given access to the portion of the online data room
containing due diligence information regarding the identity
solutions business as well the Companys corporate
structure and other corporate-level matters because it was
contemplated that, in the context of a multi-buyer transaction,
a purchaser of the identity solutions business group would
acquire the Company concurrently with, or following, a sale of
the intelligence services business group. During the course of
the due diligence process, the Company, with the assistance of
its financial and legal advisors, made certain additional
materials available through the online data room. Additional
materials regarding the identity solutions business group were
generally
28
made available to all potential buyers of that business group
who remained interested in pursing a transaction at the time the
information was made available, and additional materials
regarding the intelligence services business were generally made
available to all potential buyers of that business group who
remained interested in pursing a transaction at the time the
information was made available. In the case of the intelligence
services business group, the Company (in consultation with
outside counsel) limited access by strategic buyers to certain
information that was determined to be competitively sensitive.
In addition, during the course of the diligence review,
potential buyers were given substantially similar access to
members of the Companys management team in connection with
their due diligence review, and in response to requests by
potential buyers, the Company held calls with a number of
potential buyers to address supplemental diligence questions.
Subsequent to the management presentations and prior to being
given access to the online data room, the potential buyer that
had previously expressed an interest in an acquisition of the
entire Company communicated to the financial advisors that it no
longer wished to pursue a whole-company transaction, but that it
was interested in a potential acquisition of only the identity
solutions business group. Accordingly, such potential buyer was
given access to the same diligence information provided to other
potential buyers of the identity solutions business group.
On July 1, 2010, at a telephonic meeting, the board of
directors received an update from Mr. LaPenta on the
strategic alternatives process and the management presentations
that had taken place to date.
On July 2, 2010, the special committee held a telephonic
meeting to discuss, among other things, recent developments with
respect to the strategic alternatives process and certain
amounts that would become payable to executive officers of the
Company upon a change of control of the Company under
pre-existing contracts with such executives. Representatives of
Steptoe advised the special committee.
On July 3, 2010, at the direction of the Companys
management and following discussions with representatives of
Steptoe, representatives of the financial advisors distributed
the applicable forms of the auction draft transaction agreements
and multi-buyer term sheets to the four potential buyers
interested in the Companys identity solutions business
group (including Safran) and the five potential buyers
interested in the Companys intelligence services business
group.
On July 6, 2010, the board of directors held a telephonic
meeting, with representatives of the financial advisors and
Skadden attending. The board of directors received an update on
the current status of the process, including the management
presentations conducted to date and the draft transaction
agreements that had been distributed to the potential buyers.
Representatives of Skadden also reviewed with the board of
directors their fiduciary duties in connection with the
strategic alternatives process.
During early July 2010, at the direction of the Companys
management, representatives of Skadden and the financial
advisors held calls with certain potential buyers, including
Safran, to discuss the proposed multi-buyer transaction
structure (including the matters addressed by the term sheet
that had previously been distributed) and to answer questions
from the potential buyers. In addition, throughout July and
early August 2010, the potential buyers continued their due
diligence review of the Company and certain of the potential
buyers communicated to the financial advisors that they were no
longer interested in pursuing a possible transaction due to
various factors. Based on feedback received by the financial
advisors from these potential buyers, these factors included
(i) that the applicable buyer was not in a position to
offer financial terms competitive with other potential buyers
and (ii) that the applicable buyer had determined that a
transaction with the Company would not be a proper strategic fit
in light of such buyers views in respect of its business
and operations
and/or
factors relating the economic environment and the industries in
which the Company and the buyer operate. The potential buyers
that remained interested in a transaction with the Company were
given access to hard copy data rooms containing additional due
diligence information, including additional contracts to which
the Company was a party. In cases where the review of due
diligence information in the hard copy data room required
security clearance, access to the hard copy data rooms was
restricted to those representatives of the potential buyers that
had the requisite security clearances. In addition, during this
time, the Company and its advisors had discussions with
representatives of Safran and another potential foreign buyer of
the identity solutions business regarding CFIUS and related
regulatory matters.
On July 26, 2010, following review and comment by
management, Skadden, Steptoe and the financial advisors, and at
the direction of the Companys management, a final bid
instruction letter was distributed to (i) the three
potential buyers that continued to be interested in an
acquisition of the Companys identity solutions business
29
group (including Safran) and (ii) the three potential
buyers that continued to be interested in an acquisition of the
Companys intelligence services business group. The final
bid instruction letter requested that each potential buyer
submit, by August 10, 2010, a final written proposal for
the potential acquisition of the applicable business group,
together with a markup of the relevant transaction documents
that had previously been delivered to the parties.
Representatives of the financial advisors also communicated to
the potential buyers that they were invited to submit markups of
the applicable transaction documents prior to the final bid
deadline with a view to receiving (and revising their markups in
response to) feedback from the Company and Skadden regarding
such markup. Subsequent to the distribution of the final bid
instruction letter, two of the potential buyers that had
previously expressed an interest in an acquisition of the
Companys identity solutions business group, and one of the
potential buyers that had previously expressed an interest in an
acquisition of the Companys intelligence services business
group, indicated that they were no longer interested in a
potential transaction. Consequently, Safran emerged as the only
active participant in the sale process for the identity
solutions group, and two bidders (which, at the time, did not
include BAE) remained engaged in the sale process for the
intelligence services group.
On July 27, 2010, the board of directors held a meeting at
the Companys corporate headquarters in Stamford,
Connecticut. During this meeting, members of management reviewed
with the board of directors several ordinary course business
matters, including the Companys second quarter financial
results. Mr. LaPenta also provided an update to the board
of directors as to the strategic alternatives review process and
the current status of discussions with the potential buyers.
On July 28, 2010, the special committee held a meeting at
the offices of Steptoe in New York City, with representatives of
Steptoe, the financial advisors and Skadden in attendance. The
group discussed, among other things, the current status of
discussions with potential buyers, as well as the proposed
structures for the sale of the Companys intelligence
services business group and identity solutions business group in
a multi-buyer transaction. The financial advisors also discussed
their preliminary financial analyses of certain strategic
alternatives potentially available to the Company.
Also on July 28, 2010, during the Companys conference
call regarding its second quarter 2010 earnings, the Company
reported on, among other things, the progress of the strategic
alternatives review process, including that the Company had
received initial indications of interest from multiple parties,
both domestic and foreign.
On July 29, 2010, the Company engaged McDermott,
Will & Emery (which we refer to in this proxy
statement as McDermott) as outside antitrust counsel to the
Company in connection with the strategic alternatives review
process.
On July 30, 2010, representatives of Safran delivered a
markup of the merger agreement providing for the sale of the
Companys identity solutions business group that had
previously been distributed to potential buyers of that business
group.
On August 3 and 5, 2010, the Company provided revised
projections prepared by the Companys management to the
potential buyers, which projections included revised earnings
before interest, taxes, depreciation and amortization, or
EBITDA, figures for 2010. The 2010 EBITDA figures were revised
to reflect the Companys actual results for the six-month
period ended June 30, 2010, which were contained in the
financial statements included in the Companys Quarterly
Report on
Form 10-Q
for the period ended June 30, 2010 that was filed with the
SEC on July 27, 2010.
On August 4, 2010, representatives of the Company and its
regulatory counsel had a meeting with the Defense Security
Service to engage in preliminary discussions regarding the
possibility of a transaction involving the Company. During this
meeting, the Company reported to the Defense Security Service
that it was in discussions with a number of potential domestic
and foreign buyers.
On August 5, 2010, representatives of Skadden discussed the
terms of the markup submitted by Safran with representatives of
Weil, Gotshal & Manges LLP (which we refer to in this
proxy statement as Weil) and Kaye Scholer LLP, outside counsel
to Safran. The Skadden team clarified certain aspects of the
proposed multi-buyer transaction structure and identified
certain aspects of Safrans markup that should be improved
in order to make Safrans markup (and, accordingly,
Safrans forthcoming acquisition proposal) more attractive
to the Company, including, among other things, matters relating
to termination fees and efforts to obtain regulatory approvals.
30
On August 6, 2010, a potential financial buyer that had
expressed interest in the intelligence services business group
(which we refer to in this proxy statement as
Bidder X) submitted a markup of the purchase agreement
for the acquisition of the intelligence services business group.
On August 9, 2010, representatives of Skadden discussed the
terms of this markup with Bidder X and its outside counsel.
On August 10, 2010, Safran submitted a final bid for the
acquisition of the identity solutions business group, together
with a markup of the merger agreement that had been revised from
the markup previously submitted on July 30, 2010, including
to incorporate certain of the August 5th discussions
among the parties respective outside counsel.
Safrans final bid contemplated an acquisition of the
identity solutions business group at an enterprise value of
$1.225 billion. Among other things, Safrans final bid
indicated that Safran would require Mr. LaPenta and Aston
Capital Partners L.P. (which we refer to in this proxy statement
as Aston) sign a voting and support agreement with respect to
the transaction with Safran (see the section of this proxy
statement entitled Interests of Certain Persons
in the Merger Relationships with Aston and Stone
Key for information regarding Aston). Safrans
final bid also included a request that the Company enter into an
exclusivity agreement with respect to the identity solutions
business group. Also on August 10, 2010, Bidder X and
another potential financial buyer for the intelligence services
business group (which we refer to in this proxy statement as
Bidder Y) submitted final bids for the acquisition of
the intelligence services business group, together with markups
of the auction draft purchase agreement for that business group.
Bidder Xs markup had been revised from the
August 9th markup previously submitted, including to
incorporate certain of the August 9th discussions
between Bidder Xs counsel and representatives of
Skadden.
On August 11, 2010, the special committee held a meeting at
the offices of Steptoe in New York City, with representatives of
Steptoe, the financial advisors and Skadden in attendance. The
group reviewed and discussed the final bids that had been
received the prior evening. Following the special committee
meeting, the board of directors held a telephonic meeting,
including representatives of the financial advisors, Skadden and
Steptoe. Representatives of the financial advisors provided an
update to the board of directors regarding the final bids
received the prior evening. The financial advisors discussed
their preliminary financial analyses of a potential sale of the
Company assuming separate sales of the intelligence services
business group and of the identity solutions business group. At
the conclusion of the meeting, the board of directors authorized
the financial advisors and Skadden to revert to Safran and the
potential buyers of the intelligence services business group to
work to improve the terms of the bids submitted.
On August 12, 2010, the special committee held another
meeting at the offices of Steptoe, with representatives of
Steptoe in attendance. The special committee continued
discussions of the final bids that were submitted and also
reviewed other potential strategic alternatives, including
(i) continuing to operate the Company on a standalone
basis, (ii) selling only the intelligence services business
group and using the proceeds to reduce the Companys
outstanding indebtedness and (iii) refinancing the
Companys existing debt. The special committee continued to
hold regular meetings in respect of the strategic alternatives
process throughout August.
From August 12, 2010 through August 20, 2010,
representatives of Skadden exchanged draft term sheets with
Safran, Bidder X and Bidder Y regarding certain key
issues raised by each potential buyers markup of the
applicable transaction agreement. Principal issues under
discussion included financial terms, whether the closing of the
sale of the intelligence services group would be conditioned on
the closing of the identity solutions business group, the extent
of efforts required by the parties to obtain regulatory
approvals, termination rights, termination fees and, in the case
of Bidder X and Bidder Y, provisions related to buyer
financing. In the case of Safran, these discussions included
negotiations regarding, among other things, the force the
vote provision requested by Safran, the circumstances
under which the Companys board of directors could consider
alternative proposals and change their recommendation in favor
of the merger agreement and the size of the termination fee
which would be payable in certain circumstances. The initial
auction drafts sent to bidders for the identity solutions group
included certain provisions addressing these matters; however,
Safrans markup of the merger agreement generally proposed
to, among other things, narrow the circumstances in which the
board of directors could consider alternative proposals and
change their recommendation and proposed a specific dollar
amount for the termination fee. During this period, at the
direction of the Companys board of directors,
representatives of the Companys financial advisors also
contacted parties that had previously expressed interest in the
intelligence services business (but which were not active
participants in the sale process at that time), including BAE
and an additional potential financial buyer that
31
had not previously submitted an indication of interest (which
we refer to in this proxy statement as Bidder Z). Also,
during this time, each of Safran, Bidder X, Bidder Y
and their respective advisors continued their due diligence
efforts, which included, from time to time, discussions with
representatives of the Company and its financial and legal
advisors.
On August 17, 2010, following the exchange of various draft
term sheets and discussions with the Companys financial
and legal advisors regarding the terms of its proposed bid,
Safran submitted a revised final bid which, among other things,
provided for an increase in Safrans proposed purchase
price to an enterprise valuation for the identity solutions
business group of $1.275 billion and certain improved terms
(including in respect of regulatory approvals and termination
fees). The revised proposal letter reiterated Safrans
exclusivity and voting and support agreement requests.
On August 18, 2010, the special committee held a telephonic
meeting, with representatives of Steptoe, Skadden and the
financial advisors in attendance. The group reviewed the terms
of Safrans revised final bid and the ongoing discussions
with Safran. Representatives of the financial advisors also
updated the special committee on ongoing discussions with
potential buyers of the intelligence services business group and
noted that Bidders X and Y had not submitted revised financial
terms from the bids that they had previously submitted.
On the morning of August 19, 2010, the Company issued a
press release providing an update on the strategic alternatives
process. The press release disclosed that the Company had
received bids from several interested parties and that the
Company continued to evaluate the various proposals. Later that
morning, the board of directors held a telephonic meeting with
representatives of the financial advisors, Skadden and Steptoe
in attendance. Representatives of the financial advisors
provided an update to the board of directors regarding Safran
(including the terms of its revised August 17th bid),
as well as discussions with the potential buyers for the
intelligence services business group. Among other things, the
board of directors discussed entering into an exclusivity
agreement with Safran with respect to the identity solutions
business group and, after weighing the advantages and
disadvantages of such an agreement and discussing other parties
that may potentially be interested in the identity solutions
business group, the board of directors authorized management to
enter into an exclusivity agreement with Safran.
Also on August 19, 2010, following a series of discussions
with representatives of Stone Key, BAE communicated an interest
in a potential acquisition of the Companys intelligence
services business group and was given access to the online data
room to conduct due diligence in respect of the intelligence
services business group as well as a hard copy data room
containing certain contracts to which the Company was a party
and which had been provided to other potential buyers of the
intelligence services business group. Representatives of BAE
communicated to representatives of Stone Key that, subject to
due diligence, BAE may be willing to consider a purchase price
for the intelligence services business group of at least
$300,000,000 (a purchase price in excess of the range of prices
contemplated by each of Bidders X and Y). A draft purchase
agreement for the acquisition of the intelligence services
business group was sent to BAE on August 20, 2010. Also on
August 20, 2010, following discussions between
representatives of Bidder Z and representatives of Stone
Key, Bidder Z was given access to the online data room and
a draft purchase agreement for the intelligence services
business group was delivered to Bidder Z. The draft
purchase agreements delivered to BAE and Bidder Z
incorporated certain revisions based on comments from
Bidder Xs and Bidder Ys
mark-ups of
the auction draft of the purchase agreement. Further, the
purchase agreement delivered to BAE incorporated certain
provisions relating to regulatory matters applicable to a
foreign strategic buyer. In addition, representatives of Skadden
sent a draft exclusivity agreement with respect to the
Companys identity solutions business group to Weil as
counsel to Safran.
On August 21, 2010, representatives of Skadden delivered a
revised draft merger agreement to Weil incorporating certain
terms that had been addressed by the parties during the exchange
of term sheets. Representatives of Skadden and Weil also
exchanged drafts of the proposed exclusivity agreement. An
exclusivity agreement providing for a period of exclusive
negotiations through September 3, 2010 was executed by the
Company and Safran later that day.
From August 21, 2010 through August 23, 2010,
representatives of Skadden and the financial advisors continued
to exchange term sheets with Bidder Y in respect of
Bidder Ys previously submitted bid for the
intelligence services group and continued ongoing discussions
with BAE, Bidder X and Bidder Z. During this time,
representatives of Skadden and the financial advisors worked to
negotiate the most favorable transaction terms with
32
these parties, including maximum price and, in the case of
bidders X and Y, minimum financing conditionality. In addition,
during this time the Companys management, with the
assistance of the Companys financial and legal advisors,
began exploring the possibility of spinning-off the
Companys intelligence services business group in
conjunction with a sale of the remaining Company to Safran.
On August 23, 2010, the special committee held a telephonic
meeting with representatives of Steptoe in attendance to review
various matters related to the strategic alternatives process.
That afternoon, the board of directors also held a telephonic
meeting with representatives of the financial advisors, Skadden
and Steptoe attending. The Companys advisors provided an
update to the board of directors regarding Safran and the
potential intelligence services buyers. The board of directors
discussed a request from Bidder Y for a period of exclusive
negotiations in respect of the intelligence services business
group. After weighing the advantages and disadvantages of
exclusivity, including a discussion of the other parties that
may potentially be interested in acquiring the intelligence
services business group (including the status of BAE and Bidders
X and Z), the board of directors determined not to enter into an
exclusivity agreement with Bidder Y at that time. Also at
the meeting, members of management discussed with the board of
directors certain projections prepared by management that had
previously been distributed to potential buyers and the possible
need to deliver revised projections with respect to certain
forecasted metrics for the 2013 and 2014 fiscal years reflecting
managements best estimates and current views concerning,
among other things, growth rates in future years, competition in
the industry, various contracts that were to come up for
re-compete and other revised business expectations. After
subsequent discussion among the board of directors and the
special committee, the revised projections prepared by
management were distributed to Safran on August 30, 2010.
Following the meeting of the board of directors, the special
committee held an additional telephonic meeting with
representatives of Steptoe to review the various matters that
had been discussed at the meeting of the board of directors.
On August 23 and 24, 2010, representatives of Skadden and
Weil continued to discuss the terms of the draft merger
agreement.
On August 24, 2010, the special committee held a telephonic
meeting, with representatives of Steptoe and the financial
advisors in attendance. The special committee discussed
potential strategic alternatives available to the Company
(including the potential sale transactions contemplated by
ongoing discussions with bidders). The special committee
reconvened with representatives of Steptoe later that evening
and on August 25, 2010 to continue their discussions.
On August 25, 2010, representatives of Weil delivered a
further revised draft of the merger agreement to Skadden. Also
on August 25, 2010, representatives of the Company, Safran
and their respective regulatory counsel had a meeting with the
Defense Security Service to discuss matters regarding a
potential acquisition of the Company by Safran, including the
regulatory review process that would be implicated as a result
of Safran being a
non-U.S. entity.
Also on August 25, 2010, Bidder Y contacted the
financial advisors to communicate Bidder Ys intention
to reduce its proposed purchase price on account of the absence
of a working capital adjustment with respect to the intelligence
services business group, as had been discussed during the
exchange of term sheets with Bidder Y.
On August 26, 2010, representatives of Skadden discussed
with representatives of Crowell & Moring LLP (which we
refer to in this proxy statement as Crowell), outside counsel to
BAE, aspects of the draft purchase agreement that had previously
been provided to BAE. In addition, on August 26, 2010,
Bidder Z indicated to the Companys financial advisors
that it could not significantly increase its purchase price
beyond the price indicated in its initial indication of
interest. Bidder Z did not officially contact the financial
advisors to withdraw itself from the process, but no further
negotiations took place with Bidder Z regarding a potential
transaction in light of Bidder Zs inability to raise
its purchase price within a range that was competitive with the
pricing under discussion with BAE.
Also on August 26, 2010, the special committee held a
telephonic meeting, with representatives of Steptoe and the
financial advisors in attendance. The special committee
discussed potential strategic alternatives available to the
Company. Representatives of the financial advisors also provided
an update regarding Safran and the potential intelligence
services buyers and discussed their preliminary financial
analysis of a potential sale of the Company and a potential
spin-off of the Companys intelligence services business
group.
33
On August 27, 2010, the special committee held a telephonic
meeting, with representatives of Steptoe in attendance.
Representatives of the financial advisors and Skadden were
invited to join the latter portion of the meeting. The
Companys advisors updated the special committee as to the
status of negotiations with Safran and the potential
intelligence services buyers. Representatives of Skadden also
reviewed with the special committee certain matters regarding
the BAE purchase agreement that had been raised by Crowell on
behalf of BAE. At the meeting, representatives of the financial
advisors also reported that Bidder Y had resubmitted its
prior request for an exclusivity agreement with respect to the
intelligence services business group and that Bidder Y
stated that it was not willing to engage in further discussions
without exclusivity. Following an extended discussion (including
a review of the other parties that were potentially interested
in the intelligence services business group, including BAE), the
special committee determined to recommend that the Company not
enter into an exclusivity agreement with Bidder Y at that
time in order to give other potentially interested parties more
time to submit their bids. After the meeting, at the direction
of the special committee, representatives of Goldman Sachs
relayed this determination to Bidder Y and, in response,
Bidder Y subsequently notified the Company in writing that
it was no longer interested in pursuing a potential transaction
involving the Company.
On August 29, 2010, representatives of Skadden sent a
revised draft of the merger agreement to Weil and, on
August 30, 2010, engaged in discussions with
representatives of Weil regarding the draft.
On August 30, 2010, the special committee met
telephonically, with representatives of Steptoe, the financial
advisors and Skadden in attendance. Following an update
regarding Safran and the potential intelligence services buyers,
representatives of the financial advisors separately discussed
with the special committee their preliminary financial analyses
of a potential transaction with Safran (using illustrative
purchase prices for the intelligence services business group)
and a potential spin-off of the intelligence services business
group in lieu of a sale to a third party, and the group
discussed certain financial analyses in respect of this scenario.
On August 31, 2010, the board of directors held a
telephonic meeting, with representatives of the financial
advisors, Skadden and Steptoe in attendance. Representatives of
the financial advisors reported on their discussions with
Safrans financial advisors, including the possibility of a
spin-off of the intelligence services business group in lieu of
a sale to a third party and the possibility of entering into and
announcing an acquisition agreement with Safran without a
definitive agreement for the disposition of the intelligence
services business group in place at the time of such
announcement. At this meeting, representatives of the financial
advisors also reviewed with the full board of directors the
preliminary financial analyses that had been discussed with the
special committee the prior day. Following the board of
directors meeting, the special committee held a telephonic
meeting with representatives of Steptoe to review the current
status of discussions with Safran and the potential intelligence
services buyers.
Also on August 31, 2010, BAE submitted an indication of
interest to Stone Key in respect of the intelligence services
business group, with a proposed purchase price of $305,000,000
(on a cash and debt-free basis, subject to the inclusion of
certain indemnification provisions in the draft purchase
agreement and inclusive of certain assumed obligations). On
September 1, 2010, representatives of the financial
advisors and Skadden met with management of BAE at the offices
of Stone Key in Greenwich, Connecticut. At this meeting, the
group discussed BAEs proposal, including the purchase
price for the acquisition, the applicable adjustments to the
purchase price and certain obligations to be assumed by BAE as
part of the transaction. The parties also discussed certain
aspects of the draft purchase agreement, including, among other
things, indemnification rights, allocation of liabilities,
conditionality and certain matters related to employees of the
Transferred Intel Companies and, as a result of such discussions
and BAE agreeing to forego any indemnification rights in respect
of breaches of representations and warranties, representatives
of BAE indicated a revised total purchase price of $303,000,000
(inclusive of certain assumed obligations). Following the
meeting with BAE, the special committee and, thereafter, the
board of directors, convened telephonic meetings to receive an
update from the Companys financial and legal advisors
regarding the days meetings with BAE and the terms of
BAEs proposal.
Later in the evening of September 1, 2010, representatives
of Weil sent a revised merger agreement to Skadden.
Throughout the first two weeks of September, the special
committee met frequently (with representatives of Steptoe in
attendance for all meetings and representatives of the financial
advisors and Skadden in attendance for certain meetings) to
discuss the status of discussions with Safran and BAE and
related matters. During this period,
34
the board of directors also held three meetings to discuss
similar matters, with representatives of the financial advisors,
Skadden and Steptoe in attendance.
On September 2, 2010, BAE submitted a markup of the draft
purchase agreement for the acquisition of the intelligence
services business group.
On September 3, 2010, following approval by the board of
directors, the Company extended its exclusivity agreement with
Safran through September 10, 2010. The exclusivity
agreement was further extended on September 10, 2010
through September 17, 2010 following approval by the board
of directors. On September 4, 2010, in connection with
negotiations between Safran and the Company to finalize the
price per share merger consideration, Goldman delivered to
Safran and its advisors an estimate provided by the Company of
net debt of $464,800,000 as of December 31, 2010, before
the payment of transaction costs, which assumed that the Merger
and BAE Transaction would not have occurred prior to
January 1, 2011, and included other assumptions regarding
operating results and cash flows.
Throughout early September 2010, the Company, BAE and their
respective counsel continued to negotiate the terms of the
intelligence services business group purchase agreement, and the
Company, Safran and their respective counsel continued to
negotiate the merger agreement and the voting and support
agreement in respect of the acquisition of the Companys
identity solutions business group. During this time,
representatives of the Companys financial advisors also
engaged in discussions with representatives of Safrans
financial advisors concerning the price per share of Company
common stock to be paid by Safran in the proposed merger
(previously, Safran had proposed a purchase price for the
identity solutions group on an enterprise value basis). Also
during this time, each of BAE, Safran and their respective
representatives and advisors continued their due diligence
efforts, which included, from time to time, discussions with
representatives of the Company and its financial and legal
advisors.
During the first two weeks of September, the Company, BAE,
certain members of senior management of the intelligence
services business group and their respective counsel negotiated
the terms of a retention and bonus plan for a group of certain
intelligence services business group employees and severance
arrangements and non-competition agreements for three senior
members of the intelligence services business group.
On September 9, 2010, upon the approval of each of Safran
and BAE, representatives of Skadden provided Weil with selected
portions of the BAE purchase agreement and provided Crowell with
certain portions of the Safran merger agreement (including,
among others, closing conditions), in each case, on a
no-names basis. On September 13, 2010, the
Company, Safran and BAE entered into a Co-Buyer Disclosure
Agreement, pursuant to which the identities of Safran and BAE
were disclosed to one another and, in accordance with the terms
of the Co-Buyer Disclosure Agreement, Skadden delivered to
representatives of Weil the current draft of the BAE purchase
agreement and delivered to representatives of Crowell the
current draft of the Safran merger agreement.
From September 14 through September 16, 2010, the Company,
BAE and their respective counsel continued to negotiate the
terms of the intelligence services business group purchase
agreement, and the Company, Safran and their respective counsel
continued to negotiate the terms of the identity solutions
merger agreement. During this time, the parties discussed
various matters including, among other things, the allocation of
liabilities between Safran and BAE. In addition, during this
time, representatives of Safran, the Company and their
respective financial advisors continued their discussions in
respect of the translation of Safrans proposed
identity solutions enterprise value into a price per share of
Company common stock. In light of the structure of the sale
process (whereby Safran was bidding on the identity solutions
business group), discussions regarding Safrans proposed
purchase price had previously centered on an aggregate
enterprise value for the identity solutions group. As
discussions with both Safran and BAE progressed toward a
combined transaction ultimately providing for a fixed per share
merger consideration to the Companys stockholders, it was
necessary to agree upon that fixed per share price with Safran
(which required, among other things, agreement as to the number
of shares projected to be outstanding as of closing, the
outstanding debt of the Company as of closing and expected
transaction expenses payable by the Company). In the discussions
of the price per share to be paid in the Merger, Safran took the
position that such price per share was tied to the BAE purchase
price on a
dollar-for-dollar
basis, in that the proceeds to be received in the BAE
transaction were included in the pool of funds
(together with the price to be paid by Safran for the identity
solutions group) to be divided among stockholders after
providing for the repayment of indebtedness and the payment of
transaction expenses.
35
Also during the period from September 14 through
September 16, 2010, the special committee continued to hold
regular telephonic meetings (with representatives of Steptoe
and, in certain cases, the financial advisors and Skadden, in
attendance), to discuss, among other things, the status of
discussions with Safran and BAE. On September 15, 2010, the
board of directors held a telephonic meeting with
representatives of the financial advisors, Skadden and Steptoe.
The group discussed the status of discussions with Safran and
BAE and the price per share contemplated by a combined BAE and
Safran transaction. The group also discussed potential
alternatives that may be available to the Company if the Company
were not able to reach final agreement on a transaction with
either Safran or BAE on terms that the board of directors
determined to be favorable to the Companys stockholders.
As of the close of business on September 16, 2010, BAE and
the Company had resolved the principal open items in the BAE
purchase agreement, other than with respect to the allocation of
certain liabilities between BAE and Safran. During the evening
of September 16, 2010, representatives of Skadden and the
financial advisors engaged with BAE management and
representatives of Crowell and reached a proposed compromise
position in respect of such liability allocation matters
(subject to the agreement of Safran).
With respect to the Safran merger agreement, discussions
regarding purchase price and certain open matters in the draft
merger agreement continued among Safran, the Company and their
respective financial and legal advisors through the evening of
September 16, 2010. During the late morning of
September 17, 2010, representatives of Safran delivered a
package of compromise positions with respect to key open items
in the draft merger agreement (including certain regulatory and
employment matters), and a proposed per share price of $11.93.
Also during the morning of September 17, 2010,
representatives of BAE confirmed a purchase price for the
intelligence services business group of $303,000,000 (comprising
$295,833,000 in cash and approximately $7,291,000 of certain
assumed obligations related to payments to officers and
employees of the Transferred Intel Companies under the Intel
Companies Special Employee Plan to be adopted in connection with
the BAE Transaction (see the section of this proxy statement
entitled BAE Agreement
Representations and Warranties, Termination Rights, Covenants
and Certain Employee Matters)), on a cash and
debt-free basis and subject to certain adjustments, and
representatives of the Companys financial advisors
communicated this purchase price to representatives of Safran.
Representatives of Skadden continued to engage with
representatives of Weil throughout the day on September 17,
2010, during which time all remaining key open items in the
Safran merger agreement (other than purchase price) were
resolved, including matters relating to the allocation of
liabilities between Safran and BAE. During this time, Company
management and representatives of the Companys financial
advisors also had a number of discussions with Safran management
and representatives of Safrans financial advisors. At the
conclusion of these discussions, Safran agreed to increase its
proposed purchase price for the acquisition of the Company
(following the sale of the intelligence services business group)
to $11.97 per share of Company common stock and, during further
discussions on the morning of September 18, 2010, Safran
agreed to proposed merger consideration of $12.00 per share in
cash, which price assumed the Companys receipt of net
proceeds to be paid by BAE for the intelligence services
business group pursuant to BAEs proposal.
On the afternoon of September 18, 2010, the special
committee held a telephonic meeting, with representatives of
Steptoe, the financial advisors and Skadden in attendance. The
Companys advisors updated the special committee as to the
status of discussions with Safran and BAE and reviewed the
proposed terms of the BAE purchase agreement and the Safran
merger agreement. Representatives of Goldman Sachs and Stone Key
made separate presentations with respect to their financial
analyses of Safrans proposed merger consideration of
$12.00 per share in cash. Representatives of Skadden then
addressed the status of negotiations and the key terms of the
proposed agreements. Later that evening, the special committee
held another telephonic meeting, with representatives of Steptoe
in attendance, and unanimously resolved to recommend that the
full board of directors consider and approve the execution,
delivery, performance and consummation of the Safran merger
agreement and BAE purchase agreement and the transactions
contemplated thereby as advisable and in the best interests of
the Company and its stockholders.
Following the special committee meeting, on the evening of
September 18, 2010, the board of directors held a
telephonic meeting. Representatives of the financial advisors,
Skadden, McDermott and Steptoe were also in attendance. At the
meeting, representatives of Goldman Sachs and Stone Key each
made presentations as to their financial analyses with respect
to Safrans proposed merger consideration of $12.00 per
share in cash (which presentations had been shared with the
special committee earlier in the day and circulated to the full
board of
36
directors prior to the meeting). Each of Goldman Sachs and Stone
Key then separately delivered to the board of directors its oral
opinion, which was subsequently confirmed in writing, dated
September 19, 2010, in the case of Goldman Sachs, and dated
September 18, 2010, in the case of Stone Key, that, as of
such date, and based on and subject to the various limitations
and assumptions described in the applicable opinion, the $12.00
per share in cash to be paid to the holders (other than Safran
and its affiliates) of the outstanding shares of common stock of
the Company pursuant to the merger agreement was fair from a
financial point of view to such holders (copies of the written
opinions of Goldman Sachs and Stone Key are attached to this
proxy statement as Annex C and Annex D, respectively).
The board of directors then discussed with Company management
and representatives of the financial advisors and legal counsel
the proposed transactions with each of Safran and BAE, and
representatives of Skadden reviewed the terms of the proposed
Safran merger agreement and BAE purchase agreement (including
the matters that had been reviewed with the special committee
earlier in the day). In addition, representatives of Skadden
again reviewed with the board of directors its fiduciary duties
in connection with the review and, if applicable, approval of
the proposed transactions. The group also discussed certain
risks associated with the Safran merger and the BAE transaction
and the rationale for entering into the proposed transactions,
including a discussion of the factors described in the section
of this proxy statement entitled Reasons for the
Merger; Recommendation of Our Board of Directors.
After careful consideration, the board of directors, upon the
unanimous recommendation by the special committee, unanimously
voted to adopt resolutions approving and declaring advisable the
execution, delivery and performance of the Safran merger
agreement and the BAE purchase agreement and the transactions
contemplated thereby (including the Safran merger), and
determined that the merger agreement, the purchase agreement and
the transactions contemplated thereby (including the Safran
merger) were advisable and in the best interests of the
Companys stockholders.
Through the night of September 18, 2010 and into the
morning of September 19, 2010, the parties worked to
finalize the terms of the Safran merger agreement and the BAE
purchase agreement in accordance with the terms discussed with
the board of directors and, in the afternoon of
September 19, 2010, the parties executed and delivered the
Safran merger agreement, the voting and support agreement, the
BAE purchase agreement and certain related documents. Prior to
the open of trading in the European securities markets and the
NYSE on September 20, 2010, each of the Company, Safran and
BAE issued press releases announcing the transactions.
Reasons
for the Merger; Recommendation of Our Board of
Directors
Our board of directors, with the advice and assistance of our
management and legal and financial advisors, at a meeting on
September 18, 2010, carefully evaluated the proposed
Merger, including the terms and conditions of the Merger
Agreement and the BAE Agreement. Our board of directors
unanimously (i) determined that the Merger Agreement and
the Merger are advisable and in the best interests of the
Company and its stockholders, (ii) approved the Merger
Agreement and the Merger and (iii) resolved to recommend
the adoption of the Merger Agreement and approval of the Merger
to our stockholders.
In the course of reaching its determination, our board of
directors consulted with our management and its legal and
financial advisors and considered a number of substantive
factors and potential benefits of the Merger. Our board of
directors believed that, taken as a whole, the following factors
supported its decision to approve the proposed Merger:
|
|
|
|
|
the board of directors familiarity with the Companys
business, operations, assets, properties, business strategy and
competitive position and the nature of the industries in which
the Company operates, industry trends, and economic and market
conditions, both on a historical and on a prospective basis;
|
|
|
|
the financial condition and prospects of the Company, as well as
the risks involved in achieving those prospects and the risks
and uncertainties associated with operating the Companys
business, including:
|
|
|
|
|
|
risks described in the Companys filings with the SEC;
|
|
|
|
certain macroeconomic factors, including the impact of potential
budget cuts and delays in key defense and homeland security
programs, shortfalls in state and local government funding and
the material impact of the global economic downturn, and how
these factors could impact the Company; and
|
37
|
|
|
|
|
the Companys current financial plan, including the risks
associated with achieving and executing upon the Companys
business plan, in particular the risks of slower adoption of the
Companys new products and services, delays in the awarding
of certain contracts and increased pressure from competitors;
|
|
|
|
|
|
the fact that the Company conducted an extensive and thorough
strategic alternatives review process that was first
publicly-disclosed in January 2010 and included the assistance
of Goldman Sachs and Stone Key beginning in March 2010;
|
|
|
|
the board of directors belief that, after consideration of
potential alternatives, the Merger is expected to provide
greater benefits to the Companys stockholders than the
range of possible alternatives to the sale of the Company,
including continuing to operate the Company on a standalone
basis, the sale or other disposition of one or more of the
Companys businesses without a sale of the whole Company
and other strategic alternatives;
|
|
|
|
the board of directors assessment, after discussions with
the Companys management and advisors, of the risks of
remaining an independent company and the prospects of the
Company going forward as an independent entity, including the
risks that the Company would not be in compliance with the
financial covenants contained in the Companys credit
agreement and would need to refinance its debt on a long-term
basis;
|
|
|
|
the fact that the $12.00 per share merger consideration
contemplated to be received by the Companys stockholders
in connection with the Merger represents a premium to historic
trading prices, including (i) a premium of 66% over the
closing sale price of $7.23 on the New York Stock Exchange on
January 5, 2010, the trading day prior to the
Companys public announcement of its strategic alternatives
review process and (ii) a premium of approximately 24% over
the closing sale price of $9.70 on the New York Stock Exchange
on September 17, 2010, the last trading day prior to
announcement of the Merger;
|
|
|
|
(i) the financial analysis presented by Goldman Sachs, as
well as the oral opinion of Goldman Sachs, which was later
confirmed in writing, that, as of September 19, 2010, and
based upon and subject to the limitations and assumptions set
forth therein, the $12.00 per share in cash to be paid to the
holders (other than Safran and its affiliates) of the
outstanding shares of common stock of the Company pursuant to
the Merger Agreement was fair from a financial point of view to
such holders; and (ii) Stone Keys opinion that, as of
September 18, 2010, and based upon and subject to the
qualifications, limitations and assumptions set forth therein,
the $12.00 per share in cash to be received by holders of our
common stock pursuant to the Merger Agreement was fair, from a
financial point of view, to such holders;
|
|
|
|
the form of consideration to be paid to holders of shares in the
Merger is cash, which will provide certainty of value and
immediate liquidity to the Companys stockholders;
|
|
|
|
the board of directors review, with the Companys
advisors, of the structure of the Merger and the BAE
Transaction, and the financial and other terms of the Merger
Agreement and the BAE Agreement. In particular, the board of
director considered the following specific aspects of the Merger
Agreement, among others:
|
|
|
|
|
|
the ability of the board of directors to withdraw or modify its
recommendation of the Merger or the Merger Agreement, or
recommend, adopt or approve an Acquisition Proposal, upon
receipt of a Superior Proposal or upon the occurrence of an
Intervening Event (as such terms are defined in the Merger
Agreement and described in the sections of this proxy statement
entitled The Merger Agreement Restrictions
on Solicitations of Other Offers and The
Merger Agreement Change of
Recommendation), in each case, if the failure to take
such action would be reasonably likely to be inconsistent with
the directors fiduciary duties and subject to payment of a
termination fee of $25,000,000 to Safran (as discussed in the
section of this proxy statement entitled The Merger
Agreement Termination Fees and Reimbursement of
Expenses);
|
|
|
|
the circumstances under which the termination fee is payable by
the Company to Safran and the size of such termination fee,
which the board of directors views as reasonable in light of the
size and benefits of the Merger and not preclusive of a Superior
Proposal, if one were to emerge;
|
38
|
|
|
|
|
the circumstances under which a termination fee is payable by
Safran to the Company and the size of such termination fee (see
the section of this proxy statement entitled The Merger
Agreement Termination Fees and Reimbursement of
Expenses);
|
|
|
|
the Companys ability to engage in negotiations with, and
provide information to, a third party that makes an unsolicited
written Acquisition Proposal, if the board of directors
determines in good faith, after consultation with its outside
legal and financial advisors, that such proposal constitutes or
could reasonably be expected to result in a Superior Proposal,
if the failure to take such action would be reasonably likely to
be inconsistent with the directors fiduciary duties;
|
|
|
|
the fact that there are no financing conditions to the
completion of the Merger; and
|
|
|
|
the requirement that the Company obtain stockholder approval as
a condition to completion of the Merger;
|
|
|
|
|
|
the fact that Safran and BAE committed to providing employees
who remain employed following the applicable transaction with
the continuation of certain benefits and salary; and
|
|
|
|
the fact that the special committee of the board of directors
considered and reviewed the terms of the Merger Agreement and
the BAE Agreement, evaluated the transactions independently from
the Companys management and recommended such transactions
to the board of directors.
|
In addition, the board of directors was aware of and considered
the interests that certain individuals, including our directors
and executive officers, may have with respect to the Merger that
may differ from, or may be in addition to, their interests as
stockholders of the Company, as described in the section of this
proxy statement entitled Interests of Certain
Persons in the Merger.
Our board of directors also considered potential risks or
negative factors relating to the Merger and the BAE Transaction,
including but not limited to the following:
|
|
|
|
|
the risks and contingencies relating to the announcement and
pendency of the Merger and the BAE Transaction and the risks and
costs to the Company if the BAE Transaction and / or
the Merger do not close or such closings are not timely,
including the effect of an announcement of termination of either
or both transactions on the trading price of our common stock,
operating results and our relationships with customers,
suppliers and employees;
|
|
|
|
our ability to attract and retain key personnel and the risk of
diverting management focus and employee resources from
operational matters during the pendency of the Merger and the
BAE Transaction;
|
|
|
|
the possible disruption to the Companys business that may
result from the announcement of the Merger and the BAE
Transaction;
|
|
|
|
the risks associated with various provisions of the Merger
Agreement and the BAE Agreement, including:
|
|
|
|
|
|
the fact that the Merger Agreement and the BAE Agreement contain
certain limitations (subject to the consent of the applicable
buyer) regarding the operation of the Companys business
during the period between the signing of the agreement and
completion of the Merger or BAE Transaction, as applicable;
|
|
|
|
the fact that the closing of the Merger is conditioned upon the
closing of the BAE Transaction;
|
|
|
|
the risk that the Company might not receive the necessary
regulatory approvals and clearances; and
|
|
|
|
the requirement that under the Merger Agreement the Company must
submit the Merger Agreement and the Merger to a vote of the
Companys stockholders even if the Company receives a
Superior Proposal by a third party, and the requirement that the
Company must pay to Safran a termination fee of $25,000,000 if
the Merger Agreement is terminated under certain circumstances,
which might discourage other parties potentially interested in
an acquisition of, or combination with, the Company from
pursuing that opportunity. See the sections of this proxy
statement entitled The Merger Agreement
Stockholders Meeting; Proxy Statement and The
Merger Agreement Termination Fees and Reimbursement
of Expenses, respectively. The Companys board of
directors, after consultation with its legal and financial
advisors, believed that the termination fee payable by the
Company in such circumstance was reasonable
|
39
|
|
|
|
|
in light of the size and benefits of the Merger and not
preclusive of a Superior Proposal, if one were to
emerge; and
|
|
|
|
|
|
the fact that if the Merger is consummated, the Company will no
longer exist as an independent company and the Companys
stockholders will no longer participate in the companys
future earnings and growth.
|
The foregoing discussion summarizes certain material factors
considered by the board of directors in its consideration of the
Merger. In view of the wide variety of factors considered by the
board of directors, and the complexity of these matters, the
board of directors did not find it practicable to quantify or
otherwise assign relative weights to the foregoing factors. In
addition, individual members of the board of directors may have
assigned different weights to various factors. Our board of
directors concluded that the potentially negative factors
associated with the Merger Agreement and BAE Agreement were
substantially outweighed by the opportunity for the
Companys stockholders to realize a premium on the value of
their shares of common stock and to monetize their investment in
the Company. Accordingly, our board of directors, by unanimous
vote, approved and declared advisable the execution, delivery
and performance of the Merger Agreement and the transactions
contemplated by the Merger Agreement, including the Merger, and
determined that the Merger Agreement and the transactions
contemplated by the Merger Agreement, including the Merger, are
advisable and in the best interests of the Companys
stockholders.
Our board of directors recommends that you vote
FOR the proposal to adopt the Merger Agreement and
approve the Merger and FOR the adjournment or
postponement of the special meeting, if necessary or
appropriate, to solicit additional proxies.
Opinion
of Goldman, Sachs & Co.
Goldman Sachs delivered its opinion to the Companys board
of directors that, as of September 19, 2010 and based upon
and subject to the limitations and assumptions set forth
therein, the $12.00 per share merger consideration to be paid in
cash to the holders (other than Safran and its affiliates) of
the outstanding shares of common stock of the Company pursuant
to the Merger Agreement was fair from a financial point of view
to such holders.
The full text of the written opinion of Goldman Sachs, dated
September 19, 2010, which sets forth assumptions made,
procedures followed, matters considered and limitations on the
review undertaken in connection with the opinion, is attached as
Annex C to this proxy statement. Goldman Sachs provided its
opinion for the information and assistance of the Companys
board of directors in connection with its consideration of the
Merger. The Goldman Sachs opinion is not a recommendation as to
how any holder of the Companys common stock should vote
with respect to the Merger or any other matter.
In connection with rendering the opinion described above and
performing its related financial analyses, Goldman Sachs
reviewed, among other things:
|
|
|
|
|
the Merger Agreement;
|
|
|
|
the BAE Agreement;
|
|
|
|
annual reports to stockholders and Annual Reports on
Form 10-K
of the Company for the four years ended December 31, 2009;
|
|
|
|
certain interim reports to stockholders and Quarterly Reports on
Form 10-Q
of the Company;
|
|
|
|
certain other communications from the Company to its
stockholders;
|
|
|
|
certain publicly available research analyst reports for the
Company; and
|
|
|
|
certain internal financial analyses and forecasts for the
Company prepared by its management in late August 2010, as
approved by the Company for use by Goldman Sachs (which are
referred to in this proxy statement as the Forecasts).
|
Goldman Sachs also held discussions with members of the senior
management of the Company regarding their assessment of the past
and current business operations, financial condition and future
prospects of the Company. In
40
addition, Goldman Sachs reviewed the reported price and trading
activity for the shares of common stock of the Company, compared
certain financial and stock market information for the Company
with similar information for certain other companies the
securities of which are publicly traded, reviewed the financial
terms of certain recent business combinations in the defense
industry and in other industries, and performed such other
studies and analyses, and considered such other factors, as
Goldman Sachs deemed appropriate.
For purposes of rendering the opinion described above, Goldman
Sachs relied upon and assumed, without assuming any
responsibility for independent verification, the accuracy and
completeness of all of the financial, legal, regulatory, tax,
accounting and other information provided to, discussed with or
reviewed by it, and Goldman Sachs does not assume any
responsibility for any such information. In that regard, Goldman
Sachs assumed with the Companys board of directors
consent that the Forecasts were reasonably prepared on a basis
reflecting the best currently available estimates and judgments
of the management of the Company. Goldman Sachs did not make an
independent evaluation or appraisal of the assets and
liabilities (including any contingent, derivative or other
off-balance-sheet assets and liabilities) of the Company or any
of its subsidiaries and was not furnished with any such
evaluation or appraisal. Goldman Sachs assumed that all
governmental, regulatory or other consents and approvals
necessary for the consummation of the Merger and the BAE
Transaction will be obtained without any adverse effect on the
expected benefits of the Merger and the BAE Transaction in any
way meaningful to Goldman Sachs analysis. Goldman Sachs
also assumed that the Merger and the BAE Transaction will be
consummated on the terms set forth in the Merger Agreement and
the BAE Agreement without the waiver or modification of any term
or condition of the Merger Agreement or the BAE Agreement, the
effect of which would be in any way meaningful to its analysis.
In addition, Goldman Sachs opinion did not address the
underlying business decision of the Company to engage in the
Merger or the BAE Transaction, or the relative merits of the
Merger or the BAE Transaction as compared to any strategic
alternatives that may be available to the Company, nor does it
address any legal, regulatory, tax or accounting matters.
Goldman Sachs opinion addresses only the fairness from a
financial point of view, as of September 19, 2010, to the
holders (other than Safran and its affiliates) of the
outstanding shares of common stock of the Company of the $12.00
per share merger consideration to be paid in cash to such
holders pursuant to the Merger Agreement. Goldman Sachs does not
express any view on, and its opinion does not address, any other
term or aspect of the Merger Agreement, the BAE Agreement, the
Merger, the BAE Transaction, or any term or aspect of any other
agreement or instrument contemplated by the Merger Agreement or
the BAE Agreement or entered into or amended in connection with
the Merger or the BAE Transaction, or the impact thereof on the
Company, Safran or BAE or the fairness of the BAE Transaction,
or the fairness of the Merger to, or any consideration received
in connection therewith by, the holders of any other class of
securities, creditors, or other constituencies of the Company;
nor as to the fairness of the amount or nature of any
compensation to be paid or payable to any of the officers,
directors or employees of the Company, or class of such persons,
in connection with the Merger or the BAE Transaction, whether
relative to the $12.00 per share merger consideration to be paid
to the holders (other than Safran and its affiliates) of the
outstanding shares of common stock of the Company pursuant to
the Merger Agreement or otherwise. Goldman Sachs did not express
any opinion as to the impact of the Merger or the BAE
Transaction or any transaction entered into in connection
therewith on the solvency or viability of the Company, Safran or
BAE or the ability of the Company, Safran or BAE to pay their
respective obligations when they come due. Goldman Sachs
opinion is necessarily based on economic, monetary, market and
other conditions as in effect on, and the information made
available to Goldman Sachs as of the date of the opinion and
Goldman Sachs assumed no responsibility for updating, revising
or reaffirming its opinion based on circumstances, developments
or events occurring after the date of its opinion. Goldman
Sachs advisory services and the opinion expressed herein
were provided for the information and assistance of the board of
directors of the Company in connection with its consideration of
the Merger and such opinion does not constitute a recommendation
as to how any holder of shares of common stock of the Company
should vote with respect to the Merger or any other matter.
Goldman Sachs opinion was approved by a fairness committee
of Goldman Sachs.
The following is a summary of the material financial analyses
delivered by Goldman Sachs to the board of directors in
connection with rendering the opinion described above. The
following summary, however, does not purport to be a complete
description of the financial analyses performed by Goldman
Sachs, nor does the order of analyses described represent
relative importance or weight given to those analyses by Goldman
Sachs. Some of the
41
summaries of the financial analyses include information
presented in tabular format. The tables must be read together
with the full text of each summary and are alone not a complete
description of Goldman Sachs financial analyses. Except as
otherwise noted, the following quantitative information, to the
extent that it is based on market data, is based on market data
as it existed on or before September 17, 2010 and is not
necessarily indicative of current market conditions.
Premia
Paid Analysis
Goldman Sachs analyzed the $12.00 per share merger consideration
to be paid in cash to the holders of the outstanding shares of
common stock of the Company pursuant to the Merger Agreement in
relation to the closing price of the shares of common stock of
the Company on January 5, 2010, the day before the Company
announced its intention to consider strategic alternatives, and
the closing price of the shares on September 17, 2010, the
last trading day prior to the delivery of Goldman Sachs
opinion. This analysis was undertaken to assist the
Companys board of directors in understanding how the
$12.00 per share merger consideration compared to recent
historical market prices of the Companys common stock. The
$12.00 per share merger consideration reflected a premium of 24%
over the September 17, 2010 market price of $9.70 per share
of the common stock of the Company and a 66% premium over the
January 4, 2010 market price of $7.23 per share of the
common stock of the Company.
Selected
Companies Analysis
Goldman Sachs reviewed and compared certain financial
information, ratios and public market multiples for the Company
to corresponding financial information, ratios and public market
multiples for the following publicly traded corporations in the
personal identity security and technology industry:
|
|
|
|
|
American Science & Engineering, Inc.;
|
|
|
|
Cogent, Inc. (market data as of August 27, 2010, the last
trading day prior to Cogents announcement of a transaction
with 3M);
|
|
|
|
|
|
Smiths Group plc (which we collectively refer to in this proxy
statement as the Selected Companies).
|
Although none of the Selected Companies is directly comparable
to the Company, the companies included were chosen because they
are publicly traded companies with operations that for the
purposes of analysis may be considered similar to certain
operations of the Company.
With respect to the Company, Goldman Sachs first calculated the
following multiples:
|
|
|
|
|
enterprise value (which we refer to in this proxy statement as
EV), which is the market value of common equity on a diluted
basis (including outstanding warrants, options and restricted
stock) plus the par value of total debt (including convertible
debt), preferred equity and minority interest less cash and cash
equivalents per the latest publicly available financial
statements, as a multiple of the last twelve months (which
we refer to in this proxy statement as LTM) estimated fiscal
year earnings before interest, taxes, depreciation and
amortization (which we refer to in this proxy statement as
EBITDA); and
|
|
|
|
EV as a multiple of estimated 2011 EBITDA.
|
With respect to the Selected Companies, Goldman Sachs calculated
the following multiples:
|
|
|
|
|
EV as a multiple of LTM EBITDA;
|
|
|
|
EV as a multiple of estimated 2011 EBITDA; and
|
|
|
|
|
|
mean of EV as a multiple of forward year estimated EBITDA for
the one-year, two-year, three-year and five-year periods ended
September 17, 2010 (except for Cogent, for which periods
ended August 27, 2010).
|
The calculations for the Company were generated based on market
data available as of January 5, 2010 and September 17,
2010, the $12.00 per share merger consideration to be paid
pursuant to the Merger Agreement, the Forecasts and estimates
from the Institutional Brokers Estimate System (which we
refer to in this proxy statement
42
as IBES). Calculations based on the January 5, 2010 and
September 17, 2010 data used figures for net debt of the
Company of $465,000,000 as of June 30, 2010 per the
Companys public filings. Calculations based on the $12.00
per share merger consideration to be paid pursuant to the Merger
Agreement used figures for net debt of $479,000,000 as of
June 30, 2010, gross of $11,200,000 of unamortized discount
in respect of the Companys $175,000,000 Convertible Notes
and $2,600,000 of original issue discount in respect of the
Companys Senior Secured Term Loan. The calculations for
each of the Selected Companies were generated based on market
data available as of September 17, 2010 (and for Cogent
Inc., as of August 27, 2010) and IBES median estimates.
The results of Goldman Sachs EV/LTM EBITDA analysis (for
the Company and Selected Companies) are shown in the table below.
EV/LTM
EBITDA
|
|
|
|
|
Company (at $12.00 per share)
|
|
|
22.2
|
x
|
Company (at September 17, 2010)
|
|
|
19.0
|
x
|
Company (at January 5, 2010)
|
|
|
15.8
|
x
|
Selected
Companies(a)
|
|
|
|
|
At September 17,
2010(b)
|
|
|
9.7
|
x
|
1-Year Mean
|
|
|
9.8
|
x
|
2-Year Mean
|
|
|
8.6
|
x
|
3-Year Mean
|
|
|
9.7
|
x
|
5-Year Mean
|
|
|
11.3
|
x
|
|
|
|
(a) |
|
Selected Company multiples calculated as mean of multiples for
American Science & Engineering, Cogent, OSI Systems
and Smiths Group at September 17, 2010 (except for Cogent,
which is at August 27, 2010). One-year, two-year,
three-year and five-year averages, calculated as the mean of EV
as a multiple of LTM EBITDA for the Selected Companies as a
group for the one-year, two-year, three-year and five-year
periods ended September 17, 2010 (except for Cogent, for
which periods ended at August 27, 2010). |
|
|
|
(b) |
|
Except for Cogent, which is at August 27th, 2010. |
The results of Goldman Sachs EV / 2011E EBITDA
analysis (for the Company and Selected Companies) are shown in
the table below.
EV/2011E
EBITDA
|
|
|
|
|
Company (at $12.00 per share (IBES))
|
|
|
14.2
|
x
|
Company (at $12.00 per share (Forecasts))
|
|
|
12.7
|
x
|
Company (at September 17, 2010 (IBES))
|
|
|
12.1
|
x
|
Company (at September 17, 2010 (Forecasts))
|
|
|
10.9
|
x
|
Company (at January 5, 2010 (IBES))
|
|
|
10.1
|
x
|
Company (at January 5, 2010 (Forecasts))
|
|
|
9.1
|
x
|
Selected
Companies(a)
|
|
|
|
|
At September 17,
2010(b)
|
|
|
8.1
|
x
|
|
|
|
(a) |
|
Selected Company multiples calculated as median of multiples for
American Science & Engineering (7.5x), Cogent (4.6x),
OSI Systems (8.6x) and Smiths Group (9.1x) as a group at
September 17, 2010 (except for Cogent, which is at
August 27, 2010). |
|
|
|
(b) |
|
Except for Cogent, which is at August 27, 2010. |
43
The results of Goldman Sachs EV / forward year
EBITDA analysis (for the Selected Companies) are shown in the
table below.
EV/FORWARD
YEAR EBITDA
|
|
|
|
|
Selected Companies
|
|
|
|
|
1-Year Mean
|
|
|
8.6
|
x
|
2-Year Mean
|
|
|
8.2
|
x
|
3-Year Mean
|
|
|
8.6
|
x
|
5-Year Mean
|
|
|
9.9
|
x
|
Illustrative
Present Value of Future Share Price Analysis
Goldman Sachs performed an illustrative analysis of the implied
present value of the future prices of the Companys common
stock using the Forecasts. The analysis was designed to provide
an indication of the present value of a theoretical future price
of the Companys equity as a function of the Companys
estimated future EBITDA. For this analysis, Goldman Sachs used
the Forecasts for each of the fiscal years 2010 to 2014.
Goldman Sachs first calculated the illustrative future values
per share of the Companys common stock by applying EV to
EBITDA multiples of 8.0x to 11.0x to estimates of EBITDA for the
applicable forward fiscal year for each of fiscal years 2010
through 2014. The illustrative future values per share of the
Companys common stock in each year were then discounted
back to June 30, 2010, using a discount rate of 14.7%,
including a size adjustment of 1.7% per Ibbotson Associates,
reflecting the Companys estimated cost of equity. In
deriving a discount rate of 14.7% for the purposes of this
analysis, Goldman Sachs utilized the capital asset pricing
model, which takes into account certain financial metrics,
including betas, for the Company, as well as certain financial
metrics for the United States financial markets generally. This
resulted in illustrative ranges of present values per share of
the Companys common stock for each of fiscal years 2010
through 2014 as follows:
|
|
|
|
|
|
|
Illustrative Range of Present
|
Fiscal Year
|
|
Value of Future Share Price
|
|
2010
|
|
$
|
2.93 $ 5.97
|
|
2011
|
|
$
|
5.66 $ 9.50
|
|
2012
|
|
$
|
7.39 $11.47
|
|
2013
|
|
$
|
8.10 $11.99
|
|
2014
|
|
$
|
9.02 $12.73
|
|
Illustrative
Discounted Cash Flow Analysis
Goldman Sachs performed an illustrative discounted cash flow
analysis on the Company using the Forecasts, information from
the Companys public filings as at June 30, 2010 and
information relating to the Companys net operating loss
provided by the Companys management. Goldman Sachs
calculated indications of net present value of unlevered free
cash flows for the Company for the years 2010 through 2014 using
discount rates ranging from 11% to 13%, reflecting the
Companys estimated weighted average cost of capital. In
deriving discount rates ranging from 11% to 13% for the purposes
of this analysis, Goldman Sachs utilized the capital asset
pricing model, which takes into account certain financial
metrics, including betas, for the Company, as well as certain
financial metrics for the United States financial markets
generally. Goldman Sachs then calculated the illustrative
present value of the terminal value using multiples of estimated
2014 EBITDA ranging from 8.0x to 11.0x. Goldman Sachs assumed a
mid-year convention and a 39% marginal tax rate, and discounted
the results to June 30, 2010. Using information provided by
management, Goldman Sachs then calculated the illustrative
present value of the Companys net operating loss, using a
discount rate of 9% reflecting an estimate of the Companys
cost of debt. This calculation yielded a present value of the
Companys net operating loss of approximately
$125 million, or $1.39 per share. This analysis yielded
equity values in a range of $7.93 to $12.57 per share. Goldman
Sachs also performed a similar illustrative discounted cash flow
analysis but using implied perpetuity growth rates after 2014
44
ranging from 3.0% to 7.0% to calculate an illustrative terminal
value. This analysis generated equity values in a range of $3.49
to $12.19 per share.
Selected
Transactions Analysis
Goldman Sachs analyzed certain information relating to selected
transactions with an EV over $500,000,000 in the defense
industry during the period from 2000 to 2010:
|
|
|
|
|
Harris Corporations acquisition of CapRock Holdings
announced in May 2010;
|
|
|
|
CGI Group Inc.s acquisition of Stanley, Inc. announced in
May 2010;
|
|
|
|
L-3 Communication Holdings Inc.s acquisition of Insight
Technology Incorporated announced in May 2010;
|
|
|
|
Cerberus Capital Management LPs acquisition of DynCorp
International Inc. announced in April 2010;
|
|
|
|
Babcock International Group Plcs acquisition of VT Group
Plc announced in March 2010;
|
|
|
|
Kohlberg Kravis Roberts & Co.s and General
Atlantic LLCs acquisition of Northrop Grumman
Corporations TASC division announced in November 2009;
|
|
|
|
General Dynamics Corporations acquisition of Axsys
Technologies, Inc. announced in June 2009;
|
|
|
|
General Dynamics Corporations acquisition of AxleTech
International announced in November 2008;
|
|
|
|
Serco Group plcs acquisition of SI International Inc.
announced in August 2008;
|
|
|
|
BAE Systems (Holdings) Limiteds acquisition of Detica
Group plc announced in July 2008;
|
|
|
|
The Carlyle Groups acquisition of Booz Allen Hamilton Inc.
announced in May 2008;
|
|
|
|
Finmeccanica SpAs acquisition of DRS Technologies, Inc.
announced in May 2008;
|
|
|
|
BAE Systems Plcs acquisition of Tenix Defence announced in
January 2008;
|
|
|
|
Textron Inc.s acquisition of United Industrial Corporation
announced in October 2007;
|
|
|
|
ITT Corporations acquisition of EDO Corp. announced in
September 2007;
|
|
|
|
The Carlyle Groups acquisition of ARINC Incorporated
announced in July 2007;
|
|
|
|
Veritas Capital, Golden Gate Capitals and GS Directs
acquisition of Aeroflex announced in May 2007;
|
|
|
|
BAE Systems Plcs acquisition of Armor Holdings Inc.
announced in May 2006;
|
|
|
|
Northrop Grumman Corporations acquisition of Essex Corp.
announced in November 2006;
|
|
|
|
Lockheed Martin Corporations acquisition of Pacific
Architects and Engineers Incorporated announced in August 2006;
|
|
|
|
Armor Holdings Inc.s acquisition of Stewart &
Stevenson Services Inc. announced in February 2006;
|
|
|
|
General Dynamics Corporations acquisition of Anteon
International Corporation announced in December 2005;
|
|
|
|
DRS Technologies Inc.s acquisition of Engineered Support
Systems Inc. announced in September 2005;
|
|
|
|
L-3 Communications Holdings Inc.s acquisition of The Titan
Corp. announced in June 2005;
|
|
|
|
BAE Systems Plcs acquisition of United Defense Industries
Inc. announced in March 2005;
|
|
|
|
Veritas Capitals acquisition of DynCorp International LLC
announced in December 2004;
|
|
|
|
ITT Industries Inc.s acquisition of Eastman Kodak
Companys Remote Sensing Systems business announced in
February 2004;
|
45
|
|
|
|
|
L-3 Communications Holdings Inc.s acquisition of Vertex
Aerospace LLC announced in October 2003;
|
|
|
|
Lockheed Martin Corporations acquisition of Affiliated
Computer Services Inc. announced in August 2003;
|
|
|
|
DRS Technologies Inc.s acquisition of Integrated Defense
Technologies Inc. announced in August 2003;
|
|
|
|
General Dynamics Corporations acquisition of Veridian
Corporation announced in June 2003;
|
|
|
|
General Dynamics Corporations acquisition of General
Motors Defense announced in December 2002;
|
|
|
|
Northrop Grumman Corporations acquisition of TRW Inc.
announced in July 2002;
|
|
|
|
L-3 Communications Holdings Inc.s acquisition of Raytheon
Aircraft Integration Systems announced in January 2002;
|
|
|
|
General Dynamics Corporations acquisition of
Motorolas Integrated Information Systems Group announced
in August 2001;
|
|
|
|
Northrop Grumman Corporations acquisition of Newport News
Shipbuilding announced in May 2001;
|
|
|
|
Northrop Grumman Corporations acquisition of Litton
Industries Inc. announced in December 2000;
|
|
|
|
General Dynamics Corporations acquisition of Primex
Technologies Inc. announced in November 2000; and
|
|
|
|
BAE Systems North America Inc.s acquisition of Lockheed
Martin Control Systems announced in April 2000.
|
While none of the businesses or companies that participated in
these selected transactions are directly comparable to the
Companys current businesses and operations, the businesses
and companies that participated in the selected transactions are
businesses and companies with operations that, for the purposes
of analysis, may be considered similar to certain of the
Companys results, market size, product profile and end
market exposure.
For selected transactions, Goldman Sachs calculated the EV of
the transaction as a multiple of LTM revenue, a multiple of LTM
EBITDA, a multiple of estimated forward revenue and a multiple
of estimated forward EBITDA. Forward multiples were generated
using estimates from IBES as of the date of the public
announcement of the relevant transaction. The results of these
calculations are listed in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multiples
|
|
Multiples
|
|
Multiples of
|
|
Multiples of
|
|
|
|
|
|
|
Transaction
|
|
|
of LTM
|
|
of LTM
|
|
Forward
|
|
Forward
|
Date
|
|
Target
|
|
Acquiror
|
|
EV
|
|
|
Revenue
|
|
EBITDA
|
|
Revenue
|
|
EBITDA
|
|
May 2010
|
|
CapRock
|
|
Harris
|
|
$
|
525
|
|
|
1.5x
|
|
9.7x
|
|
NA
|
|
NA
|
May 2010
|
|
Stanley, Inc.
|
|
CGI
|
|
$
|
1,070
|
|
|
1.3x
|
|
12.0x
|
|
1.2x
|
|
11.3x
|
May 2010
|
|
Insight Technology
|
|
L-3
|
|
$
|
613
|
|
|
2.0x
|
|
9.4x
|
|
NA
|
|
NA
|
Apr. 2010
|
|
DynCorp International
|
|
Cerberus Capital
|
|
$
|
1,493
|
|
|
0.5x
|
|
6.5x
|
|
0.4x
|
|
6.6x
|
Mar. 2010
|
|
VT Group
|
|
Babcock International
|
|
$
|
2,000
|
|
|
NA
|
|
10.5x
|
|
NA
|
|
NA
|
Nov. 2009
|
|
Northrop Grumman TASC
|
|
KKR / General Atlantic
|
|
$
|
1,650
|
|
|
1.0x
|
|
~11.0x
|
|
0.9x
|
|
NA
|
June 2009
|
|
Axsys
|
|
General Dynamics
|
|
$
|
645
|
|
|
2.3x
|
|
12.2x
|
|
2.0x
|
|
11.0x
|
Nov. 2008
|
|
AxelTech
|
|
General Dynamics
|
|
|
NA
|
|
|
NA
|
|
NA
|
|
NA
|
|
NA
|
Aug. 2008
|
|
SI International
|
|
Serco
|
|
$
|
510
|
|
|
0.9x
|
|
12.2x
|
|
0.8x
|
|
10.2x
|
July 2008
|
|
Detica Group
|
|
BAE Systems
|
|
$
|
1,062
|
|
|
2.6x
|
|
16.9x
|
|
2.2x
|
|
13.0x
|
May 2008
|
|
Booz Allen Hamilton
|
|
Carlyle Group
|
|
$
|
2,540
|
|
|
NA
|
|
~10.5x
|
|
NA
|
|
NA
|
May 2008
|
|
DRS Technologies
|
|
Finmeccanica
|
|
$
|
5,205
|
|
|
1.7x
|
|
12.7x
|
|
1.5x
|
|
11.4x
|
Jan. 2008
|
|
Tenix
|
|
BAE Systems
|
|
$
|
686
|
|
|
1.0x
|
|
12.3x
|
|
NA
|
|
NA
|
Oct. 2007
|
|
UIC
|
|
Textron
|
|
$
|
1,100
|
|
|
1.6x
|
|
13.3x
|
|
1.4x
|
|
11.4x
|
Sept. 2007
|
|
EDO
|
|
ITT
|
|
$
|
1,881
|
|
|
1.6x
|
|
16.0x
|
|
1.4x
|
|
12.7x
|
July 2007
|
|
ARINC
|
|
Carlyle Group
|
|
|
NA
|
|
|
NA
|
|
NA
|
|
NA
|
|
NA
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multiples
|
|
Multiples
|
|
Multiples of
|
|
Multiples of
|
|
|
|
|
|
|
Transaction
|
|
|
of LTM
|
|
of LTM
|
|
Forward
|
|
Forward
|
Date
|
|
Target
|
|
Acquiror
|
|
EV
|
|
|
Revenue
|
|
EBITDA
|
|
Revenue
|
|
EBITDA
|
|
June 2007
|
|
Aeroflex
|
|
Veritas / Golden Gate / GS
|
|
$
|
1,067
|
|
|
1.9x
|
|
12.1x
|
|
1.8x
|
|
11.4x
|
May 2006
|
|
Armor Holdings
|
|
BAE
|
|
$
|
4,534
|
|
|
1.6x
|
|
14.8x
|
|
1.3x
|
|
11.5x
|
Nov. 2006
|
|
Essex Corp.
|
|
Northrop Grumman
|
|
$
|
542
|
|
|
2.3x
|
|
28.1x
|
|
1.6x
|
|
15.7x
|
Aug. 2006
|
|
PAE
|
|
Lockheed Martin
|
|
$
|
700
|
|
|
NA
|
|
NA
|
|
NA
|
|
NA
|
Feb. 2006
|
|
Stewart & Stevenson
|
|
Armor Holdings
|
|
$
|
757
|
|
|
1.0x
|
|
Not meaningful
due to depressed
LTM EBITDA
|
|
NA
|
|
NA
|
Dec. 2005
|
|
Anteon
|
|
General Dynamics
|
|
$
|
2,200
|
|
|
1.5x
|
|
15.9x
|
|
1.3x
|
|
13.5x
|
Sept. 2005
|
|
Engineered Support Services
|
|
DRS
|
|
$
|
1,960
|
|
|
1.9x
|
|
14.0x
|
|
1.6x
|
|
10.5x
|
June 2005
|
|
Titan
|
|
L-3 Communications
|
|
$
|
2,741
|
|
|
1.4x
|
|
15.8x
|
|
1.1x
|
|
12.9x
|
Mar. 2005
|
|
United Defense Industries
|
|
BAE Systems
|
|
$
|
4,199
|
|
|
1.8x
|
|
12.3x
|
|
1.7x
|
|
13.0x
|
Dec. 2004
|
|
DynCorp International
|
|
Veritas Capital
|
|
$
|
910
|
|
|
0.6x
|
|
8.5x
|
|
NA
|
|
NA
|
Feb. 2004
|
|
Remote Sensing Systems (Eastman Kodak)
|
|
ITT Industries
|
|
$
|
725
|
|
|
1.7x
|
|
12.5x
|
|
NA
|
|
NA
|
Oct. 2003
|
|
Vertex Aerospace
|
|
L-3 Communications
|
|
$
|
650
|
|
|
0.8x
|
|
10.2x
|
|
NA
|
|
NA
|
Aug. 2003
|
|
Affiliated Computer Services
|
|
Lockheed Martin
|
|
$
|
658
|
|
|
0.9x
|
|
NA
|
|
NA
|
|
NA
|
Aug. 2003
|
|
Integrated Defense
|
|
DRS
|
|
$
|
550
|
|
|
1.6x
|
|
11.3x
|
|
1.3x
|
|
8.2x
|
June 2003
|
|
Veridian
|
|
General Dynamics
|
|
$
|
1,500
|
|
|
1.6x
|
|
18.0x
|
|
1.3x
|
|
14.3x
|
Dec. 2002
|
|
GM Defense
|
|
General Dynamics
|
|
$
|
1,100
|
|
|
1.1x
|
|
NA
|
|
NA
|
|
NA
|
July 2002
|
|
TRW*
|
|
Northrop Grumman
|
|
$
|
11,708
|
|
|
0.7x
|
|
9.1x
|
|
NA
|
|
NA
|
Jan. 2002
|
|
Raytheon AIS
|
|
L-3 Communications
|
|
$
|
1,130
|
|
|
1.4x
|
|
12.3x
|
|
NA
|
|
NA
|
Aug. 2001
|
|
Motorola (Information Systems)
|
|
General Dynamics
|
|
$
|
825
|
|
|
1.4x
|
|
12.9x
|
|
NA
|
|
NA
|
May 2001
|
|
Newport News
|
|
Northrop Grumman
|
|
$
|
2,801
|
|
|
1.3x
|
|
10.5x
|
|
1.3x
|
|
NA
|
Dec. 2000
|
|
Litton
|
|
Northrop Grumman
|
|
$
|
5,152
|
|
|
0.9x
|
|
7.7x
|
|
NA
|
|
NA
|
Nov. 2000
|
|
Primex Technologies
|
|
General Dynamics
|
|
$
|
517
|
|
|
1.0x
|
|
7.0x**
|
|
NA
|
|
NA
|
Apr. 2000
|
|
Lockheed Martin Control Systems
|
|
BAE Systems
|
|
$
|
510
|
|
|
1.4x
|
|
NA
|
|
NA
|
|
NA
|
|
|
|
* |
|
Enterprise value includes ASG division, which is to be sold to
Goodrich for $1.5 billion, as well as automotive business.
Multiples are estimated SS&E multiples. |
|
** |
|
LTM EBITDA estimated by keeping depreciation and amortization as
a percentage of sales constant. |
47
Goldman Sachs then generated the high, mean, median and low of
the EV and the multiples for the selected transactions as a
group. Using the $12.00 per share merger consideration to be
paid in cash to holders of the outstanding shares of common
stock of the Company pursuant to the Merger Agreement, Goldman
Sachs calculated the same LTM and forward multiples for the
Merger and compared these figures against the LTM and forward
multiples for the selected transactions. The following table
presents the results of this analysis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multiples of
|
|
Multiples of
|
|
Multiples of
|
|
Multiples of
|
|
|
LTM Revenue
|
|
LTM EBITDA
|
|
Forward Revenue
|
|
Forward EBITDA
|
|
Selected Transactions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
2.6
|
x
|
|
|
28.1
|
x
|
|
|
2.2
|
x
|
|
|
15.7
|
x
|
Mean
|
|
|
1.41
|
x
|
|
|
12.2
|
x
|
|
|
1.49
|
x
|
|
|
12.3
|
x
|
Median
|
|
|
1.40
|
x
|
|
|
12.2
|
x
|
|
|
1.40
|
x
|
|
|
12.7
|
x
|
Low
|
|
|
0.5
|
x
|
|
|
6.5
|
x
|
|
|
0.4
|
x
|
|
|
6.6
|
x
|
Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$12.00 per share
|
|
|
2.4
|
x
|
|
|
22.2
|
x
|
|
|
2.2
|
x
|
|
|
17.2
|
x
|
The preparation of a fairness opinion is a complex process and
is not necessarily susceptible to partial analysis or summary
description. Selecting portions of the analyses or of the
summary set forth above, without considering the analyses as a
whole, could create an incomplete view of the processes
underlying Goldman Sachs opinion. In arriving at its
fairness determination, Goldman Sachs considered the results of
all of its analyses and did not attribute any particular weight
to any factor or analysis considered by it. Rather, Goldman
Sachs made its determination as to fairness on the basis of its
experience and professional judgment after considering the
results of all of its analyses. No company or transaction used
in the above analyses as a comparison is directly comparable to
the Company or the contemplated Merger.
Goldman Sachs prepared these analyses for purposes of Goldman
Sachs providing its opinion to the board of directors as
to the fairness from a financial point of view of the $12.00 per
share merger consideration to be paid in cash to the holders
(other than Safran and its affiliates) of the outstanding shares
of common stock of the Company pursuant to the Merger Agreement.
These analyses do not purport to be appraisals nor do they
necessarily reflect the prices at which businesses or securities
actually may be sold. Analyses based upon forecasts of future
results are not necessarily indicative of actual future results,
which may be significantly more or less favorable than suggested
by these analyses. Because these analyses are inherently subject
to uncertainty, being based upon numerous factors or events
beyond the control of the parties or their respective advisors,
none of the Company, Goldman Sachs or any other person assumes
responsibility if future results are materially different from
those forecast.
The merger consideration was determined through
arms-length negotiations between the Company and Safran
and was approved by the board of directors of the Company.
Goldman Sachs provided advice to the Company during these
negotiations. Goldman Sachs did not, however, recommend any
specific amount of consideration to the Company or the board of
directors or that any specific amount of consideration
constituted the only appropriate consideration for the Merger.
As described above, Goldman Sachs opinion to the board of
directors of the Company was one of many factors taken into
consideration by the board of directors in making its
determination to approve the Merger Agreement and the Merger.
The foregoing summary does not purport to be a complete
description of the analyses performed by Goldman Sachs in
connection with the fairness opinion and is qualified in its
entirety by reference to the written opinion of Goldman Sachs
attached as Annex C to this proxy statement.
Goldman Sachs and its affiliates are engaged in investment
banking and financial advisory services, commercial banking,
securities trading, investment management, principal investment,
financial planning, benefits counseling, risk management,
hedging, financing, brokerage activities and other financial and
non-financial activities and services for various persons and
entities. In the ordinary course of these activities and
services, Goldman Sachs and its affiliates may at any time make
or hold long or short positions and investments, as well as
actively trade or effect transactions, in the equity, debt and
other securities (or related derivative securities) and
financial instruments (including bank loans and other
obligations) of the Company, Safran, any of their respective
affiliates or third parties, including BAE Systems plc and its
affiliates, or any currency or commodity that may be
48
involved in the Merger or the BAE Transaction for their own
account and for the accounts of their customers. Goldman Sachs
acted as financial advisor to the Company in connection with,
and has participated in certain of the negotiations leading to,
the Merger and the BAE Transaction. Goldman Sachs has provided
certain investment banking services to BAE Systems plc and its
affiliates from time to time for which Goldman Sachs
Investment Banking Division has received, and may receive,
compensation, including having acted as joint bookrunning
manager with respect to the private placement of 4.95%
Guaranteed Bonds due June 2014 (aggregate principal amount
$500,000,000) and 6.375% Guaranteed Bonds due June 2019
(aggregate principal amount $1,000,000,000) issued by BAE
Systems Holdings Inc., a subsidiary of BAE Systems plc, in June
2009. During the two year period prior to the delivery of its
opinion, dated September 19, 2010, Goldman Sachs has not
been engaged to provide investment banking services to the
Company and its affiliates (other than in connection with the
Merger) or to Safran and its affiliates for which the Investment
Banking Division of Goldman Sachs has received compensation.
Goldman Sachs may in the future provide investment banking
services to the Company, Safran, BAE and their respective
affiliates for which our Investment Banking Division may receive
compensation.
The board of directors selected Goldman Sachs as its financial
advisor because it is an internationally recognized investment
banking firm that has substantial experience in transactions
similar to the Merger. Pursuant to a letter agreement, dated
February 26, 2010, the Company engaged Goldman Sachs to act
as its financial advisor in connection with the Companys
exploration of strategic alternatives to enhance stockholder
value, including the possible sale of all or a portion of the
common stock or assets of the Company. Pursuant to the terms of
this engagement letter, the Company has agreed to pay Goldman
Sachs a fee totaling approximately $11 million, of which
approximately $9.4 million will be paid upon the
consummation of the Merger. In addition, the Company has agreed
to reimburse Goldman Sachs for certain expenses and to indemnify
Goldman Sachs against certain liabilities arising out of Goldman
Sachs engagement.
Opinion
of Stone Key Partners LLC
Overview
Pursuant to an engagement letter dated February 28, 2010,
the Company retained Stone Key to act as its financial advisor
in connection with the Companys exploration of strategic
alternatives to enhance stockholder value, including the
possible sale of all or a portion of the Company common stock or
the assets of the Company and / or its subsidiaries.
In selecting Stone Key, the Companys board of directors
considered, among other things, the fact that Stone Key is an
internationally recognized investment banking firm with
substantial experience advising companies in the defense
technology, homeland security and government services industries
as well as substantial experience providing strategic advisory
services. Stone Key, as part of its investment banking business,
is continuously engaged in the evaluation of businesses and
their debt and equity securities in connection with mergers and
acquisitions, underwritings, private placements and other
securities offerings, valuations and general corporate advisory
services.
At the September 18, 2010 meeting of the Companys
board of directors, Stone Key delivered its oral opinion, which
was subsequently confirmed in writing, that, as of
September 18, 2010, and based upon and subject to the
assumptions, qualifications and limitations set forth in the
written opinion, the $12.00 per share merger consideration was
fair, from a financial point of view, to the stockholders of the
Company.
The full text of Stone Keys written opinion is attached
as Annex D to this proxy statement and you should read the
opinion carefully and in its entirety. The opinion sets forth
the assumptions made, certain of the matters considered and
qualifications to and limitations of the review undertaken by
Stone Key. The Stone Key opinion, which was authorized for
issuance by the Fairness Opinion and Valuation Committee of
Stone Key, is subject to the assumptions and conditions
contained in the opinion and is necessarily based on economic,
market and other conditions and the information made available
to Stone Key as of the date of the Stone Key opinion. Stone Key
has no responsibility for updating or revising its opinion based
on circumstances or events occurring after the date of the
rendering of the opinion.
49
In reading the discussion of the fairness opinion set forth
below, you should be aware that Stone Keys opinion:
|
|
|
|
|
was provided to the Companys board of directors for its
benefit and use in connection with its consideration of the
Merger;
|
|
|
|
did not constitute a recommendation to the board of directors of
the Company;
|
|
|
|
does not constitute a recommendation to any stockholder of the
Company as to how to vote in connection with the Merger or
otherwise;
|
|
|
|
did not address the Companys underlying business decision
to pursue the Merger or the BAE Transaction, the relative merits
of the Merger and BAE Transaction as compared to any alternative
business or financial strategies that might exist for the
Company or the effects of any other transaction in which the
Company might engage;
|
|
|
|
did not express any view or opinion with respect to the merits
of the Merger to any holder of the Company equity relative to
any other holder of the Company equity or as to the fairness of
the Merger, from a financial point of view, to Safran and its
affiliates; and
|
|
|
|
did not express any view or opinion as to the fairness,
financial or otherwise, of the amount or nature of any
compensation payable to or to be received by any of the
Companys officers, directors or employees, or any class of
these persons, in connection with the Merger or the BAE
Transaction relative to the $12.00 per share merger
consideration or the purchase price to be paid by BAE pursuant
to the BAE Agreement.
|
The Company did not provide specific instructions to, or place
any limitations on, Stone Key with respect to the procedures to
be followed or factors to be considered by it in performing its
analyses or providing its opinion.
In connection with rendering its opinion, Stone Key:
|
|
|
|
|
reviewed drafts of the Merger Agreement, BAE Agreement and
voting and support agreement in substantially final form;
|
|
|
|
reviewed the Companys Annual Reports to Shareholders and
Annual Reports on
Form 10-K
for the years ended December 31, 2007, 2008 and 2009, its
Quarterly Report on
Form 10-Q
for the periods ended March 31, 2010 and June 30, 2010
and its Current Reports on
Form 8-K
filed since December 31, 2009;
|
|
|
|
reviewed certain operating and financial information relating to
the Companys business and prospects, including the
Forecasts, all as prepared and provided to Stone Key by the
Companys management;
|
|
|
|
met with certain members of the Companys senior management
to discuss the Companys business, operations, historical
and projected financial results and future prospects;
|
|
|
|
reviewed the historical prices, trading multiples and trading
volume of the Company common stock;
|
|
|
|
reviewed certain publicly available financial data, stock market
performance data and trading multiples of companies which Stone
Key deemed generally comparable to the Company;
|
|
|
|
reviewed the terms of certain relevant mergers and acquisitions
involving companies that Stone Key deemed generally comparable
to the Company;
|
|
|
|
performed discounted cash flow analyses based on the
Forecasts; and
|
|
|
|
conducted those other studies, analyses, inquiries and
investigations as Stone Key deemed appropriate.
|
In connection with rendering its opinion, Stone Key further
noted that:
|
|
|
|
|
Stone Key relied upon and assumed, without independent
verification, the accuracy and completeness of the financial and
other information provided to it by the Company or obtained by
Stone Key from public sources, including, without limitation,
the Forecasts.
|
|
|
|
With respect to the Forecasts, Stone Key relied on
representations that they had been reasonably prepared on bases
reflecting the best then-currently available estimates and
judgments of the senior management of the Company as to the
expected future performance of the Company.
|
50
|
|
|
|
|
Stone Key did not assume any responsibility for the independent
verification of any information referred to above, including,
without limitation, the Forecasts; Stone Key expressed no view
or opinion as to the Forecasts and the assumptions upon which
they were based; and Stone Key further relied upon the
assurances of the senior management of the Company that they
were unaware of any facts that would have made the information
and Forecasts incomplete or misleading.
|
|
|
|
In arriving at its opinion, Stone Key did not perform or obtain
any independent appraisal of the assets or liabilities
(contingent or otherwise) of the Company, nor was Stone Key
furnished with any such appraisals.
|
|
|
|
During the course of Stone Keys engagement, Stone Key was
asked by the board of directors of the Company to solicit
indications of interest from various third parties regarding a
transaction involving the Company and/or the Companys
intelligence services business group, and Stone Key considered
the results of such solicitation in rendering its opinion.
|
|
|
|
Stone Key assumed that the Merger will be consummated in a
timely manner and in accordance with the terms of the Merger
Agreement without any limitations, restrictions, conditions,
amendments or modifications, regulatory or otherwise, that
collectively would have a material effect on the Company.
|
|
|
|
The credit, financial and stock markets are experiencing unusual
volatility; Stone Key expressed no opinion or view as to the
effects of such volatility on the Merger or the parties thereto.
|
|
|
|
Stone Key is not a legal, regulatory, tax or accounting expert
and has relied on the assessments made by the Company and its
advisors with respect to these issues.
|
|
|
|
Stone Key did not express any opinion as to the price or range
of prices at which the Company common stock or the
Companys 3.75% Convertible Notes due 2027 may
trade subsequent to the announcement of either of the Merger or
the BAE Transaction.
|
Summary
of Analyses
The following is a summary of the principal financial and
valuation analyses performed by Stone Key and presented to the
Companys board of directors in connection with rendering
its fairness opinion. Some of the financial and valuation
analyses summarized below include summary data and information
presented in tabular format. In order to understand fully the
financial and valuation analyses, the summary data and tables
must be read together with the full text of the summary.
Considering the summary data and tables alone could create a
misleading or incomplete view of Stone Keys financial and
valuation analyses.
Transaction
Valuation Overview
Based on approximately 90 million shares of the Company
common stock that are expected to be outstanding as of
December 31, 2010 on a basic basis (i.e., assuming that
options are net cash settled), Stone Key noted that the merger
consideration of $12.00 per share implied an equity value of
approximately $1.1 billion. Net of approximately
$2.8 million of cash and cash equivalents and approximately
$481.4 million of debt (as of June 30, 2010), Stone
Key noted that the $12.00 per share merger consideration implied
an enterprise value of approximately $1.6 billion.
Stone Key also reviewed the historical trading prices and
volumes for the Company common stock for the
12-month
periods ended September 17, 2010 (the last trading day
before the announcement of the execution of the Merger
Agreement) and January 5, 2010 (the last trading day prior
to the public announcement that the Company was exploring
strategic alternatives) (we refer to the price as of
January 5, 2010 in this proxy statement as the Unaffected
Price). In addition, Stone Key analyzed the consideration to be
received by holders of the shares of the Company common stock
pursuant to the Merger Agreement in relation to the share price
on September 17, 2010; the share price on January 5,
2010; the average share prices for the 30 and 90 trading days
and the 12 months ending on September 17, 2010 and
January 5, 2010; and the high and low share prices for the
12 months ending
51
September 17, 2010 and January 5, 2010. The closing
share prices and implied premiums to the merger consideration of
$12.00 per share are detailed below.
|
|
|
|
|
|
|
|
|
|
|
Price
|
|
Premium
|
|
Unaffected Closing Price as of 1/05/2010
|
|
$
|
7.23
|
|
|
|
66.0
|
%
|
30-Trading Day Average Prior to Unaffected
|
|
|
6.50
|
|
|
|
84.6
|
%
|
90-Trading Day Average Prior to Unaffected
|
|
|
6.64
|
|
|
|
80.6
|
%
|
12-Month
Average Prior to Unaffected
|
|
|
6.87
|
|
|
|
74.6
|
%
|
52-Week High as of 1/05/2010
|
|
|
9.50
|
|
|
|
26.3
|
%
|
52-Week Low as of 1/05/2010
|
|
|
3.23
|
|
|
|
271.5
|
%
|
Closing Price as of 9/17/2010
|
|
|
9.70
|
|
|
|
23.7
|
%
|
30-Trading Day Average Prior to 9/17/2010
|
|
|
9.14
|
|
|
|
31.3
|
%
|
90-Trading Day Average Prior to 9/17/2010
|
|
|
8.31
|
|
|
|
44.4
|
%
|
12-Month
Average Prior to 9/17/2010
|
|
|
7.81
|
|
|
|
53.6
|
%
|
52-Week High as of 9/17/2010
|
|
|
10.42
|
|
|
|
15.2
|
%
|
52-Week Low as of 9/17/2010
|
|
|
5.67
|
|
|
|
111.6
|
%
|
Stone
Keys Valuation Analyses
Discounted Cash Flow Analyses. Stone Key
performed discounted cash flow analyses based on the
Companys projected unlevered after-tax free cash flows and
an estimate of its terminal value at the end of the projection
horizon.
In performing its discounted cash flow analyses:
|
|
|
|
|
Stone Key based its discounted cash flow analyses on the
Forecasts provided by the Companys senior management.
|
|
|
|
|
|
Stone Key estimated the Companys weighted average cost of
capital to be within a range of 10.0-12.0% based on, among other
factors, (i) a review of the Companys Bloomberg
five-year historical adjusted beta and its Bloomberg two-year
historical adjusted beta as well as similar beta information for
the comparable companies, (ii) Stone Keys estimate of
the U.S. equity risk premium and the risk-free rate of
return, (iii) a size premium derived from the Ibbotson SBBI
Valuation Yearbook, (iv) the Companys assumed target
capital structure on a prospective basis, based on its
historical average capital structure and cost of debt and
(v) Stone Keys investment banking and capital markets
judgment and experience in valuing companies similar to L-1.
|
|
|
|
|
|
In calculating the Companys terminal value for purposes of
its discounted cash flow analyses, Stone Key used a reference
range of (i) terminal enterprise value / forward
earnings before interest, taxes, depreciation and amortization,
or EBITDA, multiples of 6.0 to 9.0x and (ii) perpetual
growth rates of 4.0%-6.0%.
|
|
|
|
Utilizing the terminal value methodology, Stone Keys
discounted cash flow analyses resulted in an overall reference
range of $6.65 to $11.71 per share for purposes of valuing the
Company common stock.
|
|
|
|
Utilizing the perpetual growth methodology, Stone Keys
discounted cash flow analyses resulted in an overall reference
range of $5.29 to $13.26 per share for purposes of valuing the
Company common stock.
|
|
|
|
Stone Key included $115 million of net present value
attributable to the Companys tax benefits associated with
its net operating loss carryforwards (an estimated $1.28 of
value per share) in its discounted cash flow reference ranges.
|
Comparable Company Analysis. Stone Key
compared and analyzed the Companys historical stock price
performance, historical and projected financial performance and
valuation metrics against other publicly traded companies in the
biometrics, homeland security and government services sectors.
52
The following publicly traded comparable companies were used in
the analysis of the Company and were selected on the basis of
their financial and operating metrics, including product and
service offerings, risk profile, size, end customers, geographic
footprint and scale of operations:
|
|
|
|
|
ActivIdentity Corporation
|
|
|
|
American Science & Engineering, Inc.
|
|
|
|
CACI International Inc
|
|
|
|
Cogent, Inc. (Cogent, Inc. was analyzed as of its unaffected
stock price as of August 27, 2010, the last trading day
prior to the announcement of its sale to 3M on August 30,
2010.)
|
|
|
|
Dynamics Research Corporation
|
|
|
|
ManTech International Corporation
|
|
|
|
Maximus, Inc.
|
|
|
|
NCI, Inc.
|
|
|
|
NIC Inc.
|
|
|
|
OSI Systems, Inc.
|
|
|
|
SRA International, Inc.
|
|
|
|
VASCO Data Security International, Inc.
|
|
|
|
Zebra Technologies Corporation
|
Stone Key calculated the following trading multiples for the
above comparable companies based on Wall Street consensus
estimates and the most recent publicly available filings:
Selected
Peer Group Trading Multiples
|
|
|
|
|
|
|
|
|
|
|
Enterprise Value/EBITDA
|
|
|
Calendar
|
|
Calendar
|
|
|
Year
|
|
Year
|
|
|
2010
|
|
2011
|
|
|
Estimate
|
|
Estimate
|
|
Peer: Mean
|
|
|
8.3
|
x
|
|
|
7.4
|
x
|
Median
|
|
|
6.9
|
|
|
|
6.7
|
|
High
|
|
|
15.2
|
|
|
|
11.7
|
|
Low
|
|
|
4.5
|
|
|
|
4.2
|
|
L-1:
|
|
|
|
|
|
|
|
|
Trading Basis
|
|
|
14.9
|
x
|
|
|
11.0
|
x
|
Merger Basis
|
|
|
17.2
|
|
|
|
12.7
|
|
In performing its comparable company analysis:
|
|
|
|
|
Based on the results of this analysis and on Stone Keys
judgment and expertise, Stone Key selected an Enterprise
Value / calendar year 2011 estimated (2011E) EBITDA
multiple range of
6.0x-9.0x.
This range was derived from the companies which Stone Key deemed
most representative of the Companys trading value.
|
|
|
|
Using the reference range of
6.0x-9.0x
the estimated EBITDA contained in the Forecasts, including
stock-based compensation expense for calendar year 2011, after
adding net cash and option proceeds and dividing by the fully
diluted number of shares of the Company common stock
outstanding, this analysis resulted in an overall reference
range of $2.89 to $6.98 per share (without having assumed any
acquisition premium) for purposes of valuing the Company common
stock.
|
53
|
|
|
|
|
Using the reference range of
6.0x-9.0x
the estimated EBITDA contained in the Forecasts, excluding
stock-based compensation expense for calendar year 2011, after
adding net cash and option proceeds and dividing by the fully
diluted number of shares of the Company common stock
outstanding, this analysis resulted in an overall reference
range of $4.27 to $9.03 per share (without having assumed any
acquisition premium) for purposes of valuing the Company common
stock.
|
Precedent Merger and Acquisition Transactions
Analysis. Stone Key reviewed and analyzed certain
relevant precedent merger and acquisition transactions during
the past several years involving the biometrics, homeland
security and government services industries.
The following precedent merger and acquisition transactions were
considered by Stone Key:
|
|
|
|
|
3M Companys acquisition of Cogent, Inc.
announced August 30, 2010
|
|
|
|
AECOM Technology Corporations acquisition of McNeil
Technologies, Inc. announced August 4, 2010
|
|
|
|
CGI Group Inc.s acquisition of Stanley, Inc.
announced May 7, 2010
|
|
|
|
ManTech International Corporations acquisition of Sensor
Technologies Inc. announced December 21, 2009
|
|
|
|
Safrans acquisition of GE (Homeland
Protection) announced April 24, 2009
|
|
|
|
New Mountain Capitals acquisition of Camber
Corporation announced December 1, 2008
|
|
|
|
Serco Group plcs acquisition of SI International,
Inc. announced August 27, 2008
|
|
|
|
BAE Systems acquisition of Detica Group plc
announced July 28, 2008
|
|
|
|
BAE Systems acquisition of MTC Technologies,
Inc. announced December 21, 2007
|
|
|
|
CACI International, Inc.s acquisition of Athena Innovative
Solutions, Inc. announced September 19, 2007
|
|
|
|
General Dynamics Corporations acquisition of Anteon
International Corporation announced
December 14, 2005
|
|
|
|
L-3 Communications Corporation acquisition of The Titan
Corporation announced June 3, 2005
|
|
|
|
General Dynamics Corporations acquisition of Veridian
Corporation announced June 9, 2003
|
A summary of Stone Keys analysis of the precedent merger
and acquisition transactions is presented below:
In performing its precedent merger and acquisition transactions
analysis:
|
|
|
|
|
Stone Key selected a reference range of transaction multiples
consisting of a merger enterprise value/forward EBITDA multiple
range of
9.0x-12.0x
based on 2011E EBITDA, including stock-based compensation
expense.
|
|
|
|
Stone Keys analysis of the select relevant precedent
merger and acquisition transactions resulted in an overall
reference range of $6.98 to $11.01 per share for purposes of
valuing the Company common stock.
|
Other
Considerations
The preparation of a fairness opinion is a complex process and
involves various judgments and determinations as to the most
appropriate and relevant assumptions and financial and valuation
analyses and the application of those methods to the particular
circumstances involved. A fairness opinion is therefore not
readily susceptible to partial analysis or summary description,
and taking portions of the analyses set out above, without
considering the
54
analysis as a whole, would in the view of Stone Key create an
incomplete and misleading picture of the processes underlying
the analyses considered in rendering the Stone Key opinion. In
arriving at its opinion, Stone Key:
|
|
|
|
|
based its analyses on assumptions that it deemed reasonable,
including assumptions concerning general business and economic
conditions, capital markets considerations and industry-specific
and company-specific factors;
|
|
|
|
did not form a view or opinion as to whether any individual
analysis or factor, whether positive or negative, considered in
isolation, supported or failed to support the Stone Key opinion;
|
|
|
|
considered the results of all its analyses and did not attribute
any particular weight to any one analysis or factor; and
|
|
|
|
arrived at its ultimate opinion based on the results of all
analyses undertaken by it and assessed as a whole and believes
that the totality of the factors considered and analyses
performed by Stone Key in connection with its opinion operated
collectively to support its determination as to the fairness of
the $12.00 per share merger consideration, from a financial
point of view, to the stockholders of the Company.
|
Stone Key also noted that:
|
|
|
|
|
The analyses performed by Stone Key, particularly those based on
estimates and projections, are not necessarily indicative of
actual values or actual future results, which may be
significantly more or less favorable than suggested by these
analyses.
|
|
|
|
None of the public companies used in the comparable company
analysis described above are identical to the Company, and none
of the precedent merger and acquisition transactions used in the
precedent transactions analysis described above are identical to
the Merger.
|
|
|
|
Accordingly, the analyses of publicly traded comparable
companies and precedent merger and acquisition transactions are
not mathematical; rather, such analyses involve complex
considerations and judgments concerning the differences in
financial, operating and capital markets-related characteristics
and other factors regarding the companies and precedent merger
and acquisition transactions to which the Company and the Merger
were compared.
|
|
|
|
The analyses performed by Stone Key do not purport to be
appraisals or to reflect the prices at which any securities may
trade at the present time or at any time in the future.
|
The type and amount of consideration payable in the Merger were
determined through negotiations between the Company and Safran
and were approved by the Company board of directors. The
decision to enter into the Merger Agreement and the BAE
Agreement was solely that of the Companys board of
directors. The Stone Key opinion was just one of the many
factors taken into consideration by the Companys board of
directors. Consequently, Stone Keys analyses should not be
viewed as determinative of the decision of the Companys
board of directors with respect to the fairness of the merger
consideration, from a financial point of view, to the
stockholders of the Company.
Pursuant to the engagement letter between Stone Key and the
Company, the Company has agreed to pay Stone Key a fee totaling
approximately $8 million, of which approximately
$1.2 million was payable in connection with delivery of its
opinion and the remaining portion of which will be paid upon the
consummation of the transactions. In addition, the Company has
agreed to reimburse Stone Key for certain expenses and to
indemnify Stone Key against certain liabilities arising out of
Stone Keys engagement.
Stone Key may seek to provide Safran, BAE and their respective
affiliates with certain investment banking and other services
unrelated to the Merger and BAE Transaction in the future.
Michael J. Urfirer is a co-owner and co-founder of Stone Key
Partners LLCs parent company, Stone Key Group LLC (which
we refer to in this proxy statement as SKG) and the husband of
Ms. Fordyce, the Companys Executive Vice President of
Corporate Communications. Both Mr. Urfirer and Denis A.
Bovin, each a Co-Chairman and Co-Chief Executive Officer of
Stone Key Partners LLC, hold personal investments, as minority
limited partners, in Aston. See the section of this proxy
statement entitled Interests of Certain
Persons in the Merger
55
Relationships with Aston and Stone Key.
Mr. Urfirer has confirmed to the Company that he has no
specific interest in any fees paid to Stone Key in connection
with the Merger and BAE Transaction that are attributable to his
status as co-owner of SKG and its affiliates or otherwise, and
that he will not receive any commission, direct participation or
similar payment in connection with Stone Keys receipt of
any such fees. In his capacity as an employee of SKG,
Mr. Urfirer receives a salary from SKG which is not based
on fees paid to SKG. In addition, in his capacity as the holder
of an interest in SKG, Mr. Urfirer is entitled to a
percentage of SKGs profits. The profits interest in SKG
held by Mr. Urfirer is not a fixed percentage and varies
based on the revenues and expenses of SKG, the operation of
payment priorities in SKGs LLC Agreement and potential
future dilution. Under certain scenarios,
Mr. Urfirers interest in SKGs 2010 profits
could be equal to but will in no event exceed 50% and,
therefore, Mr. Urfirers share of the fees payable to
Stone Key in connection with the Merger and BAE Transaction
could approximate $4.0 million, before considering related
operating costs and expenses.
Certain
Forecasts
L-1 does not as a matter of general practice publicly disclose
financial forecasts or internal projections as to future
performance, earnings or other results, other than the
Companys publicly disclosed current year guidance. In the
course of the process resulting in the Merger Agreement,
management of the Company prepared certain non-public, internal
financial forecasts, which in the view of management were
prepared on a reasonable basis and at the time of their
preparation reflected the best available estimates and
judgments, and presented, to the best of managements
knowledge and belief, the expected courses of action and the
expected future results of operations of the Company for the
fiscal years 2010 through 2014. This information did not take
into account the proposed Merger between the Company and Merger
Sub as set forth in the Merger Agreement or the BAE Transaction
between the Company and BAE as set forth in the BAE Agreement.
As described in the section of this proxy statement entitled
Background of the Merger, in late
August 2010, management of the Company prepared a set of such
internal financial forecasts that were shared with the board of
directors, our financial advisors and Safran (in this proxy
statement we refer to the financial forecasts prepared in late
August 2010 as the Forecasts). The Forecasts used by the
financial advisors were the same financial forecasts delivered
to Safran on August 30, 2010. The Forecasts differed from
the financial forecasts delivered to potential buyers in early
August 2010 and from the forecasts included in the confidential
marketing materials that had been delivered upon execution of a
confidentiality agreement in that certain forecasted metrics for
2013 and 2014 included in the Forecasts were adjusted downward,
reflecting managements then best estimates and current
views concerning, among other things, growth rates in future
years, competition in the industry, various contracts that were
to come up for re-compete and other revised business
expectations. The Forecasts and the financial forecasts
delivered to potential buyers in early August 2010 differed from
the financial forecasts included in the confidential marketing
materials delivered to bidders upon execution of a
confidentiality agreement in that the 2010 financial metrics
included in the Forecasts and the early August 2010 forecasts
were revised to reflect the Companys actual results for
the six months ended June 30, 2010. The Company approved
the use by the financial advisors of the Forecasts in connection
with their respective financial analyses of the Merger and the
separate opinions of each of Goldman Sachs and Stone Key, dated
September 19, 2010 and September 18, 2010
respectively, that as of such date, and based on and subject to
the various limitations and assumptions described in the
applicable opinion, the $12.00 per share in cash to be paid to
the holders (other than Safran and its affiliates) of the
outstanding shares of common stock of the Company pursuant to
the merger agreement was fair from a financial point of view to
such holders. We have included below a subset of the Forecasts
solely to give our stockholders access to certain non-public
information that was furnished to our financial advisors and
Safran. Neither the subset of Forecasts nor any other
prospective financial information included in the proxy
statement are being included in this proxy statement to
influence your decision whether to vote for the Merger.
Neither the Forecasts nor any other prospective financial
information included in the proxy statement were prepared with a
view toward public disclosure, nor were they prepared with a
view toward compliance with published guidelines of the SEC
regarding forward-looking statements, the guidelines established
by the American Institute of Certified Public Accountants for
preparation and presentation of prospective financial
information, or GAAP. The Forecasts and the other prospective
financial information included in this proxy statement (which we
refer to collectively in this proxy statement as the Company
Forecasts) contain certain financial measures that were
56
not calculated in accordance with GAAP. The Company Forecasts
included in this proxy statement were prepared by, and are the
responsibility of the Companys senior management. Neither
the Companys independent registered public accounting
firm, nor any other independent accountants, have compiled,
examined or performed any procedures with respect to the
prospective financial information contained herein, nor have
they expressed any opinion or any other form of assurance on
such information or its achievability, and assume no
responsibility for, and disclaim any association with, the
Company Forecasts. The Company Forecasts do not take into
account any circumstances or events occurring after the Company
Forecasts were prepared that were unforeseen by the
Companys senior management at the time of preparation.
The Company Forecasts reflect numerous estimates and assumptions
with respect to industry performance and competition, general
business, economic, regulatory, market and financial conditions
and additional matters specific to L-1s business, all of
which are difficult to predict and many of which are beyond the
Companys control, including the factors described under
Cautionary Statement Concerning Forward-Looking
Information beginning on page 18. The Company
Forecasts also reflect assumptions as to certain business
decisions that are subject to change. As a result, there can be
no assurance that the forecasted data contained therein will be
realized or that actual results will not be materially different
than estimated in the Company Forecasts. Since the Company
Forecasts cover multiple years, such information by its nature
becomes less predictive with each successive year. You are urged
to review the Companys most recent SEC filings for a
description of risk factors with respect to the Companys
business. See the section of this proxy statement entitled
Where You Can Find More Information.
Furthermore, the Company Forecasts do not take into account any
circumstance or event occurring after the date they were
prepared. In particular, since the date of the Company
Forecasts, the Company has made publicly available its actual
results of operations for the nine-month period ended
September 30, 2010. You should review the Companys
Quarterly Report on
Form 10-Q
for the nine-month period ended September 30, 2010 for this
information.
The inclusion of prospective financial information in this
document should not be regarded as an indication that our board
of directors or any of L-1, Safran or their respective
affiliates, financial and legal advisors or their respective
representatives considered, or now considers, the Company
Forecasts to be predictive of actual future results, and the
Company Forecasts should not be relied upon as such. None of our
board of directors, L-1, Safran or their respective affiliates,
financial and legal advisors or their respective representatives
can give you any assurance that actual results will not differ
from the Company Forecasts. The Company Forecasts, including the
subset of the Forecasts set forth below, speak only as of the
time they were prepared in connection with our board of
directors and financial advisors evaluation of the
fairness of the merger consideration. L-1 has made no
representation to Safran in the Merger Agreement or otherwise,
concerning the Company Forecasts.
The Forecasts for fiscal years 2010 through 2014 as of August
2010 provided to our financial advisors and Safran included the
information in the following two tables:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
|
($ in millions)
|
|
Revenue
|
|
$
|
720
|
|
|
$
|
851
|
|
|
$
|
975
|
|
|
$
|
1,073
|
|
|
$
|
1,180
|
|
Growth Percentage
|
|
|
11
|
%
|
|
|
18
|
%
|
|
|
15
|
%
|
|
|
10
|
%
|
|
|
10
|
%
|
Adjusted EBITDA*
|
|
$
|
114
|
|
|
$
|
144
|
|
|
$
|
171
|
|
|
$
|
185
|
|
|
$
|
200
|
|
Margin Percentage
|
|
|
16
|
%
|
|
|
17
|
%
|
|
|
18
|
%
|
|
|
17
|
%
|
|
|
17
|
%
|
EBITDA (including stock-based compensation expense)
|
|
$
|
91
|
|
|
$
|
123
|
|
|
$
|
150
|
|
|
$
|
164
|
|
|
$
|
180
|
|
Margin Percentage
|
|
|
13
|
%
|
|
|
14
|
%
|
|
|
15
|
%
|
|
|
15
|
%
|
|
|
15
|
%
|
* Adjusted EBITDA represents EBITDA, adjusted to exclude
stock-based compensation expense.
57
Key cash flow items for fiscal years 2010 through 2014 as of
August 2010 provided to our financial advisors and Safran
included the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2011
|
|
|
2012
|
|
|
2013
|
|
|
2014
|
|
|
|
($ in millions)
|
|
|
Depreciation & Amortization
|
|
$
|
42
|
|
|
$
|
43
|
|
|
$
|
43
|
|
|
$
|
43
|
|
|
$
|
37
|
|
Capital Expenditures
|
|
$
|
(55
|
)
|
|
$
|
(37
|
)
|
|
$
|
(22
|
)
|
|
$
|
(16
|
)
|
|
$
|
(20
|
)
|
Change in Net Working Capital
|
|
$
|
(7
|
)
|
|
$
|
(8
|
)
|
|
$
|
(10
|
)
|
|
$
|
(12
|
)
|
|
$
|
(15
|
)
|
Readers of this proxy statement are cautioned not to place undue
reliance on the Company Forecasts set forth in this proxy
statement. No representation is made by L-1 or any other person
to any stockholder of the Company regarding the ultimate
performance of L-1 compared to the information included in the
Company Forecasts set forth in this proxy statement.
THE COMPANY DOES NOT INTEND TO UPDATE OR OTHERWISE REVISE THE
COMPANY FORECASTS SET FORTH IN THIS PROXY STATEMENT TO REFLECT
CIRCUMSTANCES EXISTING AFTER THE DATE WHEN MADE OR TO REFLECT
THE OCCURRENCE OF FUTURE EVENTS, EVEN IN THE EVENT THAT ANY OR
ALL OF THE ASSUMPTIONS UNDERLYING SUCH COMPANY FORECASTS ARE NO
LONGER APPROPRIATE.
Effects
on the Company if the Merger is Not Completed
If the Merger Agreement is not adopted and the Merger is not
approved by our stockholders or if the Merger is not completed
for any other reason, our stockholders will not receive any
payment for their shares of our common stock in connection with
the Merger. Instead, we will remain an independent public
company, and our common stock will continue to be quoted on the
New York Stock Exchange. Completion of the BAE Transaction and
the sale of the Companys intelligence services business
group to BAE is not conditioned on the Merger, and this
transaction may be completed even if the Merger is not completed
or the Merger Agreement is terminated.
If the Merger is not consummated, there can be no assurance as
to the effect of these risks and opportunities on the future
value of your shares of our common stock. In the event the
Merger is not completed, our board of directors will continue to
evaluate and review our business operations, projects and
capitalization, make such changes as are deemed appropriate and
seek to identify acquisitions, joint ventures or strategic
alternatives to enhance stockholder value. If the Merger
Agreement is not adopted and the Merger not approved by our
stockholders or if the Merger is not consummated for any other
reason, there can be no assurance that any other transaction
acceptable to us will be offered or that our business, prospects
or results of operations will not be adversely impacted.
If the Merger Agreement is terminated under certain
circumstances, we will be obligated to pay Safran a termination
fee or reimburse Safran for certain of its
out-of-pocket
expense. Safran may also be required to pay L-1 a termination
fee under certain circumstances. See the section of this proxy
statement entitled The Merger Agreement
Termination Fees and Reimbursement of Expenses.
Financing
of the Merger
The obligations of Safran and Merger Sub under the Merger
Agreement are not subject to a condition regarding Safrans
or Merger Subs obtaining of funds to consummate the Merger
and the other transactions contemplated by the Merger Agreement.
Safran and Merger Sub have represented in the Merger Agreement
that Safran has, and as of the closing of the Merger, Safran
will have, sufficient funds available (through existing credit
arrangements or otherwise) to fully fund all of its and Merger
Subs obligations under the Merger Agreement, including
payment of the aggregate merger consideration and other cash
consideration in respect of equity awards pursuant to the Merger
Agreement, and payment of all fees and expenses related to the
transactions contemplated by the Merger Agreement, and any
refinancing of indebtedness of Safran or the Company or their
respective subsidiaries in connection with the transactions
contemplated by the Merger Agreement.
BAEs obligations under the BAE Agreement are not subject
to a condition regarding BAE obtaining funds to consummate the
BAE Transaction. BAE has represented in the BAE Agreement that
it has, and as of the closing of
58
the BAE Transaction, BAE will have, sufficient funds available
(through existing credit arrangements or otherwise) to fully
fund all of its obligations under the BAE Agreement.
Material
U.S. Federal Income Tax Consequences
The following is a general summary of material U.S. federal
income tax consequences of the Merger to U.S. holders whose
shares of our common stock are converted into the right to
receive cash in the Merger. This summary does not purport to
consider all aspects of U.S. federal income taxation that
might be relevant to our stockholders. For purposes of this
summary, the term U.S. holder means a
beneficial owner of shares of our common stock that is, for
U.S. federal income tax purposes:
|
|
|
|
|
an individual who is a citizen or resident of the United States;
|
|
|
|
a corporation (or other entity taxable as a corporation) created
or organized under the laws of the United States or any of its
political subdivisions;
|
|
|
|
a trust if (i) a U.S. court is able to exercise
primary supervision over the trusts administration and one
or more U.S. persons is authorized to control all
substantial interests of the trust; or (ii) it was in
existence on August 30, 1996 and has a valid election in
effect under applicable U.S. Treasury regulations to be
treated as a domestic trust for U.S. federal income tax
purposes; or
|
|
|
|
an estate that is subject to U.S. federal income tax on its
income regardless of its source.
|
If a partnership (including an entity treated as a partnership
for U.S. federal income tax purposes) holds common stock,
the tax treatment of a partner generally will depend on the
status of the partners and the activities of the partnership. A
partner of a partnership holding common stock should consult its
independent tax advisor.
This summary is based on the Internal Revenue Code of 1986, as
amended (which we refer to in this proxy statement as the Code),
its legislative history, U.S. Treasury regulations
promulgated thereunder, published rulings by the Internal
Revenue Service, and judicial and administrative decisions in
effect as of the date of this proxy statement, all of which are
subject to change, possibly with retroactive effect. This
summary applies only to beneficial owners who are
U.S. holders and hold shares of our common stock as
capital assets within the meaning of
Section 1221 of the Code and does not apply to shares of
our common stock received in connection with the exercise of
employee stock options or otherwise as compensation for services
or through a tax-qualified retirement plan, stockholders who
hold an equity interest, directly or indirectly, in Safran after
the Merger, shares held by holders who properly demand and
perfect their appraisal rights under Delaware law or to certain
types of beneficial owners who may be subject to special rules
(such as insurance companies, banks, tax-exempt organizations,
financial institutions, broker dealers, dealers in currencies,
partnerships, S corporations or other pass-through entities
(or investors in an S corporation or other pass-through
entity), mutual funds, real estate investment trusts, traders in
securities who elect the
mark-to-market
method of accounting for their securities, stockholders subject
to the alternative minimum tax, stockholders that have a
functional currency other than the U.S. dollar, or
stockholders who hold common stock as part of a hedge, straddle,
constructive sale, conversion transaction or other integrated
transaction). This summary does not address any aspect of state,
local, foreign or estate and gift tax laws.
Exchange
of Shares of Common Stock for Cash Pursuant to the Merger
Agreement
The receipt of cash in exchange for shares of our common stock
pursuant to the Merger will be a taxable transaction for
U.S. federal income tax purposes. In general, a
U.S. holder whose shares of common stock are converted into
the right to receive cash in the Merger will recognize capital
gain or loss for U.S. federal income tax purposes equal to
the difference, if any, between the amount of cash received in
the Merger with respect to such shares and the holders
adjusted tax basis in such shares. Gain or loss will be
determined separately for each block of shares (i.e., shares
acquired at the same cost in a single transaction). Such gain or
loss will be long-term capital gain or loss, provided that a
U.S. holders holding period is more than one year at
the time of the consummation of the Merger. Certain limitations
apply to the use of capital losses.
59
Backup
Withholding and Information Reporting
The receipt of cash in exchange for shares of our common stock
by a U.S. holder pursuant to the Merger may be subject to
information reporting and backup withholding tax at the
applicable rate, unless the U.S. holder (i) timely
furnishes an accurate taxpayer identification number and
otherwise complies with applicable U.S. information
reporting or certification requirements (typically by completing
and signing an Internal Revenue Service
Form W-9,
a copy of which will be included as part of the letter of
transmittal to be timely returned to the paying agent) or
(ii) is a corporation or other exempt recipient and, when
required, establishes such fact. Backup withholding is not an
additional tax and any amounts withheld under the backup
withholding rules may be refunded or credited against a
U.S. holders U.S. federal income tax liability,
if any, provided that the required information is furnished to
the Internal Revenue Service in a timely manner.
The U.S. federal income tax consequences described above
are not intended to constitute tax advice nor a complete
discussion of all tax consequences relating to the Merger.
Because individual circumstances may differ, each stockholder
should consult its independent tax advisor regarding the
applicability of the rules discussed above and the particular
tax effects to the stockholder of the Merger in light of such
stockholders particular circumstances, the application of
state, local and foreign tax laws, and, if applicable, the tax
consequences of the receipt of cash in connection with the
cancellation or exchange of options, warrants, restricted stock
awards or deferred stock units to purchase shares of common
stock, including the transactions described in this proxy
statement relating to our other equity compensation and benefit
plans.
Voting
and Support Agreement
Contemporaneously with the execution of the Merger Agreement, on
September 19, 2010, Safran, Merger Sub, Mr. LaPenta
and Aston entered into a voting and support agreement pursuant
to which Mr. LaPenta and Aston have agreed, among other
things, to vote their shares of Company common stock:
|
|
|
|
|
in favor of adoption of the Merger Agreement and the approval of
the transactions contemplated by the Merger Agreement; and
|
|
|
|
against (i) any alternative acquisition or takeover
proposal and (ii) any action or agreement or amendment of
the Companys organizational documents that is intended or
could reasonably be expected to prevent, impede, interfere with,
delay, postpone or discourage the consummation of the Merger or
would result in a breach of the Companys representations
and warranties and obligations in the Merger Agreement.
|
As of December 27, 2010, the record date for the special
meeting, Mr. LaPenta and Aston together beneficially owned
approximately 14.59% of our outstanding shares.
Each of Mr. LaPenta and Aston has appointed Safrans
designees, with full power of substitution, as such
stockholders proxy and attorney-in-fact, for and in such
stockholders name, to vote all shares of Company common
stock owned by such stockholder in the manner described above.
Each of Mr. LaPenta and Aston also agreed that he or it
will not (i) solicit, initiate, cause, facilitate or
encourage any inquiries or proposals that constitute, or may
reasonably be expected to lead to, an alternative acquisition or
takeover proposal, (ii) participate in any discussions or
negotiations with any third party regarding any alternative
acquisition or takeover proposal or (iii) enter into any
agreement related to any alternative acquisition or takeover
proposal, in each case, except to the extent the Company is
permitted to take such actions pursuant to the Merger Agreement.
See the section of this proxy statement entitled The
Merger Agreement Restrictions on Solicitations of
Other Offers.
The voting and support agreement will terminate upon the
earliest of (i) the mutual agreement of Safran, Merger Sub,
Mr. LaPenta and Aston, (ii) the termination of the
Merger Agreement in accordance with its terms or (iii) the
consummation of the Merger, provided, however, that
Mr. LaPentas and Astons voting obligations and
the appointment of proxies with respect to the subject shares
will terminate upon our board of directors changing its
recommendation that stockholders vote for the adoption of the
Merger Agreement and approval of the Merger. See the section of
this proxy statement entitled The Merger
Agreement Change of Recommendation.
60
Interests
of Certain Persons in the Merger
In considering the recommendation of the board of directors with
respect to the Merger Agreement, you should be aware that the
Companys directors and executive officers, including
individuals who participated in meetings of the board of
directors regarding the Merger Agreement and the Merger, and
certain other individuals may have interests in the Merger that
are different from, or in addition to, the interests of our
stockholders generally, as more fully described below. Our board
of directors was aware of these potentially differing interests
and considered them, among other matters, in reaching its
decision to approve the Merger Agreement and the Merger and to
recommend that you vote in favor of adopting the Merger
Agreement and approving the Merger.
Employment
Agreements
Each of Robert V. LaPenta, our Chairman of the Board, President
and Chief Executive Officer, James A. DePalma, our Executive
Vice President, Chief Financial Officer and Treasurer, Joseph
Atick, our Executive Vice President and Chief Strategic Officer,
Mark S. Molina, our Executive Vice President, Chief Legal
Officer and Secretary, Joseph S. Paresi, our Executive Vice
President and Chief Marketing Officer and Doni L. Fordyce, our
Executive Vice President of Corporate Communications, is party
to an employment agreement with the Company (each of which we
refer to in this proxy statement as an Employment Agreement).
Each of the Employment Agreements was entered into as of
August 29, 2006, and amended as of July 31, 2009. Each
Employment Agreement provides that the executive officer is
entitled to severance benefits if the executive officer is
terminated by the Company without cause or if the
executive officer terminates employment for good
reason.
Upon the occurrence of one of such events, these executive
officers will be entitled to the following payments and benefits:
|
|
|
|
|
payment of an amount equal to two times the executive
officers annual base salary at the rate in effect on the
date of termination;
|
|
|
|
payment of an amount equal to the bonus payment awarded to the
executive officer for the most recently completed calendar year
for which a bonus was determined by our board of directors and,
if the executive officer is terminated following the end of a
completed year but prior to the determination of the bonus for
that calendar year, an amount equal to the target level bonus
for that calendar year (in the case of Messrs. DePalma,
Atick, Molina, and Paresi and Ms. Fordyce, such target
level bonus cannot be less than 60% of the individuals
applicable base salary and, in the case of Mr. LaPenta,
such target level bonus cannot be less than 75% of his
applicable base salary);
|
|
|
|
accelerated vesting of all outstanding equity awards; and
|
|
|
|
COBRA payments (or an equivalent amount) and term life insurance
payments (or an equivalent amount) until the earlier of the
expiration of the
12-month
period following the date of termination and the date such
benefits are provided by a successor employer.
|
Mr. Molinas agreement also provides that following
any termination of employment occurring after a change in
control, the Company or its successor will pay all costs and
expenses arising out of or related to the relocation of him and
his family within the mainland United States (or, if elected by
Mr. Molina, the lump sum cash value thereof) on terms no
less favorable to Mr. Molina than those set forth in an
identified company relocation policy. His agreement also
requires thirty days prior notice of termination or payment in
lieu thereof.
To receive such severance benefits, Messrs. LaPenta,
DePalma and Paresi and Ms. Fordyce must execute a general
release of claims in favor of the Company. Cash severance in
respect of the salary and bonus components described above for
Messrs. LaPenta, DePalma, Paresi, Atick and Molina will be
paid in two equal lump sum payments the first lump
sum payment to be made within five business days after the
termination date and the second lump sum payment to be made on
the next business day after the six-month anniversary of the
termination date. Cash severance in respect of the salary and
bonus components described above for Ms. Fordyce will be
paid in one lump sum payment within five days following the
six-month anniversary of the date of termination. In addition,
each Employment Agreement provides for an additional payment to
compensate the executive officer for any excise tax incurred by
such executive officer under Section 4999 of the Code. In
the Merger Agreement, Safran and the
61
Company agreed to cooperate, and the Company agreed to take all
actions reasonably requested by Safran, on or prior to
December 31, 2010, as are necessary to reduce and/or avoid
the application of Section 280G of the Code to the payments
to be made to such executive officers. Pursuant to such
obligations, our board of directors took action prior to the end
of 2010 to (i) pay Messrs. LaPenta, DePalma and Molina and
Ms. Fordyce, prior to the end of 2010, a portion of his or
her bonus for services in 2010 in an amount equal to 25% of the
executives 2010 target annual bonus and
(ii) accelerate the vesting of 12,000 and 5,000 restricted
shares held by Messrs. LaPenta and DePalma, respectively,
which restricted shares would have in the ordinary course become
vested in February 2011. In addition, our board of directors
resolved that, following the end of 2010, it will assess,
determine and pay, in the ordinary course, the balance of any
2010 bonus amount payable to each of those executives and the
amount of 2010 bonus payable to Messrs. Atick and Paresi,
pursuant to the Companys 2010 bonus plan, provided that
total 2010 bonus amounts, in the case of each executive, shall
not be less than, in the aggregate, 25% of his or her 2010
target annual bonus nor exceed, in the aggregate, 50% of his or
her 2010 target annual bonus (taking into account the 25% of any
such 2010 target bonus amount paid prior to the end of 2010).
Pursuant to their Employment Agreements, each of
Messrs. LaPenta and DePalma have deferred annual bonuses in
the form of deferred stock units, which will be paid upon a
change in control or any termination of their employment.
Vincent A. DAngelo, our Senior Vice President of Finance
and Chief Accounting Officer, has an offer letter from the
Company, dated September 21, 2006, which provides for the
following severance benefits if he is terminated by the Company
without cause or if he terminates for good
reason:
|
|
|
|
|
payment of an amount equal to one times base salary, payable as
monthly salary continuation;
|
|
|
|
continuation of benefit and premium coverage for the twelve
month period following the date of termination; and
|
|
|
|
accelerated vesting of all outstanding equity awards.
|
Robert V. LaPenta, Jr., the son of the Companys Chief
Executive Officer and the Companys Vice President,
M&A/Corporate Development, is entitled to a cash severance
payment equal to his annual base salary (currently $165,000) in
the event of a qualifying termination of employment.
Mr. LaPenta, Jr.s entitlement to such cash
severance payment was awarded pursuant to a severance program
established in September 2010 for approximately 25 other Company
headquarters non-executive officer employees, which provides for
aggregate severance payments of approximately $3,661,238,
payable in the event these employees incur qualifying
terminations of employment.
Transaction
Bonuses
Mr. DAngelo and Mr. LaPenta, Jr. will each
be entitled to receive a cash transaction bonus equal to
$150,000 and $175,000, respectively, upon closing of the Merger.
These cash transaction bonuses are payable pursuant to an award
of cash transaction bonuses made in September 2010 to
Mr. DAngelo and approximately 30 non-executive
officer employees of the Company (including
Mr. LaPenta, Jr.) in recognition of their efforts with
respect to the Merger and BAE Transaction. The cash transaction
bonuses, in the aggregate, total approximately $1,491,000.
Potential
Cash Severance Payments to Executive Officers Upon Termination
or Qualifying Termination After a Change in
Control
Consummation of the Merger will constitute a change in control
under the Employment Agreements. Pursuant to the Merger
Agreement, Safran has agreed to cause the surviving corporation
to terminate the employment of Messrs. DePalma, LaPenta and
Molina and Ms. Fordyce immediately following the closing of
the Merger and has agreed that such terminations of employment
shall be treated as terminations without cause for
purposes of the Employment Agreements.
62
The following table sets forth an estimate of the potential cash
severance payments that would be paid to the Companys
executive officers pursuant to the Employment Agreements,
assuming the Merger is consummated on February 3, 2011 and
the employment of each of the executive officers is terminated
immediately following the closing of the Merger in accordance
with the terms of each such agreement and in a manner entitling
them to severance benefits.
|
|
|
|
|
Executive Officer
|
|
Cash Severance Payments(1)
|
|
Robert V. LaPenta
|
|
$
|
1,864,375
|
|
James A. DePalma
|
|
$
|
908,500
|
|
Joseph Atick
|
|
$
|
920,000
|
|
Mark S. Molina
|
|
$
|
1,018,500
|
|
Joseph S. Paresi
|
|
$
|
770,500
|
|
Doni L. Fordyce
|
|
$
|
632,500
|
|
Vincent A. DAngelo
|
|
$
|
285,000
|
|
|
|
|
(1) |
|
The bonus component used for calculating the estimated figures
shown above (other than for Mr. DAngelo, whose cash
severance payment does not include a bonus component) is 50% of
the executives target bonus for 2010. Figures will be
adjusted to reflect actual 2010 annual bonuses awarded to the
executives. The amount reflected above for Mr. Molina
includes $225,000 that Mr. Molina has elected to receive
per his employment agreement in lieu of certain relocation
payments and benefits he would otherwise be entitled to receive. |
Treatment
of Stock Options, Restricted Stock Awards and Long-Term Cash
Awards
As of December 27, 2010, there were 7,130,421 shares of
common stock subject to outstanding stock options granted under
the Companys L-1 Identity Solutions, Inc. 2010 Long-Term
Incentive Plan, L-1 Identity Solutions, Inc. 2008 Long-Term
Incentive Plan, Viisage Technology, Inc. 2005 Long-Term
Incentive Plan, Viisage Technology, Inc. Second Amended and
Restated 1996 Management Stock Option Plan, Viisage Technology,
Inc. Amended and Restated 1996 Directors Stock Option Plan,
2002 Equity Incentive Plan of Identix Incorporated, Identix
Incorporated New Employee Stock Incentive Plan, Identix
Incorporated Nonemployee Directors Stock Option Plan, Identix
Incorporated Equity Incentive Plan, Visionics Corporation 1990
Stock Option Plan, Visionics Corporation 1998 Stock Option Plan,
Visionics Corporation Stock Incentive Plan, Bioscrypt Inc.
Primary Stock Option Plan, ZN Employee Share Option Plan,
Imaging Automation, Inc. 2003 Employee, Director and Consultant
Stock Plan and Imaging Automation Inc. 1996 Stock Option Plan,
each as amended from time to time (which we collectively refer
to in this proxy statement as the Equity Plans).
Pursuant to the terms of the Merger Agreement, each stock option
outstanding immediately prior to the effective time of the
Merger that represents the right to acquire shares of our common
stock and was issued under one of the Equity Plans will, to the
extent not then vested and exercisable, become fully vested and
exercisable as of immediately prior to the effective time and
each stock option to acquire shares of our common stock that is
then outstanding will, at the effective time of the Merger, be
cancelled in exchange for the right to receive a cash payment
equal to the excess, if any, of the $12.00 merger consideration
per share of our common stock underlying the stock option over
the exercise price payable in respect of such share of our
common stock issuable under such stock option, less any
applicable withholding taxes.
63
The table set forth below summarizes the outstanding vested and
unvested options held, as of December 27, 2010, by our
directors, executive officers and Mr. LaPenta, Jr., and the
consideration that each of them will receive in consideration
for the cancellation of their options in connection with the
Merger:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
|
|
|
Shares
|
|
Spread of
|
|
Shares
|
|
Spread of
|
|
Total
|
|
|
Subject to
|
|
Unvested
|
|
Subject to
|
|
Vested
|
|
Spread of All
|
|
|
Unvested
|
|
Options at
|
|
Vested
|
|
Options at
|
|
Options at
|
Name
|
|
Options
|
|
$12.00
|
|
Options
|
|
$12.00
|
|
$12.00
|
|
Robert V. LaPenta
|
|
|
315,000
|
|
|
$
|
1,139,550
|
|
|
|
562,632
|
|
|
$
|
379,850
|
|
|
$
|
1,519,400
|
|
James A. DePalma
|
|
|
172,500
|
|
|
$
|
659,213
|
|
|
|
336,430
|
|
|
$
|
219,738
|
|
|
$
|
878,951
|
|
Joseph Atick
|
|
|
152,500
|
|
|
$
|
641,700
|
|
|
|
677,329
|
|
|
$
|
298,189
|
|
|
$
|
939,889
|
|
Mark S. Molina
|
|
|
113,750
|
|
|
$
|
445,313
|
|
|
|
416,974
|
|
|
$
|
247,293
|
|
|
$
|
692,606
|
|
Joseph S. Paresi
|
|
|
108,750
|
|
|
$
|
445,313
|
|
|
|
200,857
|
|
|
$
|
148,438
|
|
|
$
|
593,751
|
|
Doni L. Fordyce
|
|
|
112,500
|
|
|
$
|
427,800
|
|
|
|
217,081
|
|
|
$
|
142,600
|
|
|
$
|
570,400
|
|
Vincent A. DAngelo
|
|
|
28,750
|
|
|
$
|
70,050
|
|
|
|
126,426
|
|
|
$
|
23,350
|
|
|
$
|
93,400
|
|
Robert V. LaPenta, Jr.
|
|
|
15,000
|
|
|
$
|
31,950
|
|
|
|
25,000
|
|
|
$
|
10,650
|
|
|
$
|
42,600
|
|
B. G. Beck
|
|
|
0
|
|
|
|
|
|
|
|
13,000
|
|
|
$
|
600
|
|
|
$
|
600
|
|
Milton E. Cooper
|
|
|
0
|
|
|
|
|
|
|
|
85,140
|
|
|
$
|
35,830
|
|
|
$
|
35,830
|
|
Robert S. Gelbard
|
|
|
0
|
|
|
|
|
|
|
|
15,000
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Malcolm J. Gudis
|
|
|
0
|
|
|
|
|
|
|
|
56,760
|
|
|
$
|
13,622
|
|
|
$
|
13,622
|
|
John E. Lawler
|
|
|
0
|
|
|
|
|
|
|
|
49,665
|
|
|
$
|
13,622
|
|
|
$
|
13,622
|
|
James M. Loy
|
|
|
0
|
|
|
|
|
|
|
|
25,000
|
|
|
$
|
0
|
|
|
$
|
0
|
|
Harriet Mouchly-Weiss
|
|
|
0
|
|
|
|
|
|
|
|
32,667
|
|
|
$
|
20,752
|
|
|
$
|
20,752
|
|
Peter Nessen
|
|
|
0
|
|
|
|
|
|
|
|
38,500
|
|
|
$
|
10,500
|
|
|
$
|
10,500
|
|
B. Boykin Rose
|
|
|
0
|
|
|
|
|
|
|
|
25,000
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
(1) |
|
The spread of such vested and unvested options was calculated by
multiplying (i) the excess (if any) of $12.00 over the per
share exercise price of the options by (ii) the number of
shares subject to the options, and without regard to deductions
for income taxes and other withholding. |
Pursuant to the terms of the Merger Agreement, each restricted
stock award outstanding immediately prior to the effective time
of the Merger will, at the effective time of the Merger, be
cancelled and holders thereof will only have the right to
receive the per share consideration of $12.00, less any
applicable withholding taxes. In addition, each deferred stock
unit relating to a bonus previously earned but deferred that is
outstanding immediately prior to the effective time of the
Merger will be cancelled in exchange for the right to receive an
amount equal to the merger consideration, less any applicable
withholding taxes.
64
The table set forth below summarizes the unvested restricted
stock awards as of December 27, 2010, held by our
directors, executive officers and Mr. LaPenta, Jr., and the
consideration that each of them will receive in connection with
the Merger with respect to their restricted stock awards. For
Messrs. LaPenta and DePalma, the table below also
summarizes the number of deferred stock units credited to their
deferred compensation accounts as of December 27, 2010, and
the consideration that each of them will receive in connection
with the Merger upon the payment of such vested deferred stock
units.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares/
|
|
Number of Units/
|
|
|
Value of Unvested
|
|
Value of Vested
|
|
|
Restricted Stock
|
|
Deferred Stock Units
|
Name
|
|
at
$12.00(1)
|
|
at $12.00
|
|
Robert V. LaPenta
|
|
228,000/$
|
2,736,000
|
|
|
67,039/$
|
804,468
|
|
James A. DePalma
|
|
133,750/$
|
1,605,000
|
|
|
36,995/$
|
443,940
|
|
Joseph Atick
|
|
135,000/$
|
1,620,000
|
|
|
|
|
|
Mark S. Molina
|
|
93,750/$
|
1,125,000
|
|
|
|
|
|
Joseph S. Paresi
|
|
93,750/$
|
1,125,000
|
|
|
|
|
|
Doni L. Fordyce
|
|
90,000/$
|
1,080,000
|
|
|
|
|
|
Vincent A. DAngelo
|
|
40,000/$
|
480,000
|
|
|
|
|
|
Robert V. LaPenta, Jr.
|
|
17,500/$
|
210,000
|
|
|
|
|
|
B. G. Beck
|
|
10,417/$
|
125,004
|
|
|
|
|
|
Milton E. Cooper
|
|
10,417/$
|
125,004
|
|
|
|
|
|
Robert S. Gelbard
|
|
10,417/$
|
125,004
|
|
|
|
|
|
Malcolm J. Gudis
|
|
10,417/$
|
125,004
|
|
|
|
|
|
John E. Lawler
|
|
10,417/$
|
125,004
|
|
|
|
|
|
James M. Loy
|
|
10,417/$
|
125,004
|
|
|
|
|
|
Harriet Mouchly-Weiss
|
|
10,417/$
|
125,004
|
|
|
|
|
|
Peter Nessen
|
|
10,417/$
|
125,004
|
|
|
|
|
|
B. Boykin Rose
|
|
10,417/$
|
125,004
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts for Messrs. LaPenta and DePalma reflect the
accelerated vesting of restricted shares that would otherwise
have vested in February 2011, as described above under the
heading Employment Agreements. |
In addition, under the Companys compensation policy
applicable to its non-employee directors, each non-employee
member of the board of directors is entitled to receive, as one
component of annual compensation, $100,000 in restricted shares
of Company common stock on the first business day of each
calendar year. The next regularly scheduled grant date for such
shares of stock is January 3, 2011. The policy provides
that the shares vest 25% per year over a four-year period and
vesting of all unvested shares is accelerated in the event of a
change of control, including the Merger. Under the
terms of the Merger Agreement, subject to certain exceptions,
the Company is restricted from issuing additional shares of
stock. In light of these restrictions, in lieu of the restricted
stock grant on January 3, 2011, each non-employee director
will be paid $100,000 in cash on January 3, 2011.
Pursuant to the terms of the Merger Agreement, each long-term
cash award granted in February 2010 will become fully vested as
of the effective time of the Merger and will be payable by the
Company no less than 10 business days following the effective
time of the Merger. Mr. DAngelo and approximately
forty-eight non-executive officer employees of the Company
(including Mr. LaPenta, Jr.) were the recipients of such
long-term cash awards, which were granted with a three-year
vesting schedule and, in the aggregate, total approximately
$4,050,000. Assuming that the Merger is consummated on
February 3, 2011, Mr. DAngelo and
Mr. LaPenta, Jr. would be entitled to payments equal to
$100,000 and $50,000, respectively.
The following table sets forth the cumulative estimated
compensation, each component of which has been described and set
forth in the preceding tables, that may be payable in connection
with the Merger to the Companys executive officers
pursuant to the severance provisions, and, in the case of
Mr. Molina, the provision relating to moving expenses, of
their Employment Agreements (or, in the case of
Mr. DAngelo, his offer letter), the terms of
65
the Merger Agreement that provide for the vesting and payment of
their equity-based awards and long-term cash awards and, in the
case of Mr. DAngelo, pursuant to the Companys
cash transaction bonus award. As with the preceding tables,
where relevant, values are based on the $12.00 per share merger
consideration.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Severance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and Payment
|
|
Total Value of
|
|
|
|
Total Value
|
|
Cash
|
|
|
|
|
|
|
in Lieu of
|
|
All Stock
|
|
Total Value of
|
|
of Deferred
|
|
Transaction
|
|
Long-Term
|
|
|
Name
|
|
Relocation
|
|
Options
|
|
Restricted Stock
|
|
Stock Units
|
|
Bonus
|
|
Cash Award
|
|
Total
|
|
Robert V. LaPenta
|
|
$
|
1,864,375
|
|
|
$
|
1,519,400
|
|
|
$
|
2,736,000
|
|
|
$
|
804,468
|
|
|
|
|
|
|
|
|
|
|
$
|
6,924,243
|
|
James A. DePalma
|
|
$
|
908,500
|
|
|
$
|
878,951
|
|
|
$
|
1,605,000
|
|
|
$
|
443,940
|
|
|
|
|
|
|
|
|
|
|
$
|
3,836,391
|
|
Joseph Atick
|
|
$
|
920,000
|
|
|
$
|
939,889
|
|
|
$
|
1,620,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3,479,889
|
|
Mark S. Molina
|
|
$
|
1,018,500
|
|
|
$
|
692,606
|
|
|
$
|
1,125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,836,106
|
|
Joseph S. Paresi
|
|
$
|
770,500
|
|
|
$
|
593,751
|
|
|
$
|
1,125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,489,251
|
|
Doni L. Fordyce
|
|
$
|
632,500
|
|
|
$
|
570,400
|
|
|
$
|
1,080,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,282,900
|
|
Vincent A. DAngelo
|
|
$
|
285,000
|
|
|
$
|
93,400
|
|
|
$
|
480,000
|
|
|
|
|
|
|
$
|
150,000
|
|
|
$
|
100,000
|
|
|
$
|
1,108,400
|
|
Employment
Following the Merger
The Merger Agreement requires that, for eighteen months
following the Merger, Safran will, and will cause its affiliates
to, provide to employees of the Company immediately prior to the
consummation of the Merger who remain in the employment of the
surviving corporation certain comparable levels of compensation
and employee benefits (see the section of this proxy statement
entitled The Merger Agreement Employee
Matters). Notwithstanding Safrans obligations in
respect of individuals that remain employed with the Company
following the Merger, the Merger Agreement expressly provides
that Safran has no obligation to continue the employment of any
person and that Safran is not restricted in its ability to
terminate any such employment. In addition, as noted above, the
Merger Agreement obligates Safran to cause the terminations of
employment, immediately following the closing of the Merger, of
Messrs. LaPenta, DePalma and Molina and Ms. Fordyce.
Director
and Officer Indemnification and Insurance
The Merger Agreement provides that Safran and Merger Sub will
(i) continue in full force and effect all rights to
indemnification for acts and omissions occurring prior to the
effective time of the Merger (including any matters arising in
connection with the transactions contemplated by the Merger
Agreement and the BAE Agreement), whether asserted or claimed
prior to, at or after the effective time of the Merger, existing
in favor of the current or former directors, officers and
members of the boards of managers of the Company and its
subsidiaries (other than the Intel Companies) and the current or
former employees of the Company or its subsidiaries as provided
in the organizational documents of the Company and its
subsidiaries or any contract with the Company, in each case as
in effect on the date of the Merger Agreement and
(ii) indemnify, defend, hold harmless and advance expenses
to the current and former directors and officers of the Company
and its subsidiaries (other than the Intel Companies) with
respect to all acts or omissions by them in their capacities as
such at any time prior to the effective time of the Merger
(including any matters arising in connection with the
transactions contemplated by the Merger Agreement and the BAE
Agreement), to the fullest extent that the Company or its
subsidiaries would be permitted by applicable law. See the
section of this proxy statement entitled The Merger
Agreement Director and Officer Indemnification and
Insurance.
In addition, under the terms of the Merger Agreement, Safran
will also provide, or cause the surviving corporation to
provide, for a period of six years after the effective time of
the Merger, insurance and indemnification policies, or
tail policies, in each case, that provide coverage
for events occurring at or prior to the effective time of the
Merger for those individuals who were insured by the
Companys directors and officers insurance and
indemnification policies, which coverage shall be on terms that
are no less favorable than the existing policies of the Company
as of the date of the Merger Agreement or, if substantially
equivalent insurance coverage is unavailable, the best available
coverage. Safrans and the surviving corporations
obligation to provide this insurance coverage is subject to a
premium cap of 300% of the last annual premium paid by the
Company for its policies prior to the date of the Merger
Agreement. See the section of this proxy statement entitled
The Merger Agreement Director and Officer
Indemnification and Insurance.
Under the terms of the Merger Agreement, following the closing
of the Merger, Safran is also required to honor the
Companys director and officer litigation reimbursement
policy, pursuant to which all current and former
66
directors and former officers of the Company are entitled to
compensation for time and services related to appearances or
attendance at any third party proceeding (including without
limitation, depositions, court appearances and legal
proceedings) in any case related to his or her current or past
service as a director or officer, as the case may be. This
compensation is in addition to reimbursement of all reasonable
out-of-pocket
costs and expenses associated with such appearance or
attendance. See the section of this proxy statement entitled
The Merger Agreement Director and Officer
Indemnification and Insurance.
Relationships
with Aston and Stone Key
Aston is a private investment fund organized as a limited
partnership and managed by its general partner, Aston Capital
Partners GP LLC, and L-1 Investment Partners LLC, its investment
manger. Aston owns approximately 8.14% of the outstanding shares
of the Company common stock as of December 27, 2010, the
record date for the special meeting, and is controlled by
certain of the Companys executive officers, including
Messrs. LaPenta, DePalma and Paresi and Ms. Fordyce.
Messrs. LaPenta, DePalma and Paresi and Ms. Fordyce
are also the managing members of Aston Capital Partners GP LLC
and L-1 Investment Partners LLC and directly and indirectly hold
all the beneficial ownership interests of Aston Capital Partners
GP LLC and L-1 Investment Partners LLC.
Michael J. Urfirer is a co-owner and co-founder of Stone
Keys parent company, Stone Key Group LLC, and the husband
of Ms. Fordyce, the Companys Executive Vice President
of Corporate Communications. Both Mr. Urfirer and Denis A.
Bovin, each a Co-Chairman and Co-Chief Executive Officer of
Stone Key Partners LLC, hold personal investments, as minority
limited partners, in Aston. In connection with the Merger and
BAE Transaction and pursuant to an engagement letter between
Stone Key and the Company, the Company has agreed to pay Stone
Key certain fees in connection with the transactions. See the
section of this proxy statement entitled Opinion
of Stone Key Partners LLC.
Contemporaneously with the execution of the Merger Agreement, on
September 19, 2010, Safran, Merger Sub, Mr. LaPenta
and Aston entered into a voting and support agreement. See the
section of this proxy statement entitled Voting
and Support Agreement.
Governmental
and Regulatory Approvals
Antitrust
Clearance
Under the HSR Act, and the rules promulgated thereunder by the
FTC, the Merger may not be completed until notification and
report forms have been filed with the FTC and the Antitrust
Division of the DOJ, and the applicable waiting period has
expired or been terminated. L-1 and Safran filed the
notification and report forms under the HSR Act with the FTC and
the DOJ on December 13, 2010, which triggered an initial
30-day
waiting period. The Antitrust Division of the DOJ, the FTC,
state Attorneys General or private parties may also challenge
the Merger on antitrust grounds either before or after the
transaction has closed. Accordingly, while the parties believe
that the transaction complies with the applicable antitrust
laws, it is possible that at any time before or after expiration
or termination of the HSR Act waiting period or even after the
completion of the Merger, any of the Antitrust Division, the
FTC, state Attorneys General or private parties could take
action under the antitrust laws as deemed necessary or desirable
in the public or other interest, including without limitation
seeking to enjoin the completion of the Merger or permitting
completion subject to regulatory concessions or conditions.
At any time before or after consummation of the Merger,
notwithstanding early termination of the waiting period under
the HSR Act, the Antitrust Division of the DOJ or the FTC could
take such action under the antitrust laws as it deems necessary
or desirable in the public interest, including seeking to enjoin
the consummation of the Merger or seeking divestiture of
substantial assets of L-1 or Safran. At any time before or after
the consummation of the Merger, and notwithstanding the early
termination of the waiting period under the HSR Act, any state
could take such action under the antitrust laws as it deems
necessary or desirable in the public interest. Such action could
include seeking to enjoin the consummation of the Merger or
seeking divestiture of substantial assets of L-1 or Safran.
Under the Merger Agreement, Safran is not required to divest any
assets in order to obtain antitrust clearance (see the section
of this proxy statement entitled The Merger
Agreement Agreement to Take Appropriate
Actions). Private parties may also seek to take legal
action under the antitrust laws under certain circumstances. The
term antitrust laws means the Sherman Act, as
amended, the Clayton Act, as amended, the HSR Act, the
67
Federal Trade Commission Act, as amended, all applicable foreign
antitrust laws and all other applicable laws issued by any
government, court, regulatory or administrative agency,
commission or authority or other governmental instrumentality,
whether federal, state or local, domestic, foreign or
multinational, designed or intended to prohibit, restrict or
regulate actions having the purpose or effect of monopolization
or restraint of trade or lessening of competition through merger
or acquisition.
CFIUS
The Merger Agreement provides for the parties to file a joint
voluntary notice under Section 721 of the Defense
Production Act of 1950, as amended by Section 5021 of the
Omnibus Trade and Competitiveness Act of 1988 and subsequent
amendments (which we refer to in this proxy statement as
Exon-Florio). Exon-Florio provides for national security reviews
and, where appropriate, investigations by the Committee on
Foreign Investment in the United States (which we refer to in
this proxy statement as CFIUS) when a foreign company acquires
control of a U.S. company. CFIUS consists of
representatives of various government agencies including, among
others, the Departments of Treasury, State, Defense, Energy,
Justice, Commerce and Homeland Security, the U.S. Trade
Representative, and, as a non-voting member, the Director of
National Intelligence. CFIUS is chaired by the Treasury
Department. CFIUS conducts an initial
30-day
review of transactions of which it is notified. For transactions
involving entities controlled by a foreign government (within
the meaning of control under the Exon-Florio
regulations) and / or certain sensitive assets, CFIUS
may conduct an additional investigation that must be completed
within 45 days. Also, the CFIUS review period may be
extended by mutual consent of the parties and CFIUS. In certain
situations, a report may be sent to the President who then has
15 days to decide whether to block the transaction or to
take other action. On November 24, 2010, the Company and
Safran submitted a joint voluntary filing to CFIUS. The initial
30-day CFIUS
review period was completed on December 28, 2010. On
December 28, 2010, the parties received a letter advising
that CFIUS would proceed with a
45-day
investigation of the Merger, which was expected given the nature
of the Companys business and the French governments
ownership stake in Safran.
CFIUS considers many factors in determining whether a proposed
transaction threatens to impair national security, including
domestic production needed for national defense requirements,
the capability of domestic industries to meet national defense
requirements, and the potential effects on
U.S. international technological leadership in areas
affecting national security.
CFIUS reviews also provide an opportunity for
U.S. government agencies to ensure compliance with various
regulations relating to national security, such as the
requirement to obtain export licenses for exports of controlled
technical data. The parties are required to submit information
about classified and other defense-related contracts of the
acquired company. In addition, the National Industrial Security
Program Operating Manual (which we refer to in this proxy
statement as NISPOM), for which the Department of Defense is the
executive agent, prohibits the performance of classified
contracts by companies that are subject to foreign ownership,
control or influences (which we refer to in this proxy statement
as FOCI), unless steps are taken to mitigate FOCI. None of the
CFIUS or NISPOM regulations (or the FOCI or other mitigation
measures that may be imposed in connection therewith) require
that Safran agree to retain the Companys management team
in connection with the CFIUS review process.
It is expected that the Defense Security Service will carefully
examine the parties proposed FOCI and other mitigation
measures concurrently with the CFIUS review of the transaction.
We expect that the Company will enter into a proxy agreement
under NISPOM with the Defense Security Service that will cover
the operations of the Company at its facility in Arlington,
Virginia. In 2009, revenues relating to the covered operations
in Arlington were less than 6% of the Companys 2009
consolidated revenues reported in its Annual Report on
Form 10-K.
We believe that, with the proposed FOCI and other mitigation
measures, the Merger will not give rise to national security
concerns that would cause the transaction to be blocked under
Exon-Florio.
With respect to the covered operations, a proxy agreement vests
voting power in proxy holders and imposes various restrictions
on directors as well as certain officers and personnel. With a
proxy agreement, the proxy holders assume full responsibility
for overseeing the exercise of all management prerogatives for
the covered operations except for the following:
|
|
|
|
|
the disposition of capital assets of the isolated company;
|
68
|
|
|
|
|
pledging or encumbering assets of the isolated company for
purposes other than obtaining working capital or funds for
capital improvements;
|
|
|
|
any merger, reorganization, or dissolution of the isolated
company; and
|
|
|
|
the filing of any bankruptcy petition or similar action.
|
Under the NISPOM rules, individuals serving as trustees, proxy
holders, or outside directors must, among other things, be
disinterested individuals with no prior involvement with the
applicable company, the entities with which it is affiliated, or
the foreign owner.
We cannot assure you that an antitrust, CFIUS or other
regulatory challenge to the Merger will not be made. If a
challenge is made, we cannot predict the result.
Delisting
and Deregistration of Company Common Stock
If the Merger is completed, L-1s common stock will no
longer be traded on the New York Stock Exchange and will be
deregistered under the Exchange Act, and we will no longer be
required to file periodic reports with the SEC in respect of our
common stock.
BAE
Agreement
Explanatory
Note Regarding the BAE Agreement and the Summary of the BAE
Agreement: Representations, Warranties and Covenants in the BAE
Agreement Are Not Intended to Function or Be Relied on as Public
Disclosures
The following description of certain terms and conditions of
the BAE Agreement does not purport to be complete and may not
contain all the information about the BAE Agreement that is
important to you. This description is qualified in its entirety
by reference to the full text of the BAE Agreement attached as
Annex B to, and incorporated by reference into, this proxy
statement. You are encouraged to read the BAE Agreement in its
entirety because it is the legal document that governs the BAE
Transaction.
The BAE Agreement and the description of certain of its terms
in this proxy statement have been included to provide
information about the terms and conditions of the BAE Agreement.
The terms and information in the BAE Agreement are not intended
to provide any other public disclosure of factual information
about L-1, BAE or any of their respective subsidiaries or
affiliates. The representations, warranties and covenants
contained in the BAE Agreement are made by L-1 and BAE only for
the purposes of the BAE Agreement and were qualified by, and
subject to, certain limitations and exceptions agreed to by L-1
and BAE in connection with negotiating the terms of the BAE
Agreement. In particular, in your review of the representations
and warranties contained in the BAE Agreement, it is important
to bear in mind that the representations and warranties were
made solely for the benefit of the parties to the BAE Agreement
and were negotiated for the purpose of allocating contractual
risk among the parties to the BAE Agreement rather than to
establish matters as facts. The representations and warranties
may also be subject to a contractual standard of materiality or
material adverse effect different from those generally
applicable to stockholders and reports and documents filed with
the SEC and in some cases may be qualified by disclosures made
by one party to the other, which are not necessarily reflected
in the BAE Agreement. Moreover, information concerning the
subject matter of the representations and warranties, which do
not purport to be accurate as of the date of this proxy
statement, may have changed since the date of the BAE Agreement,
and subsequent developments or new information qualifying a
representation or warranty may have been included in or
incorporated by reference into this proxy statement.
For the foregoing reasons, the representations, warranties
and covenants or any descriptions of those provisions should not
be read alone or relied upon as characterizations of the actual
state of facts or condition of L-1, BAE or any of their
respective subsidiaries or affiliates. Instead, such provisions
or descriptions should be read only in conjunction with the
other information provided elsewhere in this document or
incorporated by reference into this proxy statement.
On September 19, 2010, simultaneously with the execution of
the Merger Agreement, the Company entered into the BAE
Agreement, pursuant to which BAE will acquire the Companys
intelligence services business group
69
through the acquisition of the outstanding capital stock and
membership interests of the Transferred Intel Companies for a
purchase price of $295,833,000 in cash and approximately
$7,291,000 of certain assumed obligations related to the
payments to officers and employees of the Transferred Intel
Companies under the Intel Companies Special Employee Plan, as
described below. A copy of the BAE Agreement is attached as
Annex B to this proxy statement.
Conditions
to Completion of the BAE Transaction
The obligations of the Company and BAE to consummate the BAE
Transaction are subject to the satisfaction (or waiver, if
permissible under applicable law) of the following conditions:
|
|
|
|
|
expiration or termination of any waiting period (including any
extension) under the HSR Act applicable to the consummation of
the BAE Transaction (termination of the applicable waiting
period was granted on November 3, 2010);
|
|
|
|
receipt by the Company and BAE of written notice from CFIUS that
review of the BAE Transaction has been concluded and that there
are no unresolved national security concerns with respect to
such transactions (which notice has been received); and
|
|
|
|
absence of any judgment, order, ruling, injunction, decree,
stipulation, determination or similar order or law in effect
which has the effect of enjoining, making illegal or otherwise
prohibiting the consummation of the BAE Transaction (unless
vacated, terminated, withdrawn or repealed).
|
In addition, the obligations of BAE to consummate the BAE
Transaction are subject to the satisfaction or waiver, prior to
or at the closing under the BAE Agreement, of the following
conditions, among other customary conditions:
|
|
|
|
|
the representations and warranties made by the Company regarding
(i) the ownership and capitalization of the Intel
Companies, (ii) the Companys corporate authority to
enter into, and enforceability of, and the actions of the
Companys board of directors relative to, the BAE
Agreement, (iii) compliance with certain export control
laws (including the International Traffic in Arms Regulations)
and certain anti-bribery laws (including the Foreign Corrupt
Practices Act), (iv) the absence of certain guarantees and
misallocated contracts and (v) the absence of litigation
against, or liabilities of, the Transferred Intel Companies, in
each case, relating to the Companys identity solutions
business group, being true and correct in all material respects
as of the date of the BAE Agreement and as of the closing date
under the BAE Agreement;
|
|
|
|
the representations and warranties of the Company regarding
compliance with laws (other than those described above) and
government contracts being true and correct in all respects as
of the date of the BAE Agreement and as of the closing date
under the BAE Agreement, except where the failure of such
representations and warranties to be true and correct has not
resulted and would not reasonably be expected to result,
individually or in the aggregate, in losses to the Transferred
Intel Companies and / or BAE in excess of $15,000,000;
|
|
|
|
all other representations and warranties of the Company being
true and correct in all respects as of the date of the BAE
Agreement and as of the closing date under the BAE Agreement,
except where the failure of such representations and warranties
to be true and correct would not have, individually or in the
aggregate, a Business Material Adverse Effect (as defined in the
BAE Agreement and as described below);
|
|
|
|
the Companys performance in all material respects of all
of its material obligations and covenants under the BAE
Agreement required to be performed by it on or prior to the
closing date under the BAE Agreement;
|
|
|
|
the absence of a Business Material Adverse Effect since the date
of the BAE Agreement;
|
|
|
|
McClendon, LLC having entered into an organizational conflict of
interest mitigation plan with respect to a certain government
contract or the novation of such contract having been completed,
in either case on terms reasonably acceptable by BAE; and
|
|
|
|
an existing organizational conflict of interest mitigation plan
for a certain government subcontract having been fully
implemented and complied with or an organizational conflict of
interest mitigation plan having
|
70
|
|
|
|
|
been entered into by McClendon, LLC with respect to such
subcontract, in either case in a manner reasonably acceptable to
BAE.
|
In addition, the obligations of the Company to consummate the
BAE Transaction are subject to the satisfaction or waiver, prior
to or at the closing under the BAE Agreement, of the following
conditions, among other customary conditions:
|
|
|
|
|
the representations and warranties of BAE contained in the BAE
Agreement being true, correct and complete in all respects as of
the date of the BAE Agreement and as of the closing date under
the BAE Agreement, except where the failure of such
representations and warranties to be true and correct would not,
individually or in the aggregate, reasonably be expected to
prevent or materially delay or impair the ability of BAE to
consummate the transactions contemplated by the BAE
Agreement; and
|
|
|
|
BAEs performance in all material respects of all of its
material obligations and covenants under the BAE Agreement
required to be performed by it on or prior to the closing date
under the BAE Agreement.
|
The closing of the Merger is conditioned on the prior
consummation of the BAE Transaction; however, the BAE
Transaction is not conditioned on the consummation of the Merger.
Business
Material Adverse Effect Definition
Under the BAE Agreement, Business Material Adverse
Effect means any change, effect or circumstance which,
individually or in the aggregate, has or would reasonably be
expected to result in a materially adverse effect on the
business, financial condition or results of operations of the
business of the Intel Companies or the Intel Companies, taken as
a whole; however, changes, effects or circumstances relating to
or resulting from the following shall be excluded from the
determination of Business Material Adverse Effect:
|
|
|
|
|
any change, effect or circumstance in any of the industries or
markets in which the Intel Companies operate;
|
|
|
|
any change in any law or GAAP (or changes in interpretations of
any law or GAAP);
|
|
|
|
changes in general economic, regulatory or political conditions
or the financial, credit or securities markets in general
(including changes in interest or exchange rates) in the United
States;
|
|
|
|
any acts of God, natural disasters, terrorism, armed
hostilities, sabotage, war or any escalation or worsening of
acts of war;
|
|
|
|
the negotiation, execution, announcement, consummation or
existence of the BAE Agreement or the transactions contemplated
by such agreement (including the impact of any of the foregoing
on relationships with customers, suppliers, employees or
regulators);
|
|
|
|
any action required to be taken by the BAE Agreement or taken
with the consent or at the direction of BAE; and
|
|
|
|
any failure by the Intel Companies to meet internal,
analysts or other earnings estimates or financial
projections or changes in credit ratings.
|
The exclusions provided for in the first, second, third and
fourth items in the preceding list will not apply to the extent
the Intel Companies are materially disproportionately affected
by any of the changes, effects or circumstances described in
such items relative to other participants in the industries in
which the Intel Companies participate. In addition, a Business
Material Adverse Effect will be deemed to have occurred if any
change, effect or circumstance that, individually or in the
aggregate, has resulted, or would reasonably be expected to
result, in a suspension or debarment of (i) the Company or
L-1 Identity Solutions Operating Company, a wholly-owned
subsidiary of the Company, or any of their directors, officers
or senior management personnel (in their capacity as such) if
arising from or relating to the business of the Transferred
Intel Companies or the Transferred Intel Companies or
(ii) the Transferred Intel Companies or any of their
directors, officers or senior personnel (in their capacity as
such).
71
Representations
and Warranties, Termination Rights, Covenants and Certain
Employee Matters
The BAE Agreement contains various representations and
warranties that are subject, in some cases, to exceptions and
qualifications (including exceptions and qualifications based on
Business Material Adverse Effect).
The BAE Agreement contains certain termination rights for each
of the parties, including the right to terminate the BAE
Agreement if closing of the BAE Transaction has not occurred by
January 19, 2011 (subject to extension at (i) the
election of either the Company or BAE for an additional two
months if the closing has not occurred solely as a result of
failure to obtain regulatory approvals or (ii) the
discretion of the Company for an additional two months if the
closing has not occurred as a result of the conditions related
to organizational conflicts of interest described above not
having been satisfied).
The BAE Agreement also provides for various covenants,
including, among others things, with respect to the conduct of
the Companys intelligence services business in the
ordinary course of business during the period between execution
of the BAE Agreement and the closing of the BAE Transaction,
cooperation in obtaining regulatory approvals and the sale or
disposal by Advanced Concepts, Inc. of its 49% interest in
Patriot.
In connection with the negotiation and execution of the BAE
Agreement, the parties agreed to the material terms of an Intel
Companies Special Employee Plan to be adopted by Spectal, LLC
and McClendon, LLC prior to the closing of the BAE Transaction.
The plan provides for retention pay to approximately
30 employees of the Transferred Intel Companies,
transaction bonuses to approximately 14 of those
30 employees, and specifies the treatment of Company equity
and long-term cash awards held by employees of the Transferred
Intel Companies. In addition, as of execution of the BAE
Agreement, three senior executives of the Transferred Intel
Companies entered into new severance and non-compete
arrangements with SpecTal, LLC in connection with the plan. The
aggregate payments potentially payable under the Intel Companies
Special Employee Plan total approximately $7,291,000.
Litigation
Related to the Merger and the BAE Transaction
The Company was named as a defendant in five putative
stockholder class actions filed in the Superior Court of
Connecticut, Judicial District of Stamford-Norwalk at Stamford,
arising out of the proposed transactions with Safran and BAE
pursuant to the Merger Agreement and BAE Agreement. The actions
were captioned: Michael Palma v. Robert LaPenta et
al., CV-10-6006781-S (Conn. Super. Ct.), Barry P.
Kranz, Jr. v. L-1 Identity Solutions et al.,
CV-10-6006760-S (Conn. Super. Ct.), Michael Matteo v.
L-1 Identity Solutions et al., CV-10-6006759-S (Conn. Super.
Ct.), Dart Seasonal Products Retirement Plan v. L-1
Identity Solutions et al., CV-10-6006835-S (Conn. Super.
Ct.), and George F. Chrisman v. Robert LaPenta et
al., CV-10-6006886-S (Conn. Super. Ct.).
The plaintiffs in these stockholder actions generally alleged
the members of the Companys board of directors and certain
officers of the Company breached their fiduciary duties to
stockholders by, among other things, allegedly failing to
receive maximum value for their shares, failing to conduct an
appropriate sale process and agreeing to certain terms in the
Merger Agreement that allegedly discourage competing offers from
other potential bidders and / or benefit defendants.
The stockholder actions generally alleged that the Company aided
and abetted these alleged breaches of fiduciary duty. Certain of
the suits also alleged claims against Safran, Merger Sub, BAE
and BAE Systems, Inc. for aiding and abetting the foregoing
alleged breaches of fiduciary duty. The stockholder actions
generally sought preliminary and permanent relief, including,
among other things, permission to proceed as a class action,
declaratory relief declaring that defendants have breached their
fiduciary duties, an injunction enjoining the transactions
contemplated by the Merger Agreement and BAE Agreement,
rescissionary damages in the event that the transactions are
consummated, costs and attorneys and experts fees.
On December 1, 2010, the plaintiffs reported that they had
agreed on a lead counsel and lead plaintiff structure whereby
the Matteo, Kranz & Dart Seasonal Products Retirement
Plan plaintiffs became co-lead plaintiffs and their counsel
co-lead counsel. On December 3, 2010, the Court entered an
order consolidating the actions and appointing a leadership
structure consisting of Kranz and Dart Seasonal Products
Retirement Plan as Lead Plaintiffs, the law firms of Robbins
Umeda LLP and Robbins Geller Rudman & Dowd LLP as
Co-Lead Counsel for Plaintiffs, and the law firms of Wofsey
Rosen Kweskin Kuriansky, LLP and Diserio Martin
OConnor & Castiglioni LLP as Co-Liaison Counsel
for Plaintiffs. The caption for the consolidated cases is: In
re L-1 Identity Solutions, Inc. Shareholder Litigation, Lead
Case
No. X05-FST-CVIO-6006759-S.
72
On December 6, 2010, Lead Plaintiffs filed a Motion for
Limited Expedited Discovery and for a Briefing and Hearing
Schedule on Plaintiffs Anticipated Motion for Equitable
Relief and Objection to Defendants Request for Extension
of Time to Respond to Plaintiffs Discovery Requests in the
Court. On December 10 and 13, 2010, the Company and the other
defendants (except the BAE defendants who had already filed
motions to strike and to stay), respectively, filed motions to
strike the Complaint and motions to stay discovery pending
adjudication of the motions to strike and objections to Lead
Plaintiffs motion to expedite discovery.
On December 15, 2010, after arms length negotiations,
the parties entered into a memorandum of understanding to settle
the litigation, which will be memorialized in a final settlement
agreement to be submitted to the Court for approval. Pursuant to
the memorandum of understanding, the Company agreed to make
certain additional disclosures in this proxy statement.
Additionally, pursuant to the memorandum of understanding, the
plaintiffs will be afforded the opportunity to conduct
confirmatory discovery sufficient to confirm the fairness and
reasonableness of the terms of the final settlement agreement.
The Company continues to vigorously deny any and all liability
with respect to the facts and claims alleged in the action.
THE
MERGER AGREEMENT
The following is a summary of the material terms and
conditions of the Merger Agreement. This summary may not contain
all the information about the Merger Agreement that is important
to you. This summary is qualified in its entirety by reference
to the full text of the Merger Agreement attached as
Annex A to, and incorporated by reference into, this proxy
statement. You are encouraged to read the Merger Agreement in
its entirety because it is the legal document that governs the
Merger.
Explanatory
Note Regarding the Merger Agreement and the Summary of the
Merger Agreement: Representations, Warranties and Covenants in
the Merger Agreement Are Not Intended to Function or Be Relied
on as Public Disclosures
The Merger Agreement and the summary of its terms in this
proxy statement have been included to provide information about
the terms and conditions of the Merger Agreement. The terms and
information in the Merger Agreement are not intended to provide
any other public disclosure of factual information about L-1,
Safran or any of their respective subsidiaries or affiliates.
The representations, warranties and covenants contained in the
Merger Agreement are made by L-1, Safran and Merger Sub only for
the purposes of the Merger Agreement and were qualified by, and
subject to, certain limitations and exceptions agreed to by L-1,
Safran and Merger Sub in connection with negotiating the terms
of the Merger Agreement. In particular, in your review of the
representations and warranties contained in the Merger Agreement
and described in this summary, it is important to bear in mind
that the representations and warranties were made solely for the
benefit of the parties to the Merger Agreement and were
negotiated for the purpose of allocating contractual risk among
the parties to the Merger Agreement rather than to establish
matters as facts. The representations and warranties may also be
subject to a contractual standard of materiality or material
adverse effect different from those generally applicable to
stockholders and reports and documents filed with the SEC and in
some cases may be qualified by disclosures made by one party to
the other, which are not necessarily reflected in the Merger
Agreement. Moreover, information concerning the subject matter
of the representations and warranties, which do not purport to
be accurate as of the date of this proxy statement, may have
changed since the date of the Merger Agreement, and subsequent
developments or new information qualifying a representation or
warranty may have been included in or incorporated by reference
into this proxy statement.
For the foregoing reasons, the representations, warranties
and covenants or any descriptions of those provisions should not
be read alone or relied upon as characterizations of the actual
state of facts or condition of L-1, Safran or any of their
respective subsidiaries or affiliates. Instead, such provisions
or descriptions should be read only in conjunction with the
other information provided elsewhere in this document or
incorporated by reference into this proxy statement.
The
Merger
Upon the terms and subject to the conditions set forth in the
Merger Agreement, Merger Sub, a wholly owned subsidiary of
Safran, will merge with and into L-1. After the Merger, L-1 will
continue as the surviving corporation
73
and as a wholly owned subsidiary of Safran, and L-1s
common stock will cease to be listed on the New York Stock
Exchange, will be deregistered under the Exchange Act and will
no longer be publicly traded.
Upon consummation of the Merger, the directors of Merger Sub
will be the initial directors of the surviving corporation, the
officers of Merger Sub will be the initial officers of the
surviving corporation and the certificate of incorporation and
bylaws of the surviving corporation will be in the form attached
as Exhibit B and Exhibit C to the Merger Agreement,
respectively, until amended as provided by applicable law and in
accordance with their respective terms. All directors and
officers of the surviving corporation will hold their positions
until their successors are duly elected or appointed or
qualified or their earlier death, resignation or removal.
Effective
Time
The Merger will be effective at the time the certificate of
merger is filed with the Secretary of State of the State of
Delaware (or at a later time, if agreed upon in writing by the
parties and specified in the certificate of merger). Unless
otherwise agreed in writing by the Company and Safran, the
Company and Safran are required to close the Merger no later
than the second business day after the satisfaction or waiver of
the conditions to closing contained in the Merger Agreement
(other than those conditions that by their nature are to be
satisfied at the closing, but subject to the satisfaction or
waiver of those conditions). The conditions to the closing of
the Merger are described in the section of this proxy statement
entitled Conditions to the Completion of the
Merger.
Merger
Consideration
Except as noted below, each share of our common stock issued and
outstanding immediately prior to the effective time of the
Merger will be automatically cancelled and converted into the
right to receive $12.00 in cash, without interest and less any
applicable withholding taxes. The following shares will not
receive the $12.00 per share merger consideration:
|
|
|
|
|
shares held by holders who have properly demanded and perfected
their appraisal rights under Delaware law (see the section of
this proxy statement entitled Appraisal
Rights);
|
|
|
|
shares held in treasury by us, or shares owned by Safran or
Merger Sub (which shares will be cancelled at the effective time
of the Merger); and
|
|
|
|
shares owned by our subsidiaries (which shares outstanding
immediately prior to the effective time of the Merger will
remain outstanding).
|
Subject to the above exceptions, after the effective time of the
Merger, each holder of a certificate representing any shares of
common stock will no longer have any rights with respect to the
shares, except for the right to receive the $12.00 per share
merger consideration, without interest and less applicable
withholding taxes.
Payment
Procedures
Safran will appoint a paying agent reasonably satisfactory to us
for the benefit of the holders of shares of our common stock. At
or prior to the closing of the Merger, Safran will deposit with
the paying agent sufficient funds in cash for payment of the
aggregate merger consideration. At and after the effective time
of the Merger, there will be no further transfers of shares of
our common stock.
Promptly after the effective time of the Merger, Safran will
cause the paying agent to mail to each holder of record of
shares of our common stock whose shares were converted into the
right to receive the merger consideration a letter of
transmittal and instructions advising you how to exchange
certificates for the $12.00 per share merger consideration. The
paying agent will pay you your $12.00 per share merger
consideration after you have (i) surrendered your
certificates to the paying agent and (ii) provided to the
paying agent your completed and signed letter of transmittal and
any other items specified in the letter of transmittal or
instructions thereto. Interest will not be paid or accrued in
respect of the $12.00 per share merger consideration. The paying
agent will reduce the amount of any merger consideration paid to
you by any required withholding taxes. YOU SHOULD NOT FORWARD
YOUR STOCK CERTIFICATES TO THE PAYING AGENT WITHOUT A LETTER OF
74
TRANSMITTAL AND YOU SHOULD NOT RETURN YOUR STOCK CERTIFICATES
WITH THE ENCLOSED PROXY CARD.
If any cash deposited with the paying agent is not claimed
within nine months following the effective time of the Merger,
such cash (including any interest from or the proceeds of any
investments thereof) will be delivered to the surviving
corporation. Holders of our common stock who have not complied
with the above payment procedures may thereafter look only to
the surviving corporation with respect to payment of any unpaid
merger consideration.
If you have lost a certificate, or if it has been stolen or
destroyed, then before you will be entitled to receive the
merger consideration, you will be required to provide an
affidavit of the loss, theft or destruction, and if required by
Safran or the surviving corporation, post a bond in a reasonable
and customary amount as indemnity against any claim that may be
made with respect to such certificate. These procedures will be
described in the letter of transmittal and related instructions
that you will receive, which you should read carefully and in
their entirety.
Treatment
of Stock Options, Equity-Based Awards and Long-Term Cash
Awards
Immediately prior to the consummation of the Merger, all
outstanding and unvested stock options and restricted stock
awards will become vested. Upon the consummation of the Merger,
(i) each outstanding stock option will be cancelled in
exchange for the right to receive a cash payment equal to the
excess, if any, of the $12.00 per share merger consideration per
share of our common stock underlying the stock option over the
per share exercise price of such stock option, less any
applicable withholding taxes and paid without interest and
(ii) holders of restricted stock awards and deferred stock
units will be entitled to receive the $12.00 per share merger
consideration per share of our common stock subject to a
restricted stock award or per deferred stock unit, as
applicable, in each case, paid without interest and subject to
applicable tax withholding.
All outstanding long term cash awards will become vested
immediately prior to the consummation of the Merger and payment
will be made with respect to such awards no later than 10
business days following the consummation of the Merger.
For a further description of the vesting of the Companys
stock options and other equity-based awards, and long-term cash
awards, see the section of this proxy statement entitled
The Merger Interests of Certain Persons in
the Merger.
Treatment
of Warrants
In accordance with the terms of the Merger Agreement, warrants
to purchase Company stock will be converted into the right to
receive a cash payment, subject to the same contractual terms
and conditions (including vesting terms) as were in effect
immediately prior to the effective time of the Merger. Each
warrant that is vested and exercisable at the effective time of
the Merger will be converted into the right to receive a payment
in cash, paid without interest and subject to applicable tax
withholding, equal to (i) the number of shares of Company
stock subject to the warrant multiplied by the $12.00 per share
merger consideration minus (ii) the number of shares of
Company stock subject to such warrant multiplied by the per
share exercise price of such warrant (provided, that if the
foregoing calculation results in a negative number, the cash
payment will be $0).
Representations
and Warranties
The Company makes various representations and warranties in the
Merger Agreement that are subject, in some cases, to exceptions
and qualifications (including exceptions and qualifications
based on Company Material Adverse Effect). See the section of
this proxy statement entitled Company Material
Adverse Effect Definition for the definition of
Company Material Adverse Effect. Subject to certain
exceptions, our representations and warranties relate to the
Company after giving effect to the BAE Transaction. Our
representations and warranties relate to, among other things:
|
|
|
|
|
due organization, good standing and qualification,
capitalization and other corporate matters with respect to us
and our subsidiaries;
|
|
|
|
our corporate authority and authorization to enter into, and
enforceability of, the Merger Agreement;
|
75
|
|
|
|
|
actions taken by our board of directors;
|
|
|
|
the absence of conflicts with or defaults under organizational
documents, contracts and applicable laws and the creation of any
liens;
|
|
|
|
the stockholder action required to approve the Merger Agreement;
|
|
|
|
required regulatory filings and consents and approvals of
governmental entities;
|
|
|
|
documents filed with the SEC and the accuracy of the information
in those documents, including our financial statements;
|
|
|
|
the absence of certain undisclosed liabilities;
|
|
|
|
our internal control over financial reporting and our disclosure
controls and procedures;
|
|
|
|
the absence of certain changes or events since December 31,
2009 through the date of the Merger Agreement, including the
absence of a Company Material Adverse Effect;
|
|
|
|
litigation and government orders;
|
|
|
|
compliance with laws and permits;
|
|
|
|
tax matters;
|
|
|
|
employee benefit and labor matters;
|
|
|
|
intellectual property;
|
|
|
|
the accuracy of certain information to be included in the proxy
materials filed with the SEC relating to the Merger and the
Merger Agreement;
|
|
|
|
state anti-takeover statutes;
|
|
|
|
real property, including leased real property;
|
|
|
|
contracts, including government contracts;
|
|
|
|
security clearances;
|
|
|
|
registrations and/or licenses under, and compliance with,
certain export regulations and laws;
|
|
|
|
compliance with certain international trade laws and regulations;
|
|
|
|
assets and liabilities of the Company (after giving effect to
the BAE Transaction);
|
|
|
|
opinions of our financial advisors;
|
|
|
|
agreements between us and BAE;
|
|
|
|
certain matters related to the Transferred Intel Companies
(including litigation and intercompany arrangements); and
|
|
|
|
brokers and finders fees.
|
The Merger Agreement also contains various representations and
warranties made jointly and severally by Safran and Merger Sub
that are subject, in some cases, to exceptions and
qualifications. The representations and warranties of Safran and
Merger Sub relate to, among other things:
|
|
|
|
|
due organization, good standing and qualification;
|
|
|
|
corporate authority and authorization to enter into, and
enforceability of, the Merger Agreement;
|
|
|
|
required regulatory filings and consents and approvals of
governmental entities;
|
|
|
|
the absence of conflicts with or defaults under organizational
documents, contracts and applicable law and the creation of any
liens;
|
76
|
|
|
|
|
the absence of any required stockholder action to approve the
Merger Agreement;
|
|
|
|
the formation, operations and capitalization of Merger Sub;
|
|
|
|
the accuracy of certain information to be included in the proxy
materials filed with the SEC relating to the Merger and the
Merger Agreement;
|
|
|
|
Safran and Merger Sub not being an interested
stockholder as defined under Section 203 of the DGCL;
|
|
|
|
Safran and Merger Subs absence of ownership of, or rights
to acquire, our common stock;
|
|
|
|
litigation;
|
|
|
|
the absence of agreements between Safran and BAE;
|
|
|
|
the sufficiency of funds to fund all of their obligations under
the Merger Agreement; and
|
|
|
|
brokers and finders fees.
|
The representations and warranties of the parties will expire
upon completion of the Merger.
Company
Material Adverse Effect Definition
Many of our representations and warranties are qualified by a
Company Material Adverse Effect standard. For the purposes of
the Merger Agreement, Company Material Adverse
Effect means any change, effect, event, development, state
of facts, occurrence or circumstance which, individually or in
the aggregate with all other changes, effects, events,
developments, state of facts, occurrences or circumstances, is
or would reasonably be expected to be materially adverse to the
business, assets, financial condition or results of operations
of the Company (after giving effect to the BAE Transaction),
taken as a whole; however, changes, effects, events,
developments, state of facts, occurrences or circumstances to
the extent relating to or resulting from the following are
excluded from the determination of Company Material Adverse
Effect:
|
|
|
|
|
any change, effect or circumstance in any of the industries or
markets in which the Company (after giving effect to the BAE
Transaction) operates;
|
|
|
|
any change in any law or GAAP (or changes in interpretations of
any law or GAAP) applicable to the Company (after giving effect
to the BAE Transaction);
|
|
|
|
changes in general economic, regulatory or political conditions
or the financial, credit or securities markets in general
(including changes in interest or exchange rates) in any country
or region in which the Company (after giving effect to the BAE
Transaction) conducts business;
|
|
|
|
any acts of God, natural disasters, terrorism, armed
hostilities, sabotage, war or any escalation or worsening of
acts of war;
|
|
|
|
the negotiation, execution, announcement, consummation or
existence of the Merger Agreement, the BAE Agreement or the
transactions contemplated by such agreements (including the
impact of any of the foregoing on relationships with customers,
suppliers, employees or regulators and any suit, action or
proceeding arising from such agreements or transactions);
|
|
|
|
any action taken as expressly permitted or required by the
Merger Agreement or the BAE Agreement or with the consent or at
the direction of Safran or Merger Sub (or any action not taken
as a result of the failure of Safran to consent to any action
requiring Safrans consent pursuant to the interim
operating covenants of the Company under the Merger Agreement as
described in the section of this proxy statement entitled
Conduct of Business Prior to
Closing); and
|
|
|
|
any changes in the market price or trading volume of our common
stock, any failure by us or our subsidiaries to meet internal,
analysts or other earnings estimates or financial
projections or changes in credit ratings.
|
If the Company (after giving effect to the BAE Transaction) is
materially disproportionately adversely affected by changes or
events in the first, second, third or fourth items in the
preceding list relative to other participants in the industry in
which it participates, the extent of such materially
disproportionate effect will be taken into account in
77
determining whether a Company Material Adverse Effect has
occurred, but only to the extent of the materially
disproportionate effect.
Conduct
of Business Prior to Closing
We have agreed in the Merger Agreement that, until the
consummation of the Merger or termination of the Merger
Agreement pursuant to its terms (and subject to certain
exceptions, including as (i) required by law,
(ii) contemplated by the Merger Agreement or the BAE
Agreement, or (iii) agreed to in writing by Safran):
|
|
|
|
|
the business of the Company (after giving effect to the BAE
Transaction) will be conducted only in the ordinary course of
business and in a manner consistent with past practice in all
material respects; and
|
|
|
|
to the extent consistent with the above, we will, and we will
cause our subsidiaries to, use commercially reasonable efforts
to: (i) with respect to the Company (after giving effect to
the BAE Transaction), preserve substantially intact our business
organization and maintain our business relationships with
material suppliers, contractors, distributors, customers,
licensors, licensees and others having material business
relationships with it, and (ii) keep available the services
of our present officers, employees and consultants who are
integral to the operation of our businesses as presently
conducted.
|
We have also agreed in the Merger Agreement that, until the
consummation of the Merger or termination of the Merger
Agreement pursuant to its terms, except as (i) required by
law, (ii) contemplated by the Merger Agreement or the BAE
Agreement or (iii) agreed to in writing by Safran (which
consent will not be unreasonably withheld, delayed or
conditioned under certain circumstances), we will not, and we
will not permit any of our subsidiaries to, to the extent
relating to the Company (after giving effect to the BAE
Transaction):
|
|
|
|
|
amend any of our organizational documents or those of our
subsidiaries;
|
|
|
|
split, combine, purchase or redeem, issue, sell, pledge, grant
or encumber any of the equity interests in the Company or any of
our subsidiaries or any securities convertible into or
exchangeable for such equity interests, except for transactions
among the Company and our wholly owned subsidiaries (other than
the Intel Companies) or among our wholly owned subsidiaries
(other than the Intel Companies), and except as otherwise
provided in the Merger Agreement or pursuant to the exercise of
Company stock options, warrants or convertible notes existing as
of the date of the Merger Agreement;
|
|
|
|
declare or pay dividends or distributions on equity interests of
the Company or our subsidiaries, other than by a subsidiary of
the Company to the Company or a wholly owned subsidiary of the
Company (however, cash dividends may be paid from any of the
Intel Companies to us or any of our subsidiaries);
|
|
|
|
except as required pursuant to contracts or our benefit plans in
effect as of the date of the Merger Agreement or as otherwise
required by law:
|
|
|
|
|
|
increase compensation, bonus opportunity or other benefits
payable to directors, officers or employees, except in the
ordinary course of business consistent with past practice;
|
|
|
|
enter into any employment, deferred compensation or similar
agreement (or amendment) with any director, officer or employee
other than employment agreements with new employees entered into
in the ordinary course of business consistent with past practice
or extensions of existing employment agreements in the ordinary
course of business consistent with past practices;
|
|
|
|
grant or increase any severance or termination pay to any
director, officer or employee; or
|
|
|
|
establish, amend or terminate any benefit plan or any
arrangement that would have been classified as a Benefit
Plan under the Merger Agreement if it were in existence as
of the date of the Merger Agreement.
|
|
|
|
|
|
pay or accrue bonuses in advance of when they would ordinarily
become due, paid or accrued in the ordinary course of business
and in a manner consistent with past practices;
|
|
|
|
grant options, convertible securities, restricted stock units or
other equity rights in the Company or our subsidiaries, except
as may be required under any contract in effect as of the date
of the Merger Agreement;
|
78
|
|
|
|
|
acquire any entity or business organization (or any division) or
any material amount of assets other than (i) inventory from
suppliers in the ordinary course of business,
(ii) transactions that involve a purchase price of not more
than certain amounts individually or in the aggregate, or
(iii) pursuant to contracts as in effect as of the date of
the Merger Agreement;
|
|
|
|
make, change or revoke any material tax election, adopt or
change any material tax accounting method, file any material
amended tax return, enter into any closing agreement with
respect to a material amount of taxes, settle any material tax
claim or assessment or surrender any right to claim a refund of
a material amount of taxes;
|
|
|
|
incur any long-term indebtedness for borrowed money or guarantee
such indebtedness, enter into any keep well or
similar agreement or issue or sell any debt securities or rights
to acquire such securities, except for indebtedness
(i) existing as of the date of the Merger Agreement or
incurred under the Companys existing credit facilities;
(ii) in an aggregate principal amount not to exceed a
certain amount to finance working capital requirements;
(iii) among the Company and any of its wholly owned
subsidiaries or among any of its wholly owned subsidiaries; or
(iv) in the form of interest rate or foreign currency swaps
on customary commercial terms consistent with past practice in
all material respects and not exceeding a certain amount of
notional debt in the aggregate;
|
|
|
|
amend or terminate any Company Material Contract
under the Merger Agreement, other than in the ordinary course of
business consistent with past practice or amendments that are
immaterial;
|
|
|
|
enter into any new contract that would have been classified as a
Company Material Contract under the Merger
Agreement, other than customer contracts entered into in the
ordinary course of business consistent with past practice;
|
|
|
|
enter into any contract with any affiliate or any
related person (as such terms are defined in
Item 404(a) of
Regulation S-K
under the Exchange Act);
|
|
|
|
enter into any material contract that has any change in control
provision that would be triggered by the consummation of the
transactions contemplated by the Merger Agreement and the BAE
Agreement or any other change in control of the Company;
|
|
|
|
release any person from, or modify or waive any provision of,
any confidentiality, standstill or similar agreement in
connection with an Acquisition Proposal;
|
|
|
|
authorize or take any action to make the provisions of
Delawares anti-takeover statute (or any other
business combination, control share
acquisition, fair price or other similar
anti-takeover law) inapplicable to any transaction contemplated
by an Acquisition Proposal;
|
|
|
|
make any material change to methods of accounting in effect at
June 30, 2010, except (i) as required by law, GAAP,
Regulation S-X
under the Exchange Act or as required by any governmental or
quasi-governmental entity, (ii) to permit the audit of
financial statements in compliance with GAAP, or (iii) as
disclosed in documents filed with the SEC;
|
|
|
|
sell, lease, license or encumber any material portion of any
properties or assets other than (i) transactions among the
Company and its wholly owned subsidiaries or among its wholly
owned subsidiaries (in each case, other than the Intel
Companies); (ii) inventory in the ordinary course of
business consistent with past practice; or (iii) as may be
required by applicable law or any governmental entity in order
to permit or facilitate the consummation of the transactions
contemplated by the Merger Agreement and the BAE Agreement;
|
|
|
|
other than as reserved for or reflected on the balance sheets
included in the consolidated financial statements (including the
related notes) of the Company included in documents filed with
the SEC, pay or settle any claims or litigation against the
Company (after giving effect to the BAE Transaction) for a
settlement (i) in excess of certain amounts individually or
in the aggregate or (ii) relating to any claim by or
litigation with an employee (other than bona fide settlements of
claims or litigation in good faith not intended as compensation
to such employee);
|
79
|
|
|
|
|
make or commit to make any capital expenditures in excess of
certain amounts individually or in the aggregate, other than
pursuant to certain capital expenditure plans;
|
|
|
|
make any investment, loan or advance (other than travel and
similar advances to our employees in the ordinary course of
business consistent with past practice) to any person, other
than in or to any wholly owned subsidiary in the ordinary course
of business (however, the Company and its subsidiaries may make
cash management investments in the ordinary course of business
consistent with past practice (including investments, loans and
advances to the Transferred Intel Companies if in the ordinary
course of business consistent with practices and so long as
cancelled, repaid or returned prior to the closing under the BAE
Agreement));
|
|
|
|
create any new subsidiary of the Company;
|
|
|
|
fail in any material respect to pay any maintenance or similar
fees or take any other actions necessary to prevent the
abandonment or loss of, or which the failure to take would
reasonably be expected to result in the diminution in value of,
any material intellectual property of the Company (after giving
effect to the BAE Transaction); provided that reasonable steps
taken in the course of prosecution of any registrations or
applications for registration of intellectual property rights of
the Company (after giving effect to the BAE Transaction) will
not be deemed a breach of the foregoing restriction; or
|
|
|
|
authorize or enter into any written agreement or otherwise make
any commitment to do any of the foregoing.
|
Restrictions
on Solicitations of Other Offers
We have agreed that, subject to the exceptions described below,
from the date of the Merger Agreement until the effective time
of the Merger or, if earlier, the termination of the Merger
Agreement in accordance with its terms, we will not, nor will we
authorize or permit any of our subsidiaries to, and we will use
our best efforts to cause our and their respective officers,
directors, employees and other representatives not to:
|
|
|
|
|
initiate, solicit, knowingly encourage, or knowingly induce or
knowingly take any other action designed to or which would
reasonably be expected to, directly or indirectly, lead to the
making of any Acquisition Proposal (as defined below); or
|
|
|
|
participate or engage in negotiations or discussions with, or
furnish any material nonpublic information to, any person or
take any action to knowingly facilitate any inquiries relating
to, or the making of any proposal that constitutes, or would
reasonably be expected to lead to, an Acquisition Proposal.
|
In addition, subject to certain exceptions described below, our
board of directors may not approve or recommend, or allow us or
any of our affiliates to execute or enter into, any agreement
constituting or related to, or that is intended to or would
reasonably be expected to lead to, any Acquisition Proposal.
Notwithstanding these restrictions, the Merger Agreement
provides that if, at any time prior to approval of the Merger
Agreement by our stockholders, we receive an unsolicited, bona
fide written Acquisition Proposal made after the date of the
Merger Agreement in circumstances not involving a breach of the
Merger Agreement by us, we and our board of directors may engage
in negotiations or discussions with, or furnish any information
and other access to, any person making such Acquisition Proposal
and its representatives or potential sources of financing if our
board of directors determines in good faith, after consultation
with our outside legal and financial advisors, that:
|
|
|
|
|
such Acquisition Proposal constitutes or could reasonably be
expected to result in a Superior Proposal (as defined
below); and
|
|
|
|
the failure to take such action would be reasonably likely to be
inconsistent with the directors fiduciary duties to our
stockholders under applicable law.
|
Under the Merger Agreement, prior to furnishing any material
nonpublic information pursuant to the provisions summarized
above, we are required to receive from such person an executed
confidentiality agreement containing terms that are not
materially less favorable to us than those contained in our
confidentiality agreement with Safran (any such confidentiality
agreement need not restrict the making of Acquisition
Proposals). In addition,
80
we have agreed to provide to Safran any material nonpublic
information not previously provided to Safran substantially
concurrently with providing it to such other person or its
representatives.
We are required to promptly advise Safran in writing of any
Acquisition Proposal, and in no event later than within
twenty-four hours, if any proposal, offer or inquiry is received
by, any information is requested from, or any discussions or
negotiations are sought to be initiated or continued with, us in
respect of any Acquisition Proposal and the identity of the
person making any such proposal, offer or inquiry and its terms
and conditions. We are also obligated to (i) keep Safran
promptly and reasonably informed of all material developments
affecting the status and material details of any such
Acquisition Proposal and any discussions and negotiations
concerning its material terms and conditions and
(ii) provide to Safran as soon as practicable copies of all
material written correspondence relating to any such Acquisition
Proposal exchanged between us or any of our subsidiaries and the
person making the proposal, offer or inquiry.
As used in the Merger Agreement, an Acquisition
Proposal means any proposal or offer made by any person
(other than Safran, Merger Sub or any of their affiliates) to
purchase or otherwise acquire, directly or indirectly, in one
transaction or a series of related transactions:
|
|
|
|
|
beneficial ownership (as defined under Section 13(d) of the
Exchange Act) of 20% or more of any class of equity securities
of the Company pursuant to a merger, consolidation or other
business combination, sale of shares of capital stock, tender
offer, exchange offer or similar transaction; or
|
|
|
|
any one or more assets or businesses of the Company and our
subsidiaries that constitute 20% or more of the revenues,
earnings or assets of the Company and its subsidiaries, taken as
a whole.
|
As used in the Merger Agreement, a Superior Proposal
means a bona fide written proposal or offer made by any person,
obtained after the date of the Merger Agreement and not in
breach of the Merger Agreement, which is on terms which our
board of directors determines in its good faith judgment, after
consultation with our outside legal and financial advisors, to
be more favorable to our stockholders than the transactions
contemplated by the Merger Agreement from a financial point of
view and reasonably capable of being completed on the terms
proposed (based upon, among other things, the availability of
financing and the expectation of obtaining required approvals),
to purchase or otherwise acquire, directly or indirectly, in one
transaction or a series of related transactions:
|
|
|
|
|
beneficial ownership of more than 75% of the outstanding shares
of our common stock pursuant to a merger, consolidation or other
business combination, sale of shares of our common stock, tender
offer, exchange offer or similar transaction; or
|
|
|
|
all or substantially all of the assets of the business of the
Company and its subsidiaries, other than the Intel Companies.
|
Change of
Recommendation
In connection with the meeting of our stockholders to approve
the Merger Agreement (see the section of this proxy statement
entitled Stockholders Meeting; Proxy
Statement), our board of directors has unanimously
resolved to recommend that our stockholders adopt the Merger
Agreement and approve the Merger.
We have agreed that our board of directors may not, except under
certain circumstances set forth below:
|
|
|
|
|
withdraw or modify (in a manner adverse to Safran or Merger
Sub), or publicly propose to withdraw (or so modify), our board
of directors recommendation of the Merger or the Merger
Agreement; or
|
|
|
|
recommend, adopt or approve, or publicly propose to recommend,
adopt or approve, any Acquisition Proposal (including by taking
no position with respect to a tender or exchange offer).
|
However, prior to receipt of our stockholders approval of
the Merger, our board of directors may take the actions
described in the paragraph above if it determines in good faith
(after consultation with its outside legal and
81
financial advisors) that the failure to take such action would
be reasonably likely to be inconsistent with the directors
fiduciary duties to our stockholders under applicable law either:
|
|
|
|
|
based upon any fact, event, circumstance, development or change
that was unknown to the Companys board of directors as of
the date of the Merger Agreement but becomes known prior to the
meeting of our stockholders (or if known, the magnitude or
consequences of which were not reasonably foreseeable by the
Companys board of directors as of the date of the Merger
Agreement) (which we refer to in this proxy statement as an
Intervening Event); or
|
|
|
|
if our board of directors determines in good faith (after
consultation with its outside legal and financial advisors) that
the Company has received an Acquisition Proposal which
constitutes a Superior Proposal (as defined in the Merger
Agreement and described in the section of this proxy statement
entitled Restrictions on Solicitations of Other
Offers).
|
Pursuant to the Merger Agreement, our board of directors may not
take any such action until after the fifth business day
following Safrans receipt of written notice from us that
our board of directors intends to take such action and
specifying its reasons for the action (including if the basis of
the proposed action is an Intervening Event, the details of such
event, or if a Superior Proposal, the terms and conditions of
such Superior Proposal). In addition, pursuant to the Merger
Agreement, during such five business day period, if requested by
Safran, we must engage in good faith negotiations to amend the
Merger Agreement in such a manner that such Intervening Event is
no longer a basis for such action, or the Acquisition Proposal
that was determined to constitute a Superior Proposal is no
longer a Superior Proposal, as applicable.
Any amendment to the financial or other material terms of a
Superior Proposal will entitle Safran to a new notice and an
additional five day business period. During such five business
day period, Safran may engage in discussions with BAE with
respect to modifications to the BAE Agreement in furtherance of
such good faith negotiations with Company, so long as such
agreement, arrangement or understanding is not materially
adverse to the Company. In determining whether to make a change
in recommendation or in determining whether an Acquisition
Proposal constitutes a Superior Proposal, our board of directors
is required to take into account any changes to the terms of the
Merger Agreement proposed by Safran.
Stockholders
Meeting; Proxy Statement
We have agreed, as soon as reasonably practicable, to hold a
special meeting of our stockholders for the purpose of obtaining
their approval of the Merger Agreement. In connection with that
meeting, we have filed this proxy statement with the SEC and
have furnished it to you. Except in the circumstances described
above (see the section of this proxy statement entitled
Change of Recommendation), the board
of directors must recommend that the stockholders of the Company
adopt the Merger Agreement and such recommendation must be
included in the proxy statement. The Company must use reasonable
best efforts to solicit such stockholder approval. We must hold
the stockholders meeting and submit the Merger Agreement and
Merger for adoption and approval by our stockholders at the
special meeting, even if our board of directors has changed,
qualified, withdrawn or modified its recommendation (or taken
any of the actions described in the section of this proxy
statement entitled Change of
Recommendation) or an Acquisition Proposal has been
received, disclosed or commenced.
Agreement
to Take Appropriate Actions
Subject to the terms and conditions set forth in the Merger
Agreement, the Company and Safran have agreed to (and to cause
their respective subsidiaries to) use their respective
reasonable best efforts promptly to:
|
|
|
|
|
take, or to cause to be taken, all actions, and to do, or to
cause to be done, and to assist and cooperate with the other
parties in doing all things necessary, proper or advisable under
applicable law or otherwise to consummate and make effective the
transactions contemplated by the Merger Agreement and the BAE
Agreement in the most expeditious manner practicable;
|
|
|
|
obtain from any governmental entities any actions, non-actions,
clearances, waivers, consents, approvals, permits or orders
required to be obtained by the Company or Safran or any of their
subsidiaries in connection
|
82
|
|
|
|
|
with the authorization, execution, delivery and performance of
the Merger Agreement and the consummation of the transactions
contemplated by the Merger Agreement;
|
|
|
|
|
|
make all registrations, filings, notifications or submissions
which are necessary or advisable, and thereafter promptly make
any other required submissions and responses, with respect to
the transactions contemplated by the Merger Agreement including:
|
|
|
|
|
|
those required under the HSR Act and certain foreign antitrust,
competition or merger control laws;
|
|
|
|
certain actions with respect to CFIUS and FOCI mitigation, as
described in the section of this proxy statement entitled
CFIUS and FOCI Mitigation; and
|
|
|
|
filings required under any other applicable law, including
submission of notification of the transactions contemplated by
the Merger Agreement to the United States Department of State at
least sixty days in advance of the closing of the transactions
contemplated by the Merger Agreement;
|
|
|
|
|
|
furnish all information reasonably required for any filing to be
made pursuant to applicable law in connection with the
transactions contemplated by the Merger Agreement;
|
|
|
|
act in good faith and reasonably cooperate with the other
parties in connection with any filings;
|
|
|
|
keep the other party informed in all material respects of any
material communication received by such party from, or given by
such party to, any governmental entity and of any material
communication received or given in connection with any
proceeding by a private party, in each case, relating to the
transactions contemplated by the Merger Agreement;
|
|
|
|
provide the other parties prior notice of any communication
with, and any proposed understanding, undertaking or agreement
with, any governmental entity regarding any filings;
|
|
|
|
consult and cooperate with each other party in connection with
any analyses, appearances, presentations, memoranda, briefs,
arguments, opinions and proposals made or submitted by or on
behalf of any party in connection with proceedings relating to
or arising out of the filings;
|
|
|
|
not participate independently in any meeting, primarily relating
to the transactions contemplated by the Merger Agreement and
involving any substantive conversation, with any governmental
entity in respect of any such filings or any investigations or
other inquiries relating to such filings without giving the
other parties prior notice of the meeting or conversation and,
unless prohibited by such governmental entity, the opportunity
to attend or participate;
|
|
|
|
obtain all necessary consents, approvals or waivers under
contracts with third parties (provided that none of the Company,
Safran or Merger Sub is required to make any payments to any
such third parties or concede anything of value to obtain such
consents, approvals or waivers);
|
|
|
|
avoid the entry of, or have vacated or terminated, any decree,
order, or judgment that would restrain, prevent or delay the
consummation of the transactions contemplated the Merger
Agreement, including vigorously defending any lawsuits or other
legal proceedings, whether judicial or administrative,
challenging the Merger Agreement or the transactions
contemplated by the Merger Agreement;
|
|
|
|
in the case of the Company only, (i) obtain novation or
termination of each contract performed at a Company facility
other than the Arlington, Virginia facility that would involve
access to classified information, or that would require the
Company to hold Facility Security Clearance (which we refer to
in this proxy statement as FCL), or any of the Companys
personnel to hold a Personnel Security Clearance (which we refer
to in this proxy statement as PCL), (ii) terminate all FCLs
and related PCLs at all Company facilities other than the
Arlington, Virginia facility pursuant to the relevant provisions
of the National Industrial Security Program Operating Manual
(which we refer to in this proxy statement as the NISPOM),
(iii) receive written confirmation that each such FCL and
related PCL was terminated and (iv) obtain the assignment
or termination of a certain contract involving classified
information; and
|
|
|
|
execute and deliver any additional instruments necessary to
consummate the transactions contemplated by the Merger Agreement.
|
83
No parties to the Merger Agreement can consent to any voluntary
delay of the consummation of the transactions contemplated the
Merger Agreement at the behest of any governmental entity
without the consent of the other parties to the Merger Agreement.
Nothing in the Merger Agreement will require Safran to do any of
the following:
|
|
|
|
|
offer, accept or agree to sell, divest, dispose of, or, subject
to the terms of the Merger Agreement as described in the section
of this proxy statement entitled CFIUS and FOCI
Mitigation, hold separate any part of its or the
Companys businesses, operations, assets or product lines
(or a combination of Safrans and the Companys
respective businesses, operations, assets or product lines) or
take or commit to take any action that could reasonably be
expected to limit its freedom of action with respect to, or
ability to retain, one or more of the Companys businesses,
product lines or assets;
|
|
|
|
offer, accept or agree to not compete in any geographic area or
line of business; and/or
|
|
|
|
subject to the terms of the Merger Agreement as described in the
section of this proxy statement entitled CFIUS
and FOCI Mitigation, restrict the manner in which, or
whether, Safran, the Company, the surviving corporation or any
of their affiliates may carry on business in any part of the
world.
|
Under the Merger Agreement, the Company cannot, without
Safrans prior written consent, commit to any divestiture
transaction or, subject to the terms of the Merger Agreement as
described in this section and the section of this proxy
statement entitled CFIUS and FOCI
Mitigation, agree to any restriction on its business.
In addition, the Company agreed that the Company and its board
of directors (i) will use their respective commercially
reasonable efforts to ensure that no state takeover statute or
similar statute or regulation is or becomes applicable to the
transactions contemplated by the Merger Agreement, and
(ii) if any state takeover statute or similar statute
becomes applicable to the transactions contemplated by the
Merger Agreement, use their commercially reasonable efforts to
ensure that such transactions may be consummated as promptly as
practicable on the terms contemplated by the Merger Agreement
and otherwise to minimize the effect of such statute or
regulation on the transactions contemplated by the Merger
Agreement.
CFIUS and
FOCI Mitigation
In addition and subject to the terms of the Merger Agreement
described above in the section of this proxy statement entitled
Agreement to Take Appropriate Actions,
we and Safran have agreed:
|
|
|
|
|
to prepare, prefile and file with CFIUS a joint voluntary notice
of the transactions contemplated by the Merger Agreement
pursuant to Exon-Florio as soon as practicable after the date of
the Merger Agreement;
|
|
|
|
to our and their fullest ability, provide CFIUS with any
additional or supplemental information requested by CFIUS or its
member agencies during the Exon-Florio review process; and
|
|
|
|
in cooperation with each other, to use reasonable best efforts
to take all steps advisable, necessary or desirable to finally
and successfully complete the Exon-Florio review process as
promptly as practicable and to make any and all commercially
reasonable undertakings necessary to obtain a written
notification issued by CFIUS that it has concluded its review
(or, if CFIUS deems necessary, its investigation) and determined
that there are no unresolved national security concerns with
respect to the transactions contemplated hereby so as to enable
the consummation of the transactions contemplated by the Merger
Agreement to occur as soon as reasonably possible.
|
As soon as practicable after the date of the Merger Agreement,
the Company is obligated to prepare and submit to the Defense
Security Service of the United States Department of Defense and,
to the extent applicable, any other agency of the
U.S. government notification of the transactions
contemplated by the Merger Agreement pursuant to the NISPOM and
any other applicable national or industrial security
regulations, and the Company is required to fully cooperate with
Safran in requesting from the Defense Security Service approval
to operate certain businesses of the Company located in
Arlington, Virginia pursuant to a FOCI mitigation arrangement in
accordance with the NISPOM and the remainder of the
Companys business free of any such NISPOM mitigation
arrangement. Such cooperation by the Company shall include using
its reasonable best efforts to novate or terminate certain
contracts
84
involving classified information. The Company, Safran and Merger
Sub have agreed to take any and all commercially reasonable
steps, including agreeing to actions, restrictions or conditions
proposed by CFIUS or any other agency or branch of the
U.S. Government, including the Department of Defense, to
obtain CFIUS and Department of Defense approval for the
transactions contemplated by the Merger Agreement on the terms
summarized above.
Financing
The obligations of Safran and Merger Sub under the Merger
Agreement are not subject to a condition regarding Safrans
or Merger Subs obtaining of funds to consummate the Merger
and the other transactions contemplated by the Merger Agreement.
Safran and Merger Sub have represented in the Merger Agreement
that Safran has, and as of the closing of the Merger, Safran
will have, sufficient funds available (through existing credit
arrangements or otherwise) to fully fund all of its and Merger
Subs obligations under the Merger Agreement, including
payment of the aggregate merger consideration and other cash
consideration in respect of equity awards pursuant to the Merger
Agreement, and payment of all fees and expenses related to the
transactions contemplated by the Merger Agreement and any
refinancing of indebtedness of Safran or the Company or their
respective subsidiaries in connection with the transactions
contemplated by the Merger Agreement.
Employee
Matters
The Merger Agreement generally provides that for eighteen months
following the Merger, Safran will, and will cause its affiliates
to, provide to employees of the Company immediately prior to the
consummation of the Merger who remain in the employment of the
surviving corporation (i) base salary or hourly wage rates
that, on an
individual-by-individual
basis, are no less favorable than those provided to such
employees immediately prior to the Merger; (ii) total
incentive compensation opportunities (excluding any equity or
equity-based compensation opportunities, and retention and other
incentives implemented in connection with the transactions
contemplated by the Merger Agreement and the BAE Agreement)
that, on an
individual-by-individual
basis, are no less favorable than those incentive compensation
opportunities (excluding any equity or equity-based compensation
opportunities except to the extent determined by Safran, and
retention and other incentives implemented in connection with
the transactions contemplated by the Merger Agreement and the
BAE Agreement) available immediately prior to the Merger; and
(iii) employee benefits that are substantially comparable
in the aggregate to the employee benefits (excluding defined
benefit and other pension plans) provided to such employees
immediately prior to the Merger. Safran has no obligation to
provide equity based incentives or defined benefit or other
pension plans following the Merger.
In general, Safran has agreed to, and to cause its affiliates
(including the surviving corporation and its subsidiaries) to,
recognize the service of employees with us prior to the Merger
in connection with any employee benefit plans made available to
our employees following the Merger for all purposes of vesting,
eligibility and benefit entitlement (but excluding benefit
accruals), except to the extent such service credit would result
in a duplication of benefits for the same period. Safran has
also agreed to cause (i) each employee benefit plan made
available to employees of the Company as of the closing of the
transactions contemplated by the Merger Agreement who remain
employed following the Merger to waive pre-existing condition
limitations to the extent waived or not applicable under the
analogous benefit plan of the Company, and (ii) such
employees to be given credit under the applicable benefit plans
made available to such employees following the Merger for
amounts paid prior to the Merger during the year in which the
Merger occurs under a corresponding benefit plan of the Company
during the same period for purposes of applying deductibles,
co-payments and
out-of-pocket
maximums as though such amounts had been paid in accordance with
the terms and conditions of such employee benefit plan.
Safran and the Company have agreed that the Merger will
constitute a Change in Control for purposes of all
Company benefit plans in which the term is relevant. The Merger
Agreement also provides that for eighteen months following the
Merger, Safran will, and will cause its affiliates (including
the surviving corporation and its subsidiaries) to, pay to any
employee of the Company (after giving effect to the BAE
Transaction) immediately prior to the effective time of the
Merger who remains in the employment of the surviving
corporation and whose service with Safran and its affiliates is
terminated during such eighteen month period severance benefits
that are no
85
less favorable than those provided to such employee under the
terms of the Company severance plan or program in which such
individual is eligible to participate as of the date of the
Merger Agreement.
Following the date of the Merger Agreement, Safran and the
Company have agreed to cooperate, and the Company has agreed to
take all actions reasonably requested by Safran, on or prior to
December 31, 2010, as are necessary to reduce and/or avoid
the application of Section 280G of the Code to the payments
to be made to specified executives.
Safran has also agreed to cause the Company, following the
Merger, to honor, subject to certain adjustments, the
Companys existing bonus plan with respect to the fiscal
year in which the Merger occurs.
Immediately following the closing of the Merger, Safran has
agreed to cause the surviving corporation to terminate the
employment of Messrs. DePalma, LaPenta and Molina and
Ms. Fordyce. Safran agrees that such terminations shall be
treated as terminations of employment without cause
for purposes of the employment agreements entered into between
the Company and such individuals. Safran also agrees to cause
the surviving corporation to pay each such individual all
amounts contemplated for payment to such individual by his or
her employment agreement.
Director
and Officer Indemnification and Insurance
The Merger Agreement provides that Safran and Merger Sub will do
the following:
|
|
|
|
|
continue in full force and effect all rights to exculpation and
indemnification for acts or omissions occurring at or prior to
the effective time of the Merger (including any matters arising
in connection with the transactions contemplated by the Merger
Agreement and the BAE Agreement), whether asserted or claimed
prior to, at or after the effective time of the Merger, existing
in favor of the current and former directors, officers and
members of the boards of managers of the Company and its
subsidiaries other than the Intel Companies (which we refer to
in this proxy statement as the D&O Indemnified Parties) and
the current and former employees of the Company and any of its
subsidiaries other than the Intel Companies (which, together
with the D&O Indemnified Parties, we refer to in this proxy
statement as the Company Indemnified Parties) as provided in the
organizational documents of the Company or its subsidiaries or
in any contract, in each case, as in effect on the date of the
Merger Agreement;
|
|
|
|
indemnify, defend, hold harmless and advance expenses to the
D&O Indemnified Parties with respect to all acts or
omissions by them in their capacities as such at any time prior
to the effective time of the Merger (including any matters
arising in connection with the transactions contemplated by the
Merger Agreement and the BAE Agreement), to the fullest extent
that the Company or its subsidiaries would be permitted by
applicable law; and
|
|
|
|
indemnify, defend, hold harmless and advance expenses to, the
Company Indemnified Parties with respect to all acts or
omissions by them in their capacities as such at any time prior
to the effective time of the Merger to the fullest extent
required by the organizational documents of the Company or any
of its subsidiaries as in effect on the date of the Merger
Agreement.
|
Under the terms of the Merger Agreement, Safran will also
provide, or cause the surviving corporation to provide, for a
period of six years after the effective time of the Merger, with
either insurance and indemnification policies, or tail
policies, in each case, that provide coverage for events
occurring at or prior to the effective time of the Merger for
the D&O Indemnified Parties who were insured by the
Companys directors and officers insurance and
indemnification policies that are no less favorable than the
existing policies of the Company as of the date of the Merger
Agreement or, if substantially equivalent insurance coverage is
unavailable, the best available coverage. Safrans and the
surviving corporations obligation to provide this
insurance coverage is subject to a premium cap of 300% of the
last annual premium paid by the Company for its policies prior
to the date of the Merger Agreement.
In addition, under the terms of the Merger Agreement, following
the closing of the Merger, Safran is required to honor the
Companys director and officer litigation reimbursement
policy, pursuant to which all current and former directors and
former officers of the Company are entitled to compensation for
time and services related to appearances or attendance at any
third party proceeding (including without limitation,
depositions, court
86
appearances and legal proceedings) in any case related to his or
her current or past service as a director or officer, as the
case may be. This compensation is in addition to reimbursement
of all reasonable
out-of-pocket
costs and expenses associated with such appearance or attendance.
Other
Covenants
The Merger Agreement contains additional agreements between the
Company and Safran relating to, among other things:
|
|
|
|
|
the filing of this proxy statement with the SEC (and cooperation
in response to any comments from the SEC with respect to this
proxy statement);
|
|
|
|
the special meeting of our stockholders;
|
|
|
|
Safrans access to our properties, books, contracts,
records and other information between the date of the Merger
Agreement and the closing under the Merger Agreement (subject to
applicable legal obligations and restrictions);
|
|
|
|
press releases and other public announcements relating to the
Merger and the BAE Transaction;
|
|
|
|
notification of certain matters;
|
|
|
|
certain tax matters, including, if requested by Safran,
performance of a tax basis study;
|
|
|
|
if requested by Safran, conversion of certain subsidiaries of
the Company into limited liability companies;
|
|
|
|
the cash, indebtedness and working capital of the Intel
Companies;
|
|
|
|
compliance with terms of the indenture related to the
Companys outstanding convertible notes;
|
|
|
|
stockholder litigation;
|
|
|
|
restrictions on entering into agreements with BAE and on the
Company amending the BAE Agreement, and compliance with
obligations under the BAE Agreement; and
|
|
|
|
actions necessary to cause dispositions of certain common stock
and equity-based securities pursuant to the Merger Agreement to
be exempt under
Rule 16b-3
promulgated under the Exchange Act.
|
Conditions
to the Completion of the Merger
The obligations of the Company, Safran and Merger Sub to
consummate the Merger are subject to the satisfaction (or
waiver, if permissible under applicable law) of the following
conditions at or prior to the closing of the Merger:
|
|
|
|
|
approval of the Merger Agreement by the holders of a majority of
the outstanding shares of our common stock;
|
|
|
|
absence of any injunction, law, judgment, order, decree or
ruling in effect which seeks to or has the effect of enjoining
or otherwise prohibiting the consummation of the Merger (unless
vacated, terminated or withdrawn) or making the consummation of
the Merger illegal;
|
|
|
|
expiration or termination of any waiting period (including any
extension) applicable to the consummation of the Merger under
the HSR Act;
|
|
|
|
receipt by Safran and the Company of written confirmation by
CFIUS of the completion of the review, and if applicable,
investigation process, under Exon-Florio and CFIUSs
determination that there are no unresolved national security
concerns with respect to the transactions contemplated by the
Merger Agreement and the BAE Agreement; and
|
|
|
|
the expiration of a 35 trading day notice period under the terms
governing the Companys convertible notes.
|
87
In addition, Safrans and Merger Subs obligations to
consummate the Merger are subject to the satisfaction (or waiver
by Safran and Merger Sub, if permissible under applicable law)
of, among other customary conditions, the following conditions
at or prior to the closing of the Merger:
|
|
|
|
|
the representations and warranties made by the Company regarding
the Companys capital structure, the Companys
corporate authority to enter into, and enforceability of, and
the actions of the Companys board of directors relative
to, the Merger Agreement, brokers and finders fees
and delivery of engagement letters, opinions of financial
advisors, the required vote of the Company stockholders and the
absence of agreements with BAE being true and correct in all
respects as of the date of the Merger Agreement and the closing
of the Merger;
|
|
|
|
the representations and warranties of the Company regarding
certain matters relating to the Companys subsidiaries and
matters relating to the Transferred Intel Companies being true
and correct in all material respects as of the date of the
Merger Agreement and the closing of the Merger;
|
|
|
|
each of the representations and warranties made by the Company
under the Merger Agreement other than those listed above being
true and correct (without giving effect to any materiality or
Company Material Adverse Effect qualifications set forth in any
such representation or warranty) as of the date of the Merger
Agreement and the closing of the Merger, except where the
failure to be true and correct would not constitute a Company
Material Adverse Effect (see the section of this proxy statement
entitled Company Material Adverse Effect
Definition for the definition of Company
Material Adverse Effect);
|
|
|
|
the Companys performance in all material respects of all
of its material obligations under the Merger Agreement to be
performed by it at or prior to the closing of the Merger;
|
|
|
|
the absence of a Company Material Adverse Effect since the date
of the Merger Agreement;
|
|
|
|
the receipt by the Company of the purchase price to be paid by
BAE to the Company in connection with the closing of the BAE
Transaction (for a discussion of the BAE Agreement and the BAE
Transaction, see the section of this proxy statement entitled
The Merger BAE Agreement);
|
|
|
|
completion of novation, assignment, termination, or expiration
(and receipt of written notice from the Company thereof) of
certain contracts involving classified information; and
|
|
|
|
since the date of the Merger Agreement, no contracts, assets
(other than cash and cash equivalents as expressly permitted in
the BAE Agreement) or liabilities primarily relating to the
business of the Intel Companies or the Intel Companies having
been assigned or novated (or otherwise transferred) to the
Company or any of its subsidiaries (other than the Intel
Companies).
|
In addition, the obligations of the Company to consummate the
Merger are further subject to the satisfaction (or waiver by the
Company, if permissible under applicable law) of the following
conditions at or prior to the closing of the Merger:
|
|
|
|
|
the representations and warranties made by Safran and Merger Sub
regarding corporate authority to enter into, and enforceability
of, the Merger Agreement; the formation, operations and
capitalization of Merger Sub; Safran and Merger Sub not being an
interested stockholder as defined under
Section 203 of the DGCL; and the absence of agreements with
BAE being true and correct in all respects as of the date of the
Merger Agreement and the closing of the Merger;
|
|
|
|
each of the representations and warranties made by Safran and
Merger Sub under the Merger Agreement other than those listed
above being true and correct as of the date of the Merger
Agreement and the closing of the Merger, except where the
failure to be so true and correct would not reasonably be
expected to prevent or materially impede, interfere with, hinder
or delay the consummation by Safran or Merger Sub of the
transactions contemplated by the Merger Agreement; and
|
|
|
|
Safrans and Merger Subs performance in all material
respects of all material obligations required to be performed by
each of them under the Merger Agreement at or prior to the
closing of the Merger.
|
88
Termination
of the Merger Agreement
The Merger Agreement may be terminated as follows:
|
|
|
|
|
at any time, by the mutual written agreement of the Company and
Safran;
|
|
|
|
by either the Company or Safran if:
|
|
|
|
|
|
the Merger has not been consummated on or prior to the
nine-month anniversary of the date of the Merger Agreement
(which we refer to in this proxy statement as the Termination
Date), subject to a three-month extension at the election of
either the Company or Safran if all conditions to the Merger
have been satisfied (other than (i) those conditions which
by their nature can only be satisfied at or immediately prior to
the effective time of the Merger or (ii) the condition
related to the receipt by the Company of the purchase price to
be paid by BAE to the Company in connection with the closing of
the BAE Transaction to the extent the failure of such condition
to be satisfied is the result of the failure to obtain
regulatory approvals for the BAE Transaction) except those
conditions related to regulatory approvals or the novation,
assignment, termination, or expiration of certain contracts
involving classified information, or in connection with the
Companys substitution rights relating to the sale of the
Transferred Intel Companies discussed in the section of this
proxy statement entitled Certain Substitution
Rights in Connection with the Sale of the Transferred Intel
Companies, and the party seeking to terminate the
Merger Agreement on this basis has not failed to fulfill any
obligation under the Merger Agreement which failure has been a
principal cause of, or resulted in, the failure of the Merger to
be consummated;
|
|
|
|
any governmental entity having jurisdiction over the Company,
Safran or Merger Sub has issued an injunction, law, judgment,
order, decree or ruling permanently enjoining or otherwise
prohibiting the consummation of the Merger and such injunction,
law, judgment, order, decree or ruling has become final and
non-appealable, and the party seeking to terminate the Merger
Agreement on this basis has not failed to fulfill any obligation
under the Merger Agreement which failure has been the primary
cause of, or primarily resulted in, such order, decree, ruling
or action and has used reasonable best efforts to cause any such
decree, ruling or action to be vacated or lifted;
|
|
|
|
the BAE Agreement has been terminated in accordance with its
terms, subject to the Companys exercise of its
substitution rights in accordance with the Merger Agreement
relating to the sale of the Transferred Intel Companies pursuant
to the provisions of the Merger Agreement described in the
section of this proxy statement entitled Certain
Substitution Rights in Connection with the Sale of the
Transferred Intel Companies. Safran may exercise such
right in the event a Substitute Intel Buyer and Substitute Intel
Agreement (as each is defined in the Merger Agreement and as
described below) would reasonably be expected to materially and
adversely affect Safrans rights and obligations (as
compared with BAE and the BAE Agreement), including if
(i) the purchase price under the Substitute Intel Agreement
is less than the purchase price set forth in the BAE Agreement,
(ii) there is materially increased conditionality imposed
on the Merger and the sale of the Transferred Intel Companies
(including with respect to financing), (iii) there is an
increase in potential liabilities of the Company after giving
effect to the BAE Transaction or (iv) certain provisions of
the BAE Agreement are not replicated in the Substitute Intel
Agreement;
|
|
|
|
the Companys stockholders do not approve the Merger
Agreement at the Company stockholders meeting, except that the
right of the Company to terminate the Merger Agreement on this
basis will not be available if it has failed to comply in all
material respects with its obligations related to such meeting
and this proxy statement, or with its obligations related to
Acquisition Proposals and the recommendation of the board of
directors described under the sections of this proxy statement
entitled Restrictions on Solicitations of Other
Offers and Change of
Recommendation;
|
|
|
|
the other party has breached any of its representations,
warranties, covenants or agreements contained in the Merger
Agreement, which breach would result in a failure of a condition
to the obligations of the party seeking to terminate to
consummate the Merger and has not been waived by the
non-breaching party and is incapable of being cured, or is not
cured by the breaching party within 45 days following
receipt of a written notice of such breach by the party seeking
to terminate (the party seeking to terminate the
|
89
|
|
|
|
|
agreement cannot have materially breached any of its material
obligations under the Merger Agreement); or
|
|
|
|
|
|
the Companys board of directors has changed its
recommendation of the Merger or the Merger Agreement, or has
recommended, adopted or approved, or publicly proposed to
recommend, adopt or approve, any Acquisition Proposal;
|
|
|
|
the Company has breached its obligations under the Merger
Agreement by failing to (i) call the meeting of the
Companys stockholders, (ii) mail to its stockholders
a proxy statement in accordance with the terms of the Merger
Agreement or (iii) include in the proxy statement the board
of directors recommendation that the stockholders adopt
and approve the Merger Agreement and the Merger; or
|
|
|
|
the Company has violated or breached in any material respect any
of its material obligations described in the sections of this
proxy statement entitled Restrictions on
Solicitations of Other Offers or
Change of Recommendation.
|
Termination
Fees and Reimbursement of Expenses
The Company has agreed to pay Safran a termination fee of
$25,000,000 in cash (minus any amounts paid by the Company in
connection with the reimbursement of expenses described below)
if:
|
|
|
|
|
prior to the stockholders meeting to adopt the Merger
Agreement and approve the Merger, the Merger Agreement is
terminated by Safran pursuant to its termination rights in
connection with (i) a change in recommendation by the
Companys board of directors, or the recommendation,
adoption or approval, or public proposal to recommend, adopt or
approve, any Acquisition Proposal by the Companys board of
directors, (ii) the breach by the Company of certain of its
obligations with respect to the stockholders meeting or the
proxy statement or (iii) the Companys violation or
breach in any material respect of any of its material
obligations described under the sections of this proxy statement
entitled Restrictions on Solicitations of Other
Offers and Change of
Recommendation; or
|
|
|
|
each of the following has occurred:
|
|
|
|
|
|
(x) Safran terminates the Merger Agreement pursuant to its
termination rights related to the Companys breach of its
representations, warranties, covenants or agreements contained
in the Merger Agreement, which breach would result in a failure
of a condition to Safrans and Merger Subs
obligations to consummate the Merger; (y) either Safran or
the Company terminates the Merger Agreement as a result of the
Merger failing to be consummated by the Termination Date; or
(z) the stockholders do not approve the Merger at the
special meeting;
|
|
|
|
an Acquisition Proposal is publicly announced (prior to the
special meeting, in the case of clause (z) above); and
|
|
|
|
within nine months after termination the Company enters into
(and subsequently consummates) an agreement with any person
(other than Safran, Merger Sub or any of their affiliates) to
purchase or otherwise acquire, directly or indirectly, in one
transaction or a series of related transactions
(i) beneficial ownership of 50% or more of any class of
equity securities of the Company pursuant to a merger,
consolidation or other business combination, sale of shares of
capital stock, tender offer, exchange offer or similar
transaction or (ii) any one or more assets or businesses of
the Company and our subsidiaries that constitute 50% or more of
the revenues, earnings or assets of the Company and its
subsidiaries, taken as a whole.
|
Safran has agreed to pay the Company a termination fee of
$75,000,000 in cash if the Merger Agreement is terminated and
all conditions to the consummation of the Merger have been
satisfied, other than those conditions related to regulatory
approvals and those to be satisfied at or immediately prior to
the closing.
90
The Company is required to reimburse up to $12,500,000 of
Safrans documented
out-of-pocket
fees and expenses in connection with the transaction if:
|
|
|
|
|
either Safran or the Company terminates the Merger Agreement as
a result of the Merger failing to be consummated by the
Termination Date (as described in the section of this proxy
statement entitled Termination of the Merger
Agreement), and at the time of termination all
conditions related to regulatory approvals have been
satisfied; or
|
|
|
|
the BAE Agreement is terminated (subject to the Companys
substitution rights relating to the sale of the Companys
intelligence services business, which are discussed in the
section of this proxy statement entitled Certain
Substitution Rights in Connection with the Sale of the
Transferred Intel Companies).
|
The Merger Agreement provides that in no event will the Company
be required to pay the $25,000,000 termination fee to Safran on
more than one occasion and in no event will Safran be required
to pay the $75,000,000 termination fee to the Company on more
than one occasion. In addition, if the Merger Agreement is
terminated under circumstances that give rise to the obligation
of the Company or Safran to pay the applicable termination fee,
payment of the termination fee is the sole and exclusive remedy
available to the Company or Safran and Merger Sub, as
applicable, against Safran and Merger Sub or the Company, as
applicable, with respect to the Merger Agreement and the
transactions contemplated by the Merger Agreement. The Company
will not be required to reimburse any of Safrans expenses
if the $25,000,000 termination fee has already been paid under
the Merger Agreement.
Certain
Substitution Rights in Connection with the Sale of the
Transferred Intel Companies
Pursuant to the Merger Agreement, if the BAE Agreement is
terminated, the Company may elect to defer Safrans rights
to terminate the Merger Agreement and may initiate, solicit and
encourage the making of a proposal or offer from, engage in
negotiations or discussions with, and furnish any material
nonpublic information to, any person (which we refer to in this
proxy statement as a Substitute Intel Buyer) with respect to the
potential acquisition (which we refer to in this proxy statement
as a Substitute Intel Transaction) by such person, directly or
indirectly, in one transaction or a series of transactions, of
the Intel Companies.
In order to exercise the rights described above, the Company is
obligated under the Merger Agreement to notify Safran of its
intention to do so within five days after the termination of the
BAE Agreement.
The Company must promptly advise Safran of any negotiations or
discussions with any Substitute Intel Buyer with respect to a
potential Substitute Intel Transaction, the material terms and
conditions of any such Substitute Intel Transaction and the
identity of the Substitute Intel Buyer, and to keep Safran
reasonably informed of the status and material details of any
such negotiations or discussions and provide to Safran as soon
as practicable copies of all material written correspondence
relating to any such Substitute Intel Transaction exchanged
between the Company or any of its subsidiaries and the
Substitute Intel Buyer.
In the event that the Company determines to enter into an
agreement (which we refer to in this proxy statement as a
Substitute Intel Agreement) with a Substitute Intel Buyer
providing for a Substitute Intel Transaction (which we refer to
in this proxy statement as the Failed Intel Buyer Substitution
Right), the Company is required to deliver written notice to
Safran of the Companys intention to exercise the Failed
Intel Buyer Substitution Right no later than four business days
prior to entry into such Substitute Intel Agreement, which
notice shall include a substantially final draft of the
Substitute Intel Agreement and a statement by the Company as to
whether the Substitute Intel Buyer and Substitute Intel
Agreement would not reasonably be expected to materially and
adversely affect Safrans rights or obligations (as
compared with BAE and the BAE Agreement), taking into account
all relevant factors, including the terms and conditions of the
Substitute Intel Agreement and the financial position of the
Substitute Intel Buyer (which we refer to in this proxy
statement as the Substitute Determination).
Safran will be deemed to accept the Substitute Determination
unless Safran provides written notice of disagreement to the
Company within three business days of Safrans receipt of
the Companys notice of its intention to exercise the
Failed Intel Buyer Substitution Right. Safran may terminate the
Merger Agreement if the Substitute Intel Buyer and Substitute
Intel Agreement would reasonably be expected to materially and
adversely affect Safrans rights and obligations as
described in the section of this proxy statement entitled
Termination of the
91
Merger Agreement. The Company is required to notify
Safran in writing within two business days following execution
of the Substitute Intel Agreement.
In the event that the Company enters into a Substitute Intel
Agreement and the purchase price payable under such agreement is
greater than the $295,833,000 purchase price set forth in the
BAE Agreement, the $12.00 per share merger consideration payable
to stockholders under the Merger Agreement will be increased by
a per share amount in cash determined based on the excess amount
of the purchase price provided for in the Substitute Intel
Agreement over $295,833,000 using the same methodology used by
the Company and Safran in determining the $12.00 per share
merger consideration.
There can be no assurance that a Substitute Intel Transaction
will be successfully implemented if the BAE Transaction fails to
close and we seek to exercise the foregoing rights. If we elect
to seek a Substitute Intel Buyer, there can be no assurance that
such buyer will be acceptable to Safran. In addition, the timing
and certainty of closing of a Substitute Intel Transaction may
be subject to a number of risks which could affect our ability
to consummate the Merger.
Amendment
Subject to the applicable provisions of the DGCL, at any time
prior to the effective time of the Merger, the parties may
modify or amend the Merger Agreement by written agreement of the
respective parties; except that after our stockholders have
adopted the Merger Agreement, no amendment (other than a
termination of the Merger Agreement in accordance with its
terms) can be made which changes the consideration payable in
the Merger or adversely affects the rights of the Companys
stockholders under the Merger Agreement or is otherwise required
under any applicable law to be approved by such stockholders
without such approval having been obtained.
Specific
Performance
The parties have agreed that, if for any reason a party fails to
perform its obligations under the Merger Agreement, a party
seeking to enforce the Merger Agreement against such
nonperforming party will be entitled to specific performance and
injunctive and other equitable relief, in addition to and not in
limitation of any other remedy to which it is entitled at law or
in equity.
Third-Party
Beneficiaries
The Merger Agreement disclaims third-party beneficiary rights,
except for (a) the rights of the D&O Indemnified
Parties and the Company Indemnified Parties to enforce the
relevant provisions of the Merger Agreement with respect to
indemnification and insurance and (b) the rights of the
Companys stockholders and holders of Company options,
restricted stock awards, deferred stock units and warrants to
enforce the relevant provisions of the Merger Agreement with
respect to their rights to receive the applicable consideration
as provided in the Merger Agreement from and after the effective
time of the Merger.
92
APPRAISAL
RIGHTS
Under the DGCL, you have the right to dissent from the Merger
and to receive payment in cash for the fair value of your common
stock as determined by the Delaware Court of Chancery, together
with a fair rate of interest, if any, as determined by the
court, in lieu of the consideration you would otherwise be
entitled to pursuant to the Merger Agreement. These rights are
known as appraisal rights. Stockholders electing to exercise
appraisal rights must comply with the provisions of
Section 262 of the DGCL in order to perfect their rights.
Strict compliance with the statutory procedures will be required.
The following is intended as a brief summary of the material
provisions of the Delaware statutory procedures required to be
followed by a stockholder in order to dissent from the Merger
and perfect appraisal rights. This summary, however, is not a
complete statement of all applicable requirements and is
qualified in its entirety by reference to Section 262 of
the DGCL, the full text of which appears in Annex E to this
proxy statement. Failure to precisely follow any of the
statutory procedures set forth in Section 262 of the DGCL
may result in a termination or waiver of your appraisal rights.
Section 262 requires that stockholders be notified that
appraisal rights will be available not less than 20 days
before the stockholders meeting to vote on the Merger. A
copy of Section 262 must be included with such notice. This
proxy statement constitutes our notice to our stockholders of
the availability of appraisal rights in connection with the
Merger in compliance with the requirements of Section 262.
If you wish to consider exercising your appraisal rights, you
should carefully review the text of Section 262 contained
in Annex E to this proxy statement because failure to
timely and properly comply with the requirements of
Section 262 will result in the loss of your appraisal
rights under the DGCL.
If you elect to demand appraisal of your shares, you must
satisfy each of the following conditions:
|
|
|
|
|
You must deliver to us a written demand for appraisal of your
shares before the vote with respect to the Merger is taken. This
written demand for appraisal must be in addition to and separate
from any proxy or vote abstaining from or voting against the
adoption of the Merger Agreement. Voting against or failing to
vote for the adoption of the Merger Agreement by itself does not
constitute a demand for appraisal within the meaning of
Section 262.
|
|
|
|
You must not vote in favor of the adoption of the Merger
Agreement. A vote in favor of the adoption of the Merger
Agreement will constitute a waiver of your appraisal rights in
respect of the shares so voted and will nullify any previously
filed written demands for appraisal. A proxy which does not
contain voting instructions will, unless revoked, be voted in
favor of the Merger Agreement. Therefore, a stockholder who
votes by proxy and who wishes to exercise appraisal rights must
vote against the Merger Agreement or abstain from voting on the
Merger Agreement.
|
If you fail to comply with either of these conditions and the
Merger is completed, you will be entitled to receive the cash
payment for your shares of common stock as provided for in the
Merger Agreement, but you will have no appraisal rights with
respect to your shares of common stock.
All demands for appraisal should be addressed to L-1 Identity
Solutions, Inc., 177 Broad Street, Stamford, Connecticut 06901,
Attention: Secretary, and must be delivered before the vote on
the Merger Agreement is taken at the special meeting, and should
be executed by, or on behalf of, the record holder of the shares
of common stock. The demand must reasonably inform us of the
identity of the stockholder and the intention of the stockholder
to demand appraisal of his, her or its shares.
To be effective, a demand for appraisal by a holder of common
stock must be made by, or in the name of, such registered
stockholder, fully and correctly, as the stockholders name
appears on his or her stock certificate(s). Beneficial owners
who do not also hold the shares of record may not directly make
appraisal demands to us. The beneficial holder must, in such
cases, have the registered owner, such as a broker, bank or
other nominee, submit the required demand in respect of those
shares. If shares are owned of record in a fiduciary
capacity, such as by a trustee, guardian or custodian, execution
of a demand for appraisal should be made by or for the
fiduciary; and if the shares are owned of record by more than
one person, as in a joint tenancy or tenancy in common, the
demand should be executed by or for all joint owners. An
authorized agent, including an authorized agent for two or
93
more joint owners, may execute the demand for appraisal for a
stockholder of record; however, the agent must identify the
record owner or owners and expressly disclose the fact that, in
executing the demand, he or she is acting as agent for the
record owner. A record owner, such as a broker, who holds shares
as a nominee for others, may exercise his or her right of
appraisal with respect to the shares held for one or more
beneficial owners, while not exercising this right for other
beneficial owners. In that case, the written demand should state
the number of shares as to which appraisal is sought. Where no
number of shares is expressly mentioned, the demand will be
presumed to cover all shares held in the name of the record
owner.
If you hold your shares of common stock in a brokerage
account or in other nominee form and you wish to exercise
appraisal rights, you should consult with your broker or the
other nominee to determine the appropriate procedures for the
making of a demand for appraisal by the nominee.
Within ten days after the effective time of the Merger, the
surviving corporation must give written notice that the Merger
has become effective to each stockholder who has properly filed
a written demand for appraisal and who did not vote in favor of
the Merger Agreement. At any time within 60 days after the
effective time, any stockholder who has demanded an appraisal
has the right to withdraw the demand and to accept the cash
payment specified by the Merger Agreement for his or her shares
of common stock. Within 120 days after the effective date
of the Merger, any stockholder who has complied with
Section 262 will, upon written request to the surviving
corporation, be entitled to receive a written statement setting
forth the aggregate number of shares not voted in favor of the
Merger Agreement and with respect to which demands for appraisal
rights have been received and the aggregate number of holders of
such shares. Such written statement will be mailed to the
requesting stockholder within ten days after such written
request is received by the surviving corporation or within ten
days after expiration of the period for delivery of demands for
appraisal, whichever is later. Within 120 days after the
effective time, either the surviving corporation or any
stockholder who has complied with the requirements of
Section 262 may file a petition in the Delaware Court of
Chancery demanding a determination of the fair value of the
shares held by all stockholders entitled to appraisal. Upon the
filing of the petition by a stockholder, service of a copy of
such petition shall be made upon the surviving corporation. We
have no present obligation or intention to file such a petition
or to initiate negotiations in the event there are dissenting
stockholders. Accordingly, the failure of a stockholder to file
such a petition within the period specified could nullify the
stockholders previously written demand for appraisal.
If a petition for appraisal is duly filed by a stockholder and a
copy of the petition is delivered to the surviving corporation,
the surviving corporation will then be obligated, within
20 days after receiving service of a copy of the petition,
to file in the office of the Register in Chancery in which the
petition was filed a duly verified list containing the names and
addresses of all stockholders who have demanded an appraisal of
their shares and with whom agreements as to the value of their
shares have not been reached by the surviving corporation. After
notice to dissenting stockholders who demanded appraisal of
their shares, the Delaware Court of Chancery is empowered to
conduct a hearing upon the petition, and to determine those
stockholders who have complied with Section 262 and who
have become entitled to the appraisal rights provided by
Section 262. The Delaware Court of Chancery may require the
stockholders who have demanded appraisal for their shares to
submit their stock certificates to the Register in Chancery for
notation thereon of the pendency of the appraisal proceedings;
and if any stockholder fails to comply with that direction, the
Delaware Court of Chancery may dismiss the proceedings as to
that stockholder.
After determination of the stockholders entitled to appraisal of
their shares of common stock, the Delaware Court of Chancery
will appraise the shares, determining their fair value exclusive
of any element of value arising from the accomplishment or
expectation of the Merger, together with a fair rate of
interest, if any. When the value is determined, the Delaware
Court of Chancery will direct the payment of such value, with
interest thereon accrued during the pendency of the proceeding,
if the Delaware Court of Chancery so determines, to the
stockholders entitled to receive the same, upon surrender by
such holders of the certificates representing those shares.
In determining fair value, and, if applicable, a fair rate of
interest, the Delaware Court of Chancery is required to take
into account all relevant factors. In Weinberger v. UOP,
Inc., the Delaware Supreme Court discussed the factors that
could be considered in determining fair value in an appraisal
proceeding, stating that proof of value by any techniques
or methods which are generally considered acceptable in the
financial community and otherwise admissible in court
should be considered, and that fair price obviously
requires consideration of all relevant factors involving the
value of a company.
94
You should be aware that the fair value of your shares as
determined under Section 262 could be more than, the same
as, or less than the value that you are entitled to receive
under the terms of the Merger Agreement. You should also be
aware that investment banking opinions as to the fairness from a
financial point of view of the consideration payable in a merger
are not opinions as to fair value under Section 262.
Costs of the appraisal proceeding may be imposed upon the
surviving corporation and the stockholders participating in the
appraisal proceeding by the Delaware Court of Chancery as the
Court deems equitable in the circumstances. Upon the application
of a stockholder, the Delaware Court of Chancery may order all
or a portion of the expenses incurred by any stockholder in
connection with the appraisal proceeding, including, without
limitation, reasonable attorneys fees and the fees and
expenses of experts, to be charged pro-rata against the value of
all shares entitled to appraisal. Any stockholder who had
demanded appraisal rights will not, after the effective time of
the Merger, be entitled to vote shares subject to that demand
for any purpose or to receive payments of dividends or any other
distribution with respect to those shares, other than with
respect to payment as of a record date prior to the effective
time; however, if no petition for appraisal is filed within
120 days after the effective time of the Merger, or if the
stockholder delivers a written withdrawal of his or her demand
for appraisal and an acceptance of the terms of the Merger
within 60 days after the effective time of the Merger, then
the right of that stockholder to appraisal will cease and that
stockholder will be entitled to receive the cash payment for
shares of his, her or its common stock pursuant to the Merger
Agreement. Any withdrawal of a demand for appraisal made more
than 60 days after the effective time of the Merger may
only be made with the written approval of the surviving
corporation and must, to be effective, be made within
120 days after the effective time.
In view of the complexity of Section 262, stockholders
who may wish to dissent from the Merger and pursue appraisal
rights should consult their legal advisors.
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS, DIRECTORS
AND EXECUTIVE OFFICERS
Ownership
of Common Stock by Certain Beneficial Owners
The following table sets forth certain information with respect
to beneficial ownership of our common stock as of
December 27, 2010, unless otherwise set forth below, for:
(1) each person or entity known to L-1 to be the beneficial
owner of more than 5% of the outstanding shares of our common
stock, (2) each of our directors, (3) each of our
named executive officers and (4) all of our executive
officers and directors as a group. Unless otherwise indicated,
the percentage ownership of common stock is based on the number
of shares outstanding as of December 27, 2010 of
93,623,464. Unless otherwise indicated below, the business
address of each person and entity listed is
c/o L-1
Identity Solutions, Inc., 177 Broad Street, Stamford, CT 06901
In general, beneficial ownership means the sole or
shared power to vote, or to direct the voting of, a security, or
the sole or shared investment power with respect to a security
(i.e., the power to dispose of, or to direct the disposition of,
a security). In addition, under SEC rules, a person is deemed,
as of any date, to have beneficial ownership of any
security that such person has the right to acquire within
60 days after such date. The number of shares beneficially
owned by each stockholder is determined according to the rules
of the SEC, and the information is not necessarily indicative of
beneficial ownership for any other purpose. Under current rules,
beneficial ownership includes any shares as to which the
individual or entity has sole or shared voting power or
investment power. As a consequence, several persons may be
deemed to be the beneficial owners of the same
shares.
95
|
|
|
|
|
|
|
|
|
|
|
Securities Beneficially Owned
|
|
|
|
Shares
|
|
|
Percentage of
|
|
Name and Address of Beneficial Owner
|
|
Beneficially Owned
|
|
|
Shares Outstanding
|
|
|
Principal Securityholders
|
|
|
|
|
|
|
|
|
Safran SA(1)
|
|
|
13,744,662
|
|
|
|
14.59
|
%
|
2, boulevard du Général Martial Valin
75724 Paris Cedex 15
France
+33 14 0 60 84 28
|
|
|
|
|
|
|
|
|
Iridian Asset Management LLC(2)
|
|
|
7,662,846
|
|
|
|
8.18
|
%
|
276 Post Road West
Westport, CT 06880
|
|
|
|
|
|
|
|
|
Aston Capital Partners L.P.(3)
|
|
|
7,619,047
|
|
|
|
8.14
|
%
|
L-1 Investment Partners, LLC(4)
|
|
|
7,619,047
|
|
|
|
8.14
|
%
|
Dimensional Fund Advisors LP(5)
|
|
|
5,183,234
|
|
|
|
5.54
|
%
|
6300 Bee Cave Road
Building One
Austin, TX 78746
|
|
|
|
|
|
|
|
|
MHR Institutional Partners III LP(6)
|
|
|
4,859,112
|
|
|
|
5.19
|
%
|
40 West 57th Street, 24th Floor
New York, NY 10019
|
|
|
|
|
|
|
|
|
Directors
|
|
|
|
|
|
|
|
|
B.G. Beck(7)
|
|
|
1,128,420
|
|
|
|
1.21
|
%
|
Milton E. Cooper(8)
|
|
|
132,287
|
|
|
|
*
|
|
Robert S. Gelbard(9)
|
|
|
54,932
|
|
|
|
*
|
|
Malcolm J. Gudis(10)
|
|
|
103,907
|
|
|
|
*
|
|
John E. Lawler(11)
|
|
|
108,082
|
|
|
|
*
|
|
James M. Loy(12)
|
|
|
48,417
|
|
|
|
*
|
|
Harriet Mouchly-Weiss(13)
|
|
|
76,925
|
|
|
|
*
|
|
Peter Nessen(14)
|
|
|
80,096
|
|
|
|
*
|
|
B. Boykin Rose(15)
|
|
|
48,417
|
|
|
|
*
|
|
Named Executive Officers
|
|
|
|
|
|
|
|
|
Robert V. LaPenta(16)
|
|
|
13,744,662
|
|
|
|
14.59
|
%
|
Chairman, President, and Chief Executive Officer
|
|
|
|
|
|
|
|
|
James DePalma(17)
|
|
|
8,164,509
|
|
|
|
8.69
|
%
|
Executive Vice President, Chief Financial Officer and
Treasurer
|
|
|
|
|
|
|
|
|
Joseph Atick(18)
|
|
|
1,450,577
|
|
|
|
1.54
|
%
|
Executive Vice President, Chief Strategy Officer
|
|
|
|
|
|
|
|
|
Mark S. Molina(19)
|
|
|
554,527
|
|
|
|
*
|
|
Executive Vice President, Chief Legal Officer and
Secretary
|
|
|
|
|
|
|
|
|
Joseph Paresi(20)
|
|
|
7,963,815
|
|
|
|
8.49
|
%
|
Executive Vice President, Chief Marketing Officer
|
|
|
|
|
|
|
|
|
All directors and executive officers as a group(21)
(16 persons)
|
|
|
18,962,968
|
|
|
|
19.64
|
%
|
|
|
|
* |
|
indicates less than 1%. |
|
(1) |
|
Based solely on the Schedule 13D filed by Safran, Safran
USA, Inc. and Laser Acquisition Sub Inc. on September 19,
2010 and the information set forth below, consists of
13,744,662 shares of common stock beneficially owned by
Aston and Mr. LaPenta, over which the reporting person may
be deemed to have beneficial ownership by virtue of certain
provisions of the Voting and Support Agreement. See the section
of this proxy statement entitled Voting and
Support Agreement. |
|
(2) |
|
Based solely on the Schedule 13G/A filed by Iridian Asset
Management LLC (which we refer to in this proxy statement as
Iridian), David L. Cohen and Harold J. Levy on January 28,
2010. According to the 13G/A, effective June 30, 2009
Messrs. Cohen and Levy indirectly acquired ownership and
control of 100% of the |
96
|
|
|
|
|
equity interest of Iridian from BIAM (US) Inc., an indirectly
wholly owned subsidiary of the Governor and Company of the Bank
of Ireland. Thus, on that date, Messrs. Cohen and Levy may
be deemed to have acquired beneficial ownership of all shares of
common stock beneficially owned by Iridian. Iridian is majority
owned by Arovid Associates LLC, a Delaware limited liability
company owned and controlled by the following: 12.5% by
Mr. Cohen, 12.5% by Mr. Levy, 37.5% by LLMD LLC, a
Delaware limited liability company, and 37.5% by ALHERO LLC, a
Delaware limited liability company. LLMD LLC is owned 1% by
Mr. Cohen and 99% by a family trust controlled by
Mr. Cohen. ALHERO LLC is owned 1% by Mr. Levy and 99%
by a family trust controlled by Mr. Levy. |
|
(3) |
|
The ultimate controlling persons of Aston Capital Partners L.P.
are Robert V. LaPenta, James A. DePalma, Doni L. Fordyce and
Joseph Paresi, (each of whom is an executive officer of the
Company), a managing member of L-1 Investment Partners LLC, the
investment manager of Aston Capital Partners L.P., and a
managing member of Aston Capital Partners GP LLC, the general
partner of Aston Capital Partners L.P. |
|
(4) |
|
Comprised of 7,619,047 shares of common stock held by Aston
Capital Partners L.P., of which L-1 Partners is the investment
manager. |
|
(5) |
|
Based solely on the Schedule 13G/A filed by Dimensional
Fund Advisors LP (which we refer to in this proxy statement
as Dimensional) on February 8, 2010. According to the
13G/A, in its role as investment advisor
sub-advisor
or investment manager, neither Dimensional nor its subsidiaries
possess voting and/or investment power over shares of common
stock owned by Dimensional, its subsidiaries, trusts and
accounts. According to the 13G/A, Dimensional disclaims
beneficial ownership of such shares. |
|
(6) |
|
Based solely on the Schedule 13G filed by MHR Institutional
Partners III LP (which we refer to in this proxy statement
as MHR) on February 13, 2009. According to the 13G, MHR
Institutional Advisors III LLC (which we refer to in this
proxy statement as MHR GP) is a Delaware limited liability
company that is the general partner of MHR and, in such
capacity, may be deemed to beneficially own the shares of common
stock held for the account of MHR. According to the 13G, MHR
Fund Management LLC (which we refer to in this proxy
statement as MHR Fund) is a Delaware limited liability company
that is an affiliate of and has an investment management
agreement with MHR, and other affiliated entities, pursuant to
which it has the power to vote or direct the vote and to dispose
or to direct the disposition of the shares of common stock held
for the account of MHR and, accordingly, it may be deemed to
beneficially own the shares of common stock held for the account
of MHR. According to the 13G, Dr. Mark H. Rachesky is the
managing member of MHR GP and MHR Fund and, in such capacity,
may be deemed to beneficially own the shares of common stock
held for the account of MHR. |
|
|
|
(7) |
|
Includes 13,000 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(8) |
|
Includes 85,140 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(9) |
|
Includes 15,000 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(10) |
|
Includes 56,760 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(11) |
|
Includes 49,665 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(12) |
|
Includes 25,000 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(13) |
|
Includes 32,667 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(14) |
|
Includes 38,500 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
|
|
|
(15) |
|
Includes 25,000 shares of common stock issuable pursuant to
stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. |
97
|
|
|
(16) |
|
Includes 580,132 shares of common stock issuable pursuant
to stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date and units in the L-1 Identity Solutions, Inc. 401(k) Plan
representing 3,063 shares of common stock. Also includes
7,619,047 shares of common stock held by Aston.
Mr. LaPenta is a managing member of L-1 Partners.
Mr. LaPenta disclaims beneficial ownership of the shares
held by Aston. |
|
|
|
(17) |
|
Includes 345,180 shares of common stock issuable pursuant
to stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date and units in the L-1 Identity Solutions, Inc. 401(k) Plan
representing 3,284 shares of common stock. Also includes
7,619,047 shares of common stock held by Aston.
Mr. DePalma is a managing member of L-1 Partners.
Mr. DePalma disclaims beneficial ownership of the shares
held by Aston. |
|
|
|
(18) |
|
Includes 684,829 shares of common stock issuable pursuant
to stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date and units in the L-1 Identity Solutions, Inc. 401(k) Plan
representing 3,474 shares of common stock. |
|
|
|
(19) |
|
Includes 423,224 shares of common stock issuable pursuant
to stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date and units in the L-1 Identity Solutions, Inc. 401(k) Plan
representing 5,572 shares of common stock. |
|
|
|
(20) |
|
Includes 207,107 shares of common stock issuable pursuant
to stock options which were exercisable as of December 27,
2010, or which become exercisable within 60 days of such
date. Also includes 7,619,047 shares of common stock held
by Aston. Mr. Paresi is a managing member of L-1 Partners.
Mr. Paresi disclaims beneficial ownership of the shares
held by Aston. |
|
|
|
(21) |
|
Consists of 2,934,711 shares of common stock issuable
pursuant to stock options which were exercisable as of
December 27, 2010, or which become exercisable within
60 days of such date, and 16,028,257 shares of common
stock held by the executive officers and directors as a group
and deemed to be beneficially held by the directors and
executive officers as a group, including 7,619,047 shares
of common stock held by Aston. |
MARKET
PRICE OF THE COMPANY
COMMON STOCK AND DIVIDEND INFORMATION
Our common stock is traded on the New York Stock Exchange under
the trading symbol ID. The following table sets
forth, for the indicated calendar periods, the daily high and
low sales prices of our common stock as reported by the New York
Stock Exchange:
|
|
|
|
|
|
|
|
|
|
|
High
|
|
Low
|
|
Fiscal Year Ending December 31, 2010:
|
|
|
|
|
|
|
|
|
Fourth Quarter (through December 28, 2010)
|
|
|
11.95
|
|
|
|
11.73
|
|
Third Quarter
|
|
|
11.75
|
|
|
|
7.11
|
|
Second Quarter
|
|
|
9.06
|
|
|
|
6.78
|
|
First Quarter
|
|
|
9.46
|
|
|
|
6.96
|
|
Fiscal Year Ending December 31, 2009:
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
|
7.90
|
|
|
|
5.67
|
|
Third Quarter
|
|
|
8.64
|
|
|
|
6.74
|
|
Second Quarter
|
|
|
9.50
|
|
|
|
4.93
|
|
First Quarter
|
|
|
8.16
|
|
|
|
3.23
|
|
Fiscal Year Ended December 31, 2008
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
|
15.28
|
|
|
|
4.33
|
|
Third Quarter
|
|
|
17.22
|
|
|
|
11.66
|
|
Second Quarter
|
|
|
16.02
|
|
|
|
12.77
|
|
First Quarter
|
|
|
18.54
|
|
|
|
10.66
|
|
98
We paid no dividends in 2008, 2009 or, as of the date of this
proxy statement, in 2010. We presently intend to retain any cash
for use in the operation and expansion of our business and,
therefore, do not anticipate paying any cash dividends in the
foreseeable future. In addition, we are prohibited from paying
dividends pursuant to our credit agreement with Bank of America,
N.A.
Our common stock is listed on the New York Stock Exchange under
the trading symbol ID. The closing sale price of our
common stock on the New York Stock Exchange on
September 17, 2010, the last trading day prior to
announcement of the execution of the Merger Agreement, was $9.70
per share. The closing sale price of our common stock on the New
York Stock Exchange was $7.23 on January 5, 2010, the
trading day prior to our public announcement of the strategic
alternatives review process. On December 28, 2010, which is
the most recent practicable date prior to the date of this proxy
statement, the closing sale price of our common stock was $11.90
per share. You are encouraged to obtain current market
quotations for L-1 common stock.
FUTURE
STOCKHOLDER PROPOSALS
If the Merger is completed, we will have no public stockholders
and there will be no public participation in any of our future
stockholder meetings. We intend to hold the 2011 Annual Meeting
of Stockholders (which we refer to in this proxy statement as
the 2011 Annual Meeting) only if the Merger is not completed.
If a stockholder wishes to submit a proposal for inclusion in
the proxy statement and form of proxy for the 2011 Annual
Meeting of Stockholders, in accordance with
Rule 14a-8
under the Exchange Act, such proposal must have been received by
the Company at its principal executive offices not later than
November 16, 2010. To properly present matters outside the
Rule 14a-8
process or to nominate directors at the 2011 Annual Meeting of
Stockholders, stockholders must comply with the advance notice
requirements contained in the Companys by-laws. Such
notices must be received by the Company not earlier than
January 5, 2011 nor later than February 19, 2011
(unless the 2011 Annual Meeting of Stockholders is held on
a date more than 7 days prior to May 5, 2011) and
must include the specified information concerning the proposal
or nominee as described in the Companys by-laws.
HOUSEHOLDING
OF SPECIAL MEETING MATERIALS
Some banks, brokers, and other nominee record holders may be
participating in the practice of householding proxy
statements and annual reports. This means that only one copy of
this notice and proxy statement may have been sent to multiple
stockholders in your household unless we have received contrary
instructions. If you would prefer to receive separate copies of
a proxy statement or annual report either now or in the future,
please contact Computershare Inc., at
(877) 282-1168
or by writing to Computershare Inc., at 250 Royall Street,
Canton, Massachusetts 02021. Upon written or oral request, we
will promptly provide a separate copy of the annual reports and
proxy statements. In addition, stockholders sharing an address
can request delivery of a single copy of annual reports or proxy
statements if you are receiving multiple copies upon written or
oral request to our Secretary at 177 Broad Street,
Stamford, Connecticut 06901, telephone
(203) 504-1109.
OTHER
MATTERS
At this time, we know of no other matters to be submitted to our
stockholders at the special meeting or any adjournment or
postponement of the special meeting. If any other matters
properly come before the special meeting or at any adjournment
or postponement of the special meeting, it is the intention of
the persons named in the enclosed proxy card to vote the shares
they represent in accordance with their best judgment.
WHERE YOU
CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements
and other information with the SEC. You may read and copy any
document we file at the SECs public reference room located
at 100 F Street, N.E., Room 1580,
Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330
for further information on the public reference room. Our SEC
filings are also available to the public at the SECs
website at
http://www.sec.gov.
You also may obtain free copies of the documents we file with
the SEC by going to the Investor Relations section of our
website at
99
http://www.L1id.com.
The information provided on our website is not part of this
proxy statement, and therefore is not incorporated by reference.
Any person, including any beneficial owner, to whom this proxy
statement is delivered may request copies of proxy statements
and any of the documents incorporated by reference in this
document or other information concerning us, without charge, by
written or telephonic request directed to L-1 Identity
Solutions, Inc., 177 Broad Street, Stamford, Connecticut 06901,
Attention: Investor Relations, telephone
(203) 504-1109,
or on our website at
http://www.L1id.com
or from the SEC through the SECs website at
http://www.sec.gov.
Documents incorporated by reference are available without
charge, excluding any exhibits to those documents unless the
exhibit is specifically incorporated by reference into those
documents.
Safran has supplied all information pertaining to Safran and
Merger Sub in this proxy statement and we have supplied all
information pertaining to us.
THIS PROXY STATEMENT DOES NOT CONSTITUTE THE SOLICITATION OF A
PROXY IN ANY JURISDICTION TO OR FROM ANY PERSON TO WHOM OR FROM
WHOM IT IS UNLAWFUL TO MAKE SUCH PROXY SOLICITATION IN THAT
JURISDICTION. YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED
OR INCORPORATED BY REFERENCE IN THIS PROXY STATEMENT TO VOTE
YOUR SHARES AT THE SPECIAL MEETING. WE HAVE NOT AUTHORIZED
ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM
WHAT IS CONTAINED IN THIS PROXY STATEMENT.
INCORPORATION
BY REFERENCE
The SEC allows us to incorporate by reference certain
information into this proxy statement. This means that we can
disclose important information to you by referring you to
another document filed separately with the SEC. The information
incorporated by reference is considered to be a part of this
proxy statement, and later information that we file with the SEC
will update and supersede that information. We incorporate by
reference the documents listed below and any documents filed by
us pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Exchange Act after the date of this proxy statement and prior to
the date of the special meeting:
|
|
|
L-1 Identity Solutions, Inc. Filings:
|
|
Periods/Report Dates:
|
|
Annual Report on
Form 10-K
|
|
Year ended December 31, 2009, as amended by Form 10-K/A filed on
July 2, 2010
|
Quarterly Reports on
Form 10-Q
|
|
Quarters ended March 31, 2010, June 30, 2010 and September 30,
2010
|
Current Reports on
Form 8-K
|
|
December 15, 2010
|
|
|
November 17, 2010
|
|
|
September 21, 2010
|
|
|
September 20, 2010
|
|
|
August 31, 2010
|
|
|
May 7, 2010
|
Notwithstanding the foregoing, information furnished under
items 2.02 and 7.01 of any Current Report on
Form 8-K,
including the related exhibits, is not incorporated by reference
in this proxy statement.
Any person, including any beneficial owner, to whom this proxy
statement is delivered may request copies of reports, proxy
statements or other information concerning us, without charge,
as described in the section of this proxy statement entitled
Where You Can Find More Information.
We have not authorized anyone to provide information that is
different from what is contained in this proxy statement and, if
given, such information must not be relied upon as having been
authorized by us or any other person.
THIS PROXY STATEMENT IS DATED JANUARY 3, 2011. YOU SHOULD
NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS PROXY
STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT DATE OR
SUCH OTHER DATE AS MAY BE SPECIFIED HEREIN, AND THE MAILING OF
THIS PROXY STATEMENT TO STOCKHOLDERS DOES NOT CREATE ANY
IMPLICATION TO THE CONTRARY.
100
|
|
|
|
|
|
|
ARTICLE I
DEFINITIONS AND TERMS
|
Section 1.1
|
|
Definitions
|
|
|
A-1
|
|
Section 1.2
|
|
Other Definitional Provisions; Interpretation
|
|
|
A-9
|
|
|
ARTICLE IITHE MERGER
|
Section 2.1
|
|
The Merger
|
|
|
A-10
|
|
Section 2.2
|
|
Effective Time
|
|
|
A-10
|
|
Section 2.3
|
|
Closing
|
|
|
A-10
|
|
Section 2.4
|
|
Certificate of Incorporation and Bylaws of the Surviving
Corporation
|
|
|
A-10
|
|
Section 2.5
|
|
Directors and Officers of the Surviving Corporation and its
Subsidiaries
|
|
|
A-10
|
|
|
ARTICLE III
CONVERSION OF SHARES
|
Section 3.1
|
|
Conversion of Shares
|
|
|
A-11
|
|
Section 3.2
|
|
Exchange of Certificates Representing Shares
|
|
|
A-11
|
|
Section 3.3
|
|
Stock Options and Other Equity-Based Awards; Long Term Cash
Awards; Warrants
|
|
|
A-13
|
|
Section 3.4
|
|
Adjustments
|
|
|
A-14
|
|
Section 3.5
|
|
Dissenting Shares
|
|
|
A-14
|
|
|
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
|
Section 4.1
|
|
Organization and Good Standing
|
|
|
A-14
|
|
Section 4.2
|
|
Capitalization; Subsidiaries
|
|
|
A-15
|
|
Section 4.3
|
|
Authorization; No Conflict
|
|
|
A-16
|
|
Section 4.4
|
|
Governmental Consents
|
|
|
A-17
|
|
Section 4.5
|
|
SEC Reports
|
|
|
A-17
|
|
Section 4.6
|
|
Internal Controls; Sarbanes-Oxley Act
|
|
|
A-18
|
|
Section 4.7
|
|
No Undisclosed Liabilities
|
|
|
A-18
|
|
Section 4.8
|
|
Absence of Certain Changes
|
|
|
A-18
|
|
Section 4.9
|
|
Employee Benefit Plans; ERISA
|
|
|
A-18
|
|
Section 4.10
|
|
Litigation
|
|
|
A-20
|
|
Section 4.11
|
|
Permits; Compliance with Law
|
|
|
A-20
|
|
Section 4.12
|
|
Taxes
|
|
|
A-21
|
|
Section 4.13
|
|
Intellectual Property
|
|
|
A-21
|
|
Section 4.14
|
|
Leasehold Real Property
|
|
|
A-23
|
|
Section 4.15
|
|
Labor Matters
|
|
|
A-23
|
|
Section 4.16
|
|
Information Supplied
|
|
|
A-23
|
|
Section 4.17
|
|
Takeover Laws
|
|
|
A-23
|
|
Section 4.18
|
|
Contracts
|
|
|
A-24
|
|
Section 4.19
|
|
Government Contracts
|
|
|
A-25
|
|
Section 4.20
|
|
Security Clearances
|
|
|
A-25
|
|
Section 4.21
|
|
Export Controls
|
|
|
A-25
|
|
Section 4.22
|
|
International Trade Laws and Regulations
|
|
|
A-26
|
|
A-ii
|
|
|
|
|
|
|
Section 4.23
|
|
Voting Requirements
|
|
|
A-26
|
|
Section 4.24
|
|
Identity Business Assets and Liabilities
|
|
|
A-26
|
|
Section 4.25
|
|
Brokers or Finders
|
|
|
A-26
|
|
Section 4.26
|
|
Opinion of Financial Advisor
|
|
|
A-26
|
|
Section 4.27
|
|
Agreements with Intel Buyer
|
|
|
A-26
|
|
Section 4.28
|
|
Transferred Intel Companies
|
|
|
A-26
|
|
Section 4.29
|
|
No Other Representations
|
|
|
A-27
|
|
|
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
|
Section 5.1
|
|
Organization and Good Standing
|
|
|
A-27
|
|
Section 5.2
|
|
Authorization; Validity of Agreement; Necessary Action
|
|
|
A-27
|
|
Section 5.3
|
|
Consents and Approvals; No Violations
|
|
|
A-27
|
|
Section 5.4
|
|
Merger Subs Operations
|
|
|
A-28
|
|
Section 5.5
|
|
Information Supplied
|
|
|
A-28
|
|
Section 5.6
|
|
Sufficient Funds
|
|
|
A-28
|
|
Section 5.7
|
|
Share Ownership
|
|
|
A-28
|
|
Section 5.8
|
|
Investigation by Parent and Merger Sub
|
|
|
A-28
|
|
Section 5.9
|
|
Litigation
|
|
|
A-29
|
|
Section 5.10
|
|
Brokers or Finders
|
|
|
A-29
|
|
Section 5.11
|
|
Agreements with Intel Buyer
|
|
|
A-29
|
|
|
ARTICLE VICOVENANTS
|
Section 6.1
|
|
Interim Operations of the Company
|
|
|
A-29
|
|
Section 6.2
|
|
Notification of Certain Matters
|
|
|
A-32
|
|
Section 6.3
|
|
Access to Information
|
|
|
A-32
|
|
Section 6.4
|
|
Acquisition Proposals
|
|
|
A-33
|
|
Section 6.5
|
|
Employee Benefits
|
|
|
A-35
|
|
Section 6.6
|
|
Publicity
|
|
|
A-36
|
|
Section 6.7
|
|
Directors and Officers Insurance and Indemnification
|
|
|
A-37
|
|
Section 6.8
|
|
Company Special Meeting; Proxy Statement
|
|
|
A-38
|
|
Section 6.9
|
|
Appropriate Actions
|
|
|
A-39
|
|
Section 6.10
|
|
Merger Sub and Surviving Corporation
|
|
|
A-41
|
|
Section 6.11
|
|
No Control of Other Partys Business
|
|
|
A-41
|
|
Section 6.12
|
|
Certain Tax Matters
|
|
|
A-41
|
|
Section 6.13
|
|
Stockholder Litigation
|
|
|
A-41
|
|
Section 6.14
|
|
Section 16 Matters
|
|
|
A-41
|
|
Section 6.15
|
|
Voting of Shares
|
|
|
A-42
|
|
Section 6.16
|
|
Convertible Notes
|
|
|
A-42
|
|
Section 6.17
|
|
Intel Business Cash and Indebtedness
|
|
|
A-42
|
|
Section 6.18
|
|
Intel Purchase Agreement; Intel Transaction Matters
|
|
|
A-42
|
|
A-iii
|
|
|
|
|
|
|
Section 6.19
|
|
Conversion Transactions
|
|
|
A-43
|
|
Section 6.20
|
|
Basis Study
|
|
|
A-43
|
|
|
ARTICLE VIICONDITIONS
|
Section 7.1
|
|
Conditions to the Obligations of Each Party to Effect the Merger
|
|
|
A-43
|
|
Section 7.2
|
|
Additional Conditions to Obligations of Parent and Merger Sub to
Effect the Merger
|
|
|
A-44
|
|
Section 7.3
|
|
Additional Conditions to Obligations of the Company to Effect
the Merger
|
|
|
A-45
|
|
Section 7.4
|
|
Frustration of Conditions
|
|
|
A-45
|
|
|
ARTICLE VIIITERMINATION
|
Section 8.1
|
|
Termination
|
|
|
A-45
|
|
Section 8.2
|
|
Effect of Termination
|
|
|
A-47
|
|
Section 8.3
|
|
Certain Substitution Rights
|
|
|
A-48
|
|
|
ARTICLE IX
MISCELLANEOUS
|
Section 9.1
|
|
Amendment and Modification
|
|
|
A-49
|
|
Section 9.2
|
|
Nonsurvival of Representations and Warranties
|
|
|
A-49
|
|
Section 9.3
|
|
Notices
|
|
|
A-49
|
|
Section 9.4
|
|
Interpretation
|
|
|
A-50
|
|
Section 9.5
|
|
Counterparts
|
|
|
A-50
|
|
Section 9.6
|
|
Entire Agreement; Third-Party Beneficiaries
|
|
|
A-50
|
|
Section 9.7
|
|
Severability
|
|
|
A-51
|
|
Section 9.8
|
|
Governing Law
|
|
|
A-51
|
|
Section 9.9
|
|
Jurisdiction
|
|
|
A-51
|
|
Section 9.10
|
|
Service of Process
|
|
|
A-51
|
|
Section 9.11
|
|
Waiver of Jury Trial
|
|
|
A-51
|
|
Section 9.12
|
|
Specific Performance
|
|
|
A-51
|
|
Section 9.13
|
|
Assignment
|
|
|
A-52
|
|
Section 9.14
|
|
Expenses
|
|
|
A-52
|
|
Section 9.15
|
|
Waivers
|
|
|
A-52
|
|
|
|
|
|
|
|
|
Annex A
|
|
Foreign Filings and Approvals
|
|
|
|
|
Exhibit A
|
|
Intel Purchase Agreement
|
|
|
|
|
Exhibit B
|
|
Certificate of Incorporation
|
|
|
|
|
Exhibit C
|
|
Bylaws
|
|
|
|
|
A-iv
AGREEMENT
AND PLAN OF MERGER
AGREEMENT AND PLAN OF MERGER, dated as of September 19,
2010 (this Agreement), by and among L-1
Identity Solutions, Inc., a Delaware corporation (the
Company), Safran SA, a French
société anonyme (Parent),
and Laser Acquisition Sub Inc., a Delaware corporation and
wholly owned Subsidiary of Parent (Merger
Sub).
WHEREAS, the respective Boards of Directors of the Company and
Merger Sub have unanimously approved this Agreement and resolved
that the transactions contemplated by this Agreement (including
the consummation of the merger of Merger Sub with and into the
Company, with the Company continuing as the surviving
corporation (the Merger), upon the terms and
subject to the conditions set forth in this Agreement and in
accordance with the relevant provisions of the General
Corporation Law of the State of Delaware
(DGCL)), are advisable and in the best
interests of their respective stockholders;
WHEREAS, the Board of Directors of Parent has approved this
Agreement and authorized the consummation of the transactions
contemplated by this Agreement;
WHEREAS, the Board of Directors of the Company unanimously
resolved to recommend that its stockholders approve the Merger
and this Agreement and the transactions contemplated by this
Agreement, in each case, upon the terms and subject to the
conditions set forth in this Agreement;
WHEREAS, Parent has required, as a condition to its willingness
to enter into this Agreement, that Robert V. LaPenta and
Aston Capital Partners L.P. (the Principal
Stockholders) each enter into a Voting and Support
Agreement, dated as of the date hereof (the Support
Agreement), simultaneously herewith, pursuant to
which, among other things, the Principal Stockholders have
agreed to vote to adopt this Agreement and take certain other
actions in furtherance of the Merger, in each case on the terms
and subject to the conditions provided for in the Support
Agreement, and in order to induce Parent and Merger Sub to enter
into this Agreement, the Board of Directors of the Company has
approved the execution and delivery of the Support Agreement by
the Principal Stockholders; and
WHEREAS, concurrently with the execution of this Agreement, the
Company and BAE Systems Information Solutions Inc., a Virginia
corporation (Intel Buyer), are entering into
a Purchase Agreement, dated as of the date of this Agreement
(together with all annexes and exhibits thereto, the
Intel Purchase Agreement), a copy of which is
attached as Exhibit A to this Agreement, pursuant to
which, at the Intel Closing, which is expected to occur prior to
the Closing, Intel Buyer will, upon the terms and subject to the
conditions set forth in the Intel Purchase Agreement, acquire
from L-1 Identity Solutions Operating Company, a Delaware
corporation and a wholly owned Subsidiary of the Company, and
the Company will cause to be sold to Intel Buyer (the
Intel Transaction), all of the issued and
outstanding shares of capital stock or membership interests (as
applicable) of each of McClendon, LLC, SpecTal, LLC and Advanced
Concepts, Inc. (the Transferred Intel
Companies), which entities, together with Patriot, LLC
(Patriot and, collectively with the
Transferred Intel Companies, the Intel
Companies) comprise the Intel Business of the Company.
NOW, THEREFORE, in consideration of the foregoing and the
representations, warranties, covenants and agreements set forth
herein, and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties
hereto, intending to be legally bound hereby, agree as follows:
ARTICLE I
DEFINITIONS
AND TERMS
Section 1.1 Definitions. As
used in this Agreement, the following terms shall have the
meanings set forth below:
6.9(a)(1) Contract has the meaning set
forth in Section 6.9(a).
Acquisition Proposal means any
proposal or offer made by any Person (other than Parent, Merger
Sub or any Affiliate thereof) to purchase or otherwise acquire,
directly or indirectly, in one transaction or a series of
related transactions, (i) beneficial ownership (as defined
under Section 13(d) of the Exchange Act) of twenty
A-1
percent (20%) or more of any class of equity securities of the
Company pursuant to a merger, consolidation or other business
combination, sale of shares of capital stock, tender offer,
exchange offer or similar transaction or (ii) any one or
more assets or businesses of the Company and its Subsidiaries
that constitute twenty percent (20%) or more of the revenues,
earnings or assets of the Company and its Subsidiaries, taken as
a whole.
Affiliate has the meaning set forth in
Rule 12b-2
under the Exchange Act.
Agreement has the meaning set forth in
the Preamble.
Basis Study Firm has the meaning set forth in
Section 6.20.
Benefit Plans has the meaning set
forth in Section 4.9(a).
Book-Entry Shares has the meaning set
forth in Section 3.1(d).
Business Day means a day other than a
Saturday, a Sunday or another day on which commercial banking
institutions in New York, New York or Paris, France are
authorized or required by Law to be closed.
Certificate of Merger has the meaning
set forth in Section 2.2(a).
Certificates has the meaning set forth
in Section 3.1(d).
CFIUS means the Committee on Foreign
Investment in the United States.
Change in Recommendation has the
meaning set forth in Section 6.4(c).
Closing has the meaning set forth in
Section 2.3.
Closing Date has the meaning set forth
in Section 2.3.
Co-Buyer Disclosure Agreement means
the Co-Buyer Disclosure Agreement, dated as of
September 13, 2010, among the Company, BAE Systems, Inc.
and Parent.
Code means the Internal Revenue Code
of 1986, as amended.
Company has the meaning set forth in
the Preamble.
Company Board Recommendation has the
meaning set forth in Section 6.8(c).
Company Deferred Stock Unit has the
meaning set forth in Section 3.3(c).
Company Disclosure Schedule means the
disclosure schedules delivered by the Company to Parent
simultaneously with the execution of this Agreement.
Company Financial Advisors means
Goldman, Sachs & Co. and Stone Key.
Company Indemnified Parties means the
D&O Indemnified Parties and the current and former
employees of the Company and its Subsidiaries (other than the
Intel Companies).
Company Intellectual Property Rights
means Intellectual Property owned by the Post-Sale Company.
Company Leases has the meaning set
forth in Section 4.14(a).
Company Material Adverse Effect means
any change, effect, event, development, state of facts,
occurrence or circumstance which, individually or in the
aggregate with all other changes, effects, events, developments,
state of facts, occurrences or circumstances, is or would
reasonably be expected to be materially adverse to the business,
assets, financial condition or results of operations of the
Post-Sale Company, taken as a whole; provided,
however, that changes, effects, events, developments,
state of facts, occurrences or circumstances to the extent
relating to or resulting from the following shall be excluded
from the determination of Company Material Adverse Effect:
(i) any change, effect or circumstance in any of the
industries or markets in which the Post-Sale Company operates;
(ii) any change in any Law or GAAP (or changes in
interpretations of any Law or GAAP) applicable to the Post-Sale
Company; (iii) changes in general economic, regulatory or
political conditions or the financial, credit or securities
markets in general (including changes in interest or exchange
rates) in any country or region in which the Post-Sale Company
conducts business; (iv) any acts of
A-2
God, natural disasters, terrorism, armed hostilities, sabotage,
war or any escalation or worsening of acts of war; (v) the
negotiation, execution, announcement, consummation or existence
of this Agreement, the Intel Purchase Agreement or the
Transactions (including the impact of any of the foregoing on
relationships with customers, suppliers, employees or regulators
and any suit, action or proceeding arising therefrom or in
connection therewith (it being understood and agreed that the
facts and circumstances that may have given rise to such suit,
action or proceeding that are not otherwise excluded from the
determination of a Company Material Adverse Effect by reason of
the exclusions to this definition may be taken into account in
determining whether there has been a Company Material Adverse
Effect); provided that, solely for the purposes of
Section 4.3(c)(iii), any contractual consequence (in
accordance with the terms of the applicable Contract) of the
execution of this Agreement or the consummation of the
Transactions shall not be excluded under this proviso);
(vi) any action taken as expressly permitted or required by
this Agreement or the Intel Purchase Agreement or with the
consent or at the direction of Parent or Merger Sub (or any
action not taken as a result of the failure of Parent to consent
to any action requiring Parents consent pursuant to
Section 6.1); and (vii) any changes in the
market price or trading volume of the Shares, any failure by the
Company or its Subsidiaries to meet internal, analysts or
other earnings estimates or financial projections or changes in
credit ratings; provided that this clause (vii)
shall not preclude any change, effect, event, development, state
of facts, occurrence or circumstance that may have contributed
to or caused such failure to the extent not otherwise excluded
from the determination of a Company Material Adverse Effect by
reason of the exclusions to this definition from being taken
into account in determining whether a Company Material Adverse
Effect has occurred (except, with respect to clauses
(i) (iv), to the extent the Post-Sale Company is
materially disproportionately adversely affected by such changes
or events relative to other participants in the industry in
which the Post-Sale Company participates, in which case only the
materially disproportionate extent of the effect may be taken
into account in determining whether a Company Material Adverse
Effect has occurred).
Company Material Contract has the
meaning set forth in Section 4.18(a).
Company Option has the meaning set
forth in Section 3.3(a).
Company Permits has the meaning set
forth in Section 4.11(a).
Company SEC Reports has the meaning
set forth in Section 4.5.
Company Special Meeting has the
meaning set forth in Section 6.8(b).
Company Stockholder Approval means the
affirmative vote (in person or by proxy), at the Company Special
Meeting, or any adjournment or postponement of the Company
Special Meeting, of the holders of a majority of the outstanding
Shares in favor of approving this Agreement.
Company Termination Fee has the
meaning set forth in Section 8.2(b).
Company Warrants has the meaning set
forth in Section 4.2(a).
Confidentiality Agreement means the
confidentiality agreement, dated May 19, 2010, between the
Company and Parent (as amended or supplemented).
Consent has the meaning set forth in
Section 4.4.
Consideration Fund has the meaning set
forth in Section 3.2(a).
Continuing Employees has the meaning
set forth in Section 6.5(a).
Contract means any contract,
subcontract, lease, sublease, conditional sales contract,
purchase order, sales order, task order, delivery order,
license, indenture, note, bond, loan, instrument, understanding,
permit, concession, franchise, commitment or other agreement.
Conversion-Eligible Subsidiaries has
the meaning set forth in Section 6.19.
Conversion Right has the meaning set
forth in Section 6.16.
Convertible Notes has the meaning set
forth in Section 4.2(a).
A-3
D&O Indemnified Parties means the
current and former directors, officers and members of the boards
of managers of the Company and its Subsidiaries (other than the
Intel Companies).
D&O Insurance has the meaning set
forth in Section 6.7(c).
DGCL has the meaning set forth in the
Recitals.
Dissenting Shares has the meaning set
forth in Section 3.5.
DoD has the meaning set forth in
Section 6.9(c).
DSS has the meaning set forth in
Section 4.20.
EAR has the meaning set forth in
Section 4.21.
Effective Time has the meaning set
forth in Section 2.2(a).
Environmental Law means any Law
relating to the protection of human health and safety (as
related to the exposure to or handling of Hazardous Materials),
the environment or natural resources including the Comprehensive
Environmental Response, Compensation and Liability Act
(42 U.S.C. § 9601 et seq.), the Hazardous
Materials Transportation Act (49 U.S.C. App.
§ 1801 et seq.), the Resource Conservation and
Recovery Act (42 U.S.C. § 6901 et seq.),
the Clean Water Act (33 U.S.C. § 1251 et
seq.), the Clean Air Act (42 U.S.C. § 7401
et seq.) the Toxic Substances Control Act (15 U.S.C.
§ 2601 et seq.), the Federal Insecticide,
Fungicide, and Rodenticide Act (7 U.S.C. § 136
et seq.), and the Occupational Safety and Health Act
(29 U.S.C. § 651 et seq.) (as related to
the exposure to or handling of Hazardous Materials), as each has
been amended and the regulations that have been promulgated
pursuant thereto.
Equity Plans has the meaning set forth
in Section 3.3(a).
ERISA has the meaning set forth in
Section 4.9(a).
ERISA Affiliate means any trade or
business, whether or not incorporated, that together with any
company would be deemed a single employer within the
meaning of Section 4001(b) of ERISA.
ESPP has the meaning set forth in
Section 3.3(g).
Exchange Act means the Securities
Exchange Act of 1934, as amended.
Exon-Florio has the meaning set forth
in Section 4.4.
Failed Buyer Substitution Notice has
the meaning set forth in Section 8.3(d).
Failed Intel Buyer Substitution Right
has the meaning set forth in Section 8.3(d).
FAR has the meaning set forth in
Section 4.4.
FCL has the meaning set forth in
Section 6.9(a).
FCPA has the meaning set forth in
Section 4.11(d).
Filings has the meaning set forth in
Section 6.9(a).
Financial Statements has the meaning
set forth in Section 4.5.
FOCI means foreign ownership, control
or influence.
Foreign Plan has the meaning set forth
in Section 4.9(a).
GAAP has the meaning set forth in
Section 4.5.
Government Contract means any
Contract, including any prime contract, subcontract, facility
contract, teaming agreement or arrangement, joint venture
agreement, basic ordering agreement, pricing agreement, letter
contract, purchase order, delivery order, task order or other
contractual arrangement of any kind, as modified by binding
modification or change orders, between the Company or any of its
Subsidiaries and (a) any Governmental Entity (acting on its
own behalf or on behalf of another country or international
A-4
organization), (b) any prime contractor of any Governmental
Entity, or (c) any subcontractor to the Company or any of
its Subsidiaries with respect to any Contract of a type
described in clauses (a) or (b) above. For purposes of
clarity, a task order, purchase order or delivery order issued
pursuant to a Government Contract shall be considered a part of
the Government Contract to which it relates.
Governmental Entity has the meaning
set forth in Section 4.4.
Hazardous Material means any
substance, material or waste that is regulated, classified, or
otherwise characterized under or pursuant to any Environmental
Law as hazardous, toxic,
pollutant, contaminant,
radioactive, or words of similar meaning or effect,
including petroleum and its by-products, asbestos,
polychlorinated biphenyls, radon, toxic mold and urea
formaldehyde insulation.
HSR Act means the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended.
Identity Business means the businesses
of the Company and its Subsidiaries, other than the Intel
Business.
Identity Companies means the Company
and all of its Subsidiaries, other than the Intel Companies.
Intel Business means the business
conducted by the Intel Companies as of the Closing Date (as
defined in the Intel Purchase Agreement).
Intel Buyer has the meaning set forth
in the Recitals.
Intel Closing means the Closing as
defined in the Intel Purchase Agreement.
Intel Companies has the meaning set
forth in the Recitals.
Intel Purchase Agreement has the
meaning set forth in the Recitals.
Intel Transaction has the meaning set
forth in the Recitals.
Intellectual Property means, in any
and all jurisdictions throughout the world, all
(i) patents, patent applications and patent disclosures,
including continuations, divisionals, reissue and reexaminations
(Patents), (ii) registered and
unregistered trademarks, trademark applications, trade names,
trade dress, service marks, logos, corporate names and Internet
domain names, together with all goodwill associated with each of
the foregoing (Trademarks),
(iii) registered and unregistered copyrights, mask works,
works of authorship, moral rights, and copyrights in Software
(Copyrights), (iv) trade secrets, and
proprietary confidential information, data, databases and
know-how (whether or not patentable and whether or not reduced
to practice) (Trade Secrets) and (v) to
the extent not included in the foregoing (i) (iv),
all other intellectual property arising from or relating to
Technology.
International Trade Laws and
Regulations means all Laws concerning the
importation of merchandise, the export or re-export of products,
services and technology, the terms and conduct of international
transactions, making or receiving international payments and the
authorization to hold an ownership interest in a business
located in a country other than the United States, including
United States Code, Title 13, Chapter 9 Collection and
Publication of Foreign Commerce and Trade Statistics
administered by the United States Census Bureau, the Tariff Act
of 1930, as amended, and other laws administered by the United
States Customs and Border Protection, regulations issued or
enforced by the United States Customs and Border Protection, the
Export Administration Act of 1979, as amended, the Export
Administration Regulations, the International Emergency Economic
Powers Act, the Arms Export Control Act, the International
Traffic in Arms Regulations, any other export controls
administered by an agency of the U.S. Government, Executive
Orders of the President regarding embargoes and restrictions on
trade with designated countries and Persons, the embargoes and
restrictions administered by the United States Office of Foreign
Assets Control, the FCPA, the antiboycott regulations
administered by the United States Department of Commerce, the
antiboycott regulations administered by the United States
Department of the Treasury, legislation and regulations of the
United States and other countries implementing the North
American Free Trade Agreement, antidumping and countervailing
duty laws and regulations, laws and regulations by other
countries concerning the ability of U.S. Persons to own
businesses and conduct business in those countries, laws and
regulations by other countries implementing
A-5
the OECD Convention on Combating Bribery of Foreign Officials,
restrictions by other countries on holding foreign currency and
repatriating funds and other laws and regulations adopted by the
governments or agencies of other countries relating to the same
subject matter as the United States statutes and regulations
described above.
Intervening Event has the meaning set
forth in Section 6.4(c).
IRS means the United States Internal
Revenue Service.
ITAR has the meaning set forth in
Section 4.4.
Judgment means any judgment, order,
ruling, award, assessment, writ, injunction, decree, stipulation
or determination.
Knowledge means the actual knowledge,
after reasonable inquiry of the direct reports who would
reasonably be expected to be in possession of the knowledge of
the type addressed by the applicable representations and
warranties that are subject to the applicable
Knowledge qualifier used in such
representation and warranty, of (i) as to the Company, the
persons identified in Section 1.1 of the Company
Disclosure Schedule, and (ii) as to Parent or Merger
Sub, the persons identified in Section 1.1 of the Parent
Disclosure Schedule.
Law means any federal, state, local or
foreign law, statute, ordinance, rule, regulation, Judgment,
franchise, license, agency requirement or permit of any
Governmental Entity.
Liens means all pledges, liens,
easements,
rights-of-way,
encroachments, restrictions, charges, mortgages, encumbrances
and security interests.
Merger has the meaning set forth in
the Recitals.
Merger Consideration means $12.00 per
share, in cash without interest; provided,
however, that if the purchase price payable pursuant to a
Substitute Intel Agreement as of the Intel Closing is greater
than the Purchase Price set forth in the Intel Purchase
Agreement as of the date of this Agreement (the amount of any
such excess, the Additional Aggregate Intel Purchase
Price), the Merger Consideration shall be increased by
a per share amount in cash determined based on the Additional
Aggregate Intel Purchase Price using the same methodology used
by the parties in determining the Merger Consideration.
Merger Sub has the meaning set forth
in the Preamble.
NISPOM has the meaning set forth in
Section 4.4.
Note Holder has the meaning set forth
in Section 7.1(e).
Notes Indenture has the meaning set
forth in Section 6.16.
Notice of Adverse Recommendation has
the meaning set forth in Section 6.4(c).
NYSE means the New York Stock Exchange.
Open Source has the meaning set forth
in Section 4.13(h).
Option Consideration has the meaning
set forth in Section 3.3(a).
Other Facilities has the meaning set
forth in the Section 6.9(a).
Parent has the meaning set forth in
the Preamble.
Parent Company means any direct or
indirect wholly owned Subsidiary of Parent, Parent and Merger
Sub.
Parent Disclosure Schedule means the
disclosure schedules delivered by Parent to the Company
simultaneously with the execution of this Agreement.
Parent Expenses has the meaning set
forth in Section 8.2(d).
A-6
Parent Material Adverse Effect means
any change, effect or circumstance which, individually or in the
aggregate, would reasonably be expected to prevent or materially
impede, interfere with, hinder or delay the consummation by
Parent or Merger Sub of the transactions contemplated by this
Agreement.
Parent Termination Fee means
$75,000,000 in cash.
Patriot has the meaning set forth in
the Recitals.
Paying Agent has the meaning set forth
in Section 3.2(a).
Permitted Liens means (i) Liens
for current Taxes not yet due and payable, or the validity or
amount of which is being contested in good faith by appropriate
proceedings (provided, in each case that a reserve has
been established for such Taxes in the Companys Financial
Statements in an amount in accordance with GAAP),
(ii) Liens of any materialmen, mechanics, workmen,
repairmen, contractors, warehousemen, carriers, suppliers,
vendors or equivalent Liens arising in the ordinary course of
business consistent with past practice in respect of amounts
that are not yet due or payable, or the validity or amount of
which is being contested in good faith by appropriate
proceedings, (iii) Liens that secure any indebtedness
reflected as liabilities in the Financial Statements and
(iv) any other Liens that are not material in amount or do
not materially detract from the value of or materially impair
the existing use of the property affected by such Lien.
Person means an individual,
corporation, limited liability company, partnership,
association, trust, unincorporated organization, other entity or
group (as defined in the Exchange Act).
PCL has the meaning set forth in
Section 6.9(a).
Post-Closing Plans has the meaning set
forth in Section 6.5(a).
Post-Sale Company means the Company
and its Subsidiaries, after giving effect to the Intel
Transaction (as though such transaction had been consummated in
accordance with the Intel Purchase Agreement).
Principal Stockholders has the meaning
set forth in the Recitals.
Proxy Statement means the proxy
statement filed with the SEC (together with all amendments and
supplements thereto) relating to the Merger and this Agreement.
Release means any release, spill,
emission, leaking, pumping, poring, injection, deposit, dumping,
emptying, disposal, discharge, dispersal, leaching or migration
into the indoor or outdoor environment, or into or out of any
property.
Representatives has the meaning set
forth in Section 6.3.
Restraints has the meaning set forth
in Section 7.1(b).
Restricted Stock Award has the meaning
set forth in Section 3.3(b).
Sarbanes-Oxley Act has the meaning set
forth in Section 4.5.
SEC means the United States Securities
and Exchange Commission.
Securities Act means the Securities
Act of 1933, as amended.
Shares means the issued and
outstanding shares of common stock, par value $0.001 per share,
of the Company.
Software means any and all
(i) computer programs, including screens, user interfaces,
report formats, firmware, development tools, templates, menus,
buttons, icons used therein and any and all software
implementations of algorithms, models and methodologies, whether
in source code or object code form, (ii) databases and
compilations, whether machine readable or otherwise and
(iii) all documentation, including user manuals and other
training documentation, related to any of the foregoing.
Stone Key has the meaning set forth in
Section 4.25.
A-7
Subsidiary means, as to any Person,
any Person (i) of which such first Person directly or
indirectly owns securities or other equity interests
representing more than fifty percent (50%) of the aggregate
voting power, or (ii) of which such first Person possesses
the right to elect more than fifty percent (50%) of the
directors or Persons holding similar positions. Notwithstanding
the foregoing, with respect to the Company, for purposes of this
Agreement, Subsidiaries shall include Patriot.
Substitute Determination has the
meaning set forth in Section 8.1(b)(iv).
Substitute Intel Agreement has the
meaning set forth in Section 8.3(d).
Substitute Intel Buyer has the meaning
set forth in Section 8.3(c).
Substitute Intel Transaction has the
meaning set forth in Section 8.3(a).
Substitution Exercise Notice has the
meaning set forth in Section 8.3.
Superior Proposal means a bona fide
written proposal or offer made by any Person to purchase or
otherwise acquire, directly or indirectly, in one transaction or
a series of related transactions, (i) beneficial ownership
(as defined under Section 13(d) of the Exchange Act) of
more than seventy-five percent (75%) of the outstanding Shares
pursuant to a merger, consolidation or other business
combination, sale of Shares, tender offer, exchange offer or
similar transaction, excluding the Intel Business or
(ii) all or substantially all of the assets of the Identity
Business, obtained after the date hereof and not in breach of
this Agreement, which is on terms which the Companys Board
of Directors determines in its good faith judgment, after
consultation with the Companys outside legal and financial
advisors to be more favorable to the Companys stockholders
than the transactions contemplated by this Agreement (taking
into account such factors as the Companys Board of
Directors deems appropriate, including any changes to the terms
of this Agreement proposed by Parent (which changes may be based
on changes to the terms of the Intel Purchase Agreement proposed
by Intel Buyer) in response to such offer or otherwise) from a
financial point of view and reasonably capable of being
completed on the terms proposed (based upon, among other things,
the availability of financing and the expectation of obtaining
required approvals).
Support Agreement has the meaning set
forth in the Recitals.
Surviving Corporation has the meaning
set forth in Section 2.1.
Tax means all federal, state, local or
municipal (whether domestic or foreign) taxes, assessments,
duties, fees, levies or similar charges of any kind, including
all sales, payroll, employment, withholding taxes or other
charges imposed by a Governmental Entity, and including all
interest, penalties and additions imposed with respect to such
amounts.
Tax Return means all national,
federal, state, local or municipal (whether domestic or foreign)
tax returns, declarations, statements, reports, schedules, forms
and information returns and any amended tax return relating to
Taxes.
Technology means, collectively,
(i) all designs, formulas, algorithms, procedures,
techniques, ideas, know-how, Software, Internet websites and web
content, tools, inventions (whether patentable or unpatentable
and whether or not reduced to practice), invention disclosures,
creations and other similar items; (ii) all recordings,
graphs, drawings, reports, analyses, other writings and any
other embodiment of the foregoing, in any form or media, whether
or not specifically listed herein and (iii) all related
technology and documentation used in, incorporated in or
embodied in any of the foregoing (i) or (ii), or used or
useful in the design, development, reproduction, maintenance,
improvement or modification of any of the foregoing (i) or
(ii).
Termination Date has the meaning set
forth in Section 8.1(b)(i).
Third Party means any Person other
than the Company and its Subsidiaries.
Total Contract Loss with respect to
any Government Contract for the sale of goods or services by the
Company or its Subsidiaries means the amount by which the sum of
direct costs of performance and allocations of indirect costs of
performance exceed the total revenue (all determined in
accordance with GAAP and consistent with the Companys past
practices) under such Contract from inception to the date of
this
A-8
Agreement, or is expected to be greater than the total revenue
under such Contract from inception to the Closing Date or
through the earlier date of completion of performance under such
Contract.
Transactions means, collectively, the
transactions contemplated by this Agreement and by the Intel
Purchase Agreement.
Transferred Company Business means the
businesses and operations of the Transferred Intel Companies.
Transferred Intel Companies has the
meaning set forth in the Recitals.
Warrant Consideration has the meaning
set forth in Section 3.3(e).
Section 1.2 Other
Definitional Provisions; Interpretation.
(a) The words hereof, herein,
hereby, hereunder and
herewith and words of similar import shall refer to
this Agreement as a whole and not to any particular provision of
this Agreement, and the phrases transactions contemplated
by this Agreement or transactions contemplated
hereby or phrases of similar import, when used in this
Agreement, shall not include the transactions contemplated by
the Intel Purchase Agreement.
(b) References to articles, sections, paragraphs, exhibits,
annexes and schedules are to the articles, sections and
paragraphs of, and exhibits, annexes and schedules to, this
Agreement, unless otherwise specified, and the table of contents
and headings in this Agreement are for reference purposes only
and shall not affect in any way the meaning or interpretation of
this Agreement.
(c) Whenever the words include,
includes or including are used in this
Agreement, they shall be deemed to be followed by the phrase
without limitation.
(d) Words describing the singular number shall be deemed to
include the plural and vice versa, words denoting any gender
shall be deemed to include all genders, words denoting natural
persons shall be deemed to include business entities and vice
versa and references to a Person are also to its permitted
successors and assigns.
(e) The phrases the date of this Agreement and
the date hereof and terms or phrases of similar
import shall be deemed to refer to September 19, 2010,
unless the context requires otherwise.
(f) When used in reference to the Company or its
Subsidiaries, the term material shall be measured
against the Post-Sale Company, taken as a whole.
(g) References to any statute shall be deemed to refer to
such statute as amended from time to time and to any rules or
regulations promulgated thereunder (provided, that for
purposes of any representations and warranties contained in this
Agreement that are made as of a specific date or dates,
references to any statute shall be deemed to refer to such
statute, as amended, and to any rules or regulations promulgated
thereunder, in each case, as of such date).
(h) Terms defined in the text of this Agreement have such
meaning throughout this Agreement, unless otherwise indicated in
this Agreement, and all terms defined in this Agreement shall
have the meanings when used in any certificate or other document
made or delivered pursuant hereto unless otherwise defined
therein.
(i) Notwithstanding any other provision in this Agreement,
to the extent any covenant or agreement of the Company in this
Agreement directly or indirectly requires any action or
forbearance by Patriot, then solely with respect to such action
or forbearance by Patriot, the Companys obligations in
respect of such covenant or agreement shall be deemed satisfied
for all purposes of this Agreement if the Company shall have
used its reasonable efforts to cause such action or forbearance.
(j) Notwithstanding any other provision in this Agreement,
the representations and warranties made by the Company in this
Agreement with respect to any of the Company and its
Subsidiaries (other than the representations contained in
Section 4.5 (SEC Reports), Section 4.6
(Internal Controls; Sarbanes-Oxley Act),
Section 4.12 (Taxes), Section 4.28
(Transferred Intel Companies) and Section 4.29 (No
Other Representations)) shall only apply with respect to the
Post-Sale Company, and no representations or warranties are made
in respect of the Intel Companies or any of their businesses,
assets, liabilities, operations, employees or related matters.
A-9
ARTICLE II
THE
MERGER
Section 2.1 The
Merger. Subject to the terms and conditions
of this Agreement and in accordance with the DGCL, at the
Effective Time, the Company and Merger Sub shall consummate the
Merger pursuant to which (i) Merger Sub shall merge with
and into the Company and the separate corporate existence of
Merger Sub shall thereupon cease and (ii) the Company shall
be the surviving corporation (the Surviving
Corporation) in the Merger and shall continue to be
governed by the laws of the State of Delaware. The Merger shall
have the effects set forth in the DGCL.
Section 2.2 Effective
Time.
(a) Parent, Merger Sub and the Company shall cause a
certificate of merger (the Certificate of
Merger) to be filed on the Closing Date (or on such
other date as Parent and the Company may agree in writing) with
the Secretary of State of the State of Delaware as provided in
the DGCL, and shall make all other filings or recordings
required by the DGCL in connection with the Merger. The Merger
shall become effective at the time at which the Certificate of
Merger is duly filed with the Secretary of State of the State of
Delaware or at such later time as is agreed upon in writing by
the parties and specified in the Certificate of Merger, and such
time is hereinafter referred to as the Effective
Time.
(b) From and after the Effective Time, the Surviving
Corporation shall possess all properties, rights, privileges,
powers and franchises of the Company and Merger Sub, and all of
the claims, obligations, liabilities, debts and duties of the
Company and Merger Sub shall become the claims, obligations,
liabilities, debts and duties of the Surviving Corporation.
Section 2.3 Closing. The
closing of the Merger (the Closing) will take
place at 9:00 a.m., New York time, on a date to be
specified by the parties, which shall be no later than two
(2) Business Days after the satisfaction or waiver of all
of the conditions set forth in Article VII hereof
(other than conditions that by their terms are to be satisfied
at the Closing, but subject to the satisfaction or waiver of
such conditions at the Closing), at the offices of Skadden,
Arps, Slate, Meagher & Flom LLP, Four Times Square,
New York, New York 10036, unless another time, date or place is
agreed to in writing by the parties hereto. The date on which
the Closing is to take place is referred to in this Agreement as
the Closing Date.
Section 2.4 Certificate
of Incorporation and Bylaws of the Surviving
Corporation. The certificate of incorporation
and bylaws of the Surviving Corporation shall be in the form
attached hereto as Exhibit B and
Exhibit C, respectively, until thereafter amended as
provided by Law, and by such certificate of incorporation and
bylaws.
Section 2.5 Directors
and Officers of the Surviving Corporation and its
Subsidiaries. The directors of Merger Sub
immediately prior to the Effective Time shall, from and after
the Effective Time, be the directors of the Surviving
Corporation until their successors shall have been duly elected
or appointed or qualified or until their earlier death,
resignation or removal in accordance with the Surviving
Corporations certificate of incorporation and bylaws. The
officers of Merger Sub immediately prior to the Effective Time
shall, from and after the Effective Time, be the officers of the
Surviving Corporation until their successors shall have been
duly elected or appointed or qualified or until their earlier
death, resignation or removal in accordance with the Surviving
Corporations certificate of incorporation and bylaws. If
requested by Parent prior to the Effective Time, the Company
shall use its commercially reasonable efforts to cause the
directors of each of the Companys Subsidiaries (or certain
of the Companys Subsidiaries as indicated by Parent), in
each case other than the Intel Companies, to tender their
resignations as directors, effective as of the Effective Time
and to deliver to Parent written evidence of such resignations
at the Effective Time.
A-10
ARTICLE III
CONVERSION
OF SHARES
Section 3.1 Conversion
of Shares.
(a) At the Effective Time, each Share issued and
outstanding immediately prior to the Effective Time (other than
Shares to be cancelled pursuant to Section 3.1(c),
Shares held by any Subsidiary of the Company and Dissenting
Shares) shall, by virtue of the Merger and without any action on
the part of the holder thereof, be converted into the right to
receive the Merger Consideration, without any interest thereon.
(b) Each share of common stock, par value $0.01 per share,
of Merger Sub issued and outstanding immediately prior to the
Effective Time shall, at the Effective Time, by virtue of the
Merger and without any action on the part of Parent, be
converted into one (1) fully paid and nonassessable share
of common stock, par value $0.01 per share, of the Surviving
Corporation.
(c) Each Share held by the Company as treasury stock or
owned by Parent or Merger Sub immediately prior to the Effective
Time shall, at the Effective Time, be cancelled and retired and
shall cease to exist, and no consideration shall be delivered in
exchange therefor. Each Share held by any Subsidiary of the
Company immediately prior to the Effective Time shall remain
outstanding, with appropriate adjustment to the number thereof
to preserve any such Subsidiarys percentage ownership in
the Company.
(d) Each Share converted into the right to receive the
Merger Consideration without any interest thereon pursuant to
Section 3.1(a) shall be automatically cancelled and
shall cease to exist, and the holders immediately prior to the
Effective Time of outstanding Shares not represented by
certificates (Book-Entry Shares) and the
holders of certificates that, immediately prior to the Effective
Time, represented outstanding Shares (the
Certificates) shall cease to have any rights
with respect to such Shares other than the right to receive,
upon surrender of such Book-Entry Shares or Certificates in
accordance with Section 3.2, the Merger
Consideration, without any interest thereon, for each such Share
held by them.
Section 3.2 Exchange
of Certificates Representing Shares.
(a) At or prior to the Closing, Parent shall deliver or
cause to be delivered, in trust, to a bank or trust company
designated by Parent and reasonably satisfactory to the Company
(the Paying Agent), for the benefit of
the holders of Shares immediately prior to the Effective Time
(other than holders of Shares to be cancelled pursuant to
Section 3.1(c), Shares held by any Subsidiary of the
Company and Dissenting Shares) sufficient funds for timely
payment of the aggregate Merger Consideration (such cash being
hereinafter referred to as the Consideration
Fund) to be paid pursuant to this
Section 3.2 in exchange for all outstanding Shares
immediately prior to the Effective Time (other than Shares to be
cancelled pursuant to Section 3.1(c), Shares held by
any Subsidiary of the Company and Dissenting Shares). The
Consideration Fund shall not be used for any other purposes.
(b) Promptly after the Effective Time, Parent shall cause
the Paying Agent to mail to each holder of record of
Certificates or Book-Entry Shares whose Shares were converted
into the right to receive Merger Consideration pursuant to
Section 3.1(a) (i) a letter of transmittal that
shall specify that delivery of such Certificates or Book-Entry
Shares shall be deemed to have occurred, and risk of loss and
title to the Certificates or Book-Entry Shares, as applicable,
shall pass, only upon proper delivery of the Certificates (or
affidavits of loss in lieu thereof together with any required
indemnity) or Book-Entry Shares to the Paying Agent and
(ii) instructions for use in effecting the surrender of the
Certificates or Book-Entry Shares in exchange for payment of the
Merger Consideration, the form and substance of which letter of
transmittal and instructions shall be substantially as
reasonably agreed to by the Company and Parent and prepared
prior to the Closing. Upon surrender of a Book-Entry Share or a
Certificate for cancellation to the Paying Agent together with
such letter of transmittal, duly executed and completed in
accordance with the instructions thereof, and with such other
documents as may be required pursuant to such instructions, the
holder of such Book-Entry Share or Certificate shall be entitled
to receive in exchange therefor, subject to any required
withholding of Taxes, the Merger Consideration pursuant to the
provisions of this Article III, and the Book-Entry
Share or Certificate so surrendered shall forthwith be
cancelled. No interest shall be paid or accrued on the Merger
Consideration payable to holders of Book-Entry Shares or
Certificates. If any Merger Consideration is to be paid to a
Person other than a Person in whose name the Book-Entry Share or
Certificate
A-11
surrendered in exchange therefor is registered, it shall be a
condition precedent of such exchange that the Person requesting
such exchange present proper evidence of transfer and pay to the
Paying Agent any transfer or other Taxes required by reason of
payment of the Merger Consideration to a Person other than the
registered holder of the Book-Entry Share or Certificate
surrendered, or shall establish to the reasonable satisfaction
of the Paying Agent that such Tax has been paid or is not
applicable.
(c) The Consideration Fund shall be invested by the Paying
Agent as directed by Parent or the Surviving Corporation.
Earnings on the Consideration Fund shall be the sole and
exclusive property of Parent and the Surviving Corporation and
shall be paid to Parent or the Surviving Corporation, as Parent
directs. No investment of the Consideration Fund shall relieve
Parent, the Surviving Corporation or the Paying Agent from
making the payments required by this Article III,
and following any net losses from any such investment, Parent
shall promptly provide additional funds to the Paying Agent for
the benefit of the applicable holders of Shares immediately
prior to the Effective Time in the amount of such net losses,
which additional funds shall be deemed to be part of the
Consideration Fund. No investment of the Consideration Fund
shall have maturities that could prevent or delay payments to be
made pursuant to this Agreement.
(d) At and after the Effective Time, there shall be no
transfers on the stock transfer books of the Company of the
Shares that were outstanding immediately prior to the Effective
Time. If, after the Effective Time, Certificates or Book-Entry
Shares are presented to the Surviving Corporation or the Paying
Agent for any reason, they shall be cancelled and exchanged for
the Merger Consideration pursuant to this
Article III, except as otherwise provided by Law.
(e) Any portion of the Consideration Fund (including any
interest from or the proceeds of any investments thereof) that
remains unclaimed by the applicable former stockholders of the
Company nine (9) months after the Effective Time shall be
delivered to the Surviving Corporation. Any holders of
Certificates or Book-Entry Shares who have not theretofore
complied with this Article III with respect to such
Certificates or Book-Entry Shares shall thereafter look only to
the Surviving Corporation (subject to abandoned property,
escheat or similar Laws, only as a general creditor thereof)
for, and the Surviving Corporation shall remain liable for,
payment of their claim for Merger Consideration in respect
thereof (if any).
(f) Notwithstanding the foregoing, neither the Paying Agent
nor any party hereto shall be liable to any Person in respect of
cash from the Consideration Fund delivered to a public official
pursuant to any applicable abandoned property, escheat or
similar Law. If any Certificate or Book-Entry Share shall not
have been surrendered prior to the date on which any Merger
Consideration in respect thereof would otherwise escheat to or
become the property of any Governmental Entity, any such Merger
Consideration in respect of such Certificate or Book-Entry Share
shall, to the extent permitted by applicable Law, become the
property of the Surviving Corporation, and any holder of such
Certificate or Book-Entry Share who has not theretofore complied
with this Article III with respect thereto shall
thereafter look only to the Surviving Corporation for payment of
its claim for Merger Consideration in respect thereof (if any).
(g) If any Certificate shall have been lost, stolen or
destroyed, upon the making of an affidavit of that fact (such
affidavit shall be in a form reasonably satisfactory to Parent
and the Paying Agent) by the Person claiming such Certificate to
be lost, stolen or destroyed, and, if required by Parent or the
Surviving Corporation, the posting by such Person of a bond in
such reasonable and customary amount as Parent or the Surviving
Corporation may direct as indemnity against any claim that may
be made with respect to such Certificate, the Paying Agent shall
issue in exchange for such lost, stolen or destroyed Certificate
the Merger Consideration to which such Person is entitled in
respect of such Certificate pursuant to this
Article III.
(h) Prior to the Effective Time, the Company shall take all
steps reasonably necessary to cause the transactions
contemplated hereby and any other dispositions of equity
securities of the Company in connection with this Agreement by
each individual who is subject to the reporting requirements of
Section 16(a) of the Exchange Act to be exempt under
Rule 16b-3
promulgated under the Exchange Act.
(i) Parent, Merger Sub, the Surviving Corporation or the
Paying Agent shall be entitled to deduct and withhold from the
consideration otherwise payable pursuant to this Agreement to
any holder of Shares, Company Deferred Stock Units, Company
Options or Company Warrants such amounts as Parent, Merger Sub,
the Surviving
A-12
Corporation or the Paying Agent is or may be reasonably required
to deduct and withhold with respect to the making of such
payment under the Code, or any provision of state, local or
foreign Tax Law. To the extent that amounts are so withheld and
paid over to the appropriate taxing authority by Parent, Merger
Sub, the Surviving Corporation or the Paying Agent, such
withheld amounts shall be treated for all purposes of this
Agreement as having been paid to the applicable holder in
respect of which such deduction and withholding was made by
Parent, Merger Sub, the Surviving Corporation or the Paying
Agent.
Section 3.3 Stock
Options and Other Equity-Based Awards; Long Term Cash Awards;
Warrants.
(a) Each option to purchase Shares granted under the
Companys L-1 Identity Solutions, Inc. 2010 Long-Term
Incentive Plan, L-1 Identity Solutions, Inc. 2008 Long-Term
Incentive Plan, Viisage Technology, Inc. 2005 Long-Term
Incentive Plan, Viisage Technology, Inc. Second Amended and
Restated 1996 Management Stock Option Plan, Viisage Technology,
Inc. Amended and Restated 1996 Directors Stock Option Plan,
2002 Equity Incentive Plan of Identix Incorporated, Identix
Incorporated New Employee Stock Incentive Plan, Identix
Incorporated Nonemployee Directors Stock Option Plan, Identix
Incorporated Equity Incentive Plan, Visionics Corporation 1990
Stock Option Plan, Visionics Corporation 1998 Stock Option Plan,
Visionics Corporation Stock Incentive Plan, Bioscrypt Inc.
Primary Stock Option Plan, ZN Employee Share Option Plan,
Imaging Automation, Inc. 2003 Employee, Director and Consultant
Stock Plan and Imaging Automation Inc. 1996 Stock Option Plan,
each as amended from time to time (collectively, the
Equity Plans), and options to purchase Shares
granted outside a plan (any such option, whether granted under
an Equity Plan or otherwise, a Company
Option) and outstanding immediately prior to the
Effective Time, shall, to the extent not then vested and
exercisable, become fully vested and exercisable as of
immediately prior to the Effective Time. As of the Effective
Time, each Company Option then outstanding shall be cancelled,
and the holder of each Company Option shall be entitled to
receive from the Company, as of the Effective Time and with
respect to each Company Option, cash equal to the product of
(i) the excess, if any, of the Merger Consideration over
the exercise price per Share of such Company Option, multiplied
by (ii) the number of Shares covered by such Company Option
(the aggregate amount of such cash, the Option
Consideration), with payment subject to applicable Tax
withholding and paid without interest.
(b) Restrictions on each restricted stock award granted
under the Equity Plans and outstanding immediately before the
Effective Time (each, a Restricted Stock
Award) shall lapse as of the Effective Time and such
Restricted Stock Award shall become fully vested. As of the
Effective Time, each Restricted Stock Award shall be treated in
the same manner as other Shares under Section 3.1,
with payment subject to applicable Tax withholding and paid
without interest.
(c) Each stock unit award relating to a bonus previously
earned but deferred by an employee of the Company pursuant to
the terms of such employees employment agreement with the
Company (each, a Company Deferred Stock
Unit) shall be canceled, and the holder of each such
Company Deferred Stock Unit shall be entitled to receive from
the Company as of the Effective Time, with respect to each
Company Deferred Stock Unit, an amount equal to the Merger
Consideration, with payment subject to applicable Tax
withholding and paid without interest.
(d) Each long-term cash award granted in February 2010
concurrently with the Companys regular annual grant of
equity incentive awards shall become fully vested as of the
Effective Time. As of the Effective Time, each such long-term
cash award shall become payable by the Company, such payment to
be made as soon as practicable, and in no event less than ten
(10) Business Days following, the Effective Time, with such
payment subject to applicable Tax withholding and paid without
interest.
(e) Each Company Warrant outstanding immediately before the
Effective Time shall, pursuant to the terms thereof, as of the
Effective Time, cease to represent a right to acquire Shares and
shall be converted, at the Effective Time, into a right to
receive from the Company a payment in cash, on the same
contractual terms and conditions as were in effect immediately
prior to the Effective Time under the terms of the Company
Warrant, in an amount equal to, with respect to Company Warrants
held by a specified holder, (i) the product of (A) the
number of Shares subject to the Company Warrants of such holder
and (B) the Merger Consideration minus (ii) the
product of (A) the number of Shares subject to the Company
Warrants of such holder and (B) the per share exercise
price of such Company Warrants immediately prior to the
Effective Time (provided, that if the foregoing
calculation results in a negative number, the cash payment shall
be $0) (the aggregate amount of such cash, the Warrant
Consideration). All
A-13
amounts payable in respect of such Company Warrants pursuant to
this Section 3.3(e) shall be subject to applicable
Tax withholding and paid without interest.
(f) Prior to the Effective Time, the Company shall use its
reasonable best efforts to take all such actions as may be
required to effectuate the provisions of this
Section 3.3. No later than the Effective Time,
Parent shall provide, or shall cause to be provided, to the
Surviving Corporation or the Paying Agent all funds necessary to
fulfill the obligations under this Section 3.3.
(g) With respect to the L-1 Identity Solutions, Inc.
Amended and Restated 2006 Employee Stock Purchase Plan (the
ESPP), (i) no new offering period shall
commence after the date of this Agreement; (ii) any
offering period under the ESPP that is in effect as of the date
of this Agreement shall terminate on September 30, 2010 and
amounts credited to the accounts of participants shall be used
to purchase Shares in accordance with the terms of the ESPP; and
(iii) such Shares shall be treated as other outstanding
Shares in accordance with Section 3.1 of this
Agreement.
Section 3.4 Adjustments. Notwithstanding
any provision of this Article III to the contrary,
if between the date of this Agreement and the Effective Time the
outstanding Shares shall have been changed into a different
number of shares or a different class by reason of the
occurrence or record date of any stock dividend, subdivision,
reclassification, recapitalization, stock split (including a
reverse stock split), combination, exchange of shares or similar
transaction, the Merger Consideration shall be equitably
adjusted to reflect such stock dividend, subdivision,
reclassification, recapitalization, stock split (including a
reverse stock split), combination, exchange of shares or similar
transaction.
Section 3.5 Dissenting
Shares. Notwithstanding
Section 3.1(a) hereof, to the extent that holders of
Shares are entitled to appraisal rights under Section 262
of the DGCL, Shares issued and outstanding immediately prior to
the Effective Time and held by a holder who has properly
exercised and perfected his or her demand for appraisal rights
under Section 262 of the DGCL (the
Dissenting Shares) shall not be
converted into the right to receive the Merger Consideration,
but the holders of such Dissenting Shares shall be entitled to
receive such consideration as shall be determined pursuant to
Section 262 of the DGCL; provided, however,
that if any such holder shall have failed to perfect or shall
have effectively withdrawn or lost his or her right to appraisal
and payment under the DGCL, such holders Shares shall
thereupon be deemed to have been converted as of the Effective
Time into the right to receive the Merger Consideration, without
any interest thereon, and such Shares shall not be deemed to be
Dissenting Shares. The Company shall promptly provide Parent
with notice of any demands for appraisal of any Shares, and
Parent shall have the right to participate in and direct all
negotiations and proceedings with respect to such demands. Prior
to the Effective Time, the Company shall not, without the prior
written consent of Parent, voluntarily make any payment with
respect to, or settle or offer to settle, any such demands, or
agree to do any of the foregoing. Any portion of the Merger
Consideration made available to the Paying Agent pursuant to
Section 3.2(a) to pay for Dissenting Shares shall be
returned to Parent upon demand.
ARTICLE IV
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
Except as disclosed in (i) the Company SEC Reports
(excluding any (A) risk factor disclosures contained under
the heading Risk Factors (other than any historical
information included therein), (B) any disclosure of risks
included in any forward-looking statements
disclaimers and (C) any other statements included in such
Company SEC Reports to the extent that such disclosures are
predictive or forward-looking in nature) and (ii) the
Company Disclosure Schedule (subject to the third sentence of
Section 9.4), the Company represents and warrants to
Parent and Merger Sub as follows:
Section 4.1 Organization
and Good Standing. Each of the Company and
its Subsidiaries is duly organized, validly existing and (to the
extent applicable) in good standing under the laws of the
jurisdiction of its incorporation or organization and has the
requisite corporate or similar power and authority to own or
lease all of its properties and assets and to conduct its
business as it is now being conducted, except with respect to
the Subsidiaries of the Company only where the failure to be so
organized, existing and (to the extent applicable) in good
standing or to have such power and authority would not have a
Company Material Adverse Effect. Each of the Company and its
A-14
Subsidiaries is duly qualified or licensed to do business and
(to the extent applicable) is in good standing in each
jurisdiction in which the property leased or operated by it or
the nature of the business conducted by it makes such
qualification or licensing necessary, except where the failure
to be so duly qualified, licensed and in good standing would not
have a Company Material Adverse Effect. The Company has made
available to Parent a copy of its Amended and Restated
Certificate of Incorporation and Amended and Restated Bylaws and
the organizational documents of each of its Subsidiaries listed
in Section 4.1 of the Company Disclosure Schedule,
in each case, as currently in effect. All such organizational
documents of the Company and its Subsidiaries are in full force
and effect and neither the Company nor any of its Subsidiaries
is in material violation of any of their respective provisions.
Section 4.2 Capitalization;
Subsidiaries.
(a) As of September 17, 2010, the authorized capital
stock of the Company consists of
(i) 125,000,000 Shares, 93,184,172 of which were
issued and outstanding (excluding shares held by the Company as
treasury stock) and 5,443,416 of which were reserved for
issuance pursuant to the Equity Plans and 124,162 of which were
reserved for issuance upon exercise of the Company Warrants, and
(ii) 2,000,000 shares of preferred stock, par value
$0.001 per share, of the Company, none of which were issued and
outstanding. Company Warrants refer to the
warrants listed in Section 4.2(a) of the Company
Disclosure Schedule. All the outstanding shares of the
Companys capital stock are duly authorized, validly
issued, fully paid, nonassessable and free of preemptive rights.
As of the date hereof, other than (i) pursuant to the
Equity Plans and the Company Warrants and (ii) the
Companys 3.75% convertible senior notes due 2027 (the
Convertible Notes), there are no
outstanding options, warrants, calls, stock appreciation rights,
phantom stock awards, subscriptions, convertible securities, or
any bonds, debentures, notes or other indebtedness having the
right to vote on any matters on which stockholders of the
Company may vote (or that are convertible into securities having
such rights), or other rights, agreements or commitments of any
kind to which the Company or any of its Subsidiaries is a party
obligating the Company or any of its Subsidiaries to issue,
transfer or sell any shares of capital stock or other equity
interest in the Company or securities convertible into or
exchangeable for such shares or equity interests, and there are
no voting trusts or similar agreements to which the Company or
any of its Subsidiaries is a party with respect to the voting of
the capital stock of the Company. Section 4.2(a) of the
Company Disclosure Schedule sets forth a list, as of
September 17, 2010, of (A) all Company Options and
other outstanding options to purchase Shares issued under Equity
Plans or otherwise, the number of Shares subject thereto, the
grant dates, exercise or base prices (if applicable), the vested
or unvested status thereof and the names of the holders thereof
and (B) all Shares or other Share-based awards that were
outstanding but were subject to vesting or other forfeiture
restrictions, including Restricted Stock Awards under Equity
Plans or otherwise, the grant dates, the vested or unvested
status thereof, repurchase price (if any) thereof and the names
of the holders thereof, which list accurately sets forth the
aggregate number of Shares described in the preceding
clauses (A) and (B) (except for de minimis errors and
omissions) and, with respect to the other information set forth
therein, is true and correct in all material respects. Each of
the outstanding shares of capital stock, voting securities or
other equity interests of each Subsidiary of the Company is
owned by the Company or another Subsidiary of the Company. There
are no outstanding options, warrants, calls, subscriptions or
other rights, convertible securities, agreements or commitments
of any kind to which the Company or any of its Subsidiaries is a
party obligating the Company or any of its Subsidiaries to
issue, transfer or sell any shares of issued or unissued, as the
case may be, capital stock or other equity interest in any
Subsidiary of the Company, or securities convertible into or
exchangeable for shares of capital stock or other equity
interest in any Subsidiary of the Company.
(b) Section 4.2(b) of the Company Disclosure
Schedule lists, as of the date hereof, each of the
Subsidiaries of the Company and, for each such Subsidiary, its
respective jurisdiction of incorporation or formation. Each of
the outstanding shares of capital stock, voting securities or
other equity interests of each Subsidiary of the Company is duly
authorized, validly issued, fully paid, nonassessable and free
of any preemptive rights (to the extent applicable), and are
owned free and clear of all Liens other than Permitted Liens.
There are no voting trusts or similar agreements to which the
Company or any of its Subsidiaries is a party with respect to
the voting of the capital stock of any Subsidiary of the Company.
(c) Except as described in Section 4.2(c) of the
Company Disclosure Schedule and other than with respect to
the Companys Subsidiaries and cash management investments
in the ordinary course of business, the Company does not own or
control, directly or indirectly, any equity interest in any
Person, or have any obligation or has made
A-15
any commitment to acquire any such equity interest, to provide
funds to, or to make any investment (in the form of a loan,
capital contribution, advance or otherwise) in any other Person.
(d) All Company Options were granted at an exercise price
at least equal to the fair market value (within the meaning of
Section 409A of the Code) of a Share on the date of grant
and no Company Option has been extended, amended or repriced
since the date of the grant.
Section 4.3 Authorization;
No Conflict.
(a) The Company has the requisite corporate power and
authority to execute and deliver this Agreement and, subject to
obtaining the Company Stockholder Approval, to perform its
obligations hereunder and to consummate the transactions
contemplated by this Agreement. The execution, delivery and
performance by the Company of this Agreement, and the
consummation by it of the transactions contemplated by this
Agreement, have been duly and validly authorized by all
necessary corporate action by the Company (including by its
Board of Directors), and except for the Company Stockholder
Approval, no other corporate action or proceeding on the part of
the Company is necessary to authorize the execution, delivery
and performance by the Company of this Agreement and the
consummation by it of the transactions contemplated by this
Agreement. This Agreement has been duly executed and delivered
by the Company and, assuming due authorization, execution and
delivery of this Agreement by the other parties hereto,
constitutes a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its
terms, except that (i) such enforcement may be subject to
applicable bankruptcy, insolvency, reorganization, moratorium or
other similar Laws, now or hereafter in effect, affecting
creditors rights and remedies generally and (ii) the
remedies of specific performance and injunctive and other forms
of equitable relief may be subject to equitable defenses and to
the discretion of the court before which any proceeding therefor
may be brought.
(b) The Companys Board of Directors, at a meeting
duly called and held, has unanimously (i) adopted this
Agreement and the transactions contemplated hereby,
(ii) determined that this Agreement and the transactions
contemplated hereby are advisable and in the best interests of
the Company and Companys stockholders, (iii) directed
that the Company submit the adoption of this Agreement to a vote
at a meeting of the stockholders of the Company in accordance
with the terms of this Agreement and (iv) resolved to
recommend that the Companys stockholders approve the
Merger and this Agreement at the Company Special Meeting.
(c) The execution and delivery of this Agreement by the
Company does not, and the consummation of the transactions
contemplated hereby by the Company will not, (i) conflict
with or violate the certificate of incorporation or bylaws (or
equivalent organizational documents) of (A) the Company or
(B) any of its Subsidiaries, (ii) assuming the
Consents, registrations, declarations, filings and notices
referred to in Section 4.4 have been obtained or
made, any applicable waiting periods referred to therein have
terminated or expired and any condition precedent to any such
Consent has been satisfied, conflict with or violate any Law
applicable to the Company or any of its Subsidiaries or by which
any property or asset of the Company or any of its Subsidiaries
is bound or affected, (iii) result in any breach of, or
constitute a default (with or without notice or lapse of time,
or both) under, or give rise to any right of termination,
amendment, acceleration or cancellation of any payments pursuant
to any of the terms, conditions or provisions of any Company
Material Contract or Company Permit or (iv) result in the
creation of a Lien, other than any Permitted Lien, upon any of
the material properties or assets of the Company or any of its
Subsidiaries, other than, in the case of clauses (ii),
(iii) and (iv), any such conflict, violation, breach,
default, termination, amendment, acceleration, cancellation or
Lien that would not (x) have a Company Material Adverse
Effect or (y) prevent or materially impede, materially
interfere with, materially hinder or materially delay the
consummation of the Merger or any of the other transactions
contemplated by this Agreement. The execution and delivery of
this Agreement by the Company does not, and the consummation of
the transactions contemplated hereby by the Company will not,
require any penalties (other than interest rate period break
fees) or make whole payments to be paid by the Company or any of
its Subsidiaries with respect to indebtedness for borrowed money
of the Company, including the Convertible Notes.
(d) The Company has made available to Parent complete
copies of the minutes (or in the case of minutes that have not
yet been finalized, drafts thereof) of all meetings of the Board
of Directors and each committee of the Board of Directors of the
Company, since January 1, 2008 through the date of this
Agreement, in each case with redactions with respect to
potentially sensitive or other information, as deemed
appropriate by the Company, and, in
A-16
any event, other than such minutes (or portions thereof) that
relate to the Transactions or alternative transactions
considered by the Board of Directors of the Company or any
committee thereof.
Section 4.4 Governmental
Consents. No consent, approval, license,
permit, order or authorization
(a Consent) of, or registration,
declaration or filing with, or notice to, any supranational,
national, federal, state, local or municipal (whether domestic
or foreign) government or any court of competent jurisdiction,
tribunal, arbitrator, judicial body, administrative or
regulatory agency, authority, commission or board or other
governmental department, bureau, branch, authority or
instrumentality (a Governmental Entity) is
required to be obtained or made by or with respect to the
Company or any of its Subsidiaries in connection with the
execution, delivery and performance of this Agreement or the
consummation of the transactions contemplated hereby, other than
(i) the filing with the SEC of (A) a Proxy Statement
(if applicable) and (B) such reports under the Exchange Act
as may be required in connection with this Agreement and the
Transactions, (ii) the filing of the Certificate of Merger
with the Secretary of State of the State of Delaware and
appropriate documents with the relevant authorities of the other
jurisdictions in which the Company or any of its Subsidiaries is
qualified to do business, (iii) such filings as may be
required in connection with the Taxes described in
Section 9.14, (iv) such other items required
solely by reason of the participation of Parent (as opposed to
any other third-party) in the transactions contemplated hereby,
(v) such Consents, registrations, declarations, filings or
notices set forth in Section 4.4 of the Company
Disclosure Schedule, (vi) compliance with and filings
or notifications under (A) the HSR Act and other applicable
U.S. and
non-U.S. competition
Laws, (B) the National Industrial Security Program
Operating Manual (NISPOM), and (C) the
International Traffic in Arms Regulations
(ITAR), (vii) the filing of a joint
voluntary notice with CFIUS pursuant to the Exon-Florio
Amendment to the Defense Production Act of 1950, 50 U.S.C.
app. § 2170, as amended
(Exon-Florio), and written confirmation by
CFIUS of the successful completion of the Exon-Florio review
process, (viii) such filings as may be required in
connection with the U.S. Federal Acquisition Regulation
(FAR) and the Defense Federal Acquisition
Regulation Supplement, and (ix) such other Consents,
registrations, declarations, filings or notices the failure of
which to be obtained or made would not (1) have a Company
Material Adverse Effect or (2) prevent or materially
impede, materially interfere with, materially hinder or
materially delay the consummation of the Merger or any of the
other transactions contemplated by this Agreement.
Section 4.5 SEC
Reports. The Company has timely filed all
forms, documents, proxy statements and reports with the SEC
required to be filed by the Company since January 1, 2009
under the Exchange Act and the Securities Act, as the case may
be, together with any certificates required pursuant to the
Sarbanes-Oxley Act of 2002, as amended (Sarbanes-Oxley
Act) (as such reports and statements may have been
amended since the date of their filing, the
Company SEC Reports). As of their
respective filing dates, or, if amended or restated prior to the
date of this Agreement, as of the date of the last such
amendment or applicable subsequent filing, the Company SEC
Reports (i) complied in all material respects with, to the
extent in effect at the time of filing, the applicable
requirements of the Securities Act and the Exchange Act, as the
case may be, the Sarbanes-Oxley Act and the applicable rules and
regulations of the SEC thereunder, and (ii) did not contain
any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in
order to make the statements therein, in light of the
circumstances under which they were made, not misleading. None
of the Companys Subsidiaries is currently required to file
any forms, schedules, statements, reports or other documents
with the SEC. To the Knowledge of the Company, none of the
Company SEC Reports is the subject of ongoing SEC review or
outstanding SEC comment. The consolidated financial statements
(including the related notes) of the Company included in the
Company SEC Reports (the Financial
Statements) (i) fairly present in all material
respects the consolidated financial position of the Company and
its consolidated Subsidiaries as at the respective dates thereof
and their consolidated results of operations and consolidated
cash flows and changes in stockholders equity of the
Company and its consolidated Subsidiaries for the respective
periods then ended (subject, in the case of the unaudited
statements, to normal year-end audit adjustments and to any
other adjustments described therein including the notes thereto)
and (ii) have been prepared in accordance with accounting
principles generally accepted in the United States
(GAAP) (except, in the case of the unaudited
statements, as permitted by
Form 10-Q
of the SEC) applied on a consistent basis during the periods
involved (except as may be indicated therein or in the notes
thereto).
A-17
Section 4.6 Internal
Controls; Sarbanes-Oxley Act.
(a) The Company has designed and maintains a system of
internal control over financial reporting (as defined in
Rules 13a-15(f)
and
15d-15(f) of
the Exchange Act) sufficient to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of the Company financial statements for external
purposes in accordance with GAAP. The Company has established
and maintains disclosure controls and procedures (as defined in
Rules 13a-15(e)
and
15d-15(e) of
the Exchange Act) designed to provide reasonable assurance that
material information required to be disclosed by the
Companys periodic and current reports under the Exchange
Act is communicated to the Companys principal executive
officer and principal financial officer as appropriate to allow
timely decisions regarding required disclosure. The Company is
in compliance in all material respects with (x) all
applicable provisions of the Sarbanes-Oxley Act and (y) the
applicable listing and corporate governance rules and
regulations of the NYSE. Since January 1, 2010 and through
June 30, 2010, and to the Knowledge of the Company since
June 30, 2010 through the date hereof, the Company has not
identified (i) any material weaknesses in the design or
operation of internal control over financial reporting which is
reasonably likely to adversely affect the Companys ability
to record, process, summarize and report financial information
or (ii) any fraud or allegation of fraud, whether or not
material, that involves management or other employees who have a
significant role in the Companys internal control over
financial reporting. As of the date hereof, to the Knowledge of
the Company, there are no facts or circumstances that would
prevent its chief executive officer and chief financial officer
from giving the certifications and attestations required
pursuant to the rules and regulations adopted pursuant to
Section 404 of the Sarbanes-Oxley Act, without
qualification, when next due.
(b) Neither the Company nor any of its Subsidiaries is a
party to, or has any commitment to become a party to, any joint
venture, off balance sheet partnership or any similar contract
or arrangement (including any Contract relating to any
transaction or relationship between or among the Company and any
of its Subsidiaries, on the one hand, and any unconsolidated
affiliate, including any structured finance, special purpose or
limited purpose entity or Person, on the other hand, or any
off balance sheet arrangements (as defined in
item 303(a) of
Regulation S-K
under the Exchange Act)), where the result, purpose or intended
effect of such Contract is to avoid disclosure of any material
transaction involving, or material liabilities of, the Company
or any of its Subsidiaries in the Companys published
financial statements or other Company SEC Reports.
Section 4.7 No
Undisclosed Liabilities. Except (a) as
reflected in the Financial Statements included in the Company
SEC Reports, (b) for those liabilities and obligations
incurred in the ordinary course of business consistent with past
practice in all material respects since June 30, 2010 or
(c) for liabilities and obligations incurred in connection
with the Transactions, as of the date hereof, neither the
Company nor any of its Subsidiaries has any material liabilities
or obligations of any nature, whether or not accrued, contingent
or otherwise, that would be required by GAAP to be reflected on
a consolidated balance sheet (or the notes thereto) of the
Post-Sale Company.
Section 4.8 Absence
of Certain Changes. Since December 31,
2009 through the date of this Agreement, except for matters in
connection with the Transactions, the businesses of the Company
and its Subsidiaries have been conducted in the ordinary course
of business consistent with past practice in all material
respects, and there has not been any Company Material Adverse
Effect.
Section 4.9 Employee
Benefit Plans; ERISA.
(a) Section 4.9(a) of the Company Disclosure
Schedule sets forth a complete list, as of the date hereof,
of each material deferred compensation, bonus or other incentive
compensation, stock purchase, stock option and other equity
compensation plan, program, agreement or arrangement; each
material severance or termination pay, medical, surgical,
hospitalization, life insurance and other welfare
plan, fund or program (within the meaning of Section 3(1)
of the Employee Retirement Income Security Act of 1974
(ERISA)); each material profit-sharing, stock
bonus or other pension plan, fund or program (within
the meaning of Section 3(2) of ERISA); each material
employment, termination, change in control, retention or
severance agreement; and each other material employee benefit
plan, fund, program, agreement or arrangement, in each case,
under which any current or former employee, director or
individual independent contractor of the Company or any of its
Subsidiaries has any right to benefits and that is sponsored,
maintained or contributed to or required to be contributed to by
the Company or by an ERISA Affiliate thereof, or to which the
Company or any of its Subsidiaries has or would reasonably be
expected to have any liability, including as a result of its or
their ERISA Affiliates, excluding for this purpose any foreign
plan,
A-18
program, agreement or arrangement that is mandated by applicable
Law (the Benefit Plans).
Section 4.9(a) of the Company Disclosure Schedule
identifies each Benefit Plan maintained outside of the United
States substantially for the benefit of current and former
directors and employees who are situated outside of the United
States (each, a Foreign Plan). The Company
has made available to Parent a true and complete copy of each
Benefit Plan and all amendments thereto (or, in the case of any
unwritten Benefit Plans, descriptions thereof) and a true and
complete copy of the following items (in each case, only if
applicable): (i) each trust or other funding arrangement,
(ii) each summary plan description and summary of material
modifications, (iii) the most recently filed annual report
on IRS Form 5500 and all schedules thereto and
(iv) the most recently received IRS determination letter.
(b) Each of the Benefit Plans has been operated and
administered in all material respects in accordance with its
terms and applicable Laws, including ERISA and the Code. Except
as would not reasonably be expected to result in a material
liability to the Company and its Subsidiaries taken as a whole,
(i) neither the Company nor any party in
interest or disqualified person with respect
to the Benefit Plans has engaged in a non-exempt
prohibited transaction within the meaning of
Section 4975 of the Code or Section 406 of ERISA and
(ii) no fiduciary has incurred any liability for breach of
fiduciary duty or any other failure to act or comply in
connection with the administration or investment of the assets
of any Benefit Plan.
(c) Except as would not reasonably be expected to result in
a material liability to the Company and its Subsidiaries taken
as a whole, each Benefit Plan intended to qualify under
Section 401(a) of the Code has either received a favorable
determination letter from the IRS with respect to each such
Benefit Plan as to its qualified status under the Code, or with
respect to a prototype Benefit Plan, the prototype sponsor has
received a favorable IRS opinion letter, or the Benefit Plan or
prototype sponsor has remaining a period of time under
applicable Code regulations or pronouncements of the IRS in
which to apply for such a letter and make any amendments
necessary to obtain a favorable determination or opinion as to
the qualified status of each such Benefit Plan, and the trusts
maintained pursuant to each such Benefit Plan are exempt from
federal income taxation under Section 501 of the Code.
Nothing has occurred since the most recent determination or
opinion letter or application therefor relating to any such
Benefit Plan that would reasonably be expected to cause the loss
of such qualification or exemption or the imposition of any
liability, penalty or tax under ERISA or the Code.
(d) With respect to each Foreign Plan, except as would not
reasonably be expected to result in a material liability to the
Company and its Subsidiaries taken as a whole:
(i) all employer and employee contributions to each Foreign
Plan required by Law or by the terms of such Foreign Plan have
been made, or, if applicable, accrued in accordance with normal
accounting practices;
(ii) the fair market value of the assets of each funded
Foreign Plan, the liability of each insurer for any Foreign Plan
funded through insurance or the book reserve established for any
Foreign Plan, together with any accrued contributions, is
sufficient to procure or provide for the accrued benefit
obligations, as of the Closing Date, with respect to all current
or former participants in such plan according to the actuarial
assumptions and valuations most recently used to determine
employer contributions to such Foreign Plan and no transaction
contemplated by this Agreement shall cause such assets or
insurance obligations to be less than such benefit
obligations; and
(iii) each Foreign Plan required to be registered has been
registered and has been maintained in good standing with
applicable regulatory authorities.
(e) No material liability under Section 302 or
Title IV of ERISA or Section 412 of the Code has been
incurred by the Company or any ERISA Affiliate that has not been
satisfied in full. Neither the Company nor any of its ERISA
Affiliates has in the last six (6) years contributed to or
has been obligated to contribute to any Benefit Plan that is
subject to Section 302 or Title IV of ERISA or
Section 412 of the Code, including a multiemployer
plan (within the meaning of Section 3(37) of ERISA)
or a multiple employer plan (within the meaning of
Section 413(c) of the Code). None of the employees of the
Company or any of its Subsidiaries or ERISA Affiliates
participates in any multiemployer plan within the
meaning of Section 3(37) of ERISA, or any pension or
retirement plan sponsored by any union or similar employee
representative or sponsored by more than one unrelated employer.
A-19
(f) Except as set forth in Section 4.9(f) of the
Company Disclosure Schedule, except as would not reasonably
be expected to result in a material liability to the Company and
its Subsidiaries taken as a whole, (i) there are no claims
pending, or, to the Knowledge of the Company, threatened or
anticipated (other than routine claims for benefits), against or
involving any Benefit Plan or the assets of any Benefit Plan or
against the Company, any of its Subsidiaries or any ERISA
Affiliate, in each case, with respect to any Benefit Plan,
(ii) there are no audits pending or, to the Knowledge of
the Company, threatened by any Governmental Entity involving any
Benefit Plan and (iii) the Company has not received written
notice of any investigations, and to the Knowledge of the
Company, no investigations are threatened, in each case, by any
Governmental Entity involving any Benefit Plan.
(g) Except as would not reasonably be expected to result in
a material liability to the Company and its Subsidiaries taken
as a whole, each Benefit Plan that is a non-qualified
deferred compensation plan within the meaning of
Section 409A of the Code has been maintained and operated
in compliance with Section 409A of the Code and the
applicable guidance issued thereunder.
(h) Except as set forth in Section 4.9(h) of the
Company Disclosure Schedule, neither the execution or
delivery of this Agreement nor the consummation of the Merger
will, either alone or in conjunction with any other event,
(i) entitle any current or former director, employee,
consultant or independent contractor of the Company or any of
its Subsidiaries to severance pay, unemployment compensation or
any other payment, except as expressly provided in this
Agreement, (ii) increase the amount or value of any benefit
or compensation otherwise payable or required to be provided to
any such director, employee, consultant or independent
contractor, (iii) accelerate the time of payment, vesting
or funding of compensation due any such director, employee,
consultant or independent contractor or (iv) result in any
payments that (1) would not be deductible under
Section 280G of the Code or (2) would result in any excise
tax on any employee or independent contractor of the Company or
any of its Subsidiaries under Section 4999 of the Code or
any other comparable Law.
(i) None of the Company or its Subsidiaries has any
material obligations for post-retirement health or life
insurance benefits under any Benefit Plan (other than for
continuation coverage required to be provided pursuant to
Section 4980B of the Code).
Section 4.10 Litigation. As
of the date of this Agreement, there is no suit, claim, action,
hearing, notice of violation, investigation, mediation, inquiry,
arbitration, demand letter or any other judicial or
administrative proceeding pending or, to the Knowledge of the
Company, threatened against the Company or any of its
Subsidiaries, or which affects any of its or their respective
properties or assets, except where such suit, claim, action,
hearing, notice, investigation, mediation, inquiry, arbitration,
demand letter or other proceeding would not reasonably be
expected to result in a Judgment for money damages in excess of
$2,000,000 and would not reasonably be expected to result in any
material injunctive relief. As of the date hereof, there are no
material Judgments of any Governmental Entity outstanding
against, or, to the Knowledge of the Company, threatened to be
imposed by any Governmental Entity involving, the Company or any
of its Subsidiaries.
Section 4.11 Permits;
Compliance with Law.
(a) The Company and its Subsidiaries are in possession of
all material franchises, grants, authorizations, licenses,
permits, easements, variances, exceptions, consents,
certificates, exemptions, registrations, approvals and orders
necessary for the Company and its Subsidiaries to carry on its
business as it is now being conducted (the Company
Permits). The Company and its Subsidiaries are in
compliance with the terms of the Company Permits, and all of the
Company Permits are valid and in full force and effect, and no
suspension or cancellation of any of the Company Permits is
pending or, to the Knowledge of the Company, threatened, except
for such non-compliance, invalidity, suspension or cancellation
of any Company Permits that, individually or in the aggregate,
would not be material to the Company and its Subsidiaries taken
as a whole. Except as, individually or in the aggregate, would
not be material to the Company and its Subsidiaries taken as a
whole, since January 1, 2009, neither the Company nor any
of its Subsidiaries has received any written notice that any
Governmental Entity has commenced, or threatened to initiate,
any action to revoke, cancel or terminate any Company Permit.
(b) None of the Company or its Subsidiaries is in default
or violation of any Law (including any Environmental Law)
applicable to the Company or any of its Subsidiaries or by which
any property or asset of the Company or any of its Subsidiaries
is bound or affected, except for any such defaults or violations
that, individually or in the
A-20
aggregate, would not be material to the Company and its
Subsidiaries, taken as a whole. Except as, individually or in
the aggregate, would not be material to the Company and its
Subsidiaries taken as a whole, since January 1, 2009,
neither the Company nor any of its Subsidiaries has received
written notice to the effect that a Governmental Entity claims
or alleged that the Company or any of its Subsidiaries was not
in compliance with Laws applicable to the Company or any of its
Subsidiaries, any of their properties or other assets or any of
their businesses or operations.
(c) To the Knowledge of the Company, none of the Company or
its Subsidiaries has caused the Release of Hazardous Materials,
except for any such Release that would not result in material
liabilities under applicable Environmental Laws.
(d) To the Knowledge of the Company, neither the Company
nor any of its Subsidiaries nor any director, officer, agent or
employee of the Company or any of its Subsidiaries is aware of
any action, or any allegation of any action, or has taken any
action, directly or indirectly, that would constitute a
violation in any material respect by such Persons of the Foreign
Corrupt Practices Act of 1977, as amended, and the rules and
regulations thereunder (the FCPA), including
making use of the mails or any means or instrumentality of
interstate commerce corruptly in furtherance of an offer,
payment, promise to pay or authorization of the payment of any
money, or other property, gift, promise to give, or
authorization of the giving of anything of value to any
foreign official (as such term is defined in the
FCPA) or any foreign political party or official thereof or any
candidate for foreign political office, in contravention of the
FCPA.
Section 4.12 Taxes.
(a) Each of the Company and its Subsidiaries has timely
filed, or has caused to be timely filed on its behalf, all
material Tax Returns required to be filed by it (in each case
taking due account of lawful extensions validly obtained), and
all such Tax Returns are true, complete and correct in all
material respects. All material Taxes (whether or not shown to
be due on such Tax Returns) have been timely paid or have been
adequately reserved against on the Financial Statements. All
Taxes that the Company and each of its Subsidiaries were
required by Law to withhold or collect have been duly withheld
or collected and, to the extent required, have been properly
paid to the appropriate Governmental Entity.
(b) No material deficiency, audit examination, refund
litigation, proposed adjustment or matter in controversy with
respect to any Taxes has been proposed, asserted or assessed (or
threatened in writing) against the Company or any of its
Subsidiaries for which a reserve has not been provided in the
Financial Statements in an amount in accordance with GAAP. There
is no material agreement or other document waiving or extending,
or having the effect of waiving or extending, the period of
assessment or collection of Taxes.
(c) There are no material Liens for Taxes (other than for
current Taxes not yet due and payable or Taxes being contested
in good faith by the appropriate proceeding) on the assets of
the Company or any of its Subsidiaries. Neither the Company nor
any of its Subsidiaries is bound by any agreement with respect
to Taxes, other than customary tax indemnification or other
arrangements contained in any credit or other commercial
agreements the primary purpose of which does not relate to Taxes.
(d) Neither the Company nor any of its Subsidiaries has any
material liability for the Taxes of any person (other than the
Company or any of its Subsidiaries) under Treasury
Regulation Section 1.1502-6
(or any similar provision of state, local or foreign Law), or as
a transferee or successor, by contract or otherwise. Neither the
Company nor any of its Subsidiaries has been, within the past
two (2) years or otherwise as part of a plan (or
series of related transactions) within the meaning of
Section 355(e) of the Code of which the Merger is also a
part, a distributing corporation or a
controlled corporation (within the meaning of
Section 355(a)(1)(A) of the Code) in a distribution of
stock intended to qualify for Tax-free treatment under
Section 355 of the Code.
(e) As of the date hereof, the Intel Purchase Agreement
expressly provides that, for federal income tax purposes, the
Intel Transaction will be treated as a sale of the assets of
each of McClendon, LLC, SpecTal, LLC and Advanced Concepts, Inc.
Section 4.13 Intellectual
Property.
(a) To the Knowledge of the Company, the Company and its
Subsidiaries solely and exclusively (except for any joint
ownership provided for pursuant to any written agreement with
any third Person) own or have a valid right
A-21
to use all material Intellectual Property and Technology used in
the conduct of the business of the Company and its Subsidiaries
as currently conducted. All Company Intellectual Property Rights
and Technology owned by the Company or any of its Subsidiaries
are owned free and clear of any Liens (except Permitted Liens).
(b) Section 4.13(b) of the Company Disclosure
Schedule sets forth an accurate and complete list in all
material respects, as of the date of this Agreement, of all
registered and pending applications for Patents, Trademarks and
Copyrights and material unregistered Trademarks included in the
Company Intellectual Property Rights. All material Intellectual
Property registrations and applications set forth in
Section 4.13(b) of the Company Disclosure Schedule
are valid, subsisting and, to the Knowledge of the Company,
enforceable, and all necessary registration, maintenance,
renewal, and other relevant filing fees and actions required to
register or maintain such material Intellectual Property
registrations and applications that are due through thirty
(30) days after the Closing have been, or shall prior to
the Closing be, paid to and taken in the applicable United
States or foreign registrars.
(c) There are no material ongoing interferences,
oppositions, reissues, reexaminations, cancellations, challenges
or other proceedings involving any of the material registrations
and applications included in the Company Intellectual Property
Rights in the United States Patent and Trademark Office, the
United States Copyright Office or in any equivalent foreign
office, except for office actions and similar ex parte
proceedings in the ordinary course.
(d) To the Knowledge of the Company, the conduct of the
business of the Company and its Subsidiaries as currently
conducted and the Company Intellectual Property Rights do not
infringe on, misappropriate or otherwise violate any
Intellectual Property of any other Person in any material
respect. In the two (2) years preceding the date hereof, no
material suits, actions or proceedings are or have been pending
or, to the Knowledge of the Company, threatened in writing,
alleging that the Company or any of its Subsidiaries is
infringing, misappropriating or otherwise violating the
Intellectual Property of any other Person. To the Knowledge of
the Company, no Person is infringing, misappropriating or
otherwise violating the Company Intellectual Property Rights in
any material respect.
(e) Except in the ordinary course of business, the Company
and its Subsidiaries do not license Intellectual Property or
Technology that is material to the business of the Company and
its Subsidiaries to third Persons.
(f) The Company and its Subsidiaries take commercially
reasonable steps to protect the confidentiality of material
Trade Secrets owned or held by the Company or any of its
Subsidiaries, which steps are reasonable in view of
confidentiality practices that, to the Knowledge of the Company,
are generally engaged in within the industry in which the
Company operates.
(g) Except where the failure to do so would not have a
Company Material Adverse Effect, the Company and its
Subsidiaries have executed written agreements with (i) all
of its past and present employees involved primarily in the
development of material Company Technology and material Company
Intellectual Property, pursuant to which such employees have
assigned to the Company and its Subsidiaries all their rights in
and to all Technology and Intellectual Property they may develop
within the scope of their employment and agreed to hold all
Trade Secrets of the Company and its Subsidiaries in confidence
both during and after their employment and (ii) all past
and present consultants and independent contractors who have
been retained by or on behalf of the Company or its Subsidiaries
primarily in the development of material Company Technology and
material Company Intellectual Property, pursuant to which the
consultants and independent contractors have assigned to the
Company and its Subsidiaries all their rights in and to such
Technology and Intellectual Property and agreed to hold all
Trade Secrets of the Company and its Subsidiaries in confidence
both during and after the term of their engagements.
(h) None of the Company or any of its Subsidiaries has
licensed or provided to any third Person, or otherwise
authorized any third Person to access or use, any code for
material Software owned by the Company or any of its
Subsidiaries, except pursuant to a written confidentiality or
license agreement or as set forth in Section 4.13(h) of
the Company Disclosure Schedule. None of the Company or any
of its Subsidiaries is currently a party to any source code
escrow agreement or any other written agreement (or a party to
any written agreement obligating the Company or any of its
Subsidiaries to enter into a source code escrow agreement)
requiring the deposit of source code for any such Software,
except as set forth in Section 4.13(h) of the Company
Disclosure Schedule. None of the Company or any of its
Subsidiaries (or, to the Knowledge of the Company, any
consultant or independent contractor of the Company or any of
its Subsidiaries) has incorporated any open source
or other Software having similar licensing
A-22
or distribution models (Open Source) in any
Software owned by the Company or any of its Subsidiaries in a
manner that requires the contribution or disclosure to any third
Person, including the Open Source community, of any source code
of such Software owned by the Company or any of its Subsidiaries.
Section 4.14 Leasehold
Real Property.
(a) Section 4.14(a) of the Company Disclosure
Schedule sets forth each lease and sublease that is material
to the business of the Company and its Subsidiaries, taken as a
whole (the Company Leases). The Company has
made available to Parent or its Representatives materially true,
correct and complete copies of all Company Leases, including all
modifications and amendments thereto. Except for leases that are
no longer used or useful in the conduct of their respective
businesses or as have been disposed of in the ordinary course of
business, each Company Lease is valid and binding, free and
clear of all Liens, except for Permitted Liens, and in full
force and effect and has not been assigned.
(b) Except as would not have a Company Material Adverse
Effect, the Company and its Subsidiaries are in compliance with
the terms of all Company Leases (subject to any applicable grace
periods under such leases) to which each is a party and all such
leases are in full force and effect.
(c) Except as would not have a Company Material Adverse
Effect, to the Knowledge of the Company, there are no existing
defects due to unrestored damage or destruction by casualty, the
elements, acts of God or other events of force majeure at any of
the locations subject to Company Leases.
(d) Except as would not have a Company Material Adverse
Effect, neither the Company nor any of its Subsidiaries has
received notice of any pending, and to the Knowledge of the
Company there is no threatened, condemnation (or any consensual
agreement in lieu thereof) or rezoning application or proceeding
with respect to any of the Company Leases.
(e) None of the Company or any of its Subsidiaries owns any
real property.
Section 4.15 Labor
Matters.
(a) There are no collective bargaining or other labor union
agreements to which the Company or any of its Subsidiaries is a
party or by which the Company or any of its Subsidiaries is
bound. As of the date of this Agreement, none of the employees
of the Company or any of its Subsidiaries are represented by any
union with respect to their employment by the Company or such
Subsidiary. To the Knowledge of the Company, as of the date
hereof, there is no union organization activity involving any of
the employees of the Company or its Subsidiaries, pending or
threatened, nor has there ever been union representation
involving any of the employees of the Company or any of its
Subsidiaries.
(b) From January 1, 2009 through the date of this
Agreement, neither the Company nor any of its Subsidiaries has
experienced any material labor disputes, union organization
attempts or picketing, strikes, work stoppages, slowdowns or
lockouts or arbitrations involving any of the employees of the
Company or any of its Subsidiaries nor are any such disputes
pending or, to the Knowledge of the Company, threatened.
(c) There has been no mass layoff or
plant closing as defined by the Work Adjustment and
Retraining Notification Act and any similar state or local
mass layoff or plant closing Laws with
respect to the Company and its Subsidiaries within the six
(6) month period immediately prior to the Effective Time.
Section 4.16 Information
Supplied. None of the information supplied or
to be supplied by or on behalf of the Company for inclusion or
incorporation by reference in the Proxy Statement will, on the
date the Proxy Statement (or any amendment or supplement
thereto) is first mailed to stockholders of the Company or at
the time of the Company Special Meeting, contain any untrue
statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which
they were made, not misleading, except, in each case, that no
representation or warranty is made by the Company with respect
to statements made or incorporated by reference therein based on
information supplied by or on behalf of Parent or Merger Sub for
inclusion or incorporation by reference therein.
Section 4.17 Takeover
Laws. The Company has taken all action
necessary to exempt the Merger, this Agreement and the other
transactions contemplated hereby from the provisions of
Section 203 of the DGCL, and
A-23
such action is effective as of the date hereof. To the Knowledge
of the Company, no other state takeover statute or other similar
Law applies to the Merger, this Agreement or the other
transactions contemplated by this Agreement.
Section 4.18 Contracts.
(a) Section 4.18 of the Company Disclosure
Schedule sets forth a list, as of the date hereof, of each
Company Material Contract. For purposes of this Agreement,
Company Material Contract means any Contract
affecting the Post-Sale Company to which the Company or any of
its Subsidiaries is a party or to which any of their respective
properties or assets are bound and that:
(i) constitutes a material contract (as such
term is defined in Item 601(b)(10) of
Regulation S-K
of the SEC) of the Company;
(ii) is a joint venture, strategic alliance or partnership
agreement (other than any teaming and distribution agreements)
that is material to the operation of the Company and its
Subsidiaries, taken as whole;
(iii) is a loan, guarantee of indebtedness or credit
agreement, note, mortgage, indenture or other binding commitment
(other than those between the Company and its Subsidiaries
(excluding the Intel Companies to the extent any such
indebtedness between the Company and an Intel Company would not
be cancelled on or prior to the Intel Closing), capital lease
obligations and purchase money obligations) relating to
indebtedness for borrowed money (other than the sales of
securities subject to repurchase, in each case in the ordinary
course of business) in an amount in excess of $10,000,000
individually;
(iv) is an acquisition agreement, asset purchase agreement,
stock purchase agreement or other similar agreement entered into
after January 1, 2009 and which has not yet been
consummated, pursuant to which (A) the Company reasonably
expects that it is required to pay total consideration
(including assumption of debt) after the date hereof in excess
of $3,000,000 or (B) any other Person has the right to
acquire any assets of the Company or any of its Subsidiaries (or
any interests therein) after the date of this Agreement with a
purchase price of more than $3,000,000;
(v) (A) is currently active and involves total
estimated contract revenues (estimated as of the date hereof) to
the Company or its Subsidiaries in excess of $10,000,000 over
the entire duration of such contract (including option years),
based on the specifications contained in such contract, or
(B) is with a Governmental Entity and requires access to
information determined to be classified under Executive Order
12958, as amended;
(vi) is a contract with a supplier (including any supplier
of services) to the Company or its Subsidiaries and involves
payments by the Company or its Subsidiaries in excess of
$2,500,000 per year, other than any such Contract that is
terminable at will on sixty (60) days or less notice
without payment of a penalty in excess of $100,000;
(vii) contains any non-solicitation or
no-hire provision that restricts in any material
respect the Company or any of its Subsidiaries;
(viii) (A) is currently active and involves total
estimated contract revenues (estimated as of the date hereof) to
the Company or its Subsidiaries in excess of $5,000,000 over the
entire duration of such contract (including option years), based
on the specifications contained in such contract and
(B) contains a most favored nation right or
provision (or any similar right or provision) in favor of any
person;
(ix) involves the voting or registration of capital stock
or other equity of the Company and any of its Subsidiaries;
(x) is a standstill or similar agreement restricting the
Company from acquiring the securities of, soliciting proxies
respecting, or affecting the control of, any Person;
(xi) is a financial derivatives master agreement or other
agreement evidencing financial hedging or similar trading
activities;
(xii) grants any Person a Lien, right of first refusal,
right of first offer or similar right with respect to any
material properties, assets or businesses of the Company or any
of its Subsidiaries;
A-24
(xiii) grants the Company or its Subsidiaries the right to
use third-party Intellectual Property or Technology that is
material to the business of the Company and its Subsidiaries,
other than inbound commercial
off-the-shelf
licenses for any Software application with respect to which
Software application the Company or its Subsidiaries pays
$1,000,000 or less per year for each license;
(xiv) prohibits the Company or any of its Subsidiaries from
(a) engaging or competing in any material line of business,
in any geographical location or with any Person or
(b) selling any products or services of or to any other
Person or in any geographic region; or
(xv) commits the Company or any of its Subsidiaries to
enter into any of the foregoing.
(b) Neither the Company nor any Subsidiary of the Company
is in material breach of or material default under the terms of
any Company Material Contract, or in receipt of any written
notice of termination or cancellation under any Company Material
Contract, nor, to the Knowledge of the Company, does any
condition exist that, with notice or lapse of time or both,
would constitute a material breach of or material default under
any Company Material Contract by the Company or its Subsidiaries
party thereto. To the Knowledge of the Company, no other party
to any Company Material Contract is in material breach of or
material default under the terms of any Company Material
Contract. Each Company Material Contract is a valid and binding
obligation of the Company and, to the Knowledge of the Company,
the other parties thereto and is in full force and effect (other
than due to the ordinary expiration of the terms thereof);
except (i) as may be limited by (x) applicable
bankruptcy, insolvency, reorganization, moratorium or other
similar Laws, now or hereafter in effect, relating to
creditors rights and remedies generally and (y) the
remedies of specific performance and injunctive and other forms
of equitable relief may be subject to equitable defenses and to
the discretion of the court before which any proceeding therefor
may be brought and (ii) as would not reasonably be expected
to be material to the Company and its Subsidiaries taken as a
whole. Except as prohibited by the terms of the applicable
Company Material Contract or applicable Law, the Company has
made available to Parent or its Representatives correct and
complete copies of each Company Material Contract, together with
any and all material amendments and supplements thereto, in each
case, subject to redactions as deemed appropriate by the Company.
Section 4.19 Government
Contracts.
(a) Except as would not reasonably be expected to be
material to the Company and its Subsidiaries taken as a whole,
neither the Company nor any of its Subsidiaries has incurred or
currently projects a Total Contract Loss for any Government
Contract for the sale of goods or services by the Company or its
Subsidiaries.
(b) Since January 1, 2005, neither the Company nor any
of its Subsidiaries has made any disclosure to any Governmental
Entity pursuant to any voluntary disclosure agreement or the FAR
mandatory disclosure provisions (FAR 9.406-2, 9.407-2 &
52.203-13).
(c) None of the current material Government Contracts or
Government bids is subject to termination by a Governmental
Entity solely as a result of the execution of this Agreement.
(d) The Company and its Subsidiaries are in compliance in
all material respects with all national security obligations,
including those specified in the National Industrial Security
Program Operating Manual, DOD 5220.22-M (February 28,
2006), as amended.
Section 4.20 Security
Clearances. Section 4.20 of the
Company Disclosure Schedule sets forth a true, correct and
complete list of all facility security clearances held by the
Company and its Subsidiaries and all personnel security
clearances held by the Companys and its Subsidiaries
employees. The Company and its Subsidiaries hold and, at all
relevant times since January 1, 2005 held, at least a
satisfactory rating from the Defense Security
Service (DSS) with respect to the facility
security clearances. The clearances set forth in
Section 4.20 of the Company Disclosure Schedule are
all of the facility and personnel security clearances necessary
to conduct the business of the Company and its Subsidiaries as
currently being conducted in all material respects.
Section 4.21 Export
Controls. Section 4.21 of the Company
Disclosure Schedule sets forth the registrations
and/or
licenses of the Company and its Subsidiaries with the
Directorate of Defense Trade Controls, U.S. Department of
State under the ITAR
and/or the
Bureau of Industrial Security, U.S. Department of Commerce
under the Export Administration Regulations
(EAR). To the Knowledge of the Company, the
Company and its
A-25
Subsidiaries have not manufactured defense articles,
exported defense articles or furnished defense
services or technical data, as those terms are
defined in 22 C.F.R. Part 120, to foreign persons in
the United States or abroad except pursuant to valid licenses or
approvals or otherwise in accordance with applicable Law. The
Company and its Subsidiaries have not exported any
EAR-controlled items or technology except pursuant to valid
licenses or approvals or otherwise in accordance with applicable
Law, except as would not be material to the Company and its
Subsidiaries taken as a whole.
Section 4.22 International
Trade Laws and Regulations. The Company and
its Subsidiaries are currently in compliance with in all
material respects, and at all times since January 1, 2005,
have been in compliance with in all material respects, all
applicable International Trade Laws and Regulations.
Section 4.23 Voting
Requirements. Assuming the accuracy of the
representation given by Parent and Merger Sub in
Section 5.7, the Company Stockholder Approval is the
only vote of the holders of any class or series of capital stock
of the Company necessary to approve this Agreement and the
transactions contemplated hereby.
Section 4.24 Identity
Business Assets and Liabilities. Subject to
Section 4.3(c), (i) the assets of the Post-Sale
Company constitute all of the material assets held by the
Identity Business and used in the conduct of the Identity
Business in substantially the manner as currently conducted, and
(ii) the liabilities of the Post-Sale Company, constitute
liabilities incurred by and primarily relating to the Identity
Business.
Section 4.25 Brokers
or Finders. No investment banker, broker,
finder, consultant or intermediary other than (i) Goldman,
Sachs & Co. and (ii) Stone Key Partners LLC and
the Stone Key securities division of Hudson Partners Securities
LLC (together, Stone Key), the fees and
expenses of which will be paid by the Company, is entitled to
any investment banking, brokerage, finders or similar fee
or commission in connection with this Agreement or the
Transactions based upon arrangements made by or on behalf of the
Company or any of its Subsidiaries. The Company has heretofore
delivered to Parent a complete and correct copy of the
Companys engagement letters with the Company Financial
Advisors, which letters describe all fees payable to the Company
Financial Advisors in connection with the Transactions, all
agreements under which any such fees or any expenses are payable
in connection with the Transactions and all indemnification and
other agreements related to the engagement of the Company
Financial Advisors in connection with the Transactions.
Section 4.26 Opinion
of Financial Advisor. The Board of Directors
of the Company has received the opinions of (i) Goldman,
Sachs & Co., dated as of the date of this Agreement,
and (ii) Stone Key, dated as of the date prior to the date
of this Agreement, to the effect that, as of such date and based
upon and subject to the limitations and assumptions set forth
therein, the $12.00 per Share to be received by the holders of
Shares (other than Parent and its Affiliates) pursuant to this
Agreement is fair, from a financial point of view, to such
holders, and correct and complete copies of such opinions will
be delivered by the Company to Parent after receipt thereof by
the Company.
Section 4.27 Agreements
with Intel Buyer. As of the date hereof,
there are no agreements, arrangements or understandings (other
than as provided in this Agreement, the Intel Purchase Agreement
and a confidentiality agreement, as amended by the Co-Buyer
Disclosure Agreement) between the Company or its Affiliates, on
the one hand, and Intel Buyer or its Affiliates, on the other
hand, with respect to the Transactions. True and complete copies
of the Intel Purchase Agreement and such confidentiality
agreement have been delivered to Parent.
Section 4.28 Transferred
Intel Companies
(a) To the Knowledge of the Company, there are no
(i) Contracts with a Third Party to which any Identity
Company is or was a party which primarily relate to the
Transferred Company Business or (ii) obligations of any
Identity Company under any guaranties, bonding arrangements,
keepwells, net worth maintenance agreements, reimbursement
obligations or letters of comfort obtained by or binding the
Identity Companies for the benefit of any Transferred Intel
Company.
(b) There is no material suit, claim, action or proceeding
pending or, to the Knowledge of the Company, threatened, against
any Identity Company primarily relating to the Transferred
Company Business. To the Knowledge of the Company, no event has
occurred which, with notice or lapse of time, would result in a
material liability of any Identity Company primarily relating to
the Transferred Company Business.
A-26
Section 4.29 No
Other Representations. Except for the
representations and warranties contained in this
Article IV, neither the Company nor any other Person
acting on behalf of the Company makes any representation or
warranty, express or implied, with respect to the Company, its
Subsidiaries or with respect to any other information provided
to Parent or Merger Sub in connection with the Transactions.
Neither the Company nor any other Person will have or be subject
to any liability or indemnification obligation to Parent, Merger
Sub or any other Person resulting from the distribution to
Parent or Merger Sub, or Parents or Merger Subs use
of, any such information, including any information, documents,
projections, forecasts of other material made available to
Parent or Merger Sub in certain data rooms
(electronic or otherwise) or management presentations in
expectation of the Transactions, unless any such information is
expressly included in a representation or warranty contained in
this Article IV.
ARTICLE V
REPRESENTATIONS
AND WARRANTIES OF PARENT AND MERGER SUB
Parent and Merger Sub jointly and severally represent and
warrant to the Company as follows:
Section 5.1 Organization
and Good Standing. Each of Parent and Merger
Sub is duly organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or
organization and has the requisite corporate or similar power
and authority to own or lease all of its properties and assets
and to conduct its business as it is now being conducted, except
where the failure to be so organized, existing and in good
standing or to have such power and authority would not have a
Parent Material Adverse Effect. Each of Parent and Merger Sub is
duly qualified or licensed to do business and (to the extent
applicable) is in good standing in each jurisdiction in which
the property owned, leased or operated by it or the nature of
the business conducted by it makes such qualification or
licensing necessary, except where the failure to be so duly
qualified, licensed and in good standing would not have a Parent
Material Adverse Effect.
Section 5.2 Authorization;
Validity of Agreement; Necessary Action. Each
of Parent and Merger Sub has all requisite corporate or similar
power and authority to execute and deliver this Agreement, to
perform their respective obligations hereunder and to consummate
the transactions contemplated by this Agreement. The execution,
delivery and performance by Parent and Merger Sub of this
Agreement, and the consummation by Parent and Merger Sub of the
transactions contemplated by this Agreement, have been duly and
validly authorized by all necessary corporate action by Parent
and Merger Sub (including by each of their respective Boards of
Directors), and no other corporate action or proceeding on the
part of Parent and Merger Sub is necessary to authorize the
execution, delivery and performance by Parent and Merger Sub of
this Agreement and the consummation by them of the transactions
contemplated by this Agreement. This Agreement has been duly
executed and delivered by Parent and Merger Sub and, assuming
due authorization, execution and delivery of this Agreement by
the other parties hereto, constitutes a legal, valid and binding
obligation of each of Parent and Merger Sub, enforceable against
each of them in accordance with its terms, except that
(i) such enforcement may be subject to applicable
bankruptcy, insolvency, reorganization, moratorium or other
similar Laws, now or hereafter in effect, affecting
creditors rights and remedies generally and (ii) the
remedies of specific performance and injunctive and other forms
of equitable relief may be subject to equitable defenses and to
the discretion of the court before which any proceeding therefor
may be brought.
Section 5.3 Consents
and Approvals; No Violations.
(a) The execution and delivery by each of Parent and Merger
Sub of this Agreement do not, and the consummation of the
transactions contemplated hereby by them will not,
(i) conflict with or violate the certificate of
incorporation or bylaws (or equivalent organizational documents)
of Parent or its Subsidiaries, (ii) assuming the Consents,
registrations, declarations, filings and notices referred to in
Section 5.3(b) have been obtained or made, any
applicable waiting periods referred to therein have terminated
or expired and any condition precedent to any such Consent has
been satisfied, conflict with or violate any Law applicable to
Parent or its Subsidiaries or by which their properties or
assets is bound or affected, or (iii) result in any breach
of, or constitute a default (with or without notice or lapse of
time, or both) under, or give rise to any right of termination,
amendment, acceleration or cancellation of, any Contract to
which Parent or any of its Subsidiaries is a party or by which
any of their respective
A-27
properties or assets is bound, or result in the creation of a
Lien, other than any Permitted Lien, upon any of the material
properties or assets of Parent or any of its Subsidiaries, other
than, in the case of clauses (ii) and (iii), any such
conflict, violation, breach, default, termination, amendment,
acceleration, cancellation or Lien that would not have a Parent
Material Adverse Effect.
(b) No Consent of, or registration, declaration or filing
with, or notice to, any Governmental Entity is required to be
obtained or made by or with respect to Parent or any of its
Subsidiaries in connection with the execution, delivery and
performance of this Agreement or the consummation of the
transactions contemplated hereby, other than (i) the filing
with the SEC of such reports under the Exchange Act as may be
required in connection with this Agreement and the Transactions,
(ii) the filing of the Certificate of Merger with the
Secretary of State of the State of Delaware, (iii) such
filings as may be required in connection with the Taxes
described in Section 9.14, (iv) such other
items required solely by reason of the participation of the
Company (as opposed to any other third-party) in the
transactions contemplated hereby, (v) compliance with and
filings or notifications under (A) the HSR Act and other
applicable U.S. and
non-U.S. competition
Laws, (B) the ITAR, (vi) the filing of a joint
voluntary notice with CFIUS pursuant to Exon-Florio, and written
confirmation by CFIUS of the successful completion of the
Exon-Florio review process, (vii) such filings as may be
required in connection with FAR and the Defense Federal
Acquisition Regulation Supplement, and (viii) such
other Consents, registrations, declarations, filings or notices
the failure of which to be obtained or made would not have a
Parent Material Adverse Effect.
(c) No vote of, or consent by, the holders of any class or
series of capital stock of Parent is necessary to authorize the
execution, delivery and performance by Parent of this Agreement
and the consummation of the transactions contemplated hereby or
otherwise required by the certificate of incorporation or bylaws
of Parent, applicable Law (including any stockholder approval
provisions under the rules of any applicable securities
exchange) or any Governmental Entity.
Section 5.4 Merger
Subs Operations. Merger Sub was formed
solely for the purpose of engaging in the transactions
contemplated hereby and has not owned any assets, engaged in any
business activities or conducted any operations other than in
connection with the transactions contemplated hereby. Parent
owns beneficially (directly or indirectly) all of the
outstanding capital stock of Merger Sub.
Section 5.5 Information
Supplied. None of the information supplied or
to be supplied by or on behalf of Parent or Merger Sub for
inclusion or incorporation by reference in the Proxy Statement
will, on the date the Proxy Statement (or any amendment or
supplement thereto) is first mailed to stockholders of the
Company or at the time of the Company Special Meeting, contain
any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in
order to make the statements therein, in light of the
circumstances under which they were made, not misleading,
except, in each case, that no representation or warranty is made
by Parent or Merger Sub with respect to statements made or
incorporated by reference therein based on information supplied
by or on behalf of the Company for inclusion or incorporation by
reference therein.
Section 5.6 Sufficient
Funds. Parent has, and as of the Closing
Parent shall have, sufficient funds available (through existing
credit arrangements or otherwise) to fully fund all of
Parents and Merger Subs obligations under this
Agreement, including payment of the aggregate Merger
Consideration, the Option Consideration, the Warrant
Consideration and payment of all fees and expenses related to
the transactions contemplated by this Agreement and any
refinancing of indebtedness of Parent or the Company or their
respective Subsidiaries in connection therewith. Parent and
Merger Sub acknowledge and agree that their obligations
hereunder are not subject to any conditions regarding
Parents, Merger Subs or any other Persons
ability to obtain financing for the consummation of the
transactions contemplated by this Agreement.
Section 5.7 Share
Ownership. Neither Parent nor Merger Sub has
been, at any time during the three (3) years preceding the
date hereof, an interested stockholder of the
Company, as defined in Section 203 of the DGCL. As of the
date of this Agreement, none of Parent, Merger Sub or their
respective controlled Affiliates owns (directly or indirectly,
beneficially or of record) any Shares and none of Parent, Merger
Sub or their respective controlled Affiliates holds any rights
to acquire any Shares except pursuant to this Agreement.
Section 5.8 Investigation
by Parent and Merger Sub. Each of Parent and
Merger Sub has conducted its own independent review and analysis
of the businesses, assets, condition, operations and prospects
of the Company and
A-28
its Subsidiaries and acknowledges that each of Parent and Merger
Sub has been provided with reasonable access to the properties,
premises and records of the Company and its Subsidiaries for
this purpose. In entering into this Agreement, each of Parent
and Merger Sub has relied solely upon its own investigation and
analysis, and each of Parent and Merger Sub acknowledges that,
except for the representations and warranties of the Company
expressly set forth in Article IV, none of the
Company or its Subsidiaries nor any of their respective
Representatives makes any representation or warranty, either
express or implied, as to the accuracy or completeness of any of
the information provided or made available to Parent or Merger
Sub or any of their Representatives. Without limiting the
generality of the foregoing, none of the Company or its
Subsidiaries nor any of their respective Representatives or any
other Person has made a representation or warranty to Parent or
Merger Sub with respect to (a) any projections, estimates
or budgets for the Company or its Subsidiaries or
(b) except as expressly and specifically covered by a
representation or warranty set forth in Article IV,
any material, documents or information relating to the Company
or its Subsidiaries made available to each of Parent or Merger
Sub or their Representatives in any data room
(electronic or otherwise), confidential memorandum or otherwise.
Section 5.9 Litigation. As
of the date hereof, there is no suit, claim, action, hearing,
notice of violation, investigation, mediation, arbitration,
demand letter or any other judicial or administrative proceeding
pending or, to the Knowledge of Parent, threatened against
Parent or any of its Subsidiaries that would have a Parent
Material Adverse Effect. There are no material Judgments of any
Governmental Entity outstanding against, or, to the Knowledge of
Parent, threatened to be imposed by any Governmental Entity
involving, Parent or any of its Subsidiaries that would have a
Parent Material Adverse Effect.
Section 5.10 Brokers
or Finders. No investment banker, broker,
finder, consultant or intermediary other than Royal Bank of
Canada and Société Générale
Corporate & Investment Bank, the fees and expenses of
which will be paid by Parent, is entitled to any investment
banking, brokerage, finders or similar fee or commission
in connection with this Agreement or the Transactions based upon
arrangements made by or on behalf of Parent or any of its
Subsidiaries.
Section 5.11 Agreements
with Intel Buyer. As of the date hereof,
there are no agreements, arrangements or understandings (other
than as provided in this Agreement, the Intel Purchase Agreement
and the Co-Buyer Disclosure Agreement) between Parent or its
Affiliates, on the one hand, and Intel Buyer or its Affiliates,
on the other hand, with respect to the Transactions.
ARTICLE VI
COVENANTS
Section 6.1 Interim
Operations of the Company. The Company
covenants and agrees that, between the date of this Agreement
and the Effective Time or the date, if any, on which this
Agreement is terminated pursuant to Section 8.1,
except (i) as may be required by Law, (ii) as may be
agreed to in writing by Parent, (iii) as may be
contemplated by this Agreement or the Intel Purchase Agreement
or (iv) as set forth in Section 6.1 of the Company
Disclosure Schedule, the business of the Post-Sale Company
shall be conducted only in the ordinary course of business and
in a manner consistent with past practice in all material
respects; and, to the extent consistent therewith, the Company
shall, and shall cause its Subsidiaries to, use their respective
commercially reasonable efforts to (x) preserve
substantially intact the Post-Sale Companys business
organization and maintain the Post-Sale Companys business
relationships with material suppliers, contractors,
distributors, customers, licensors, licensees and others having
material business relationships with the Post-Sale Company; and
(y) to keep available the services of those of their
present officers, employees and consultants who are integral to
the operation of their businesses as presently conducted;
provided, however, that no action by the Company
or its Subsidiaries with respect to matters specifically
addressed by any of the following provisions of this
Section 6.1 shall be deemed a breach of this
sentence unless such action would constitute a breach of such
specific provision. Without limiting the generality of the
foregoing, the Company agrees that, between the date of this
Agreement and the Effective Time or the date, if any, on which
this Agreement is terminated pursuant to
Section 8.1, except (A) as may be required by
Law, (B) as may be agreed to in writing by Parent (which
consent shall not be unreasonably withheld, delayed or
conditioned with respect to Sections 6.1(d),
(h)(iii), (i)(i)-(iv), (n)(ii), (o)
or, with respect to the foregoing sections of
Section 6.1 only, (q)), (C) as may be
contemplated by this Agreement or the Intel Purchase Agreement
or (D) as
A-29
set forth in Section 6.1 of the Company Disclosure
Schedule, the Company shall not (and shall not permit its
Subsidiaries to), to the extent relating to the Post-Sale
Company:
(a) amend or otherwise change the Amended and Restated
Certificate of Incorporation or Amended and Restated Bylaws of
the Company or such equivalent organizational documents of any
of its Subsidiaries;
(b) split, combine, subdivide, reclassify, purchase, redeem
or otherwise acquire, or issue, sell, pledge, grant, dispose or
otherwise encumber any shares of capital stock or other equity
interests of the Company or its Subsidiaries, or any options,
warrants, calls, commitments, convertible securities or other
rights to acquire any shares of its or its Subsidiaries
capital stock, any shares of any securities convertible into or
exchangeable for such shares of capital stock, any voting
securities or other equity interests, except for transactions
among the Company and its wholly owned Subsidiaries (other than
the Intel Companies) or among the Companys wholly owned
Subsidiaries (other than among an Intel Company and another
Subsidiary), as otherwise contemplated in
Section 6.1(e) or pursuant to the exercise of any
Company Option, Company Warrant or Convertible Notes;
(c) declare, authorize, set aside, make or pay any dividend
or other distribution, payable in cash, stock, property or
otherwise, with respect to the Companys or any of its
Subsidiaries capital stock, other than dividends paid by
any Subsidiary of the Company to the Company or to any wholly
owned Subsidiary of the Company (it being understood that cash
dividends may be paid from any Intel Company to the Company or
any of its Subsidiaries subject to the Intel Agreement);
(d) (i) increase the compensation, bonus opportunity
or other benefits payable or to become payable to directors,
officers or employees of the Company or any of its Subsidiaries
except in the ordinary course of business consistent with past
practice (including, without limitation, with respect to amount
and timing) (including, for this purpose, the normal salary,
bonus and compensation review process conducted each year),
(ii) enter into any employment, deferred compensation or
similar agreement (or amendment to any such existing agreement)
with any director, officer or employee of the Company or any of
its Subsidiaries (except (A) for agreements with new
employees entered into in the ordinary course of business
consistent with past practice or (B) for extension of
employment agreements in the ordinary course of business
consistent with past practice), (iii) grant or increase any
severance or termination pay to any director, officer or
employee of the Company or any of its Subsidiaries,
(iv) establish, adopt, enter into, amend or terminate any
Benefit Plan or any plan, agreement, program, policy, trust,
fund or other arrangement that would be a Benefit Plan if it
were in existence as of the date of this Agreement, except, in
each case, as required pursuant to Contracts in effect as of the
date hereof and set forth on Section 6.1(d) of the
Company Disclosure Schedule or Benefit Plans in effect as of
the date hereof, or as otherwise required by Law or (v) pay
or accrue any bonuses in advance or prior to the time such
amounts would other be due, paid or accrued in the ordinary
course of business and in a manner consistent with the past
practices of the Company and its Subsidiaries;
(e) grant, confer or award options, convertible securities,
restricted stock units or other rights to acquire any shares of
the Companys or its Subsidiaries capital stock or
other equity interests, except as may be required under any
Contract in effect as of the date hereof and set forth on
Section 6.1(e) of the Company Disclosure Schedule;
(f) acquire, including by merger, consolidation, or
acquisition of stock or assets, any corporation, partnership,
limited liability company, other business organization or any
division thereof, or any material amount of assets, in each
case, other than (i) inventory from the Companys
suppliers in the ordinary course of business, (ii) pursuant
to acquisitions or investments with a purchase price not in
excess of $3,000,000 for any transaction individually or
$5,000,000 in the aggregate for a related series of transactions
or (iii) pursuant to Contracts as in effect as of the date
of this Agreement and set forth on Section 6.1(f) of the
Company Disclosure Schedule;
(g) make, change or revoke any material Tax election, adopt
or change any material Tax accounting method, file any material
amended Tax Return, enter into any closing agreement with
respect to a material amount of Taxes, settle any material Tax
claim or assessment or surrender any right to claim a refund of
a material amount of Taxes;
A-30
(h) incur any long-term indebtedness for borrowed money or
guarantee any such indebtedness for any Person or enter into a
keep well or similar agreement or issue or sell any
debt securities or options, warrants, calls or other rights to
acquire any debt securities of the Company or any of its
Subsidiaries, except for indebtedness (i) existing as of
the date of this Agreement or thereafter incurred under the
Companys existing credit facilities described in
Section 6.1(h) of the Company Disclosure Schedule,
(ii) for borrowed money incurred pursuant to Contracts as
in effect as of the date of this Agreement as disclosed in
Section 6.1(h) of the Company Disclosure Schedule,
(iii) except as otherwise permitted pursuant to this
Section 6.1(h), in an aggregate principal amount not
to exceed $10,000,000 to finance working capital requirements,
(iv) among the Company and any of its wholly owned
Subsidiaries or among any of such Subsidiaries (for the
avoidance of doubt, including any indebtedness or guarantees to
a Transferred Intel Company consistent with past practice in all
material respects and subject to the Intel Agreement, but only
to the extent such indebtedness or guarantees will be cancelled
or repaid on or prior to the Intel Closing), or (v) in the
form of interest rate or foreign currency swaps on customary
commercial terms consistent with past practice in all material
respects and not to exceed $10,000,000 of notional debt in the
aggregate in connection with debt permitted under this
Section 6.1(h);
(i) (i) modify, amend or terminate any Company
Material Contract other than (A) in the ordinary course of
business consistent with past practice or (B) modifications
or amendments which are immaterial; (ii) enter into any new
Contract or agreement that, if entered into prior to the date of
this Agreement, would have been required to be listed in
Section 4.18 of the Company Disclosure Schedule as a
Company Material Contract other than customer contracts entered
into in the ordinary course of business consistent with past
practice (it being understood that the foregoing exception to
this clause (ii) shall not permit the entry into any
Contract with an Affiliate or a related person (as
such terms is defined in item 404(a) of
Regulation S-K
under the Exchange Act)); (iii) enter into any material
Contract that would be breached by, or require the consent of
any third party in order to continue in full force following the
consummation of the Transactions; (iv) enter into any
material Contract with any third party that grants such third
party any rights or which provides for any diminution of rights
of the Company or its Subsidiaries or that can be terminated by
such third party, in each case, upon a change of control of the
Company; (v) release any Person from, or modify or waive
any provision of, any confidentiality, standstill or similar
agreement in connection with an Acquisition Proposal or
(vi) authorize or take any action to make the provisions of
Section 203 of the DGCL (or any other business
combination, control share acquisition,
fair price or other similar anti-takeover Law)
inapplicable to any transaction contemplated by an Acquisition
Proposal;
(j) make any material change to its methods of accounting
in effect at June 30, 2010, except (i) as required by
GAAP (or any interpretation thereof),
Regulation S-X
of the Exchange Act or as required by a Governmental Entity or
quasi-Governmental Entity (including the Financial Accounting
Standards Board or any similar organization), (ii) to
permit the audit of the Companys financial statements in
compliance with GAAP, (iii) as required by a change in
applicable Law or (iv) as disclosed in the Company SEC
Reports;
(k) sell, lease, license, transfer, mortgage or otherwise
encumber, or subject to any Lien (other than Permitted Liens) or
otherwise dispose of any material portion of its properties or
assets, other than (i) transactions among the Company and
its wholly owned Subsidiaries (except for the Intel Companies)
or among such Subsidiaries (except among an Intel Company and
another Subsidiary), (ii) inventory in the ordinary course
of business consistent with past practice, (iii) pursuant
to Contracts as in effect as of the date of this Agreement as
disclosed on Section 6.1(k) of the Company Disclosure
Schedule or (iv) as may be required by applicable Law
or any Governmental Entity in order to permit or facilitate the
consummation of the Transactions;
(l) other than as reserved for or reflected on the balance
sheets included in the Financial Statements of the Company, pay,
discharge, settle or satisfy any claims or litigation against
the Post-Sale Company for a settlement payment (i) in
excess of $500,000 individually or $3,000,000 in the aggregate
or (ii) relating to any claim by or litigation with an
employee, other than in the case of clause (ii) bona fide
settlements of claims or litigation in good faith and not
intended as compensation to such employees;
A-31
(m) make or commit to make capital expenditures (or any
obligation or liability) in excess of $2,000,000 individually or
$5,000,000 in the aggregate other than as set forth in the
Companys fiscal 2010 or 2011 capital expenditure plans set
forth in Section 6.1(m) of the Company Disclosure
Schedule;
(n) make any (i) investment (by contribution of
capital, property transfers, purchase of securities or otherwise
and other than cash management investments in the ordinary
course of business) in, or (ii) loan or advance (other than
travel and similar advances to its employees in the ordinary
course of business consistent with past practice) to, in each
case, any Person other than a direct or indirect wholly owned
Subsidiary of the Company in the ordinary course of business (it
being understood that the Company and its Subsidiaries may make
any cash management investment, loan or advance to any
Transferred Intel Company in the ordinary course of business
consistent with past practice and subject to the Intel Agreement
but only to the extent such investment, loan or advance will be
cancelled, repaid or returned on or prior to the Intel Closing);
(o) create any subsidiary of the Company, other than the
present Subsidiaries of the Company;
(p) fail in any material respect to pay any maintenance and
similar fees and take any other actions necessary to prevent the
abandonment or loss of, or which the failure to take would
reasonably be expected to result in the diminution of value of,
any material Company Intellectual Property Rights;
provided that reasonable steps taken in the course
of prosecution of any registrations or applications for
registration of Company Intellectual Property Rights will not be
deemed a breach of this Section 6.1(p); or
(q) authorize or enter into any written agreement or
otherwise make any commitment to do any of the foregoing.
Section 6.2 Notification
of Certain Matters. The Company shall give
prompt notice to Parent, and Parent shall give prompt notice to
the Company, of (i) any notice or other communication
received by such party from any Governmental Entity in
connection with this Agreement or the transactions contemplated
hereby, (ii) any notice or other communication received
from any Person alleging that the consent of such Person is or
may be required in connection with the transactions contemplated
hereby, if the subject matter of such communication or the
failure of such party to obtain such consent could be material
to the Company, the Surviving Corporation or Parent,
(iii) any actions, suits, claims, investigations or
proceedings commenced or, to such partys Knowledge,
threatened against, relating to or involving or otherwise
affecting such party or any of its Affiliates which relate to
this Agreement or the transactions contemplated hereby,
(iv) the discovery of any fact or circumstance that, or the
occurrence or non-occurrence of any event the occurrence or
non-occurrence of which, would give rise to the failure of a
condition set forth Section 7.2(a) or (b);
provided, however, that the delivery of any notice
pursuant to this Section 6.2 shall not have any
effect on the representations, warranties, covenants or
agreements contained in this Agreement for purposes of
determining satisfaction of any condition contained herein.
Section 6.3 Access
to Information. From the date hereof until
the earlier of the Effective Time or the date on which this
Agreement is terminated in accordance with its terms, the
Company shall, and shall cause each of its Subsidiaries and the
officers, directors, employees and agents of the Company and its
Subsidiaries, to afford to Parent, and to Parents
directors, officers, employees, accountants, counsel, financial
advisors, agents and other representatives (the foregoing, with
respect to any Person, its Representatives),
reasonable access during normal business hours and upon
reasonable prior notice from Parent to their respective
properties, books and records, and shall, to the extent
permitted by applicable Law, as promptly as practicable, furnish
Parent and Merger Sub (i) a copy of each report, schedule
and other document filed or submitted by it pursuant to the
requirements of federal or state securities Laws and a copy of
any communication (including comment letters)
received by the Company from the SEC concerning compliance with
securities laws, and (ii) all other information as Parent
may reasonably request regarding the business, assets,
liabilities, employees and other aspects of the Post-Sale
Company. All information exchanged pursuant to this
Section 6.3 shall be subject to the Confidentiality
Agreement and the parties shall comply with, and shall cause
their respective Representatives (as defined in the
Confidentiality Agreement) to comply with, all of their
respective obligations thereunder. Notwithstanding the
foregoing, the Company shall not be required to provide access
to, or cause its Subsidiaries to provide access to, any
information or documents which would, in the reasonable judgment
of the Company, (i) constitute a waiver of the
attorney-client or other privilege held by the Company or any of
its Subsidiaries, (ii) otherwise violate any applicable Laws,
(iii) result in a competitor of the Company or any of its
Subsidiaries receiving material information which is
competitively
A-32
sensitive or (iv) breach any agreement of the Company or
any of its Subsidiaries with any third-party; provided, that
with respect to the foregoing clauses (i) through (iv), the
Company shall use its commercially reasonable efforts to, as
applicable (A) develop an alternative to providing such
information so as to address such matters in a manner that is
reasonably acceptable to the Company, (B) obtain the
required consent of such third party to provide such access or
disclosure, or (C) in the case of clauses (i) and
(ii), enter into a joint defense agreement or implement such
other arrangements to the extent the Company reasonably
determines that doing so would permit the disclosure of such
information without jeopardizing such privilege or violating
applicable Law.
Section 6.4 Acquisition
Proposals.
(a) The Company shall, and shall cause its Subsidiaries to,
and shall direct, and use best efforts to cause, its and its
Subsidiaries respective Representatives to, immediately
cease and cause to be terminated any discussions or negotiations
with any Person (other than the Intel Buyer) conducted
heretofore with respect to an Acquisition Proposal, and use
commercially reasonable efforts to obtain the return from all
such Persons or cause the destruction of all copies of
confidential information previously provided to such parties by
the Company, its Subsidiaries or their respective
Representatives in accordance with the terms of the applicable
confidentiality agreements. Except as otherwise provided in this
Agreement, from the date of this Agreement until the Effective
Time or, if earlier, the termination of this Agreement in
accordance with its terms, the Company will not, nor shall it
authorize or permit any of its Subsidiaries to, and will use its
best efforts to cause its and their respective officers,
directors, employees and other Representatives not to,
(i) initiate, solicit, knowingly encourage (including by
way of furnishing information), or knowingly induce or knowingly
take any other action designed to or which would reasonably be
expected to, directly or indirectly, lead to the making of any
Acquisition Proposal or (ii) other than informing Persons
of the provisions contained in this Section 6.4,
participate or engage in negotiations or discussions with, or
furnish any material nonpublic information to, any Person or
take any action to knowingly facilitate any inquiries relating
to, or the making of any proposal that constitutes, or would
reasonably be expected to lead to, an Acquisition Proposal.
Notwithstanding anything to the contrary in this Agreement or
the Confidentiality Agreement, the Company shall be permitted to
notify parties to confidentiality agreements with the Company
that Parent was a Process Participant (as defined in the
Confidentiality Agreement) and may respond to inquiries from
such parties solely in respect of the same.
(b) Notwithstanding anything to the contrary in this
Agreement, at any time prior to the receipt of the Company
Stockholder Approval, in the event that the Company receives an
unsolicited, bona fide written Acquisition Proposal made after
the date hereof in circumstances not involving a breach of this
Agreement by the Company, the Company and its Board of Directors
may engage in negotiations or substantive discussions
(including, as a part thereof, making counterproposals) with, or
furnish any information and other access to, any Person making
such Acquisition Proposal and its Representatives or potential
sources of financing if the Companys Board of Directors
determines in good faith, after consultation with the
Companys outside legal and financial advisors, that
(A) such Acquisition Proposal constitutes or could
reasonably be expected to result (including after the taking of
any actions permitted by this Section 6.4(b)
following such determination by the Companys Board of
Directors) in a Superior Proposal and (B) the failure to
take such action would be reasonably likely to be inconsistent
with the directors fiduciary duties to the stockholders of
the Company under applicable Law; provided that
(x) prior to furnishing any material nonpublic information,
the Company receives from such Person an executed
confidentiality agreement containing terms that are not
materially less favorable to the Company than those contained in
the Confidentiality Agreement (it being understood and agreed
that such confidentiality agreement need not restrict the making
of Acquisition Proposals (and related communications) to the
Company or the Companys Board of Directors, and shall
contain provisions that expressly permit the Company to comply
with the provisions of this Section 6.4); provided
that such confidentiality agreement may not include any
provision calling for an exclusive right to negotiate with the
Company; and (y) any such material nonpublic information so
furnished has been previously provided to Parent or is provided
to Parent substantially concurrently with it being so furnished
to such Person or its Representatives. The Company shall provide
Parent with a correct and complete copy of any confidentiality
agreement entered into pursuant to this paragraph within
twenty-four (24) hours of the execution thereof. The
Company shall direct, and use commercially reasonable efforts to
ensure that its Representatives are aware of the provisions of
this Section 6.4(b). Without limiting the foregoing,
it is understood that any violation of the foregoing
restrictions by the Companys Subsidiaries or
Representatives shall be deemed to be a breach of this
A-33
Section 6.4(b) by the Company. Nothing in this
Agreement shall restrict the Company from taking or disclosing a
position contemplated by
Rules 14d-9
or 14e-2(a)
under the Exchange Act, or otherwise making disclosure to comply
with applicable Law; provided, that any such disclosure that
constitutes a Change in Recommendation shall be subject to
Section 6.4(c) (it being agreed that a stop,
look and listen communication by the Board of Directors to
the Companys stockholders pursuant to
Rule 14d-9(f)
under the Exchange Act or a factually accurate public statement
by the Company that describes the Companys receipt of an
Acquisition Proposal and the operation of this Agreement with
respect thereto shall not be deemed to be a Change in
Recommendation).
(c) Except as expressly provided or permitted by this
Section 6.4(c), the Board of Directors of the
Company shall not (i) (A) withdraw (or modify in a manner
adverse to Parent or Merger Sub), or publicly propose to
withdraw (or so modify), the recommendation by the Board of
Directors of the Company of the Merger or this Agreement or
(B) recommend, adopt or approve, or propose publicly to
recommend, adopt or approve, any Acquisition Proposal
(including, for these purposes (but subject to the parenthetical
in the last sentence of Section 6.4(b), which
disclosures shall not constitute the recommendation of an
Acquisition Proposal), by taking no position with respect to the
acceptance by the Companys stockholders of a tender or
exchange offer, which shall constitute the recommendation of an
Acquisition Proposal) (any action described in this
clause (i) being referred to as a Change in
Recommendation) or (ii) approve or recommend, or
allow the Company or any of its Affiliates to execute or enter
into, any letter of intent, memorandum of understanding,
agreement in principle, merger agreement, acquisition agreement,
option agreement, joint venture agreement, partnership agreement
or other similar agreement constituting or related to, or that
is intended to or would reasonably be expected to lead to, any
Acquisition Proposal (other than a confidentiality agreement
referred to in Section 6.4(b)). Notwithstanding
anything in this Agreement to the contrary, at any time prior to
the receipt of the Company Stockholder Approval, the Board of
Directors of the Company may make a Change in Recommendation if
the Board of Directors of the Company determines in good faith
(after consultation with its outside legal and financial
advisors) that the failure to take such action would be
reasonably likely to be inconsistent with the directors
fiduciary duties to the stockholders of the Company under
applicable Law either (i) based only upon any fact, event,
circumstance, development or change that is unknown to the
Companys Board of Directors as of the date hereof but
becomes known prior to the Company Special Meeting (or if known,
the magnitude or consequences of which were not reasonably
foreseeable by the Companys Board of Directors as of the
date hereof) (an Intervening Event), or
(ii) if the Board of Directors of the Company determines in
good faith (after consultation with its outside legal and
financial advisors) that the Company has received an Acquisition
Proposal which constitutes a Superior Proposal; provided,
however, that no Change in Recommendation may be made
(A) until after the fifth (5th) Business Day following
Parents receipt of written notice from the Company
advising Parent that the Board of Directors of the Company
intends to make a Change in Recommendation (a Notice of
Adverse Recommendation) and specifying the reasons
therefor, including, if the basis of the proposed action by the
Companys Board of Directors is (x) an Intervening
Event, details of such event or (y) a Superior Proposal,
the terms and conditions of any such Superior Proposal (it being
understood and agreed that any amendment to the financial terms
or any other material term of such Superior Proposal shall
require a new Notice of Adverse Recommendation and a new five
(5) Business Day period) and (B) provided, that,
during the five (5) Business Day period following the date
of receipt of the Notice of Adverse Recommendation, if requested
by Parent, the Company shall engage in good-faith negotiations
with Parent to amend this Agreement in such a manner that
(v) the Intervening Event is no longer a basis for a Change
in Recommendation or (w) the Acquisition Proposal that was
determined to constitute a Superior Proposal is no longer a
Superior Proposal, as applicable. Any Notice of Adverse
Recommendation shall be accompanied by a copy of the most
current version of any written agreement (or draft thereof)
relating to the transaction that constitutes the related
Superior Proposal. In determining whether to make a Change in
Recommendation or in determining whether an Acquisition Proposal
constitutes a Superior Proposal, the Board of Directors of the
Company shall take into account any changes to the terms of this
Agreement proposed by Parent (which changes may be based on
changes to the terms of the Intel Purchase Agreement proposed by
Intel Buyer) in response to a Notice of Adverse Recommendation
or otherwise. Notwithstanding any other provisions of this
Agreement, in the event Parent receives a Notice of Adverse
Recommendation, Parent may, during such five (5) Business
Day period, engage in discussions with the Intel Buyer with
respect to modifications to the Intel Purchase Agreement related
to such good faith negotiations with Parent and enter into any
agreement, arrangement or understanding in furtherance thereof
provided that such agreement, arrangement or understanding is
not materially adverse to the Company; it being understood and
agreed
A-34
that any agreement, arrangement or understanding which limits or
impairs the ability of the Intel Buyer to engage in discussions
with or provide information to any Person shall be deemed
materially adverse to the Company.
(d) In addition to the other obligations of the Company set
forth in this Section 6.4, the Company shall
promptly advise Parent in writing of any Acquisition Proposal,
and in no event later than twenty-four (24) hours after
receipt, if any proposal, offer or inquiry is received by, any
information is requested from, or any discussions or
negotiations are sought to be initiated or continued with, the
Company in respect of any Acquisition Proposal (including any
changes thereto) and the identity of the Person making any such
proposal, offer or inquiry and the terms and conditions thereof
(and shall include with such notice copies of any written
materials received from or on behalf of such Person relating to
any Acquisition Proposal). The Company shall (i) keep
Parent promptly and reasonably informed of all material
developments affecting the status and material details
(including any material change to the terms thereof) of any such
Acquisition Proposal and any discussions and negotiations
concerning the material terms and conditions thereof and
(ii) provide to Parent as soon as practicable after receipt
or delivery thereof copies of all material written
correspondence relating to any such Acquisition Proposal
exchanged between the Company or any of its Subsidiaries, on the
one hand, and the Person making the proposal, offer, inquiry or
request, on the other hand.
Section 6.5 Employee
Benefits.
(a) For eighteen (18) months following the Effective
Time, subject to any requirements imposed by local Law, Parent
shall, and shall cause its Affiliates (including the Surviving
Corporation and its Subsidiaries) to, provide to those
individuals who are employed by the Post-Sale Company
immediately prior to the Effective Time (the Continuing
Employees) and who remain in the employment of the
Surviving Corporation (i) base salary or hourly wage rates
that, on an
individual-by-individual
basis, are no less favorable than those provided to such
Continuing Employees immediately prior to the Effective Time
(ii) total incentive compensation opportunities (excluding
any (A) equity or equity-based compensation opportunities
and (B) retention and other incentives implemented in
connection with the Transactions) that, on an
individual-by-individual
basis, are no less favorable than the total incentive
compensation opportunities (excluding any (A) equity or
equity-based compensation opportunities, except to the extent
deemed appropriate by Parent, and (B) retention and other
incentives implemented in connection with the Transactions)
available to such Continuing Employees immediately prior to the
Effective Time; and (iii) employee benefits (excluding
defined benefit and other pension plans) that are substantially
comparable in the aggregate to the employee benefits (excluding
defined benefit and other pension plans) provided to such
Continuing Employees immediately prior to the Effective Time.
Parent shall have no obligation to provide equity based
incentives or defined benefit or other pension plans to the
Continuing Employees following the Effective Time. Parent shall,
and shall cause its Affiliates (including the Surviving
Corporation and its Subsidiaries) to, cause any employee benefit
plans covering any of the Continuing Employees following the
Effective Time (collectively, the Post-Closing
Plans) to recognize the service of each Continuing
Employee (to the extent such service was recognized by the
Company and its Affiliates under Benefit Plans) for all purposes
of vesting, eligibility and benefit entitlement (but excluding
benefit accruals), except to the extent such service credit
would result in a duplication of benefits for the same period.
Parent shall cause each Post-Closing Plan to waive pre-existing
condition limitations to the extent waived or not applicable
under the analogous Benefit Plan, and Parent shall cause the
Continuing Employees to be given credit under the applicable
Post-Closing Plan for amounts paid prior to the Effective Time
during the year in which the Effective Time occurs under a
corresponding Benefit Plan during the same period for purposes
of applying deductibles, co-payments and
out-of-pocket
maximums as though such amounts had been paid in accordance with
the terms and conditions of the Post-Closing Plan.
(b) Parent and the Company hereby agree that the occurrence
of the Effective Time shall constitute a Change in
Control for purposes of all Benefit Plans in which the
term is relevant.
(c) For eighteen (18) months following the Effective
Time, Parent shall, and shall cause its Affiliates (including
the Surviving Corporation and its Subsidiaries) to, pay to any
Continuing Employee whose service with Parent and its Affiliates
is terminated during such eighteen (18) month period
severance benefits that are no less favorable than those
provided to such Continuing Employee under the terms of the
Company severance plan or program in which such individual is
eligible to participate as of the date hereof.
A-35
(d) Following the date hereof, Parent and the Company shall
cooperate, and the Company shall take all actions reasonably
requested by Parent, on or prior to December 31, 2010, as
are necessary to reduce
and/or avoid
the application of Section 280G of the Code to the payments
to be made to the individuals whose names are set forth on
Section 6.5(g) of the Company Disclosure Schedule
(which actions may include, for example, accelerating the
vesting or payment of equity awards or accelerating the payment
of 2010 bonuses); provided, that in determining whether a Parent
request is reasonable, the Company shall take into account
potential material financial effects on the executives as well
as the Companys ability to retain the executives in the
event the Closing does not occur.
(e) Notwithstanding the foregoing, no provision of this
Agreement shall (i) create any right in any employee to
continued employment by Parent, the Company, the Post-Sale
Company, the Surviving Corporation or any respective Subsidiary
thereof, or preclude the ability of Parent, the Company, the
Surviving Corporation or any respective Subsidiary thereof to
terminate the employment of any employee for any reason or
(ii) require Parent, the Company, the Post-Sale Company,
the Surviving Corporation, or any respective Subsidiary thereof,
to continue any Benefit Plan or prevent the amendment,
modification, or termination thereof in accordance with plan
terms after the Closing Date.
(f) This Section 6.5 shall be binding upon and
shall inure solely to the benefit of each of the parties to this
Agreement, and nothing in this Section 6.5, express
or implied, is intended to confer upon any other Person any
rights or remedies of any nature whatsoever under or by reason
of this Section 6.5 or is intended to be, shall
constitute or be construed as an amendment to or modification of
any employee benefit plan, program, arrangement or policy of
Parent, the Company, the Post-Sale Company, the Surviving
Corporation or any respective Subsidiary thereof.
(g) Immediately following the Closing, Parent shall cause
the Surviving Corporation to terminate the employment of the
individuals listed on Section 6.5(g) of the Company
Disclosure Schedule. Parent agrees that such terminations
shall be treated as terminations of employment by the Surviving
Corporation without cause for purposes of the
employment agreements entered into between the Company and such
individuals. Parent shall cause the Surviving Corporation to pay
each such individual all amounts contemplated for payment to
such individual by his or her employment agreement, in each case
in the manner and as determined by the terms of his or her
employment agreement in effect on the date hereof, and in each
case consistent with the methodologies utilized by the Company
in the calculations previously delivered by the Company to
Parent on September 14, 2010.
Section 6.6 Publicity. Neither
the Company nor Parent (nor any of their respective Affiliates)
shall issue any press release or make any public announcement
with respect to this Agreement or the transactions contemplated
hereby without the prior agreement of the other party (and none
of Parent or its Affiliates shall issue or make any press
release or other public announcement with respect to the Intel
Purchase Agreement or the Intel Transaction without the prior
agreement of the Company). Notwithstanding the foregoing, with
respect to any communications to be delivered orally, including
by conference call or webcast, this Section 6.6
shall be deemed satisfied if, to the extent practicable, the
disclosing party gives advance notice of such disclosure to the
other party, including copies of any talking points, scripts or
similar documents, and consults with the other party and
considers in good faith any comments by such other party with
respect thereto; provided, however, the prior
agreement of the other party shall be required with respect to
such disclosures to the extent that the non-disclosing party
reasonably determines that any such disclosure would be
materially adverse to the non-disclosing party. Notwithstanding
the foregoing sentences of this Section 6.6,
(i) each party shall be permitted to issue any press
release or make any public announcement or disclosure as
provided by this Agreement or as may be required by Law or by
any listing agreement with a national securities exchange, in
which case the party proposing to issue such press release or
make such public announcement or disclosure shall use its
reasonable efforts to consult in good faith with the other party
before making any such public announcements, and
(ii) either party may make any oral or written public
announcements, releases or statements without complying with the
foregoing procedures if the substance of such announcements,
releases or statements was publicly disclosed and previously
subject to the foregoing requirements for agreement
and/or
consultation and consideration. For the avoidance of doubt, the
Company will no longer be required to consult with Parent in
connection with any such press release or public announcement if
the Companys Board of Directors has effected any Change in
Recommendation or shall have resolved to do so.
A-36
Section 6.7 Directors
and Officers Insurance and Indemnification.
(a) Parent and Merger Sub agree that all rights to
exculpation and indemnification for acts or omissions occurring
at or prior to the Effective Time, whether asserted or claimed
prior to, at or after the Effective Time (including any matters
arising in connection with the Transactions), now existing in
favor of the Company Indemnified Parties as provided in the
organizational documents of the Company or its Subsidiaries or
in any Contract, in each case as in effect on the date of this
Agreement, accurate and complete copies of which (or forms
thereof) have been provided to Parent (except as provided
herein), shall survive the Merger and shall continue in full
force and effect. Parent shall (and Parent shall cause the
Surviving Corporation to) (A) indemnify, defend and hold
harmless, and advance expenses to D&O Indemnified Parties
with respect to all acts or omissions by them in their
capacities as such at any time prior to the Effective Time
(including any matters arising in connection with the
Transactions), to the fullest extent that the Company or its
Subsidiaries would be permitted by applicable Law and
(B) indemnify, defend and hold harmless, and advance
expenses to Company Indemnified Parties with respect to all acts
or omissions by them in their capacities as such at any time
prior to the Effective Time (including any matters arising in
connection with the Transactions) to the fullest extent required
by the organizational documents of the Company or its
Subsidiaries as in effect on the date of this Agreement;
provided that in the case of clauses (A) and (B),
the Person to whom expenses are advanced provides a customary
undertaking to repay such advances if it is finally determined
that such Person was not entitled to indemnification with
respect to the applicable act or omission. Parent shall cause
the certificate of incorporation, bylaws or other organizational
documents of the Surviving Corporation and its Subsidiaries to
contain provisions with respect to indemnification, advancement
of expenses and limitation of director, officer, member of board
of managers and employee liability that are no less favorable to
the Company Indemnified Parties than those set forth in the
Companys and its Subsidiaries organizational
documents as of the date of this Agreement, which provisions
thereafter shall not be amended, repealed or otherwise modified
in any manner that would adversely affect the rights thereunder
of the Company Indemnified Parties, unless such modification
shall be required by applicable Law.
(b) Without limiting the provisions of
Section 6.7(a), to the fullest extent that the
Company would be permitted by applicable Law to do so, Parent
shall (and shall cause the Surviving Corporation to):
(i) indemnify and hold harmless each D&O Indemnified
Party against and from any costs or expenses (including
reasonable attorneys fees), judgments, fines, losses,
claims, damages, liabilities and amounts paid in settlement in
connection with any claim, action, suit, proceeding or
investigation, whether civil, criminal, administrative or
investigative, to the extent such claim, action, suit,
proceeding or investigation arises out of or pertains to:
(A) any action or omission or alleged action or omission
taken or not taken in such D&O Indemnified Partys
capacity as a director, officer or employee of the Company or
any of its Subsidiaries prior to the Effective Time; or
(B) this Agreement, the Intel Purchase Agreement and any of
the Transactions; and (ii) pay in advance of the final
disposition of any such claim, action, suit, proceeding or
investigation the reasonable expenses (including attorneys
fees) of any D&O Indemnified Party upon receipt of an
undertaking by or on behalf of such D&O Indemnified Party
to repay such amount if it shall ultimately be determined that
such D&O Indemnified Party is not entitled to be
indemnified; provided, however, that Parent and
the Surviving Corporation shall not be liable for any settlement
effected without Parents or the Surviving
Corporations prior written consent (such consent not to be
unreasonably withheld, conditioned or delayed). Notwithstanding
anything to the contrary contained in this
Section 6.7(b) or elsewhere in this Agreement,
Parent shall not (and Parent shall cause the Surviving
Corporation not to) settle or compromise or consent to the entry
of any judgment or otherwise seek termination with respect to
any claim, action, suit, proceeding or investigation, unless
such settlement, compromise, consent or termination includes an
unconditional release of all of the D&O Indemnified Parties
covered by the claim, action, suit, proceeding or investigation
from all liability arising out of such claim, action, suit,
proceeding or investigation.
(c) Parent shall provide or cause the Surviving Corporation
to provide, for a period of not less than six (6) years
after the Effective Time, the D&O Indemnified Parties who
are insured under the Companys directors and
officers insurance and indemnification policies (a correct
and complete copy of which has been made available to Parent)
with insurance and indemnification policies, or tail
policies, in each case, that provides coverage for events
occurring at or prior to the Effective Time (the
D&O Insurance) that is no less favorable
than the existing policies of the Company or, if substantially
equivalent insurance coverage is unavailable, the best available
coverage; provided, however, that Parent and the
Surviving Corporation shall not be required to pay an annual
A-37
premium for the D&O Insurance (or an amount for any such
tail policy) in excess of three hundred percent
(300%) of the last annual premium paid by the Company for such
insurance prior to the date hereof; provided,
further, that if the annual premiums of such insurance
coverage (or cost of such tail policy) exceed such amount,
Parent and the Surviving Corporation shall be obligated to
obtain policies (or a tail policy) with the greatest
coverage available for a cost not exceeding such amount. The
D&O Indemnified Parties may be required to make reasonable
application and provide reasonable and customary representations
and warranties to applicable insurance carriers for the purpose
of obtaining such insurance.
(d) The D&O Indemnified Parties and Company
Indemnified Parties to whom this Section 6.7 applies
shall be third-party beneficiaries of this
Section 6.7. The provisions of this
Section 6.7 are intended to be for the benefit of
each D&O Indemnified Party and Company Indemnified Party
and his or her successors, heirs or representatives. Parent
shall pay all reasonable expenses, including reasonable
attorneys fees, that may be incurred by any D&O
Indemnified Party or Company Indemnified Party in enforcing its
indemnity and other rights under this Section 6.7.
(e) Notwithstanding any other provision of this Agreement,
this Section 6.7 shall survive the consummation of
the Merger indefinitely and shall be binding, jointly and
severally, on all successors and assigns of Parent and the
Surviving Corporation, and shall be enforceable by the D&O
Indemnified Parties and Company Indemnified Parties and their
successors, heirs or representatives. In the event that Parent
or the Surviving Corporation or any of its successors or assigns
consolidates with or merges into any other Person and shall not
be the continuing or surviving Person of such consolidation or
merger, or transfers or conveys all or a majority of its
properties and assets to any Person, then, and in each such
case, proper provision shall be made so that the successors and
assigns of Parent or the Surviving Corporation, as applicable,
shall succeed to the obligations set forth in this
Section 6.7.
(f) From and after the Closing, Parent shall, and shall
cause the Surviving Corporation to, honor the director and
officer litigation reimbursement policy in effect as of the date
hereof, a copy of which is set forth in Section 6.7(f)
of the Company Disclosure Schedule.
Section 6.8 Company
Special Meeting; Proxy Statement.
(a) As soon as reasonably practicable following the date of
this Agreement, the Company shall prepare with Parent and file
with the SEC a preliminary Proxy Statement and furnish the
information required to be provided to the stockholders of the
Company pursuant to the DGCL and any other applicable Laws. The
Company shall use its reasonable efforts to respond to any
comments of the SEC or its staff and cause the Proxy Statement
to be mailed to the stockholders of the Company as soon as
reasonably practicable after the Proxy Statement has been
cleared by the SEC for mailing to the stockholders of the
Company. Each of the Company and Parent shall supply such
information specifically for inclusion or incorporation by
reference in the Proxy Statement necessary so that, at the date
it is first mailed to the Companys stockholders or at the
time of the Company Special Meeting, the Proxy Statement shall
not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of
the circumstances under which they are made, not misleading.
Each of the parties hereto shall use their reasonable efforts so
that the Proxy Statement will comply as to form in all material
respects with the requirements of the Exchange Act and the rules
and regulations thereunder. If at any time prior to the
Effective Time any information relating to Parent or the Company
or any of their respective Affiliates, officers or directors
should become known to Parent or the Company which should be set
forth in an amendment or supplement to the Proxy Statement, so
that such document would not include any untrue statement of a
material fact or omit to state any material fact necessary to
make the statements therein, in light of the circumstances under
which they were made, not misleading, the party which discovers
such information shall promptly notify the other parties hereto
and an appropriate amendment or supplement describing such
information shall be promptly filed with the SEC and, to the
extent required by Law, disseminated to the stockholders of the
Company. The Company agrees to provide Parent and its counsel
any comments or communications, whether written or oral, that
the Company or its counsel may receive from time to time from
the SEC or its staff with respect to the Proxy Statement
promptly after receipt of such comments or communications. Prior
to the filing or mailing of the Proxy Statement (or any
amendment or supplement thereto) or responding to any comments
of the SEC or its staff with respect thereto, Parent and its
counsel shall be given a reasonable opportunity to review and
comment on such document or any proposed responses to such
comments or communications, and the
A-38
Company shall give due consideration to all reasonable
additions, deletions or changes suggested thereto by Parent and
its counsel.
(b) The Company shall, as soon as reasonably practicable
after the Proxy Statement is cleared by the SEC for mailing to
the stockholders of the Company, in accordance with applicable
Law and its Amended and Restated Certificate of Incorporation
and Amended and Restated Bylaws, establish a record date for,
duly call, give notice of, convene and hold a special meeting of
the Companys stockholders (including any adjournment or
postponement thereof, the Company Special
Meeting) for the purpose of obtaining the Company
Stockholder Approval. The Companys obligations pursuant to
this Section 6.8 shall not be diminished or
otherwise affected by (i) the receipt, disclosure or
commencement of any Acquisition Proposal (whether or not a
Superior Proposal) or (ii) any proposed or actual change,
qualification, withdrawal or modification of the Company Board
Recommendation.
(c) The Company shall, through the Board of Directors of
the Company (in the case of clauses (i) and (ii)), but
subject to the right to make a Change in Recommendation in
accordance with Section 6.4, (i) recommend to
the stockholders of the Company that such stockholders adopt
this Agreement and give the Company Stockholder Approval (the
Company Board Recommendation),
(ii) include the Company Board Recommendation in the Proxy
Statement and (iii) use reasonable best efforts to solicit
the Company Stockholder Approval. If there shall have been a
Change in Recommendation, the Company shall nevertheless submit
this Agreement and the Merger to a vote of its stockholders, and
the Proxy Statement and any and all accompanying materials
(including, if the Change in Recommendation occurs after the
mailing of the Proxy Statement to stockholders of the Company,
the proxy card, which shall provide that signed proxies which do
not specify the manner in which the Shares subject thereto are
to be voted shall be voted FOR adopting this
Agreement) shall be identical in form and content to proxy
materials that would have been prepared by the Company had no
Change in Recommendation been made, except for appropriate
changes to the disclosure in the Proxy Statement stating that
such Change in Recommendation has been made and, if applicable,
describing matters relating to the Superior Proposal or
Intervening Event giving rise to the Change in Recommendation to
the extent required by applicable Law, and provided that the
Company shall not be obligated to recommend to its stockholders
the adoption of this Agreement or the approval of the Merger at
the Company Special Meeting if the Board of Directors of the
Company shall have made a Change in Recommendation in accordance
with Section 6.4. Prior to any Change in
Recommendation, the Company shall provide Parent with such
information with respect to the solicitation of the Company
Stockholder Approval as Parent may reasonably request.
Section 6.9 Appropriate
Actions.
(a) Upon the terms and subject to the conditions set forth
in this Agreement, each of the parties hereto shall (and shall
cause their applicable Subsidiaries to) use its respective
reasonable best efforts promptly to (i) take, or to cause
to be taken, all actions, and to do, or to cause to be done, and
to assist and cooperate with the other parties in doing all
things necessary, proper or advisable under applicable Law or
otherwise to consummate and make effective the Transactions in
the most expeditious manner practicable; (ii) obtain from
any Governmental Entities any actions, non-actions, clearances,
waivers, consents, approvals, permits or orders required to be
obtained by the Company or Parent or any of their Subsidiaries
in connection with the authorization, execution, delivery and
performance of this Agreement and the consummation of the
transactions contemplated hereby; (iii) make all
registrations, filings, notifications or submissions
(Filings) (in each case, promptly after the
date of this Agreement) which are necessary or advisable, and
thereafter promptly make any other required submissions and
responses, with respect to the transactions contemplated by this
Agreement including (A) those required under the HSR Act
and such other foreign antitrust, competition or merger control
Law, as listed on Annex A (except as otherwise
agreed by the parties, such Filings under the HSR Act shall be
made no later than ten (10) Business Days after the date of
this Agreement, and such foreign Filings shall be made no later
than twenty (20) Business Days after the date of this
Agreement), except any foreign Filings that must be filed by an
earlier date (B) the actions with respect to CFIUS and FOCI
mitigation described in Section 6.9(c), and
(C) Filings required under any other applicable Law,
including submission of notification of the transactions
contemplated by this Agreement to the United States Department
of State at least sixty (60) days in advance of Closing
pursuant to 22 C.F.R. § 122.4(b);
(iv) furnish all information reasonably required for any
Filings to be made pursuant to any applicable Law in connection
with the transactions contemplated by this Agreement;
(v) act in good faith and reasonably cooperate with the
other parties in connection with any Filings (including to
provide copies of all such Filings to outside
A-39
counsel for the non-filing party and, if requested by the other
party, to consider in good faith all reasonable additions,
deletions or changes suggested by the other party);
(vi) keep the other party informed in all material respects
of any material communication received by such party from, or
given by such party to, any Governmental Entity and of any
material communication received or given in connection with any
proceeding by a private party, in each case, relating to the
transactions contemplated by this Agreement; (vii) provide
the other parties prior notice of any communication with, and
any proposed understanding, undertaking or agreement with, any
Governmental Entity regarding any Filings; (viii) consult
and cooperate with each other party in connection with any
analyses, appearances, presentations, memoranda, briefs,
arguments, opinions and proposals made or submitted by or on
behalf of any party in connection with proceedings relating to
or arising out of the Filings; (ix) not participate
independently in any meeting, primarily relating to the
transactions contemplated by this Agreement and involving any
substantive conversation, with any Governmental Entity in
respect of any such Filings or any investigations or other
inquiries relating thereto without giving the other parties
prior notice of the meeting or conversation and, unless
prohibited by such Governmental Entity, the opportunity to
attend or participate; (x) obtain all necessary consents,
approvals or waivers under Contracts with third parties
(provided that none of the Company, Parent or Merger Sub shall
be required to make any payments to any such third parties or
concede anything of value to obtain such consents, approvals or
waivers); (xi) avoid the entry of, or have vacated or
terminated, any decree, order, or judgment that would restrain,
prevent or delay the consummation of the transactions
contemplated hereby, including vigorously defending any lawsuits
or other legal proceedings, whether judicial or administrative,
challenging this Agreement or the transactions contemplated
hereby; (xii) in the case of the Company only,
(A) obtain novation or termination of each contract
(including those contracts listed in Section 6.9(a) of
the Company Disclosure Schedule) performed at a Company
facility other than the Arlington, Virginia facility
(Other Facilities) that would involve access
to classified information, or that would require the Company to
hold a Facility Security Clearance (FCL) or
any of the Companys personnel to hold a Personnel Security
Clearances (PCL) (a 6.9(a)(1)
Contract), (B) terminate all FCLs and related
PCLs at all Other Facilities pursuant to
Section 2-110
of the NISPOM, (C) receive written confirmation that each
such FCL and related PCL was terminated and (D) obtain the
assignment or termination of the contract set forth on
Section 6.9(a)(2) of the Company Disclosure
Schedule; and (xiii) execute and deliver any additional
instruments necessary to consummate the transactions
contemplated hereby. No parties to this Agreement shall consent
to any voluntary delay of the consummation of the transactions
contemplated hereby at the behest of any Governmental Entity
without the consent of the other parties to this Agreement, it
being understood that withdrawal of a Filing and subsequent
refiling thereof by a party shall require the consent of the
other party.
(b) Notwithstanding Section 6.9(a), or any
other provision of this Agreement, the Company shall not,
without Parents prior written consent, commit to any
divestiture transaction or, subject to the terms of
Section 6.9(c), agree to any restriction on its
business, and nothing in this Section 6.9 shall
(i) limit any applicable rights a party may have to
terminate this Agreement pursuant to Section 8.1 so
long as such party has up to then complied in all material
respects with its obligations under this
Section 6.9, or (ii) require Parent to offer,
accept or agree to (A) sell, divest, dispose of, or,
subject to the terms of Section 6.9(c), hold
separate any part of its or the Companys businesses,
operations, assets or product lines (or a combination of
Parents and the Companys respective businesses,
operations, assets or product lines), (B) not compete in
any geographic area or line of business,
and/or
(C) subject to the terms of Section 6.9(c),
restrict the manner in which, or whether, Parent, the Company,
the Surviving Corporation or any of their Affiliates may carry
on business in any part of the world. Notwithstanding anything
to the contrary contained herein, Parent
and/or
Merger Sub shall not be required to agree to sell, divest,
dispose of or, subject to the terms of
Section 6.9(c), hold separate any assets or
businesses, or, subject to the terms of
Section 6.9(c), otherwise take or commit to take any
action that could reasonably be expected to limit its freedom of
action with respect to, or ability to retain, one or more of the
Companys businesses, product lines or assets.
(c) In connection with and without limiting anything in
this Agreement, as soon as practicable after the date hereof,
Parent and the Company shall prepare, prefile and file with
CFIUS a joint voluntary notice of the transactions contemplated
hereby pursuant to Exon-Florio. Parent and the Company shall
each, to their fullest ability, provide CFIUS with any
additional or supplemental information requested by CFIUS or its
member agencies during the Exon-Florio review process. Subject
to the terms and conditions set forth in this
Section 6.9(c), Parent and the Company, in
cooperation with each other, shall each use reasonable best
efforts to take all steps advisable, necessary or desirable to
finally and successfully complete the Exon-Florio review process
as promptly
A-40
as practicable and to make any and all commercially reasonable
undertakings necessary to obtain a written notification issued
by CFIUS that it has concluded its review (or, if CFIUS deems a
forty-five (45) day investigation necessary, its
investigation) and determined that there are no unresolved
national security concerns with respect to the transactions
contemplated hereby so as to enable the consummation of the
transactions contemplated hereby to occur as soon as reasonably
possible (and in any event, with the consummation of the Merger
to occur no later than the Termination Date). In addition, as
soon as practicable after the date hereof, the Company shall
prepare and submit to the DSS of the United States Department of
Defense (DoD) and, to the extent applicable,
any other agency of the United States Government, notification
of the transactions contemplated hereby pursuant to the NISPOM
and any other applicable national or industrial security
regulations, and the Company shall fully cooperate with Parent
in requesting from DSS approval to operate the business of the
Company, located in Arlington, Virginia, pursuant to a FOCI
mitigation arrangement in accordance with the NISPOM and the
remainder of the Companys business free of any such NISPOM
mitigation arrangement. Such cooperation by the Company shall
include using its reasonable best efforts to novate or terminate
each 6.9(a)(1) Contract. The Company, Parent, and Merger Sub
each agrees to take any and all commercially reasonable steps,
including agreeing to actions, restrictions or conditions
proposed by CFIUS or any other agency or branch of the
U.S. Government, including the DoD, as a condition to
obtaining CFIUS and DoD approval for the transactions
contemplated hereby on the terms above.
(d) The Company and its Board of Directors shall
(i) use their commercially reasonable efforts to ensure
that no state takeover statute or similar statute or regulation
is or becomes applicable to the transactions contemplated by
this Agreement and (ii) if any state takeover statute or
similar statute becomes applicable to the transactions
contemplated by this Agreement, use their commercially
reasonable efforts to ensure that such transactions may be
consummated as promptly as practicable on the terms contemplated
by this Agreement and otherwise to minimize the effect of such
statute or regulation on the transactions contemplated by this
Agreement.
Section 6.10 Merger
Sub and Surviving Corporation. Parent shall
take all actions necessary to (a) cause Merger Sub and the
Surviving Corporation to perform promptly their respective
obligations under this Agreement, (b) cause Merger Sub to
consummate the Merger on the terms and conditions set forth in
this Agreement and (c) ensure that, prior to the Effective
Time, Merger Sub shall not conduct any business, make any
investments or incur or guarantee any indebtedness, other than
consummating the Merger pursuant to this Agreement.
Section 6.11 No
Control of Other Partys
Business. Nothing contained in this Agreement
is intended to give Parent or Merger Sub, directly or
indirectly, the right to control or direct the Companys or
its Subsidiaries operations prior to the Effective Time.
Prior to the Effective Time, the Company shall exercise,
consistent with the terms and conditions of this Agreement,
complete control and supervision over its and its
Subsidiaries respective operations in accordance with the
provisions of this Agreement.
Section 6.12 Certain
Tax Matters. During the period from the date
of this Agreement to the Closing Date, the Company and its
Subsidiaries shall (a) prepare and timely file all Tax
Returns that are due on or before the Closing Date in accordance
with past practice, (b) pay all Taxes due and payable in
respect of such Tax Returns, (c) accrue a reserve in the
books and financial statements of any such entity at such times
and in such amounts as are in accordance with past practice for
all Taxes payable by such entity for which no Tax Return is due
prior to the Closing Date and (d) promptly notify Parent of
any suit, claim, action, investigation, proceeding, or audit
that is or becomes pending against or with respect to the
Post-Sale Company in respect of Taxes or Tax Returns and not
settle or compromise any such matter without Parents
consent (which will not be unreasonably withheld, delayed or
conditioned).
Section 6.13 Stockholder
Litigation. The Company shall give Parent the
opportunity to participate (at Parents expense) in the
defense or settlement of any stockholder litigation against the
Company
and/or its
directors relating to the Transactions, and no such settlement
shall be agreed to without Parents prior written consent
(such consent not to be unreasonably withheld, delayed or
conditioned).
Section 6.14 Section 16
Matters. Prior to the Closing, the Company
shall use reasonable efforts to cause any dispositions of the
Shares (including derivative securities with respect to the
Shares) resulting from the transactions contemplated by this
Agreement by each individual who is subject to the reporting
requirements of Section 16(a) of the Exchange Act with
respect to the Company to be exempt under
Rule 16b-3
promulgated under the Exchange Act.
A-41
Section 6.15 Voting
of Shares. Parent shall vote (or cause to be
voted) all Shares beneficially owned by any Parent Company in
favor of approval of the Merger at the Company Special Meeting.
Section 6.16 Convertible
Notes. The Company shall comply with its
obligations and duties in connection with the transactions
contemplated by this Agreement under the terms of the Indenture,
dated as of May 17, 2007 (the Notes
Indenture), between the Company and The Bank of New
York, as trustee, including (A) the delivery of notice to
each Note Holder of the right to convert the Convertible Notes
into Company Shares (the Conversion Right),
(B) the execution of a supplemental indenture to the
Convertible Notes, if necessary, (C) the issuances of a
notice in a newspaper of general circulation in the City of New
York or the publishing of notice on the website of the Company
(or such other public medium as the Company may use) announcing
the Conversion Right and (D) delivery of an Officers
Certificate and Opinion of Counsel (as such terms are defined in
the Indenture).
Section 6.17 Intel
Business Cash and Indebtedness.
(a) Subject to Section 6.12 of the Intel Purchase
Agreement, immediately prior to the Intel Closing, the Company
shall cause any cash and cash equivalents (as determined in
accordance with GAAP) in the Transferred Intel Companies to be
transferred by dividend or otherwise to the Company or its
Subsidiaries (other than the Intel Companies).
(b) At or prior to the Intel Closing, in accordance with
Section 6.12(b) of the Intel Purchase Agreement,
(1) the Company shall cause to be terminated, paid in full
or otherwise discharged all liabilities of the Transferred Intel
Companies in respect of (i) indebtedness for borrowed
money, (ii) indebtedness evidenced by notes, debentures or
similar instruments, (iii) letters of credit or similar
facilities and (iv) payments under interest rate or foreign
currency swap or similar arrangements, and (2) the Company
shall cause all Liens against the Transferred Shares (as defined
in the Intel Purchase Agreement) or any assets of the
Transferred Intel Companies securing any indebtedness to be
terminated and released.
(c) The Company shall cause any cash and cash equivalents
received by the Company as proceeds in the Intel Transaction at
the Intel Closing to be used first to satisfy obligations in
respect of indebtedness and any excess shall be used for working
capital.
(d) Except as expressly contemplated by this Agreement or
the Intel Purchase Agreement, the Company shall, and shall cause
the Intel Companies to, during the period beginning on the date
hereof through the Intel Closing, manage the working capital of
the Intel Business (other than the business of Patriot),
including the collection of receivables or the payment of
payables prior to the Intel Closing, in the ordinary course of
business consistent with past practices.
Section 6.18 Intel
Purchase Agreement; Intel Transaction Matters.
(a) To the extent requested by the Company, Parent and
Merger Sub shall cooperate with the Company in causing the
consummation of the Intel Transaction and the Closing
contemplated by this Agreement to occur and be effected on the
same date, with the Intel Closing to precede the Closing, in
each case, on the terms and subject to the conditions set forth
in this Agreement and the Intel Purchase Agreement. Subject to
the last sentence of Section 6.4(c), without the
prior written consent of the other party, prior to the Effective
Time each of Parent and the Company shall not, and shall cause
its respective Affiliates not to, enter into any agreement,
arrangement or understanding (other than as provided in this
Agreement and the Intel Purchase Agreement) with Intel Buyer or
its Affiliates with respect to the Transactions.
(b) Without the prior written consent of Parent, the
Company shall not (i) amend, modify or waive any provision
of the Intel Purchase Agreement in a manner that materially and
adversely affects Parents rights and obligations; it being
understood and agreed that any amendment, modification or waiver
which (A) decreases the price paid by the Intel Buyer for
the Intel Business, (B) materially increases the
conditionality of the closing of the Intel Transaction
(including with respect to the related acquisition financing, if
any), (C) increases the potential liability of such
transaction to Parent or the Post-Sale Company (including
through a modification to Section 9.2 or 9.3 of the Intel
Purchase Agreement) or (D) amends, modifies or waives
Section 6.10, Annex A, 6.12, 6.16 or 6.17 of the Intel
Purchase Agreement or materially amends or modifies
Section 2.3 of the Intel Purchase Agreement, in each case,
shall be deemed, without exclusion of other amendments,
modifications or waivers, to materially and
A-42
adversely affect Parents rights and obligations, or
(ii) terminate the Intel Purchase Agreement by the mutual
written agreement of the Company and Intel Buyer. Subject to the
foregoing, the Company shall deliver promptly to Parent copies
of all amendments, modifications and waivers to the Intel
Purchase Agreement.
(c) Except as otherwise prohibited by Law, the Company
shall, as promptly as practicable, deliver to Parent copies of
all material notices and other material written communications
delivered pursuant to the Intel Purchase Agreement and shall
provide Parent reasonably prompt notice of any material
developments relating to consummation of the transactions
pursuant to the Intel Purchase Agreement.
(d) The Company shall comply in all material respects with
its material obligations under the Intel Purchase Agreement, to
the extent not waived by the Intel Buyer.
Section 6.19 Conversion
Transactions. From and after the date hereof,
the Company shall cooperate with Parent in good faith to assist
Parent in identifying direct or indirect domestic corporate
Subsidiaries of the Company, other than the Intel Companies,
that can be converted into domestic limited liability companies
without requiring novation, third party consents or otherwise
adversely impacting customer relationships
(Conversion-Eligible Subsidiaries). Upon
written request of Parent delivered within the later of
(i) sixty (60) days after the date hereof or
(ii) ten (10) days after obtaining the necessary
information, to the extent such information reasonably is
available and in accordance with Section 6.3, that
is reasonably required for Parent to determine whether it is
advantageous to it from a U.S. federal income tax
perspective to convert any of the Conversion-Eligible
Subsidiaries into a limited liability company, the Company shall
use commercially reasonable efforts to convert the
Conversion-Eligible Subsidiaries specified in such request to
limited liability companies, provided, that Parent shall be
liable for the payment of any and all costs or expenses related
to the conversion of the Conversion-Eligible Subsidiaries into
limited liability companies, and shall remit such payment to the
Company prior to any such conversion. In no event shall the
Company be required to effect any such conversion prior to one
day before the Effective Time. In the event that a conversion is
effected, the Company shall, and shall cause its Subsidiaries
to, refrain from making any election under Treasury
Regulation Section 301.7701-3
to treat the resulting domestic limited liability company as an
association taxable as a corporation.
Section 6.20 Basis
Study. At Parents written request, and
subject to Parents approval of the engagement letter and
the scope of work, the Company shall engage an accounting firm
(the Basis Study Firm) to perform a tax basis
study with respect to the stock of one or more of the
Companys direct or indirect Subsidiaries that are
controlled foreign corporations for
U.S. federal income tax purposes. The information that the
Company and its Subsidiaries shall be required to provide to the
Basis Study Firm shall be governed by Section 6.3,
and solely for purposes of the application of
Section 6.3 to the provision of information to the
Basis Study Firm, the Basis Study Firm shall be deemed to be a
Representative of Parent. The Basis Study Firm shall
be directed to provide its final report, and any interim drafts
of such report, to each of the Company and Parent. Parent shall
pay the costs, fees and expenses of the Basis Study Firm under
the terms of the engagement contemplated by this
Section 6.20. The engagement letter with the Basis
Study Firm shall not impose any completion date on the Company
that is related to the Basis Study Firms work thereunder,
and in no event shall the Closing be impeded or delayed as a
result of the timing of the completion of the Basis Study
Firms work thereunder.
ARTICLE VII
CONDITIONS
Section 7.1 Conditions
to the Obligations of Each Party to Effect the
Merger. The obligations of the Company, on
the one hand, and Parent and Merger Sub, on the other hand, to
consummate the Merger are subject to the satisfaction (or waiver
by the Company, Parent and Merger Sub, if permissible under
applicable Law) of the following conditions at or prior to the
Closing:
(a) The Company Stockholder Approval shall have been
obtained; provided that Parent and Merger Sub shall, and
shall cause any other Parent Company to, vote all Shares held by
them in favor of the approval of this Agreement;
A-43
(b) No Governmental Entity having jurisdiction over the
Company, Parent or Merger Sub shall have issued or entered any
injunction, Law, judgment, order, decree or ruling
(collectively, Restraints) which is
then in effect and which seeks or has the effect of enjoining or
otherwise prohibiting the consummation of the Merger, unless
such Restraint is vacated, terminated or withdrawn, and no Laws
shall be in effect enjoining or prohibiting consummation of the
Merger or making consummation of the Merger illegal;
(c) Any waiting period (and extension thereof) applicable
to the consummation of the Merger under the HSR Act shall have
expired or been terminated;
(d) Written confirmation by CFIUS of the completion of the
review, and if applicable, investigation process, under
Exon-Florio and CFIUSs determination that there are no
unresolved national security concerns with respect to the
Transactions shall have been received by Parent and the
Company; and
(e) Thirty-five (35) Scheduled Trading Days (as
defined in the Notes Indenture) shall have elapsed from the date
the Company (A) delivers notice to each holder of the
Convertible Notes (each, a Note Holder) of
the right of the Note Holders to convert the Convertible Notes
into Shares and (B) publishes such notice in a newspaper of
general circulation in The City of New York or on the
Companys website.
Section 7.2 Additional
Conditions to Obligations of Parent and Merger Sub to Effect the
Merger. The obligations of Parent and Merger
Sub to consummate the Merger are further subject to the
satisfaction (or waiver by Parent and Merger Sub, if permissible
under applicable Law) of the following conditions at or prior to
the Closing:
(a) (i) Each representation or warranty of the Company
contained in Sections 4.2(a), 4.3(a),
4.3(b), 4.23, 4.25, 4.26 and
4.27 shall be true and correct in all respects as of the
date of this Agreement and at and as of the Closing with the
same force and effect as if made at and as of the Closing (other
than those representations and warranties that address matters
only as of a particular date or only with respect to a specific
period of time, which need only be true and correct as of such
date or with respect to such period), (ii) each
representation and warranty of the Company contained in
Sections 4.2(b) and 4.28 shall be true and
correct in all material respects as of the date of this
Agreement and at and as of the Closing with the same force and
effect as if made at and as of the Closing and (iii) the
representations and warranties of the Company contained in any
other section of this Agreement shall be true and correct
(without giving effect to any limitation as to materiality or
Company Material Adverse Effect set forth therein) as of the
date of this Agreement and at and as of the Closing with the
same force and effect as if made at and as of the Closing (other
than those representations and warranties that address matters
only as of a particular date or only with respect to a specific
period of time, which need only be true and correct as of such
date or with respect to such period), except where the failure
of such representations and warranties to be true and correct
would not constitute a Company Material Adverse Effect;
(b) The Company shall have performed in all material
respects all of its material obligations under this Agreement to
be performed by it at or prior to the Closing;
(c) Parent and Merger Sub shall have received a certificate
signed by the Chief Executive Officer and Chief Financial
Officer of the Company, dated as of the Closing Date, certifying
on behalf of the Company that the conditions specified in
Section 7.2(a), Section 7.2(b) and
Section 7.2(d) have been satisfied;
(d) Since the date of this Agreement, there shall not have
occurred a Company Material Adverse Effect;
(e) The Company shall have received at least $295,833,000
in purchase price by reason of the occurrence of the Intel
Closing;
(f) Completion of novation, assignment, termination, or
expiration (and receipt of written notice from the Company
thereof) of all 6.9(a)(1) Contracts and all contracts listed in
Section 6.9(a)(2) of the Company Disclosure
Schedule; and
(g) Since the date of this Agreement, no Contracts, assets
(other than cash and cash equivalents as expressly permitted in
the Intel Agreement) or liabilities primarily relating to the
Intel Business or the Intel Companies shall have been assigned
or novated (or otherwise transferred) to the Company or any of
its Subsidiaries (other than the Intel Companies).
A-44
Section 7.3 Additional
Conditions to Obligations of the Company to Effect the
Merger. The obligations of the Company to
consummate the Merger are further subject to the satisfaction
(or waiver by the Company, if permissible under applicable Law)
of the following conditions at or prior to the Closing:
(a) (i) Each representation or warranty of Parent and
Merger Sub contained in Sections 5.2, 5.4,
5.7 and 5.11 shall be true and correct in all
respects as of the date of this Agreement and at and as of the
Closing with the same force and effect as if made at and as of
the Closing (other than those representations and warranties
that address matters only as of a particular date or only with
respect to a specific period of time, which need only be true
and correct as of such date or with respect to such period) and
(ii) the representations and warranties of Parent and
Merger Sub contained in any other section of this Agreement
shall be true and correct (without giving effect to any
limitation as to materiality or Parent Material Adverse Effect
set forth therein) as of the date of this Agreement and at and
as of the Closing with the same force and effect as if made at
and as of the Closing (other than those representations and
warranties that address matters only as of a particular date or
only with respect to a specific period of time, which need only
be true and correct as of such date or with respect to such
period), except where the failure of such representations and
warranties to be true and correct would not have a Parent
Material Adverse Effect; and
(b) Parent and Merger Sub shall have performed in all
material respects all of their material obligations under this
Agreement to be performed by each of them at or prior to the
Closing.
Section 7.4 Frustration
of Conditions. None of the Company, Parent or
Merger Sub may rely on the failure of any condition set forth in
Sections 7.1, 7.2 or 7.3 to be
satisfied if such failure was caused by such partys
failure to act in good faith or use its reasonable best efforts
to consummate the transactions contemplated by this Agreement,
as required by and subject to Section 6.9.
ARTICLE VIII
TERMINATION
Section 8.1 Termination. Notwithstanding
anything in this Agreement to the contrary, this Agreement may
be terminated and the Merger contemplated by this Agreement may
be abandoned as follows:
(a) at any time, by the mutual written agreement of the
Company and Parent;
(b) by either the Company or Parent:
(i) if the Merger has not been consummated on or prior to
the nine (9) month anniversary of the date hereof (the
Termination Date) by delivering written
notice to the other party no earlier than five (5) Business
Days following such nine (9) month anniversary;
provided, however, that if, as of the Termination
Date, (A) any of the conditions to the Merger set forth in
Section 7.1(b) (to the extent related to regulatory
approvals), Section 7.1(c),
Section 7.1(d) or Section 7.2(f) have not
been satisfied or waived, but all other conditions to the Merger
have been satisfied or waived (other than (1) those
conditions which by their nature can only be satisfied at or
immediately prior to the Effective Time, which conditions would
be satisfied if the Closing Date were the Termination Date, or
(2) the condition in Section 7.2(e) to the extent
that the failure of such condition to be satisfied is the result
of the failure of any of the conditions set forth in
Section 7.1 of the Intel Purchase Agreement) or
(B) the Company has delivered to Parent a Substitution
Exercise Notice pursuant to Section 8.3, then either
the Company or Parent, in such partys sole discretion, may
extend the Termination Date for up to three (3) additional
months by delivering written notice to the other party at any
time prior to the date that is five (5) Business Days after
the date which is nine (9) months after the date hereof;
provided, further, that the right to terminate
this Agreement under this Section 8.1(b)(i) shall
not be available to any party whose failure to fulfill any
obligation under this Agreement has been a principal cause of,
or resulted in, the failure of the Merger to be consummated on
or prior to such date;
(ii) if any Governmental Entity having jurisdiction over
the Company, Parent or Merger Sub shall have issued a Restraint
permanently enjoining or otherwise prohibiting the consummation
of the Merger and such Restraint shall have become final and
non-appealable; provided, however, that the right
to
A-45
terminate this Agreement under this
Section 8.1(b)(ii) shall not be available to any
party whose failure to fulfill any obligation under this
Agreement has been the primary cause of, or primarily resulted
in, such order, decree, ruling or action, and provided,
further, that the party seeking to terminate this
Agreement under this Section 8.1(b)(ii) shall have
used reasonable best efforts to cause any such order, decree,
ruling or action to be vacated or lifted or to ameliorate the
effects thereof to the extent required to do so by the terms of
this Agreement;
(iii) if the Intel Purchase Agreement has been terminated
in accordance with its terms; provided, however,
that the right to terminate this Agreement under this
Section 8.1(b)(iii) shall not be available to Parent
until the date that is five (5) Business Days after the
date that the Intel Purchase Agreement is terminated in
accordance with its terms; provided, further,
that, the right to terminate this Agreement under this
Section 8.1(b)(iii) shall not be available to Parent
in the event that the Company delivers a Substitution Exercise
Notice to Parent prior to the date that is five
(5) Business Days after the date that the Intel Purchase
Agreement is terminated in accordance with its terms;
(iv) if the Intel Purchase Agreement has been terminated in
accordance with its terms and the Company has entered into a
Substitute Intel Agreement pursuant to Section 8.3;
provided, however, that the right to terminate
this Agreement under this Section 8.1(b)(iv) must be
exercised by Parent by written notice to the Company within
three (3) Business Days of Parents receipt of notice
that the Substitute Intel Agreement has been executed;
provided, further, that the right to terminate
this Agreement under this Section 8.1(b)(iv) shall
not be available to Parent if the Substitute Intel Buyer and
Substitute Intel Agreement would not reasonably be expected to
materially and adversely affect Parents rights or
obligations (as compared with the Intel Buyer and Intel Purchase
Agreement), taking into account all relevant factors, including
the terms and conditions of the Substitute Intel Agreement and
the financial position of the Substitute Intel Buyer (the
Substitute Determination); provided
that the Company and Parent agree that it would not be
unreasonable for Parent to exercise its termination right
pursuant to this Section 8.1(b)(iv) if (A) the
purchase price in such Substitute Intel Agreement is less than
the Purchase Price (as defined in the Intel Purchase Agreement),
(B) there was materially increased conditionality imposed
on the Transactions (including by reason of the identity and
nature of the Substitute Intel Buyer
and/or its
financing arrangements), including the Intel Transaction,
(C) there is an increase in the potential liability to
Parent or the Post-Sale Company pursuant to the Substitute Intel
Agreement from the Intel Purchase Agreement (including through
failure to replicate Section 9.2 or 9.3 of the Intel
Purchase Agreement) or (D) there are one or more failures
to replicate Section 2.3, 6.10, 6.12, 6.16 or 6.17 of the
Intel Purchase Agreement which failure is materially adverse to
Parent or the Post-Sale Company;
(v) if the Company Stockholder Approval shall not have been
obtained at the Company Special Meeting duly convened therefor
or at any adjournment or postponement thereof; provided,
however, that the right to terminate this Agreement
pursuant to this Section 8.1(b)(v) shall not be
available to the Company if it has failed to comply in all
material respects with its obligations under
Sections 6.4 and 6.8; or
(c) by the Company if Parent or Merger Sub shall have
breached any of its representations, warranties, covenants or
agreements set forth in this Agreement, which breach
(A) would give rise to the failure of a condition set forth
in Section 7.3(a) or Section 7.3(b) and
(B) has not been waived by the Company and is incapable of
being cured, or is not cured, by Parent or Merger Sub, as
applicable, within forty-five (45) days following receipt
of a written notice of such breach from the Company;
provided, however, that the right to terminate
this Agreement under this Section 8.1(c) shall not
be available to the Company if it has materially breached any of
its material obligations under this Agreement; or
(d) by Parent:
(i) if the Company shall have breached any of its
representations, warranties, covenants or agreements set forth
in this Agreement, which breach (A) would give rise to the
failure of a condition set forth in Section 7.2(a)
or Section 7.2(b), and (B) has not been waived
by Parent and is incapable of being cured, or is not cured, by
the Company within forty-five (45) days following receipt
of a written notice of such breach from Parent; provided,
however, that the right to terminate this Agreement under
A-46
this Section 8.1(d)(i) shall not be available to
Parent if it or Merger Sub has materially breached any of their
material obligations under this Agreement; or
(ii) if (A) a Change in Recommendation shall have
occurred, (B) the Company shall have breached its
obligations under this Agreement by reason of a failure to call
the Company Special Meeting or a failure to prepare and mail to
its stockholders the Proxy Statement in all material respects in
accordance with Section 6.8, (C) the Company
shall have failed to include the Company Board Recommendation in
the Proxy Statement or (D) the Company shall have violated
or breached in any material respect any of its material
obligations under Section 6.4.
Section 8.2 Effect
of Termination.
(a) If this Agreement is terminated pursuant to
Section 8.1, this Agreement shall become void and of
no effect without liability of any party (or such partys
Affiliates or its or their directors, officers, employees,
Representatives or stockholders) to the other parties hereto
other than, with respect to Parent, Merger Sub and the Company,
the obligations pursuant to this Section 8.2 and
Article IX, provided, however, that no
party shall be relieved or released from any liabilities or
damages (i) arising out of any breach of its obligations
under this Agreement or (ii) fraud by either party or any
breach by Parent or Merger Sub of the representations and
warranties in Section 5.6 (Sufficient Funds).
Neither the preceding sentence nor any other provision of this
Agreement shall limit the right of any party to seek damages
based on what such party believes to be an appropriate theory of
damages, including on whose behalf such damages may be sought.
(b) If (i) this Agreement is terminated by Parent
pursuant to Section 8.1(d)(ii) prior to the Company
Special Meeting or (ii) (A) this Agreement is terminated by
Parent pursuant to Section 8.1(d)(i) or by either
Parent or the Company pursuant to Section 8.1(b)(i)
(only if at such time Parent would not be prohibited from
terminating this Agreement by application of the proviso of
Section 8.1(b)(i)) or Section 8.1(b)(v),
(B) after the date hereof (but prior to the Company Special
Meeting in the case of a termination pursuant to
Section 8.1(b)(v)), an Acquisition Proposal has been
publicly announced and (C) within nine (9) months
after such termination, the Company enters into a definitive
agreement with respect to, or consummates an Acquisition
Proposal, then, in such event, the Company shall pay to Parent a
termination fee of $25,000,000 in cash (the Company
Termination Fee) minus any amounts paid by the Company
to Parent pursuant to Section 8.2(d),
(x) concurrently with any termination of this Agreement (in
the case of a payment required by clause (i) above) or
(y) on the date of consummation of the transaction referred
to in clause (ii)(C) (in the case of a payment required by
clause (ii) above). For purposes of clause (ii)(C) of the
immediately preceding sentence, the term Acquisition
Proposal shall have the meaning assigned to such term
in Section 1.1, except that the references to
twenty percent (20%) therein shall be deemed to be
references to fifty percent (50%). Notwithstanding
the foregoing, in no event shall the Company be required to pay
the fee referred to in this Section 8.2(b)
(X) on more than one (1) occasion or (Y) if, at
the time this Agreement is terminated, this Agreement could have
been terminated by the Company pursuant to
Section 8.1(b)(ii) or Section 8.1(c).
The parties agree that the payment of the Company Termination
Fee (minus any amounts paid by the Company to Parent pursuant to
Section 8.2(d)) shall be the sole and exclusive
remedy available to Parent and Merger Sub with respect to this
Agreement and the transactions contemplated hereby in the event
any such payment becomes due and payable, and, upon payment of
the Company Termination Fee (minus any amounts paid by the
Company to Parent pursuant to Section 8.2(d)), the
Company (and the Companys Affiliates and its and their
respective directors, officers, employees, stockholders and
Representatives) shall have no further liability to Parent and
Merger Sub hereunder.
(c) If this Agreement is terminated by the Company or
Parent pursuant to Section 8.1(b)(i) or
Section 8.1(b)(ii) (to the extent related to
regulatory approvals) and, at the time of such termination, any
of the conditions to the Merger set forth in
Section 7.1(b) (to the extent related to regulatory
approvals), Section 7.1(c) or
Section 7.1(d) have not been satisfied or waived,
and all other conditions to the Merger (including the condition
set forth in Section 7.2(f)) (other than those
conditions which by their nature can only be satisfied at or
immediately prior to the Closing, which conditions would be
satisfied if the Closing Date were the date of termination) have
been satisfied or waived, then, in such event, Parent shall pay
to the Company the Parent Termination Fee, concurrently with any
termination of this Agreement. Notwithstanding the foregoing, in
no event shall Parent be required to pay the fee referred to in
this Section 8.2(c) (X) on more than one
(1) occasion or (Y) if, at the time this Agreement is
terminated, this Agreement could have been terminated by Parent
pursuant to Section 8.1(d)(i). The parties agree
that the payment of the Parent
A-47
Termination Fee shall be the sole and exclusive remedy available
to the Company with respect to this Agreement and the
transactions contemplated hereby in the event any such payment
becomes due and payable, and, upon payment of the Parent
Termination Fee, Parent and Merger Sub (and their Affiliates and
their respective directors, officers, employees, stockholders
and Representatives) shall have no further liability to the
Company hereunder.
(d) If this Agreement is terminated by (x) the Company
or Parent pursuant to Section 8.1(b)(i) and at the
time of such termination, the conditions to the Merger set forth
in Section 7.1(b) (to the extent related to
regulatory approvals), Section 7.1(c) and
Section 7.1(d) have been satisfied or
(y) Parent or the Company pursuant to
Section 8.1(b)(iv) or (z) Parent pursuant to
Section 8.1(b)(iii), and in each case, no Company
Termination Fee is payable in respect thereof pursuant to
Section 8.2(b) at the time of such termination, then
the Company shall pay to Parent, within five (5) Business
Days after the Companys receipt of Parents demand
therefor, an amount equal to the Parent Expenses (as defined
below). The parties agree that, subject to the Companys
obligation to pay to Parent the Company Termination Fee (minus
the amount of Parent Expenses previously actually paid to Parent
pursuant to the preceding sentence) if the Company Termination
Fee becomes payable pursuant to Section 8.2(b), the
payment of the Parent Expenses shall be the sole and exclusive
remedy available to Parent and Merger Sub with respect to this
Agreement and the transactions contemplated hereby in the event
any such payment becomes due and payable, and, upon payment of
the Parent Expenses, the Company (and the Companys
Affiliates and its and their respective directors, officers,
employees, stockholders and Representatives) shall have no
further liability to Parent and Merger Sub hereunder.
Parent Expenses shall mean all documented
out-of-pocket
fees and expenses (including fees and expenses of counsel,
accountants, financial advisors and investment bankers) up to an
aggregate amount of $12,500,000 incurred by or on behalf of
Parent or its Affiliates in connection with the authorization,
preparation, negotiation, execution and performance of this
Agreement and the filing of any required notices under
(i) applicable U.S. or foreign antitrust or
competition Laws or other regulations or (ii) Exon-Florio
or NISPOM.
(e) The payments contemplated by
Section 8.2(b), Section 8.2(c) and
Section 8.2(d) shall be made by wire transfer of
immediately available funds to an account designated by Parent
and the Company, respectively, and shall be reduced by any
amounts required to be deducted or withheld therefrom under
applicable Law in respect of Taxes.
Section 8.3 Certain
Substitution Rights. If, at any time prior to
the date that is five (5) Business Days after termination
of the Intel Purchase Agreement, the Company notifies Parent in
writing that the Company is exercising its rights under this
Section 8.3 (a Substitution Exercise
Notice):
(a) The Company may initiate, solicit and encourage the
making of a proposal or offer from, engage in negotiations or
discussions with, and furnish any material nonpublic information
to, any Person with respect to the potential acquisition by such
Person, directly or indirectly, in one transaction or a series
of transactions, of the Intel Business (a Substitute
Intel Transaction).
(b) If requested by the Company, Parent shall reasonably
cooperate with the Company in connection with any discussions
and negotiations in respect of any potential Substitute Intel
Transaction.
(c) The Company shall promptly advise Parent orally or in
writing of any negotiations or discussions with any Person (a
Substitute Intel Buyer) with respect to a
potential Substitute Intel Transaction, the material terms and
conditions of any such Substitute Intel Transaction and the
identity of the Substitute Intel Buyer. The Company shall
(i) keep Parent reasonably informed of the status and
material details (including any material change to the terms
thereof) of any such negotiations or discussions and
(ii) provide to Parent as soon as practicable after receipt
or delivery thereof copies of all material written
correspondence relating to any such Substitute Intel Transaction
exchanged between the Company or any of its Subsidiaries, on the
one hand, and the Substitute Intel Buyer, on the other hand.
(d) In the event that, following delivery of the
Substitution Exercise Notice, the Company determines to enter
into an agreement or agreements (a Substitute Intel
Agreement) with a Substitute Intel Buyer providing for
a Substitute Intel Transaction (the Failed Intel Buyer
Substitution Right), the Company shall, no later than
four (4) Business Days prior to entry into such Substitute
Intel Agreement, deliver written notice (the Failed
Buyer Substitution Notice) to Parent of the
Companys intention to exercise the Failed Intel Buyer
Substitution Right, which notice shall include (i) a
substantially final draft of the Substitute Intel Agreement and
(ii) a statement by the Company as to the Substitute
Determination; it being agreed that Parent shall be
A-48
deemed to accept the Substitute Determination unless Parent
provides written notice of disagreement to the Company within
three (3) Business Days of Parents receipt of the
Failed Buyer Substitution Notice. The Company shall notify
Parent in writing within two (2) Business Days following
execution of the Substitute Intel Agreement.
(e) For all purposes of this Agreement, upon execution and
delivery of the Substitute Intel Agreement, all references
herein to the Intel Transaction, Intel
Purchase Agreement, and Intel Buyer shall
become references to the Substitute Intel Transaction,
Substitute Intel Agreement and Substitute Intel Buyer,
respectively.
ARTICLE IX
MISCELLANEOUS
Section 9.1 Amendment
and Modification. Subject to the applicable
provisions of the DGCL, at any time prior to the Effective Time,
the parties hereto may modify or amend this Agreement, by
written agreement executed and delivered by duly authorized
officers of the respective parties; provided,
however, that after approval of this Agreement by the
stockholders of the Company, no amendment (other than a
termination of this Agreement in accordance with the provisions
hereof) shall be made which changes the consideration payable in
the Merger or adversely affects the rights of the Companys
stockholders hereunder or is otherwise required under any
applicable Law to be approved by such stockholders without, in
each case, the approval of such stockholders.
Section 9.2 Nonsurvival
of Representations and Warranties. None of
the representations and warranties of the Company in this
Agreement or in any schedule, instrument or other document
delivered pursuant to this Agreement shall survive the Merger.
This Section 9.2 shall not limit any covenant or
agreement contained in this Agreement that by its terms is to be
performed in whole or in part after the Closing Date.
Section 9.3 Notices. All
notices, consents and other communications hereunder shall be in
writing and shall be given (and shall be deemed to have been
duly given upon receipt) by hand delivery, by prepaid overnight
courier (providing written proof of delivery) or by confirmed
facsimile transmission, addressed as follows:
(a) if to Parent or Merger Sub, to:
Safran SA
2, boulevard du General Martial-Valin
75724 Paris Cedex 15 France
Facsimile: +33 1 40 60 81 03
Attention: Celeste Thomasson, Vice President Legal Affairs
with a copy to:
Weil, Gotshal & Manges LLP
767 Fifth Avenue
New York, New York 10153
Facsimile:
(212) 310-8007
Attention: Frederick S. Green and Raymond O. Gietz
and
Kaye Scholer LLP
425 Park Avenue
New York, New York 10022
Facsimile:
(212) 836-8689
Attention: Fred H. Marcusa
A-49
(b) if to the Company, to:
L-1 Identity Solutions, Inc.
177 Broad Street, 12th Floor
Stamford, Connecticut 06901
Facsimile:
(203) 504-1140
Attention: General Counsel
with a copy to:
Skadden, Arps, Slate, Meagher & Flom LLP
Four Times Square
New York, New York 10036
Facsimile:
(212) 735-2000
Attention: Peter Allan Atkins and Eric L. Cochran
or to such other address or facsimile number for a party as
shall be specified in a notice given in accordance with this
section; provided that any notice received by facsimile
transmission or otherwise at the addressees location on
any Business Day after 5:00 P.M. (addressees local
time) or on any day that is not a Business Day shall be deemed
to have been received at 9:00 A.M. (addressees local
time) on the next Business Day; provided, further,
that notice of any change to the address or any of the other
details specified in or pursuant to this section shall not be
deemed to have been received until, and shall be deemed to have
been received upon, the later of the date specified in such
notice or the date that is five (5) Business Days after
such notice would otherwise be deemed to have been received
pursuant to this section. A partys rejection or other
refusal to accept notice hereunder or the inability of another
party to deliver notice to such party because of such
partys changed address or facsimile number of which no
notice was given by such party shall be deemed to be receipt of
the notice by such party as of the date of such rejection,
refusal or inability to deliver.
Section 9.4 Interpretation. The
parties have participated jointly in the negotiation and
drafting of this Agreement. In the event an ambiguity or
question of intent or interpretation arises, this Agreement
shall be construed as if drafted jointly by the parties, and no
presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any
provisions of this Agreement. Disclosure of any fact,
circumstance or information in any Section of the Company
Disclosure Schedule or Parent Disclosure Schedule shall be
deemed to be disclosure of such fact, circumstance or
information with respect to any other Sections of the Company
Disclosure Schedule or Parent Disclosure Schedule, respectively,
if it is reasonably apparent that such disclosure relates to one
or more or all of such Sections. The inclusion of any item in
the Company Disclosure Schedule or Parent Disclosure Schedule
shall not be deemed to be an admission or evidence of
materiality of such item, nor shall it establish any standard of
materiality for any purpose whatsoever.
Section 9.5 Counterparts. This
Agreement may be executed in multiple counterparts, all of which
shall together be considered one and the same agreement.
Delivery of an executed signature page to this Agreement by
electronic transmission shall be as effective as delivery of a
manually signed counterpart of this Agreement.
Section 9.6 Entire
Agreement; Third-Party Beneficiaries. This
Agreement (including the Company Disclosure Schedule, the Parent
Disclosure Schedule and the exhibits hereto, together with the
other instruments referred to herein), the Confidentiality
Agreement and, when referenced herein, the Intel Purchase
Agreement (a) constitute the entire agreement and supersede
all prior agreements and understandings, both written and oral,
among the parties with respect to the subject matter hereof and
(b) are not intended to confer upon any Person other than
the parties hereto any rights or remedies hereunder;
provided, however, that it is specifically
intended that (A) the D&O Indemnified Parties and
Company Indemnified Parties (with respect to
Section 6.7 from and after the Effective Time) and
(B) the Companys stockholders and holders of Company
Options, Restricted Stock Awards, Company Deferred Stock Units
and Company Warrants (with respect to their rights under
Article III of this Agreement from and after the
Effective Time) are third-party beneficiaries. Notwithstanding
the foregoing, the first sentence of paragraph 3 of the
Co-Buyer Disclosure Agreement (which amends the Confidentiality
Agreement) shall be superseded by this Agreement.
A-50
Section 9.7 Severability. If
any term, provision, covenant or restriction of this Agreement
is held by a court of competent jurisdiction or other authority
to be invalid, void, unenforceable or against its regulatory
policy, the remainder of the terms, provisions, covenants and
restrictions of this Agreement shall remain in full force and
effect and shall in no way be affected, impaired or invalidated
and the parties hereto shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the
parties as closely as possible in an acceptable manner to the
end that the transactions contemplated hereby are fulfilled to
the extent possible.
Section 9.8 Governing
Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware,
without giving effect to any choice or conflict of laws
provision or rule (whether of the State of Delaware or any other
jurisdiction) that would cause the application of the Laws of
any jurisdiction other than the State of Delaware.
Section 9.9 Jurisdiction. Each
of the parties hereto hereby (a) expressly and irrevocably
submits to the exclusive personal jurisdiction of the Delaware
Court of Chancery, any other court of the State of Delaware or
any Federal court sitting in the State of Delaware in the event
any dispute arises out of this Agreement or any of the
Transactions, (b) agrees that it will not attempt to deny
or defeat such personal jurisdiction by motion or other request
for leave from any such court, (c) agrees that it will not
bring any action relating to this Agreement or any of the
Transactions in any court other than the Delaware Court of
Chancery, any other court of the State of Delaware or any
Federal court sitting in the State of Delaware and
(d) agrees that each of the other parties shall have the
right to bring any action or proceeding for enforcement of a
judgment entered by the Delaware Court of Chancery, any other
court of the State of Delaware or any Federal court sitting in
the State of Delaware. Each of Parent, Merger Sub and the
Company agrees that a final judgment in any action or proceeding
shall be conclusive and may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by Law.
Section 9.10 Service
of Process. Each party irrevocably consents
to the service of process outside the territorial jurisdiction
of the courts referred to in Section 9.9 in any such
action or proceeding by mailing copies thereof by registered or
certified United States mail, postage prepaid, return receipt
requested, to its address as specified in or pursuant to
Section 9.3. However, the foregoing shall not limit
the right of a party to effect service of process on the other
party by any other legally available method.
Section 9.11 Waiver
of Jury Trial. EACH OF PARENT, MERGER SUB AND
THE COMPANY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY
IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON
CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS OR THE ACTIONS OF PARENT, MERGER
SUB OR THE COMPANY IN THE NEGOTIATION, ADMINISTRATION,
PERFORMANCE AND ENFORCEMENT OF THIS AGREEMENT.
Section 9.12 Specific
Performance. Notwithstanding anything in this
Agreement, the parties agree that immediate, extensive and
irreparable damage would occur for which monetary damages would
not be an adequate remedy in the event that any of the
provisions of this Agreement are not performed in accordance
with their specific terms or are otherwise breached.
Accordingly, the parties agree that, if for any reason Parent,
Merger Sub or the Company shall have failed to perform its
obligations under this Agreement, then the party seeking to
enforce this Agreement against such nonperforming party under
this Agreement shall be entitled to specific performance and the
issuance of immediate injunctive and other equitable relief
without the necessity of proving the inadequacy of money damages
as a remedy, and the parties further agree to waive any
requirement for the securing or posting of any bond in
connection with the obtaining of any such injunctive or other
equitable relief, this being in addition to and not in
limitation of any other remedy to which they are entitled at Law
or in equity. Without limiting the foregoing, each of the
parties hereby acknowledges and agrees that it may be difficult
to prove damages with reasonable certainty, that it may be
difficult to procure suitable substitute performance, and that
injunctive relief
and/or
specific performance will not cause an undue hardship to the
parties. Each of the parties hereby further acknowledges and
agrees that the existence of any other remedy contemplated by
this Agreement shall not diminish the availability of specific
performance of the obligations hereunder or any other injunctive
relief and agrees that in the event of any action by the other
party for specific performance or injunctive relief, it will not
assert that a remedy at Law or other remedy would be adequate or
that specific performance or injunctive relief in respect of
such breach or violation should not be available on the grounds
that money damages are adequate or any other grounds. Any
A-51
such remedies, and any and all other remedies provided for in
this Agreement, shall be cumulative in nature and not exclusive
and shall be in addition to any other remedies whatsoever which
any party may otherwise have.
Section 9.13 Assignment. Neither
this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned by any of the parties hereto
(whether by operation of law or otherwise) without the prior
written consent of the other parties; provided, that
Parent and Merger Sub may assign their rights and obligations
pursuant to this Agreement to any direct or indirect wholly
owned Subsidiary of Parent so long as Parent continues to remain
primarily liable for all of such rights and obligations. Subject
to the preceding sentence, this Agreement will be binding upon,
inure to the benefit of and be enforceable by the parties and
their respective permitted successors and assigns.
Section 9.14
Expenses. Except as otherwise provided herein,
all costs and expenses incurred in connection with this
Agreement and the consummation of the transactions contemplated
hereby shall be paid by the party incurring such costs and
expenses, whether or not the transactions contemplated hereby
are consummated, provided that Parent shall pay all costs and
expenses in connection with the filings of the notification and
report forms under the HSR Act in connection with the
transactions contemplated by this Agreement and the notice to
CFIUS of the transactions contemplated by this Agreement
pursuant to Exon-Florio. Other than Taxes imposed upon a holder
of Shares, Company Options, Restricted Stock Awards, Company
Deferred Stock Units or Company Warrants, Parent shall pay all
Taxes incident to preparing for, entering into and carrying out
this Agreement (including (i) transfer, stamp and
documentary Taxes or fees and (ii) sales, use, gains, real
property transfer and other or similar Taxes or fees). For the
avoidance of doubt, none of Parent, Merger Sub or the Company
shall be responsible for the payment of income Taxes imposed
upon a holder of Shares which result from the transactions
contemplated herein.
Section 9.15 Waivers. Except
as otherwise provided in this Agreement, any failure of any of
the parties to comply with any obligation, covenant, agreement
or condition herein may be waived at any time prior to the
Effective Time by the party or parties entitled to the benefits
thereof only by a written instrument signed by the party
expressly granting such waiver, but such waiver or failure to
insist upon strict compliance with such obligation, covenant,
agreement or condition shall not operate as a waiver of, or
estoppel with respect to, any subsequent or other failure.
[Signature
page follows.]
A-52
IN WITNESS WHEREOF, the Company, Parent and Merger Sub have
caused this Agreement to be signed by their respective officers
thereunto duly authorized as of the date first written above.
L-1 IDENTITY SOLUTIONS, INC.
|
|
|
|
By:
|
/s/ Robert
V. LaPenta
|
Name: Robert V. LaPenta
|
|
|
|
Title:
|
Chairman of the Board, President
|
and Chief Executive Officer
SAFRAN SA
|
|
|
|
By:
|
/s/ Jean-Paul
Herteman
|
Name: Jean-Paul Herteman
|
|
|
|
Title:
|
Chief Executive Officer
|
LASER ACQUISITION SUB INC.
|
|
|
|
By:
|
/s/ Jean-Pierre
Cojan
|
Name: Jean-Pierre Cojan
|
|
|
|
Title:
|
President, Secretary and Treasurer
|
A-53
Exhibit A
INTEL
PURCHASE AGREEMENT
A copy of
the Intel Purchase Agreement is attached to this proxy statement
as
Annex B
BAE Purchase Agreement
A-55
Exhibit B
CERTIFICATE
OF INCORPORATION
OF
L-1
IDENTITY SOLUTIONS, INC.
FIRST: The name of the corporation is L-1
Identity Solutions, Inc. (the
Corporation).
SECOND: The address of the registered office
of the Corporation in the State of Delaware is The Corporation
Trust Company, 1209 Orange Street, in the City of
Wilmington, County of New Castle, Delaware 19801. The name of
the registered agent of the Corporation at such address is The
Corporation Trust Company.
THIRD: The purpose of the Corporation is to
engage in any lawful act or activity for which corporations may
be organized under the General Corporation Law of the State of
Delaware, as from time to time amended.
FOURTH: The total number of shares of capital
stock which the Corporation shall have authority to issue is one
thousand (1,000) shares of common stock having a par value of
$0.01. Except as otherwise provided by law, the shares of stock
of the Corporation may be issued by the Corporation from time to
time in such amounts, for such consideration and for such
corporate purposes as the Board of Directors may from time to
time determine.
FIFTH: In furtherance and not in limitation of
the powers conferred by law, subject to any limitations
contained elsewhere in this Certificate of Incorporation, Bylaws
of the Corporation may be adopted, amended or repealed by a
majority of the Board of Directors of the Corporation, but any
Bylaws adopted by the Board of Directors may be amended or
repealed by the stockholders entitled to vote thereon. Election
of directors need not be by written ballot.
SIXTH: (a) A director of the Corporation
shall not be personally liable to the Corporation or its
stockholders for monetary damages for breach of fiduciary duty
as a director, provided that this provision shall not eliminate
or limit the liability of a director (i) for any breach of
the directors duty of loyalty to the Corporation or its
stockholders, (ii) for acts or omissions not in good faith
or which involve intentional misconduct or a knowing violation
of law, (iii) under Section 174 of the Delaware
General Corporation Law, or (iv) for any transaction from
which the director derived an improper personal benefit. If the
General Corporation Law of the State of Delaware is amended
after the effective date of this Certificate of Incorporation to
authorize corporate action further eliminating or limiting the
personal liability of directors, then the liability of a
director of the Corporation shall be eliminated or limited to
the fullest extent permitted by the General Corporation Law of
the State of Delaware, as so amended.
(b) Any repeal or modification of this
Article Sixth (i) by the stockholders of the
Corporation or (ii) by an amendment to the General
Corporation Law of the State of Delaware shall not adversely
affect any right or protection existing at the time of such
repeal or modification with respect to any acts or omissions
occurring before such repeal or modification of a person serving
as a director at the time of such repeal or modification.
SEVENTH: The Corporation shall, to the maximum
extent permitted from time to time under Section 145 of the
General Corporation Law of the State of Delaware, as that
section may be amended from time to time, indemnify and upon
request, so long as in accordance with the provisions of said
Section 145 and this Certificate of Incorporation and the
Bylaws, shall advance expenses to, any person who is or was a
party or is threatened to be made a party to any threatened,
pending or completed action, suit, proceeding or claim, whether
civil, criminal, administrative or investigative, by reason of
the fact that he is or was or has agreed to be a director or
officer of the Corporation or while a director or officer is or
was serving at the request of the Corporation as a director,
officer, partner, trustee, employee or agent of any corporation,
partnership, joint venture, trust or other enterprise, including
service with respect to employee benefit plans, against any and
all expenses (including attorneys fees and expenses),
judgments, fines, penalties and amounts paid in settlement or
incurred in connection with the investigation, preparation to
defend or defense of such action, suit, proceeding or claim;
provided, however, that the foregoing shall not require the
Corporation to indemnify or advance expenses to any person in
connection with any action, suit, proceeding, claim or
counterclaim initiated by or on behalf of such person. Such
indemnification shall not be exclusive of other indemnification
rights arising under any bylaw, agreement, vote of directors or
stockholders or otherwise and shall inure to the benefit of the
heirs and legal representative of such person.
A-56
EIGHTH: The Corporation expressly elects in
this, its original Certificate of Incorporation, not to be
governed by Section 203 of the General Corporation Law of
the State of Delaware.
NINTH: No repeal, alteration or amendment of
this Certificate of Incorporation shall be made unless the same
is first approved by the Board of Directors pursuant to a
resolution adopted by the affirmative vote of a majority of the
directors then in office, and thereafter approved by
stockholders. Whenever any vote of the holders of capital stock
is required, and in addition to any other vote of holders of
capital stock that is required by law, the affirmative vote of
the holders of at least two-thirds (or such greater proportion
as may be required by law) of the total votes eligible to be
cast by holders of capital stock with respect to such repeal,
alteration or amendment, voting together as a single class, at a
duly constituted meeting of stockholders called expressly for
such purpose shall be required to repeal, alter or amend any
provision of, or adopt any provisions inconsistent with, any
provision of this Article Ninth,
Article Sixth or Article Seventh.
* * * * *
A-57
Exhibit C
BYLAWS
OF
L-1
IDENTITY SOLUTIONS, INC.
(a
Delaware corporation)
ARTICLE I
Stockholders
Section 1. Annual
Meetings. The annual meeting of stockholders
for the election of directors and for the transaction of such
other business as may properly come before the meeting shall be
held each year at such date and time, within or without the
State of Delaware, as the Board of Directors shall determine.
Section 2. Special
Meetings. Special meetings of stockholders
for the transaction of such business as may properly come before
the meeting may be called by order of the Board of Directors or
by stockholders holding together at least a majority of all the
shares of the Corporation entitled to vote at the meeting, and
shall be held at such date and time, within or without the State
of Delaware, as may be specified by such order.
Section 3. Notice
of Meetings. Written notice of all meetings
of the stockholders, stating the place (if any), date and hour
of the meeting, the means of remote communications, if any, by
which stockholders and proxy holders may be deemed to be present
in person and vote at such meeting, and the place within the
city or other municipality or community at which the list of
stockholders may be examined, shall be mailed or delivered to
each stockholder not less than ten (10) nor more than sixty
(60) days prior to the meeting. Notice of any special
meeting shall state in general terms the purpose or purposes for
which the meeting is to be held.
Section 4. Stockholder
Lists. The officer who has charge of the
stock ledger of the Corporation shall prepare and make, at least
ten (10) days before every meeting of stockholders, a
complete list of the stockholders entitled to vote at the
meeting, arranged in alphabetical order, and showing the address
of each stockholder and the number of shares registered in the
name of each stockholder. Such list shall be open to the
examination of any stockholder, for any purpose germane to the
meeting, either at a place within the city where the meeting is
to be held, which place shall be specified in the notice of the
meeting, or, if not so specified, at the place where the meeting
is to be held. The list shall also be produced and kept at the
time and place of the meeting during the whole time thereof, and
may be inspected by any stockholder who is present.
The stock ledger shall be the only evidence as to who are the
stockholders entitled to examine the stock ledger, the list
required by this section or the books of the Corporation, or to
vote in person or by proxy at any meeting of stockholders.
Section 5. Quorum. Except
as otherwise provided by law or the Corporations
Certificate of Incorporation, a quorum for the transaction of
business at any meeting of stockholders shall consist of the
holders of record of a majority of the issued and outstanding
shares of the capital stock of the Corporation entitled to vote
at the meeting, present in person or by proxy. If there be no
such quorum, the holders of a majority of such shares so present
or represented may adjourn the meeting from time to time,
without further notice, until a quorum shall have been obtained.
When a quorum is once present it is not broken by the subsequent
withdrawal of any stockholder.
Section 6. Organization. Meetings
of stockholders shall be presided over by the Chairman, if any,
or if none or in the Chairmans absence the President, if
any, or if none or in the Presidents absence a
Vice-President, or, if none of the foregoing is present, by a
chairman to be chosen by the stockholders entitled to vote who
are present in person or by proxy at the meeting. The Secretary
of the Corporation, or in the Secretarys absence an
Assistant Secretary, shall act as secretary of every meeting,
but if neither the Secretary nor an Assistant Secretary is
present, the presiding officer of the meeting shall appoint any
person present to act as secretary of the meeting.
A-58
Section 7. Voting;
Proxies; Required Vote.
(a) At each meeting of stockholders, every stockholder
shall be entitled to vote in person or by proxy appointed by
instrument in writing, subscribed by such stockholder or by such
stockholders duly authorized attorney-in-fact (but no such
proxy shall be voted or acted upon after three years from its
date, unless the proxy provides for a longer period), and,
unless the Certificate of Incorporation provides otherwise,
shall have one vote for each share of stock entitled to vote
registered in the name of such stockholder on the books of the
Corporation on the applicable record date fixed pursuant to
these Bylaws. At all elections of directors the voting may but
need not be by ballot and a plurality of the votes of the shares
present in person or represented by proxy at the meeting and
entitled to vote on the election of directors shall elect.
Except as otherwise required by law or the Certificate of
Incorporation, any other action shall be authorized by the vote
of the majority of the shares present in person or represented
by proxy at the meeting and entitled to vote on the subject
matter.
(b) Any action required or permitted to be taken at any
meeting of stockholders may, except as otherwise required by law
or the Certificate of Incorporation, be taken without a meeting,
without prior notice and without a vote, if a consent in
writing, setting forth the action so taken, shall be signed by
the holders of record of the issued and outstanding capital
stock of the Corporation having not less than the minimum number
of votes that would be necessary to authorize or take such
action at a meeting at which all shares entitled to vote thereon
were present and voted, and the writing or writings are filed
with the permanent records of the Corporation. Prompt notice of
the taking of corporate action without a meeting by less than
unanimous written consent shall be given to those stockholders
who have not consented in writing.
(c) At all meetings of the stockholders at which a quorum
is present, all matters, except as otherwise provided by law or
the Certificate of Incorporation, shall be decided by the vote
of the holders of a majority of the shares entitled to vote
thereat present in person or by proxy.
Section 8. Inspectors. The
Board of Directors, in advance of any meeting, may, but need
not, appoint one or more inspectors of election to act at the
meeting or any adjournment thereof. If an inspector or
inspectors are not so appointed, the person presiding at the
meeting may, but need not, appoint one or more inspectors. In
case any person who may be appointed as an inspector fails to
appear or act, the vacancy may be filled by appointment made by
the directors in advance of the meeting or at the meeting by the
person presiding thereat. Each inspector, if any, before
entering upon the discharge of his or her duties, shall take and
sign an oath faithfully to execute the duties of inspector at
such meeting with strict impartiality and according to the best
of his ability. The inspectors, if any, shall determine the
number of shares of stock outstanding and the voting power of
each, the shares of stock represented at the meeting, the
existence of a quorum, and the validity and effect of proxies,
and shall receive votes, ballots or consents, hear and determine
all challenges and questions arising in connection with the
right to vote, count and tabulate all votes, ballots or
consents, determine the result, and do such acts as are proper
to conduct the election or vote with fairness to all
stockholders. On request of the person presiding at the meeting,
the inspector or inspectors, if any, shall make a report in
writing of any challenge, question or matter determined by such
inspector or inspectors and execute a certificate of any fact
found by such inspector or inspectors.
ARTICLE II
Board of
Directors
Section 1. General
Powers. The business, property and affairs of
the Corporation shall be managed by, or under the direction of,
the Board of Directors.
Section 2. Qualification;
Number; Term; Remuneration.
(a) Each director shall be at least 18 years of age. A
director need not be a stockholder, a citizen of the United
States, or a resident of the State of Delaware. The number of
directors constituting the entire Board shall be at least one
(1), or such larger number as may be fixed from time to time by
action of the stockholders or Board of Directors, one of whom
may be selected by the Board of Directors to be its Chairman.
The use of the phrase entire Board herein refers to
the total number of directors which the Corporation would have
if there were no vacancies.
A-59
(b) Directors who are elected at an annual meeting of
stockholders, and directors who are elected in the interim to
fill vacancies and newly created directorships, shall hold
office until the next annual meeting of stockholders and until
their successors are elected and qualified or until their
earlier resignation or removal.
(c) Directors may be paid such compensation for their
services and such reimbursement for expenses of attendance at
meetings as the Board of Directors may from time to time
determine. No such payment shall preclude any director from
serving the Corporation or any of its parent or subsidiary
corporations in any other capacity and receiving compensation
for such service. Members of special or standing committees may
be allowed like compensation for attending committee meetings.
Section 3. Quorum
and Manner of Voting. Except as otherwise
provided by law, a majority of the entire Board shall constitute
a quorum. A majority of the directors present, whether or not a
quorum is present, may adjourn a meeting from time to time to
another time and place without notice. The vote of the majority
of the directors present at a meeting at which a quorum is
present shall be the act of the Board of Directors.
Section 4. Places
of Meetings. Meetings of the Board of
Directors may be held at any place within or without the State
of Delaware, as may from time to time be fixed by resolution of
the Board of Directors, or as may be specified in the notice of
meeting.
Section 5. Annual
Meeting. Following the annual meeting of
stockholders, the newly elected Board of Directors shall meet
for the purpose of the election of officers and the transaction
of such other business as may properly come before the meeting.
Such meeting may be held without notice immediately after the
annual meeting of stockholders at the same place at which such
stockholders meeting is held.
Section 6. Regular
Meetings. Regular meetings of the Board of
Directors shall be held at such times and places as the Board of
Directors shall from time to time by resolution determine.
Notice need not be given of regular meetings of the Board of
Directors held at times and places fixed by resolution of the
Board of Directors.
Section 7. Special
Meetings. Special meetings of the Board of
Directors shall be held whenever called by the Chairman of the
Board, President, Secretary or by a majority of the directors
then in office.
Section 8. Notice
of Meetings. A notice of the place, date and
time and the purpose or purposes of each meeting of the Board of
Directors shall be given to each director by mailing the same at
least two days before the special meeting, or by telephoning,
faxing or emailing the same or by delivering the same personally
prior to the meeting.
Section 9. Organization. At
all meetings of the Board of Directors, the Chairman, if any, or
if none or in the Chairmans absence or inability to act
the President, or in the Presidents absence or inability
to act any Vice-President who is a member of the Board of
Directors, or in such Vice-Presidents absence or inability
to act a chairman chosen by the directors, shall preside. The
Secretary of the Corporation shall act as secretary at all
meetings of the Board of Directors when present, and, in the
Secretarys absence, the presiding officer may appoint any
person to act as secretary.
Section 10. Resignation. Any
director may resign at any time upon written notice to the
Corporation and such resignation shall take effect upon receipt
thereof by the President or Secretary, unless otherwise
specified in the resignation. Any or all of the directors may be
removed, with or without cause, by the holders of a majority of
the shares of stock outstanding and entitled to vote for the
election of directors.
Section 11. Vacancies. Unless
otherwise provided in these Bylaws, vacancies on the Board of
Directors, whether caused by resignation, death,
disqualification, removal, an increase in the authorized number
of directors or otherwise, may be filled by the affirmative vote
of a majority of the remaining directors, although less than a
quorum, or by a sole remaining director, or at a special meeting
of the stockholders, by the holders of shares entitled to vote
for the election of directors.
Section 12. Action
by Written Consent. Any action required or
permitted to be taken at any meeting of the Board of Directors
may be taken without a meeting if all the directors consent
thereto in writing, and the writing is (or writings are) filed
with the minutes of proceedings of the Board of Directors.
A-60
ARTICLE III
Committees
Section 1. Appointment. From
time to time the Board of Directors by a resolution adopted by a
majority of the entire Board may appoint any committee or
committees for any purpose or purposes, to the extent lawful,
which shall have powers as shall be determined and specified by
the Board of Directors in the resolution of appointment.
Section 2. Procedures,
Quorum and Manner of Acting. Each committee
shall fix its own rules of procedure, and shall meet where and
as provided by such rules or by resolution of the Board of
Directors. Except as otherwise provided by law, the presence of
a majority of the then appointed members of a committee shall
constitute a quorum for the transaction of business by that
committee, and in every case where a quorum is present the
affirmative vote of a majority of the members of the committee
present shall be the act of the committee. Each committee shall
keep minutes of its proceedings, and actions taken by a
committee shall be reported to the Board of Directors.
Section 3. Action
by Written Consent. Any action required or
permitted to be taken at any meeting of any committee of the
Board of Directors may be taken without a meeting if all the
members of the committee consent thereto in writing, and the
writing or writings are filed with the minutes of proceedings of
the committee.
Section 4. Term;
Termination. In the event any person shall
cease to be a director of the Corporation, such person shall
simultaneously therewith cease to be a member of any committee
appointed by the Board of Directors.
ARTICLE IV
Officers
Section 1. Election
and Qualifications. The Board of Directors
shall elect the officers of the Corporation, which shall include
a President and a Secretary, and may include, by election or
appointment, one or more Vice-Presidents (any one or more of
whom may be given an additional designation of rank or
function), a Treasurer and such other officers as the Board may
from time to time deem proper. Each officer shall have such
powers and duties as may be prescribed by these Bylaws and as
may be assigned by the Board of Directors or the President. Any
two or more offices may be held by the same person.
Section 2. Term
of Office and Remuneration. The term of
office of all officers shall be one year and until their
respective successors have been elected and qualified, but any
officer may be removed from office, either with or without
cause, at any time by the Board of Directors. Any vacancy in any
office arising from any cause may be filled for the unexpired
portion of the term by the Board of Directors. The remuneration
of all officers of the Corporation may be fixed by the Board of
Directors or in such manner as the Board of Directors shall
provide.
Section 3. Resignation;
Removal. Any officer may resign at any time
upon written notice to the Corporation and such resignation
shall take effect upon receipt thereof by the President or
Secretary, unless otherwise specified in the resignation. Any
officer shall be subject to removal, with or without cause, at
any time by vote of a majority of the entire Board.
Section 4. Chairman
of the Board. The Chairman of the Board of
Directors, if there be one, shall preside at all meetings of the
Board of Directors and shall have such other powers and duties
as may from time to time be assigned by the Board of Directors.
Section 5. President. The
President shall be the principal executive officer of the
Corporation, and shall have such duties as customarily pertain
to that office. The President shall have general management and
supervision of the property, business and affairs of the
Corporation and over its other officers; may appoint and remove
assistant officers and other agents and employees, other than
officers referred to in Section 1 of this
Article IV; and may execute and deliver in the name
of the Corporation powers of attorney, contracts, bonds and
other obligations and instruments.
Section 6. Vice-President. Any
Vice-President may execute and deliver in the name of the
Corporation contracts and other obligations and instruments
pertaining to the regular course of the duties of said office,
and shall have such other authority as from time to time may be
assigned by the Board of Directors or the President.
A-61
Section 7. Treasurer. The
Treasurer shall in general have all duties incident to the
position of Treasurer and such other duties as may be assigned
by the Board of Directors or the President.
Section 8. Secretary. The
Secretary shall in general have all the duties incident to the
office of Secretary and such other duties as may be assigned by
the Board of Directors or the President.
Section 9. Assistant
Officers. Any assistant officer shall have
such powers and duties of the officer such assistant officer
assists as such officer or the Board of Directors shall from
time to time prescribe.
Section 10. Salaries. Officers
of the Corporation shall be entitled to such salaries,
compensation or reimbursement as shall be fixed or allowed from
time to time by the Board of Directors.
ARTICLE V
Books and
Records
Section 1. Location. The
books and records of the Corporation may be kept at such place
or places within or outside the State of Delaware as the Board
of Directors or the respective officers in charge thereof may
from time to time determine. The record books containing the
names and addresses of all stockholders, the number and class of
shares of stock held by each and the dates when they
respectively became the owners of record thereof shall be kept
by the Secretary as prescribed in the Bylaws and by such officer
or agent as shall be designated by the Board of Directors.
Section 2. Addresses
of Stockholders. Notices of meetings and all
other corporate notices may be delivered personally or mailed to
each stockholder at the stockholders address as it appears
on the records of the Corporation.
Section 3. Fixing
Date for Determination of Stockholders of Record.
(a) In order that the Corporation may determine the
stockholders entitled to notice of or to vote at any meeting of
stockholders or any adjournment thereof, the Board of Directors
may fix a record date, which record date shall not precede the
date upon which the resolution fixing the record date is adopted
by the Board of Directors and which record date shall not be
more than sixty (60) nor less than ten (10) days
before the date of such meeting. If no record date is fixed by
the Board of Directors, the record date for determining
stockholders entitled to notice of or to vote at a meeting of
stockholders shall be at the close of business on the day next
preceding the day on which notice is given, or, if notice is
waived, at the close of business on the day next preceding the
day on which the meeting is held. A determination of
stockholders of record entitled to notice of or to vote at a
meeting of stockholders shall apply to any adjournment of the
meeting; provided, however, that the Board of Directors may fix
a new record date for the adjourned meeting.
(b) In order that the Corporation may determine the
stockholders entitled to consent to corporate action in writing
without a meeting, the Board of Directors may fix a record date,
which record date shall not precede the date upon which the
resolution fixing the record date is adopted by the Board of
Directors and which date shall not be more than ten
(10) days after the date upon which the resolution fixing
the record date is adopted by the Board of Directors. If no
record date has been fixed by the Board of Directors, the record
date for determining stockholders entitled to consent to
corporate action in writing without a meeting, when no prior
action by the Board of Directors is required, shall be the first
date on which a signed written consent setting forth the action
taken or proposed to be taken is delivered to the Corporation by
delivery to its registered office in this State, its principal
place of business, or an officer or agent of the Corporation
having custody of the book in which proceedings of meetings of
stockholders are recorded. Delivery made to the
Corporations registered office shall be by hand or by
certified or registered mail, return receipt requested. If no
record date has been fixed by the Board of Directors and prior
action by the Board of Directors is required by this
Article V, the record date for determining
stockholders entitled to consent to corporate action in writing
without a meeting shall be at the close of business on the day
on which the Board of Directors adopts the resolution taking
such prior action.
(c) In order that the Corporation may determine the
stockholders entitled to receive payment of any dividend or
other distribution or allotment of any rights or the
stockholders entitled to exercise any rights in respect of any
change, conversion or exchange of stock, or for the purpose of
any other lawful action, the Board of Directors may fix a record
date, which record date shall not precede the date upon which
the resolution fixing the record date is adopted by the Board of
Directors and which record date shall be not more than sixty
(60) days prior to such action. If no record date is fixed,
the record date for determining stockholders for any such
purpose shall be at the close of business on the day on which
the Board of Directors adopts the resolution relating thereto.
A-62
ARTICLE VI
Certificates
Representing Stock
Section 1. Certificates;
Signatures. The shares of the Corporation
shall be represented by certificates, provided that the Board of
Directors of the Corporation may provide by resolution or
resolutions that some or all of any or all classes or series of
its stock shall be uncertificated shares. Any such resolution
shall not apply to shares represented by a certificate until
such certificate is surrendered to the Corporation.
Notwithstanding the adoption of such a resolution by the Board
of Directors, every holder of stock represented by certificates
and upon request every holder of uncertificated shares shall be
entitled to have a certificate, signed by or in the name of the
Corporation by the Chairman or Vice-Chairman of the Board of
Directors, or the President or Vice-President, and by the
Treasurer or an Assistant Treasurer, or the Secretary or an
Assistant Secretary of the Corporation, representing the number
of shares registered in certificate form. Any and all signatures
on any such certificate may be facsimiles. In case any officer,
transfer agent or registrar who has signed or whose facsimile
signature has been placed upon a certificate shall have ceased
to be such officer, transfer agent or registrar before such
certificate is issued, it may be issued by the Corporation with
the same effect as if he were such officer, transfer agent or
registrar at the date of issue. The name of the holder of record
of the shares represented thereby, with the number of such
shares and the date of issue, shall be entered on the books of
the Corporation.
Section 2. Transfers
of Stock. Upon compliance with provisions
restricting the transfer or registration of transfer of shares
of stock, if any, shares of capital stock shall be transferable
on the books of the Corporation only by the holder of record
thereof in person, or by duly authorized attorney, upon
surrender and cancellation of certificates for a like number of
shares, properly endorsed, and the payment of all taxes due
thereon.
Section 3. Fractional
Shares. The Corporation may, but shall not be
required to, issue certificates for fractions of a share where
necessary to effect authorized transactions, or the Corporation
may pay in cash the fair value of fractions of a share as of the
time when those entitled to receive such fractions are
determined, or it may issue scrip in registered or bearer form
over the manual or facsimile signature of an officer of the
Corporation or of its agent, exchangeable as therein provided
for full shares, but such scrip shall not entitle the holder to
any rights of a stockholder except as therein provided.
The Board of Directors shall have power and authority to make
all such rules and regulations as it may deem expedient
concerning the issue, transfer and registration of certificates
representing shares of the Corporation.
Section 4. Lost,
Stolen or Destroyed Certificates. The
Corporation may issue a new certificate of stock in place of any
certificate, theretofore issued by it, alleged to have been
lost, stolen or destroyed, and the Board of Directors may
require the owner of any lost, stolen or destroyed certificate,
or his legal representative, to give the Corporation a bond
sufficient to indemnify the Corporation against any claim that
may be made against it on account of the alleged loss, theft or
destruction of any such certificate or the issuance of any such
new certificate.
ARTICLE VII
Dividends
Subject always to the provisions of law and the Certificate of
Incorporation, the Board of Directors shall have full power to
determine whether any, and, if any, what part of any, funds
legally available for the payment of dividends shall be declared
as dividends and paid to stockholders; the division of the whole
or any part of such funds of the Corporation shall rest wholly
within the lawful discretion of the Board of Directors, and it
shall not be required at any time, against such discretion, to
divide or pay any part of such funds among or to the
stockholders as dividends or otherwise; and before payment of
any dividend, there may be set aside out of any funds of the
Corporation available for dividends such sum or sums as the
Board of Directors from time to time, in its absolute
discretion, thinks proper as a reserve or reserves to meet
contingencies, or for equalizing dividends, or for repairing or
maintaining any property of the Corporation, or for such other
purpose as the Board of Directors shall think conducive to the
interest of the Corporation, and the Board of Directors may
modify or abolish any such reserve in the manner in which it was
created.
A-63
ARTICLE VIII
Ratification
Any transaction, questioned in any law suit on the ground of
lack of authority, defective or irregular execution, adverse
interest of director, officer or stockholder, non-disclosure,
miscomputation, or the application of improper principles or
practices of accounting, may be ratified before or after
judgment, by the Board of Directors or by the stockholders, and
if so ratified shall have the same force and effect as if the
questioned transaction had been originally duly authorized. Such
ratification shall be binding upon the Corporation and its
stockholders and shall constitute a bar to any claim or
execution of any judgment in respect of such questioned
transaction.
ARTICLE IX
Corporate
Seal
The Corporation may have a corporate seal. The corporate seal
shall have inscribed thereon the name of the Corporation and the
year of its incorporation, and shall be in such form and contain
such other words
and/or
figures as the Board of Directors shall determine. The corporate
seal may be used by printing, engraving, lithographing, stamping
or otherwise making, placing or affixing, or causing to be
printed, engraved, lithographed, stamped or otherwise made,
placed or affixed, upon any paper or document, by any process
whatsoever, an impression, facsimile or other reproduction of
said corporate seal.
ARTICLE X
Fiscal
Year
The fiscal year of the Corporation shall be fixed, and shall be
subject to change, by the Board of Directors. Unless otherwise
fixed by the Board of Directors, the fiscal year of the
Corporation shall be the calendar year.
ARTICLE XI
Waiver of
Notice
Whenever notice is required to be given by these Bylaws or by
the Certificate of Incorporation or by law, a written waiver
thereof, signed by the person or persons entitled to said
notice, whether before or after the time stated therein, shall
be deemed equivalent to notice.
ARTICLE XII
Bank
Accounts, Drafts, Contracts,
Etc.
Section 1. Bank
Accounts and Drafts. In addition to such bank
accounts as may be authorized by the Board of Directors, the
primary financial officer or any person designated by said
primary financial officer, whether or not an employee of the
Corporation, may authorize such bank accounts to be opened or
maintained in the name and on behalf of the Corporation as he
may deem necessary or appropriate, payments from such bank
accounts to be made upon and according to the check of the
Corporation in accordance with the written instructions of said
primary financial officer, or other person so designated by the
Treasurer.
Section 2. Contracts. The
Board of Directors may authorize any person or persons, in the
name and on behalf of the Corporation, to enter into or execute
and deliver any and all deeds, bonds, mortgages, contracts and
other obligations or instruments, and such authority may be
general or confined to specific instances.
Section 3. Proxies;
Powers of Attorney; Other Instruments. The
Chairman, the President or any other person designated by either
of them shall have the power and authority to execute and
deliver proxies, powers of attorney and other instruments on
behalf of the Corporation in connection with the rights and
powers incident to the ownership of stock by the Corporation.
The Chairman, the President or any other person authorized by
proxy or power of attorney executed and delivered by either of
them on behalf of the Corporation may attend and vote at any
A-64
meeting of stockholders of any company in which the Corporation
may hold stock, and may exercise on behalf of the Corporation
any and all of the rights and powers incident to the ownership
of such stock at any such meeting, or otherwise as specified in
the proxy or power of attorney so authorizing any such person.
The Board of Directors, from time to time, may confer like
powers upon any other person.
Section 4. Financial
Reports. The Board of Directors may appoint
the primary financial officer or other fiscal officer
and/or the
Secretary or any other officer to cause to be prepared and
furnished to stockholders entitled thereto any special financial
notice
and/or
financial statement, as the case may be, which may be required
by any provision of law.
ARTICLE XIII
Indemnification
The Corporation shall, to the fullest extent permitted by and in
accordance with Section 145 of the General Corporation Law
of Delaware, as that Section may be amended and supplemented
from time to time, indemnify any director, officer or trustee
which it shall have power to indemnify under that Section
against any expenses, liabilities or other matters referred to
in or covered by that Section; provided, however, that the
foregoing shall not require the Corporation to indemnify or
advance expenses to any person in connection with any action,
suit, proceeding, claim or counterclaim initiated by or on
behalf of such person. The Corporation may, in the discretion of
the Board of Directors, indemnify to the fullest extent
permitted by and in accordance with Section 145 of the
General Corporation Law of Delaware, as that Section may be
amended and supplemented from time to time, any other employee
or agent of the Corporation (i.e., an employee or agent who is
not a director, officer or trustee of the Corporation) which it
shall have power to indemnify under that Section against any
expenses, liabilities or other matters referred to in or covered
by that Section. The indemnification provided for in this
Article (i) shall not be deemed exclusive of any other
rights to which those indemnified may be entitled under any
bylaw, agreement or vote of stockholders or disinterested
directors or otherwise, both as to action in their official
capacities and as to action in another capacity while holding
such office or position, (ii) shall continue as to a person
who has ceased to be a director, officer, trustee, or other
employee or agent and (iii) shall inure to the benefit of
the heirs, executors and administrators of such a person. The
Corporations obligation to provide indemnification under
this Article shall be offset to the extent of any other source
of indemnification or any otherwise applicable insurance
coverage under a policy maintained by the Corporation or any
other person.
To assure indemnification under this Article of all such persons
who are determined by the Corporation or otherwise to be or to
have been fiduciaries of any employee benefit plan
of the Corporation which may exist from time to time, such
Section 145 shall, for the purposes of this Article, be
interpreted as follows: an other enterprise shall be
deemed to include such an employee benefit plan, including,
without limitation, any plan of the Corporation which is
governed by the Act of Congress entitled Employee
Retirement Income Security Act of 1974, as amended from
time to time; the Corporation shall be deemed to have requested
a person to serve an employee benefit plan where the performance
by such person of his duties to the Corporation also imposes
duties on, or otherwise involves services by, such person to the
plan or participants or beneficiaries of the plan; excise taxes
assessed on a person with respect to an employee benefit plan
pursuant to such Act of Congress shall be deemed
fines; and action taken or omitted by a person with
respect to an employee benefit plan in the performance of such
persons duties for a purpose reasonably believed by such
person to be in the interest of the participants and
beneficiaries of the plan shall be deemed to be for a purpose
which is not opposed to the best interests of the Corporation.
ARTICLE XIV
Amendments
The Board of Directors shall have power to adopt, amend or
repeal Bylaws. Bylaws adopted by the Board of Directors may be
repealed or changed, and new Bylaws made, by the stockholders,
and the stockholders may prescribe that any Bylaw made by them
shall not be altered, amended or repealed by the Board of
Directors.
* * * * *
A-65
Annex B
EXECUTION
VERSION
PURCHASE
AGREEMENT
by and between
BAE SYSTEMS INFORMATION SOLUTIONS INC.
and
L-1 IDENTITY SOLUTIONS, INC.
September 19, 2010
B-i
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
Article I
DEFINITIONS AND TERMS
|
Section 1.1
|
|
Definitions
|
|
|
B-1
|
|
Section 1.2
|
|
Other Definitional Provisions; Interpretation
|
|
|
B-9
|
|
|
Article II
PURCHASE AND SALE
|
Section 2.1
|
|
Purchase and Sale of the Transferred Shares
|
|
|
B-10
|
|
Section 2.2
|
|
Purchase Price
|
|
|
B-10
|
|
Section 2.3
|
|
Allocation of Purchase Price
|
|
|
B-10
|
|
|
Article III
THE CLOSING
|
Section 3.1
|
|
Closing
|
|
|
B-11
|
|
Section 3.2
|
|
The Companys Deliveries at Closing
|
|
|
B-11
|
|
Section 3.3
|
|
Purchasers Deliveries at Closing
|
|
|
B-12
|
|
Section 3.4
|
|
Proceedings at Closing
|
|
|
B-12
|
|
Section 3.5
|
|
Withholding
|
|
|
B-12
|
|
|
Article IV
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
|
Section 4.1
|
|
Organization and Good Standing
|
|
|
B-12
|
|
Section 4.2
|
|
Transferred Shares; Subsidiaries; Capitalization
|
|
|
B-13
|
|
Section 4.3
|
|
Authorization; No Conflict
|
|
|
B-13
|
|
Section 4.4
|
|
Governmental Consents
|
|
|
B-14
|
|
Section 4.5
|
|
Intel Financial Statements
|
|
|
B-14
|
|
Section 4.6
|
|
No Undisclosed Liabilities
|
|
|
B-15
|
|
Section 4.7
|
|
Absence of Certain Changes
|
|
|
B-15
|
|
Section 4.8
|
|
Employee Plans; ERISA
|
|
|
B-15
|
|
Section 4.9
|
|
Litigation
|
|
|
B-17
|
|
Section 4.10
|
|
Permits; Compliance with Law; Governmental Authorizations
|
|
|
B-17
|
|
Section 4.11
|
|
Taxes
|
|
|
B-18
|
|
Section 4.12
|
|
Intellectual Property
|
|
|
B-19
|
|
Section 4.13
|
|
Real Property; Tangible Personal Property
|
|
|
B-20
|
|
Section 4.14
|
|
Labor Matters
|
|
|
B-20
|
|
Section 4.15
|
|
Contracts
|
|
|
B-21
|
|
Section 4.16
|
|
Government Contracts
|
|
|
B-22
|
|
Section 4.17
|
|
Intel Business Assets
|
|
|
B-24
|
|
Section 4.18
|
|
Brokers or Finders
|
|
|
B-24
|
|
Section 4.19
|
|
Title to Transferred Shares
|
|
|
B-24
|
|
Section 4.20
|
|
Affiliate Transactions; Intercompany Arrangements
|
|
|
B-24
|
|
Section 4.21
|
|
Environmental Matters
|
|
|
B-25
|
|
Section 4.22
|
|
Insurance
|
|
|
B-25
|
|
Section 4.23
|
|
SEC Filings.
|
|
|
B-25
|
|
Section 4.24
|
|
No Other Representations
|
|
|
B-25
|
|
B-ii
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
Article V
REPRESENTATIONS AND WARRANTIES OF PURCHASER
|
Section 5.1
|
|
Organization and Good Standing
|
|
|
B-26
|
|
Section 5.2
|
|
Authorization; Validity of Agreement; Necessary Action
|
|
|
B-26
|
|
Section 5.3
|
|
Consents and Approvals; No Violations
|
|
|
B-26
|
|
Section 5.4
|
|
Sufficient Funds
|
|
|
B-27
|
|
Section 5.5
|
|
Investigation by Purchaser
|
|
|
B-27
|
|
Section 5.6
|
|
Litigation
|
|
|
B-27
|
|
Section 5.7
|
|
Brokers or Finders
|
|
|
B-27
|
|
Section 5.8
|
|
Acquisition of Transferred Shares for Investment
|
|
|
B-27
|
|
|
Article VI
COVENANTS
|
Section 6.1
|
|
Interim Operations of the Transferred Companies
|
|
|
B-27
|
|
Section 6.2
|
|
Notification of Certain Matters
|
|
|
B-30
|
|
Section 6.3
|
|
Access to Information
|
|
|
B-30
|
|
Section 6.4
|
|
Employees; Employee Benefits
|
|
|
B-31
|
|
Section 6.5
|
|
Publicity
|
|
|
B-32
|
|
Section 6.6
|
|
Directors and Officers Indemnification
|
|
|
B-32
|
|
Section 6.7
|
|
Appropriate Actions
|
|
|
B-34
|
|
Section 6.8
|
|
No Control of Other Partys Business
|
|
|
B-35
|
|
Section 6.9
|
|
Tax Matters
|
|
|
B-35
|
|
Section 6.10
|
|
Guaranties and Intercompany Agreements
|
|
|
B-39
|
|
Section 6.11
|
|
Insurance
|
|
|
B-40
|
|
Section 6.12
|
|
Intel Business Cash, Indebtedness and Working Capital
|
|
|
B-41
|
|
Section 6.13
|
|
Identity Marks
|
|
|
B-41
|
|
Section 6.14
|
|
Confidentiality
|
|
|
B-42
|
|
Section 6.15
|
|
Intel Acquisition Agreements
|
|
|
B-43
|
|
Section 6.16
|
|
OCI Mitigation
|
|
|
B-43
|
|
Section 6.17
|
|
Divestiture of Patriot
|
|
|
B-43
|
|
Section 6.18
|
|
Employee Equity Awards
|
|
|
B-43
|
|
Section 6.19
|
|
Cooperation
|
|
|
B-44
|
|
Section 6.20
|
|
Intel Companies Special Employee Plan.
|
|
|
B-44
|
|
Section 6.21
|
|
No Limitations on Claims, Legal Rights
|
|
|
B-44
|
|
|
Article VII
CONDITIONS
|
Section 7.1
|
|
Conditions to the Obligations of Each Party
|
|
|
B-45
|
|
Section 7.2
|
|
Conditions to Obligations of Purchaser
|
|
|
B-45
|
|
Section 7.3
|
|
Conditions to Obligations of the Company
|
|
|
B-46
|
|
Section 7.4
|
|
Frustration of Conditions
|
|
|
B-46
|
|
|
Article VIII
TERMINATION
|
Section 8.1
|
|
Termination
|
|
|
B-46
|
|
Section 8.2
|
|
Effect of Termination
|
|
|
B-47
|
|
B-iii
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
Article IX
INDEMNIFICATION
|
Section 9.1
|
|
Nonsurvival of Companys Representations and Warranties
|
|
|
B-47
|
|
Section 9.2
|
|
Indemnification of Purchaser
|
|
|
B-48
|
|
Section 9.3
|
|
Indemnification of the Company
|
|
|
B-48
|
|
Section 9.4
|
|
Claims
|
|
|
B-48
|
|
Section 9.5
|
|
Certain Limitations and Other Indemnification Provisions
|
|
|
B-49
|
|
Section 9.6
|
|
Characterization of Indemnification Payments; Exclusivity of Tax
Provisions
|
|
|
B-49
|
|
|
Article X
MISCELLANEOUS
|
Section 10.1
|
|
Amendment and Modification
|
|
|
B-49
|
|
Section 10.2
|
|
Notices
|
|
|
B-50
|
|
Section 10.3
|
|
Interpretation
|
|
|
B-50
|
|
Section 10.4
|
|
Counterparts
|
|
|
B-51
|
|
Section 10.5
|
|
Entire Agreement; Third-Party Beneficiaries
|
|
|
B-51
|
|
Section 10.6
|
|
Severability
|
|
|
B-51
|
|
Section 10.7
|
|
Governing Law
|
|
|
B-51
|
|
Section 10.8
|
|
Jurisdiction
|
|
|
B-51
|
|
Section 10.9
|
|
Service of Process
|
|
|
B-51
|
|
Section 10.10
|
|
Waiver of Jury Trial
|
|
|
B-51
|
|
Section 10.11
|
|
Specific Performance
|
|
|
B-52
|
|
Section 10.12
|
|
Assignment
|
|
|
B-52
|
|
Section 10.13
|
|
Expenses
|
|
|
B-52
|
|
Section 10.14
|
|
Waivers
|
|
|
B-52
|
|
Annex A
|
|
Form of Master Termination and Release Agreement
|
|
|
|
|
Annex B
|
|
Form of Assignment Agreement
|
|
|
|
|
B-iv
PURCHASE
AGREEMENT
PURCHASE AGREEMENT, dated as of September 19, 2010 (this
Agreement), by and between L-1 Identity
Solutions, Inc., a Delaware corporation (the
Company), and BAE Systems Information
Solutions Inc., a Virginia corporation
(Purchaser).
WHEREAS, L-1 Identity Solutions Operating Company, a Delaware
corporation and a wholly owned Subsidiary of the Company
(Operating Company), owns 100% of the
membership interests (the McClendon
Interests) of McClendon, LLC, a Virginia limited
liability company (McClendon), 100% of the
membership interests (the SpecTal Interests)
of SpecTal, LLC, a Virginia limited liability company
(SpecTal), and all of the issued and
outstanding shares of capital stock (the ACI
Shares and, together with the McClendon Interests and
the SpecTal Interests, the Transferred
Shares) of Advanced Concepts, Inc., a Maryland
corporation (ACI and, together with McClendon and
SpecTal, the Transferred Companies);
WHEREAS, ACI owns 49% (the Patriot Interests)
of the membership interests of Patriot, LLC, a Maryland limited
liability company (Patriot and, together with
the Transferred Companies, the Intel
Companies);
WHEREAS, it is proposed that, on the terms and subject to the
conditions set forth in this Agreement, at the Closing, the
Company will cause Operating Company to sell to Purchaser, and
Purchaser will purchase from Operating Company, the Transferred
Shares;
WHEREAS, it is further proposed that, prior to the Closing, ACI
will transfer, assign or otherwise divest itself of the Patriot
Interests, such that Purchaser will not acquire a direct or
indirect interest in Patriot pursuant to this Agreement or the
transactions contemplated hereby; and
WHEREAS, the respective Boards of Directors of the Company,
Operating Company and Purchaser have approved this Agreement and
resolved that the transactions contemplated by this Agreement
(upon the terms and subject to the conditions set forth in this
Agreement) are advisable and in the best interests of their
respective stockholders.
NOW, THEREFORE, in consideration of the foregoing and the
representations, warranties, covenants and agreements set forth
herein, and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties
hereto, intending to be legally bound hereby, agree as follows:
ARTICLE I
DEFINITIONS
AND TERMS
Section 1.1 Definitions. As
used in this Agreement, the following terms shall have the
meanings set forth below:
2010 Bonuses has the meaning set forth
in Section 6.4(b)(v).
338(h)(10) Election has the meaning
set forth in Section 6.9(a)(i).
409A Plan has the meaning set forth in
Section 4.8(j).
ACI has the meaning set forth in the
Recitals.
ACI Shares has the meaning set forth
in the Recitals.
Affiliate has the meaning set forth in
Rule 12b-2
under the Exchange Act.
Affiliate Agreement has the meaning
set forth in Section 4.20.
Agreement has the meaning set forth in
the Preamble.
Anti-Bribery Laws has the meaning set
forth in Section 4.10(d).
Assignment Agreements has the meaning
set forth in Section 6.15.
Audited Intel Financial Statements has
the meaning set forth in Section 4.5(a).
B-1
Bank of America Credit Facility means
the Second Amended and Restated Credit Agreement, dated
August 5, 2008, among Operating Company, the Company, Bank
of America, N.A., Wachovia Bank, National Association, Banc of
America Securities LLC, Wachovia Capital Markets LLC, Royal Bank
of Canada, Société Générale and TD Bank,
N.A., as amended, and the other Contracts comprising the Credit
Agreement and Related Agreements (as defined in the Company
Disclosure Schedule).
Benefit Arrangement means each
employment, severance or other similar contract, arrangement or
policy (written or oral) and each plan or arrangement (written
or oral) providing for severance benefits, insurance coverage
(including any self-insured arrangements), workers
compensation, disability benefits, supplemental unemployment
benefits, vacation benefits, retirement benefits or for deferred
compensation, profit-sharing, bonuses, stock options, stock
appreciation rights or other forms of incentive compensation or
post-retirement insurance, compensation or benefits which
(A) is not an Employee Plan, (B) is maintained or
contributed to by the Company or any ERISA Affiliate of the
Company and (C) covers any employee or former employee of
any of the Transferred Companies.
Bid means any outstanding quotation,
bid or proposal by any Intel Company that, if accepted or
awarded, could result in a Government Contract.
Business Confidential Information has
the meaning set forth in Section 6.14(a).
Business Day means a day other than a
Saturday, a Sunday or another day on which commercial banking
institutions in New York, New York are authorized or required by
Law to be closed.
Business Material Adverse Effect means
any change, effect or circumstance which, individually or in the
aggregate, (A) has resulted or would reasonably be expected
to result in a material adverse effect on the business,
financial condition or results of operations of the Intel
Business or the Intel Companies, taken as a whole or
(B) would prevent or materially delay or impair the ability
of the Company or Operating Company to consummate the
transactions contemplated by this Agreement; provided,
however, that changes, effects or circumstances relating
to or resulting from the following shall be excluded from the
determination of Business Material Adverse Effect: (i) any
change, effect or circumstance in any of the industries or
markets in which the Intel Companies operate; (ii) any
change in any Law or GAAP (or changes in interpretations of any
Law or GAAP) applicable to the Intel Companies;
(iii) changes in general economic, regulatory or political
conditions or the financial, credit or securities markets in
general (including changes in interest or exchange rates) in the
United States; (iv) any acts of God, natural disasters,
terrorism, armed hostilities, sabotage, war or any escalation or
worsening of acts of war; (v) the negotiation, execution,
announcement, consummation or existence of this Agreement, or
the transactions contemplated hereby (including the impact of
any of the foregoing on relationships with customers, suppliers,
employees or regulators); (vi) any action taken as required
by this Agreement or with the consent or at the direction of
Purchaser; and (vii) any failure by the Intel Companies to
meet internal, analysts or other earnings estimates or
financial projections or changes in credit ratings;
provided that this clause (vii) shall not exclude
any change, effect, event, development, state of facts,
occurrence or circumstance that may have contributed to or
caused such failure from being taken into account in determining
whether a Business Material Adverse Effect has occurred (unless
separately excluded under clauses (i) (vi) of
this definition); provided, further, that the
exclusions provided for in clauses (i)
(iv) shall not apply to the extent (and only to the extent)
the Intel Companies are materially disproportionately adversely
affected by any of the changes, effects or circumstances
described in such clauses relative to other participants in the
industry in which the Intel Companies participate. Without
limiting the generality of the foregoing, any change, effect or
circumstance (whether or not previously disclosed in the Company
Disclosure Schedule or in the Company SEC Reports publicly
available prior to the date of this Agreement or otherwise)
that, individually or in the aggregate, has resulted in, or that
would reasonably be expected to result in a suspension or
debarment of (i) the Company or the Operating Company or
any of their directors, officers or senior management personnel
(in their capacity as such) if arising from or relating to the
Intel Business as conducted by the Transferred Companies or any
of the Transferred Companies, or (ii) any of the
Transferred Companies or any of their directors, officers or
senior management personnel (in their capacity as such), shall
be deemed to have had a Business Material Adverse Effect.
CFIUS means the Committee on Foreign
Investment in the United States.
B-2
Closing has the meaning set forth in
Section 3.1.
Closing Date has the meaning set forth
in Section 3.1.
Code means the Internal Revenue Code
of 1986, as amended.
Company has the meaning set forth in
the Preamble.
Company Affiliated Group means the
Company and the members of the affiliated group of corporations
of which the Company is the common parent corporation within the
meaning of Section 1504(a)(1) of the Code, including,
through the Closing Date, the Transferred Companies.
Company Common Stock means the issued
and outstanding shares of common stock, par value $0.001 per
share, of the Company.
Company Confidential Information has
the meaning set forth in Section 6.14(b).
Company Disclosure Schedule means the
disclosure schedules delivered by the Company to Purchaser
simultaneously with the execution of this Agreement.
Company Indemnified Parties has the
meaning set forth in Section 9.3.
Company SEC Reports means the forms,
documents, proxy statements and reports with the SEC filed prior
to the date hereof by the Company since January 1, 2008
under the Exchange Act or the Securities Act (as such reports
and statements may have been amended since the date of their
filing).
Company State Group means some or all
of the members of the Company Affiliated Group that have been
filing or hereafter shall file returns of state or local income
Taxes as a group of which the Company or Operating Company is
the common parent corporation, including through the Closing
Date, the Transferred Companies.
Confidentiality Agreement means the
confidentiality agreement, dated May 21, 2010, between the
Company and Purchaser, as the same may be amended or
supplemented.
Continuing Employees has the meaning
given in Section 6.18.
Contract means any contract,
subcontract, lease, sublease, conditional sales contract,
purchase order, sales order, task order, delivery order,
license, indenture, note, bond, loan, instrument, understanding,
permit, concession, franchise, commitment or other agreement,
whether written or oral.
D&O Indemnified Parties has the
meaning set forth in Section 6.6(a).
D&O Insurance has the meaning set
forth in Section 6.6(c).
Employee Plan means each
employee benefit plan, as such term is defined in
Section 3(3) of ERISA, that is subject to any provision of
ERISA and is maintained or contributed to by the Company or any
ERISA Affiliate for the benefit of any employee or former
employee of any of the Transferred Companies.
Environmental Laws means all Laws
relating to pollution or protection of the environment and human
health including (a) Laws relating to Releases or
threatened Releases of Hazardous Substances, and the treatment,
storage, disposal, transport or handling of any Hazardous
Substances, (b) the Comprehensive Environmental Response,
Compensation and Liability Act of 1980, as amended, (c) the
Resource Conservation and Recovery Act of 1976, as amended,
(d) the Clean Water Act, as amended, (e) the Clean Air
Act, as amended, (f) the Toxic Substances Control Act,
(g) the Emergency Planning and Community Right to Know Act,
and (h) any other Laws relating to protection of the
environment and human health.
ERISA means the Employee Retirement
Income Security Act of 1974, as amended.
ERISA Affiliate means any trade or
business, whether or not incorporated, that together with any
company would be deemed a single employer within the
meaning of Section 4001(b) of ERISA.
Estimated Closing Balance Sheet has
the meaning set forth in Section 6.12(c).
Estimated Net Working Capital Amount
has the meaning set forth in Section 6.12(c).
B-3
Exchange Act means the Securities
Exchange Act of 1934, as amended.
Exon-Florio has the meaning set forth
in Section 4.4.
Export Control Laws has the meaning
set forth in Section 4.10(c).
FAR means the Federal Acquisition
Regulation and the government agency supplements thereto.
Filings has the meaning set forth in
Section 6.7(a).
Final Purchase Price Allocation has
the meaning set forth in Section 2.3(b).
FOCI means foreign ownership, control
or influence.
GAAP has the meaning set forth in
Section 4.5(a).
Good Faith Transfer Negotiations shall
consist of, with respect to a given Intel Misallocated Contract
or Identity Misallocated Contract, (i) negotiating in good
faith with the applicable parties in connection with the
assignment of such Intel Misallocated Contract or Identity
Misallocated Contract to the Company Subsidiary to which it most
closely relates, (ii) the appropriate party providing the
other party with such information and documentation regarding
such Intel Misallocated Contract or Identity Misallocated
Contract as it may reasonably request in order to conduct a
customary due diligence investigation of such Intel Misallocated
Contract or Identity Misallocated Contract and its performance,
(iii) the results of such due diligence investigation being
reasonably satisfactory to Purchaser (in the case of an Intel
Misallocated Contract) or the Company (in the case of an
Identity Misallocated Contract), (iv) negotiating in good
faith the transfer and assignment to such Transferred Company or
Identity Company of the applicable assets, rights and personnel
of the Identity Companies or Transferred Company, as applicable,
that have been utilized in the performance of such Intel
Misallocated Contract or Identity Misallocated Contract, and
(v) if such Intel Misallocated Contract or Identity
Misallocated Contract is assigned to a Transferred Company or
Identity Company, entering into a written agreement with the
assigning Identity Company or Transferred Company pursuant to
which such assignee Transferred Company or Identity Company will
agree to indemnify and hold harmless such assigning Identity
Company or Transferred Company with respect to all future
Liabilities arising under such Intel Misallocated Contract or
Identity Misallocated Contract, as applicable (but subject to
the limitations included in the indemnities set forth in
Sections 6.10(g) and (h)); provided that any such
agreement must be in form and substance acceptable to the
parties thereto (which acceptance shall not be unreasonably
withheld, delayed or conditioned).
Government Contract means any Contract
entered into between any of the Intel Companies and (a) any
Governmental Entity, (b) any prime contractor or upper-tier
subcontractor to any Governmental Entity (in its capacity as
such), or (c) any lower-tier subcontractor with respect to
any Contract described in clause (a) or (b).
Governmental Authorization means any
consent, approval, order, license, franchise, registration,
security clearance, authorization, variance, exemption,
certificate or permit issued, granted, given or otherwise made
available by or under the authority of any Governmental Entity
or pursuant to any Law.
Governmental Entity means any
government, court, tribunal, or arbitrator, any governmental
entity or municipality or political or other subdivision
thereof, or any agency, department, board, self-regulating
authority, bureau, branch, commission, authority, official or
instrumentality of any of the foregoing.
Hazardous Substance means (a) any
petroleum, crude oil, natural gas, or any fraction, product or
derivative thereof, radioactive materials or asbestos (whether
or not friable); and (b) any chemicals, materials,
substances or wastes that are defined as or included in the
definition of hazardous substances, hazardous chemicals,
hazardous wastes, hazardous materials, extremely hazardous
substances, toxic substances, pollutants, contaminants or words
of similar import under any Environmental Laws.
Hazardous Substance Activity means the
possession, transportation, transfer, recycling, storage, use,
treatment, manufacture, removal, Release, remediation, exposure
of Persons to, sale, distribution or other handling of any
Hazardous Substance.
HSR Act means the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended.
B-4
Identity Business means the businesses
and operations of the Identity Companies.
Identity Companies means the Company
and all of its Subsidiaries, other than the Intel Companies.
Identity Contract means a Contract
with a Third Party existing as of or prior to the Closing Date
that primarily relates to the Identity Business, meaning that
such Contract is performed primarily by employees of one or more
Identity Companies
and/or
primarily relates to assets or rights that are owned, held or
utilized by any of the Identity Companies.
Identity Guaranties has the meaning
set forth in Section 6.10(b).
Identity Marks means all Trademarks
owned by the Company and its Subsidiaries (other than the Intel
Companies).
Identity Misallocated Contract has the
meaning set forth in Section 6.10(e).
Indebtedness means, without
duplication, the aggregate amount of (a) all obligations
for borrowed money, all interest accruing thereon and all
accrued but unpaid prepayment premiums or penalties and any
other fees and expenses paid to satisfy such indebtedness,
(b) all obligations evidenced by bonds, debentures, notes
or similar instruments, (c) all obligations under
conditional sale or other title retention agreements relating to
property purchased, (d) all obligations issued or assumed
as the deferred purchase price of property or services
(excluding obligations to creditors for goods and services
incurred in the ordinary course of business and accrued
expenses), (e) all capitalized lease obligations,
(f) all obligations of others secured by any Lien on
property or assets owned or acquired, whether or not the
obligations secured thereby have been assumed, (g) all
obligations under standby letters of credit, and (h) all
guarantees and arrangements having the economic effect of a
guarantee of any Indebtedness (as defined in clauses
(a) (h) of this sentence) of any other Person.
Indemnified Parties has the meaning
set forth in Section 9.3.
Indemnifying Party has the meaning set
forth in Section 9.3.
Independent Accounting Firm has the
meaning set forth in Section 2.3(b).
Insurance Policies has the meaning set
forth in Section 4.22.
Intel Acquisition Agreements means,
collectively, (i) that certain Securities Purchase
Agreement, dated September 11, 2006, by and among Operating
Company, SpecTal and the Sellers Representative on behalf of the
Members, relating to the acquisition of SpecTal, (ii) that
certain Agreement and Plan of Merger, dated June 18, 2007,
by and among the Company, Operating Company, McClendon, the
Stockholders Representative and the Selling Stockholders
signatory thereto, relating to the acquisition of McClendon and
(iii) that certain Stock Purchase Agreement, dated
May 1, 2007, by and among, ACI, the Selling Stockholders
signatory thereto, the Sellers Representative and Operating
Company, relating to the acquisition of ACI.
Intel Business means the businesses
and operations of the Intel Companies.
Intel Companies has the meaning set
forth in the Recitals.
Intel Company Awards has the meaning
set forth in Section 6.18.
Intel Company Intellectual Property
Rights means Intellectual Property owned by the
Intel Companies.
Intel Company Material Contract has
the meaning set forth in Section 4.15(a)
Intel Company Permits has the meaning
set forth in Section 4.10(a).
Intel Contract means a Contract with a
Third Party existing as of or prior to the Closing Date that
primarily relates to the Intel Business, meaning that such
Contract is performed primarily by employees of one or more
Intel Companies
and/or
primarily relates to assets or rights that are owned, held or
utilized by any of the Intel Companies.
Intel Financial Statements has the
meaning set forth in Section 4.5(a).
Intel Guaranties has the meaning set
forth in Section 6.10(a).
B-5
Intel Leases has the meaning set forth
in Section 4.13(a).
Intel Misallocated Contract has the
meaning set forth in Section 6.10(d).
Intel Termination Date has the meaning
set forth in Section 8.1(b).
Intel Vesting Event has the meaning
set forth in Section 6.18.
Intellectual Property means, in any
and all jurisdictions throughout the world, all
(i) patents, patent applications and patent disclosures
(Patents), (ii) registered and
unregistered trademarks, trademark applications, trade names,
service marks, logos, corporate names and Internet domain names,
together with all goodwill associated with each of the foregoing
(Trademarks), (iii) registered and
unregistered copyrights, copyright applications and other works
of authorship (Copyrights), (iv) trade
secrets, mask works and proprietary confidential information,
including any comprising data, databases, know-how, inventions,
methods, processes and techniques (whether or not patentable and
whether or not reduced to practice), and proprietary
confidential business plans and proposals and consumer lists
(Trade Secrets), (v) computer software
(including source code and executable code) and documentation
therefor and (vi) to the extent not included in the
foregoing (i) (v), other intellectual property
rights.
Interim Intel Financial Statements has
the meaning set forth in Section 4.5(a).
IRS means the United States Internal
Revenue Service.
ITAR has the meaning set forth in
Section 4.10(c).
Joint Filing has the meaning set forth
in Section 6.7(c).
Judgment means any judgment, order,
ruling, award, assessment, writ, injunction, decree,
stipulation, determination or similar order of any Governmental
Entity, in each case, whether preliminary or final.
Knowledge means the actual knowledge
after reasonable inquiry of the direct reports who would
reasonably be expected to be in possession of the knowledge of
the type addressed by the applicable representations and
warranties that are subject to the applicable
Knowledge qualifier used in such representation and
warranty of (i) as to the Company, the persons identified
in Section 1.1 of the Company Disclosure Schedule
and (ii) as to Purchaser, the persons identified in
Section 1.1 of the Purchaser Disclosure Schedule.
Law means any federal, state, local or
foreign law, statute, ordinance, rule, regulation, Judgment,
franchise, license, agency requirement or permit of any
Governmental Entity.
Leased Real Property means all Real
Property leased pursuant to the Intel Leases.
Liabilities means any direct or
indirect liability, Indebtedness, guaranty, claim, loss, damage,
deficiency, assessment, obligation, whether fixed or unfixed,
determined or determinable, due or to become due, liquidated or
unliquidated, secured or unsecured, accrued or unaccrued,
absolute, known or unknown, asserted or unasserted, matured or
unmatured, or contingent or otherwise.
Liens means all pledges, liens,
charges, mortgages, encumbrances, security interests,
attachments, claims, transfer restrictions, options, puts, calls
and rights of first refusal and encumbrances of any kind.
Losses means all costs, damages,
Liabilities, assessments, Judgments, losses, penalties, fines,
settlements, awards, expenses and fees (including reasonable
legal, accounting or other professional fees and disbursements
and the costs of or arising from any Proceeding).
McClendon has the meaning set forth in
the Recitals.
McClendon Interests has the meaning
set forth in the Recitals.
Merger Agreement means that certain
Agreement and Plan of Merger, dated as of the date hereof, by
and among the Company, Safran SA and Laser Acquisition Sub Inc.
Merger Date has the meaning set forth
in Section 6.18.
Merger Termination Date has the
meaning set forth in Section 6.18.
B-6
Net Working Capital means, as of the
date and time of determination, the difference between
(i) the sum (without duplication) of the current assets of
the Transferred Companies, on a combined basis, as of such date
and time, and (ii) the sum (without duplication) of the
current liabilities of the Transferred Companies, on a combined
basis, as of such date and time, in each case calculated in
accordance with GAAP applied in a manner consistent with the
accounting practices, policies and methodologies used in the
preparation of the Audited Intel Financial Statements;
provided, however, that all cash, cash
equivalents, deferred tax assets, deferred tax liabilities and
inter-company receivables and payables shall be excluded;
provided, further, that all payment obligations
arising under the Special Employee Plan Term Sheet or Special
Employee Plan shall be also excluded.
NISPOM has the meaning set forth in
Section 4.4.
Novation Contract has the meaning set
forth in Section 6.7(e).
OCI has the meaning set forth in
Section 6.16.
OCI Prime Contract has the meaning set
forth in Section 6.16 of the Company Disclosure
Schedule.
OCI Subcontract has the meaning set
forth in Section 6.16 of the Company Disclosure
Schedule.
OCI Subcontract Mitigation Plan has
the meaning set forth in Section 6.16 of the Company
Disclosure Schedule.
Operating Company has the meaning set
forth in the Recitals.
Patriot has the meaning set forth in
the Recitals.
Patriot Interests has the meaning set
forth in the Recitals.
Permits means all licenses, permits,
exemptions, consents, authorizations, approvals, registrations,
security clearances, variances, waivers, certificates and other
authorizations issued, granted, given under the authority of any
Governmental Entity or pursuant to any Law.
Permitted Liens means (i) Liens
for current Taxes not yet due and payable, or the validity or
amount of which is being contested in good faith by appropriate
proceedings, and for which reserves have been established in
accordance with GAAP, (ii) Liens of any materialmen,
mechanics, workmen, repairmen, contractors, warehousemen,
carriers, suppliers, vendors or equivalent Liens arising in the
ordinary course of business consistent with past practice in
respect of amounts that are not yet due or payable, and for
which reserves have been established in accordance with GAAP and
(iii) any other Liens that are not material in amount or do
not materially detract from the value of or materially impair
the existing use of the property affected by such Lien.
Person means any individual,
corporation, limited liability company, partnership, joint
venture, association, joint-stock company, trust, unincorporated
organization, Governmental Entity or other entity or group (as
defined in the Exchange Act).
Plan Funding Amount means $7,291,000.
Pre-Closing Tax Period means,
individually, any taxable year or period that ends on or before
the Closing Date and the portion of a Straddle Period that
begins on or before the Closing Date and ends on the Closing
Date, and, collectively, all such periods considered together,
as the context may require.
Proceeding means any action, suit,
claim, complaint, investigation, litigation, demand, grievance,
citation, summons, subpoena, audit (except routine or ordinary
course audits relating to Government Contracts), proceeding or
arbitration, civil, criminal, regulatory or otherwise, by or
before any Governmental Entity.
Proposed McClendon 1060 Allocation has
the meaning set forth in Section 2.3(b).
Proposed SpecTal Section 338
Allocation has the meaning set forth in
Section 2.3(b).
Proposed Purchase Price Allocation has
the meaning set forth in Section 2.3(b).
Purchased Assets has the meaning set
forth in Section 2.3(a).
Purchase Price has the meaning set
forth in Section 2.2.
B-7
Purchaser has the meaning set forth in
the Preamble.
Purchaser Disclosure Schedule means
the disclosure schedules delivered by Purchaser to the Company
simultaneously with the execution of this Agreement.
Purchaser Indemnified Parties has the
meaning set forth in Section 9.2.
Purchaser Material Adverse Effect
means any change, effect or circumstance which, individually or
in the aggregate, would reasonably be expected to prevent or
materially delay or impair the ability of Purchaser to
consummate the transactions contemplated by this Agreement.
Real Property means land together with
all rights and interests arising out of the ownership thereof or
appurtenant thereto and improvements thereon.
Release means any release, spill,
emission, leaking, pumping, injection, deposit, disposal,
dumping, discharge, dispersal, leaching, escaping or migration
of any Hazardous Substance in, into or onto the environment.
Representatives has the meaning set
forth in Section 6.3(a).
SEC means the United States Securities
and Exchange Commission.
Section 4.20 Affiliate has the
meaning set forth in Section 4.20.
SecureMetrics has the meaning set
forth in Section 6.7(e).
Securities Act means the Securities
Act of 1933, as amended.
Separate Tax Returns means Tax Returns
that are filed by the Transferred Companies on a separate return
basis, excluding, for the avoidance of doubt, any Tax Return
that is filed by the Transferred Companies as members of the
Company Affiliated Group or any Company State Group.
Special Employee Plan means the Intel
Companies Special Employee Plan to be established by SpecTal and
McClendon prior to the Closing and funded by Purchaser at the
Closing, in each case, pursuant to Section 6.20.
Special Employee Plan Term Sheet means
that certain Term Sheet for the Intel Companies Special Employee
Plan of even date herewith among the Company, SpecTal,
McClendon, Ann John, Kevin Rummel and Yvonne Vervaet.
Special Employee Plan Escrow Account
has the meaning set forth in Section 6.20.
Special Employee Plan Escrow Agent has
the meaning set forth in Section 6.20.
SpecTal has the meaning set forth in
the Recitals.
SpecTal Interests has the meaning set
forth in the Recitals.
SpecTal Tax Returns has the meaning
set forth in Section 6.9(b)(i).
Stone Key means Stone Key Partners LLC
and the Stone Key securities division of Hudson Partners
Securities LLC.
Straddle Period means any taxable
period or portion thereof that begins on or before the Closing
Date and ends after the Closing Date.
Subsidiary means, as to any Person,
any Person (i) of which such first Person directly or
indirectly owns securities or other equity interests
representing more than fifty percent (50%) of the aggregate
voting power, or (ii) of which such first Person possesses
the right to elect more than fifty percent (50%) of the
directors or Persons holding similar positions. Notwithstanding
the foregoing, with respect to the Company, for purposes of this
Agreement, Subsidiaries shall include Patriot.
Tangible Property means all furniture,
equipment (including motor vehicles), computers, office
equipment, apparatuses, tools and machinery owned or leased by
any of the Transferred Companies.
B-8
Target Net Working Capital means
(i) $21,617,000 if the Closing takes place between
September 16, 2010 and October 15, 2010,
(ii) $22,171,000 if the Closing takes place between
October 16, 2010 and November 15, 2010,
(iii) $20,918,000 if the Closing takes place between
November 16, 2010 and December 15, 2010,
(iv) $19,060,000 if the Closing takes place between
December 16, 2010 and January 15, 2011,
(v) $20,871,000 if the Closing takes place between
January 16, 2011 and February 15, 2011,
(vi) $21,750,000 if the Closing takes place between
February 16, 2011 and March 15, 2011, and
(vii) $26,043,000 if the Closing takes place between
March 16, 2011 and April 15, 2011. In the event that
the Closing does not occur on or prior to April 15, 2011,
the parties shall negotiate in good faith an appropriate Target
Net Working Capital consistent with the approach utilized in
this definition for prior time periods.
Tax means all federal, state, local or
municipal (whether domestic or foreign) taxes, assessments,
customs duties, fees, levies or similar charges of any kind,
including all income, franchise, profits, alternative or add-on
minimum, estimated, capital gains, capital stock, stamp,
transfer, sales, use, value added, escheat or unclaimed
property, license, property, excise, payroll, employment, social
security, unemployment, withholding or other taxes or similar
charges imposed by a Governmental Entity, including all
interest, penalties and additions imposed with respect to such
amounts.
Tax Benefit means a reduction in the
Liability for Taxes of a taxpayer (or of the affiliated,
consolidated, combined or unitary group of which it is a member)
for any taxable period. Except as otherwise provided in this
Agreement, a Tax Benefit shall be deemed to have been realized
or received from a Tax item in a taxable period only if and to
the extent that the actual cash Liability for Taxes of the
taxpayer (or of the affiliated, consolidated, combined or
unitary group of which it is a member) for such period, after
taking into account the effect of the Tax item on the Liability
for Taxes of such taxpayer in the current period and all prior
periods, is less than it would have been if such Liability for
Taxes were determined without regard to such Tax item.
Tax Claims has the meaning set forth
in Section 6.9(d).
Tax Return means any return,
declaration, report, claim for refund, information return or
statement or similar statement that is filed or that is required
to be filed with respect to any Tax (including any attached
schedules or any amendments or supplements), including any
information return, claim for refund, amended return or
declaration of estimated Tax.
Third Party means any Person other
than the Company and its Subsidiaries.
Third-Party Claim has the meaning set
forth in Section 9.4(a).
Trademark Transition Period has the
meaning set forth in Section 6.13.
Transfer Taxes has the meaning set
forth in Section 6.9(f).
Transferred Companies has the meaning
set forth in the Recitals.
Transferred Company Business means the
businesses and operations of the Transferred Companies.
Transferred Shares has the meaning set
forth in the Recitals.
Treasury Regulation means the
regulations promulgated under the Code by the
U.S. Department of the Treasury.
WARN Act has the meaning set forth in
Section 4.14(f).
Section 1.2 Other
Definitional Provisions; Interpretation.
(a) The words hereof, herein,
hereby, hereunder and
herewith and words of similar import shall refer to
this Agreement as a whole and not to any particular provision of
this Agreement.
(b) References to articles, sections, paragraphs, exhibits,
annexes and schedules are to the articles, sections and
paragraphs of, and exhibits, annexes and schedules to, this
Agreement, unless otherwise specified, and the table of contents
and headings in this Agreement are for reference purposes only
and shall not affect in any way the meaning or interpretation of
this Agreement.
B-9
(c) Whenever the words include,
includes or including are used in this
Agreement, they shall be deemed to be followed by the phrase
without limitation.
(d) Words describing the singular number shall be deemed to
include the plural and vice versa, words denoting any gender
shall be deemed to include all genders, words denoting natural
persons shall be deemed to include business entities and vice
versa and references to a Person are also to its permitted
successors and assigns.
(e) The phrases the date of this Agreement and
the date hereof and terms or phrases of similar
import shall be deemed to refer to September 19, 2010,
unless the context requires otherwise.
(f) References to any statute shall be deemed to refer to
such statute as amended from time to time and to any rules or
regulations promulgated thereunder (provided, that for
purposes of any representations and warranties contained in this
Agreement that are made as of a specific date or dates,
references to any statute shall be deemed to refer to such
statute, as amended, and to any rules or regulations promulgated
thereunder, in each case, as of such date).
(g) Terms defined in the text of this Agreement have such
meaning throughout this Agreement, unless otherwise indicated in
this Agreement, and all terms defined in this Agreement shall
have the meanings when used in any certificate or other document
made or delivered pursuant hereto unless otherwise defined
therein.
(h) Notwithstanding any other provision in this Agreement,
to the extent any representation or warranty made by the Company
in this Agreement constitutes a representation or warranty with
respect to Patriot or its business, assets, liabilities,
operations, employees or related matters (either individually or
in conjunction with such other matters as may be addressed by
such representation or warranty), then, solely with respect to
such matters, such representation and warranty shall be deemed
for all purposes of this Agreement to be made to the
Knowledge of the Company. Notwithstanding any other
provision in this Agreement, to the extent any covenant or
agreement of the Company in this Agreement directly or
indirectly requires any action or forbearance by Patriot, then
solely with respect to such action or forbearance by Patriot
(which shall, for the avoidance of doubt, exclude
Section 6.17), the obligations in respect of such
covenant or agreement shall be deemed satisfied for all purposes
of this Agreement if the Company shall have used its reasonable
efforts to cause such action or forbearance.
ARTICLE II
PURCHASE
AND SALE
Section 2.1 Purchase
and Sale of the Transferred Shares. Upon the
terms and subject to the conditions of this Agreement, at the
Closing, the Company shall cause Operating Company to sell,
assign, transfer and convey to Purchaser, and Purchaser shall
purchase, acquire and accept from Operating Company, the
Transferred Shares free and clear of all Liens, other than
restrictions under applicable securities Laws.
Section 2.2 Purchase
Price. In consideration for the sale of the
Transferred Shares, the aggregate purchase price payable by
Purchaser to Operating Company at the Closing shall consist of
cash in immediately available funds in an amount equal to
$295,833,000 (the Purchase Price).
Section 2.3 Allocation
of Purchase Price.
(a) For purposes of this Section 2.3(a),
consideration means the sum of (i) the Purchase
Price after any adjustments effected in accordance with this
Article II or elsewhere in this Agreement, and
(ii) the amount of the Liabilities of the Transferred
Companies that are recognized as liabilities and deemed to be
assumed by Purchaser for United States federal income Tax
purposes (and any similar provision of state, local or foreign
Law, as appropriate). The consideration shall be allocated among
the assets of McClendon, SpecTal and ACI (the Purchased
Assets) in accordance with the provisions of this
Section 2.3(a).
(b) Within ninety (90) days after the Closing Date,
Purchaser shall provide to the Company: (i) a proposed
division of the consideration among the McClendon Interests, the
SpecTal Interests and the ACI Shares, (ii) as required by
Section 1060 of the Code and the Treasury Regulations
thereunder (and any similar provision of state, local or foreign
Law, as appropriate), a proposed allocation of the portion of
the consideration that is paid with respect to the McClendon
Interests among the assets of McClendon (the Proposed
McClendon 1060 Allocation);
B-10
(iii) as required by Section 338 of the Code and the
Treasury Regulations thereunder (and any similar provision of
state, local or foreign Law, as appropriate), a proposed
allocation of the portion of the consideration that is paid with
respect to the SpecTal Interests among the assets of SpecTal
(the Proposed SpecTal Section 338
Allocation); and (iv) as required by
Section 338 of the Code and the Treasury Regulations
thereunder (and any similar provision of state, local or foreign
Law, as appropriate), a proposed allocation of the portion of
the consideration that is paid with respect to the ACI Shares
among the assets of ACI (together with the Proposed McClendon
1060 Allocation and the Proposed SpecTal Section 338
Allocation, the Proposed Purchase Price
Allocation). If within thirty (30) days after
Purchaser has provided the Proposed Purchase Price Allocation to
the Company, the Company has not objected in writing to the
Proposed Purchase Price Allocation, the Proposed Purchase Price
Allocation shall become final (the Final Purchase Price
Allocation). If the Company objects to the Proposed
Purchase Price Allocation, it shall notify Purchaser in writing
of such disputed item (or items) and the basis for its
objection. The Company and Purchaser shall negotiate in good
faith to agree upon the Final Purchase Price Allocation. If the
Company and Purchaser are unable to agree on the Final Purchase
Price Allocation within a sixty (60) day period from
receipt of written notice from the Company objecting to the
Proposed Purchase Price Allocation, then all remaining disputed
items shall be submitted to a nationally recognized independent
accounting firm mutually chosen by the parties (the
Independent Accounting Firm) for a decision
that shall be rendered in a timely manner in order to permit the
timely filing of all applicable forms with the IRS and other
Governmental Entities. The Independent Accounting Firms
review shall be final and binding on all parties. The fees and
expenses of the Independent Accounting Firm shall be borne
equally by the Company and Purchaser.
(c) Each of the Company, Operating Company, each
Transferred Company and Purchaser shall (i) timely file all
forms (including IRS Form 8594 and Form 8023) and
Tax Returns required to be filed in connection with the Final
Purchase Price Allocation, (ii) be bound by the Final
Purchase Price Allocation for purposes of determining Taxes,
(iii) prepare and file, and cause its Affiliates to prepare
and file, its Tax Returns on a basis consistent with the Final
Purchase Price Allocation and (iv) take no position, and
cause its Affiliates to take no position, inconsistent with the
Final Purchase Price Allocation on any applicable Tax Return or
for any Tax purpose, including any communication with any
Governmental Entity. Purchaser and the Company shall provide
each other with copies of IRS Forms 8594 and 8023 and any
required exhibits thereto, consistent with the allocation
determined pursuant to this Section 2.3, upon
request. In the event that an allocation set forth on the Final
Purchase Price Allocation is disputed by any Governmental
Entity, the party receiving notice of such dispute shall
promptly notify the other party concerning the existence of,
material developments regarding and resolution of such dispute.
ARTICLE III
THE
CLOSING
Section 3.1 Closing. The
closing of the transactions contemplated by this Agreement (the
Closing) will take place at 9:00 a.m.,
New York time, on a date to be specified by the parties, which
shall be no later than two (2) Business Days after the
satisfaction or waiver of all of the conditions set forth in
Article VII hereof (other than conditions that by
their terms are to be satisfied at the Closing, but subject to
the satisfaction or waiver of such conditions at the Closing),
at the offices of Skadden, Arps, Slate, Meagher & Flom
LLP, Four Times Square, New York, New York 10036, unless another
time, date or place is agreed to in writing by the parties
hereto. The date on which the Closing is to take place is
referred to in this Agreement as the Closing
Date.
Section 3.2 The
Companys Deliveries at Closing. At the
Closing, the Company shall, or shall cause Operating Company to,
deliver to Purchaser:
(a) stock certificates or similar evidence representing the
ACI Shares, duly endorsed in blank or with stock powers executed
in proper form for transfer, and with any required stock
transfer stamps affixed thereto;
(b) evidence of the transfer and assignment of the
McClendon Interests and the SpecTal Interests in accordance with
this Agreement and in form and substance reasonably acceptable
to Purchaser, together with duly executed amendments to any
applicable limited liability company agreement or similar
documents as may be reasonably required to evidence such
transfer;
B-11
(c) resignations of the officers, directors and managers
(as applicable) of the Transferred Companies, designated by
Purchaser in writing at least ten (10) Business Days prior
to the Closing Date;
(d) the officers certificate required pursuant to
Section 7.2(f), duly executed by an appropriate
executive officer of the Company;
(e) a duly executed certificate of non-foreign status from
Operating Company in a form and manner that complies with
section 1445 of the Code and the Treasury Regulations
promulgated thereunder; and
(f) all such additional instruments, documents and
certificates provided for by this Agreement as may be reasonably
required in connection with the Closing.
Section 3.3 Purchasers
Deliveries at Closing. At the Closing,
Purchaser shall deliver:
(a) payment of the Purchase Price, by wire transfer of
immediately available funds to the account or accounts
designated by the Company in writing at least two
(2) Business Days prior to the Closing (it being understood
that such accounts may include the account of a paying agent
acting on behalf of the Company), of an amount equal to the
Purchase Price;
(b) to the Company the officers certificate required
pursuant to Section 7.3(d), duly executed by an
appropriate executive officer of Purchaser; and
(c) to the Company all such additional instruments,
documents and certificates provided for by this Agreement as may
be reasonably required in connection with the Closing.
Section 3.4 Proceedings
at Closing. All proceedings to be taken, all
documents to be executed and delivered, and all payments to be
made and consideration to be delivered at the Closing shall be
deemed to have been taken, executed, delivered and made
simultaneously, and, except as provided hereunder, no
proceedings shall be deemed taken nor any documents executed or
delivered until all have been taken, executed and delivered.
Section 3.5 Withholding. Purchaser
shall be entitled to deduct and withhold from any amounts
payable pursuant to this Agreement such amounts as it reasonably
determines that it is required to deduct and withhold under
applicable Tax Law with respect to the making of such payment;
provided, however, that before making any such
deduction or withholding, Purchaser shall notify the Company and
shall not make such deduction or withholding without the
Companys consent, which consent shall not be unreasonably
conditioned, delayed, or withheld. To the extent that amounts
are so withheld and paid over to the appropriate Governmental
Entity by Purchaser, such withheld amounts shall be treated for
all purposes of this Agreement as having been paid to the
Company.
ARTICLE IV
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
Except as disclosed in (i) the Company SEC Reports to the
extent a disclosure therein specifically relates to the Intel
Companies and it is reasonably apparent that such disclosure is
applicable to one or more sections of this
Article IV (excluding any risk factor disclosures
contained under the heading Risk Factors or any
disclosure of risks included in any forward-looking
statements disclaimers in such Company SEC Reports, in
each case, to the extent that such statements are predictive or
forward-looking in nature) or (ii) the Company Disclosure
Schedule (subject to the third sentence of
Section 10.3), the Company represents and warrants
to Purchaser as follows:
Section 4.1 Organization
and Good Standing. The Company, Operating
Company and each of the Intel Companies is duly incorporated or
duly formed, validly existing and in good standing under the
laws of the jurisdiction of its incorporation or formation and
has the requisite corporate or limited liability company power
and authority to conduct its business as it is now being
conducted, except where the failure to be so incorporated or
formed, existing and in good standing or to have such power and
authority would not have a Business Material Adverse Effect. The
Company, Operating Company and each of the Intel Companies is
duly qualified or licensed to do business and is in good
standing in each jurisdiction in which the property leased or
operated by it or the nature of the business conducted by it
makes such qualification or licensing necessary except where the
failure to be so duly qualified, licensed and in good standing
would not have a Business Material Adverse Effect. The Company
has
B-12
made available to Purchaser a copy of its and Operating
Companys certificates of incorporation and bylaws and the
organizational documents of each of the Intel Companies, as
currently in effect. None of the Company, Operating Company or
any of the Intel Companies is in material violation of any
provision of its certificate of incorporation or formation,
bylaws, limited liability company agreement or similar
organizational documents.
Section 4.2 Transferred
Shares; Subsidiaries; Capitalization.
(a) All of the Transferred Shares are beneficially and
legally owned by Operating Company, in each case, free and clear
of all Liens (except Permitted Liens) and all such shares or
interests are duly authorized, validly issued, fully paid,
nonassessable and are free of and were not issued or acquired in
violation of any preemptive rights or rights of first refusal or
similar rights. The Patriot Interests (until divested pursuant
to Section 6.17) are beneficially and legally owned
by ACI free and clear of all Liens (except Permitted Liens).
(b) Section 4.2(b) of the Company Disclosure
Schedule lists as of the date hereof each of the Intel
Companies and, for each such Intel Company, its respective
jurisdiction of incorporation or formation. Except for the
Transferred Shares, (i) there are no issued or outstanding
shares of capital stock, membership interests, equity
securities, partnership interests or other similar ownership
interests of any class or type of or in the Transferred
Companies, (ii) there are no outstanding or authorized
options, warrants, calls, purchase rights, subscription rights,
conversion rights, exchange rights or other rights, convertible
securities, agreements or commitments of any kind to which the
Company, Operating Company or any of the Transferred Companies
is a party obligating the Company, Operating Company or any of
the Transferred Companies to issue, transfer or sell any shares
of capital stock, membership interests or other equity interest
in, any Transferred Company or securities convertible into or
exchangeable for such shares, membership interests or equity
interests, and (iii) there are no voting trusts, proxies,
shareholder agreements or similar agreements or understandings
to which the Company, Operating Company or any of the
Transferred Companies is a party with respect to the voting of
the capital stock or equity interests of any Transferred
Company. There are no outstanding or authorized stock
appreciation, phantom stock, profits interest, economic
interests, participation interests, or other similar rights with
respect to any of the Transferred Companies.
Section 4.2(b) of the Company Disclosure Schedule
also sets forth the percentage of outstanding equity or voting
interests (including partnership interests and limited liability
company interests) owned by the Company or its Subsidiaries in
each of the Transferred Companies, and the identity, if any, of
each other owner of such outstanding equity or voting interests
and their percentage interest.
(c) None of the Intel Companies owns any shares of capital
stock, membership interests or other equity or voting interests
in (including any securities exercisable or exchangeable for or
convertible into capital stock, membership interests or other
equity or voting interests in) any other Person, other than
ordinary course investments. There is no outstanding or
authorized obligation or agreement of any kind requiring any of
the Intel Companies to make an investment in or to acquire the
capital stock of membership interests or other equity interest
in or any other security or other interest in any Person.
Section 4.3 Authorization;
No Conflict.
(a) Each of the Company and Operating Company has the
requisite corporate power and authority to execute and deliver
this Agreement, to perform its obligations hereunder and to
consummate the transactions contemplated hereby. The execution,
delivery and performance by the Company of this Agreement, and
the consummation by it and Operating Company of the transactions
contemplated hereby, have been duly and validly authorized by
all necessary corporate action by the Company and Operating
Company (including by their respective Boards of Directors), and
no other corporate action or proceeding on the part of the
Company or Operating Company is necessary to authorize the
execution, delivery and performance by the Company and Operating
Company (as applicable) of this Agreement and the consummation
by such parties of the transactions contemplated hereby. This
Agreement has been duly executed and delivered by the Company
and, assuming due authorization, execution and delivery of this
Agreement by Purchaser, constitutes a legal, valid and binding
obligation of the Company, enforceable against the Company in
accordance with its terms, except that (i) such enforcement
may be subject to applicable bankruptcy, insolvency,
reorganization, moratorium or other similar Laws, now or
hereafter in effect, affecting creditors rights and
remedies generally and (ii) the remedies of specific
performance and injunctive and other forms of equitable relief
may be subject to equitable defenses and to the discretion of
the court before which any Proceeding therefor may be brought.
B-13
(b) The execution and delivery by the Company of this
Agreement does not and the consummation of the transactions
contemplated hereby by the Company and Operating Company will
not, (i) conflict with or violate the certificate of
incorporation or bylaws (or equivalent organizational documents)
of (A) the Company, (B) Operating Company or
(C) any of the Transferred Companies, (ii) assuming
the Governmental Authorizations, registrations, declarations,
filings and notices referred to in Section 4.4 have
been obtained or made, any applicable waiting periods referred
to therein have expired and any condition precedent to any such
Governmental Authorization has been satisfied, conflict with or
violate, or give rise to any right or requirement of
termination, modification or cancellation of, or require any
notice, report or other filing under, any Law, Judgment or
Governmental Authorization applicable to the Company, Operating
Company or any of the Intel Companies or by which any property
or asset of the Company, Operating Company or any of the
Transferred Companies is bound or affected, (iii) violate
or conflict with, result in any breach of, or constitute a
default (with or without notice or lapse of time, or both)
under, or give rise to any right of termination, amendment,
acceleration or cancellation of or require any notice, report or
other filing under, any Intel Company Material Contract,
(iv) result in the creation of any Lien (other than
Permitted Liens) upon any of the material properties or assets
of the Intel Companies or the Transferred Shares, other than, in
the case of clause (iii), any such conflict, violation, breach,
default, termination, amendment, acceleration, cancellation or
Lien that has not resulted and would not reasonably be expected
to result, individually or in the aggregate, in a material Loss.
Section 4.4 Governmental
Consents. No Governmental Authorization, or
registration, declaration or filing with or notice to any
Governmental Entity, is required to be obtained or made by, or
with respect to the Company, Operating Company or any of the
Intel Companies in connection with the execution, delivery and
performance of this Agreement or the consummation of the
transactions contemplated hereby, other than (i) the filing
with the SEC of such reports under the Exchange Act as may be
required in connection with this Agreement and the transactions
contemplated hereby, (ii) such filings as may be required
in connection with the Taxes described in
Section 6.9(f), (iii) such other items required
solely by reason of the participation of Purchaser (as opposed
to any other third-party) in the transactions contemplated
hereby, (iv) such Governmental Authorizations set forth in
Section 4.4 of the Company Disclosure Schedule and
(v) compliance with and filings or notifications under
(A) the HSR Act and other applicable U.S. and
non-U.S. competition
Laws, (B) the Exon-Florio Amendment to the Defense
Production Act of 1950, 50 U.S.C. app. § 2170, as
amended (Exon-Florio) and (C) the
National Industrial Security Program Operating Manual
(NISPOM).
Section 4.5 Intel
Financial Statements.
(a) Purchaser has previously been provided with complete
copies of (i) the L-1 Identity Solutions Government
Consulting Services Business audited combined balance sheets as
of December 31, 2009 and December 31, 2008 and the
related audited combined statements of operations and cash flows
for each of the three years ended December 31, 2009, 2008
and 2007 accompanied by the audit report of Deloitte &
Touche LLP (the Audited Intel Financial
Statements) and (ii) the unaudited condensed
combined balance sheet of the Intel Companies as of
June 30, 2010 and the related unaudited condensed combined
statement of operations and cash flows for the six
(6)-month
period then ended (the Interim Intel Financial
Statements and, collectively with the Audited Intel
Financial Statements, the Intel Financial
Statements). The Intel Financial Statements have been
derived from the accounting records of the Intel Companies and
those of the Company and the Operating Company. The Intel
Financial Statements (x) have been prepared in accordance
with accounting principles generally accepted in the United
States (GAAP), consistently applied (except
as disclosed in the notes thereto) throughout the periods
covered thereby, and (y) fairly present, in all material
respects, the combined financial position of the Intel Companies
and Intel Business as of the dates thereof and the combined
results of operations and cash flows of the Intel Companies for
the periods then ended (except that the Interim Intel Financial
Statements omit or condense certain information and disclosures
and subject to, in the case of the Interim Intel Financial
Statements, normal audit adjustments).
(b) Section 4.5(b) of the Company Disclosure
Schedule contains a true, correct and complete list of all
Indebtedness of each Intel Company, and separately identifies
for each item of Indebtedness the outstanding principal and
accrued but unpaid interest thereon as of August 31, 2010.
B-14
Section 4.6 No
Undisclosed Liabilities. Except (a) as
reflected in the Intel Financial Statements, (b) for
Liabilities incurred in the ordinary course of business and
consistent with past practices since June 30, 2010, that
have not had and would not reasonably be expected to have,
individually or in the aggregate, a Business Material Adverse
Effect, (c) for the employee retention bonus Liabilities
set forth in Section 4.6 of the Company Disclosure
Schedule, or (d) for other immaterial Liabilities not
exceeding $250,000 in the aggregate, none of the Intel Companies
has any Liabilities, that are required to be reflected in or
disclosed on a balance sheet in accordance with GAAP.
Section 4.7 Absence
of Certain Changes. Since December 31,
2009 through the date of this Agreement, (except for matters in
connection with the transactions contemplated by this Agreement):
(a) the businesses and operations of each of the Intel
Companies have been conducted in the ordinary course of business
consistent with past practice in all material respects;
(b) there has not been any change, effect or circumstance
that has had a Business Material Adverse Effect;
(c) none of the Transferred Companies has sold, leased,
transferred, or assigned any of its properties, rights or assets
having a value in excess of $250,000 in the aggregate or an
individual value in excess of $100,000;
(d) none of the Transferred Companies has entered into any
Contract or agreed to or suffered any termination, material
modification, amendment or extension of or waiver of any
material rights under any Contract that, in any such case, would
require or would likely require payments to or from the Company
in any one year of more than $1,000,000, excluding Government
Contracts or Intel Leases entered into in the ordinary course of
business consistent with past practices;
(e) none of the Transferred Companies has created or
permitted the creation of any Lien (other than Permitted Liens)
on any of its assets or properties;
(f) none of the Intel Companies has suffered any damage,
destruction or loss with respect to Real Property or Tangible
Property (whether or not covered by insurance), in any case or
in the aggregate, in excess of $250,000;
(g) none of the Intel Companies has made any capital
expenditure (or series of related capital expenditures)
involving more than $250,000;
(h) none of the Intel Companies has committed to do any of
the matters described in clauses (c) (g) of
this sentence; and
(i) no key employee of any of the Transferred Companies
earning an annual base salary or base compensation in excess of
$150,000 has left his or her employment or provided notice of
future resignation.
Section 4.8 Employee
Plans; ERISA.
(a) Section 4.8(a) of the Company Disclosure
Schedule sets forth a complete list, as of the date hereof,
of each Employee Plan and each Benefit Arrangement that is
sponsored, maintained or contributed to or required to be
contributed to by any Intel Company or by an ERISA Affiliate
thereof for the benefit of current and former directors and
employees of the Intel Companies. The Company has made available
to Purchaser a true and complete copy of each Employee Plan and
all amendments thereto (or, in the case of any unwritten
Employee Plans, descriptions thereof) and a true and complete
copy of the following items (in each case, only if applicable):
(i) each trust or other funding arrangement, (ii) each
summary plan description and summary of material modifications,
(iii) the most recently filed and the previous years
annual reports on IRS Form 5500 and (iv) the most
recently received IRS determination letter.
(b) Each Employee Plan and Benefit Arrangement has been
operated and administered in all material respects in accordance
with its terms and applicable Laws, including ERISA and the Code.
(c) Except as would not reasonably be expected to result in
a material Loss to any Transferred Company, each Employee Plan
intended to qualify under Section 401(a) of the Code has
either received a favorable determination
B-15
letter from the IRS with respect to each such Employee Plan as
to its qualified status under the Code, or with respect to a
prototype Employee Plan, the prototype sponsor has received a
favorable IRS opinion letter, or the Employee Plan or prototype
sponsor has remaining a period of time under applicable Code
regulations or pronouncements of the IRS in which to apply for
such a letter and make any amendments necessary to obtain a
favorable determination or opinion as to the qualified status of
each such Employee Plan, and the trusts maintained pursuant to
each such Employee Plan are exempt from federal income taxation
under Section 501 of the Code. To the Knowledge of the
Company, no event has occurred since the most recent
determination or opinion letter or application therefor relating
to any such Employee Plan that would reasonably be expected to
adversely affect the qualification of such Employee Plan.
(d) No Liability under Title IV or Section 302 of
ERISA or Section 412 of the Code has been incurred by any
of the Intel Companies or any ERISA Affiliate thereof that has
not been satisfied in full, and no event or circumstance exists
that would reasonably be expected to result in any such
Liability being incurred by any of the Intel Companies. No
Employee Plan is a multiemployer plan within the
meaning of Section 3(37) of ERISA, and no Employee Plan is
subject to Title IV of ERISA.
(e) Except as would not reasonably be expected to result in
a material Loss to any Transferred Company, there are no
(i) claims pending or, to the Knowledge of the Company,
threatened or anticipated (other than routine claims for
benefits), against or involving any Employee Plan or Benefit
Arrangement or the assets of any Employee Plan or Benefit
Arrangement or against any of the Intel Companies or any ERISA
Affiliate thereof, in each case, with respect to any Employee
Plan or Benefit Arrangement, (ii) audits pending or, to the
Knowledge of the Company, threatened, by any Governmental Entity
involving any Employee Plan or Benefit Arrangement or
(iii) to the Knowledge of the Company, investigations
pending or threatened by any Governmental Entity involving any
Employee Plan or Benefit Arrangement.
(f) Except as set forth in Section 4.8(f) of the
Company Disclosure Schedule, neither the execution or
delivery of this Agreement nor the consummation of the
transactions contemplated hereby will, either alone or in
conjunction with any other event, (i) entitle any current
or former director, employee, consultant or independent
contractor of any Intel Company to severance pay, unemployment
compensation or any other payment, except as expressly provided
in this Agreement, (ii) increase the amount or value of any
benefit or compensation otherwise payable or required to be
provided to any such director, employee, consultant or
independent contractor, or (iii) accelerate the time of
payment or vesting of compensation due any such director,
employee, consultant or independent contractor.
(g) Except as set forth on Section 4.8(g) of the
Company Disclosure Schedule, there is no Employee Plan or
Benefit Arrangement that, individually or collectively, could
give rise to the payment of any amount that would not be
deductible by reason of Section 280G of the Code. None of
the Benefit Arrangements in which employees of the Intel
Companies participates provides for any indemnity for Taxes
imposed under Section 4999 or 409A of the Code.
(h) Except as would not reasonably be expected to result in
a material Loss to any Transferred Company, no Tax under
Section 4980B or 4980D of the Code has been incurred in
respect of any Employee Plan that is a group health plan, as
defined in Section 5000(b)(1) of the Code.
(i) With respect to the employees and former employees of
the Intel Companies, none of the Intel Companies has any
material obligations for post-retirement health or life
insurance benefits under any Benefit Arrangement or Employee
Plan (other than for continuation coverage required to be
provided pursuant to Section 4980B of the Code).
(j) Except as would not reasonably be expected to result in
a material Loss to any Transferred Company, any Benefit
Arrangement or Employee Plan, any non-qualified deferred
compensation plan (as such term is defined under
section 409A(d)(1) of the Code and the guidance issued
thereunder) of the Company and any of the Intel Companies under
which the Company
and/or any
of the Intel Companies makes, is obligated to make, or promises
to make any payments or other awards to or on behalf of any
employee, officer or director of any of the Intel Companies
(each, a 409A Plan) (i) meets and has
met the requirements of Section 409A of the Code,
(ii) is and has been operated in accordance therewith,
(iii) is and has been operated in good faith compliance
with the
B-16
transitional relief and all guidance and regulations provided by
the Internal Revenue Service under Section 409A of the
Code, and (iv) has not been funded by an off-shore
arrangement described in Section 409A(b)(1) of the Code.
(k) Except as would not reasonably be expected to result in
a material Loss to any Transferred Company, any Benefit
Arrangement or Employee Plan, no non-exempt prohibited
transaction, as defined in Section 406 of ERISA or
Section 4975 of the Code, has occurred with respect to any
Employee Plan sponsored by an Intel Company.
Section 4.9 Litigation.
(a) There is no Proceeding pending or, to the Knowledge of
the Company, threatened against the Company, Operating Company
or any of their Affiliates (other than the Intel Companies) that
would have or reasonably would be expected to have a Business
Material Adverse Effect, nor is there any Judgment outstanding
against the Company, Operating Company or any such Affiliate
that would have or reasonably could be expected to have a
Business Material Adverse Effect.
(b) Since January 1, 2008, (i) there has not been
any material Proceeding pending or, to the Knowledge of the
Company, threatened against any of the Intel Companies or any of
their respective assets or properties, or any of their
respective directors or officers in their capacities as such,
(ii) none of the Intel Companies, nor any of their
respective directors or officers in their capacities as such has
been subject to any material Judgments, and (iii) there has
not been, to the Knowledge of the Company, any pending or
threatened material Proceeding against any Person whom any of
the Intel Companies has agreed to indemnify with respect to
matters subject to such indemnification.
Section 4.10 Permits;
Compliance with Law; Governmental
Authorizations.
(a) The Intel Companies are in possession of all material
Governmental Authorizations necessary for the Intel Companies to
carry on their respective businesses as they are now being
conducted (the Intel Company Permits), all
Intel Company Permits are in full force and effect, and no
suspension or cancellation of any of the Intel Company Permits
is pending or, to the Knowledge of the Company, threatened.
Except as would not be material to the Intel Companies, taken as
a whole, all required filings with respect to such Governmental
Authorizations have been timely made and all required
applications for renewal thereof have been timely filed. None of
the Intel Companies is in material default or violation of or
under any Intel Company Permit.
(b) Each of the Intel Companies is and at all times during
the period covered by the statute of limitations applicable to
each such Law, has been in compliance, in all material respects,
with all Laws applicable to it and any Judgments to which it is
subject. Since January 1, 2008, none of the Company,
Operating Company or any of the Intel Companies has received
written notice or allegation of any material violation of or
material noncompliance with any Law or Judgment on the part of
the Intel Companies or involving the Intel Business, or
directing any of the Intel Companies (or the Company or any of
its Subsidiaries in respect of the Intel Business or the Intel
Companies) to take any material remedial action with respect to
any Law or Judgment or otherwise, and no material deficiencies
of the Transferred Companies have been asserted to any of the
Intel Companies (or the Company or any of its Subsidiaries) in
writing by any Governmental Entity. Since January 1, 2008,
none of the Company, Operating Company or the Intel Companies
has conducted any internal investigation with respect to any
actual or alleged material violation of any Law or Judgment by
any of the Intel Companies or any of their officers, directors
or employees.
(c) Each of the Intel Companies is, and at all times during
the period covered by the statute of limitations applicable to
each such Law, has been, in compliance in all material respects
with all applicable statutory and regulatory requirements under
the Arms Export Control Act, the International Traffic in Arms
Regulations (ITAR), the Export Administration
Regulations and associated executive orders, and the Laws
Implemented by the Office of Foreign Assets Controls, United
States Department of the Treasury (collectively, and any
successors or replacements thereof, the Export Control
Laws). None of the Intel Companies has received any
written communication that alleges that it is not, or may not
be, in material compliance with, or has, or may have, any
material Liability under, the Export Control Laws.
(d) Each of the Intel Companies and, to the Knowledge of
the Company, each of their respective current and former agents,
representatives, distributors, advisers, contractors and
consultants (in each case, acting in their
B-17
capacity as such on behalf of the Intel Companies) are and, at
all times during the period covered by the statute of
limitations applicable to each such Law, have been in
compliance, in all material respects, with all applicable legal
requirements under (i) the Foreign Corrupt Practices Act
and the Organization for Economic Cooperation and Development
Convention Against Bribery of Foreign Public Officials in
International Business Transactions and legislation implementing
such convention, (ii) international anti-bribery
conventions (other than the convention described in clause (i))
and local anti-corruption and bribery Laws, in each case, in
jurisdictions in which the applicable Intel Company is operating
(collectively, the Anti-Bribery Laws),
(iii) the Contract Disputes Act, (iv) the False Claims
Act, 31 U.S.C.
§§ 3729-3731;
(v) the Procurement Integrity Act and (vi) all Federal
criminal laws involving fraud, conflict of interest, bribery or
gratuity violations found in Title 18 of the
U.S. Code. None of the Intel Companies has received any
written communication that alleges that it or any of its
directors, officers, agents, representatives, distributors,
advisers, contractors or consultants or employees (in each case,
acting in their capacity as such on behalf of any of the Intel
Companies) is, or may be, in material violation of, or has, or
may have, any material Liability under, the Anti-Bribery Laws.
Section 4.11 Taxes.
(a) All material Tax Returns of or with respect to the
Transferred Companies or the Purchased Assets (or income
attributable thereto) that were required to be filed by the
Company or its Affiliates on or before the Closing Date have
been timely filed (in each case, taking due account of lawful
extensions validly obtained) and, to the extent such Tax Returns
relate to the Transferred Companies or the Purchased Assets, all
such Tax Returns are true, complete and correct in all material
respects. All material Taxes due and payable (whether or not
shown to be due on such Tax Returns) by or with respect to the
Transferred Companies or the Purchased Assets have been timely
paid in full. For purposes of the preceding sentence,
Taxes shall include all items listed in the
definition thereof as well as any Liability in respect of any of
the foregoing payable by reason of contract, assumption,
transferee liability, operation of Law, Treasury Regulations
Section 1.1502-6(a)
(or any predecessor or successor thereof) or any similar
provision under Law or otherwise. Other than income Tax Returns
with respect to the taxable period ending December 31,
2009, neither the Company nor any of its Affiliates currently is
the beneficiary of any extension of time within which to file
any Tax Return of or applicable to the Transferred Companies or
the Purchased Assets. None of the Transferred Companies
(i) applied for a ruling with respect to Taxes,
(ii) entered into a closing agreement with
respect to Taxes with any Governmental Entity, or
(iii) executed any powers of attorney with respect to Tax
matters which currently remain in effect.
(b) There are no Liens for Taxes (other than Permitted
Liens) upon any of the Transferred Shares or the Purchased
Assets.
(c) No written notice of deficiency or assessment of a
material amount of Taxes has been received from any Governmental
Entity by or with respect to the Purchased Assets or the
Transferred Companies.
(d) There are no ongoing audits, disputes, claims, refund
litigations, proposed adjustments, assessments or examinations
of any Tax Returns or with respect to any material amount of
Taxes relating to or attributable to the Purchased Assets or the
Transferred Companies, and neither the Company nor any of its
Affiliates have received any written notification of any audits,
disputes, claims, refund litigations, proposed adjustments,
assessments or examinations pending or proposed as they relate
to the Transferred Companies or the Purchased Assets, and, to
the Knowledge of the Company, none are threatened with respect
thereto.
(e) No consents or waivers have been granted to
(i) extend the statutory period of limitations applicable
to any Taxes of or with respect to the Purchased Assets or the
Transferred Companies or (ii) extend the period of time
with respect to the assessment of any Taxes of or with respect
to the Purchased Assets or the Transferred Companies.
(f) Neither the Company nor any of its Affiliates has
received any written notice from any jurisdiction where the
Company or its Affiliates do not currently file Tax Returns to
the effect that such filings may be required by or with respect
to the Purchased Assets or the Transferred Companies or that the
Purchased Assets or the Transferred Companies may otherwise be
subject to taxation by such jurisdiction.
(g) All material amounts in respect of Taxes required to be
withheld, paid or collected by any Transferred Company, or by
the Company or its Affiliates with respect to Persons performing
services for any Transferred Company, have been duly withheld
and collected and have been paid to the appropriate Governmental
Entity. The
B-18
Transferred Companies, and the Company or its Affiliates with
respect to Persons performing services for any Transferred
Company, have complied with all information reporting and
withholding requirements, in connection with any material amount
paid or owing to any employee, independent contractor, or other
third party.
(h) For United States federal income Tax purposes under
Section 301.7701-3
of the Treasury Regulations and, where applicable, for state and
local purposes: (i) McClendon is classified as an entity
disregarded from its owner and (ii) each of SpecTal and ACI
is classified as a corporation and is a member of the Company
Affiliated Group.
(i) None of the Transferred Companies is a party to any Tax
allocation, Tax sharing or other similar agreement, other than
customary Tax indemnification or other provisions contained in
any credit or other ordinary course commercial agreements the
primary purpose of which does not relate to Taxes. None of the
Transferred Companies (A) has been a member of an
affiliated group filing a consolidated federal income Tax Return
or other similar group for state, local or
non-United
States Tax purposes (other than a group the common parent of
which was the Company or the Operating Company) or (B) has
any Liability for the Taxes of any person (other than the
Company and its Affiliates) under
Section 1.1502-6
of the Treasury Regulations (or any similar provision of state,
local, or
non-United
States law), as a transferee or successor, by contract, or
otherwise.
(j) Neither the Company nor any of its Affiliates is or has
ever entered into or been a party, with respect to the
Transferred Companies or the Purchased Assets, to (i) any
reportable transaction, as defined in
Section 1.6011-4(b)
of the Treasury Regulations or (ii) a tax shelter within
the meaning of Code Section 6662(d). No Tax Return filed by
the Company or any of its Affiliates contained or was required
to contain a disclosure statement with respect to the Company
under Sections 6011 or 6662 of the Code (or any predecessor
statute) or any similar provision of state, local or foreign Law.
(k) None of the Transferred Companies has been the
distributing corporation (within the meaning of Code
Section 355(a)(1)) or the controlled
corporation (within the meaning of Code
Section 355(a)(1)) (i) within the two-year period
ending as of the date of this Agreement or (ii) in a
distribution that could otherwise constitute part of a
plan or series of related transactions
(within the meaning of Code Section 355(e)) in conjunction
with this Agreement and the transactions contemplated hereby.
(l) No Transferred Company will be required to include any
material amount of income in, or exclude any material amount of
deduction from, taxable income for any taxable period (or
portion thereof) ending after the Closing as a result of any:
(i) adjustment pursuant to Code Section 481(c) by
reason of any voluntary or involuntary change in method of
accounting for a taxable period ending on or prior to the
Closing; (ii) closing agreement as described in
Code Section 7121 (or any corresponding or similar
provision of state, local or foreign income Tax Law) executed on
or prior to the Closing Date; or (iii) installment sale or
open transaction disposition made on or prior to the Closing.
(m) No Transferred Company has a permanent establishment or
branch outside the United States or conducts business outside
the United States in such a way that it is deemed to have a
permanent establishment or a foreign branch, as that term is
defined in Temporary Treasury Regulations
Section 1.367(a)-6T(g)(1).
No Transferred Company has ever participated in or cooperated
with an international boycott within the meaning of Code
Section 999 or has been requested to do so in connection
with any transaction or proposed transaction.
(n) None of the Transferred Shares is subject to a
substantial risk of forfeiture within the meaning of
Code Section 83.
Section 4.12 Intellectual
Property.
(a) Section 4.12(a) of the Company Disclosure
Schedule sets forth, with respect to each Intel Company, an
accurate and complete list in all material respects, as of the
date of this Agreement, of all registered and pending
applications for Patents, Trademarks and Copyrights included in
the Intel Company Intellectual Property Rights.
(b) None of the Intel Companies, in the ordinary course of
business, licenses Intellectual Property to third Persons.
(c) To the Knowledge of the Company, the Intel Companies
own or have a right to use all Intellectual Property used in the
conduct of the Intel Business as currently conducted, free and
clear of all Liens (except Permitted Liens
B-19
and excluding license grants and contractual restrictions other
than rights of first refusal and options to purchase), except
where the failure to so own or have a right would not have a
material impact on the Intel Business or Transferred Companies
taken as a whole.
(d) To the Knowledge of the Company, the conduct of the
business of the Intel Companies as conducted since
January 1, 2005 and the Intel Company Intellectual Property
Rights do not infringe on, misappropriate or otherwise violate
any Intellectual Property of any other Person in any material
respect. Since January 1, 2008, no material Proceedings are
or have been pending or, to the Knowledge of the Company,
threatened in writing alleging that any of the Intel Companies
is infringing, misappropriating or otherwise violating the
Intellectual Property of any other Person. To the Knowledge of
the Company, no Person is infringing, misappropriating or
otherwise violating the Intel Company Intellectual Property
Rights in any material respect.
(e) The Intel Companies take commercially reasonable steps
to protect the confidentiality of Trade Secrets owned or held by
the Intel Companies, except where the failure to do so would not
be material to the Intel Business taken as a whole.
Section 4.13 Real
Property; Tangible Personal Property.
(a) Section 4.13(a) of the Company Disclosure
Schedule sets forth each lease (the Intel
Leases) that is material to the Intel Business, taken
as a whole, pursuant to which any of the Intel Companies
occupies or uses any Real Property. The Transferred Companies
have valid leasehold interests in their respective Intel Leases,
except for such as are no longer used or useful in the conduct
of their respective businesses or as have been disposed of in
the ordinary course of business.
(b) The Intel Companies are, in all material respects, in
compliance with the terms of all Intel Leases (subject to any
applicable grace periods under such leases) to which each is a
party, (ii) to the Knowledge of the Company, each other
party to an Intel Lease is, in all material respects, in
compliance with the terms of such Intel Lease (subject to
applicable grace periods under such leases) and (iii) all
Intel Leases are in full force and effect.
(c) Except as set forth on Section 4.13(c) of the
Company Disclosure Schedule (i) the consummation of the
transactions contemplated by this Agreement does not require the
consent of any other party to such Intel Lease and will not
result in a breach of or default under such Intel Lease;
(ii) the Intel Companies have not subleased, licensed or
otherwise granted any Person the right to use or occupy any
Leased Real Property or any portion thereof.
(d) None of the Intel Companies owns any Real Property.
(e) The Transferred Companies have good and valid title to,
or in the case of property held under lease, a valid leasehold
interest in, all tangible assets and tangible properties used or
held for use by the Transferred Companies, free and clear of all
Liens other than Permitted Liens.
(f) All Tangible Property that is material to the
Transferred Companies, taken as a whole, is in good operating
condition and repair for the operation of the businesses of the
Transferred Companies in the ordinary course of business
consistent with past practice in all material respects, ordinary
wear and tear and aging excepted.
Section 4.14 Labor
Matters.
(a) There are no collective bargaining or other labor union
agreements to which any of the Intel Companies are a party or by
which the Intel Companies are bound. As of the date of this
Agreement, none of the employees of the Intel Companies are
represented by any union with respect to their employment by
such Intel Company.
(b) Since January 1, 2008, none of the Intel Companies
has to the Knowledge of the Company experienced any material
labor disputes or strikes, work stoppages, slowdowns or
lockouts. From January 1, 2008 through the date of this
Agreement, none of the Intel Companies has experienced any union
organization attempts. No strike, work stoppage, slowdown or
lockout against any of the Intel Companies is, to the Knowledge
of the Company, threatened.
(c) Each of the Intel Companies has complied with all
applicable Laws relating to employment and employment practices,
terms and conditions of employment and wages and hours,
including any such Laws relating to wages, hours, equal
opportunity, collective bargaining, classification of employees,
discrimination
B-20
against race, color, national origin, religious creed, physical
or mental disability, sex, age, ancestry, medical condition,
marital status or sexual orientation, the withholding and
payment of social security and other Taxes, workers
compensation, family and medical leave, the Immigration Reform
and Control Act, the Fair Labor Standards Act, and occupational
safety and health requirements, except for any non-compliance
which would not be reasonably likely to be material to the Intel
Business or the Intel Companies, taken as a whole. There are no
pending or, to the Knowledge of the Company, threatened charges
(by employees, their representatives or Governmental Entities)
of unfair labor practices or of employment discrimination or of
any other wrongful action with respect to any aspect of
employment of any person employed or formerly employed by any of
the Intel Companies, which, if adversely determined, would be
material to the Intel Business or the Intel Companies, taken as
a whole. To the Knowledge of the Company, as of the date of this
Agreement, no investigation of the employment policies or
practices of any of the Intel Companies by any Governmental
Entity is pending or threatened in writing.
(d) Except as set forth in Section 4.14(d) of the
Company Disclosure Schedule, to the Knowledge of the
Company, since January 1, 2008, there has been no charge of
discrimination relating to any Intel Company filed with the
Equal Employment Opportunity Commission or similar Governmental
Entity, nor to the Knowledge of the Company has any such charge
been threatened (by employees, their representatives or any
Governmental Entity).
(e) To the Knowledge of the Company, as of the date of this
Agreement, no employee of any of the Intel Companies is in
material violation of any term of any employment Contract,
patent disclosure agreement, non-competition agreement, or any
restrictive covenant to a former employer relating to the right
of any such employee to be employed by any of the Intel
Companies because of the nature of the business conducted or
presently proposed to be conducted by the Intel Companies.
(f) Within the past three (3) years, the Company has
not implemented any plant closing or layoff of Intel Business
employees that would trigger notice requirements under the
Worker Adjustment and Retraining Notification Act of 1988, as
amended, or any similar foreign, state or local Law, regulation
or ordinance (collectively, the WARN Act).
Section 4.15 Contracts.
(a) Section 4.15 of the Company Disclosure
Schedule sets forth a list, as of the date hereof, of each
Intel Company Material Contract. For purposes of this Agreement,
Intel Company Material Contract means any
Contract to which any of the Intel Companies is a party that:
(i) concerns the establishment or operation of any sharing
of profits, losses, costs or liabilities of any Intel Companies
with another Person or the establishment of a teaming
arrangement (excluding teaming agreements that have terminated
or been superseded by an award of a Government Contract),
including any strategic alliance, joint venture or partnership
agreements;
(ii) is a loan, guarantee of Indebtedness or credit
agreement, note, security agreement, mortgage, indenture or
other binding commitment (other than those between the Intel
Companies) related to Indebtedness or that creates any Liens on
assets of any of the Intel Companies;
(iii) is an acquisition agreement, asset purchase
agreement, stock purchase agreement or other similar agreement
entered into after January 1, 2007;
(iv) involves the future acquisition or sale of any assets
involving $500,000 individually (or in the aggregate, in the
case of any related series of Contracts);
(v) involves future aggregate payments from any of the
Intel Companies in any one year of more than $2,500,000 in any
one case (or in the aggregate, in the case of any related series
of Contracts);
(vi) involves total estimated contract revenues to an Intel
Company in excess of $5 million over the entire duration of
such contract (including option years), based on the
specifications contained in such contract;
(vii) is a Contract with a subcontractor or supplier to any
Intel Company that involves payments by an Intel Company in
excess of $500,000 per year;
B-21
(viii) includes covenants prohibiting or restricting any
Intel Company from (a) engaging or competing in any line of
business or materially restricting or prohibiting its ability to
conduct business in any geographical location or
(b) selling any products or services of or to any Person or
in any geographic region;
(ix) grants any of the Intel Companies any rights in third
party Intellectual Property that is material to the Intel
Business taken as a whole (in all cases excluding licenses for
commercial off-the shelf shrinkwrap, clickwrap or similar
commercially available software);
(x) relates to the purchase or sale of Real Property;
(xi) is a Government Contract for which
(A) performance has not been completed or (B) final
payment has not been received;
(xii) is in writing and is an employment agreement or
relates to or is for the benefit of sales representatives,
distributors, dealers or agents; or
(xiii) is a Contract under which the consequences of a
default or termination would have a Business Material Adverse
Effect.
(b) (i) None of the Intel Companies is in material
breach of or default under the terms of any Intel Company
Material Contract, (ii) to the Knowledge of the Company, no
other party to any Intel Company Material Contract is in
material breach of or default under the terms of such Contract,
and (iii) no event has occurred which with notice or lapse
of time would constitute a material breach of or default on the
part of any Intel Company under any Intel Company Material
Contract. Each Intel Company Material Contract is a valid,
legally binding and enforceable obligation of the applicable
Intel Company and, to the Knowledge of the Company, the other
parties thereto; provided that (i) such enforcement
may be subject to applicable bankruptcy, insolvency,
reorganization, moratorium or other similar Laws, now or
hereafter in effect, relating to creditors rights and
remedies generally, and (ii) the remedies of specific
performance and injunctive and other forms of equitable relief
may be subject to equitable defenses and to the discretion of
the court before which any Proceeding therefor may be brought.
Section 4.16 Government
Contracts.
(a) True and correct lists, as of the date of this
Agreement, of each Government Contract for which
(i) performance has not been completed or (ii) final
payment has not been received and each Bid is set forth in
Section 4.16(a) of the Company Disclosure Schedule;
provided that certain Government Contracts are identified
in a redacted manner as required to comply with applicable Laws.
(b) Except as set forth on Section 4.16(b) of the
Company Disclosure Schedule, to the Knowledge of the
Company, (i) each of the Intel Companies has complied, in
all material respects, with all terms and conditions of each of
its Government Contracts and Bids as required; (ii) each of
the Intel Companies has complied in all material respects with
all requirements of the Truth in Negotiations Act and all other
Laws applicable to any of its Government Contracts and Bids;
(iii) all representations and certifications made by each
of the Intel Companies with respect to each of its Government
Contracts and Bids were complete and accurate as of their
effective date and each of the Intel Companies has complied in
all material respects with all such representations and
certifications; (iv) no termination or default notice, cure
notice or show cause notice has been issued and is currently in
effect or is expected with respect to any of the Government
Contracts or Bids (in each case, excluding after the date of
this Agreement any notice of termination for convenience or
without fault or otherwise without cause that arises from the
announcement, consummation or existence of this Agreement or the
transactions contemplated by this Agreement (and not from issues
unrelated to this Agreement or the transactions contemplated by
this Agreement)); (v) neither any Governmental Entity nor
any prime contractor, subcontractor or other Person has notified
or indicated to any of the Intel Companies, either in writing,
or to the Knowledge of the Company, orally that such Intel
Company has breached or violated any Law, certification,
representation, clause, provision or material requirement
pertaining to any Government Contract or Bid; (vi) other
than pursuant to Government Contract requirements for
withholding of fees under reimbursement contracts and labor
withholdings under time and materials/labor hour contracts, no
amount of money due to any of the Intel Companies pertaining to
any Government Contract or Bid has been withheld or set off nor
has any claim been made to withhold or set off any amount of
money, and each of the Intel Companies is entitled to all
progress payments received with respect thereto; (vii) no
stop work order has been
B-22
issued with respect to any Government Contract or Bid;
(viii) no material cost incurred by any of the Intel
Companies pertaining to any Government Contract or Bid has been
formally questioned or challenged, is the subject of any
investigation or has been disallowed by any Governmental Entity;
and (ix) there have not been any written notices
challenging, questioning or disallowing any material costs with
respect to any Government Contract or Bid.
(c) Except as set forth on Section 4.16(c) of the
Company Disclosure Schedule, (i) none of the Intel
Companies nor, to the Knowledge of the Company, any of their
respective directors, officers employees, consultants or agents,
is (or during the last five (5) years has been) under
administrative, civil or criminal investigation or indictment by
any Governmental Entity; (ii) within the last five
(5) years, none of the Intel Companies has received any
notice of, there has not been, any audit or investigation of any
of the Intel Companies, or to the Knowledge of the Company, any
of their respective directors, officers, employees or
representatives, in each case, with respect to any alleged
irregularity, misstatement, noncompliance or omission arising
under or relating to any Government Contract or Bid or any Laws
related thereto, nor, to the Knowledge of the Company, is any
such audit or investigation threatened; and (iii) during
the last five (5) years, none of the Company nor any of the
Intel Companies has conducted or initiated any internal
investigation or made any voluntary disclosure to any
Governmental Entity with respect to any alleged irregularity,
misstatement, noncompliance or omission arising under or
relating to a Government Contract or Bid or any Laws related
thereto (including ITAR). To the Knowledge of the Company, none
of the Intel Companies have had any irregularities,
misstatements, noncompliance or omissions arising under or
relating to any Government Contract or Bid that has led or is
expected to lead, either before or after the Closing Date, to
any of the consequences set forth in clause (i) or
(ii) of the immediately preceding sentence or, to the
filing of an action under the False Claims Act (31 U.S.C.
§§ 3729-3733),
or to the extent material, any other damage, penalty assessment,
recoupment of payment or disallowance of cost.
(d) Except as set forth on Section 4.16(d) of the
Company Disclosure Schedule, to the Knowledge of the
Company, there are (i) no outstanding claims against any of
the Intel Companies, by any Governmental Entity or by any prime
contractor, subcontractor, vendor or other third party arising
under or relating to any Government Contract or Bid, and
(ii) no material disputes between any Intel Company and any
Governmental Entity under the Contract Disputes Act or any other
federal statute or between any Intel Company and any prime
contractor, subcontractor, vendor or other third party arising
under or relating to any such Government Contract or Bid. Except
as set forth on Section 4.16(d) of the Company
Disclosure Schedule, to the Knowledge of the Company, there
are no existing facts that could reasonably be expected to
result in a claim or dispute under clause (i) or
(ii) of the immediately preceding sentence.
(e) None of the Company, nor any of the Intel Companies
nor, to the Knowledge of the Company, any of their respective
directors, officers, employees, consultants or agents of the
Company or any of the Intel Companies is (or during the last
five (5) years has been) (i) suspended or debarred
from doing business with any Governmental Entity,
(ii) subject to any debarment or suspension inquiry, or
(iii) the subject of a finding of non-responsibility or
ineligibility for government contracting. To the Knowledge of
the Company, there exist no facts or circumstances that would
warrant the institution of suspension or debarment proceedings
or the finding of non-responsibility or ineligibility on the
part of any of the Intel Companies with respect to any prior,
current, or future Government Contract or Bid. During the last
five (5) years, each of the Intel Companies has conducted
its operations in compliance with the Laws pertaining to all
Government Contracts and Bids.
(f) The Company has submitted to the responsible
U.S. Government contracting officers and applicable
agencies all forward pricing indirect rates to be bid, billed
and charged by any of the Intel Companies under Government
Contracts for the years ended December 31, 2007, 2008 and
2009 and which rates cover any costs charged to Government
Contracts that have not been completed prior to June 30,
2009. In addition, each of the Intel Companies has submitted to
the responsible U.S. Government contracting officer and
applicable agencies any required incurred cost submissions for
the years ended December 31, 2007 through 2009.
(g) To the Knowledge of the Company, none of the Company
nor any of the Intel Companies is in receipt or possession of
any competitor or government proprietary or procurement
sensitive information under circumstances where there is a
reasonable basis to believe that such receipt or possession is
unlawful or unauthorized.
B-23
(h) None of the Intel Companies has submitted to any
Governmental Entity any inaccurate, untruthful or misleading
cost or pricing data, certification, bid, proposal, report,
claim or any other information relating to a Government Contract
or Bid.
(i) None of the Intel Companies is in possession of any
property, equipment, fixtures or software that (i) was in
the possession of, or directly acquired by a Governmental Entity
and (ii) was subsequently loaned, bailed or otherwise
furnished to or held by any of the Intel Companies (or any
subcontractors on behalf of the Intel Companies) by or on behalf
of the United States or any foreign country as of the date of
this Agreement.
(j) To the Knowledge of the Company, each of the Intel
Companies has, in connection with award or performance of any
Government Contract to which the requirements of 48 C.F.R.
52.203-13 apply, timely disclosed to the proper
U.S. government officials any credible evidence known to a
principal (as that term is defined in FAR 2.101) of any of the
Intel Companies of (i) violations of Federal criminal law
involving fraud, conflict of interest, bribery or gratuity
violations found in Title 18 of the U.S. Code,
(ii) violations of the civil False Claims Act,
31 U.S.C.
§§ 3729-3731,
and (iii) a significant overpayment on a Government
Contract, other than overpayments resulting from contract
financing payments as defined in FAR 32.001.
Section 4.17 Intel
Business Assets.
(a) Except as set forth in Section 4.17 of the
Company Disclosure Schedule, the assets owned, leased and
licensed by the Transferred Companies do include, and assuming
the consents or notices set forth on Section 4.3(b) and
Section 4.13(c) of the Company Disclosure Schedule are
obtained, as of Closing will include, all assets held and used
by the Transferred Companies in the conduct of the Intel
Business (other than the business of Patriot) in substantially
the manner as it is currently conducted by the Transferred
Companies.
(b) There are no Intel Guaranties, Identity Guaranties,
Intel Misallocated Contracts or Identity Misallocated Contracts.
(c) There is no material Proceeding pending or, to the
Knowledge of the Company, threatened, against any Transferred
Company primarily relating to the Identity Business or against
any Identity Company primarily relating to the Transferred
Company Business. To the Knowledge of the Company, no event has
occurred which, with notice or lapse of time, would result in a
material Liability of any Transferred Company primarily relating
to the Identity Business.
Section 4.18 Brokers
or Finders. No investment banker, broker,
finder, consultant or intermediary other than (i) Goldman,
Sachs & Co. and (ii) Stone Key, the fees and
expenses of which will be paid by the Company, is entitled to
any investment banking, brokerage, finders or similar fee
or commission in connection with this Agreement or the
transaction contemplated by this Agreement based upon
arrangements made by or on behalf of the Company or any of its
Subsidiaries.
Section 4.19 Title
to Transferred Shares. Upon consummation of
the transactions contemplated by this Agreement, including the
execution and delivery of the documents to be delivered at the
Closing, Purchaser, at the Closing, shall be vested with good
and valid title in and to the Transferred Shares, free and clear
of all Liens, except restrictions on transfer which arise under
applicable securities Laws or Liens created by Purchaser.
Section 4.20 Affiliate
Transactions; Intercompany
Arrangements. Except as set forth on
Section 4.20 of the Company Disclosure Schedule or
as contemplated by this Agreement, none of the Company or any of
its Subsidiaries (other than the Intel Companies), or any
officer, director, employee, stockholder or Affiliate (other
than the Intel Companies) of the Company or its Subsidiaries
(other than the Intel Companies) (each such Person, a
Section 4.20 Affiliate), (i) on the
one hand, is presently, or within the past three (3) years
has been, a party to any Contract, commitment, arrangement or
transaction with any of the Intel Companies, on the other hand,
or (each an Affiliate Agreement);
(ii) has any accounts receivable or rights to performance
or other satisfaction (whether or not yet accrued) in respect of
any Liability of the Intel Companies, or (iii) owns,
leases, or has any economic or other interest in any asset,
tangible or intangible, that is owned or used by any of the
Intel Companies. As of the Closing, there shall be no
outstanding receivables or outstanding or unsatisfied
Liabilities of any kind (including inter-company accounts,
notes, guarantees, loans or advances) between any of the Intel
Companies, on one hand, and any
B-24
Section 4.20 Affiliate, on the other hand; and any and all
Affiliate Agreements and all rights and obligations of the
Company and its Affiliates (including the Intel Companies)
thereunder will have terminated.
Section 4.21 Environmental
Matters. Except as set forth on
Section 4.21 of the Company Disclosure Schedule and
as would not be material to the Intel Business or Intel
Companies, taken as a whole: (a) the Intel Companies are,
and since January 1, 2007 have been, in compliance with all
applicable Environmental Laws and have no Liabilities
thereunder, (b) the Intel Companies have obtained or caused
to be obtained any and all Permits necessary to comply with all
applicable Environmental Laws, and the Intel Companies are in
material compliance with the terms and conditions of any such
Permits, (c) the Intel Companies have not received any
written notices of any Proceedings asserting any Liability
against or violation by any Intel Company pursuant to any
Environmental Law, and to the Knowledge of the Company, no such
Proceeding is threatened, and (d) no Intel Company
conducts, or has conducted in the past, any Hazardous Substance
Activity.
Section 4.22 Insurance. Section 4.22
of the Company Disclosure Schedule sets forth a true,
correct and complete list of each of the material insurance
policies maintained by the Intel Companies, or by the Company on
behalf of the Intel Companies or the Intel Business (the
Insurance Policies) and all insurance loss
runs or workers compensation claims received by the Intel
Companies for the past two (2) policy years. The Company
and each of its Subsidiaries has complied in all material
respects with the provisions of each Insurance Policy under
which it is the insured party and the premiums due thereon have
been paid in full. No insurer under any Insurance Policy has
provided notice to the Company or any of its Subsidiaries that
it has cancelled or generally disclaimed Liability under any
such Insurance Policy or indicated any intent to do so or not to
renew any such policy. There is no claim by the Company (or any
of its Subsidiaries) pending under any of such Insurance
Policies or bonds as to which coverage has been questioned,
denied or disputed by the underwriters of such Insurance
Policies or bonds or in respect of which such underwriters have
reserved their rights.
Section 4.23 SEC
Filings.
(a) With respect to all matters specifically relating to
any of the Intel Companies, the Company SEC Reports did not at
the time they were filed (and if amended or superseded by a
filing prior to the date of this Agreement then on the date of
such filing) contain any untrue statement of a material fact or
omit to state a material fact, required to be stated therein or
necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading.
None of the Transferred Companies is required to file or furnish
any reports or other documents with the SEC.
(b) The Company has established and maintains
disclosure controls and procedures (as such term is
defined in
Rule 13a-15(e)
or 15d-15(e)
promulgated under the Exchange Act); such disclosure controls
and procedures are designed to provide reasonable assurance that
material information required to be disclosed in the
Companys reports required to be filed with or submitted to
the SEC pursuant to the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the
rules and forms of the SEC, and that all such information
communicated to the Companys management as appropriate to
allow timely decisions regarding required disclosure and to make
the certifications of the principal executive officer and
principal financial officer of the Company required under the
Exchange Act with respect to such reports.
(c) The Company maintains a system of internal
control over financial reporting (as defined in
Rules 13a-15(f)
and 15(d)-15(f) of the Exchange Act) as required under
Rules 13a-15(a)
and
15d-15(a)
under the Exchange Act, and such system is designed to provide
reasonable assurance regarding the reliability of financial
reporting and preparation of financial statements in accordance
with GAAP.
Section 4.24 No
Other Representations. Except for the
representations and warranties contained in this
Article IV, neither the Company nor any other Person
acting on behalf of the Company makes any representation or
warranty, express or implied, with respect to the Company,
Operating Company, the Intel Companies or the Intel Business, or
with respect to any other information provided to Purchaser in
connection with the transactions contemplated by this Agreement.
Neither the Company nor any other Person will have or be subject
to any Liability or indemnification obligation to Purchaser or
any other Person resulting from the distribution to Purchaser,
or Purchasers use of, any such information, including any
information, documents, projections, forecasts of other material
made available to Purchaser in certain data rooms
(electronic or otherwise) or management presentations
B-25
in expectation of the transactions contemplated by this
Agreement, unless any such information is expressly included in
a representation or warranty contained in this
Article IV.
ARTICLE V
REPRESENTATIONS
AND WARRANTIES OF PURCHASER
Purchaser represents and warrants to the Company as follows:
Section 5.1 Organization
and Good Standing. Purchaser is duly
organized, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or organization and has
the requisite corporate or similar power and authority to
conduct its business as it is now being conducted, except where
the failure to be so organized, existing and in good standing or
to have such power and authority would not have a Purchaser
Material Adverse Effect. Purchaser is duly qualified or licensed
to do business and (to the extent applicable) is in good
standing in each jurisdiction in which the property owned,
leased or operated by it or the nature of the business conducted
by it makes such qualification or licensing necessary, except
where the failure to be so duly qualified, licensed and in good
standing would not have a Purchaser Material Adverse Effect.
Section 5.2 Authorization;
Validity of Agreement; Necessary
Action. Purchaser has all necessary corporate
or similar power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to
consummate the transactions contemplated hereby. The execution,
delivery and performance by Purchaser of this Agreement, and the
consummation by Purchaser of the transactions contemplated
hereby, have been duly and validly authorized by all necessary
corporate action by Purchaser (including by its Board of
Directors), and no other corporate action or proceeding on the
part of Purchaser is necessary to authorize the execution,
delivery and performance by Purchaser of this Agreement and the
consummation by it of the transactions contemplated hereby. This
Agreement has been duly executed and delivered by Purchaser and,
assuming due authorization, execution and delivery of this
Agreement by the Company, constitutes a legal, valid and binding
obligation of Purchaser, enforceable against Purchaser in
accordance with its terms, except that (i) such enforcement
may be subject to applicable bankruptcy, insolvency,
reorganization, moratorium or other similar Laws, now or
hereafter in effect, affecting creditors rights and
remedies generally and (ii) the remedies of specific
performance and injunctive and other forms of equitable relief
may be subject to equitable defenses and to the discretion of
the court before which any Proceeding therefor may be brought.
Section 5.3 Consents
and Approvals; No Violations.
(a) The execution and delivery by Purchaser of this
Agreement does not and the consummation of the transactions
contemplated hereby by Purchaser will not, (i) conflict
with or violate the certificate of incorporation or bylaws (or
equivalent organizational documents) of (A) Purchaser or
(B) any Subsidiary of Purchaser, (ii) assuming the
Governmental Authorizations, registrations, declarations,
filings and notices referred to in Section 5.3(b)
have been obtained or made, any applicable waiting periods
referred to therein have expired and any condition precedent to
any such Governmental Authorization has been satisfied, conflict
with or violate any Law applicable to Purchaser or any
Subsidiary of Purchaser or by which any properties or assets of
Purchaser or its Subsidiaries is bound or affected,
(iii) violate or conflict with, result in any breach of, or
constitute a default (with or without notice or lapse of time,
or both) under, or give rise to any right of termination,
amendment, acceleration or cancellation of, any Contract to
which Purchaser or any of its Subsidiaries is a party or by
which any of their respective properties or assets is bound, or
(iv) result in the creation of a Lien, other than any
Permitted Lien, upon any of the material properties or assets of
Purchaser or its Subsidiaries, other than, in the case of clause
(iii), any such conflict, violation, breach, default,
termination, amendment, acceleration, cancellation or Lien that
would not have a Purchaser Material Adverse Effect.
(b) No Governmental Authorization, or registration,
declaration or filing with or notice to any Governmental Entity
is required to be obtained or made by or with respect to
Purchaser or any of its Subsidiaries in connection with the
execution, delivery and performance of this Agreement or the
consummation of the transactions contemplated hereby, other than
(i) the filing with the SEC of such reports under the
Exchange Act as may be required in connection with this
Agreement and the transactions contemplated by this Agreement,
(ii) such filings as may be required in connection with the
Taxes described in Section 6.9(f), (iii) such
other items required solely by reason of
B-26
the participation of the Company (as opposed to any other
third-party) in the transactions contemplated hereby,
(iv) compliance with and filings or notifications under
(A) the HSR Act and other applicable U.S. and
non-U.S. competition
Laws, (B) Exon-Florio and (C) the NISPOM,
(v) such filings as may be required in connection with FAR,
the Defense Federal Acquisition Regulation Supplement, and
U.S. Export Laws and Regulations and approval of the
Defense Security Service of a plan to enter into an agreement to
mitigate FOCI, and (vi) such other Governmental
Authorizations, the failure of which to be obtained or made
would not have a Purchaser Material Adverse Effect.
Section 5.4 Sufficient
Funds. Purchaser has, and as of the Closing
shall have, sufficient funds available (through existing credit
arrangements or otherwise) to fully fund all of Purchasers
obligations under this Agreement, including payment of the
Purchase Price and payment of all fees and expenses related to
the transactions contemplated by this Agreement and any
refinancing of indebtedness of Purchaser or its Subsidiaries in
connection therewith. Purchaser acknowledges and agrees that its
obligations hereunder are not subject to any conditions
regarding Purchasers or any other Persons ability to
obtain financing for the consummation of the transactions
contemplated by this Agreement.
Section 5.5 Investigation
by Purchaser. In entering into this
Agreement, Purchaser has relied solely upon its own
investigation and analysis, and Purchaser acknowledges that,
except for the representations and warranties of the Company
expressly set forth in Article IV, none of the
Company or its Subsidiaries nor any of their respective
Representatives makes any representation or warranty, either
express or implied, as to the accuracy or completeness of any of
the information provided or made available to Purchaser or any
of its Representatives. Without limiting the generality of the
foregoing, none of the Company or its Subsidiaries nor any of
their respective Representatives or any other Person has made a
representation or warranty to Purchaser with respect to
(a) any projections, estimates or budgets for the Intel
Companies or the Intel Business or (b) except as expressly
and specifically covered by a representation or warranty set
forth in Article IV, any material, documents or
information relating to the Intel Companies or the Intel
Business made available to Purchaser or its Representatives in
any data room (electronic or otherwise),
confidential memorandum or otherwise.
Section 5.6 Litigation. There
is no Proceeding pending or, to the Knowledge of Purchaser,
threatened against Purchaser or any of its Subsidiaries that
would have or reasonably would be expected to have a Purchaser
Material Adverse Effect, nor is there any Judgment of any
Governmental Entity outstanding against, or, to the Knowledge of
Purchaser, investigation by any Governmental Entity involving,
Purchaser or any of its Subsidiaries that would reasonably be
expected to have a Purchaser Material Adverse Effect.
Section 5.7 Brokers
or Finders. No investment banker, broker,
finder, consultant or intermediary is entitled to any investment
banking, brokerage, finders or similar fee or commission
in connection with this Agreement or the transactions
contemplated by this Agreement based upon arrangements made by
or on behalf of Purchaser or any of its Subsidiaries.
Section 5.8 Acquisition
of Transferred Shares for
Investment. Purchaser has such knowledge and
experience in financial and business matters that it is capable
of evaluating the merits and risks of its purchase of the
Transferred Shares. Purchaser is acquiring the Transferred
Shares for investment and not with a view toward sale in
connection with any distribution thereof in violation of the
Securities Act. Purchaser hereby acknowledges and agrees that
the Transferred Shares may not be sold, transferred, offered for
sale, pledged, hypothecated or otherwise disposed of without
registration under the Securities Act, except pursuant to an
exemption from such registration available under the Securities
Act, and without compliance with state and foreign securities
Laws, in each case, to the extent applicable.
ARTICLE VI
COVENANTS
Section 6.1 Interim
Operations of the Transferred Companies. The
Company covenants and agrees that, between the date of this
Agreement and the Closing or the date, if any, on which this
Agreement is terminated pursuant to Section 8.1,
except (i) as may be required by Law, (ii) as may be
agreed in writing by Purchaser (which consent shall not be
unreasonably withheld, delayed or conditioned), (iii) as
may be contemplated by this
B-27
Agreement or (iv) as set forth in Section 6.1 of
the Company Disclosure Schedule, the Intel Business
(excluding the business of Patriot but including business
dealings between Patriot and the Transferred Companies) shall be
conducted only in the ordinary course of business and in a
manner consistent with past practice in all material respects;
and, to the extent consistent therewith, the Company shall, and
shall cause the Transferred Companies to, use their respective
commercially reasonable efforts to preserve substantially intact
the Transferred Companies business organization and the
Purchased Assets and to keep available the services of those of
their present officers, employees and consultants who are
integral to the operation of their businesses as presently
conducted; provided, however, that no action by
the Company or the Transferred Companies with respect to matters
specifically addressed by any of the following provisions of
this Section 6.1 shall be deemed a breach of this
sentence unless such action would constitute a breach of such
specific provision. The Company agrees that, between the date of
this Agreement and the Closing or the date, if any, on which
this Agreement is terminated pursuant to
Section 8.1, except (1) as may be required by
Law, (2) as may be agreed in writing by Purchaser (which
consent shall not be unreasonably withheld, delayed or
conditioned), (3) as may be contemplated by this Agreement
or (4) as set forth in Section 6.1 of the Company
Disclosure Schedule, the Company shall not, to the extent
relating to the Intel Business (excluding the business of
Patriot but including business dealings between Patriot and the
Transferred Companies), and shall not permit any of the
Transferred Companies to:
(a) amend or otherwise change, in any material respect, the
organizational documents of any Transferred Company;
(b) issue, sell, pledge, dispose or encumber any shares of
capital stock, membership interests or other equity interests of
any Transferred Company, or any options, warrants, convertible
securities or other rights to acquire any shares of capital
stock, membership interests or other equity interests of any
Transferred Company;
(c) declare, authorize, make or pay any dividend or other
distribution with respect to the capital stock, membership
interests or equity interests of any Transferred Company, except
cash dividends and distributions to the Company or Operating
Company, directly or indirectly redeem, purchase or repurchase
any shares of capital stock, membership interests or equity
interests of the Transferred Companies or other securities or
obligations convertible into or exchangeable or exercisable for
any shares of capital stock, membership interests or equity
interests in any of the Transferred Companies or any rights,
warrants or options to acquire any such shares of capital stock,
membership interests or equity interests;
(d) (i) amend in a material respect any Contract with
any of the officers, directors, employees, or consultants of any
Transferred Company, including any Contract relating to
employment, compensation, benefits, termination, retention, or
severance; (ii) increase the compensation or other benefits
payable or to become payable to directors, officers, employees
or consultants of any Transferred Company except in the ordinary
course of business consistent with past practice in all material
respects (including, for this purpose, the normal salary, bonus
and equity compensation review process conducted each year),
(iii) enter into any employment agreement with any employee
of any Transferred Company, except, in each case, as required
pursuant to Contracts, Benefit Arrangements or Employee Plans in
effect as of the date hereof, or as otherwise required by Law,
(iv) adopt, enter into, terminate or amend any existing
Employee Plan or Benefit Arrangement for the current or future
benefit or welfare of any officer, director, current or former
employee of the Transferred Companies in a way that would
materially increase benefits payable thereunder to any employee
of any Transferred Company except, in each case, as required
pursuant to Contracts or Employee Plans in effect as of the date
hereof, or as otherwise required by Law or (v) loan or
advance any money or property to any employee of the Transferred
Companies other than travel advances and other customary
advances in the ordinary course of business consistent with past
practice;
(e) (i) enter into or adopt a plan or agreement of
recapitalization, reorganization, merger or consolidation, or
adopt a plan of complete or partial liquidation or dissolution
or (ii) acquire, including by merger, consolidation, or
acquisition of stock or assets, any corporation, partnership,
limited liability company, other business organization or any
division thereof, or any material amount of assets;
(f) incur any Indebtedness or guarantee any Indebtedness
for any Person (other than a Transferred Company), except for
Indebtedness that will be repaid or discharged in full prior to
the Closing;
B-28
(g) except as permitted by Section 6.1(d)(v),
make any loans or advances of borrowed money or capital
contributions to, or equity investments in, any other Person
(other than another Transferred Company) other than the
extension of trade credit to customers and suppliers, in each
case, in the ordinary course of business consistent with past
practice and other than ordinary course investments;
(h) enter into, modify or amend in any material respect, or
terminate or waive any material rights under, any Intel Company
Material Contract, other than in the ordinary course of business;
(i) make any material change to its methods of accounting
(other than Tax accounting, which is addressed in
Section 6.1(j)) in effect at June 30, 2010,
except (i) as required by GAAP (or any interpretation
thereof),
Regulation S-X
of the Exchange Act or as required by a Governmental Entity or
quasi-Governmental Entity (including the Financial Accounting
Standards Board or any similar organization), (ii) to
permit the audit of the Intel Companies financial
statements in compliance with GAAP, (iii) as required by a
change in applicable Law or (iv) as disclosed in the Intel
Financial Statements or Company SEC Reports;
(j) with respect to or as relates to any of the Transferred
Companies or the Purchased Assets, adopt or change any material
Tax accounting principle, period, method or practice, make or
change any material Tax election, file any amended Tax Return,
settle any Tax claim or assessment with respect to items on a
Separate Tax Return, settle any material Tax claim or assessment
with respect to items on any other Tax Return, surrender any
right to claim a refund of a material amount of Taxes, or
consent to any extension or waiver of the limitation period
applicable to any Tax Claim;
(k) sell, lease, license, transfer, abandon, mortgage or
otherwise encumber, or subject to any Lien (other than Permitted
Liens) or otherwise dispose of any material portion of the
properties or assets of the Transferred Companies, other than
(i) transactions among any of the Transferred Companies,
(ii) in the ordinary course of business consistent with
past practice in all material respects, (iii) pursuant to
Contracts as in effect as of the date of this Agreement or
(iv) as may be required by applicable Law;
(l) enter into, modify or amend in any material respect, or
terminate or waive any material rights under, any Intel Lease
other than in the ordinary course of business;
(m) make any capital expenditures having an aggregate value
in excess of $1 million;
(n) waive, release, assign, settle or compromise any
Proceeding, other than waivers, releases, assignments,
settlements or compromises that involve only the payment of
monetary damages not in excess of $1 million in the
aggregate;
(o) enter into any collective bargaining agreement or
implement any employee layoffs that would trigger notice
requirements under the WARN Act;
(p) (i) enter into any Contract under which any
Transferred Company or the Company, on behalf of any Transferred
Company, would sell or agree to sell, license or otherwise
furnish any products or services to any foreign national in the
United States or abroad or to any Person for delivery or
performance outside of the United States or (ii) direct or
take any affirmative action to authorize any sales agent, sales
representative, sales consultant or distributor to market,
demonstrate or take any actions related to the sale, license or
provision of any products or services of any Transferred Company
to any foreign national in the United States or abroad or to any
Person for delivery or performance outside of the United States;
(q) authorize or enter into any written agreement or
otherwise make any commitment to do any of the foregoing; or
(r) knowingly or intentionally take, or agree to take, any
action that would prevent the satisfaction of any condition to
Closing set forth in Article VII.
From the date hereof until the earlier of the Closing and the
date on which this Agreement is terminated in accordance with
its terms, no later than fifteen (15) days after the end of
each calendar month (and, in any event, three (3) Business
Days prior to the Closing), the Chief Financial Officer of the
Company shall meet with representatives of Purchaser for the
purpose of providing Purchaser with such information as may
reasonably be
B-29
requested by Purchaser ( in any event, subject to the last
sentence of Section 6.3(a)) with respect the
Companys compliance with its obligations under this
Section 6.1.
Section 6.2 Notification
of Certain Matters.
(a) The Company shall give prompt notice to Purchaser, and
Purchaser shall give prompt notice to the Company, of
(i) any notice or other communication received by such
party from any Governmental Entity in connection with this
Agreement or the transactions contemplated hereby, or from any
Person alleging that the consent of such Person is or may be
required in connection with the transactions contemplated
hereby, and (ii) any Proceedings commenced or, to such
partys Knowledge, threatened against, relating to or
involving or otherwise affecting such party or any of its
Affiliates which relate to this Agreement or the transactions
contemplated hereby.
(b) Each of the Company and Purchaser shall give reasonably
prompt notice to the other of (i) the occurrence or failure
to occur of any event which occurrence or failure causes or is
reasonably likely to cause any of the representations or
warranties of the Company set forth in Article IV to
be untrue or inaccurate in any material respect, or,
individually or in the aggregate, results in or is reasonably
likely to result in, a Business Material Adverse Effect, and
(ii) any material failure of any party to comply with or
satisfy in any material respect any material covenant, condition
or agreement to be complied with or satisfied by such party
hereunder prior to the Closing Date, in each case, to the extent
the Company or Purchaser becomes aware of any such matter;
provided, however, any breach of this
Section 6.2(b) (unless willful and material) shall
not be considered for purposes of determining the satisfaction
of the conditions set forth in Article VII or give
rise to a right of termination under Article VIII.
No notice delivered pursuant to this Section 6.2(b)
shall be deemed by itself to (x) modify any representation,
warranty or covenant set forth herein or in the Company
Disclosure Schedule, (y) cure or prevent any such
inaccuracy or failure, or (z) limit or otherwise affect the
remedies available hereunder to Purchaser or the Company, as
applicable.
Section 6.3 Access
to Information.
(a) From the date hereof until the earlier of the Closing
or the date on which this Agreement is terminated in accordance
with its terms, the Company shall, and shall cause each of the
Intel Companies to, afford to Purchaser, and to Purchasers
directors, officers, employees, accountants, counsel, financial
advisors, financing sources and other representatives (the
foregoing, with respect to any Person, its
Representatives), reasonable access during
normal business hours and upon reasonable prior notice from
Purchaser to their respective properties, books and records and
other information as Purchaser may reasonably request regarding
the business, assets, liabilities, employees and other aspects
of the Intel Companies. All information exchanged pursuant to
this Section 6.3 shall be subject to the
Confidentiality Agreement, and the parties shall comply with,
and shall cause their respective Representatives (as defined in
the Confidentiality Agreement) to comply with, all of their
respective obligations thereunder. No information or knowledge
obtained in any investigation or examination pursuant to this
Section 6.3 shall affect or be deemed to modify any
representation or warranty contained in this Agreement or the
conditions to the obligations of the parties to consummate the
transactions contemplated hereby. Notwithstanding the foregoing,
the Company shall not be required to provide access to, or cause
the Intel Companies to provide access to, any information or
documents which would, in the reasonable judgment of the
Company, (i) constitute a waiver of the attorney-client or
other privilege held by the Company or any of its Subsidiaries,
(ii) otherwise violate any applicable Laws,
(iii) result in a competitor of the Company or any of its
Subsidiaries (other than Purchaser, to the extent permitted by
applicable Law) receiving material information which is
competitively sensitive or (iv) breach any agreement of the
Company or any of its Subsidiaries with any third-party.
(b) For a period of seven (7) years after the Closing
Date, the Company and Purchaser shall (i) provide the other
and its professional advisors with reasonable access during
normal business hours and upon reasonable prior notice to all
the books and records relating to the operation of the
Transferred Companies or Intel Business to the extent in the
possession of or under the control of the Company or Purchaser,
as the case may be, before the Closing Date if reasonably
required in connection with any litigation, any Tax audit, the
preparation of any Tax Returns or the preparation of any
financial statements that include the financial results of all
or part of the Transferred Companies or Intel Business for any
period prior to the Closing and (ii) cooperate with and
assist the other and its professional advisors in connection
with the preparation of any audited financial statements that
include the financial results of all or part of the Transferred
Companies or Intel Business for any period prior to the Closing.
B-30
Section 6.4 Employees;
Employee Benefits.
(a) Following the execution of this Agreement, the Company
shall provide Purchaser reasonable access to, and facilitate
meetings with, the employees of the Transferred Companies for
the purposes of making announcements concerning, and preparing
for the consummation of, the transactions that are the subject
of this Agreement.
(b) Continuation of Employee Benefits.
(i) For not less than twelve (12) months following the
Closing, Purchaser and its Affiliates (including the Transferred
Companies) shall pay to employees of the Transferred Companies
base salary or wages that are, on an individual by individual
basis, no less favorable than those provided as of immediately
prior to the Closing, to the extent
he/she
continues his or her employment with Purchaser and its
Affiliates (including the Transferred Companies). Except in the
case of any Intel Incentive Plan as defined
in Section 6.4(b)(iv), Purchaser covenants and
agrees that, for not less than 12 months following the
Closing, it will provide each current employee of the
Transferred Companies, to the extent
he/she
continues his or her employment with any of the Transferred
Companies or any Affiliate thereof from and after the Closing
Date, with employee benefits, whether provided under the
Employee Plans or Benefit Arrangements or otherwise, which in
the aggregate are substantially comparable to those received by
such employee immediately prior to the Closing, provided
that nothing herein will (A) prevent the amendment or
termination at any time of any specific plan or arrangement of
Purchaser, (B) require that Purchaser provide or permit
investment in the securities of Purchaser or any of the
Transferred Companies (or securities exchangeable or exercisable
or convertible therein) or (C) interfere with
Purchasers right or obligation to make such changes as are
necessary to comply with applicable Law. The plans and
arrangements of Purchaser shall recognize the service of each
current employee of any of the Transferred Companies that is
recognized under Employee Plans or Benefit Arrangements for
purposes of participation and vesting under the plans and
arrangements of Purchaser. The Company shall provide such
cooperation and assistance, including cooperation and assistance
following the execution of this Agreement, as is necessary for
Purchaser to provide the employee benefits described above.
(ii) Notwithstanding the generality of
Section 6.4(b)(i), for not less than twelve
(12) months following the Closing, Purchaser and its
Affiliates (including the Transferred Companies) shall provide
to employees of the Transferred Companies (other than those
employees whose severance pay and benefits shall be governed by
the Intel Companies Special Employee Plan) severance pay and
benefits that are no less favorable than the greater of
(A) those provided by the Transferred Companies as of the
date hereof and (B) those provided by Purchaser and its
Affiliates to their similarly situated employees.
(iii) In the case of any Intel Incentive Plan, the
Purchaser covenants and agrees that, effective for the period
from January 1, 2011 through December 31, 2011, it
will establish, or will cause the Transferred Companies to
establish, an Incentive Payment Program that will provide
employees of the Transferred Companies who continue their
employment with the Transferred Companies after
December 31, 2010, with cash payments that are
substantially comparable in the aggregate to the payments that
would have been earned and owing under the Intel Incentive
Plans; provided, however, that
(A) comparability of such payments shall exclude any
consideration of any commission program or stock or equity
investment plans maintained by or for the Transferred Companies
or the Company prior to Closing; (B) nothing herein shall
require Purchaser or the Transferred Companies to establish or
maintain any commission program or any plan providing for the
investment in stock or equities of the Purchaser or the
Transferred Companies, or any Affiliate thereof; and
(C) such Incentive Payment Program shall be established
with reference to the targeted financial performance of the
Transferred Companies set forth in Section 6.4(b) of the
Company Disclosure Schedule following consultation with
senior management employees of the Transferred Companies.
(iv) For the purposes of this Section 6.4(b),
the term Intel Incentive Plan means any
Employee Plan or Benefit Arrangement that provides for
(A) bonus payments; (B) payments based on commissions;
(C) payments based on the performance of the employee, the
employees employer, or any or all of the Transferred
Companies; (D) investments by or grants to employees of any
stock or equities of the Transferred Companies or their
Affiliates; or (E) any similar payments, investments or
incentives.
B-31
(v) To the extent not paid by the Company or the
Transferred Companies prior to Closing in accordance with such
plan, Purchaser shall cause the Transferred Companies to pay
management incentive bonuses in respect of the 2010 year
(the 2010 Bonuses) at the time in February
2011 such bonuses would ordinarily be paid to the employees of
the Transferred Companies, in accordance with the terms and
conditions of the Management Incentive Bonus Plan for the
2010 year, as in effect on the date hereof (and the Company
shall have a reasonable opportunity to review such payments
prior to the payment date). Purchasers obligations
pursuant to the preceding sentence shall be limited to the
amount accrued in respect of the 2010 Bonuses as of
December 31, 2010. Prior to the Closing, the Company shall,
and following the Closing through December 31, 2010,
Purchaser shall, make accruals with respect to the 2010 Bonuses
in the ordinary course and consistent with past practice.
(c) Notwithstanding the foregoing, no provision of this
Agreement shall (i) create any right in any employee to
continued employment by Purchaser, the Company, the Transferred
Companies or any respective Subsidiary thereof, or preclude the
ability of Purchaser, the Company, the Transferred Companies or
any respective Subsidiary thereof to terminate the employment of
any employee for any reason or (ii) require Purchaser, the
Company, the Transferred Companies or any respective Subsidiary
thereof to continue any Employee Plan or prevent the amendment,
modification, or termination thereof in accordance with plan
terms after the Closing Date.
(d) This Section 6.4 shall be binding upon and
shall inure solely to the benefit of each of the parties to this
Agreement, and nothing in this Section 6.4, express
or implied, is intended to confer upon any other Person any
rights or remedies of any nature whatsoever under or by reason
of this Section 6.4 or is intended to be, shall
constitute or be construed as an amendment to or modification of
any employee benefit plan, program, arrangement or policy of
Purchaser, the Company, the Transferred Companies or any
respective Subsidiary thereof.
(e) The Company shall provide such cooperation and
assistance, including cooperation and assistance following the
execution of this Agreement, as reasonably requested by
Purchaser for purposes of providing the employee benefits
described in this Section 6.4.
(f) At least thirty (30) days before the Closing Date,
the Company shall provide its workpapers and analysis regarding
whether any Contract, agreement, plan or arrangement covering or
with respect to any employee, director or stockholder of any
Transferred Company could, individually or collectively, give
rise to the payment of any amount that would not be deductible
by reason of Section 280G of the Code.
(g) During the period from the date hereof through the
Closing, the Company shall pay and discharge, or shall cause the
Transferred Companies to pay and discharge (on a basis
consistent with past practice), all contributions and payments
under each Employee Plan and Benefit Arrangement, in all events,
not later than the date each such contribution and payment is
required to be paid by the terms of the applicable Employee
Plan, Benefit Arrangement or Law.
Section 6.5 Publicity. Neither
the Company nor Purchaser (nor any of their respective
Affiliates) shall issue any press release or make any other
public announcement with respect to this Agreement or the
transactions contemplated hereby without the prior agreement of
the other party (which consent shall not be unreasonably
withheld or delayed) (and none of Purchaser or its Affiliates
shall issue or make any other press release or other public
announcement with respect to the Merger Agreement or the
transactions contemplated thereby without the prior agreement of
the Company), except as otherwise provided by this Agreement or
as may be required by Law or by any listing agreement with a
national securities exchange, in which case the party proposing
to issue such press release or make such public announcement
shall use its reasonable efforts to consult in good faith with
the other party before making any such public announcements.
Section 6.6 Directors
and Officers Indemnification.
(a) Purchaser agrees that all rights to exculpation and
indemnification for acts or omissions occurring at or prior to
the Closing, whether asserted or claimed prior to, at or after
the Closing (including any matters arising in connection with
the transactions contemplated by this Agreement), now existing
in favor of the current or former directors, officers, managers
or employees (D&O Indemnified Parties),
as the case may be, of the Intel Companies as provided in their
respective organizational documents or in any Contract shall
survive the Closing and shall continue in full force and effect.
Purchaser shall (and Purchaser shall cause the Intel Companies
to) indemnify, defend and hold harmless, and advance expenses to
the D&O Indemnified Parties with respect to all acts
B-32
or omissions by them in their capacities as such at any time
prior to the Closing (including any matters arising in
connection with the transactions contemplated by this
Agreement), to the fullest extent that the Company and the Intel
Companies would be permitted by applicable Law and to the
fullest extent required by the organizational documents of the
Company or the Intel Companies as in effect on the date of this
Agreement. Purchaser shall cause the certificate of
incorporation, bylaws or other organizational documents of the
Intel Companies not be amended, repealed or otherwise modified
in any manner that would adversely affect the rights of the
D&O Indemnified Parties under this Section 6.6.
(b) Without limiting the provisions of
Section 6.6(a), during the period ending on the
sixth (6th) anniversary of the Closing, to the fullest extent
that the Intel Companies would be permitted by applicable Law to
do so, Purchaser shall (and shall cause the Intel Companies to):
(i) indemnify and hold harmless each D&O Indemnified
Party against and from any Losses in connection with any
Proceeding, whether civil, criminal, administrative or
investigative, to the extent such Proceeding arises out of or
pertains to: (A) any action or omission or alleged action
or omission taken or not taken in such D&O Indemnified
Partys capacity as a director, officer, manager or
employee of the Intel Companies prior to the Closing; or
(B) this Agreement or the transactions contemplated hereby
and (ii) pay in advance of the final disposition of any
such Proceeding the expenses (including attorneys fees) of
any D&O Indemnified Party upon receipt of an undertaking by
or on behalf of such D&O Indemnified Party to repay such
amount if it shall ultimately be determined that such D&O
Indemnified Party is not entitled to be indemnified;
provided, however, that neither Purchaser nor the
Intel Companies shall be liable for any settlement effected
without either Purchasers or the Intel Companies
prior written consent (which consent shall not be unreasonably
withheld, conditioned or delayed). Notwithstanding anything to
the contrary contained in this Section 6.6(b) or
elsewhere in this Agreement, neither Purchaser nor the Intel
Companies shall (and Purchaser shall cause the Intel Companies
not to) settle or compromise or consent to the entry of any
judgment or otherwise seek termination with respect to any such
Proceeding against a D&O Indemnified Party, unless such
settlement, compromise, consent or termination includes an
unconditional release of such D&O Indemnified Party from
all Liability arising out of such Proceeding.
(c) On or prior to the date that is the earlier of
(i) the Merger Date and (ii) the expiration of
coverage under the Companys applicable directors and
officers insurance and indemnification policies (after
giving effect to the renewal of such policies as contemplated by
Section 6.1 of the Company Disclosure Schedule), the
Company shall provide or cause a Subsidiary of the Company
(other than the Intel Companies) to provide, for a period of not
less than six (6) years after the Closing, the D&O
Indemnified Parties who are insured under the Companys
directors and officers insurance and indemnification
policies with insurance and indemnification policies, or
tail policies, in each case, that provide coverage
for events occurring at or prior to the Closing (the
D&O Insurance) that is no less favorable
than the existing policies of the Company or, if substantially
equivalent insurance coverage is unavailable, the best available
coverage; provided, however, that the Company
shall not be required to pay an annual premium for the D&O
Insurance in excess of three hundred percent (300%) of the last
annual premium paid by the Company for such insurance prior to
the date hereof; provided, further, that if the
annual premiums of such insurance coverage exceed such amount,
the Company shall be obligated to obtain policies with the
greatest coverage available for a cost not exceeding such
amount. Any indemnification and other payments by Purchaser
under this Section 6.6 to or for any D&O
Indemnified Party for Losses shall be paid net of (i) any
insurance proceeds actually recovered by such D&O
Indemnified Party with respect to any Losses so indemnified and
(ii) any indemnity, contribution or other similar payment
received by the D&O Indemnified Party from any third-party
with respect to such Losses, minus the amount of reasonable
out-of-pocket
expenses actually incurred and necessary to recover such
third-party payment. In the event that an applicable insurance
or other recovery is received by any D&O Indemnified Party
with respect to any indemnification payment for which he or she
has been indemnified under this Section 6.6, then a
refund equal to the aggregate amount of such applicable recovery
with respect to such indemnification payment shall be made
promptly to Purchaser by such D&O Indemnified Party.
(d) The D&O Indemnified Parties to whom this
Section 6.6 applies shall be third-party
beneficiaries of this Section 6.6. The provisions of
this Section 6.6 are intended to be for the benefit
of each D&O Indemnified Party and his or her successors,
heirs or representatives. Purchaser shall pay all reasonable
expenses, including reasonable attorneys fees, that may be
incurred by any D&O Indemnified Party in enforcing its
indemnity and other rights under this Section 6.6.
B-33
(e) Notwithstanding any other provision of this Agreement,
this Section 6.6 shall survive the Closing
indefinitely and shall be binding on all successors and assigns
of Purchaser, and shall be enforceable by the D&O
Indemnified Parties and their successors, heirs or
representatives. In the event that Purchaser or the Intel
Companies or any of their successors or assigns consolidates
with or merges into any other Person and shall not be the
continuing or surviving Person of such consolidation or merger,
or transfers or conveys all or a majority of its properties and
assets to any Person, then, and in each such case, Purchaser
shall cause proper provision to be made so that the successors
and assigns of Purchaser or the Intel Companies shall succeed to
the obligations set forth in this Section 6.6.
Section 6.7 Appropriate
Actions.
(a) Upon the terms and subject to the conditions set forth
in this Agreement, each of the parties hereto shall (and shall
cause their applicable Subsidiaries to) use its respective
commercially reasonable efforts promptly to (i) take, or to
cause to be taken, all actions, and to do, or to cause to be
done, and to assist and cooperate with the other party in doing
all things necessary, proper or advisable under applicable Law
or otherwise to consummate and make effective the transactions
contemplated by this Agreement in the most expeditious manner
practicable; (ii) obtain from any Governmental Entities any
actions, non-actions, clearances, waivers, consents, approvals,
permits or orders required to be obtained by the Company or
Purchaser or any of their Subsidiaries in connection with the
authorization, execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated
hereby; (iii) make all registrations, filings,
notifications or submissions (Filings) (in
each case, promptly after the date of this Agreement) which are
necessary or advisable, and thereafter promptly make any other
required submissions and responses, with respect to the
transactions contemplated hereby, required under (A) the
HSR Act and any other applicable antitrust laws (except as
otherwise agreed by the parties, such Filings shall be made no
later than ten (10) Business Days after the date of this
Agreement) and (B) any other applicable Law;
(iv) furnish all information reasonably required for any
Filings to be made pursuant to any applicable Law in connection
with the transactions contemplated by this Agreement;
(v) act in good faith and reasonably cooperate with the
other party in connection with any Filings (including, to
provide copies of all such Filings to outside counsel for the
non-filing party and, if requested by the other party, to accept
all reasonable additions, deletions or changes suggested by the
other party); (vi) keep the other party informed in all
material respects of any material communication received by such
party from, or given by such party to, any Governmental Entity
and of any material communication received or given in
connection with any Proceeding by a private party, in each case,
relating to the transactions contemplated by this Agreement;
(vii) provide the other party with prior notice of any
communication with, and any proposed understanding, undertaking
or agreement with, any Governmental Entity regarding any such
Filings; (viii) consult and cooperate with each other party
in connection with any analyses, appearances, presentations,
memoranda, briefs, arguments, opinions and proposals made or
submitted by or on behalf of any party in connection with
proceedings relating to or arising out of such Filings;
(ix) obtain all necessary consents, approvals or waivers
under Contracts with third parties (provided that neither
the Company nor Purchaser shall be required to make any payments
to any such third parties or concede anything of value to obtain
such consents, approvals or waivers); (x) avoid the entry
of, or have vacated or terminated, any Judgment that would
restrain, prevent or delay the consummation of the transactions
contemplated hereby; and (xi) execute and deliver any
additional instruments necessary to consummate the transactions
contemplated hereby. Neither party to this Agreement shall
consent to any voluntary delay of the consummation of the
transactions contemplated hereby at the behest of any
Governmental Entity without the consent of the other party to
this Agreement.
(b) Except with respect to Section 6.17,
notwithstanding Sections 6.7(a), 6.7(c) and
6.7(d) or any other provision of this Agreement,
(i) nothing contained in this Agreement shall obligate or
require Purchaser or its Affiliates to agree or otherwise be
required to sell, divest, or otherwise dispose of, license, or
hold separate or otherwise materially restrict the use or
operation of all or any portion of Purchasers or the Intel
Companies businesses, operations, assets or product lines
(or any combination thereof) or (ii) in connection with
resolving any concerns of Governmental Entities in connection
with the actions addressed in Section 6.7(a) or
6.7(c), the Company shall not obligate itself, without
Purchasers prior written consent (which may be withheld in
Purchasers sole discretion) to sell, divest, or otherwise
dispose of, license, hold separate, or otherwise materially
restrict the use or operation of all or any portion of the
Transferred Companies businesses, operations, assets or
product lines (or any combination thereof).
B-34
(c) The Company and Purchaser agree that promptly after the
execution of this Agreement, they will submit a joint filing and
any requested supplemental information (collectively, the
Joint Filing) to CFIUS pursuant to
31 C.F.R. Part 800 with regard to the transactions
contemplated by this Agreement. The Company and Purchaser each
agree promptly to provide to the other all requisite information
in order for the parties to complete preparation and submission
of the Joint Filing in accordance with this
Section 6.7(c). Each of Purchaser and the Company
will keep the other party generally apprised of developments
with CFIUS and any interested U.S. Government agency with
regard to the Joint Filing. Requests for supplemental
information from any interested U.S. Government agency
pertaining to the Company or any of the Transferred Companies in
connection with the Joint Filing shall be coordinated in advance
between Purchaser and the Company, provided that the
Company shall promptly cooperate with Purchaser to ensure a
timely response to such request in compliance with applicable
regulations and, in any event, Company shall furnish to
Purchaser within one (1) Business Day from receipt of the
request all requested information pertaining to, accessible to,
or within the control of, the Company. Each of Purchaser and the
Company shall use its reasonable best efforts to secure
favorable action by CFIUS with respect to the Joint Filing.
(d) After the Closing Date, each of Purchaser and the
Company shall use its reasonable efforts from time to time to
execute and deliver at the reasonable request of the other party
such additional documents and instruments, and to take, or
refrain from taking, such other actions, as may be reasonably
required to give effect to this Agreement and the transactions
contemplated hereby.
(e) At the Companys request, from the date hereof
until the closing of the transactions contemplated by the Merger
Agreement, Purchaser shall negotiate in good faith with the
Company and SecureMetrics, Inc., a California corporation and an
Affiliate of the Company (SecureMetrics), in
connection with the novation of the Contract set forth in
Section 6.7(e) of the Company Disclosure Schedule
(Novation Contract) from SecureMetrics to
SpecTal, provided, however, that Purchasers
obligations under this Section 6.7(e) shall be
subject to (i) the Company and SecureMetrics providing
Purchaser with such information and documentation in their
possession (subject to Section 6.3) regarding the Novation
Contract as it may reasonably request in order to conduct a
customary due diligence investigation of the Novation Contract
and its performance, and (ii) the results of such due
diligence investigation by Purchaser being reasonably
satisfactory to Purchaser. Purchaser shall have a period of
30 days beginning at such time as such information in
respect of the Novation Contract has been provided to Purchaser
to determine whether it shall accept the novation of the
Novation Contract (it being understood that following such
30-day
period, the Company shall be permitted to novate to any Person
or take any other action in respect of the Novation Contract).
Section 6.8 No
Control of Other Partys
Business. Nothing contained in this Agreement
is intended to give Purchaser, directly or indirectly, the right
to control or direct the Companys or the Intel
Companies operations prior to the Closing. Prior to the
Closing, the Company shall exercise, consistent with the terms
and conditions of this Agreement, complete control and
supervision over its and the Intel Companies operations.
Section 6.9 Tax
Matters.
(a) Section 338(h)(10) Election; Tax Treatment
Matters.
(i) The Company and Purchaser shall jointly complete and
make elections under Section 338(h)(10) of the Code with respect
to the purchase and sale of the stock of SpecTal and ACI on
Form 8023 or in such other manner as may be required by
rule or regulation of the IRS, and shall jointly make comparable
elections in the manner required under any analogous provisions
of state or local Law concerning the transactions contemplated
by this Agreement (any such election under the Code or other
Law, a 338(h)(10) Election). Purchaser shall,
with the assistance and cooperation of the Company, prepare or
cause to be prepared all such forms required for making any
338(h)(10) Election, including any attachments to IRS
Form 8023 (and all forms under analogous provisions of
state or local Law), in accordance with all applicable Laws, and
Purchaser shall deliver such forms and related documents to the
Company at least ninety (90) days prior to the due date for
filing such forms. The Company shall return such forms to
Purchaser at least seventy-five (75) days prior to the
applicable due date.
(ii) The parties shall treat the purchase of the McClendon
Interests contemplated hereunder as a purchase by Purchaser of
all of the assets and liabilities of McClendon for federal,
state and local income Tax purposes
B-35
unless otherwise required by applicable Law. The Company and
Purchaser shall file, or cause to be filed, all Tax Returns in a
manner consistent with such treatment, and shall take no
position inconsistent with that characterization for federal,
state or local income Tax purposes, including in any audit or
judicial or administrative Proceeding.
(iii) Solely for purposes of the 338(h)(10) Election and
for U.S. federal income Tax purposes, this Agreement shall
constitute the plan of complete liquidation of ACI and SpecTal
for purposes of Section 332 of the Code.
(b) Preparation of Tax Returns and Payment of
Taxes.
(i) Within one hundred twenty (120) days after the
Closing, Purchaser shall provide to the Company a customary
income Tax package, including any items relating to the
Transferred Companies as the Company may reasonably request in
writing, for the preparation of any Tax Returns described in
clause (1) of this Section 6.9(b)(i). Following
the delivery of the Tax package referred to in the previous
sentence, upon written request from the Company, Purchaser shall
provide, no later than fifteen (15) Business Days following
such request, any additional information in connection with such
Tax package that is reasonably requested by the Company for the
preparation of any Tax Returns described in clause (1) of
this Section 6.9(b)(i).
(1) Other than Tax Returns in respect of Transfer Taxes,
which are addressed in Section 6.9(f) below, the
Company shall prepare or cause to be prepared and timely file or
cause to be filed, at its own cost and in a manner consistent
with past practice unless otherwise required by applicable Law,
(a) all income Tax Returns required to be filed by the
Company Affiliated Group or any Company State Group for all
taxable periods in which the Transferred Companies, or the
income or operations of the Transferred Companies, are required
to be included, (b) to the extent the income or operations
of SpecTal was not previously included in any Tax Return of the
Operating Company, Company Affiliated Group or any Company State
Group, all Separate Tax Returns of or with respect to SpecTal
for periods ending on or before the Closing, and (c) all
Separate Tax Returns of or with respect to the Transferred
Companies other than SpecTal for periods ending on or before the
Closing.
(2) To the extent the Company reasonably determines
necessary, the Company shall have the right, at its own cost, to
amend the federal and state income Tax Returns filed by the
Company Affiliated Group or any Company State Group for any year
in which SpecTal has been a member of the Company Affiliated
Group or any Company State Group to reflect SpecTal as a
corporation and as a member of the affiliated group for income
Tax purposes, and shall have the right, at its own cost, to file
any separate entity Tax Returns for such years for SpecTal that
should have been filed (such Tax Returns described in this
clause (2), whether or not the Company amends such Tax Returns,
SpecTal Tax Returns). To the extent the
Company chooses to exercise its right under this
Section 6.9(b)(i)(2) to amend or file any SpecTal
Tax Returns, such SpecTal Tax Returns will be filed in
accordance with applicable Law.
With respect to Tax Returns in this
Section 6.9(b)(i), the Company shall deliver to
Purchaser copies of the portions of such Tax Returns applicable
solely to the Transferred Companies or, to the extent this is
not reasonably practicable, a pro forma Tax Return relating
solely to the Transferred Companies, in either case no later
than forty (40) calendar days before filing of such Tax
Returns. Purchaser shall provide its comments in writing
(together with all supporting documents) at least twenty
(20) calendar days prior to the due date for the filing of
such Tax Returns, and the Company shall incorporate any
reasonable comments provided by Purchaser. In the event of a
dispute with respect to such Tax Returns the parties shall
resolve such dispute in accordance with Section
6.9(b)(iii). The Company shall be liable for and shall
timely pay or cause to be paid to the applicable Governmental
Entities all Taxes shown to be due on any Tax Returns required
to be filed or caused to be filed by the Company pursuant to
this Section 6.9(b)(i). The Company shall within ten
(10) Business Days after filing any such Tax Return provide
copies to Purchaser of the relevant portion of any such Tax
Return (to the extent applicable), in each case with proof of
full payment of all liabilities shown thereon and evidence of
timely filing thereof.
(ii) Purchaser shall prepare or cause to be prepared and
timely file or cause to be filed all Tax Returns for the
Transferred Companies or with respect to the Purchased Assets
required to be filed after the Closing Date,
B-36
other than Tax Returns described in Section 6.9(b)(i)
above. Purchaser shall be liable for and shall timely pay or
cause to be paid to the applicable Governmental Entity all Taxes
shown to be due on any such Tax Returns. For the avoidance of
doubt, Purchaser shall not be responsible for the preparation of
any Tax Returns of or regarding Patriot.
(iii) In the event of a dispute with respect to any Tax
Return, Purchaser and the Company shall negotiate in good faith,
for a period of no more than ten (10) days (or such shorter
period as is practicable under the circumstances in order to
permit timely filing of the applicable Tax Return), to resolve
such dispute. In the event that Purchaser and the Company are
unable to fully resolve such dispute within such period, they
shall refer their remaining differences to the Independent
Accounting Firm, and shall request that the Independent
Accounting Firm resolve any such differences at least two
(2) days prior to the due date for the filing (including
extensions) of the applicable Tax Return, in order that such Tax
Return may be timely filed. If the Independent Accounting Firm
does not reach a determination with respect to such dispute at
least two (2) days prior to the due date of such Tax
Return, such Tax Return shall be filed in the manner that the
party responsible for preparing such Tax Return deems correct,
and the party not responsible for filing such Tax Return shall
pay to the filing party its portion of the Taxes that are due on
such Tax Return in accordance with Section 6.9(c).
Following the Independent Accounting Firms determination,
if needed, such party shall file an amended Tax Return, and the
parties shall follow the Independent Accounting Firms
resolution in determining each partys liability in
accordance with Section 6.9(c). Following the
Independent Accounting Firm resolution, the parties shall make
any required payments to one another for any excess of amounts
previously paid prior to the due date of the original Tax Return.
(c) Allocation of Taxes and Indemnification.
(i) From and after the Closing Date, the Company shall be
responsible for, and shall indemnify and hold Purchaser and its
Affiliates harmless from and against, (1) notwithstanding
anything contained in this Section 6.9(c) to the
contrary, any cash Liability for Taxes (other than Transfer
Taxes) attributable to any 338(h)(10) Election, and any cash
Liability for Taxes arising from or attributable to any act,
failure to act or omission by the Company (or its Affiliates,
other than the Transferred Companies) that causes any such
election to become invalid or causes such election not to be
made, (2) all Transfer Taxes for which the Company is
liable pursuant to Section 6.9(f), (3) all
Taxes resulting or arising from the disposition of Patriot
described in Section 6.17, (4) all Taxes payable by
a Transferred Company pursuant to a Tax allocation, Tax sharing
or other similar agreement between the Company or one of its
Affiliates, on the one hand, and one of the Transferred
Companies, on the other hand, and (5) any Liability for the
Taxes of SpecTal resulting from the Companys decision not
to exercise its right to amend or file, as applicable, the
SpecTal Tax Returns as provided in
Section 6.9(b)(i)(2); provided, however, that the
Company shall not be required to indemnify Purchaser for any
such amount listed in clauses (1), (2), (3), (4) or
(5) of this Section 6.9(c)(i) if Purchaser is
required to indemnify Company for such amount pursuant to
Section 6.9(c)(ii) below.
(ii) From and after the Closing Date, Purchaser shall be
responsible for, and shall indemnify and hold the Company and
its Affiliates harmless from and against,
(1) notwithstanding anything contained in this
Section 6.9(c)(ii) to the contrary, any cash
Liability for Taxes that the Company is required to pay (other
than Transfer Taxes) for any taxable period arising from or
attributable to any act, failure to act or omission by Purchaser
(or any of its Affiliates) that causes any 338(h)(10) Election
to become invalid or causes such election not to be made and
(2) all Transfer Taxes for which Purchaser is liable
pursuant to Section 6.9(f); provided,
however, that notwithstanding anything to the contrary in
this Section 6.9(c), including the proviso in
Section 6.9(c)(i), Purchaser shall not be required
to indemnify the Company for any such amount listed in
clauses (1) or (2) of this
Section 6.9(c)(ii) if the Company is required to
indemnify Purchaser for such amount pursuant to
Section 6.9(c)(i) above.
(iii) For purposes of this Section 6.9(c) and
the Tax Benefit definition, a party shall be deemed to have a
cash Liability for Taxes if, but only if, such party is required
to pay additional cash Tax for a taxable period after taking
into account any available net operating losses and other Tax
attributes. Each party shall return to the other party from time
to time, as promptly as is reasonably practicable, any excess of
the amounts
B-37
previously paid by such other party under this
Section 6.9(c) over the amounts for which such other
party is properly responsible.
(iv) Notwithstanding anything contained in this Agreement
to the contrary, any indemnification payment pursuant to this
Section 6.9(c) shall be net of any Tax Benefit
available to the indemnified party resulting from such payment.
(v) A party shall be entitled to any refund or credit of
any Taxes of or with respect to the Transferred Companies or the
Purchased Assets (1) to the extent such refund or credit is
attributable to a taxable period for which such party is
required to file a Tax Return pursuant to
Section 6.9(b), or (2) for which such party
would be required to indemnify the other party or its Affiliates
pursuant to Section 6.9(c).
(d) Tax Claims; Amended Returns.
(i) The Company shall control and shall have the right to
discharge, settle or otherwise dispose of any notice of
deficiency, proposed adjustment, assessment, audit, examination,
suit, dispute or other claim (Tax Claims)
with respect to Taxes relating to any Tax Return required to be
filed by or with respect to the Company Affiliated Group or any
Company State Group; provided, however, that
(A) Purchaser shall have the right to fully participate in
any Tax Claim that could reasonably be expected to result in
Purchaser being liable to indemnify the Company and its
Affiliates under this Agreement, and (B) the Company shall
not discharge, settle or otherwise dispose of any such Tax Claim
listed in clause (A) of this Section 6.9(d)(i)
without the prior written consent of Purchaser, which shall not
to be unreasonably withheld, conditioned or delayed.
(ii) Purchaser shall control and shall have the right to
discharge, settle or otherwise dispose of all other Tax Claims
with respect to the Transferred Companies; provided,
however, that (A) the Company shall have the right
to fully participate in any Tax Claim that could reasonably be
expected to result in the Company being liable to indemnify
Purchaser under this Agreement, and (B) Purchaser shall not
discharge, settle or otherwise dispose of any such Tax Claim
listed in clause (A) of this Section 6.9(d)(ii)
without the prior written consent of the Company, which shall
not to be unreasonably withheld, conditioned or delayed.
(iii) Each party shall promptly notify the other party in
writing of the commencement of any Tax Claim of which such party
or any of its respective Affiliates has been informed in writing
by any Governmental Entity relating to Tax Returns of the
Transferred Companies for any Pre-Closing Tax Period or of any
such Tax Claim that could reasonably be expected to result in an
indemnification obligation under this Agreement. Such notice
shall describe the asserted Tax Claim in reasonable detail and
shall include copies of any notices and other documents received
from any Governmental Entity in respect,lt thereof;
provided, however, that the failure of the
notified party to give the other party notice as provided herein
shall not relieve such other party of its obligations under this
Section 6.9, except to the extent that such other
party is actually and materially prejudiced thereby.
(iv) Except as required by applicable Law, notwithstanding
Section 6.9(b), neither party shall have the right
to amend any Tax Return without the consent of the other party,
which shall not be unreasonably withheld, conditioned or
delayed, if such amendment would give rise to an indemnification
obligation on the part of the other party pursuant to
Section 6.9(c).
(e) Coordination; Survival. Any
claim for indemnification with respect to Taxes shall be
governed by this Section 6.9. For the avoidance of
doubt, if any claim for indemnification with respect to Taxes
could be governed by both Section 9.2 or
Section 9.3, on the one hand, and any clause of this
Section 6.9, on the other hand, the indemnity claim
and payment shall be governed by and treated as being made
solely pursuant to such clause of this Section 6.9.
Any such claim made pursuant to this Section 6.9
must be made within the period that is thirty (30) days
after the expiration (giving effect to any valid extensions,
waivers and tolling periods) of the applicable statutes of
limitations relating to the Taxes at issue.
(f) Transfer Taxes. Any fees,
duties, sales, use, transfer, documentary, recording,
registration, stamp or similar Taxes (all including penalties,
interest and other charges with respect thereto,
Transfer Taxes) arising as a result of the
transactions contemplated by this Agreement shall be borne
equally by the Company and Purchaser, and each of the Company
and Purchaser shall cooperate with respect to the preparation
and timely filing of any Tax
B-38
Returns with respect to Transfer Taxes, and shall cooperate in
good faith to minimize, to the fullest extent possible under
applicable Law, the amount of any such Transfer Taxes payable in
connection with the transactions contemplated by this Agreement.
(g) Cooperation and Retention of Records.
(i) The Company and Purchaser shall provide each other, and
shall cause their respective Affiliates and their respective
Representatives to provide each other, with such cooperation and
information relating to the Transferred Companies as any of them
reasonably may request in connection with any Tax matter
governed by this Agreement, including (i) the preparation
and filing of any Tax Return or form (including any pro forma
Tax Return), amended Tax Return or claim for refund;
(ii) the resolution of disputes and audits; (iii) the
contest or compromise of any Tax Claim; (iv) the
determination of any Liabilities for Taxes or right to a refund
of Taxes; (v) participation in or conduct of any Tax Claim;
(vi) furnishing each other with copies of all
correspondence received from any Governmental Entity in
connection with any audit or information request in respect of
Tax matters; and (vii) reasonable access to the Tax
Returns, Tax provisions, and Tax basis records of the
Transferred Companies, and all work papers used in, or that are
necessary to, the preparation of the Proposed Purchase Price
Allocation. Notwithstanding the foregoing, neither party nor any
of its Affiliates shall be entitled to any information
regarding, or a copy of, any consolidated, combined, affiliated
or unitary Tax Return which includes the Company or Purchaser
(provided, however, that to the extent such Tax
Return would be required to be delivered but for this sentence,
the party that would be required to deliver such Tax Return
shall instead deliver the portion of such Tax Return applicable
solely to the Transferred Companies or, to the extent this is
not reasonably practicable, a pro forma Tax Return relating
solely to the Transferred Companies). Each such party shall make
its employees available on a mutually convenient basis to
provide explanations of any documents or information provided
hereunder. Notwithstanding the obligations contained in this
Section 6.9(g), no party shall be required to
provide access or information or to disclose information where
such access or disclosure is reasonably expected to jeopardize
any attorney-client privilege of such party or its Affiliates or
contravene any applicable Law, fiduciary duty or material
Contract.
(ii) Each of the Company and Purchaser shall retain all
books and records in its possession with respect to Tax matters
pertinent to the parties hereto and the Transferred Companies
relating to any Pre-Closing Tax Period until the expiration of
the statute of limitations (and, to the extent notified by the
Company or Purchaser, as applicable, any extensions thereof) of
the respective taxable periods.
(h) Purchase Price
Adjustment. Unless otherwise required by Law,
any payment made pursuant to this Section 6.9 shall
be treated for all Tax purposes as an adjustment to the Purchase
Price.
Section 6.10 Guaranties
and Intercompany Agreements.
(a) Prior to Closing, Purchaser shall, or shall cause one
or more of its Affiliates to, use reasonable efforts to
(i) be substituted in all respects, effective as of the
Closing, for any Identity Company in respect of any obligations
of any Identity Company under any written guaranties, bonding
arrangements, keepwells, net worth maintenance agreements,
reimbursement obligations or letters of comfort obtained by or
binding any Identity Company for (and only to the extent for)
the benefit of any Transferred Company (the Intel
Guaranties) or (ii) cause such Intel Guaranties
to be terminated. Purchaser shall indemnify and hold harmless
the Identity Companies with respect to the obligations covered
by any such Intel Guaranties for which Purchaser does not effect
such substitution or termination. As a result, none of the
Identity Companies shall from and after the Closing have any
obligation whatsoever arising from or in connection with the
Intel Guaranties except for obligations, if any, for which the
Identity Companies will be fully indemnified by Purchaser.
(b) Prior to Closing, the Company shall, or shall cause one
or more of its Affiliates to, use reasonable efforts to
(i) be substituted in all respects, effective as of the
Closing, for any Transferred Company in respect of any
obligations of any Transferred Company under any written
guaranties, bonding arrangements, keepwells, net worth
maintenance agreements, reimbursement obligations or letters of
comfort obtained by or binding any Transferred Company for (and
only to the extent for) the benefit of any Identity Company (the
Identity Guaranties) or (ii) cause such
Identity Guaranties to be terminated. The Company shall
indemnify and hold harmless the Transferred Companies with
respect to the obligations covered by any such Identity
Guaranties for which the
B-39
Company does not effect such substitution or termination. As a
result, none of the Transferred Companies shall from and after
the Closing have any obligation whatsoever arising from or in
connection with the Identity Guaranties except for obligations,
if any, for which the Transferred Companies will be fully
indemnified by the Company.
(c) Prior to the Closing, (i) the Company shall, and
shall cause its Subsidiaries to, effective immediately prior to
the Closing, execute and deliver a master termination and
release agreement in substantially the form attached hereto as
Annex A, and take such other action as is necessary
to terminate, eliminate or release (by way of capital
contribution, cash settlement or as otherwise reasonably
determined by the Company, but in each case at no cost or
expense to any of the Transferred Companies) any and all
Affiliate Agreements, arrangements, commitments, receivables,
payables, claims, demands, rights, loans, Liabilities and
Contracts (including any Tax sharing, allocation or similar
agreements or arrangements) between any Intel Company, on the
one hand, and any of the Company or its Subsidiaries (other than
an Intel Company), on the other hand, and (ii) the Company
shall deliver to Purchaser a fully executed copy of such master
termination and release agreement.
(d) If, at any time after the date hereof, the Company or
Purchaser becomes aware of any material Intel Contract between
any Identity Company and any Third Party (excluding any Intel
Guaranties and the Novation Contract) (any such Contract, an
Intel Misallocated Contract), the Company or
Purchaser, as applicable shall notify the other party and the
Company shall provide Purchaser with a complete copy of the same
(subject to Section 6.3). The Company and Purchaser
shall engage in Good Faith Transfer Negotiations with respect to
such Intel Misallocated Contract.
(e) If, at any time after the date hereof, the Company or
Purchaser becomes aware of any material Identity Contract
between any Transferred Company and any Third Party (excluding
any Identity Guaranties) (any such Contract, an
Identity Misallocated Contract), the Company
or Purchaser, as applicable shall notify the other party and the
parties shall cooperate to provide for the applicable
Transferred Company to provide the Company and Purchaser with a
complete copy of the same (subject to Section 6.3).
The Company and Purchaser shall engage in Good Faith Transfer
Negotiations with respect to such Identity Misallocated Contract.
(f) For the avoidance of doubt, as of the date of this
Agreement, except as set forth in Section 4.17(b) of the
Company Disclosure Schedule, neither party is aware of any
Intel Guaranties, Intel Misallocated Contracts, Identity
Guaranties or Identity Misallocated Contracts currently in
effect, and Sections 6.10(a),(b),(d) and (e) have
been included in this Agreement as a precautionary measure. No
actions taken pursuant to Sections 6.10(a),(b),(d) and
(e) shall be deemed to cure any breach or inaccuracy in the
representations and warranties of the Company set forth in
Section 4.17(b).
(g) Solely with respect to Identity Contracts to which any
Identity Company is a party, and subject to
Sections 9.4, 9.5 and 9.6, the Company shall
indemnify and hold harmless the Transferred Companies with
respect to all Losses arising from any such Identity Contract,
except there shall be no indemnification to the extent that any
such Losses arise from any act or omission of a Transferred
Company or its directors, officers, employees or representatives
(in their capacity as such, but excluding all individuals who
have also served as officers or directors of the Company or
Operating Company).
(h) Solely with respect to Intel Contracts to which any
Intel Company is a party, and subject to Sections 9.4,
9.5 and 9.6, the Transferred Companies shall, jointly and
severally, indemnify and hold harmless the Identity Companies
(other than the Company or Operating Company) with respect to
all Losses arising from any such Intel Contract, except there
shall be no indemnification to the extent that (i) any such
Losses arise from any act or omission of an Identity Company or
its directors, officers, employees or representatives (in their
capacity as such) or (ii) any such Losses arise from any
Proceeding involving the Company or Operating Company or any
Losses suffered or incurred by the Company or Operating Company
in connection therewith.
Section 6.11 Insurance. Purchaser
acknowledges that all insurance coverage for the Intel Business
under policies of the Company and its Subsidiaries (other than
the Intel Companies) shall terminate as of the Closing and,
following the Closing, no claims may be brought against any such
policy (other than, if the events underlying such claim occurred
prior to the Closing and to the extent not covered by the
policies of the Intel Companies or their
B-40
Affiliates (after the Closing), under any occurrence based
policy of the Company and its Subsidiaries (other than the Intel
Companies) in respect of the Intel Business).
Section 6.12 Intel
Business Cash, Indebtedness and Working
Capital.
(a) Subject to Section 6.12(c), immediately
prior to the Closing, the Company shall cause any cash and cash
equivalents (as determined in accordance with GAAP) in the
Transferred Companies to be transferred by dividend or otherwise
to the Company or its Subsidiaries (other than the Intel
Companies).
(b) At or prior to the Closing, (1) the Company shall
cause to be terminated, paid in full or otherwise discharged all
Liabilities of the Transferred Companies in respect of
(i) Indebtedness for borrowed money (including all
Indebtedness under the Bank of America Credit Facility),
(ii) Indebtedness evidenced by notes, debentures or similar
instruments, (iii) letters of credit or similar facilities
and (iv) payments under interest rate or foreign currency
swap or similar arrangements, (2) the Company shall cause
all Liens against the Transferred Shares or any assets of the
Transferred Companies securing any Indebtedness (including all
Liens arising under the Bank of America Credit Facility) to be
terminated and released, and (3) the Company shall deliver
to Purchaser written evidence reasonably acceptable to Purchaser
confirming the performance and completion of the matters set
forth in clauses (1) (2) of this sentence.
(c) Except as expressly contemplated by this Agreement, the
Company shall, and shall cause its Subsidiaries to, during the
period beginning on the date hereof through the Closing Date,
manage the working capital of the Intel Business (other than the
business of Patriot), including the collection of receivables or
the payment of payables prior to the Closing, in the ordinary
course of business consistent with past practices. From the date
hereof until the earlier of the Closing and the date on which
this Agreement is terminated in accordance with its terms, no
later than twenty (20) days after the end of each calendar
month, the Company shall deliver to Purchaser (i) an
unaudited combined financial balance sheet for the Transferred
Companies as of the last day of such month, (ii) unaudited
combined statements of operations and cash flows for the
Transferred Companies for such month and (iii) a statement
setting forth a good faith estimate of Net Working Capital as of
the last day of the prior calendar month. In addition, the
Company shall prepare in good faith and deliver to Purchaser
three (3) Business Days prior to the anticipated Closing
Date, an estimated combined balance sheet of the Transferred
Companies as of the Closing Date (the Estimated Closing
Balance Sheet), together with a written statement
setting forth in reasonable detail the Companys good faith
estimate of Net Working Capital as of the Closing Date (the
Estimated Net Working Capital Amount) as
derived from the Estimated Closing Balance Sheet, in each case
determined without giving effect to the Closing but after giving
effect to the disposition of Patriot pursuant to
Section 6.17. The Estimated Closing Balance Sheet
shall be prepared in accordance with GAAP applied in a manner
consistent with the accounting practices, policies and
methodologies used in the preparation of the Audited Intel
Financial Statements. If the Estimated Net Working Capital
Amount is less than ninety percent (90%) of the Target Net
Working Capital, then, notwithstanding
Section 6.12(a), the parties will adjust the amount
of cash to be retained by the Intel Companies on the Closing
Date (and/or the Company will contribute cash to the Intel
Companies) such that the Estimated Net Working Capital Amount
together with such retained or contributed amount is equal to
the Target Net Working Capital. If the Estimated Net Working
Capital Amount is more than one hundred and ten percent (110%)
of the Target Net Working Capital, then, the Purchase Price
shall be increased by an amount equal to the amount by which the
Estimated Net Working Capital Amount exceeds the Target Net
Working Capital. Notwithstanding anything in this Agreement to
the contrary, all payment obligations arising under the Special
Employee Plan Term Sheet or the Special Employee Plan shall be
excluded for the purposes of determining Net Working Capital and
the Estimated Working Capital Amount.
Section 6.13 Identity
Marks. Purchaser hereby acknowledges and
agrees that Purchaser is not acquiring, nor are the Intel
Companies acquiring or retaining, any right, title or interest
in or to the Identity Marks; and following the Closing, neither
Purchaser nor any of the Intel Companies shall have any right,
title or interest in or to, and Purchaser, on behalf of itself
and the Intel Companies, covenants that they will not hereafter
adopt, use, or register, or authorize others to adopt, use or
register, any Trademarks (i) consisting of or incorporating
the Identity Marks or (ii) that are confusingly similar to
any of the Identity Marks; provided that, in accordance
with applicable Law, the Intel Companies may, in the ongoing
conduct of the Intel Business, transitionally utilize
stationery, forms, business cards and other similar items that
bear the Identity Marks as of the Closing Date for up to
forty-five
B-41
(45) calendar days following the Closing Date (the
Trademark Transition Period) in a manner
substantially consistent with past practice and the applicable
quality standards of the Identity Business, and such use shall
be solely on an as is basis and at the sole risk of
the Intel Companies. The Company hereby grants the Intel
Companies, effective as of the Closing, a royalty-free,
non-exclusive, nontransferable, non-sublicenseable license to
use the Identity Marks during the Trademark Transition Period
solely as set forth in this Section 6.13.
Section 6.14 Confidentiality.
(a) From and after the Closing, the Company shall, and
shall cause its Affiliates and Representatives to, keep all
information concerning the Intel Companies or the Intel Business
(Business Confidential Information) strictly
confidential and (except as required by applicable Law or legal
process in the reasonable opinion of the Companys or the
Companys applicable Representatives legal counsel,
as applicable, and only after compliance with
Section 6.14(c)) will not disclose any Business
Confidential Information to any Person. Notwithstanding anything
to the contrary set forth herein, the term Business
Confidential Information does not include any information
which (i) is generally known by the public (other than as a
result of its disclosure by the Company or the Companys
Representatives), (ii) was or becomes available to the
Company on a non-confidential basis from a Person (other than
Purchaser, its Affiliates or their respective Representatives),
to the Knowledge of the Company (after reasonable inquiry), not
prohibited from transmitting the information to the Company by
Law, contractual obligation, fiduciary duty or otherwise or
(iii) was or is developed or discovered by the Company
after the Closing without reference to Business Confidential
Information.
(b) From and after the Closing, Purchaser shall, and shall
cause its Affiliates and Representatives to, keep all non-public
information concerning the Company and its Subsidiaries (other
than the Intel Companies) and not directly related to the
operation of the Intel Business (Company Confidential
Information) strictly confidential and (except as
required by applicable Law or legal process in the reasonable
opinion of Purchasers or Purchasers applicable
Representatives legal counsel, as applicable, and only
after compliance with Section 6.14(c)) will not
disclose any Company Confidential Information to any Person.
Notwithstanding anything to the contrary set forth herein, the
term Company Confidential Information does
not include any information which (i) is generally known by
the public (other than as a result of its disclosure by
Purchaser or Purchasers Representatives), (ii) was or
becomes available to Purchaser on a non-confidential basis from
a Person (other than the Company, its Affiliates or their
respective Representatives), to the Knowledge of Purchaser
(after reasonable inquiry), not prohibited from transmitting the
information to Purchaser by Law, contractual obligation,
fiduciary duty or otherwise or (iii) was or is developed or
discovered by Purchaser after the Closing without reference to
Company Confidential Information.
(c) In the event that the Company or Purchaser or their
respective Representatives are requested or required to disclose
all or any part of the Business Confidential Information or
Company Confidential Information, as applicable, pursuant to any
Law or the terms of a valid and effective subpoena or order
issued by a court of competent jurisdiction or Governmental
Entity or pursuant to a civil investigative demand or similar
judicial process or otherwise, the applicable party will, to the
extent not prohibited by Law, and to the extent practicable
without prejudicing any the Companys, Purchasers or
any of their respective Representatives contractual or
legal obligations or any attorney client privilege (but
provided that the Company or Purchaser, as applicable,
and their respective Representatives shall use reasonable best
efforts to narrow or limit the impact of such obligations or
privilege), (i) promptly notify the other party in writing
of the existence, terms and circumstances surrounding such
request or requirement, (ii) consult with the other party
on the advisability of taking legally available steps to resist
or narrow such request or requirement, (at the other
partys sole expense to the extent such steps are taken at
the direction or with the consent of the other party),
(iii) if disclosure of any such information is required,
disclose only that portion of the information which, upon advice
of such partys legal counsel, it is legally required to
disclose and give the other party written notice of the
information to be so disclosed as far in advance of disclosure
as reasonably practicable and (iv) exercise its reasonable
best efforts to obtain a protective order or other reliable
assurance that confidential treatment will be accorded to such
information (and, in any event, if applicable, such party will
reasonably cooperate with the other party to obtain such a
protective order or other assurance). For the avoidance of
doubt, disclosures made to the extent permitted by and following
compliance with this Section 6.14 will not
constitute a breach of this Agreement.
B-42
Section 6.15 Intel
Acquisition Agreements. At the Closing, the
Company shall execute, and where applicable, shall cause
Operating Company to execute, assignment agreements in
substantially the form attached hereto as Annex B
with respect to the assignment to Purchaser of any and all
indemnification rights of the Company or any Subsidiary of the
Company under any of the Intel Acquisition Agreements in respect
of matters relating to the Intel Companies (such agreements, the
Assignment Agreements).
Section 6.16 OCI
Mitigation. Prior to the Closing, the Company
shall, and shall cause McClendon to, with respect to the OCI
Prime Contract, use commercially reasonable efforts either
(a) to negotiate and enter into an organizational conflict
of interest (OCI) mitigation plan with the
contracting officer for such Government Contract that is in
accordance with Clause(s) I.9 and I.10 of the OCI Prime Contract
and is in form and substance acceptable to Purchaser (which
acceptance shall not be unreasonably withheld, delayed or
conditioned); or (b) if it is not possible or practicable
to enter into such an OCI mitigation plan, to transfer all
related assets and novate the OCI Prime Contract to a third
party in accordance with FAR 42.1204 on terms and conditions
acceptable to Purchaser (which acceptance shall not be
unreasonably withheld, delayed or conditioned). In addition,
prior to the Closing, the Company shall, and shall cause
McClendon to, with respect to the OCI Subcontract, use
commercially reasonably efforts to (i) take such actions
and effect such arrangements as shall be necessary, after giving
effect to Purchasers acquisition and ownership of
McClendon and the McClendon Interests, to fully implement and
comply with the OCI Subcontract Mitigation Plan (such actions
and arrangements to include, as necessary, communicating and
coordinating with the prime contractor and contracting officer
for the OCI Subcontract and amending the OCI Subcontract
Mitigation Plan to address requirements of such prime contractor
and/or
contracting officer), in each case in a manner acceptable to
Purchaser (which acceptance shall not be unreasonably withheld,
delayed or conditioned); or (ii) if it is not possible or
practicable to fully implement and comply with the OCI
Subcontract Mitigation Plan as provided in clause (i) of
this sentence, negotiate and enter into an OCI mitigation plan
with the prime contractor
and/or
contracting officer for the OCI Subcontract that is in form and
substance acceptable to Purchaser (which acceptance shall not be
unreasonably withheld, delayed or conditioned). For the
avoidance of doubt, it shall be reasonable for Purchaser to
withhold its acceptance of any proposed OCI mitigation plan or
novation or any proposed arrangements and actions in relating to
the OCI Subcontract Mitigation Plan that would not avoid,
neutralize or mitigate all OCI issues for Purchaser and its
Affiliates arising from the applicable Contract referenced in
this Section 6.16.
Section 6.17 Divestiture
of Patriot. Prior to the Closing, the Company
shall cause ACI to (a) transfer, assign and convey all of
its right, title and interest in and to the Patriot Interests to
a Person not Affiliated with the Company; (b) except as set
forth in Section 6.17 of the Company Disclosure
Schedule, terminate all Contracts and business arrangements
between Patriot, on the one hand, and any of the Transferred
Companies, on the other; and (c) cause all Indebtedness and
other Liabilities owing between Patriot, on the one hand, and
any of the Transferred Companies, on the other hand, to be fully
satisfied and discharged or cancelled.
Section 6.18 Employee
Equity Awards. Prior to the Closing, the
Company shall take any and all actions necessary or desirable to
provide that options to purchase Company Common Stock, whether
or not vested as of immediately prior to the Closing,
and/or
restricted shares of Company Common Stock that are held by those
individuals who are employed by the Intel Companies immediately
prior to the Closing (the Continuing
Employees) and unvested as of immediately prior to the
Closing (such stock options and restricted stock awards, the
Intel Company Awards) shall, to the extent
such actions will not cause any additional Tax to be payable
pursuant to Section 409A of the Code with respect to such
Intel Company Awards, continue to remain outstanding as of and
after the Closing, and shall continue to vest in accordance with
their original terms as though such Continuing Employee remained
employed by the Company and its subsidiaries, until the earlier
to occur of (i) consummation of the transactions
contemplated by the Merger Agreement (the Merger
Date) and (ii) termination of the Merger
Agreement prior to consummation of the Merger Agreement (the
Merger Termination Date; and the first to
occur of such events, the Intel Vesting
Event), upon which Intel Vesting Event any then
outstanding Intel Company Awards shall become fully vested
and/or
exercisable, subject in the case of each Continuing Employee, to
the Continuing Employees continued employment with the
Intel Companies at such Intel Vesting Event; provided,
that in the event that following the Closing and prior to the
Intel Vesting Event, (x) such Continuing Employees
employment with the Intel Companies is terminated by the
Continuing Employees employer without Cause or by the
Continuing Employee for Good Reason (each term as defined in the
Special
B-43
Employee Plan Term Sheet), the Intel Company Awards held by such
Continuing Employee shall continue to remain outstanding and
eligible for vesting in accordance with this
Section 6.18 and (y) such Continuing
Employees employment with the Intel Companies is
terminated by the Continuing Employees employer for Cause
or by the Continuing Employee without Good Reason any unvested
Intel Company Awards held by such Continuing Employee shall be
cancelled and forfeited upon such termination of employment
without consideration therefor. Intel Company Awards that are
vested or become vested upon the Merger Date shall in accordance
with the Merger Agreement be cancelled and the holders thereof
shall be entitled to receive in respect thereof consideration
calculated in accordance with the Merger Agreement. Intel
Company Awards that are vested or become vested upon the Merger
Termination Date shall remain outstanding following the Merger
Termination Date in accordance with their terms. Notwithstanding
anything in this Agreement to the contrary, the foregoing
provisions of this Section 6.18 shall be of no force
and effect unless and until the Closing occurs. Prior to the
Closing, the Company shall provide to Purchaser such evidence as
Purchaser may reasonably request to evidence that the actions
provided for in this Section 6.18 have been taken.
Section 6.19 Cooperation. Purchaser
shall cooperate as reasonably requested by the Company in
connection the preparation and filing of the proxy statement
(and any amendments thereto) in connection with the transactions
contemplated by the Merger Agreement. The Company shall, and
shall cause the Operating Company and its Subsidiaries (other
than the Intel Companies), as applicable, to cooperate as
reasonably requested by Purchaser to assist Purchaser in the
transition and migration to Purchaser of the systems and
technology of the Transferred Companies in a smooth and
efficient manner.
Section 6.20 Intel
Companies Special Employee Plan. Prior to the
Closing, the Company shall cause SpecTal and McClendon to
(i) adopt and approve the Intel Companies Special Employee
Plan in accordance with the Special Employee Plan Term Sheet and
in a form acceptable to Purchaser (which acceptance shall not be
unreasonably withheld, delayed or conditioned), and
(ii) establish an escrow account (the Special Plan
Escrow Account) with Wells Fargo National Bank N.A.
(the Special Plan Escrow Agent) in accordance
with Section 7 of the Special Employee Plan Term Sheet and
pursuant to an escrow agreement in a form acceptable to
Purchaser (which acceptance shall not be unreasonably withheld,
delayed or conditioned). At the Closing, Purchaser shall cause
the Transferred Companies to pay by wire transfer of immediately
available funds an amount up to the Plan Funding Amount in
accordance with the terms of the Intel Companies Special
Employee Plan, representing the aggregate amount then required
to be deposited in the Special Plan Escrow Account or paid to
employees of the Transferred Companies under the Special
Employee Plan Term Sheet (less applicable withholdings for
Taxes); provided, however, that if, prior to
Closing the first installment of the Long Term Cash Awards (as
described in Exhibit A to the Special Employee Plan Term
Sheet) has become vested and paid in accordance with the terms
of such awards, then the amount of any such installment payment
shall be paid by Purchaser to the Transferred Companies at the
Closing (it being understood that such installment payment
amount will be cash of the Transferred Companies subject to
transfer to the Company pursuant to Section 6.12(a)).
Section 6.21 No
Limitations on Claims, Legal Rights.
(a) For the avoidance of doubt, nothing in this Agreement
or the master termination and release agreement contemplated by
Section 6.10(c) shall (i) exonerate or release
any Liabilities of any of the Transferred Companies that are
owing to any Third Party (excluding Liabilities arising under
the Bank of America Credit Facility or any other Indebtedness of
the Identity Companies and except as set forth in
Sections 6.9(b), 6.10(b) or 6.18), or
(ii) exonerate or release any Liabilities of any of the
Identity Companies that are owing to any Third Party (except as
set forth in Section 6.9(b) or
Section 6.10(a)).
(b) For the avoidance of doubt, following the Closing,
(i) each Transferred Company shall be free to implead
and/or seek
contribution from any Identity Company in the event any
Proceeding is asserted or commenced by a Third Party against
such Transferred Company if and to the extent such Transferred
Company believes that such Identity Company, in whole or in
part, is legally responsible or liable to such Third Party in
respect of the Liabilities addressed in such Proceeding;
(ii) each Identity Company shall be free to implead or seek
contribution from a Transferred Company in the event any
Proceeding is asserted or commenced by a Third Party against
such Identity Company if and to the extent such Identity Company
believes that such Transferred Company, in whole or in part, is
legally responsible or liable to such Third Party in respect of
the Liabilities addressed in such Proceeding; and
B-44
(iii) each of the Transferred Companies and Identity
Companies shall be free to defend against and refute any attempt
to implead or seek contribution from it in connection with a
Proceeding as described in clause (i) or (ii) of this
sentence.
ARTICLE VII
CONDITIONS
Section 7.1 Conditions
to the Obligations of Each Party. The
obligations of the Company and Purchaser to consummate the
transactions contemplated by this Agreement are subject to the
satisfaction (or waiver by the Company and Purchaser, if
permissible under applicable Law) of the following conditions:
(a) HSR Waiting Period. Any
waiting period (and extension thereof) applicable to the
consummation of the transactions contemplated by this Agreement
under the HSR Act shall have expired or been terminated.
(b) CFIUS. The parties shall have
received written notice from CFIUS that review under said
Section 721 of the transactions contemplated by this
Agreement has been concluded and that there are no unresolved
national security concerns with respect to such transactions.
(c) No Injunction. No Governmental
Entity having jurisdiction over the Company or Purchaser shall
have issued a Judgment and no Law shall have been enacted which
is then in effect which has the effect of enjoining, making
illegal or otherwise prohibiting the consummation of the
transactions contemplated by this Agreement unless such Judgment
or Law is vacated, terminated, withdrawn or repealed.
Section 7.2 Conditions
to Obligations of Purchaser. The obligations
of Purchaser to consummate the transactions contemplated by this
Agreement are subject to the satisfaction or waiver, prior to or
at the Closing, of each of the following conditions:
(a) The representations and warranties of the Company
contained in Sections 4.2(a), 4.2(b), 4.3(a), 4.10(c),
4.10(d), 4.17(b), 4.17(c) and 4.19 shall be true and correct
in all material respects (without giving effect to any
limitation as to materiality or Business Material Adverse
Effect) as of the date of this Agreement and as of the Closing
Date as though made as of the Closing Date.
(b) The representations and warranties of the Company
contained in Sections 4.10(b) and 4.16 shall be true
and correct, in all respects (without giving effect to any
limitation as to materiality or Business Material Adverse
Effect) as of the date of this Agreement and as of the Closing
Date as though made as of the Closing Date except where the
failure of such representations and warranties to be true and
correct have not resulted and would not reasonably be expected
to result, individually or in the aggregate, in Losses to the
Transferred Companies
and/or
Purchaser in excess of $15,000,000; provided,
however, that any such representations and warranties
that address matters only as of a particular date or only with
respect to a specific period of time, need only be so true and
correct as of such date or with respect to such period.
(c) The representations and warranties of the Company
contained in Article IV shall be true and correct in
all respects (without giving effect to any limitation as to
materiality or Business Material Adverse Effect) as of the date
of this Agreement and as of the Closing Date as though made as
of the Closing Date except where the failure of such
representations and warranties to be true and correct would not
have, individually or in the aggregate, a Business Material
Adverse Effect; provided, however, that any such
representations and warranties that address matters only as of a
particular date or only with respect to a specific period of
time, need only be so true and correct as of such date or with
respect to such period.
(d) The Company shall have performed in all material
respects all its material obligations and covenants under this
Agreement required to be performed by it on or prior to the
Closing Date.
(e) The Company shall have delivered, or caused to be
delivered, to Purchaser each of the deliverables specified in
Section 3.2.
(f) Purchaser shall have received at the Closing a
certificate dated the Closing Date, which certificate shall be
validly executed on behalf of the Company by an appropriate
executive officer of the Company,
B-45
certifying that, to the knowledge of such executive officer, the
conditions specified in Sections 7.2(a),
7.2(b) and 7.2(c) have been satisfied.
(g) Since the date of this Agreement, no change,
circumstance, or effect shall have occurred that has had a
Business Material Adverse Effect (excluding clause (B) of
the definition of Business Material Adverse Effect).
(h) An OCI mitigation plan shall have been entered into by
McClendon with respect to the OCI Prime Contract or a novation
of the OCI Prime Contract shall have been completed, and, in
either case, found acceptable by Purchaser (which acceptance
shall not be unreasonably withheld, delayed or conditioned), all
in accordance with Section 6.16.
(i) The OCI Subcontract Mitigation Plan shall have been
fully implemented and complied with in a manner acceptable to
Purchaser (which acceptance shall not be unreasonably withheld,
delayed or conditioned) or an OCI mitigation plan shall have
been entered into by McClendon with respect to the OCI
Subcontract and found acceptable by Purchaser (which acceptance
shall not be unreasonably withheld, delayed or conditioned), all
in accordance with Section 6.16.
Section 7.3 Conditions
to Obligations of the Company. The
obligations of the Company to consummate the transactions
contemplated by this Agreement are subject to the satisfaction
or waiver, prior to or at the Closing, of each of the following
conditions:
(a) The representations and warranties of Purchaser
contained in this Agreement shall be true, correct and complete,
in all respects (without giving effect to any limitation as to
materiality or Purchaser Material Adverse Effect) as of the date
of this Agreement and as of the Closing Date as though made as
of the Closing Date except where the failure of such
representations and warranties to be true and correct would not
have, individually or in the aggregate, a Purchaser Material
Adverse Effect; provided, however, that
representations and warranties that address matters only as of a
particular date or only with respect to a specific period of
time, need only be true, correct and complete in all or in all
material respects (as applicable) as of such date or with
respect to such period.
(b) Purchaser shall have performed in all material respects
all its material obligations and covenants under this Agreement
to be performed by it on or prior to the Closing Date.
(c) Purchaser shall have delivered, or caused to be
delivered, to the Company each of the deliverables specified in
Section 3.3.
(d) The Company shall have received at the Closing a
certificate dated the Closing Date, which certificate shall be
validly executed on behalf of Purchaser by an appropriate
executive officer of Purchaser, certifying that, to the
knowledge of such executive officer, the conditions specified in
Sections 7.3(a) and 7.3(b) have been
satisfied.
Section 7.4 Frustration
of Conditions. Neither party may rely on the
failure of any condition set forth in Sections 7.1,
7.2 or 7.3 to be satisfied if such failure was
caused by such partys failure to act in good faith or use
its best efforts to consummate the transactions contemplated by
this Agreement, as required by and subject to
Section 6.7.
ARTICLE VIII
TERMINATION
Section 8.1 Termination. Notwithstanding
anything in this Agreement to the contrary, this Agreement may
be terminated and the transactions contemplated by this
Agreement may be abandoned as follows:
(a) at any time, by the mutual written agreement of the
Company and Purchaser;
(b) by either Purchaser or the Company, if the transactions
contemplated by this Agreement have not been consummated on or
prior to the four (4) month anniversary of the date hereof
(the Intel Termination Date);
provided, however, that if (i), as of the Intel
Termination Date any of the conditions to the Closing set
B-46
forth in Section 7.1 have not been satisfied or
waived, but all other conditions to the Closing set forth in
Article VII have been satisfied or waived (other
than those conditions which by their nature can only be
satisfied at or immediately prior to the Closing, which
conditions would be satisfied if the Closing Date were the Intel
Termination Date), then either the Company or Purchaser may
extend the Intel Termination Date for up to two
(2) additional months by delivering written notice to the
other prior to the four (4) month anniversary of the date
hereof or (ii) as of the Intel Termination Date any of the
conditions to the Closing set forth in
Section 7.2(h) or Section 7.2(i) have
not been satisfied or waived, but all other conditions to the
Closing set forth in Article VII have been satisfied
or waived (other than (A) those conditions which by their
nature can only be satisfied at or immediately prior to the
Closing, which conditions would be satisfied if the Closing Date
were the Intel Termination Date and (B)
Section 7.1), then the Company may extend the Intel
Termination Date for up to two (2) additional months by
delivering written notice to Purchaser prior to the four
(4) month anniversary of the date hereof; provided,
further, that the right to terminate this Agreement under
this Section 8.1(b) shall not be available to any
party whose failure to fulfill any obligation under this
Agreement has been a principal cause of, or resulted in, the
failure of the Closing to be consummated on or prior to such
date;
(c) by Purchaser, if the Company shall have breached any of
its representations, warranties, covenants or agreements set
forth in this Agreement, which breach (i) would give rise
to the failure of a condition set forth in
Article VII and (ii) has not been waived by
Purchaser and has not been cured (or is incapable of being
cured) by the Company within forty-five (45) days following
receipt of a written notice of such breach from Purchaser;
provided, however, that the right to terminate
this Agreement under this Section 8.1(c) shall not
be available to Purchaser if it has materially breached any of
its material obligations under this Agreement;
(d) by the Company, if Purchaser shall have breached any of
its representations, warranties, covenants or agreements set
forth in this Agreement, which breach (i) would give rise
to the failure of a condition set forth in
Article VII and (ii) has not been waived by the
Company and has not been cured (or is incapable of being cured)
by Purchaser within forty-five (45) days following receipt
of a written notice of such breach from the Company;
provided, however, that the right to terminate
this Agreement under this Section 8.1(d) shall not
be available to the Company if it has materially breached any of
its material obligations under this Agreement; or
(e) by either Purchaser or the Company, if any Governmental
Entity having jurisdiction over the Company or Purchaser shall
have issued a Judgment or taken any other action, in each case
permanently enjoining or otherwise prohibiting the consummation
of the transactions contemplated by this Agreement, and such
Judgment or other action shall have become final and
non-appealable; provided, however, that the right
to terminate this Agreement under this
Section 8.1(e) shall not be available to any party
whose failure to fulfill any obligation under this Agreement has
been the primary cause of, or primarily resulted in, such
Judgment or action, and provided, further, that
the party seeking to terminate this Agreement under this
Section 8.1(e) shall have used commercially
reasonable efforts to cause any such Judgment or action to be
vacated or lifted or to ameliorate the effects thereof.
Section 8.2 Effect
of Termination. If this Agreement is
terminated pursuant to Section 8.1, this Agreement
shall become void and of no effect without liability of any
party (or such partys Affiliates or its or their
directors, officers, employees, Representatives or stockholders)
to the other party hereto other than, with respect to Purchaser
and the Company, the obligations pursuant to this
Section 8.2 and Article X;
provided, however, that no party shall be relieved
or released from any Liabilities (which the parties acknowledge
and agree shall not be limited to reimbursement of expenses or
out-of-pocket
costs) arising out of any breach of its obligations under this
Agreement or fraud.
ARTICLE IX
INDEMNIFICATION
Section 9.1 Nonsurvival
of Companys Representations and
Warranties. None of the representations and
warranties of the Company and Purchaser in this Agreement or in
any schedule, instrument or other document
B-47
delivered pursuant to this Agreement shall survive the Closing.
This Section 9.1 shall not limit any covenant or
agreement contained in this Agreement that by its terms is to be
performed in whole or in part after the Closing.
Section 9.2 Indemnification
of Purchaser. Subject to the terms of this
Article IX, from and after the Closing, the Company
shall indemnify, defend, save and hold harmless Purchaser and
its Affiliates (including the Intel Companies) and each of its
and their respective officers, directors, managers, employees,
agents and representatives (collectively, the Purchaser
Indemnified Parties) from, against and in respect of
Losses arising out of or resulting from:
(a) subject to Section 9.2(b), the breach of
any covenant or agreement of the Company contained in this
Agreement occurring after the Closing or the breach of any
covenant or agreement of the Company set forth in
Section 6.9(b) (solely with respect to the filing of
Tax Returns and the payment of the Taxes specified for payment
therein), 6.12(b), 6.17, or 6.20 occurring
prior to or at the Closing;
(b) the breach of any covenant or agreement contained in
Section 6.18 (provided, that notwithstanding
any other provision in this Agreement, no claims may be made
under this Section 9.2(b) at any time after the
Merger Date); or
(c) any Liability arising out of or relating to the options
or awards described in the first sentence of
Section 6.18.
Section 9.3 Indemnification
of the Company. Subject to the terms of this
Article IX, from and after the Closing, Purchaser
shall indemnify, defend, save and hold harmless the Company and
its Affiliates (other than the Intel Companies) and each of its
and their respective officers, directors, employees, agents and
representatives (collectively, the Company Indemnified
Parties and together with the Purchaser Indemnified
Parties, the Indemnified Parties, and the
party obligated to indemnify, defend, save and hold harmless any
such Indemnified Party pursuant to this Agreement, the
Indemnifying Party) from, against and in
respect of Losses arising out of or resulting from the breach of
any covenant or agreement of Purchaser contained in this
Agreement occurring after the Closing or the breach of any
covenant or agreement of Purchaser set forth in
Section 6.9(b) (solely with respect to the filing of
Tax Returns and the payment of the Taxes specified for payment
therein) or Section 6.20.
Section 9.4 Claims.
(a) With respect to any claims for Losses made by third
parties against an Indemnified Party (Third-Party
Claim) which the Indemnified Party has determined has
given or could give rise to a right of indemnification under
this Article IX, the following terms and conditions
shall apply:
(i) The Indemnified Party shall give the Indemnifying Party
prompt written notice of any such Third-Party Claim;
provided, however, that (A) failure to give
such notification shall not affect the indemnification provided
hereunder except to the extent the Indemnifying Party
demonstrates that it has been materially prejudiced as a result
of such failure; and (B) the Indemnifying Party shall have
the right, after it acknowledges in writing to the Indemnified
Party its obligation to indemnify the Indemnified Party
hereunder, to undertake the defense thereof by counsel
reasonably satisfactory to the Indemnified Party at the
Indemnifying Partys sole expense; provided, that if
the Indemnifying Party assumes such defense, the Indemnified
Party shall have the right to participate in the defense thereof
and to employ counsel, at its own expense, separate from the
counsel employed by the Indemnifying Party, it being understood
that the Indemnifying Party shall control such defense;
(ii) Within thirty (30) Business Days following the
receipt of notice of a Third-Party Claim, if the Indemnifying
Party has not assumed the defense of such Third-Party Claim or
has declined to assume the defense of such Third-Party Claim in
writing, the Indemnified Party shall (upon further written
notice to the Indemnifying Party) have the right to undertake
the defense, compromise or settlement of such Third-Party Claim
on behalf of and for the account and risk of the Indemnifying
Party subject to the right of the Indemnifying Party to assume
the defense of such Third-Party Claim at any time prior to
settlement, compromise or final determination thereof; and
(iii) Notwithstanding any provision in this
Article IX to the contrary, without the prior
written consent of the Indemnified Party (which consent shall
not be unreasonably withheld, conditioned or delayed), the
B-48
Indemnifying Party shall not admit any liability with respect
to, or settle, compromise or discharge, any Third-Party Claim or
consent to the entry of any judgment with respect thereto,
except in the case of any settlement that (A) includes as
an unconditional term thereof the delivery by the claimant or
plaintiff to the Indemnified Party of a written unconditional
release from all Liability in respect of such Third-Party Claim
and (B) provides solely for monetary relief as to which the
Indemnified Party shall be indemnified in full (subject to the
limitations set forth in Section 9.5) and does not
otherwise involve or purport to bind or limit the Indemnified
Party. In addition, if the Indemnifying Party shall have assumed
the defense of the Third-Party Claim, the Indemnified Party
shall not admit any liability with respect to, or settle,
compromise or discharge, any Third-Party Claim or consent to the
entry of any judgment with respect thereto, without the prior
written consent of the Indemnifying Party (which consent shall
not be unreasonably withheld, conditioned or delayed), and the
Indemnifying Party will not be subject to any liability for any
such admission, settlement, compromise, discharge or consent to
Judgment made by an Indemnified Party without such prior written
consent of the Indemnifying Party.
(b) In the event any Indemnified Party should have a claim
against any Indemnifying Party under Section 9.2 or
Section 9.3 that does not involve a Third-Party
Claim being asserted against or sought to be collected from such
Indemnified Party, the Indemnified Party shall, as promptly as
practicable after discovery of such claim, deliver written
notice of such claim to the Indemnifying Party. The failure by
any Indemnified Party to so notify the Indemnifying Party shall
not relieve the Indemnifying Party from any Liability which it
may have to such Indemnified Party under Section 9.2
or Section 9.3, except to the extent that the
Indemnifying Party demonstrates that it has been materially
prejudiced by such failure.
Section 9.5 Certain
Limitations and Other Indemnification
Provisions.
(a) Each of Purchaser and the Company acknowledges and
agrees that, if the Closing occurs, their sole and exclusive
monetary remedy (other than for fraud or knowing and intentional
breach of this Agreement) following the Closing with respect to
any and all claims (whether Third-Party Claims or otherwise)
relating to the subject matter of this Agreement shall be
pursuant to the provisions set forth in this
Article IX, Section 6.9 and
Section 6.10; provided, however, that
nothing contained herein shall prevent any party from pursuing
non-monetary remedies as may be available to such party under
applicable Law in the event of a partys failure to comply
with its obligations hereunder.
(b) Any indemnification payments under this Agreement for
indemnifiable Losses shall be paid net of (i) any insurance
proceeds actually recovered by the Indemnified Party or its
Affiliates with respect to such Losses and (ii) any
indemnity, contribution or other similar payment received by the
Indemnified Party or its Affiliates from any third-party with
respect to such Losses, minus the amount of reasonable
out-of-pocket
expenses actually incurred and necessary to recover such
third-party payment. In the event that an applicable insurance
or other recovery is received by any Indemnified Party or its
Affiliates with respect to any indemnification payment for which
any such Person has been indemnified under this Agreement, then
a refund equal to the aggregate amount of such applicable
recovery with respect to such indemnification payment shall be
made promptly to the Indemnifying Party.
Section 9.6 Characterization of
Indemnification Payments; Exclusivity of Tax
Provisions. Unless otherwise required by Law,
any payment made pursuant to this Article IX shall
be treated for all Tax purposes as an adjustment to the Purchase
Price. Notwithstanding anything herein to the contrary, all
matters relating to indemnification in respect of Taxes shall be
governed by Section 6.9 (except with respect to
Sections 9.2(a) and 9.3). With respect to Tax
matters, any conflict between the terms of
Section 6.9 and any other provision of this
Agreement shall be resolved in favor of Section 6.9,
unless such other provision expressly provides that it shall be
given priority over such provisions.
ARTICLE X
MISCELLANEOUS
Section 10.1 Amendment
and Modification. At any time prior to the
Closing, the parties hereto may modify or amend this Agreement,
by written agreement executed and delivered by duly authorized
officers of the respective parties.
B-49
Section 10.2 Notices. All
notices, consents and other communications hereunder shall be in
writing and shall be given (and shall be deemed to have been
duly given upon receipt) by hand delivery, by prepaid overnight
courier (providing written proof of delivery) or by confirmed
facsimile transmission, addressed as follows:
(a) if to Purchaser:
BAE Systems Information Solutions Inc.
c/o BAE
Systems, Inc.
1101 Wilson Boulevard
Suite 2000
Arlington, VA 22209
Facsimile:
(703) 312-7584
|
|
|
|
Attention:
|
Jennifer H. Adams, Vice President
|
and Associate General Counsel
with a copy to:
Crowell & Moring LLP
1001 Pennsylvania Avenue, NW
Washington, DC
20004-2595
Attention: James R. Stuart, III
Facsimile:
(202) 628-5116
if to the Company:
L-1 Identity Solutions, Inc.
177 Broad Street, 12th Floor
Stamford, Connecticut 06901
Facsimile:
(203) 504-1140
Attention: General Counsel
with a copy to:
Skadden, Arps, Slate, Meagher & Flom LLP
Four Times Square
New York, New York 10036
Facsimile:
(212) 735-2000
Attention: Peter Allan Atkins and Eric L. Cochran
or to such other address or facsimile number for a party as
shall be specified in a notice given in accordance with this
section; provided that any notice received by facsimile
transmission or otherwise at the addressees location on
any Business Day after 5:00 P.M. (addressees local
time) or on any day that is not a Business Day shall be deemed
to have been received at 9:00 A.M. (addressees local
time) on the next Business Day; provided, further,
that notice of any change to the address or any of the other
details specified in or pursuant to this section shall not be
deemed to have been received until, and shall be deemed to have
been received upon, the later of the date specified in such
notice or the date that is five (5) Business Days after
such notice would otherwise be deemed to have been received
pursuant to this section. A partys rejection or other
refusal to accept notice hereunder or the inability of another
party to deliver notice to such party because of such
partys changed address or facsimile number of which no
notice was given by such party shall be deemed to be receipt of
the notice by such party as of the date of such rejection,
refusal or inability to deliver.
Section 10.3 Interpretation. The
parties have participated jointly in the negotiation and
drafting of this Agreement. In the event an ambiguity or
question of intent or interpretation arises, this Agreement
shall be construed as if drafted jointly by the parties, and no
presumption or burden of proof shall arise favoring or
disfavoring any party by virtue of the authorship of any
provisions of this Agreement. Disclosure of any fact,
circumstance or information in any Section of the Company
Disclosure Schedule or Purchaser Disclosure Schedule shall be
deemed to be disclosure of such fact, circumstance or
information with respect to any other Sections of the Company
Disclosure Schedule or Purchaser Disclosure Schedule,
respectively, if it is reasonably apparent that such disclosure
relates to one or more or all of such Sections. The inclusion of
any item in the Company Disclosure
B-50
Schedule or Purchaser Disclosure Schedule shall not be deemed to
be an admission or evidence of materiality of such item, nor
shall it establish any standard of materiality for any purpose
whatsoever.
Section 10.4 Counterparts. This
Agreement may be executed in multiple counterparts, all of which
shall together be considered one and the same agreement, and
shall become effective when all such counterparts have been
signed by each party and delivered to the other party. Delivery
of an executed signature page to this Agreement by electronic
transmission shall be as effective as delivery of a manually
signed counterpart of this Agreement.
Section 10.5 Entire
Agreement; Third-Party Beneficiaries. This
Agreement (including the Company Disclosure Schedule, the
Purchaser Disclosure Schedule and the exhibits hereto, together
with the other instruments referred to herein) and the
Confidentiality Agreement (a) constitute the entire
agreement and supersede all prior agreements and understandings,
both written and oral, between the parties with respect to the
subject matter hereof and (b) are not intended to confer
upon any Person other than the parties hereto and their
permitted successor and assigns, and nothing herein expressed or
implied shall give or be construed to give to any Person, other
than the parties hereto and such successors and assigns, any
legal or equitable rights, remedies or claims hereunder;
provided, however, that it is specifically
intended that the D&O Indemnified Parties (with respect to
Section 6.6 from and after the Closing) and the
Indemnified Parties (with respect to Article IX from
and after the Closing) are third-party beneficiaries.
Section 10.6 Severability. If
any term, provision, covenant or restriction of this Agreement
is held by a court of competent jurisdiction or other authority
to be invalid, void, unenforceable or against its regulatory
policy, the remainder of the terms, provisions, covenants and
restrictions of this Agreement shall remain in full force and
effect and shall in no way be affected, impaired or invalidated.
Upon such a holding by a court of competent jurisdiction, the
Company and Purchaser shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the
parties as closely as possible in a mutually acceptable manner
in order that the transactions contemplated by this Agreement be
carried out and construed as originally contemplated by the
parties to the greatest extent possible.
Section 10.7 Governing
Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware,
without giving effect to any choice or conflict of laws
provision or rule (whether of the State of Delaware or any other
jurisdiction) that would cause the application of the Laws of
any jurisdiction other than the State of Delaware.
Section 10.8 Jurisdiction. Each
of the parties hereto hereby (a) expressly and irrevocably
submits to the exclusive personal jurisdiction of the Delaware
Court of Chancery, any other court of the State of Delaware or
any Federal court sitting in the State of Delaware in the event
any dispute arises out of this Agreement or any of the
transactions contemplated by this Agreement, (b) agrees
that it will not attempt to deny or defeat such personal
jurisdiction by motion or other request for leave from any such
court, (c) agrees that it will not bring any Proceeding
relating to this Agreement or any of the transactions
contemplated by this Agreement in any court other than the
Delaware Court of Chancery, any other court of the State of
Delaware or any Federal court sitting in the State of Delaware
and (d) agrees that the other party shall have the right to
bring any Proceeding for enforcement of a judgment entered by
the Delaware Court of Chancery, any other court of the State of
Delaware or any Federal court sitting in the State of Delaware.
Each of Purchaser and the Company agrees that a final judgment
in any Proceeding shall be conclusive and may be enforced in
other jurisdictions by suit on the judgment or in any other
manner provided by Law.
Section 10.9 Service
of Process. Each party irrevocably consents
to the service of process outside the territorial jurisdiction
of the courts referred to in Section 10.8 in any
such action or proceeding by mailing copies thereof by
registered or certified United States mail, postage prepaid,
return receipt requested, to its address as specified in or
pursuant to Section 10.2. However, the foregoing
shall not limit the right of a party to effect service of
process on the other party by any other legally available method.
Section 10.10 Waiver
of Jury Trial. EACH OF PURCHASER AND THE
COMPANY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN
ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON
CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS
OF
B-51
PURCHASER OR THE COMPANY IN THE NEGOTIATION, ADMINISTRATION,
PERFORMANCE AND ENFORCEMENT OF THIS AGREEMENT.
Section 10.11 Specific
Performance. Notwithstanding anything in this
Agreement, the parties agree that immediate, extensive and
irreparable damage would occur for which monetary damages would
not be an adequate remedy in the event that any of the
provisions of this Agreement are not performed in accordance
with their specific terms or are otherwise breached.
Accordingly, the parties agree that, if for any reason Purchaser
or the Company shall have failed to perform its obligations
under this Agreement, then the party seeking to enforce this
Agreement against such nonperforming party under this Agreement
shall be entitled to specific performance and the issuance of
immediate injunctive and other equitable relief without the
necessity of proving the inadequacy of money damages as a
remedy, and the parties further agree to waive any requirement
for the securing or posting of any bond in connection with the
obtaining of any such injunctive or other equitable relief, this
being in addition to and not in limitation of any other remedy
to which they are entitled at Law or in equity. Without limiting
the foregoing, each of the parties hereby acknowledges and
agrees that it may be difficult to prove damages with reasonable
certainty, that it may be difficult to procure suitable
substitute performance, and that injunctive relief
and/or
specific performance will not cause an undue hardship to the
parties. Each of the parties hereby further acknowledges and
agrees that the existence of any other remedy contemplated by
this Agreement shall not diminish the availability of specific
performance of the obligations hereunder or any other injunctive
relief and agrees that in the event of any action by the other
party for specific performance or injunctive relief, it will not
assert that a remedy at Law or other remedy would be adequate or
that specific performance or injunctive relief in respect of
such breach or violation should not be available on the grounds
that money damages are adequate or any other grounds. Any such
remedies, and any and all other remedies provided for in this
Agreement, shall be cumulative in nature and not exclusive and
shall be in addition to any other remedies whatsoever which any
party may otherwise have.
Section 10.12 Assignment. Neither
this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned by either party hereto (whether by
operation of law or in connection with a merger or sale of
substantially all the assets, stock or membership interests of
such party) without the prior written consent of the other
party. Subject to the preceding sentence, this Agreement will
apply to, be binding in all respects upon and inure to the
benefit of and be enforceable by the parties and their
respective permitted successors and assigns.
Section 10.13 Expenses. All
costs and expenses incurred in connection with the preparation,
negotiation, execution and performance of this Agreement and the
consummation of the transactions contemplated hereby shall be
paid by the party incurring such costs and expenses, whether or
not the transactions contemplated hereby are consummated,
provided that Purchaser shall pay all costs and expenses
in connection with the filings of the notification and report
forms under the HSR Act in connection with the transactions
contemplated by this Agreement and the notice to CFIUS of the
transactions contemplated by this Agreement pursuant to
Exon-Florio.
Section 10.14 Waivers. Except
as otherwise provided in this Agreement, any failure of either
party to comply with any obligation, covenant, agreement or
condition herein may be waived by the party entitled to the
benefits thereof only by a written instrument signed by the
party expressly granting such waiver, but such waiver or failure
to insist upon strict compliance with such obligation, covenant,
agreement or condition shall not operate as a waiver of, or
estoppel with respect to, any subsequent or other failure.
[Signature page follows.]
B-52
IN WITNESS WHEREOF, the Company and Purchaser have caused this
Agreement to be signed by their respective officers thereunto
duly authorized as of the date first written above.
L-1 IDENTITY SOLUTIONS, INC.
|
|
|
|
By:
|
/s/ Robert
V. LaPenta
|
Name: Robert V. LaPenta
|
|
|
|
Title:
|
Chairman of the Board, President
|
and Chief Executive Officer
BAE SYSTEMS INFORMATION SOLUTIONS INC.
|
|
|
|
By:
|
/s/ Jennifer
H. Adams
|
Name: Jennifer H. Adams
|
|
|
|
Title:
|
Vice President and Associate
|
General Counsel
B-53
ANNEX A
FORM OF
MASTER TERMINATION AND RELEASE AGREEMENT
THIS MASTER TERMINATION AND RELEASE AGREEMENT (this
Agreement), dated as of [ ],
2010, is by and among L-1 Identity Solutions, Inc., a Delaware
Corporation (the Company), and L-1 Identity
Solutions Operating Company, Inc., a Delaware Corporation
(Operating Company), for and on behalf of
themselves and the Ident Companies (as defined below), on the
one hand, and Advanced Concepts, Inc. (ACI),
a Maryland corporation, McClendon, LLC
(McClendon), a Virginia limited liability
company, and SpecTal, LLC (SpecTal), a
Virginia limited liability company (collectively, the
Intel Companies), on the other hand.
WHEREAS, there may exist certain Affiliate Agreements,
arrangements, commitments, receivables, payables, claims,
demands, rights, loans, Liabilities and Contracts (collectively,
Intercompany Arrangements) between any
one or more of the Intel Companies, on the one hand, and any of
the Company, Operating Company
and/or any
of their Subsidiaries (other than the Intel Companies), on the
other hand (collectively, the Ident
Companies);
WHEREAS, on September 19, 2010, the Company and BAE Systems
Information Solutions Inc. (Purchaser)
entered into a Purchase Agreement (as may be amended from time
to time, the Purchase Agreement), pursuant to
which Purchaser agreed to acquire from Operating Company and the
Company agreed to cause to be sold to Purchaser, all of the
issued and outstanding shares of capital stock or membership
interests (as applicable) of the Intel Companies; and
WHEREAS, pursuant to Section 6.10(c) of the Purchase
Agreement, the Company agreed to cause to be executed this
Agreement effective as of the Closing.
NOW, THEREFORE, in consideration of the mutual covenants and
promises contained herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto hereby agree as follows:
Section 1. Definitions. Capitalized
terms used but not defined herein shall have the meaning
ascribed to such terms in the Purchase Agreement.
Section 2. Termination. Effective
as of the Closing, all Intercompany Arrangements, including any
provisions that would otherwise survive the termination thereof
pursuant to the terms thereof, shall be terminated and
extinguished and be of no force or effect.
Section 3. Mutual
Release. Effective as of the Closing, the
Company and the Operating Company, for and on their own behalf
and for and on behalf of each Ident Company, hereby fully,
finally and irrevocably waive, release and discharge each Intel
Company from and against any and all claims, causes of action,
Losses, Liabilities or other rights that have arisen or may
arise under the Intercompany Arrangements. Effective as of the
Closing, the Intel Companies hereby fully, finally and
irrevocably waive, release and discharge the Company, Operating
Company and the Ident Companies from and against any and all
claims, causes of action, Losses, Liabilities or other rights
that have arisen or may arise under the Intercompany
Arrangements. For the avoidance of any doubt, the Purchase
Agreement is not an Intercompany Arrangement, and this Agreement
is not intended to waive, release or discharge any rights or
obligations of the Company or Purchaser under the Purchase
Agreement.
Section 4. Representations.
(a) Each of the Company and Operating Company hereby
represents and warrants that it has all requisite corporate (or
similar) power and authority to enter into this Agreement on its
own behalf and on behalf of each of the Ident Companies. The
execution, delivery and performance by each party of this
Agreement has been duly authorized by all necessary corporate
(or similar) action on the part of each of the Company and
Operating Company on its own behalf and on behalf of each of the
Ident Companies. This Agreement has been duly and validly
executed and delivered by the Company and Operating Company and
constitutes the valid and binding obligation of each of the
Company and Operating Company on its own behalf and on behalf of
each of the Ident Companies, enforceable against each such
Person in accordance with its terms.
B-54
(b) Each of the Intel Companies hereby represents and
warrants that it has all requisite corporate (or similar) power
and authority to enter into this Agreement. The execution,
delivery and performance by each of the Intel Companies of this
Agreement have been duly authorized by all necessary corporate
(or similar) action on the part of such Intel Company. This
Agreement has been duly and validly executed and delivered by
each Intel Company and constitutes the valid and binding
obligation of such Intel Company, enforceable against it in
accordance with its terms.
Section 5. Governing
Law; Jurisdiction. This Agreement shall be
governed by and construed in accordance with the laws of the
State of Delaware, without giving effect to any choice or
conflict of laws provision or rule (whether of the State of
Delaware or any other jurisdiction) that would cause the
application of the Laws of any jurisdiction other than the State
of Delaware.
Section 6. Successors
and Assigns. Neither this Agreement nor any
of the rights, interests or obligations hereunder shall be
assigned by any party hereto (whether by operation of law or in
connection with a merger or sale of substantially all the
assets, stock or membership interests of such party) without the
prior written consent of each of the other parties. Subject to
the preceding sentence, this Agreement will apply to, be binding
in all respects upon and inure to the benefit of and be
enforceable by the parties and their respective permitted
successors and assigns.
Section 7. Entire
Agreement; Amendments. This Agreement
constitutes the entire agreement and supersede all prior
agreements and understandings, both written and oral, between
the parties with respect to the subject matter hereof. This
Agreement may be amended and any term hereof may be amended or
waived, only if such amendment or waiver is in writing and is
signed, in the case of an amendment, by each party to this
Agreement, or in the case of a waiver, by the party against whom
the waiver is to be effective.
Section 8. Counterparts. This
Agreement may be executed in multiple counterparts, all of which
shall together be considered one and the same agreement, and
shall become effective when all such counterparts have been
signed by each party and delivered to the other party. Delivery
of an executed signature page to this Agreement by electronic
transmission shall be as effective as delivery of a manually
signed counterpart of this Agreement.
Section 9. Severability. If
any term, provision, covenant or restriction of this Agreement
is held by a court of competent jurisdiction or other authority
to be invalid, void, unenforceable or against its regulatory
policy, the remainder of the terms, provisions, covenants and
restrictions of this Agreement shall remain in full force and
effect and shall in no way be affected, impaired or invalidated.
Upon such a holding by a court of competent jurisdiction, the
parties hereto shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the parties as
closely as possible in a mutually acceptable manner in order
that the transactions contemplated by this Agreement be carried
out and construed as originally contemplated by the parties to
the greatest extent possible.
Section 10. Titles
and Subtitles. The titles of the paragraphs
of this Agreement are for convenience of reference only and are
not to be considered in construing this Agreement.
Section 11. Waiver
of Notice. Each of the parties hereto hereby
waives any notice required to be provided in connection with the
amendment or termination of any of the Intercompany Agreements.
Section 12. Cooperation. After
the Closing Date, each of the parties hereto shall use its
commercially reasonable efforts from time to time to execute and
deliver at the reasonable request of the other parties such
additional documents and instruments as may be reasonably
required to give effect to this Agreement and the transactions
contemplated by this Agreement.
[signature page follows]
B-55
IN WITNESS WHEREOF, the parties hereto have executed this
Agreement as of the date first above written.
L-1 IDENTITY SOLUTIONS, INC.
Name:
Title:
L-1 IDENTITY SOLUTIONS
OPERATING COMPANY, INC.
Name:
Title:
ADVANCED CONCEPTS, INC.
Name:
Title:
MCCLENDON, LLC
Name:
Title:
SPECTAL, LLC
Name:
Title:
B-56
ANNEX B
Forms of
Assignment Agreements
[Letterhead]
[Date]
BAE Systems Information Solutions Inc.
[Address]
Attention: [Name]
Re: Assignment of Certain Indemnification Rights
Ladies and Gentlemen:
Reference is made to the Purchase Agreement (as amended,
restated, supplemented or otherwise modified from time to time,
the Purchase Agreement), dated September 19,
2010, by and between BAE Systems Information Solutions Inc.
(Purchaser) and L-1 Identity Solutions, Inc. (the
Company). Capitalized terms used but not otherwise
defined herein shall have the meanings ascribed to such terms in
the Purchase Agreement.
In connection with the Closing, and in accordance with
Section 6.15 of the Purchase Agreement, for good and
valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, L-1 Identity Solutions Operating Company
(Operating Company), a wholly owned subsidiary of
the Company, hereby assigns and transfers to Purchaser, any and
all indemnification rights of Operating Company under that
certain Stock Purchase Agreement, dated May 1, 2007, by and
among Advanced Concepts, Inc., the Selling Stockholders
signatory thereto, Operating Company and the Sellers
Representative.
Operating Company shall, and shall cause the Subsidiaries of
Operating Company to, without further consideration, perform
such lawful acts, execute such other lawful documents, and
provide to Purchaser, its successors, assigns and other legal
representatives all other cooperation and assistance as
Purchaser may reasonably request to effectuate fully this letter
agreement.
Each party hereto represents and warrants that (i) it has
the requisite corporate power and authority to execute and
deliver this letter agreement, (ii) the execution, delivery
and performance by such party of this letter agreement has been
duly authorized by all necessary corporate action on the part of
such party and (iii) this letter has been duly and validly
executed and delivered by such party and constitutes the valid
and binding obligation of such party, enforceable against it in
accordance with its terms. This letter agreement may be executed
by the parties hereto in separate counterparts, each of which
when so executed and delivered shall be an original, but all
such counterparts shall together constitute one and the same
instrument.
[Signature Page Follows]
B-57
L-1 IDENTITY SOLUTIONS OPERATING COMPANY
Name:
Title:
Accepted and Agreed
BAE SYSTEMS INFORMATION SOLUTIONS INC.
Name:
Title:
B-58
[Letterhead]
[Date]
BAE Systems Information Solutions Inc.
[Address]
Attention: [Name]
Re: Assignment of Certain Indemnification Rights
Ladies and Gentlemen:
Reference is made to the Purchase Agreement (as amended,
restated, supplemented or otherwise modified from time to time,
the Purchase Agreement), dated September 19,
2010, by and between BAE Systems Information Solutions Inc.
(Purchaser) and L-1 Identity Solutions, Inc. (the
Company). Capitalized terms used but not otherwise
defined herein shall have the meanings ascribed to such terms in
the Purchase Agreement.
In connection with the Closing, and in accordance with
Section 6.15 of the Purchase Agreement, for good and
valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the Company hereby assigns and transfers to
Purchaser, any and all indemnification rights of the Company
under that certain Agreement and Plan of Merger, dated
June 18, 2007, by and among McClendon, LLC, the Selling
Stockholders signatory thereto, the Company, L-1 Identity
Solutions Operating Company, and the Stockholders Representative.
The Company shall, and shall cause the Subsidiaries of the
Company to, without further consideration, perform such lawful
acts, execute such other lawful documents, and provide to
Purchaser, its successors, assigns and other legal
representatives all other cooperation and assistance as
Purchaser may reasonably request to effectuate fully this letter
agreement.
Each party hereto represents and warrants that (i) it has
the requisite corporate power and authority to execute and
deliver this letter agreement, (ii) the execution, delivery
and performance by such party of this letter agreement has been
duly authorized by all necessary corporate action on the part of
such party and (iii) this letter has been duly and validly
executed and delivered by such party and constitutes the valid
and binding obligation of such party, enforceable against it in
accordance with its terms. This letter agreement may be executed
by the parties hereto in separate counterparts, each of which
when so executed and delivered shall be an original, but all
such counterparts shall together constitute one and the same
instrument.
[Signature Page Follows]
B-59
L-1 IDENTITY SOLUTIONS, INC.
Name:
Title:
Accepted and Agreed
BAE SYSTEMS INFORMATION SOLUTIONS INC.
Name:
Title:
B-60
[Letterhead]
[Date]
BAE Systems Information Solutions Inc.
[Address]
Attention: [Name]
Re: Assignment of Certain Indemnification Rights
Ladies and Gentlemen:
Reference is made to the Purchase Agreement (as amended,
restated, supplemented or otherwise modified from time to time,
the Purchase Agreement), dated September 19,
2010, by and between BAE Systems Information Solutions Inc.
(Purchaser) and L-1 Identity Solutions, Inc. (the
Company). Capitalized terms used but not otherwise
defined herein shall have the meanings ascribed to such terms in
the Purchase Agreement.
In connection with the Closing, and in accordance with
Section 6.15 of the Purchase Agreement, for good and
valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, L-1 Identity Solutions Operating Company
(Operating Company), a wholly owned subsidiary of
the Company, hereby assigns and transfers to Purchaser, any and
all indemnification rights of Operating Company under that
certain Securities Purchase Agreement, dated September 11,
2006, by and among SpecTal, LLC, Operating Company and the
Sellers Representative on behalf of the Members.
Operating Company shall, and shall cause the Subsidiaries of
Operating Company to, without further consideration, perform
such lawful acts, execute such other lawful documents, and
provide to Purchaser, its successors, assigns and other legal
representatives all other cooperation and assistance as
Purchaser may reasonably request to effectuate fully this letter
agreement.
Each party hereto represents and warrants that (i) it has
the requisite corporate power and authority to execute and
deliver this letter agreement, (ii) the execution, delivery
and performance by such party of this letter agreement has been
duly authorized by all necessary corporate action on the part of
such party and (iii) this letter has been duly and validly
executed and delivered by such party and constitutes the valid
and binding obligation of such party, enforceable against it in
accordance with its terms. This letter agreement may be executed
by the parties hereto in separate counterparts, each of which
when so executed and delivered shall be an original, but all
such counterparts shall together constitute one and the same
instrument.
[Signature Page Follows]
B-61
L-1 IDENTITY SOLUTIONS OPERATING COMPANY
Name:
Title:
Accepted and Agreed
BAE SYSTEMS INFORMATION SOLUTIONS INC.
Name:
Title:
B-62
Annex C
200 West
Street New York, New York 10282
Tel: 212-902-1000 Fax: 212-902-3000
PERSONAL
AND CONFIDENTIAL
September 19, 2010
Board of Directors
L-1 Identity Solutions, Inc.
177 Broad Street, 12th Floor
Stamford, CT 06901
Ladies and Gentlemen:
You have requested our opinion as to the fairness from a
financial point of view to the holders (other than Safran SA
(Safran) and its affiliates) of the outstanding
shares of common stock, par value $0.001 per share (the
Shares), of L-1 Identity Solutions, Inc. (the
Company) of the $12.00 per Share in cash (the
Consideration) to be paid to such holders pursuant
to the Agreement and Plan of Merger, dated as of
September 19, 2010 (the Merger Agreement), by
and among Safran, Laser Acquisition Sub, Inc., a wholly owned
subsidiary of Safran, and the Company. The Consideration is
subject to adjustment as set forth in the definition of
Merger Consideration contained in the Merger
Agreement, as to which adjustment we express no opinion. We
understand that, pursuant to the Purchase Agreement, dated as of
September 19, 2010 (the Intel Agreement and,
together with the Merger Agreement, the Agreements),
by and between BAE Systems Information Solutions, Inc.
(BAE) and the Company, prior to the Closing (as
defined in the Merger Agreement), the Company will sell to BAE
all of the issued and outstanding Transferred Shares (as defined
in the Intel Agreement) (the Intel Transaction).
Goldman, Sachs & Co. and its affiliates are engaged in
investment banking and financial advisory services, commercial
banking, securities trading, investment management, principal
investment, financial planning, benefits counseling, risk
management, hedging, financing, brokerage activities and other
financial and non-financial activities and services for various
persons and entities. In the ordinary course of these activities
and services, Goldman, Sachs & Co. and its affiliates
may at any time make or hold long or short positions and
investments, as well as actively trade or effect transactions,
in the equity, debt and other securities (or related derivative
securities) and financial instruments (including bank loans and
other obligations) of the Company, Safran, any of their
respective affiliates or third parties, including BAE and its
affiliates, or any currency or commodity that may be involved in
the transaction contemplated by the Merger Agreement (the
Merger Transaction and, together with the Intel
Transaction, the Transactions) or the Intel
Transaction for their own account and for the accounts of their
customers. We have acted as financial advisor to the Company in
connection with, and have participated in certain of the
negotiations leading to, the Transactions. We expect to receive
fees for our services in connection with the Transactions, the
principal portion of which is contingent upon consummation of
the Merger Transaction, and the Company has agreed to reimburse
our expenses arising, and indemnify us against certain
liabilities that may arise, out of our engagement. We have
provided certain investment banking services to BAE and its
affiliates from time to time for which our Investment Banking
Division has received, and may receive, compensation, including
having acted as joint bookrunning manager with respect to the
private placement of BAEs 4.95% Guaranteed Bonds due June
2014 (aggregate principal amount $500,000,000) and BAEs
6.375% Guaranteed Bonds due June 2019 (aggregate principal
amount $1,000,000,000) in June 2009. We may in the future
provide investment banking services to the Company, Safran, BAE
and their respective affiliates for which our Investment Banking
Division may receive compensation.
In connection with this opinion, we have reviewed, among other
things, the Agreements; annual reports to stockholders and
Annual Reports on
Form 10-K
of the Company for the four years ended December 31, 2009;
certain interim reports to stockholders and Quarterly Reports on
Form 10-Q
of the Company; certain other
C-1
Board of Directors
L-1 Identity Solutions, Inc.
September 19, 2010
Page Two
communications from the Company to its stockholders; certain
publicly available research analyst reports for the Company; and
certain internal financial analyses and forecasts for the
Company prepared by its management, as approved for our use by
the Company (the Forecasts). We have also held
discussions with members of the senior management of the Company
regarding their assessment of the past and current business
operations, financial condition and future prospects of the
Company; reviewed the reported price and trading activity for
the Shares; compared certain financial and stock market
information for the Company with similar information for certain
other companies the securities of which are publicly traded;
reviewed the financial terms of certain recent business
combinations in the defense industry and in other industries;
and performed such other studies and analyses, and considered
such other factors, as we deemed appropriate.
For purposes of rendering this opinion, we have relied upon and
assumed, without assuming any responsibility for independent
verification, the accuracy and completeness of all of the
financial, legal, regulatory, tax, accounting and other
information provided to, discussed with or reviewed by, us; and
we do not assume any responsibility for any such information. In
that regard, we have assumed with your consent that the
Forecasts have been reasonably prepared on a basis reflecting
the best currently available estimates and judgments of the
management of the Company. We have not made an independent
evaluation or appraisal of the assets and liabilities (including
any contingent, derivative or other off-balance-sheet assets and
liabilities) of the Company or any of its subsidiaries and we
have not been furnished with any such evaluation or appraisal.
We have assumed that all governmental, regulatory or other
consents and approvals necessary for the consummation of the
Transactions will be obtained without any adverse effect on the
expected benefits of the Transactions in any way meaningful to
our analysis. We also have assumed that the Transactions will be
consummated on the terms set forth in the Agreements without the
waiver or modification of any term or condition of the
Agreements, the effect of which would be in any way meaningful
to our analysis.
Our opinion does not address the underlying business decision of
the Company to engage in the Transactions, or the relative
merits of the Transactions as compared to any strategic
alternatives that may be available to the Company; nor does it
address any legal, regulatory, tax or accounting matters. This
opinion addresses only the fairness from a financial point of
view, as of the date hereof, to the holders (other than Safran
and its affiliates) of Shares of the Consideration to be paid to
such holders pursuant to the Merger Agreement. We do not express
any view on, and our opinion does not address, any other term or
aspect of the Agreements, the Transactions, or any term or
aspect of any other agreement or instrument contemplated by the
Agreements or entered into or amended in connection with the
Transactions, or the impact thereof on the Company, Safran or
BAE Solutions or the fairness of the Intel Transaction, or the
fairness of the Merger Transaction to, or any consideration
received in connection therewith by, the holders of any other
class of securities, creditors, or other constituencies of the
Company; nor as to the fairness of the amount or nature of any
compensation to be paid or payable to any of the officers,
directors or employees of the Company, or class of such persons,
in connection with the Transactions, whether relative to the
Consideration to be paid to the holders (other than Safran and
its affiliates) of Shares pursuant to the Merger Agreement or
otherwise. We are not expressing any opinion as to the impact of
the Transactions or any transaction entered into in connection
therewith on the solvency or viability of the Company, Safran or
BAE Solutions or the ability of the Company, Safran or BAE
Solutions to pay their respective obligations when they come
due. Our opinion is necessarily based on economic, monetary,
market and other conditions as in effect on, and the information
made available to us as of, the date hereof and we assume no
responsibility for updating, revising or reaffirming this
opinion based on circumstances, developments or events occurring
after the date hereof. Our advisory services and the opinion
expressed herein are provided for the information and assistance
of the Board of Directors of the Company in connection with its
consideration of the Merger Transaction and such opinion does
not constitute a recommendation as to how any holder of Shares
should vote with respect to such Merger Transaction or any other
matter. This opinion has been approved by a fairness committee
of Goldman, Sachs & Co.
C-2
Board of Directors
L-1 Identity Solutions, Inc.
September 19, 2010
Page Three
Based upon and subject to the foregoing, it is our opinion that,
as of the date hereof, the Consideration to be paid to the
holders (other than Safran and its affiliates) of Shares
pursuant to the Merger Agreement is fair from a financial point
of view to such holders.
Very truly yours,
(GOLDMAN, SACHS & CO.)
C-3
Annex
D
September 18, 2010
The Board of Directors
L-1 Identity Solutions, Inc.
177 Broad Street, 12th Floor
Stamford, CT 06901
Ladies and Gentlemen:
We understand that L-1 Identity Solutions, Inc.
(L-1) and Safran SA (Safran) intend to
enter into an Agreement and Plan of Merger to be dated as of
September 19, 2010 (the Merger Agreement),
pursuant to which Laser Acquisition Sub Inc., a wholly owned
subsidiary of Safran, will merge with and into L-1 and L-1 will
become a wholly owned subsidiary of Safran (the
Merger). Pursuant to the Merger Agreement, each of
the issued and outstanding shares of the common stock, par value
$0.001 per share, of L-1 (L-1 Common Stock), subject
to the provisions of, and certain limitations set forth in, the
Merger Agreement, will be converted into the right to receive
$12.00 per share, in cash without interest (the Merger
Consideration). In connection with the Merger Agreement,
Safran will require certain stockholders of L-1 (the
Principal Stockholders) to enter into a Voting and
Support Agreement, to be dated as of September 19, 2010
(the Support Agreement), pursuant to which, among
other things, the Principal Stockholders will agree to vote in
favor of the adoption of the Merger Agreement and to take
certain other actions in furtherance of the Merger, in each case
on the terms and subject to the conditions provided for in the
Support Agreement. In addition, we have been advised that L-1
and BAE Systems Information Solutions Inc. (BAE)
intend to enter into a Purchase Agreement, to be dated as of
September 19, 2010 (the Intel Purchase
Agreement and, together with the Merger Agreement and the
Support Agreement, the Transaction Documentation),
pursuant to which L-1 will cause L-1 Identity Solutions
Operating Company, a wholly owned subsidiary of L-1 (the
Operating Company), to sell to BAE, and BAE will
purchase from Operating Company (the Intel
Transaction and, together with the Merger, the
Transactions), all of the issued and outstanding
membership interests or shares of McClendon, LLC, SpecTal, LLC
and Advanced Concepts, Inc., which together comprise the
Intelligence Services business of L-1 (Intel
Services), for a purchase price of approximately
$295.8 million in cash and approximately $7.2 million
of certain assumed obligations for a total value of
$303.0 million, subject to adjustment to the extent set
forth in the Intel Purchase Agreement (the Intel Purchase
Price). We further understand that (i) the
consummation of the Intel Transaction is expected to occur prior
to the consummation of the Merger, (ii) the consummation of
the Merger is conditioned upon the consummation of the Intel
Transaction and (iii) the cash proceeds from the Intel
Transaction will be applied to the reduction of L-1s
existing indebtedness. You have provided us with a copy of the
Transaction Documentation in substantially final form.
You have asked us to render our opinion as to whether the Merger
Consideration is fair, from a financial point of view, to the
stockholders of L-1.
In the course of performing our reviews and analyses for
rendering this opinion, we have:
|
|
|
reviewed a draft (dated September 17, 2010) of the
Merger Agreement, a draft (dated September 5, 2010) of
the Support Agreement and a draft (dated September 17,
2010) of the Intel Purchase Agreement;
|
|
|
reviewed L-1s Annual Reports to Shareholders and Annual
Reports on
Form 10-K
for the years ended December 31, 2007, 2008 and 2009, its
Quarterly Report on
Form 10-Q
for the periods ended March 31, 2010 and June 30, 2010
and its Current Reports on
Form 8-K
filed since December 31, 2009;
|
Securities Services offered
through Hudson Partners Securities LLC, Member of FINRA,
SIPC
D-1
The Board of Directors
L-1 Identity Solutions, Inc.
September 18, 2010
Page 2
|
|
|
reviewed certain operating and financial information relating to
L-1s business and prospects, including projections for L-1
for the five years ended December 31, 2014, all as prepared
and provided to us by L-1s management;
|
|
|
met with certain members of L-1s senior management to
discuss L-1s business, operations, historical and
projected financial results and future prospects;
|
|
|
reviewed the historical prices, trading multiples and trading
volume of the L-1 Common Stock;
|
|
|
reviewed certain publicly available financial data, stock market
performance data and trading multiples of companies which we
deemed generally comparable to L-1;
|
|
|
reviewed the terms of certain relevant mergers and acquisitions
involving companies which we deemed generally comparable to L-1;
|
|
|
performed discounted cash flow analyses based on the projections
for L-1 furnished to us by L-1; and
|
|
|
conducted such other studies, analyses, inquiries and
investigations as we deemed appropriate.
|
We have relied upon and assumed, without independent
verification, the accuracy and completeness of the financial and
other information provided to or discussed with us by L-1 or
obtained by us from public sources, including, without
limitation, the projections referred to above. With respect to
the projections, we have relied on representations that they
have been reasonably prepared on bases reflecting the best
currently available estimates and judgments of the senior
management of L-1 as to the expected future performance of L-1.
We have not assumed any responsibility for the independent
verification of any such information, including, without
limitation, the projections; we express no view or opinion as to
such projections and the assumptions upon which they are based;
and we have further relied upon the assurances of the senior
management of L-1 that they are unaware of any facts that would
make the information and projections incomplete or misleading.
In arriving at our opinion, we have not performed or obtained
any independent appraisal of the assets or liabilities
(contingent or otherwise) of L-1, nor have we been furnished
with any such appraisals. During the course of our engagement,
we were asked by the Board of Directors to solicit indications
of interest from various third parties regarding a transaction
involving L-1
and/or Intel
Services, and we have considered the results of such
solicitation in rendering our opinion. We have assumed that the
Merger will be consummated in a timely manner and in accordance
with the terms of the Transaction Documentation without any
limitations, restrictions, conditions, amendments or
modifications, regulatory or otherwise, that collectively would
have a material effect on L-1. Moreover, as you are aware, the
credit, financial and stock markets are experiencing unusual
volatility; we express no opinion or view as to the effects of
such volatility on the Merger or the parties thereto. We are not
legal, regulatory, tax or accounting experts and have relied on
the assessments made by L-1 and its advisors with respect to
such issues.
We do not express any opinion as to the price or range of prices
at which the L-1 Common Stock or L-1s
3.75% Convertible Notes due 2027 may trade subsequent
to the announcement of either of the Transactions.
We have acted as a financial advisor to L-1 in connection with
the Merger and the Intel Transaction and will receive customary
fees for such services, a substantial portion of which is
contingent on successful consummation of the Transactions. A
portion of our compensation is payable upon delivery of this
letter and will be credited against the fees payable upon
consummation of the Transactions. In addition, L-1 has agreed to
reimburse us for certain expenses and to indemnify us against
certain liabilities arising out of our engagement.
Stone Key Partners LLC and Hudson Partners Securities LLC
(together, Stone Key) may seek to provide BAE,
Safran and their respective affiliates with certain investment
banking and other services unrelated to the Transactions in the
future.
D-2
The Board of Directors
L-1 Identity Solutions, Inc.
September 18, 2010
Page 3
As you are aware, Michael J. Urfirer and Denis A. Bovin, each a
Co-Chairman and Co-Chief Executive Officer of Stone Key Partners
LLC, hold personal investments, as minority limited partners, in
Aston Capital Partners LP, a private investment fund that owns
8.25% of the outstanding L-1 Common Stock. Aston Capital
Partners LP is controlled by certain of L-1s executive
officers, including Mr. Urfirers wife, Doni L.
Fordyce, L-1s Executive Vice President of Corporate
Communications.
It is understood that this letter is intended for the benefit
and use of the Board of Directors of L-1 in connection with its
consideration of the Merger. This letter and our opinion are not
to be used for any other purpose, or be reproduced,
disseminated, quoted from or referred to at any time, in whole
or in part, without our prior written consent; provided,
however, that this letter may be included in its entirety in
any proxy statement to be distributed to the holders of L-1
Common Stock in connection with the Merger. This letter and our
opinion do not constitute a recommendation to the Board of
Directors of L-1 in connection with the Merger, nor do this
letter and our opinion constitute a recommendation to any
holders of L-1 Common Stock as to how to vote in connection with
the Merger. Our opinion does not address L-1s underlying
business decision to pursue the Transactions, the relative
merits of the Transactions as compared to any alternative
business or financial strategies that might exist for L-1 or the
effects of any other transaction in which L-1 might engage. In
addition, we express no view or opinion with respect to the
merits of the Merger to any holder of L-1 equity relative to any
other holder of L-1 equity or as to the fairness of the Merger,
from a financial point of view, to Safran and its affiliates.
Furthermore, we do not express any view or opinion as to the
fairness, financial or otherwise, of the amount or nature of any
compensation payable to or to be received by any of L-1s
officers, directors or employees, or any class of such persons,
in connection with the Transactions relative to the Merger
Consideration or the Intel Purchase Price.
Our opinion has been authorized for issuance by the Fairness
Opinion and Valuation Committee of Stone Key. Our opinion is
subject to the assumptions, limitations, qualifications and
other conditions contained herein and is necessarily based on
economic, market and other conditions, and the information made
available to us, as of the date hereof. We assume no
responsibility for updating or revising our opinion based on
circumstances or events occurring after the date hereof.
Based on and subject to the foregoing, it is our opinion that,
as of the date hereof, the Merger Consideration is fair, from a
financial point of view, to the stockholders of L-1.
Very truly yours,
STONE KEY PARTNERS LLC
|
|
By: |
/s/ Michael
J. Urfirer
|
Co-Chairman &
Co-Chief Executive Officer
HUDSON PARTNERS SECURITIES LLC
|
|
By: |
/s/ Michael
J. Urfirer
|
Senior Managing Director
D-3
Annex E
SECTION 262
OF THE DELAWARE GENERAL CORPORATION LAW
§
262. Appraisal rights
(a) Any stockholder of a corporation of this State who
holds shares of stock on the date of the making of a demand
pursuant to subsection (d) of this section with respect to
such shares, who continuously holds such shares through the
effective date of the merger or consolidation, who has otherwise
complied with subsection (d) of this section and who has
neither voted in favor of the merger or consolidation nor
consented thereto in writing pursuant to § 228 of this
title shall be entitled to an appraisal by the Court of Chancery
of the fair value of the stockholders shares of stock
under the circumstances described in subsections (b) and
(c) of this section. As used in this section, the word
stockholder means a holder of record of stock in a
corporation; the words stock and share
mean and include what is ordinarily meant by those words; and
the words depository receipt mean a receipt or other
instrument issued by a depository representing an interest in
one or more shares, or fractions thereof, solely of stock of a
corporation, which stock is deposited with the depository.
(b) Appraisal rights shall be available for the shares of
any class or series of stock of a constituent corporation in a
merger or consolidation to be effected pursuant to
§ 251 (other than a merger effected pursuant to
§ 251(g) of this title), § 252,
§ 254, § 255, § 256,
§ 257, § 258, § 263 or
§ 264 of this title:
(1) Provided, however, that no appraisal rights under this
section shall be available for the shares of any class or series
of stock, which stock, or depository receipts in respect
thereof, at the record date fixed to determine the stockholders
entitled to receive notice of the meeting of stockholders to act
upon the agreement of merger or consolidation, were either
(i) listed on a national securities exchange or
(ii) held of record by more than 2,000 holders; and further
provided that no appraisal rights shall be available for any
shares of stock of the constituent corporation surviving a
merger if the merger did not require for its approval the vote
of the stockholders of the surviving corporation as provided in
§ 251(f) of this title.
(2) Notwithstanding paragraph (1) of this subsection,
appraisal rights under this section shall be available for the
shares of any class or series of stock of a constituent
corporation if the holders thereof are required by the terms of
an agreement of merger or consolidation pursuant to
§§ 251, 252, 254, 255, 256, 257, 258, 263 and 264
of this title to accept for such stock anything except:
a. Shares of stock of the corporation surviving or
resulting from such merger or consolidation, or depository
receipts in respect thereof;
b. Shares of stock of any other corporation, or depository
receipts in respect thereof, which shares of stock (or
depository receipts in respect thereof) or depository receipts
at the effective date of the merger or consolidation will be
either listed on a national securities exchange or held of
record by more than 2,000 holders;
c. Cash in lieu of fractional shares or fractional
depository receipts described in the foregoing subparagraphs a.
and b. of this paragraph; or
d. Any combination of the shares of stock, depository
receipts and cash in lieu of fractional shares or fractional
depository receipts described in the foregoing subparagraphs a.,
b. and c. of this paragraph.
(3) In the event all of the stock of a subsidiary Delaware
corporation party to a merger effected under § 253 or
§ 267 of this title is not owned by the parent
immediately prior to the merger, appraisal rights shall be
available for the shares of the subsidiary Delaware corporation.
(c) Any corporation may provide in its certificate of
incorporation that appraisal rights under this section shall be
available for the shares of any class or series of its stock as
a result of an amendment to its certificate of incorporation,
any merger or consolidation in which the corporation is a
constituent corporation or the sale of all or substantially all
of the assets of the corporation. If the certificate of
incorporation contains such a provision, the procedures of this
section, including those set forth in subsections (d) and
(e) of this section, shall apply as nearly as is
practicable.
E-1
(d) Appraisal rights shall be perfected as follows:
(1) If a proposed merger or consolidation for which
appraisal rights are provided under this section is to be
submitted for approval at a meeting of stockholders, the
corporation, not less than 20 days prior to the meeting,
shall notify each of its stockholders who was such on the record
date for notice of such meeting (or such members who received
notice in accordance with § 255(c) of this title) with
respect to shares for which appraisal rights are available
pursuant to subsection (b) or (c) hereof of this
section that appraisal rights are available for any or all of
the shares of the constituent corporations, and shall include in
such notice a copy of this section and, if one of the
constituent corporations is a nonstock corporation, a copy of
§ 114 of this title. Each stockholder electing to
demand the appraisal of such stockholders shares shall
deliver to the corporation, before the taking of the vote on the
merger or consolidation, a written demand for appraisal of such
stockholders shares. Such demand will be sufficient if it
reasonably informs the corporation of the identity of the
stockholder and that the stockholder intends thereby to demand
the appraisal of such stockholders shares. A proxy or vote
against the merger or consolidation shall not constitute such a
demand. A stockholder electing to take such action must do so by
a separate written demand as herein provided. Within
10 days after the effective date of such merger or
consolidation, the surviving or resulting corporation shall
notify each stockholder of each constituent corporation who has
complied with this subsection and has not voted in favor of or
consented to the merger or consolidation of the date that the
merger or consolidation has become effective; or
(2) If the merger or consolidation was approved pursuant to
§ 228, § 253, or § 267 of this
title, then either a constituent corporation before the
effective date of the merger or consolidation or the surviving
or resulting corporation within 10 days thereafter shall
notify each of the holders of any class or series of stock of
such constituent corporation who are entitled to appraisal
rights of the approval of the merger or consolidation and that
appraisal rights are available for any or all shares of such
class or series of stock of such constituent corporation, and
shall include in such notice a copy of this section and, if one
of the constituent corporations is a nonstock corporation, a
copy of § 114 of this title. Such notice may, and, if
given on or after the effective date of the merger or
consolidation, shall, also notify such stockholders of the
effective date of the merger or consolidation. Any stockholder
entitled to appraisal rights may, within 20 days after the
date of mailing of such notice, demand in writing from the
surviving or resulting corporation the appraisal of such
holders shares. Such demand will be sufficient if it
reasonably informs the corporation of the identity of the
stockholder and that the stockholder intends thereby to demand
the appraisal of such holders shares. If such notice did
not notify stockholders of the effective date of the merger or
consolidation, either (i) each such constituent corporation
shall send a second notice before the effective date of the
merger or consolidation notifying each of the holders of any
class or series of stock of such constituent corporation that
are entitled to appraisal rights of the effective date of the
merger or consolidation or (ii) the surviving or resulting
corporation shall send such a second notice to all such holders
on or within 10 days after such effective date; provided,
however, that if such second notice is sent more than
20 days following the sending of the first notice, such
second notice need only be sent to each stockholder who is
entitled to appraisal rights and who has demanded appraisal of
such holders shares in accordance with this subsection. An
affidavit of the secretary or assistant secretary or of the
transfer agent of the corporation that is required to give
either notice that such notice has been given shall, in the
absence of fraud, be prima facie evidence of the facts stated
therein. For purposes of determining the stockholders entitled
to receive either notice, each constituent corporation may fix,
in advance, a record date that shall be not more than
10 days prior to the date the notice is given, provided,
that if the notice is given on or after the effective date of
the merger or consolidation, the record date shall be such
effective date. If no record date is fixed and the notice is
given prior to the effective date, the record date shall be the
close of business on the day next preceding the day on which the
notice is given.
(e) Within 120 days after the effective date of the
merger or consolidation, the surviving or resulting corporation
or any stockholder who has complied with subsections (a)
and (d) of this section hereof and who is otherwise
entitled to appraisal rights, may commence an appraisal
proceeding by filing a petition in the Court of Chancery
demanding a determination of the value of the stock of all such
stockholders. Notwithstanding the foregoing, at any time within
60 days after the effective date of the merger or
consolidation, any stockholder who has not commenced an
appraisal proceeding or joined that proceeding as a named party
shall have the right to
E-2
withdraw such stockholders demand for appraisal and to
accept the terms offered upon the merger or consolidation.
Within 120 days after the effective date of the merger or
consolidation, any stockholder who has complied with the
requirements of subsections (a) and (d) of this
section hereof, upon written request, shall be entitled to
receive from the corporation surviving the merger or resulting
from the consolidation a statement setting forth the aggregate
number of shares not voted in favor of the merger or
consolidation and with respect to which demands for appraisal
have been received and the aggregate number of holders of such
shares. Such written statement shall be mailed to the
stockholder within 10 days after such stockholders
written request for such a statement is received by the
surviving or resulting corporation or within 10 days after
expiration of the period for delivery of demands for appraisal
under subsection (d) of this section hereof, whichever is
later. Notwithstanding subsection (a) of this section, a
person who is the beneficial owner of shares of such stock held
either in a voting trust or by a nominee on behalf of such
person may, in such persons own name, file a petition or
request from the corporation the statement described in this
subsection.
(f) Upon the filing of any such petition by a stockholder,
service of a copy thereof shall be made upon the surviving or
resulting corporation, which shall within 20 days after
such service file in the office of the Register in Chancery in
which the petition was filed a duly verified list containing the
names and addresses of all stockholders who have demanded
payment for their shares and with whom agreements as to the
value of their shares have not been reached by the surviving or
resulting corporation. If the petition shall be filed by the
surviving or resulting corporation, the petition shall be
accompanied by such a duly verified list. The Register in
Chancery, if so ordered by the Court, shall give notice of the
time and place fixed for the hearing of such petition by
registered or certified mail to the surviving or resulting
corporation and to the stockholders shown on the list at the
addresses therein stated. Such notice shall also be given by 1
or more publications at least 1 week before the day of the
hearing, in a newspaper of general circulation published in the
City of Wilmington, Delaware or such publication as the Court
deems advisable. The forms of the notices by mail and by
publication shall be approved by the Court, and the costs
thereof shall be borne by the surviving or resulting corporation.
(g) At the hearing on such petition, the Court shall
determine the stockholders who have complied with this section
and who have become entitled to appraisal rights. The Court may
require the stockholders who have demanded an appraisal for
their shares and who hold stock represented by certificates to
submit their certificates of stock to the Register in Chancery
for notation thereon of the pendency of the appraisal
proceedings; and if any stockholder fails to comply with such
direction, the Court may dismiss the proceedings as to such
stockholder.
(h) After the Court determines the stockholders entitled to
an appraisal, the appraisal proceeding shall be conducted in
accordance with the rules of the Court of Chancery, including
any rules specifically governing appraisal proceedings. Through
such proceeding the Court shall determine the fair value of the
shares exclusive of any element of value arising from the
accomplishment or expectation of the merger or consolidation,
together with interest, if any, to be paid upon the amount
determined to be the fair value. In determining such fair value,
the Court shall take into account all relevant factors. Unless
the Court in its discretion determines otherwise for good cause
shown, interest from the effective date of the merger through
the date of payment of the judgment shall be compounded
quarterly and shall accrue at 5% over the Federal Reserve
discount rate (including any surcharge) as established from time
to time during the period between the effective date of the
merger and the date of payment of the judgment. Upon application
by the surviving or resulting corporation or by any stockholder
entitled to participate in the appraisal proceeding, the Court
may, in its discretion, proceed to trial upon the appraisal
prior to the final determination of the stockholders entitled to
an appraisal. Any stockholder whose name appears on the list
filed by the surviving or resulting corporation pursuant to
subsection (f) of this section and who has submitted such
stockholders certificates of stock to the Register in
Chancery, if such is required, may participate fully in all
proceedings until it is finally determined that such stockholder
is not entitled to appraisal rights under this section.
(i) The Court shall direct the payment of the fair value of
the shares, together with interest, if any, by the surviving or
resulting corporation to the stockholders entitled thereto.
Payment shall be so made to each such stockholder, in the case
of holders of uncertificated stock forthwith, and the case of
holders of shares represented by certificates upon the surrender
to the corporation of the certificates representing such stock.
The Courts decree may be enforced as other decrees in the
Court of Chancery may be enforced, whether such surviving or
resulting corporation be a corporation of this State or of any
state.
E-3
(j) The costs of the proceeding may be determined by the
Court and taxed upon the parties as the Court deems equitable in
the circumstances. Upon application of a stockholder, the Court
may order all or a portion of the expenses incurred by any
stockholder in connection with the appraisal proceeding,
including, without limitation, reasonable attorneys fees
and the fees and expenses of experts, to be charged pro rata
against the value of all the shares entitled to an appraisal.
(k) From and after the effective date of the merger or
consolidation, no stockholder who has demanded appraisal rights
as provided in subsection (d) of this section shall be
entitled to vote such stock for any purpose or to receive
payment of dividends or other distributions on the stock (except
dividends or other distributions payable to stockholders of
record at a date which is prior to the effective date of the
merger or consolidation); provided, however, that if no petition
for an appraisal shall be filed within the time provided in
subsection (e) of this section, or if such stockholder
shall deliver to the surviving or resulting corporation a
written withdrawal of such stockholders demand for an
appraisal and an acceptance of the merger or consolidation,
either within 60 days after the effective date of the
merger or consolidation as provided in subsection (e) of
this section or thereafter with the written approval of the
corporation, then the right of such stockholder to an appraisal
shall cease. Notwithstanding the foregoing, no appraisal
proceeding in the Court of Chancery shall be dismissed as to any
stockholder without the approval of the Court, and such approval
may be conditioned upon such terms as the Court deems just;
provided, however that this provision shall not affect the right
of any stockholder who has not commenced an appraisal proceeding
or joined that proceeding as a named party to withdraw such
stockholders demand for appraisal and to accept the terms
offered upon the merger or consolidation within 60 days
after the effective date of the merger or consolidation, as set
forth in subsection (e) of this section.
(l) The shares of the surviving or resulting corporation to
which the shares of such objecting stockholders would have been
converted had they assented to the merger or consolidation shall
have the status of authorized and unissued shares of the
surviving or resulting corporation. (8 Del. C. 1953,
§ 262; 56 Del. Laws, c. 50; 56 Del. Laws, c. 186,
§ 24; 57 Del. Laws, c. 148,
§§ 27-29;
59 Del. Laws, c. 106, § 12; 60 Del. Laws, c. 371,
§§ 3-12; 63 Del. Laws, c. 25, § 14; 63
Del. Laws, c. 152, §§ 1, 2; 64 Del. Laws, c. 112,
§§ 46-54;
66 Del. Laws, c. 136,
§§ 30-32;
66 Del. Laws, c. 352, § 9; 67 Del. Laws, c. 376,
§§ 19, 20; 68 Del. Laws, c. 337,
§§ 3, 4; 69 Del. Laws, c. 61, § 10; 69
Del. Laws, c. 262, §§ 1-9; 70 Del. Laws, c. 79,
§ 16; 70 Del. Laws, c. 186, § 1; 70 Del.
Laws, c. 299, §§ 2, 3; 70 Del. Laws, c. 349,
§ 22; 71 Del. Laws, c. 120, § 15; 71 Del.
Laws, c. 339,
§§ 49-52;
73 Del. Laws, c. 82, § 21; 76 Del. Laws, c. 145,
§§ 11-16;
77 Del. Laws, c. 14, §§ 12, 13; 77 Del. Laws, c.
253,
§§ 47-50;
77 Del. Laws, c. 290, §§ 16, 17.)
E-4
1 1 12345678 12345678 12345678 12345678 12345678 12345678 12345678 12345678 000000000000 NAME
THE COMPANY NAME INC. COMMON 123,456,789,012.12345 THE COMPANY NAME INC. CLASS A
123,456,789,012.12345 THE COMPANY NAME INC. CLASS B 123,456,789,012.12345 THE COMPANY NAME INC. -
CLASS C 123,456,789,012.12345 THE COMPANY NAME INC. CLASS D 123,456,789,012.12345 THE COMPANY
NAME INC. CLASS E 123,456,789,012.12345 THE COMPANY NAME INC. CLASS F 123,456,789,012.12345 THE
COMPANY NAME INC. 401 K 123,456,789,012.12345 ? x 02 0000000000 JOB # 1 OF 2 1 OF 2 PAGE SHARES
CUSIP # SEQUENCE # THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. KEEP THIS PORTION FOR YOUR
RECORDS DETACH AND RETURN THIS PORTION ONLY TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS
FOLLOWS: Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date CONTROL # SHARES 0 0
0 0 0 0 00000797161 R1.0.0.11033 L-1 IDENTITY SOLUTIONS, INC. 177 BROAD STREET, 12TH FL STAMFORD,
CT 06901 Investor Address Line 1 Investor Address Line 2 Investor Address Line 3 Investor Address
Line 4 Investor Address Line 5 John Sample 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1 Investor
Address Line 1 Investor Address Line 2 Investor Address Line 3 Investor Address Line 4 Investor
Address Line 5 John Sample 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1 VOTE BY INTERNET -
www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery
of information up until 11:59 P.M. Eastern Time the day before the meeting date. Have your proxy
card in hand when you access the web site and follow the instructions to obtain your records and to
create an electronic voting instruction form. VOTE BY PHONE 1-800-690-6903 Use any touch-tone
telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the
meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY
MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have
provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. The
Board of Directors recommends a vote FOR proposals 1 and 2. For Against Abstain 1 Proposal to adopt
the Agreement and Plan of Merger, dated as of September 19, 2010 (as may be amended from time to
time), by and among L-1 Identity Solutions, Inc., a Delaware corporation, Safran SA, a French
société anonyme, and Laser Acquisition Sub Inc., a Delaware corporation and a wholly owned
subsidiary of Safran SA, and to approve the merger contemplated by the merger agreement. 2 Proposal
to adjourn or postpone the special meeting, if necessary or appropriate, to solicit additional
proxies if there are insufficient votes at the time of the special meeting to adopt the merger
agreement and approve the merger. Please sign exactly as your name(s) appear(s) hereon. When
signing as attorney, executor, administrator, or other fiduciary, please give full title as such.
Joint owners should each sign personally. All holders must sign. If a corporation or partnership,
please sign in full corporate or partnership name, by authorized officer. 00000797162 R1.0.0.11033 |
Important Notice Regarding the Availability of Proxy Materials for the Special Meeting: The Notice
& Proxy Statement is/are available at www.proxyvote.com . Proxy Solicited by the Board of Directors
of L-1 Identity Solutions, Inc. for the Special Meeting of Stockholders to be held on February 3,
2011 The undersigned stockholder hereby revokes all previous proxies, acknowledges receipt of the
Notice of Special Meeting of Stockholders to be held on February 3, 2011 and the proxy statement,
and appoints Robert V. LaPenta and Mark S. Molina, and each of them or such other persons as the
Board of Directors of L-1 Identity Solutions, Inc. (the Company) may designate, as attorneys and
proxies, with full power of substitution. The undersigned hereby authorizes the above appointed
proxies to vote all shares of common stock of the Company held of record by the undersigned as of
December 27, 2010 on all matters which may properly come before the Special Meeting of Stockholders
to be held at the Hyatt Regency-Greenwich hotel located at 1800 E Putnam Avenue, Old Greenwich, CT,
on February 3, 2011 at 2:00 p.m. Eastern Time, and any adjournments or postponements thereof. The
proxies shall vote subject to the directions indicated on the reverse side of this card, and
proxies are authorized to vote in their discretion upon other business as may properly come before
the meeting and any adjournments or postponements thereof. The proxies will vote as the Board of
Directors recommends where a choice is not specified. Whether or not you expect to attend the
Special Meeting, please complete, date and sign this proxy and return it prior to the Special
Meeting in the enclosed envelope so that the shares may be represented at the Special Meeting.
Continued and to be signed on reverse side |